PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ng, JL; Luo, LQ				Ng, JL; Luo, LQ			Rho GTPases regulate axon growth through convergent and divergent signaling pathways	NEURON			English	Article							ACTIN-DEPOLYMERIZING FACTOR; ABL TYROSINE KINASE; LIM-KINASE; EXCHANGE FACTOR; FAMILY GTPASES; FACTOR COFILIN; CELL POLARITY; RAC; PHOSPHORYLATION; POLYMERIZATION	Rho GTPases are essential regulators of cytoskeletal reorganization, but how they do so during neuronal morphogenesis in vivo is poorly understood. Here we show that the actin depolymerization factor cofilin is essential for axon growth in Drosophila neurons. Cofilin function in axon growth is inhibited by LIM kinase and activated by Slingshot phosphatase. Dephosphorylating cofilin appears to be the major function of Slingshot in regulating axon growth in vivo. Genetic data provide evidence that Rho or Rac/Cdc42, via effector kinases Rok or Pak, respectively, activate LIM kinase to inhibit axon growth. Importantly, Rac also activates a Pak-independent pathway that promotes axon growth, and different RacGEFs regulate these distinct pathways. These genetic analyses reveal convergent and divergent pathways from Rho GTPases to the cytoskeleton during axon growth in vivo and suggest that different developmental outcomes could be achieved by biases in pathway selection.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Ng, JL (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	julian.ng@kcl.ac.uk; lluo@stanford.edu	Ng, Julian/C-5747-2009	Ng, Julian/0000-0002-1908-4414; Luo, Liqun/0000-0001-5467-9264	NINDS NIH HHS [R01-NS 36632] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fehon RG, 1997, GENETICS, V146, P245; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Mizuno T, 2002, DEVELOPMENT, V129, P1215; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	59	145	155	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					779	793		10.1016/j.neuron.2004.11.014	http://dx.doi.org/10.1016/j.neuron.2004.11.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572110	Bronze			2022-12-28	WOS:000225548400007
J	Cannon, CM; Abdallah, L; Tecott, LH; During, MJ; Palmiter, RD				Cannon, CM; Abdallah, L; Tecott, LH; During, MJ; Palmiter, RD			Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice	NEURON			English	Review							DIAZEPAM-INDUCED HYPERPHAGIA; BETA-ADRENERGIC-RECEPTORS; NEUROPEPTIDE-Y NPY; NUCLEUS-ACCUMBENS; LATERAL HYPOTHALAMUS; FOOD-INTAKE; DEFICIENT MICE; D-2 RECEPTORS; OB/OB MICE; TAIL-PINCH	Amphetamine (AMPH) releases monoamines, transiently stimulates locomotion, and inhibits feeding. Using a genetic approach, we show that mice lacking dopamine (DA-deficient, or DD, mice) are resistant to the hypophagic effects of a moderate dose of AMPH (2 mug/g) but manifest normal AMPH-induced hypophagia after restoration of DA signaling in the caudate putamen by viral gene therapy. By contrast, AMPH-induced hypophagia in response to the same dose of AMPH is not blunted in mice lacking the ability to make norepinephrine and epinephrine (Dbh(-/-)), dopamine D-2 receptors (D2r(-/-)), dopamine D, receptors (D1r(-/-)), serotonin 2C receptors (Htr2c(-/Y)), neuropeptide Y (Npy(-/-)), and in mice with compromised melanocortin signaling (A(y)). We suggest that, at this moderate dose of AMPH, dysregulation of striatal DA is the primary cause of AMPH-induced hypophagia and that regulated striatal dopaminergic signaling may be necessary for normal feeding behaviors.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Auckland	Cannon, CM (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	caesia@u.washington.edu	During, Matthew/AAC-1388-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007278] Funding Source: NIH RePORTER; NIDA NIH HHS [T32 DA 07278] Funding Source: Medline; NIMH NIH HHS [R01 MH61624] Funding Source: Medline; NINDS NIH HHS [5 T32 NS 07332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALNASER HA, 1994, BEHAV PHARMACOL, V5, P210, DOI 10.1097/00008877-199404000-00013; ANTELMAN SM, 1975, SCIENCE, V189, P731, DOI 10.1126/science.1154024; BAILEY CJ, 1990, DIABETES RES CLIN EX, V14, P87; BALOPOLE DC, 1979, PSYCHOPHARMACOLOGY, V64, P121, DOI 10.1007/BF00427356; Banchelli G, 2001, EUR J PHARMACOL, V413, P91, DOI 10.1016/S0014-2999(01)00739-7; BAPTISTA T, 1993, PHARMACOL BIOCHEM BE, V45, P45, DOI 10.1016/0091-3057(93)90083-6; BAUNEZ C, 1995, NEUROSCIENCE, V65, P375, DOI 10.1016/0306-4522(94)00498-T; BITTNER SE, 1981, PHARMACOL BIOCHEM BE, V14, P481, DOI 10.1016/0091-3057(81)90306-3; BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7; BLUNDELL JE, 1980, APPETITE, V1, P151, DOI 10.1016/S0195-6663(80)80019-5; BOOTH DA, 1968, NATURE, V217, P869, DOI 10.1038/217869a0; BORSINI F, 1983, EUR J PHARMACOL, V94, P109, DOI 10.1016/0014-2999(83)90447-8; BRADY JV, 1956, SCIENCE, V123, P1033, DOI 10.1126/science.123.3206.1033; BREESE G R, 1973, Pharmacology Biochemistry and Behavior, V1, P319, DOI 10.1016/0091-3057(73)90124-X; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Cannon CM, 2003, J NEUROSCI, V23, P10827; Cannon CM, 2004, PHYSIOL BEHAV, V81, P741, DOI 10.1016/j.physbeh.2004.04.020; Chen JS, 2001, LANCET, V357, P1883, DOI 10.1016/S0140-6736(00)04986-2; Chen TY, 2001, J BIOMED SCI, V8, P462, DOI 10.1007/BF02256608; Cincotta AH, 1997, LIFE SCI, V61, P951, DOI 10.1016/S0024-3205(97)00599-7; CLARK JM, 1992, PSYCHOPHARMACOLOGY, V109, P331, DOI 10.1007/BF02245881; DOBRZANSKI S, 1979, PSYCHOPHARMACOLOGY, V66, P297, DOI 10.1007/BF00428323; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; DURCAN MJ, 1988, PHARMACOL BIOCHEM BE, V30, P299, DOI 10.1016/0091-3057(88)90458-3; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; FLETCHER PJ, 1990, BRIT J PHARMACOL, V99, P519, DOI 10.1111/j.1476-5381.1990.tb12961.x; FLETCHER PJ, 1991, BRAIN RES, V552, P181, DOI 10.1016/0006-8993(91)90082-7; FRAY PJ, 1983, SCIENCE, V219, P416, DOI 10.1126/science.6849143; GAROSI VL, 1995, EUR J PHARMACOL, V276, P285, DOI 10.1016/0014-2999(95)00087-2; Gautier JF, 1999, AM J CLIN NUTR, V70, P806; GILBERT DB, 1985, BRAIN RES BULL, V15, P385, DOI 10.1016/0361-9230(85)90006-1; GILLARD ER, 1993, BRAIN RES, V628, P128, DOI 10.1016/0006-8993(93)90947-L; GORMAN AL, 1993, PHARMACOL BIOCHEM BE, V45, P1; GRACE AA, 1984, J NEUROSCI, V4, P2877; HANLON EC, 2003, PSYCHOPHARMACOLOGY B; HEFFNER TG, 1977, J PHARMACOL EXP THER, V201, P386; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; HOEBEL BG, 1989, ANN NY ACAD SCI, V575, P171; INOUE K, 1995, PHARMACOL BIOCHEM BE, V50, P153, DOI 10.1016/0091-3057(94)00275-N; Inoue K, 1997, PHARMACOL BIOCHEM BE, V58, P183, DOI 10.1016/S0091-3057(97)00004-X; ITOH T, 1990, PHARMACOL BIOCHEM BE, V35, P391; JOSEPH MH, 1990, J NEUROSCI METH, V34, P143, DOI 10.1016/0165-0270(90)90052-H; JOYCE EM, 1984, PSYCHOPHARMACOLOGY, V83, P363, DOI 10.1007/BF00428546; KAPLAN JM, 1994, NEUROREPORT, V5, P1839, DOI 10.1097/00001756-199409080-00039; Kaur G, 2002, PROG NEURO-PSYCHOPH, V26, P277, DOI 10.1016/S0278-5846(01)00266-4; Kelley AE, 2000, NEUROPSYCHOPHARMACOL, V23, P455, DOI 10.1016/S0893-133X(00)00117-2; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; Kim DS, 2003, P NATL ACAD SCI USA, V100, P1346, DOI 10.1073/pnas.252753799; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P11465, DOI 10.1073/pnas.0402028101; KOLB B, 1975, J COMP PHYSIOL PSYCH, V88, P806, DOI 10.1037/h0076397; KOLB B, 1977, PHYSIOL BEHAV, V19, P93, DOI 10.1016/0031-9384(77)90165-2; KRAEUCHI K, 1985, PHARMACOL BIOCHEM BE, V23, P917, DOI 10.1016/0091-3057(85)90092-9; Kuo DY, 2003, BEHAV BRAIN RES, V147, P149, DOI 10.1016/j.bbr.2003.04.001; Kuo DY, 2002, J BIOMED SCI, V9, P126, DOI 10.1159/000048208; Kuo DY, 2001, LIFE SCI, V70, P243, DOI 10.1016/S0024-3205(01)01401-1; LAZARENO S, 1979, PSYCHOPHARMACOLOGY, V66, P133, DOI 10.1007/BF00427620; LEIBOWITZ SF, 1970, NATURE, V226, P963, DOI 10.1038/226963a0; LEIBOWITZ SF, 1975, BRAIN RES, V84, P160, DOI 10.1016/0006-8993(75)90811-2; LEIBOWITZ SF, 1978, EUR J PHARMACOL, V53, P69, DOI 10.1016/0014-2999(78)90269-8; LEIBOWITZ SF, 1986, APPETITE, V7, P1, DOI 10.1016/S0195-6663(86)80049-6; LEIBOWITZ SF, 1970, P NATL ACAD SCI USA, V67, P1063, DOI 10.1073/pnas.67.2.1063; LEIBOWITZ SF, 1975, BRAIN RES, V98, P529, DOI 10.1016/0006-8993(75)90371-6; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; LI S, 1986, NEUROSCIENCE LETT, V69; LU YB, 1993, BRAIN RES, V617, P120, DOI 10.1016/0006-8993(93)90621-S; Lutz TA, 2001, AM J PHYSIOL-REG I, V280, pR1697, DOI 10.1152/ajpregu.2001.280.6.R1697; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; MARSHALL JF, 1973, BRAIN RES, V55, P229, DOI 10.1016/0006-8993(73)90507-6; Milatovich Athena, 1992, Human Molecular Genetics, V1, P681, DOI 10.1093/hmg/1.9.681; MORLEY JE, 1987, LIFE SCI, V41, P2157, DOI 10.1016/0024-3205(87)90534-0; MORLEY JE, 1982, AM J PHYSIOL, V243, pR159, DOI 10.1152/ajpregu.1982.243.1.R159; NARUSE T, 1991, FUNDAM CLIN PHARM, V5, P677, DOI 10.1111/j.1472-8206.1991.tb00757.x; NEILL DB, 1975, PHARMACOL BIOCHEM BE, V3, P485, DOI 10.1016/0091-3057(75)90060-X; NEILL DB, 1971, J COMP PHYSIOL PSYCH, V76, P327, DOI 10.1037/h0031384; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; NISSBRANDT H, 1994, SYNAPSE, V17, P217, DOI 10.1002/syn.890170402; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Obuchowicz E, 1996, NEUROPEPTIDES, V30, P471, DOI 10.1016/S0143-4179(96)90012-8; Pal G. K., 1993, Indian Journal of Experimental Biology, V31, P750; PAPP M, 1987, BEHAV BRAIN RES, V23, P221, DOI 10.1016/0166-4328(87)90022-2; PARADA M, 1988, PHYSIOL BEHAV, V44, P607, DOI 10.1016/0031-9384(88)90325-3; PARADA MA, 1992, BRAIN RES, V577, P218, DOI 10.1016/0006-8993(92)90277-G; PARADA MA, 1988, PHARMACOL BIOCHEM BE, V30, P917, DOI 10.1016/0091-3057(88)90120-7; PARKER GC, 1991, EXP BRAIN RES, V87, P597; PELLETIER G, 1991, NEUROSCI LETT, V127, P96, DOI 10.1016/0304-3940(91)90903-7; PELLEYMOUNTER MA, 1983, BEHAV NEUROSCI, V97, P810, DOI 10.1037/0735-7044.97.5.810; PHILLIPS AG, 1975, NATURE, V258, P750, DOI 10.1038/258750a0; PHILLIPS G, 1991, PSYCHOPHARMACOLOGY, V104, P125, DOI 10.1007/BF02244566; Rahminiwati M, 1999, J VET MED SCI, V61, P777, DOI 10.1292/jvms.61.777; Rios M, 1999, J NEUROSCI, V19, P3519; Samarghandian S, 2003, NEUROSCIENCE, V116, P519, DOI 10.1016/S0306-4522(02)00712-1; SANGHVI IS, 1975, PHARMACOL BIOCHEM BE, V3, P81, DOI 10.1016/0091-3057(75)90084-2; SCHNEIDER LH, 1989, ANN NY ACAD SCI, V575, P307; Scislowski PWD, 1999, INT J OBESITY, V23, P425, DOI 10.1038/sj.ijo.0800893; Sederholm F, 2002, PSYCHOPHARMACOLOGY, V160, P161, DOI 10.1007/s00213-001-0966-1; Skinner BF, 1937, PSYCHOL REC, V1, P340; SORENSON CA, 1970, EXP NEUROL, V29, P162, DOI 10.1016/0014-4886(70)90047-6; SULZER D, 1995, J NEUROSCI, V15, P4102; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tecott LH, 2003, CNS SPECTRUMS, V8, P578, DOI 10.1017/S109285290001885X; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; VANDERHOEK GA, 1994, PHARMACOL BIOCHEM BE, V48, P135, DOI 10.1016/0091-3057(94)90509-6; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wellman P, 2002, EUR J PHARMACOL, V455, P117, DOI 10.1016/S0014-2999(02)02616-X; WELLMAN PJ, 1990, PHARMACOL BIOCHEM BE, V35, P457, DOI 10.1016/0091-3057(90)90184-J; WHITTIER JR, 1962, NEUROLOGY, V12, P529, DOI 10.1212/WNL.12.8.529; WILLNER P, 1982, PHARMACOL BIOCHEM BE, V17, P255, DOI 10.1016/0091-3057(82)90079-X; WINN P, 1984, NEUROSCIENCE, V12, P225, DOI 10.1016/0306-4522(84)90149-0; WOLGIN DL, 1988, BEHAV NEUROSCI, V102, P312, DOI 10.1037/0735-7044.102.2.312; Yang ZJ, 1997, PHARMACOL BIOCHEM BE, V58, P631, DOI 10.1016/S0091-3057(97)00022-1; YANG ZJ, 1995, NEUROREPORT, V6, P1191, DOI 10.1097/00001756-199505300-00029; Yang ZJ, 1996, AM J PHYSIOL-REG I, V270, pR315, DOI 10.1152/ajpregu.1996.270.2.R315; Zhang M, 2003, BEHAV NEUROSCI, V117, P202, DOI 10.1037/0735-7044.117.2.202; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND MJ, 1972, SCIENCE, V177, P1211	125	35	37	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					509	520		10.1016/j.neuron.2004.10.009	http://dx.doi.org/10.1016/j.neuron.2004.10.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504330	Bronze			2022-12-28	WOS:000224771700012
J	Eden, GF; Jones, KM; Cappell, K; Gareau, L; Wood, FB; Zeffiro, TA; Dietz, NAE; Agnew, JA; Flowers, DL				Eden, GF; Jones, KM; Cappell, K; Gareau, L; Wood, FB; Zeffiro, TA; Dietz, NAE; Agnew, JA; Flowers, DL			Neural changes following remediation in adult developmental dyslexia	NEURON			English	Review							POSTERIOR PARIETAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; READING-DISABILITY; BRAIN ACTIVATION; MOTOR CORTEX; FUNCTIONAL CONNECTIVITY; PHONOLOGICAL AWARENESS; WORD RECOGNITION; AUDITORY-CORTEX	Brain imaging studies have explored the neural mechanisms of recovery in adults following acquired disorders and, more recently, childhood developmental disorders. However, the neural systems underlying adult rehabilitation of neurobiologically based learning disabilities remain unexplored, despite their high incidence. Here we characterize the differences in brain activity during a phonological manipulation task before and after a behavioral intervention in adults with developmental dyslexia. Phonologically targeted training resulted in performance improvements in tutored compared to nontutored dyslexics, and these gains were associated with signal increases in bilateral parietal and right perisylvian cortices. Our findings demonstrate that behavioral changes in tutored dyslexic adults are associated with (1) increased activity in those left-hemisphere regions engaged by normal readers and (2) compensatory activity in the right perisylvian cortex. Hence, behavioral plasticity in adult developmental dyslexia involves two distinct neural mechanisms, each of which has previously been observed either for remediation of developmental or acquired reading disorders.	Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Wake Forest Univ, Med Ctr, Winston Salem, NC 27157 USA	Georgetown University; Wake Forest University	Eden, GF (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd,Bldg D,Suite 150, Washington, DC 20057 USA.	edeng@georgetown.edu	Zeffiro, Thomas/AAE-3441-2019	Zeffiro, Thomas/0000-0002-0846-4577	NCRR NIH HHS [M01-RR13297] Funding Source: Medline; NICHD NIH HHS [HD37890, HD21887, HD40095] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037890, P01HD021887, P50HD040095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR013297] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adair JC, 2000, NEUROPSY NEUROPSY BE, V13, P303; ALEXANDER AW, 1991, ANN DYSLEXIA, V41, P193, DOI 10.1007/BF02648086; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bartolomeo P, 2002, NEUROPSYCHOLOGIA, V40, P1363, DOI 10.1016/S0028-3932(01)00209-3; BELL N, 1997, SYMBOL IMAGERY TEST; Benson NJ, 1997, J EXP CHILD PSYCHOL, V64, P343, DOI 10.1006/jecp.1996.2342; BIRCH JR, 1999, MULTISENSORY TEACHIN; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cramer S C, 1999, Phys Med Rehabil Clin N Am, V10, P875; Cramer Steven C, 2003, Phys Med Rehabil Clin N Am, V14, pS47, DOI 10.1016/S1047-9651(02)00053-0; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DOWHOWER S, 1987, READING RES Q, P389; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eden GF, 1999, MAGN RESON MED, V41, P13, DOI 10.1002/(SICI)1522-2594(199901)41:1<13::AID-MRM4>3.0.CO;2-T; Eden GF, 1998, NEURON, V21, P279, DOI 10.1016/S0896-6273(00)80537-1; Ehri L.C., 1999, READING DEV TEACHING, P79; ELKINGTON PTG, 1992, EYE, V6, P510, DOI 10.1038/eye.1992.108; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; FLOWERS DL, 1991, ARCH NEUROL-CHICAGO, V48, P637, DOI 10.1001/archneur.1991.00530180095023; FLOWERS DL, 1995, DEV ACQUIRED DYSLEXI, P61; Frith U., 1999, DYSLEXIA, V5, P192, DOI [10.1002/(SICI)1099-0909(199912)5:43.0.CO;2-N, DOI 10.1002/(SICI)1099-0909(199912)5:43.0.CO;2-N, DOI 10.1002/(SICI)1099-0909(199912)5:4<192::AID-DYS144>3.0.CO;2-N]; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; INGVAR M, 1993, HUM BRAIN MAPP, P1; Kaas JH, 2002, PROG BRAIN RES, V138, P167, DOI 10.1016/S0079-6123(02)38077-4; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; LINDAMOOD C, 1971, LINDAMOOD AUDITORY C; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; LOVETT MW, 1989, BRAIN LANG, V37, P90, DOI 10.1016/0093-934X(89)90103-X; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; Maughan B, 2003, J ABNORM CHILD PSYCH, V31, P219, DOI 10.1023/A:1022534527021; Meyer MS, 1999, ANN DYSLEXIA, V49, P283, DOI 10.1007/s11881-999-0027-8; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Penhune VB, 2003, NEUROIMAGE, V20, P1215, DOI 10.1016/S1053-8119(03)00373-2; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; PRICE CJ, 1997, HUMAN BRAIN FUNCTION, P301; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Rauschecker JP, 2002, PROG BRAIN RES, V138, P73, DOI 10.1016/S0079-6123(02)38072-5; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Rayner K, 2001, PSYCHOL SCI, P31, DOI 10.1111/1529-1006.00004; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Richards TL, 2000, AM J NEURORADIOL, V21, P916; RICHARDSON E, 1985, DECODING SKILLS TEST; Rijntjes M, 2002, PROG NEUROBIOL, V66, P109, DOI 10.1016/S0301-0082(01)00027-2; ROSNER J, 1971, J LEARN DISABIL, V4, P384, DOI 10.1177/002221947100400706; RUMSEY JM, 1994, ARCH NEUROL-CHICAGO, V51, P27, DOI 10.1001/archneur.1994.00540130037011; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shaywitz SE, 1999, PEDIATRICS, V104, P1351, DOI 10.1542/peds.104.6.1351; Simos PG, 2002, NEUROLOGY, V58, P1203, DOI 10.1212/WNL.58.8.1203; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; Simos PG, 2000, CEREB CORTEX, V10, P809, DOI 10.1093/cercor/10.8.809; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Small SL, 1998, BRAIN LANG, V62, P298, DOI 10.1006/brln.1998.1951; Staudt M, 2002, NEUROIMAGE, V16, P954, DOI 10.1006/nimg.2002.1108; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Swanson HL, 1999, J LEARN DISABIL-US, V32, P504, DOI 10.1177/002221949903200605; Talavage TM, 1999, HUM BRAIN MAPP, V7, P79, DOI 10.1002/(SICI)1097-0193(1999)7:2<79::AID-HBM1>3.0.CO;2-R; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; TORGESEN JK, 1994, J LEARN DISABIL, V27, P276, DOI 10.1177/002221949402700503; Torgesen JK, 2001, J LEARN DISABIL-US, V34, P33, DOI 10.1177/002221940103400104; TRUCH S, 1994, ANN DYSLEXIA, V44, P60, DOI 10.1007/BF02648155; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Turkeltaub PE, 2004, NEURON, V41, P11, DOI 10.1016/S0896-6273(03)00803-1; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Wagner R.K., 1999, COMPREHENSIVE TEST P; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wechsler D., 2007, WASI 2 WECHSLER ABBR; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; WIEDERHOLT JL, 1994, GRAY ORAL READING TE; Wilkinson GS., 2006, WRAT 4 WIDE RANGE AC; Wise BW, 1999, J EXP CHILD PSYCHOL, V72, P271, DOI 10.1006/jecp.1999.2490; Wolf M., 1999, DYSLEXIA INT J THEOR, V5, P1; WOODCOCK RW, 1989, WOODCOCKJOHNSON PSYC; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363	109	199	202	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					411	422		10.1016/j.neuron.2004.10.019	http://dx.doi.org/10.1016/j.neuron.2004.10.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	866KF	15504323	Bronze			2022-12-28	WOS:000224771700005
J	Kim, JE; Liu, BP; Park, JH; Strittmatter, SM				Kim, JE; Liu, BP; Park, JH; Strittmatter, SM			Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE OUTGROWTH; ADULT-RAT; INHIBITOR; PROTEIN; IDENTIFICATION; HEMISECTION; EXPRESSION; OUTCOMES; LIGAND	Axon regeneration after injury to the adult mammalian CNS is limited in part by three inhibitory proteins in CNS myelin: Nogo-A, MAG, and OMgp. All three of these proteins bind to a Nogo-66 receptor (NgR) to inhibit axonal outgrowth in vitro. To explore the necessity of NgR for responses to myelin inhibitors and for restriction of axonal growth in the adult CNS, we generated ngr(-1-) mice. Mice lacking NgR are viable but display hypoactivity and motor impairment. DRG neurons lacking NgR do not bind Nogo-66, and their growth cones are not collapsed by Nogo-66. Recovery of motor function after dorsal hemisection or complete transection of the spinal cord is improved in the ngr(-1-) mice. While corticospinal fibers do not regenerate in mice lacking NgR, regeneration of some raphespinal and rubrospinal fibers does occur. Thus, NgR is partially responsible for limiting the regeneration of certain fiber systems in the adult CNS.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	Kim, Jean Jieun/G-5774-2018; Strittmatter, Stephen/F-5739-2011	Kim, Jean Jieun/0000-0003-4709-262X; Strittmatter, Stephen/0000-0001-8188-3092; Park, James/0000-0002-1377-1707				Antri M, 2002, EUR J NEUROSCI, V16, P467, DOI 10.1046/j.1460-9568.2002.02088.x; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huber AB, 2002, J NEUROSCI, V22, P3553; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Kim JE, 2003, MOL CELL NEUROSCI, V23, P451, DOI 10.1016/S1044-7431(03)00076-9; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Leblond H, 2003, J NEUROSCI, V23, P11411; Li SX, 2003, J NEUROSCI, V23, P4219; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; SARUHASHI Y, 1994, EXP NEUROL, V129, P207, DOI 10.1006/exnr.1994.1162; Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	29	274	301	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					439	451		10.1016/j.neuron.2004.10.015	http://dx.doi.org/10.1016/j.neuron.2004.10.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504325	Bronze			2022-12-28	WOS:000224771700007
J	Zito, K; Knott, G; Shepherd, GMG; Shenolikar, S; Svoboda, K				Zito, K; Knott, G; Shepherd, GMG; Shenolikar, S; Svoboda, K			Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; EXPERIENCE-DEPENDENT PLASTICITY; FILAMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; RAT BARREL CORTEX; DENDRITIC SPINES; IN-VIVO; F-ACTIN; RECEPTOR ACTIVATION; GLUTAMATE RECEPTORS	We explored the relationship between regulation of the spine actin cytoskeleton, spine morphogenesis, and synapse formation by manipulating expression of the actin binding protein Nrbl and its deletion mutants. In pyramidal neurons of cultured rat hippocampal slices, Nrbl is concentrated in dendritic spines by binding to the actin cytoskeleton. Expression of one Nrbl deletion mutant, containing the actin binding domain, dramatically increased the density and length of dendritic spines with synapses. This hyperspinogenesis was accompanied by enhanced actin polymerization and spine motility. Synaptic strengths were reduced to compensate for extra synapses, keeping total synaptic input per neuron constant. Our data support a model in which synapse formation is promoted by actin-powered motility.	Howard Hughes Med Inst, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Duke University	Svoboda, K (corresponding author), Howard Hughes Med Inst, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Shepherd, Gordon/F-2679-2010	Knott, Graham W/0000-0002-2956-9052; Zito, Karen/0000-0002-0799-0460				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Allison DW, 1998, J NEUROSCI, V18, P2423; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hering H, 2003, J NEUROSCI, V23, P11759; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAllister AK, 2000, SCI STKE; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MULY EC, 2004, IN PRESS CORTEX; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stephens DJ, 1999, J BIOL CHEM, V274, P30080, DOI 10.1074/jbc.274.42.30080; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	78	149	154	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					321	334		10.1016/j.neuron.2004.09.022	http://dx.doi.org/10.1016/j.neuron.2004.09.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473970	Bronze			2022-12-28	WOS:000224635800014
J	Zhan, XL; Clemens, JC; Neves, G; Hattori, D; Flanagan, JJ; Hummel, T; Vasconcelos, ML; Chess, A; Zipursky, SL				Zhan, XL; Clemens, JC; Neves, G; Hattori, D; Flanagan, JJ; Hummel, T; Vasconcelos, ML; Chess, A; Zipursky, SL			Analysis of Dscam diversity in regulating axon guidance in Drosophila mushroom bodies	NEURON			English	Article							HOMOPHILIC INTERCELLULAR-ADHESION; GROWTH CONE GUIDANCE; KENYON CELLS; HONEY-BEE; EXPRESSION PATTERNS; ANOPHELES-GAMBIAE; GENE-EXPRESSION; NERVOUS-SYSTEM; FASCICLIN-II; ORGANIZATION	Dscam is an immunoglobulin (Ig) superfamily member that regulates axon guidance and targeting in Drosophila. Alternative splicing potentially generates 38,016 isoforms differing in their extracellular Ig and transmembrane domains. We demonstrate that Dscam mediates the sorting of axons in the developing mushroom body (MB). This correlates with the precise spatiotemporal pattern of Dscam protein expression. We demonstrate that MB neurons express different arrays of Dscam isoforms and that single MB neurons express multiple isoforms. Two different Dscam isoforms differing in their extracellular domains introduced as transgenes into single mutant cells partially rescued the mutant phenotype. Expression of one isoform of Dscam in a cohort of MB neurons induced dominant phenotypes, while expression of a single isoform in a single cell did not. We propose that different extracellular domains of Dscam share a common function and that differences in isoforms expressed on the surface of neighboring axons influence interactions between them.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Munster	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucla.edu	Neves, Guilherme/G-8957-2011	Neves, Guilherme/0000-0001-6463-6997; Zipursky, Stephen/0000-0001-5630-7181; Vasconcelos, Maria Luisa/0000-0001-6248-3667				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brotz TM, 1997, J COMP NEUROL, V383, P42, DOI 10.1002/(SICI)1096-9861(19970623)383:1<42::AID-CNE3>3.0.CO;2-L; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Farris SM, 2001, J COMP NEUROL, V439, P331, DOI 10.1002/cne.1354; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Heisenberg M, 2002, J COMP NEUROL, V450, P1, DOI 10.1002/cne.10326; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KLICKSTEIN LB, 1995, CURRENT PROTOCOLS MO; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Malaterre J, 2002, J COMP NEUROL, V452, P215, DOI 10.1002/cne.10319; NEVES G, 2004, STOCHASTIC YET BIASE; Noveen A, 2000, DEVELOPMENT, V127, P3475; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sinakevitch I, 2001, J COMP NEUROL, V439, P352, DOI 10.1002/cne.1355; Strausfeld NJ, 2000, J COMP NEUROL, V424, P179, DOI 10.1002/1096-9861(20000814)424:1&lt;179::AID-CNE13&gt;3.0.CO;2-K; Strausfeld NJ, 1999, J COMP NEUROL, V409, P603; Strausfeld NJ, 1999, J COMP NEUROL, V409, P626, DOI 10.1002/(SICI)1096-9861(19990712)409:4<626::AID-CNE8>3.0.CO;2-B; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; WOJTOWICZ WM, 2004, IN PRESS CELL, V118; Yagi T, 2003, GENES CELLS, V8, P1, DOI 10.1046/j.1365-2443.2003.00614.x; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; YANG MY, 1995, NEURON, V15, P45; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	61	169	169	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					673	686		10.1016/j.neuron.2004.07.020	http://dx.doi.org/10.1016/j.neuron.2004.07.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339649	Bronze			2022-12-28	WOS:000223691900013
J	Snyder, LH; Lawrence, BM				Snyder, LH; Lawrence, BM			Don't go there	NEURON			English	Editorial Material							SACCADIC EYE-MOVEMENTS; RHESUS-MONKEYS; ATTENTION	Response inhibition, or impulse control, is critical for normal cognitive function. In this issue of Neuron, Hasegawa and colleagues use a spatial nonmatch-to-sample-task to reveal neurons in and around the frontal eye fields that encode where an animal should not look.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Snyder, LH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Snyder, Lawrence H/A-4593-2017					Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	10	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 5	2004	43	3					297	299		10.1016/j.neuron.2004.07.021	http://dx.doi.org/10.1016/j.neuron.2004.07.021			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294137	Bronze			2022-12-28	WOS:000223156900003
J	Balthasar, N; Coppari, R; McMinn, J; Liu, SM; Lee, CE; Tang, V; Kenny, CD; McGovern, RA; Chua, SC; Elmquist, JK; Lowell, BB				Balthasar, N; Coppari, R; McMinn, J; Liu, SM; Lee, CE; Tang, V; Kenny, CD; McGovern, RA; Chua, SC; Elmquist, JK; Lowell, BB			Leptin receptor signaling in is required for normal body POW neurons weight homeostasis	NEURON			English	Article							PROOPIOMELANOCORTIN MESSENGER-RNA; HYPOTHALAMIC NEUROPEPTIDE-Y; DIABETES-OBESITY SYNDROMES; GREEN FLUORESCENT PROTEIN; MELANOCORTIN-4 RECEPTOR; MEDIOBASAL HYPOTHALAMUS; BONE-FORMATION; POMC NEURONS; OB/OB; MICE	Neuroanatomical and electrophysiological studies have shown that hypothalamic POMC neurons are targets of the adipostatic hormone leptin. However, the physiological relevance of leptin signaling in these neurons has not yet been directly tested. Here, using the Cre/ IoxP system, we critically test the functional importance of leptin action on POMC neurons by deleting leptin receptors specifically from these cells in mice. Mice lacking leptin signaling in POMC neurons are mildly obese, hyperleptinemic, and have altered expression of hypothalamic neuropeptides. In summary, leptin receptors on POMC neurons are required but not solely responsible for leptin's regulation of body weight homeostasis.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Columbia University	Lowell, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Endocrinol, 99 Brookline Ave RN, Boston, MA 02215 USA.	jelmquis@bidmc.harvard.edu; blowell@bidmc.harvard.edu	Coppari, Roberto/B-4799-2014	COPPARI, Roberto/0000-0003-1288-6948	NIDDK NIH HHS [DK53301, DK57621, DK26687, P01 DK56116] Funding Source: Medline; NIMH NIH HHS [MH61583] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, R37DK053301, R01DK057621, P30DK026687, R01DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bergen HT, 1998, ENDOCRINOLOGY, V139, P4483, DOI 10.1210/en.139.11.4483; BJORKHOLM JE, 1998, INTEL TECHNOL J Q, V3, P1; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; BRONSTEIN DM, 1992, BRAIN RES, V587, P269, DOI 10.1016/0006-8993(92)91007-2; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CATZEFLIS C, 1993, ENDOCRINOLOGY, V132, P224, DOI 10.1210/en.132.1.224; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; COLEMAN DL, 1982, DIABETES, V31, P1; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; HOGAN B, 1986, MANIPULATING MOUSE E; Hohmann JG, 2000, AM J PHYSIOL-REG I, V278, pR50, DOI 10.1152/ajpregu.2000.278.1.R50; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; MEISTER B, 1989, EXP BRAIN RES, V76, P343; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RICHTER WO, 1987, NEUROPEPTIDES, V9, P59, DOI 10.1016/0143-4179(87)90033-3; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	55	687	695	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					983	991		10.1016/j.neuron.2004.06.004	http://dx.doi.org/10.1016/j.neuron.2004.06.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207242	Bronze			2022-12-28	WOS:000222329300013
J	van den Pol, AN; Acuna-Goycolea, C; Clark, KR; Ghosh, PK				van den Pol, AN; Acuna-Goycolea, C; Clark, KR; Ghosh, PK			Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection	NEURON			English	Article							MELANIN-CONCENTRATING-HORMONE; GREEN FLUORESCENT PROTEIN; RAT LATERAL HYPOTHALAMUS; HYPOCRETIN-OREXIN; NEUROPEPTIDE-Y; FEEDING-BEHAVIOR; ARCUATE NUCLEUS; TRANSGENIC MICE; ENERGY-BALANCE; IN-VITRO	Neurons that synthesize melanin-concentrating hormone (MCH) may modulate arousal and energy homeostasis. The scattered MCH neurons have been difficult to study, as they have no defining morphological characteristics. We have developed a viral approach with AAV for selective long-term reporter gene (GFP) expression in MCH neurons, allowing the study of their cellular physiology in hypothalamic slices. MCH neurons showed distinct membrane properties compared to other neurons infected with the same virus with a cytomegalovirus promoter. Transmitters of extrahypothalamic arousal systems, including norepinephrine, serotonin, and the acetylcholine agonist muscarine, evoked direct inhibitory actions. Orexigenic neuropeptide Y was inhibitory by pre- and postsynaptic mechanisms; an anorexigenic melanocortin agonist had no effect. In contrast, the hypothalamic arousal peptide hypocretin/orexin evoked a direct inward current and increased excitatory synaptic activity and spike frequency in the normally silent MCH neurons. Together, these data support the view that MCH neurons may integrate information within the arousal system in favor of energy conservation.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; Ohio State Univ, Columbus Childrens Res Inst, Columbus, OH 43205 USA	Yale University; University System of Ohio; Ohio State University	van den Pol, AN (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	anthony.vandenpol@yale.edu	Clark, Kelly/E-2900-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041454, R01NS037788] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48854] Funding Source: Medline; NINDS NIH HHS [NS41454, NS37788] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Broberger C, 1998, J COMP NEUROL, V402, P460; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; During MJ, 1996, CLIN NEUROSCI, V3, P292; Eggermann E, 2003, J NEUROSCI, V23, P1557; Ehlers CL, 1997, NEUROPSYCHOPHARMACOL, V17, P34; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gao XB, 2003, J NEUROPHYSIOL, V90, P3978, DOI 10.1152/jn.00593.2003; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; Guan JL, 2002, INT J OBESITY, V26, P1523, DOI 10.1038/sj.ijo.0802155; Huang QL, 1999, NEUROENDOCRINOLOGY, V69, P145, DOI 10.1159/000054413; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Liu RJ, 2002, J NEUROSCI, V22, P9453; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mochizuki T, 2003, CURR BIOL, V13, pR563, DOI 10.1016/S0960-9822(03)00474-3; Naveilhan P, 2001, EUR J NEUROSCI, V13, P2241, DOI 10.1046/j.0953-816x.2001.01601.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rhim H, 1997, J NEUROSCI, V17, P2980; ROLLS ET, 1972, J COMP PHYSIOL PSYCH, V81, P173, DOI 10.1037/h0033527; ROLLS ET, 1984, INT J OBESITY, V8, P139; Rosin DL, 2003, J COMP NEUROL, V465, P593, DOI 10.1002/cne.10860; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samulski RJ, 2000, NAT BIOTECHNOL, V18, P497, DOI 10.1038/75352; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schwartz MW, 2002, NAT MED, V8, P779, DOI 10.1038/nm0802-779; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; THOMPSON RC, 1990, DNA CELL BIOL, V9, P637, DOI 10.1089/dna.1990.9.637; Torrealba F, 2003, NEUROSCIENCE, V119, P1033, DOI 10.1016/S0306-4522(03)00238-0; VALENSTE.ES, 1966, AM J PHYSIOL, V210, P270, DOI 10.1152/ajplegacy.1966.210.2.270; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; van den Pol AN, 1998, J NEUROSCI, V18, P10640; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; van den Pol AN, 1998, J NEUROSCI, V18, P7962; van den Pol AN, 1999, J NEUROSCI, V19, P3171; vandenPol AN, 1996, J NEUROSCI, V16, P5883; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	56	165	169	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 27	2004	42	4					635	652		10.1016/S0896-6273(04)00251-X	http://dx.doi.org/10.1016/S0896-6273(04)00251-X			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157424	Bronze			2022-12-28	WOS:000221708300013
J	Andermann, ML; Ritt, J; Neimark, MA; Moore, CI				Andermann, ML; Ritt, J; Neimark, MA; Moore, CI			Neural correlates of vibrissa resonance: Band-pass and somatotopic representation of high-frequency stimuli	NEURON			English	Article							ROUGHNESS DISCRIMINATION; AUDITORY-CORTEX; SENSORY SIGNALS; NEURONS; AFFERENTS; ORGANIZATION; RATS; INTERNEURONS; INFORMATION; INTEGRATION	The array of vibrissae on a rat's face is the first stage of a high-resolution tactile sensing system. Recently, it was discovered that vibrissae (whiskers) resonate when stimulated at specific frequencies, generating several-fold increases in motion amplitude. We investigated the neural correlates of vibrissa resonance in trigeminal ganglion and primary somatosensory cortex (SI) neurons (regular and fast spiking units) by presenting low-amplitude, high-frequency vibrissa stimulation. We found that somatosensory neurons showed band-pass tuning and enhanced sensitivity to small amplitude stimuli, reflecting the resonance amplification of vibrissa motion. Further, a putative somatotopic map of frequency selectivity was observed in SI, with isofrequency columns extending along the representations of arcs of vibrissae, in agreement with the gradient in vibrissa resonance across the vibrissa pad. These findings suggest several parallels between frequency processing in the vibrissa system and the auditory system and have important implications for detection and discrimination of tactile information.	MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Program Biophys, Cambridge, MA 02115 USA; Massachusetts Gen Hosp, Martinos Ctr, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cim@ai.mit.edu	Moore, Christopher/C-5588-2009	Moore, Christopher/0000-0003-4534-1602	NINDS NIH HHS [1R01 NS 45130-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bermejo R, 1998, J NEUROSCI METH, V83, P89, DOI 10.1016/S0165-0270(98)00050-8; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; Bruno RM, 2002, J NEUROSCI, V22, P10966; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; Deschenes M, 2003, J NEUROSCI, V23, P6778; DIAMOND ME, 1995, SOMATOSENSORY THALAM, V11; GEISLER C, 1998, SOUDN SYNAPSE; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; GIBSON JM, 1983, SOMATOSENS RES, V1, P95, DOI 10.3109/07367228309144543; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; KONDOH Y, 1991, J COMP PHYSIOL A, V169, P653; LANDAU L, 1975, THEORY ELASTICITY, V9; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; LINDEN SH, 2003, J NEUROPHYSIOL, V91, P223; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 2004, J NEUROPHYSIOL, V91, P2390, DOI 10.1152/jn.00925.2003; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Neimark MA, 2003, J NEUROSCI, V23, P6499; NEIMARK MA, 2001, MECH MODE VIBRISSAE; Oshinsky ML, 2002, J NEUROSCI, V22, P7254; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; PLUMMER MR, 1981, J COMP PHYSIOL, V142, P347, DOI 10.1007/BF00605447; Roddey JC, 1996, J NEUROPHYSIOL, V75, P1365, DOI 10.1152/jn.1996.75.4.1365; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; Shimegi S, 1999, J NEUROSCI, V19, P10164; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; VONBEKESY G, 1947, J ACOUST SOC AM, V19, P452; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; YOHRO T, 1977, J MORPHOL, V153, P333, DOI 10.1002/jmor.1051530211; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	51	100	100	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					451	463		10.1016/S0896-6273(04)00198-9	http://dx.doi.org/10.1016/S0896-6273(04)00198-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134641	Bronze			2022-12-28	WOS:000221458700011
J	Zheng, J; Zagotta, WN				Zheng, J; Zagotta, WN			Stoichiometry and assembly of olfactory cyclic nucleotide-gated channels	NEURON			English	Article							SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; POTASSIUM CHANNELS; ACTIVATED CHANNEL; STRUCTURAL BASIS; CATION CHANNEL; MODULATION; CA2+-CALMODULIN; RECEPTOR; PROTEIN	Native ion channels are precisely tuned to their physiological role in neuronal signaling. This tuning frequently involves the controlled assembly of heteromeric channels comprising multiple types of subunits. Cyclic nucleotide-gated (CNG) channels of olfactory neurons are tetramers and require three types of subunits, CNGA2, CNGA4, and CNGB1b, to exhibit properties necessary for olfactory transduction. Using fluorescently tagged subunits and fluorescence resonance energy transfer (FRET), we find the subunit composition of heteromeric olfactory channels in the surface membrane is fixed, with 2:11:11 CNGA2: CNGA4:CNGB1b. Furthermore, when expressed individually with CNGA2, CNGA4 and CNGB1b subunits were still present in only a single copy and, when expressed alone, did not self-assemble. These results suggest that the precise assembly of heteromeric olfactory channels results from a mechanism where CNGA4 and CNGB1b subunits have a high affinity for CNGA2 but not for self-assembly, precluding more than one CNGA4 or CNGB1b subunit in the channel complex.	Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, POB 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu			NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [EY 10329, R01 EY010329, R01 EY010329-11] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BROWN RL, 1995, BIOCHEMISTRY-US, V34, P8365, DOI 10.1021/bi00026a018; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Finn JT, 1998, BIOPHYS J, V74, P1333, DOI 10.1016/S0006-3495(98)77846-4; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Shapiro MS, 2000, BIOPHYS J, V78, P2307, DOI 10.1016/S0006-3495(00)76777-4; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2003, J NEUROSCI, V23, P8167; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; ZHENG J, 2003, SCI STKE, pPL7; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100; Zhou L, 2002, BIOPHYS J, V82, p183A; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	50	131	143	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					411	421		10.1016/S0896-6273(04)00253-3	http://dx.doi.org/10.1016/S0896-6273(04)00253-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134638	Bronze			2022-12-28	WOS:000221458700008
J	Hummel, T; Zipursky, L				Hummel, T; Zipursky, L			Afferent induction of olfactory glomeruli requires N-cadherin	NEURON			English	Article							DROSOPHILA VISUAL-SYSTEM; ANTENNAL LOBE; WIRING SPECIFICITY; ODORANT RECEPTORS; MANDUCA-SEXTA; AXON GUIDANCE; SENSORY AXONS; NEURONS; BULB; MAP	Drosophila olfactory receptor neurons (ORNs) elaborate a precise internal representation of the external olfactory world in the antennal lobe (AL), a structure analagous to the vertebrate olfactory bulb. ORNs expressing the same odorant receptor innervate common targets in a highly organized neuropilar structure inside the AL, the glomerulus. During normal development, ORNs target to specific regions of the AL and segregate into subclass-specific aggregates called protoglomeruli prior to extensive intermingling with target dendrites to form mature glomeruli. Using a panel of ORN subclass-specific markers, we demonstrate that in the adult AL, N-cadherin (N-cad) mutant ORN terminals remain segregated from dendrites of target neurons. N-cad plays a crucial role in protoglomerulus formation but is largely dispensible for targeting to the appropriate region of the AL. We propose that N-cad, a homophilic cell adhesion molecule, acts in a permissive fashion to promote subclass-specific sorting of ORN axon terminals into protoglomeruli.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Inst Mol Biol,Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Munster	Zipursky, L (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Inst Mol Biol,Geffen Sch Med, Box 951662, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucia.edu		Zipursky, Stephen/0000-0001-5630-7181				Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Brunjes Peter C., 2003, Neuron, V38, P371, DOI 10.1016/S0896-6273(03)00263-0; Chess A, 2000, CURR BIOL, V10, pR152, DOI 10.1016/S0960-9822(00)00329-8; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Elmore T, 2003, J NEUROSCI, V23, P9906; Elmore T, 2001, INSECT BIOCHEM MOLEC, V31, P791, DOI 10.1016/S0965-1748(00)00184-3; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; GOHEEN BL, 1995, J COMP NEUROL, V352, P203, DOI 10.1002/cne.903520204; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; GRAZIADEI PPC, 1986, NEUROSCIENCE, V19, P1025, DOI 10.1016/0306-4522(86)90119-3; GRAZIADEI PPC, 1980, BRAIN RES, V201, P39, DOI 10.1016/0006-8993(80)90773-8; Hellman A, 2002, CURR BIOL, V12, pR849, DOI 10.1016/S0960-9822(02)01351-9; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2002, DEVELOPMENT, V129, P1251; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kent KS, 1999, J NEUROBIOL, V40, P28, DOI 10.1002/(SICI)1097-4695(199907)40:1<28::AID-NEU3>3.0.CO;2-E; Klenoff JR, 1998, J COMP NEUROL, V390, P256; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin DM, 1999, CURR OPIN NEUROBIOL, V9, P74, DOI 10.1016/S0959-4388(99)80009-9; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Newsome TP, 2000, DEVELOPMENT, V127, P851; OLAND LA, 1990, J NEUROSCI, V10, P2096; Oland LA, 1996, J NEUROBIOL, V30, P92; Oland LA, 1998, J NEUROBIOL, V36, P41, DOI 10.1002/(SICI)1097-4695(199807)36:1<41::AID-NEU4>3.0.CO;2-A; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rossler W, 1999, J NEUROBIOL, V38, P521, DOI 10.1002/(SICI)1097-4695(199903)38:4<521::AID-NEU8>3.0.CO;2-9; Royal SJ, 2002, BRAIN RES, V932, P1, DOI 10.1016/S0006-8993(01)03384-4; Royal SJ, 1999, J NEUROSCI, V19, P9856; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STORTKUHL KF, 1994, CELL TISSUE RES, V275, P27, DOI 10.1007/BF00305373; Stowers RS, 1999, GENETICS, V152, P1631; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; SULLIVAN SL, 1995, CURR OPIN GENET DEV, V5, P516, DOI 10.1016/0959-437X(95)90057-N; TOLBERT LP, 1990, J COMP NEUROL, V298, P69, DOI 10.1002/cne.902980106; Treloar HB, 1999, J COMP NEUROL, V413, P289; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	64	80	81	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					77	88		10.1016/S0896-6273(04)00158-8	http://dx.doi.org/10.1016/S0896-6273(04)00158-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066266	Bronze			2022-12-28	WOS:000221458400009
J	Lebrand, C; Dent, EW; Strasser, GA; Lanier, LM; Krause, M; Svitkina, TM; Borisy, GG; Gertler, FB				Lebrand, C; Dent, EW; Strasser, GA; Lanier, LM; Krause, M; Svitkina, TM; Borisy, GG; Gertler, FB			Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1	NEURON			English	Article							GROWTH CONE MOTILITY; STIMULATED PHOSPHOPROTEIN VASP; ACTIN-BASED MOTILITY; ABL TYROSINE KINASE; NERVE GROWTH; AXON GUIDANCE; BINDING; SUBSTRATE; FILAMENTS; DYNAMICS	Ena/VASP proteins play important roles in axon outgrowth and guidance. Ena/VASP activity regulates the assembly and geometry of actin networks within fibroblast lamellipodia. In growth cones, Ena/VASP proteins are concentrated at filopodia tips, yet their role in growth cone responses to guidance signals has not been established. We found that Ena/VASP proteins play a pivotal role in formation and elongation of filopodia along neurite shafts and growth cone. Netrin-1-induced filopodia formation was dependent upon Ena/VASP function and directly correlated with Ena/VASP phosphorylation at a regulatory PKA site. Accordingly, Ena/VASP function was required for filopodial formation from the growth cone in response to global PKA activation. We propose that Ena/VASP proteins control filopodial dynamics in neurons by remodeling the actin network in response to guidance cues.	MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Northwestern University	Gertler, FB (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	fgertier@mit.edu	Dent, Erik/L-6208-2019; Lebrand, Cecile/G-1394-2015; Krause, Matthias/D-9814-2013	Dent, Erik/0000-0001-8525-7136; Lebrand, Cecile/0000-0002-2750-3164; Krause, Matthias/0000-0002-3200-3199; Borisy, Gary/0000-0002-0266-8018	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062431, U54GM064346, R01GM068678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS045366] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM64346, GM62431, GM68678] Funding Source: Medline; NINDS NIH HHS [NS45366] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; CONG H, 2001, NAT CELL BIOL, V3, pE81; DAVENPORT RW, 1992, NEURON, V9, P405, DOI 10.1016/0896-6273(92)90179-H; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 2003, METHOD ENZYMOL, V361, P390; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dingwell KS, 2000, J NEUROBIOL, V44, P246; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Grevengoed EE, 2003, J CELL BIOL, V163, P1267, DOI 10.1083/jcb.200307026; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mason CA, 1997, J NEUROSCI, V17, P1086; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; Niebuhr K, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P398; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OKABE S, 1991, J NEUROSCI, V11, P1918; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zheng JQ, 1996, J NEUROSCI, V16, P1140	67	244	251	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					37	49		10.1016/S0896-6273(04)00108-4	http://dx.doi.org/10.1016/S0896-6273(04)00108-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066263	Bronze, Green Published			2022-12-28	WOS:000221458400006
J	Merabet, L; Thut, G; Murray, B; Andrews, J; Hsiao, S; Pascual-Leone, A				Merabet, L; Thut, G; Murray, B; Andrews, J; Hsiao, S; Pascual-Leone, A			Feeling by sight or seeing by touch?	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; HUMAN VISUAL-CORTEX; BLIND; DISCRIMINATION; ACTIVATION; LIP	We have addressed the role of occipital and somatosensory cortex in a tactile discrimination task. Sighted and congenitally blind subjects rated the roughness and distance spacing for a series of raised dot patterns. When judging roughness, intermediate dot spacings were perceived as being the most rough, while distance judgments generated a linear relation. Low-frequency rTMS applied to somatosensory cortex disrupted roughness without affecting distance judgments, while rTMS to occipital cortex disrupted distance but not roughness judgments. We also tested an early blind patient with bilateral occipital cortex damage. Her performance on the roughness determination task was normal; however, she was greatly impaired with distance judgments. The findings suggest a double-dissociation effect in which roughness and distance are primarily processed in somatosensory and occipital cortex, respectively. The differential effect of rTMS on task performance and corroborative clinical evidence suggest that occipital cortex is engaged in tactile tasks requiring fine spatial discrimination.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat, Boston, MA 02215 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University	Pascual-Leone, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat, 330 Brookline Ave, Boston, MA 02215 USA.	apleone@caregroup.harvard.edu	merabet, lotfi/AAU-8259-2020; Merabet, Lotfi B./V-2735-2017; Thut, Gregor/A-4374-2009; Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Murray, Brian/E-6786-2016	merabet, lotfi/0000-0002-8094-9536; Merabet, Lotfi B./0000-0002-8094-9536; Pascual-Leone, Alvaro/0000-0001-8975-0382; Murray, Brian/0000-0001-5085-0909; Thut, Gregor/0000-0003-1313-4262	NINDS NIH HHS [R01 NS034086-08, R01 NS034086-09, P01 NS038034-030003] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034086, P01NS038034] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Dinse H. R., 2002, CORTICAL AREAS UNITY, P273; Guest S, 2003, EXP BRAIN RES, V150, P201, DOI 10.1007/s00221-003-1404-x; Hamilton R, 2000, NEUROREPORT, V11, P237, DOI 10.1097/00001756-200002070-00003; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Knecht S, 2003, BIOL PSYCHIAT, V53, P175, DOI 10.1016/S0006322302013823; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Meftah EM, 2002, J NEUROPHYSIOL, V88, P3133, DOI 10.1152/jn.00121.2002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Paus T, 1997, J NEUROSCI, V17, P3178; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 1996, NEUROLOGY, V46, P1464, DOI 10.1212/WNL.46.5.1464; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Schiff William, 1982, TACTUAL PERCEPTION S, P130; Stein BE., 1993, MERGING SENSES; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	31	127	132	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					173	179		10.1016/S0896-6273(04)00147-3	http://dx.doi.org/10.1016/S0896-6273(04)00147-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066274	Bronze			2022-12-28	WOS:000221458400017
J	Bai, JH; Wang, CT; Richards, DA; Jackson, MB; Chapman, ER				Bai, JH; Wang, CT; Richards, DA; Jackson, MB; Chapman, ER			Fusion pore dynamics are regulated by synaptotagmin center dot t-SNARE interactions	NEURON			English	Article							MEMBRANE-PENETRATION ACTIVITY; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; PLASMA-MEMBRANE; CA2+ BINDING; C2B DOMAIN; CRYSTAL-STRUCTURE; CALCIUM SENSOR	Exocytosis involves the formation of a fusion pore that connects the lumen of secretory vesicles with the extracellular space. Exocytosis from neurons and neuroendocrine cells is tightly regulated by intracellular [Ca2+] and occurs rapidly, but the molecular events that mediate the opening and subsequent dilation of fusion pores remain to be determined. A putative Ca2+ sensor for release, synaptotagmin l (syt), binds directly to syntaxin and SNAP-25, which are components of a conserved membrane fusion complex. Here, we show that Ca2+-triggered syt.SNAP-25 interactions occur rapidly. The tandem C2 domains of syt cooperate to mediate binding to syntaxin/SNAP-25; lengthening the linker that connects C2A and C2B selectively disrupts this interaction. Expression of the linker mutants in PC12 cells results in graded reductions in the stability of fusion pores. Thus, the final step of Call-triggered exocytosis is regulated, at least in part, by direct contacts between syt and SNAP-25/syntaxin.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	chapman@physiology.wise.edu	Wang, Chih-Tien/GRE-8232-2022	Wang, Chih-Tien/0000-0001-7639-7508; Richards, David/0000-0001-6154-7112; Chapman, Edwin/0000-0001-9787-8140	NIGMS NIH HHS [GM 56827] Funding Source: Medline; NIMH NIH HHS [MH61876] Funding Source: Medline; NINDS NIH HHS [NS30016, NS44057] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R37NS030016, R01NS044057] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; Chow Robert H., 1995, P245; Colliver TL, 2000, J NEUROCHEM, V74, P1086; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Katz B., 1969, RELEASE NEURAL TRANS; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; RICKMAN C, 2004, IN PRESS J BIOL CHEM; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	60	158	167	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					929	942		10.1016/S0896-6273(04)00117-5	http://dx.doi.org/10.1016/S0896-6273(04)00117-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046725	Bronze			2022-12-28	WOS:000221458300012
J	Sampath, AP; Rieke, F				Sampath, AP; Rieke, F			Selective transmission of single photon responses by saturation at the rod-to-rod bipolar synapse	NEURON			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; TRANSMITTER CONCENTRATION; ACTIVATION KINETICS; FLASH RESPONSES; NMDA RECEPTORS; BINDING-SITES; DARK NOISE; G-PROTEIN; CELLS; RETINA	A threshold-like nonlinearity in signal transfer from mouse rod photoreceptors to rod bipolar cells dramatically improves the absolute sensitivity of the rod signals. The work described here reaches three conclusions about the mechanisms generating this nonlinearity. (1) The nonlinearity is caused primarily by saturation of the feedforward rod-to-rod bipolar synapse and not by feedback from horizontal or amacrine cells. This saturation renders the rod bipolar current insensitive to small changes in transmitter release from the rod. (2) Saturation occurs within the G protein cascade that couples receptors to channels in the rod bipolar dendrites, with little or no contribution from presynaptic mechanisms or saturation of the postsynaptic receptors. (3) Between 0.5 and 2 bipolar transduction channels are open in darkness at each synapse, compared to the approximately 30 channels open at the peak of the single photon response.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	rieke@u.washington.edu			NATIONAL EYE INSTITUTE [F32EY014784, R01EY011850] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11850, EY-14784] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; BORSELLI.A, 1968, J PHYSIOL-LONDON, V196, P507, DOI 10.1113/jphysiol.1968.sp008521; Bowie D, 1998, J NEUROSCI, V18, P8175; Clements JD, 1998, J NEUROSCI, V18, P119; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; DEVRIES H, 1961, PRINCIPLES SENSORY C, P159; DOWLING JE, 1973, NATURE, V242, P101, DOI 10.1038/242101a0; EDWARDS FR, 1976, J PHYSIOL-LONDON, V259, P665, DOI 10.1113/jphysiol.1976.sp011488; FALK G, 1972, HDB SENSORY PHYSL, V1, P200; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; GrayKeller MP, 1996, NEURON, V17, P323, DOI 10.1016/S0896-6273(00)80163-4; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Higgs MH, 2002, VISUAL NEUROSCI, V19, P275, DOI 10.1017/S0952523802192054; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; Johnson BG, 1999, NEUROPHARMACOLOGY, V38, P1519, DOI 10.1016/S0028-3908(99)00053-2; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; LAMB TD, 1988, J PHYSIOL-LONDON, V407, P463, DOI 10.1113/jphysiol.1988.sp017426; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nawy S, 2000, J NEUROSCI, V20, P4471, DOI 10.1523/JNEUROSCI.20-12-04471.2000; Nawy S, 1999, J NEUROSCI, V19, P2938; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Poncer JC, 1996, NEUROPHARMACOLOGY, V35, P1169, DOI 10.1016/S0028-3908(96)00055-X; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Shiells RA, 2002, J PHYSIOL-LONDON, V542, P211, DOI 10.1113/jphysiol.2002.019752; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; Shiells RA, 1999, J PHYSIOL-LONDON, V514, P343, DOI 10.1111/j.1469-7793.1999.343ae.x; SJOSTRAND FS, 1953, J CELL COMPAR PHYSL, V42, P45, DOI 10.1002/jcp.1030420104; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SMITH RG, 1986, J NEUROSCI, V6, P3505; TRIFONOV YA, 1968, BIOPHYS-USSR, V13, P948; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; van Rossum MCW, 1998, VISUAL NEUROSCI, V15, P809, DOI 10.1017/S0952523898155037; VERVEEN AA, 1969, ACTA PHYSIOL PHARM N, V15, P353; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Walraven J, 1990, VISUAL PERCEPTION NE, P53; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wright RA, 2000, N-S ARCH PHARMACOL, V362, P546, DOI 10.1007/s002100000305; Yamashita T, 2003, J NEUROSCI, V23, P3633; YEE R, 1978, J BIOL CHEM, V253, P8902; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	65	117	117	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					431	443		10.1016/S0896-6273(04)00005-4	http://dx.doi.org/10.1016/S0896-6273(04)00005-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766181	Bronze			2022-12-28	WOS:000221457900013
J	Kolleker, A; Zhu, JJ; Schupp, BJ; Qin, Y; Mack, V; Borchardt, T; Kohr, G; Malinow, R; Seeburg, PH; Osten, P				Kolleker, A; Zhu, JJ; Schupp, BJ; Qin, Y; Mack, V; Borchardt, T; Kohr, G; Malinow, R; Seeburg, PH; Osten, P			Glutamatergic plasticity by synaptic delivery of GluR-B-long-containing AMPA receptors	NEURON			English	Article							TRAFFICKING; SUBUNIT; PERMEABILITY; POTENTIATION; SYNAPSES; NEURONS; GENE; LTP; IDENTIFICATION; INTERNEURONS	Activity-driven delivery of AMPA receptors is proposed to mediate glutamatergic synaptic plasticity, both during development and learning. In hippocampal CA1 principal neurons, such trafficking is primarily mediated by the abundant GluR-A subunit. We now report a study of GluR-B-long, a C-terminal splice variant of the GluR-B subunit. GluR-Blong synaptic delivery is regulated by two forms of activity. Spontaneous synaptic activity-driven GluR-Blong transport maintains one-third of the steady-state AMPA receptor-mediated responses, while GluR-Blong delivery following the induction of LTP is responsible for approximately 50% of the resulting potentiation at the hippocampal CA3 to CA1 synapses at the time of GIuR-B-long peak expression-the second postnatal week. Trafficking of GluR-B-long-containing receptors thus mediates a GluR-A-independent form of glutamatergic synaptic plasticity in the juvenile hippocampus.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Max Planck Society; Cold Spring Harbor Laboratory; University of Virginia	Osten, P (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.	posten@mpimf-heidelberg.mpg.de	Kolleker, Alexander/U-7683-2019; Borchardt, Thilo/E-7844-2011	Kolleker, Alexander/0000-0002-1545-3040; Borchardt, Thilo/0000-0002-2960-0267				Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dryga SA, 1997, VIROLOGY, V228, P74, DOI 10.1006/viro.1996.8364; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Hughes TE, 1997, VISUAL NEUROSCI, V14, P103, DOI 10.1017/S0952523800008804; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JENSEN V, 2003, IN PRESS J PHYSL; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kask K, 1998, P NATL ACAD SCI USA, V95, P13777, DOI 10.1073/pnas.95.23.13777; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	39	60	69	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1199	1212		10.1016/S0896-6273(03)00722-0	http://dx.doi.org/10.1016/S0896-6273(03)00722-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687553	Bronze			2022-12-28	WOS:000187503400017
J	Gomeza, J; Hulsmann, S; Ohno, K; Eulenburg, V; Szoke, K; Richter, D; Betz, H				Gomeza, J; Hulsmann, S; Ohno, K; Eulenburg, V; Szoke, K; Richter, D; Betz, H			Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in Glycinergic inhibition	NEURON			English	Article							RESPIRATORY RHYTHM GENERATION; EXCITATORY AMINO-ACIDS; NONKETOTIC HYPERGLYCINEMIA; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; MICE LACKING; NMDA RECEPTOR; SPINAL-CORD; MEDULLARY SLICES; CLEAVAGE SYSTEM	The glycine transporter subtype 1 (GIyT1) is widely expressed in astroglial cells throughout the mammalian central nervous system and has been implicated in the regulation of N-methyl-D-aspartate (NMDA) receptor activity. Newborn mice deficient in GIyT1 are anatomically normal but show severe motor and respiratory deficits and die during the first postnatal day. In brainstem slices from GIyT1-deficient mice, in vitro respiratory activity is strikingly reduced but normalized by the glycine receptor (GlyR) antagonist strychnine. Conversely, glycine or the GIyT1 inhibitor sarcosine suppress respiratory activity in slices from wild-type mice. Thus, during early postnatal life, GIyT1 is essential for regulating glycine concentrations at inhibitory GlyRs, and GIyT1 deletion generates symptoms found in human glycine encephalopathy.	Max Planck Inst Brain Res, Dept Neurochem, D-50528 Frankfurt, Germany; Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Gomeza, J (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, D-50528 Frankfurt, Germany.		Eulenburg, Volker/B-7263-2013; Hülsmann, Swen/F-7169-2010; Eulenburg, Volker/B-7263-2013	Eulenburg, Volker/0000-0002-4878-5746; Hülsmann, Swen/0000-0001-5042-8724; Eulenburg, Volker/0000-0001-6314-566X				ADAMS RH, 1995, J NEUROSCI, V15, P2524, DOI 10.1523/JNEUROSCI.15-03-02524.1995; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Applegarth DA, 2001, MOL GENET METAB, V74, P139, DOI 10.1006/mgme.2001.3224; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Betz H., 2000, PHARM GABA GLYCINE N, P375; Boneh A, 1996, PEDIATR NEUROL, V15, P137, DOI 10.1016/0887-8994(96)00158-0; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Chatonnet F, 2002, EUR J NEUROSCI, V15, P684, DOI 10.1046/j.1460-9568.2002.01909.x; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dumoulin A, 1999, J CELL SCI, V112, P811; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FORTIN G, 1994, NEUROREPORT, V5, P1137, DOI 10.1097/00001756-199405000-00029; Friauf E, 1999, J COMP NEUROL, V412, P17; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Funk GD, 1997, J NEUROPHYSIOL, V78, P1414, DOI 10.1152/jn.1997.78.3.1414; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Hulsmann S, 2000, EUR J NEUROSCI, V12, P856, DOI 10.1046/j.1460-9568.2000.00973.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JOHNSTON GA, 1971, J NEUROCHEM, V18, P1951, DOI 10.1111/j.1471-4159.1971.tb09601.x; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; JURSKY F, 1995, J NEUROCHEM, V64, P1026; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIU QR, 1993, J BIOL CHEM, V268, P22802; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; Lopez-Corcuera B, 2001, MOL MEMBR BIOL, V18, P13, DOI 10.1080/09687680120521; Lu FL, 1999, PEDIATR NEUROL, V20, P295, DOI 10.1016/S0887-8994(98)00157-X; MAYOR F, 1984, NEUROCHEM PATHOL, V2, P233; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nelson N, 1998, J NEUROCHEM, V71, P1785; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; PATON JFR, 1994, NEUROSCI LETT, V170, P167, DOI 10.1016/0304-3940(94)90265-8; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramirez JM, 1996, J PHYSIOL-LONDON, V491, P799, DOI 10.1113/jphysiol.1996.sp021258; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Ritter B, 2000, EUR J NEUROSCI, V12, P2975, DOI 10.1046/j.1460-9568.2000.00152.x; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Sakata Y, 2001, MOL BRAIN RES, V94, P119, DOI 10.1016/S0169-328X(01)00225-X; SATO K, 1991, BRAIN RES, V567, P64, DOI 10.1016/0006-8993(91)91436-5; SCHLOSS P, 1994, CURR OPIN CELL BIOL, V6, P595, DOI 10.1016/0955-0674(94)90081-7; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; TADA K, 1992, EARLY HUM DEV, V29, P75, DOI 10.1016/0378-3782(92)90060-T; VERDOORN TA, 1987, SCIENCE, V238, P1114, DOI 10.1126/science.2825347; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zafra F, 1997, MOL NEUROBIOL, V14, P117, DOI 10.1007/BF02740653; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zhang W, 2002, J PHYSIOL-LONDON, V540, P435, DOI 10.1113/jphysiol.2001.013225; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; [No title captured]	66	247	256	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					785	796		10.1016/S0896-6273(03)00672-X	http://dx.doi.org/10.1016/S0896-6273(03)00672-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622582	Green Published, hybrid			2022-12-28	WOS:000186651200013
J	Frenkel, MY; Bear, MF				Frenkel, MY; Bear, MF			How monocular deprivation shifts ocular dominance in visual cortex of young mice	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; CRITICAL-PERIOD; SYNAPTIC PLASTICITY; STRIATE CORTEX; POTENTIATION; INHIBITION; ACTIVATION; DEPRESSION; NEOCORTEX; RESPONSES	We used a chronic recording method to document the kinetics of ocular dominance (OD) plasticity induced by temporary lid closure in young mice. We find that monocular deprivation (MD) induces two separate modifications: (1) rapid, deprivation-induced response depression and (2) delayed, deprivation-enabled, experience-dependent response potentiation. To gain insight into how altering retinal activity triggers these cortical responses, we compared the effects of MD by lid closure with monocular inactivation (MI) by intravitreal injection of tetrodotoxin. We find that MI fails to induce deprived-eye response depression but promotes potentiation of responses driven by the normal eye. These effects of MI in juvenile mice closely resemble the effects of MD in adult mice. Understanding how MI and MD differentially affect activity in the visual system of young mice may provide key insight into how the critical period ends.	MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Benuskova L, 1999, NETWORK-COMP NEURAL, V10, P303, DOI 10.1088/0954-898X/10/4/302; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 1999, P NATL ACAD SCI USA, V96, P1083, DOI 10.1073/pnas.96.3.1083; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V66, P1785, DOI 10.1152/jn.1991.66.5.1785; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Gordon JA, 1996, J NEUROSCI, V16, P3274; GREUEL JM, 1987, DEV BRAIN RES, V34, P141, DOI 10.1016/0165-3806(87)90203-3; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Iwai Y, 2003, J NEUROSCI, V23, P6695; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106	30	294	299	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					917	923		10.1016/j.neuron.2004.12.003	http://dx.doi.org/10.1016/j.neuron.2004.12.003			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603735	Bronze			2022-12-28	WOS:000225842300006
J	Kalia, SK; Lee, S; Smith, PD; Liu, L; Crocker, SJ; Thorarinsdottir, TE; Glover, JR; Fon, EA; Park, DS; Lozano, AM				Kalia, SK; Lee, S; Smith, PD; Liu, L; Crocker, SJ; Thorarinsdottir, TE; Glover, JR; Fon, EA; Park, DS; Lozano, AM			BAG5 inhibits parkin and enhances dopaminergic neuron degeneration	NEURON			English	Article							UBIQUITIN-PROTEIN LIGASE; DISEASE GENE-PRODUCT; HEAT-SHOCK PROTEINS; ALPHA-SYNUCLEIN; MOLECULAR CHAPERONES; CELL-DEATH; POLYGLUTAMINE PROTEINS; OVER-EXPRESSION; S-NITROSYLATION; MOUSE MODEL	Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, are the major cause of early-onset Parkinson's disease (PD). Decreases in parkin activity may also contribute to neurodegeneration in sporadic forms of PD. Here, we show that bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacts with parkin and the chaperone Hsp70. Within this complex, BAG5 inhibits both parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function. Finally, BAG5 enhances dopamine neuron death in an in vivo model of PD, whereas a mutant that inhibits BAG5 activity attenuates dopaminergic neurodegeneration. This contrasts with the antideath functions ascribed to BAG family members and suggests a potential role for BAG5 in promoting neurodegeneration in sporadic PD through its functional interactions with parkin and Hsp70.	Univ Toronto, Toronto Western Hosp, Inst Res, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; Univ Ottawa, Neurosci Res Inst, Ottawa, ON K1H 8M5, Canada; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; McGill University; University of Toronto	Lozano, AM (corresponding author), Univ Toronto, Toronto Western Hosp, Inst Res, Univ Hlth Network, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	lozano@uhnres.utoronto.ca	Lozano, Andres M/A-5058-2012	Kalia, Suneil/0000-0003-2054-1915; Park, David/0000-0002-4490-3784; Smith, Patrice/0000-0002-0731-2803; Lozano, Andres M./0000-0001-8257-3694				Adachi H, 2003, J NEUROSCI, V23, P2203; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Brive L, 2001, BIOCHEM BIOPH RES CO, V289, P1099, DOI 10.1006/bbrc.2001.6087; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kermer P, 2003, BRAIN PATHOL, V13, P495; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Nollen EAA, 2002, J CELL SCI, V115, P2809; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200; Oluwatosin-Chigbu Y, 2003, BIOCHEM BIOPH RES CO, V309, P679, DOI 10.1016/j.bbrc.2003.08.059; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Ren Y, 2003, J NEUROSCI, V23, P3316; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	67	152	158	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					931	945		10.1016/j.neuron.2004.11.026	http://dx.doi.org/10.1016/j.neuron.2004.11.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603737	Bronze			2022-12-28	WOS:000225842300008
J	Li, WJ; Wang, F; Menut, L; Gao, FB				Li, WJ; Wang, F; Menut, L; Gao, FB			BTB/POZ-zinc finger protein abrupt suppresses dendritic branching in a neuronal subtype-specific and dosage-dependent manner	NEURON			English	Article							DROSOPHILA-MELANOGASTER; PERIPHERAL NEURONS; SENSORY NEURONS; MORPHOGENESIS; DOMAIN; GENE; CUT; CONNECTIONS; MECHANISMS; PATTERNS	How dendrites of different neuronal subtypes exhibit distinct branching patterns during development remains largely unknown. Here we report the mapping and identification of loss-of-function mutations in the abrupt (ab) gene that increased the number of dendritic branches of multiple dendritic (MD) sensory neurons in Drosophila embryos. Ab encodes an evolutionarily conserved transcription factor that contains a BTB/POZ domain and C2H2 zinc finger motifs. We show that ab has a cell-autonomous function in postmitotic neurons to limit dendritic branching. Ab and the homeodomain protein Cut are expressed in distinct but complementary subsets of MD neurons, and Ab functions in a transcriptional program that does not require Cut. Deleting one copy of ab or overexpressing ab had opposite effects on the formation of higher-order dendritic branches, suggesting that the Ab level in a specific neuron directly regulates dendritic complexity. These results demonstrate that dendritic branching can be suppressed by neuronal subtype-specific transcription factors in a cell-autonomous and dosage-dependent manner.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gao, FB (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.	fgao@gladstone.ucsf.edu						Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; CAJAL RY, 1911, HIST NERVOUS SYSTEM; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Eom T, 2003, J NEUROSCI, V23, P10433; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Gao FB, 2003, TRENDS NEUROSCI, V26, P262, DOI 10.1016/S0166-2236(03)00078-X; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johannes B, 2002, MECH DEVELOP, V115, P3, DOI 10.1016/S0925-4773(02)00083-7; KALIONIS B, 1993, MECH DEVELOP, V43, P57, DOI 10.1016/0925-4773(93)90023-Q; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; ROSEMAN RR, 1995, GENETICS, V141, P1061; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Senti KA, 2000, DEVELOPMENT, V127, P2291; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; UYLINGS HBM, 1975, ADV NEUROL, V12, P247; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhang J, 2002, J NEUROSCI, V22, P10871; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	49	78	80	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					823	834		10.1016/j.neuron.2004.08.040	http://dx.doi.org/10.1016/j.neuron.2004.08.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363393	Bronze			2022-12-28	WOS:000223992000008
J	Wallman, J; Winawer, J				Wallman, J; Winawer, J			Homeostasis of eye growth and the question of myopia	NEURON			English	Review							FORM-DEPRIVATION MYOPIA; RETINAL-PIGMENT EPITHELIUM; SPECTACLE LENS COMPENSATION; VASOACTIVE-INTESTINAL-PEPTIDE; MARMOSET CALLITHRIX-JACCHUS; SPATIAL-FREQUENCY CHANNELS; INDUCED REFRACTIVE ERRORS; INDUCED AXIAL MYOPIA; MESSENGER-RNA LEVELS; OPTIC-NERVE SECTION	As with other organs, the eye's growth is regulated by homeostatic control mechanisms. Unlike other organs, the eye relies on vision as a principal input to guide growth. In this review, we consider several implications of this visual guidance. First, we compare the regulation of eye growth to that of other organs. Second, we ask how the visual system derives signals that distinguish the blur of an eye too large from one too small. Third, we ask what cascade of chemical signals constitutes this growth control system. Finally, if the match between the length and optics of the eye is under homeostatic control, why do children so commonly develop myopia, and why does the myopia not limit itself? Long-neglected studies may provide an answer to this last question.	CUNY City Coll, Dept Biol, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Wallman, J (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	jwallman@ccny.cuny.edu	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586	NCRR NIH HHS [RR 03060] Funding Source: Medline; NEI NIH HHS [EY 02727] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002727, R37EY002727] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott ML, 1998, OPHTHAL PHYSL OPT, V18, P13, DOI 10.1016/S0275-5408(97)00072-0; ANDISON ME, 1992, J COMP PHYSIOL A, V170, P565; Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; BARRINGTON M, 1989, CURR EYE RES, V8, P781, DOI 10.3109/02713688909000868; BARTMANN M, 1994, VISUAL NEUROSCI, V11, P199, DOI 10.1017/S0952523800001565; Bear JC, 1991, REFRACTIVE ANOMALIES, P57; BEDROSSIAN RH, 1979, OPHTHALMOLOGY, V86, P713; Ben-Simon Guy J, 2004, Clin Exp Optom, V87, P175; Beresford JA, 2001, OPTOMETRY VISION SCI, V78, P40, DOI 10.1097/00006324-200101010-00013; Bitzer M, 2004, OPTOMETRY VISION SCI, V81, P127, DOI 10.1097/00006324-200402000-00011; Bitzer M, 2002, INVEST OPHTH VIS SCI, V43, P246; Bitzer M, 2000, EXP EYE RES, V70, P97, DOI 10.1006/exer.1999.0762; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Buck C, 2004, INVEST OPHTH VIS SCI, V45, P402, DOI 10.1167/iovs.03-0789; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; Chen C J, 1985, Ophthalmic Paediatr Genet, V6, P353; CHRISTENSEN AM, 1991, INVEST OPHTH VIS SCI, V32, P2143; Chung K, 2002, VISION RES, V42, P2555, DOI 10.1016/S0042-6989(02)00258-4; Ciuffreda KJ, 2002, OPHTHAL PHYSL OPT, V22, P372, DOI 10.1046/j.1475-1313.2002.00069.x; Coletta NJ, 2003, OPTOMETRY VISION SCI, V80, P50, DOI 10.1097/00006324-200301000-00008; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cordain L, 2002, ACTA OPHTHALMOL SCAN, V80, P125, DOI 10.1034/j.1600-0420.2002.800203.x; Cottriall CL, 1996, INVEST OPHTH VIS SCI, V37, P1368; Crewther DP, 2000, PROG RETIN EYE RES, V19, P421, DOI 10.1016/S1350-9462(00)00004-5; Crewther SG, 2003, NEUROREPORT, V14, P1233, DOI 10.1097/00001756-200307010-00009; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; DAHLQUIST FW, 2002, SCI STKE; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Day SJ, 2000, DEVELOPMENT, V127, P2977; de Stefano ME, 1997, INVEST OPHTH VIS SCI, V38, P1241; Diether S, 1999, VISION RES, V39, P2499, DOI 10.1016/S0042-6989(99)00005-X; Diether S, 1997, VISION RES, V37, P659, DOI 10.1016/S0042-6989(96)00224-6; EBENHOLTZ SM, 1983, INVEST OPHTH VIS SCI, V24, P513; Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064; Ferree CE, 1933, ARCH OPHTHALMOL-CHIC, V9, P925, DOI 10.1001/archopht.1933.00830010949006; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FINCHAM EF, 1951, BRIT J OPHTHALMOL, V35, P381, DOI 10.1136/bjo.35.7.381; Fine I, 2002, VISION RES, V42, P191, DOI 10.1016/S0042-6989(01)00266-8; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Fischer AJ, 1999, VISION RES, V39, P685, DOI 10.1016/S0042-6989(98)00178-3; Fischer AJ, 1998, J COMP NEUROL, V392, P273; Fischer AJ, 1998, BRAIN RES, V794, P48, DOI 10.1016/S0006-8993(98)00188-7; Fitzgerald MEC, 2002, EXP EYE RES, V74, P561, DOI 10.1006/exer.2002.1142; FITZKE FW, 1985, J PHYSIOL-LONDON, V369, P33, DOI 10.1113/jphysiol.1985.sp015886; Flitcroft DI, 1998, VISION RES, V38, P2869, DOI 10.1016/S0042-6989(98)00087-X; FLITCROFT DI, 1990, VISUAL NEUROSCI, V5, P547, DOI 10.1017/S0952523800000705; Flitcroft DI, 1999, OPHTHAL PHYSL OPT, V19, P103, DOI 10.1046/j.1475-1313.1999.00432.x; Fujikado T, 1997, GRAEF ARCH CLIN EXP, V235, P320, DOI 10.1007/BF01739642; GALLEMORE RP, 1990, INVEST OPHTH VIS SCI, V31, P67; Gentle A, 1999, EXP EYE RES, V68, P155, DOI 10.1006/exer.1998.0587; Gentle A, 2002, CYTOKINE, V18, P344, DOI 10.1006/cyto.2002.1046; Gentle A, 2001, CURR EYE RES, V23, P179, DOI 10.1076/ceyr.23.3.179.5466; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; GOLSCHMIDT E, 1968, ETIOLOGY MYOPIA EPID; Goss D A, 1994, J Am Optom Assoc, V65, P117; GOTTLIEB MD, 1990, CURR EYE RES, V9, P1157, DOI 10.3109/02713689009003472; Graham B, 1999, VISION RES, V39, P177, DOI 10.1016/S0042-6989(98)00188-6; GUO SS, 1995, CURR EYE RES, V14, P385, DOI 10.3109/02713689508999936; GWIAZDA J, 1993, CLIN VISION SCI, V8, P337; GWIAZDA J, 1995, VISION RES, V35, P1299, DOI 10.1016/0042-6989(94)00238-H; GWIAZDA J, 1993, INVEST OPHTH VIS SCI, V34, P690; Gwiazda J, 2003, INVEST OPHTH VIS SCI, V44, P1492, DOI 10.1167/iovs.02-0816; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; Harrison RG, 1929, ROUX ARCH DEV BIOL, V120, P1, DOI 10.1007/BF02109662; HODOS W, 1984, INVEST OPHTH VIS SCI, V25, P652; Honda S, 1996, INVEST OPHTH VIS SCI, V37, P2519; HOOGERHEIDE J, 1971, OPHTHALMOLOGICA, V163, P209, DOI 10.1159/000306646; Hung GK, 2000, B MATH BIOL, V62, P1087, DOI 10.1006/bulm.2000.0199; Hung LF, 2000, INVEST OPHTH VIS SCI, V41, P1259; HUNG LF, 1995, NAT MED, V1, P761, DOI 10.1038/nm0895-761; HUNTER JJ, 2003, INVEST OPHTHALMOL  S, V44, P4341; IRVING EL, 1992, OPHTHAL PHYSL OPT, V12, P448, DOI 10.1111/j.1475-1313.1992.tb00315.x; ITEN LE, 1980, DEV BIOL, V75, P373, DOI 10.1016/0012-1606(80)90170-0; IUVONE PM, 1989, VISUAL NEUROSCI, V2, P465, DOI 10.1017/S0952523800012360; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jansonius NM, 1998, OPHTHAL PHYSL OPT, V18, P504, DOI 10.1016/S0275-5408(98)00022-2; Jiang BC, 1999, OPHTHAL PHYSL OPT, V19, P165, DOI 10.1046/j.1475-1313.1999.00431.x; Junghans BM, 1999, OPTOMETRY VISION SCI, V76, P796, DOI 10.1097/00006324-199911000-00028; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Kee CS, 2001, INVEST OPHTH VIS SCI, V42, P575; Kennedy R H, 2000, Binocul Vis Strabismus Q, V15, P281; Kinge B, 2000, ACTA OPHTHALMOL SCAN, V78, P26, DOI 10.1034/j.1600-0420.2000.078001026.x; KIORPES L, 1995, VISION RES, V35, P1289, DOI 10.1016/0042-6989(94)00239-I; KOH SWM, 1984, J NEUROCHEM, V43, P1522, DOI 10.1111/j.1471-4159.1984.tb06072.x; KOTULAK JC, 1986, PERCEPTION, V15, P7, DOI 10.1068/p150007; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P403, DOI 10.1007/s003590050339; Kroger RHH, 1996, J COMP PHYSIOL A, V179, P837; KRUGER PB, 1995, VISION RES, V35, P2415, DOI 10.1016/0042-6989(94)00316-5; Kruger PB, 1997, VISION RES, V37, P2511, DOI 10.1016/S0042-6989(97)00056-4; Kusakari T, 2001, EXP EYE RES, V73, P533, DOI 10.1006/exer.2001.1064; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lind GJ, 1998, INVEST OPHTH VIS SCI, V39, P2217; Llorente L, 2004, J VISION, V4, P288, DOI 10.1167/4.4.5; Logan NS, 2004, INVEST OPHTH VIS SCI, V45, P2152, DOI 10.1167/iovs.03-0875; Luft WA, 2003, INVEST OPHTH VIS SCI, V44, P1330, DOI 10.1167/iovs.02-0796; Majaj NJ, 2002, VISION RES, V42, P1165, DOI 10.1016/S0042-6989(02)00045-7; MARS WM, 1995, HEPATOLOGY, V21, P1695, DOI 10.1016/0270-9139(95)90477-8; Marzani D, 1997, INVEST OPHTH VIS SCI, V38, P1726; MATHEWS S, 1994, VISION RES, V34, P1965, DOI 10.1016/0042-6989(94)90026-4; May CA, 2003, CURR EYE RES, V27, P1, DOI 10.1076/ceyr.27.2.1.15459; McBrien NA, 1997, INVEST OPHTH VIS SCI, V38, P321; MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133; McBrien NA, 1999, OPTOMETRY VISION SCI, V76, P419, DOI 10.1097/00006324-199906000-00022; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; McBrien NA, 2001, CURR EYE RES, V23, P313, DOI 10.1076/ceyr.23.5.313.5440; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; McLean RC, 2003, INVEST OPHTH VIS SCI, V44, P449, DOI 10.1167/iovs.01-0670; MEDINA A, 1993, VISION RES, V33, P21, DOI 10.1016/0042-6989(93)90054-Z; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MILES FA, 1990, VISION RES, V30, P339, DOI 10.1016/0042-6989(90)90076-W; MILLODOT M, 1981, AM J OPTOM PHYS OPT, V58, P691; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; MORALES TI, 1988, J BIOL CHEM, V263, P12828; MORGAN I, 2004, IN PRESS PROG RETIN; Mutti DO, 2000, INVEST OPHTH VIS SCI, V41, P1022; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Napper GA, 1997, VISION RES, V37, P1557, DOI 10.1016/S0042-6989(96)00269-6; Nevin ST, 1998, CURR EYE RES, V17, P322, DOI 10.1076/ceyr.17.3.322.5220; Nickla Debora L., 1992, Experimental Eye Research, V55, pS109; Nickla DL, 1997, CURR EYE RES, V16, P320, DOI 10.1076/ceyr.16.4.320.10697; Nickla DL, 2004, OPTOMETRY VISION SCI, V81, P111, DOI 10.1097/00006324-200402000-00009; Nickla DL, 2002, INVEST OPHTH VIS SCI, V43, P2519; Nickla DL, 1998, EXP EYE RES, V66, P163, DOI 10.1006/exer.1997.0420; Nickla DL, 1999, J COMP PHYSIOL A, V185, P81, DOI 10.1007/s003590050368; Norton T T, 1995, J Am Optom Assoc, V66, P405; NORTON TT, 1994, VISUAL NEUROSCI, V11, P143, DOI 10.1017/S0952523800011184; Ofri R, 2001, AM J VET RES, V62, P812, DOI 10.2460/ajvr.2001.62.812; Ohngemach S, 1997, VISUAL NEUROSCI, V14, P493, DOI 10.1017/S0952523800012153; Ong E, 1999, OPTOMETRY VISION SCI, V76, P363, DOI 10.1097/00006324-199906000-00015; Papastergiou GI, 1998, VISION RES, V38, P1883, DOI 10.1016/S0042-6989(97)00347-7; Park T, 2001, INVEST OPHTH VIS SCI, V42, pS55; Park TW, 2003, VISION RES, V43, P1519, DOI 10.1016/S0042-6989(03)00180-9; Pendrak K, 1997, CURR EYE RES, V16, P152, DOI 10.1076/ceyr.16.2.152.5090; Phillips JR, 2004, INVEST OPHTH VIS SCI, V45, P758, DOI 10.1167/iovs.03-0732; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Pickett Seltner Ruth L., 1997, Visual Neuroscience, V14, P801; POOLE AR, 1982, J CELL BIOL, V93, P910, DOI 10.1083/jcb.93.3.910; Poukens V, 1998, INVEST OPHTH VIS SCI, V39, P1765; RADA JA, 1992, CURR EYE RES, V11, P767, DOI 10.3109/02713689209000750; Rada JA, 2002, EXP EYE RES, V74, P205, DOI 10.1006/exer.2001.1113; Rada JA, 1999, INVEST OPHTH VIS SCI, V40, P3091; Radhakrishnan H, 2004, VISION RES, V44, P1869, DOI 10.1016/j.visres.2004.03.007; RAVIOLA E, 1985, NEW ENGL J MED, V312, P1609, DOI 10.1056/NEJM198506203122505; REMPT F, 1971, OPHTHALMOLOGICA, V162, P1, DOI 10.1159/000306229; RICHLER A, 1980, AM J OPTOM PHYS OPT, V57, P861; Rodiek R.W., 1998, 1 STEPS SEEING, P562; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; ROHRER B, 1992, J PHYSIOL-LONDON, V449, P363, DOI 10.1113/jphysiol.1992.sp019090; ROSENFIELD M, 1993, OPHTHAL PHYSL OPT, V13, P266, DOI 10.1111/j.1475-1313.1993.tb00469.x; Rosenfield M, 1999, OPTOMETRY VISION SCI, V76, P303, DOI 10.1097/00006324-199905000-00018; Rucker FJ, 2001, VISION RES, V41, P911, DOI 10.1016/S0042-6989(00)00303-5; RUDOLF G, 1991, VISION RES, V31, P1841, DOI 10.1016/0042-6989(91)90178-8; Sandell LJ, 1996, ANN NY ACAD SCI, V785, P325, DOI 10.1111/j.1749-6632.1996.tb56298.x; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; SCHAEFFEL F, 1990, VISUAL NEUROSCI, V4, P177, DOI 10.1017/S0952523800002327; SCHAEFFEL F, 1988, VISION RES, V28, P639, DOI 10.1016/0042-6989(88)90113-7; Schaeffel F, 2004, OPTOMETRY VISION SCI, V81, P99, DOI 10.1097/00006324-200402000-00008; Schaeffel F, 1999, VISION RES, V39, P1585, DOI 10.1016/S0042-6989(98)00304-6; SCHAEFFEL F, 1995, VISION RES, V35, P1247, DOI 10.1016/0042-6989(94)00221-7; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; Schmid GF, 2003, CURR EYE RES, V27, P61, DOI 10.1076/ceyr.27.2.61.15454; Schmid KL, 2004, OPTOMETRY VISION SCI, V81, P137, DOI 10.1097/00006324-200402000-00012; Schmid KL, 1996, VISION RES, V36, P1023, DOI 10.1016/0042-6989(95)00191-3; Schmid KL, 1997, EXP EYE RES, V64, P837, DOI 10.1006/exer.1997.0282; Schor C, 1999, OPHTHAL PHYSL OPT, V19, P134, DOI 10.1046/j.1475-1313.1999.00409.x; Schrodl F, 2003, INVEST OPHTH VIS SCI, V44, P3705, DOI 10.1167/iovs.03-0232; Schwahn HN, 1997, VISION RES, V37, P2661, DOI 10.1016/S0042-6989(97)00114-4; Schwahn HN, 2000, VISUAL NEUROSCI, V17, P165, DOI 10.1017/S0952523800171184; SCHWAHN HN, 1994, INVEST OPHTH VIS SCI, V35, P3516; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Seidemann A, 2002, J OPT SOC AM A, V19, P2363, DOI 10.1364/JOSAA.19.002363; SEKO Y, 1994, GRAEF ARCH CLIN EXP, V232, P545, DOI 10.1007/BF00181998; Seko Y, 1998, OPHTHALMIC RES, V30, P361, DOI 10.1159/000055496; Seko Y, 1996, EXP EYE RES, V63, P443, DOI 10.1006/exer.1996.0134; Seko Y, 1997, CELL BIOCHEM FUNCT, V15, P191; SEKO Y, 1995, INVEST OPHTH VIS SCI, V36, P1183; SELTNER RLP, 1995, VISION RES, V35, P1265, DOI 10.1016/0042-6989(94)00244-G; Shaikh AW, 1999, OPTOMETRY VISION SCI, V76, P308, DOI 10.1097/00006324-199905000-00019; SHERMAN SM, 1977, BRAIN RES, V124, P154, DOI 10.1016/0006-8993(77)90872-1; Shih YF, 1999, J OCUL PHARMACOL TH, V15, P85, DOI 10.1089/jop.1999.15.85; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Siegwart JT, 1998, VISION RES, V38, P3505, DOI 10.1016/S0042-6989(98)00053-4; Smith EL, 1999, OPTOMETRY VISION SCI, V76, P428, DOI 10.1097/00006324-199906000-00023; Smith EL, 2002, INVEST OPHTH VIS SCI, V43, P291; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; Smith EL, 1998, MYOPIA NEARWORK, P57; SMITHLINE LM, 1974, J OPT SOC AM, V64, P1512, DOI 10.1364/JOSA.64.001512; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; STARK L, 1965, IEEE T BIO-MED ENG, VBM12, P138, DOI 10.1109/TBME.1965.4502370; Stone RA, 2004, ANN ACAD MED SINGAP, V33, P7; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; STONE RA, 1991, EXP EYE RES, V52, P755, DOI 10.1016/0014-4835(91)90027-C; Stone RA, 2003, INVEST OPHTH VIS SCI, V44, P3933, DOI 10.1167/iovs.02-0774; Stone RA, 2001, INVEST OPHTH VIS SCI, V42, P557; Thibos LN, 2001, INVEST OPHTH VIS SCI, V42, pS58; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P1249; TROILO D, 1987, CURR EYE RES, V6, P993, DOI 10.3109/02713688709034870; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P2043; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; Truong HT, 2002, EXP EYE RES, V74, P103, DOI 10.1006/exer.2001.1107; Twitty VC, 1931, J EXP ZOOL, V59, P61, DOI 10.1002/jez.1400590105; Walker TW, 2002, OPTOMETRY VISION SCI, V79, P424, DOI 10.1097/00006324-200207000-00010; WALLMAN J, 1981, INVEST OPHTH VIS SCI, V20, P557; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WALLMAN J, 1987, VISION RES, V27, P1139, DOI 10.1016/0042-6989(87)90027-7; WALLS GL, 1942, VERTEBRATE EYE ADAPT; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; WEISS S, 1993, J COMP PHYSIOL A, V172, P263, DOI 10.1007/BF00216608; Whatham AR, 2001, VISION RES, V41, P267, DOI 10.1016/S0042-6989(00)00250-9; WIESEL TN, 1977, NATURE, V266, P66, DOI 10.1038/266066a0; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Wildsoet CE, 2003, CURR EYE RES, V27, P371, DOI 10.1076/ceyr.27.6.371.18188; WILDSOET CF, 1988, CLIN VISION SCI, V3, P99; WILDSOET CF, 1993, VISION RES, V33, P1593, DOI 10.1016/0042-6989(93)90026-S; Wilson BJ, 2002, J OPT SOC AM A, V19, P833, DOI 10.1364/JOSAA.19.000833; Winawer J, 2002, VISION RES, V42, P2651, DOI 10.1016/S0042-6989(02)00300-0; Wolffsohn JS, 2003, INVEST OPHTH VIS SCI, V44, P2284, DOI 10.1167/iovs.02-0373; Woods RL, 1996, VISION RES, V36, P3597, DOI 10.1016/0042-6989(96)00092-2; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; Zadnik K, 1999, INVEST OPHTH VIS SCI, V40, P1050; ZADNIK K, 1987, AM J OPTOM PHYS OPT, V64, P558; Zhu XY, 2003, INVEST OPHTH VIS SCI, V44, P2818, DOI 10.1167/iovs.02-0606; ZYLBERMANN R, 1993, J PEDIATR OPHTHALMOL, V30, P319	234	655	685	4	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					447	468		10.1016/j.neuron.2004.08.008	http://dx.doi.org/10.1016/j.neuron.2004.08.008			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312645	Bronze			2022-12-28	WOS:000223436400005
J	Hansen, MJ; Dallal, GE; Flanagan, JG				Hansen, MJ; Dallal, GE; Flanagan, JG			Retinal axon response to ephrin-as shows a graded, concentration-dependent transition from growth promotion to inhibition	NEURON			English	Article							REPULSIVE GUIDANCE MOLECULE; RECEPTOR TYROSINE KINASES; GANGLION-CELL AXONS; RETINOTECTAL PROJECTION; NEURAL DEVELOPMENT; BRANCH EXTENSION; VISUAL-SYSTEM; IN-VITRO; GRADIENTS; LIGANDS	Ephrin-As act as retinal topographic mapping labels, but the molecular basis for two key aspects of mapping remains unclear. First, although mapping is believed to require balanced opposing forces, ephrin-As have been reported to be retinal axon repellents, and the counterbalanced force has not been molecularly identified. Second, although graded responsiveness across the retina is required for smooth mapping, a sharp discontinuity has instead been reported. Here, an axon growth assay was developed to systematically vary both retinal position and ephrin concentration and test responses quantitatively. Responses varied continuously with retinal position, fulfilling the requirement for smooth mapping. Ephrin-A2 inhibited growth at high concentrations but promoted growth at lower concentrations. Moreover, the concentration producing a transition from promotion to inhibition varied topographically with retinal position. These results lead directly to a mapping model where position within a concentration gradient may be specified at the neutral point between growth promotion and inhibition.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Tufts Univ, Biostat Unit, USDA, Human Nutr Res Ctr, Boston, MA 02111 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; United States Department of Agriculture (USDA)	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020		NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011559-13, R01 EY011559-11, R01 EY011559-12] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Honda H, 1998, J THEOR BIOL, V192, P235, DOI 10.1006/jtbi.1998.0662; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Osterfield M, 2003, CELL, V113, P425, DOI 10.1016/S0092-8674(03)00359-3; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; THANOS S, 1987, DEV BRAIN RES, V32, P161, DOI 10.1016/0165-3806(87)90098-8; WALTER J, 1987, DEVELOPMENT, V101, P685; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zhang JH, 1996, J NEUROSCI, V16, P7182	40	156	161	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					717	730		10.1016/j.neuron.2004.05.009	http://dx.doi.org/10.1016/j.neuron.2004.05.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182713	Bronze			2022-12-28	WOS:000221975000005
J	Lanuza, GM; Gosgnach, S; Pierani, A; Jessell, TM; Goulding, M				Lanuza, GM; Gosgnach, S; Pierani, A; Jessell, TM; Goulding, M			Genetic identification of spinal Interneurons that coordinate left-right locomotor activity necessary for walking movements	NEURON			English	Article							LAMINA-VIII INTERNEURONS; COMMISSURAL INTERNEURONS; BRAIN-STEM; FICTIVE LOCOMOTION; NEURONAL IDENTITY; IN-VITRO; CORD; PATTERN; RAT; HINDLIMB	The sequential stepping of left and right limbs is a fundamental motor behavior that underlies walking movements. This relatively simple locomotor behavior is generated by the rhythmic activity of motor neurons under the control of spinal neural networks known as central pattern generators (CPGs) that comprise multiple interneuron cell types. Little, however, is known about the identity and contribution of defined interneuronal populations to mammalian locomotor behaviors. We show a discrete subset of commissural spinal interneurons, whose fate is controlled by the activity of the homeobox gene Dbx1, has a critical role in controlling the left-right alternation of motor neurons innervating hindlimb muscles. Dbx1 mutant mice lacking these ventral interneurons exhibit an increased incidence of cobursting between left and right flexor/extensor motor neurons during drug-induced locomotion. Together, these findings identify Dbx1-dependent interneurons as key components of the spinal locomotor circuits that control stepping movements in mammals.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Salk Institute; Columbia University; Howard Hughes Medical Institute	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu	Lanuza, Guillermo/AAT-6286-2020; Pierani, Alessandra/O-6136-2017	Lanuza, Guillermo/0000-0003-3311-2263; Pierani, Alessandra/0000-0002-4872-4791				ARSHAVSKY YI, 1993, TRENDS NEUROSCI, V16, P227, DOI 10.1016/0166-2236(93)90161-E; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BARAJON I, 1992, BRAIN RES, V588, P168, DOI 10.1016/0006-8993(92)91359-M; Birinyi A, 2003, J COMP NEUROL, V461, P429, DOI 10.1002/cne.10696; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P961, DOI 10.1152/jn.1982.47.5.961; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Butt SJB, 2002, J NEUROSCI, V22, P9961; CARR PA, 1995, BRAIN RES BULL, V37, P213, DOI 10.1016/0361-9230(94)00271-2; COHEN AH, 1984, BRAIN RES, V293, P164, DOI 10.1016/0006-8993(84)91464-1; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; GRAHAMBROWN T, 1914, J PHYSIOL-LONDON, V48, P18; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; GRUNER JA, 1980, EXP BRAIN RES, V40, P361; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; JANKOWSKA E, 1990, BRAIN RES, V535, P327, DOI 10.1016/0006-8993(90)91618-Q; JASMIN L, 1994, NEUROSCIENCE, V58, P275, DOI 10.1016/0306-4522(94)90034-5; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KATO M, 1990, NEUROSCI RES, V9, P22, DOI 10.1016/0168-0102(90)90042-D; Kerman IA, 2003, J NEUROSCI, V23, P4657; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Orlovsky G, 1999, NEURAL CONTROL LOCOM; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SOFFE SR, 1982, J NEUROPHYSIOL, V48, P1279, DOI 10.1152/jn.1982.48.6.1279; SOFFE SR, 1984, J NEUROPHYSIOL, V51, P1257, DOI 10.1152/jn.1984.51.6.1257; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651; Zar JH, 1974, BIOSTATISTICAL ANAL; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	49	295	296	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					375	386		10.1016/S0896-6273(04)00249-1	http://dx.doi.org/10.1016/S0896-6273(04)00249-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134635	Bronze			2022-12-28	WOS:000221458700005
J	Sheth, SA; Nemoto, M; Guiou, M; Walker, M; Pouratian, N; Toga, AW				Sheth, SA; Nemoto, M; Guiou, M; Walker, M; Pouratian, N; Toga, AW			Linear and nonlinear relationships between neuronal activity, oxygen metabolism, and hemodynamic responses	NEURON			English	Article							CEREBRAL-BLOOD-FLOW; CONSUMPTION FOLLOWING ACTIVATION; ACTIVITY-DEPENDENT INCREASES; SOMATOSENSORY STIMULATION; IMAGING SPECTROSCOPY; OXIDATIVE-METABOLISM; SENSORY STIMULATION; EVOKED-POTENTIALS; NEGATIVE RESPONSE; NEURAL ACTIVITY	We investigated the relationship between neuronal activity, oxygen metabolism, and hemodynamic responses in rat somatosensory cortex with simultaneous optical intrinsic signal imaging and spectroscopy, laser Doppler flowmetry, and local field potential recordings. Changes in cerebral oxygen consumption increased linearly with synaptic activity but with a threshold effect consistent with the existence of a tissue oxygen buffer. Modeling analysis demonstrated that the coupling between neuronal activity and hemodynamic response magnitude may appear linear over a narrow range but incorporates nonlinear effects that are better described by a threshold or power law relationship. These results indicate that caution is required in the interpretation of perfusion-based indicators of brain activity, such as functional magnetic resonance imaging (fMRI), and may help to refine quantitative models of neurovascular coupling.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Toga, AW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90024 USA.	toga@loni.ucla.edu		Pouratian, Nader/0000-0002-0426-3241	NIGMS NIH HHS [GM08042] Funding Source: Medline; NIMH NIH HHS [MH52083, MH67432] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH067432, R01MH052083] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Duong TQ, 2000, MAGN RESON MED, V44, P231, DOI 10.1002/1522-2594(200008)44:2<231::AID-MRM10>3.0.CO;2-T; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gjedde A, 2002, J CEREBR BLOOD F MET, V22, P1, DOI 10.1097/00004647-200201000-00001; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Lindauer U, 2003, BRAIN RES, V975, P135, DOI 10.1016/S0006-8993(03)02602-7; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mayhew J, 2001, NEUROIMAGE, V13, P975, DOI 10.1006/nimg.2001.0807; Mayhew J, 2000, NEUROIMAGE, V12, P664, DOI 10.1006/nimg.2000.0656; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Parri R, 2003, NAT NEUROSCI, V6, P5, DOI 10.1038/nn0103-5; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Yacoub E, 1999, MAGN RESON MED, V41, P436, DOI 10.1002/(SICI)1522-2594(199903)41:3<436::AID-MRM2>3.0.CO;2-#; Yacoub E, 2001, MAGN RESON MED, V45, P184, DOI 10.1002/1522-2594(200102)45:2<184::AID-MRM1024>3.0.CO;2-C; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q	43	229	244	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					347	355		10.1016/S0896-6273(04)00221-1	http://dx.doi.org/10.1016/S0896-6273(04)00221-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091348	Bronze			2022-12-28	WOS:000221458500017
J	McCabe, BD; Hom, S; Aberle, H; Fetter, RD; Marques, G; Haerry, TE; Wan, H; O'Connor, MB; Goodman, CS; Haghighi, AP				McCabe, BD; Hom, S; Aberle, H; Fetter, RD; Marques, G; Haerry, TE; Wan, H; O'Connor, MB; Goodman, CS; Haghighi, AP			Highwire regulates presynaptic BMP signaling essential for synaptic growth	NEURON			English	Article							II RECEPTOR; THICK VEINS; SERINE/THREONINE KINASES; DENDRITIC SPINES; GENETIC-ANALYSIS; CELL FATE; DROSOPHILA; DPP; UBIQUITIN; PROTEIN	Highwire (Hiw), a putative RING finger E3 ubiquitin ligase, negatively regulates synaptic growth at the neuromuscular junction (NMJ) in Drosophila. hiw mutants have dramatically larger synaptic size and increased numbers of synaptic boutons. Here we show that Hiw binds to the Smad protein Medea (Med). Med is part of a presynaptic bone morphogenetic protein (BMP) signaling cascade consisting of three receptor subunits, Wit, Tkv, and Sax, in addition to the Smad transcription factor Mad. When compared to wildtype, mutants of BMP signaling components have smaller NMJ size, reduced neurotransmitter release, and aberrant synaptic ultrastructure. BMP signaling mutants suppress the excessive synaptic growth in hiw mutants. Activation of BMP signaling, which in wild-type does not cause additional, growth, in hiw mutants does lead to further synaptic expansion. These results reveal a balance between positive BMP signaling and negative regulation by Highwire, governing the growth of neuromuscular synapses.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	McCabe, BD (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	bmccabe@socrates.berkeley.edu; pejmunh@socrates.berkeley.edu	Aberle, Hermann/L-8461-2017; O'Connor, Michael B/C-9977-2014	Aberle, Hermann/0000-0002-4864-6105; O'Connor, Michael B/0000-0002-3067-5506; McCabe, Brian/0000-0003-1620-0501				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; AGATEP R, 1998, TRANSFORMATION SACCH; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; deCelis JF, 1997, DEVELOPMENT, V124, P1007; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GUAN K, 1991, J BIOL CHEM, V266, P12964; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Henderson KD, 1999, DEV BIOL, V205, P10, DOI 10.1006/dbio.1998.9113; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; James P, 2001, METH MOL B, V177, P41; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mel BW, 2002, NEURON, V34, P175, DOI 10.1016/S0896-6273(02)00669-4; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; RAFTERY LA, 1995, GENETICS, V139, P241; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Simin K, 1998, GENETICS, V148, P801; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tomoyasu Y, 1998, DEVELOPMENT, V125, P4215; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Twombly V, 1996, DEVELOPMENT, V122, P1555; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Yang HT, 2002, DEV BRAIN RES, V136, P35, DOI 10.1016/S0165-3806(02)00311-5; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	70	166	174	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					891	905		10.1016/S0896-6273(04)00073-X	http://dx.doi.org/10.1016/S0896-6273(04)00073-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046722	Bronze			2022-12-28	WOS:000221458300009
J	Mehta, SB; Kleinfeld, D				Mehta, SB; Kleinfeld, D			Frisking the whiskers: Patterned sensory input in the rat vibrissa system	NEURON			English	Review							DISCRIMINATION; WHISKING; SIGNALS	How are two prominent environmental features, surface texture and object location, transduced and encoded as rats whisk? Recent papers show that textures may excite intrinsic mechanical vibrations of the vibrissae. Although these vibrations are too rapid to be directly followed by cortical neurons, there is evidence that their speed is encoded by contact-dependent sensory signals. In addition to contact, sensory signals exist that report the angular position of the vibrissae. The combination of contact and reference signals may be used to decode spatial variations in the environment, particularly the location of objects in head-centered coordinates.	Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu		Mehta, Samar/0000-0002-9181-8363				Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahrens KF, 2002, P NATL ACAD SCI USA, V99, P15176, DOI 10.1073/pnas.222547199; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Barth DS, 2003, J NEUROSCI, V23, P2502; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; CRANCH E, 1956, J APPLIED MECHANICS, V78, P103; Deschenes M, 2003, J NEUROSCI, V23, P6778; Engel J, 1999, BIOPHYS J, V76, P1310, DOI 10.1016/S0006-3495(99)77293-0; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; FEND M, 2003, IN PRESS IEEE RSJ IN; FUNDIN BT, 1994, EXP BRAIN RES, V99, P233; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; GUSTAFSON JW, 1977, PSYCHOL BULL, V84, P477, DOI 10.1037/0033-2909.84.3.477; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Neimark MA, 2003, J NEUROSCI, V23, P6499; SCHIFFMA.HR, 1970, ANIM BEHAV, V18, P290, DOI 10.1016/S0003-3472(70)80040-9; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Vincent S. B., 1912, BEHAV MONOGR, V1, P7; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	28	51	52	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					181	184		10.1016/S0896-6273(04)00002-9	http://dx.doi.org/10.1016/S0896-6273(04)00002-9			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741099	Bronze			2022-12-28	WOS:000221457800004
J	Nakahara, H; Itoh, H; Kawagoe, R; Takikawa, Y; Hikosaka, O				Nakahara, H; Itoh, H; Kawagoe, R; Takikawa, Y; Hikosaka, O			Dopamine neurons can represent context-dependent prediction error	NEURON			English	Article							SUPPLEMENTARY EYE FIELD; MONKEY CAUDATE-NUCLEUS; PREFRONTAL CORTEX; BASAL GANGLIA; ANTERIOR CINGULATE; REWARD EXPECTANCY; NEURAL CORRELATE; MOTOR AREA; RESPONSES; MOVEMENTS	Midbrain dopamine (DA) neurons are thought to encode reward prediction error. Reward prediction can be improved if any relevant context is taken into account. We found that monkey DA neurons can encode a context-dependent prediction error. In the first noncontextual task, a light stimulus was randomly followed by reward, with a fixed equal probability. The response of DA neurons was positively correlated with the number of preceding unrewarded trials and could be simulated by a conventional temporal difference (TD) model. In the second contextual task, a reward-indicating light stimulus was presented with the probability that, while fixed overall, was incremented as a function of the number of preceding unrewarded trials. The DA neuronal response then was negatively correlated with this number. This history effect corresponded to the prediction error based on the conditional probability of reward and could be simulated only by implementing the relevant context into the TD model.	RIKEN, Brain Sci Inst, Lab Math Neurosci, Wako, Saitama 3510198, Japan; Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan; Juntendo Univ, Sch Med, Dept Physiol, Tokyo 1138421, Japan; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	RIKEN; Tokyo Institute of Technology; Juntendo University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nakahara, H (corresponding author), RIKEN, Brain Sci Inst, Lab Math Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hiro@brain.riken.go.jp	Nakahara, Hiroyuki/N-5411-2015	Nakahara, Hiroyuki/0000-0001-6891-1175; Itoh, Hideaki/0000-0001-8623-2408	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARBIB MA, 1995, MODELS INFORMATION P, P149; Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; DAYAN P, 2002, NIPS, V14, P11; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Houk JC, 1995, MODELS INFORMATION P, P249; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGOE R, 2003, IN PRESS J NEUROPHYS; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; PARENT A, 1994, J COMP NEUROL, V344, P305, DOI 10.1002/cne.903440211; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Satoh T, 2003, J NEUROSCI, V23, P9913; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Suri RE, 1998, EXP BRAIN RES, V121, P350, DOI 10.1007/s002210050467; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Suri RE, 2001, EXP BRAIN RES, V140, P234, DOI 10.1007/s002210100814; Sutton R.S., 1991, SIGART B, V2, P160, DOI [10.1145/122344.122377, DOI 10.1145/122344.122377]; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; [No title captured]	57	192	193	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					269	280		10.1016/S0896-6273(03)00869-9	http://dx.doi.org/10.1016/S0896-6273(03)00869-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741107	Bronze			2022-12-28	WOS:000221457800012
J	Zhang, XF; Schaefer, AW; Burnette, DT; Schoonderwoert, VT; Forscher, P				Zhang, XF; Schaefer, AW; Burnette, DT; Schoonderwoert, VT; Forscher, P			Rho-dependent contractile responses in the neuronal growth cone are independent of classical peripheral retrograde actin flow	NEURON			English	Article							BINDING PROTEIN-RHO; LIGHT-CHAIN KINASE; MYOSIN-II; NERVE GROWTH; LYSOPHOSPHATIDIC ACID; FOCAL ADHESIONS; STRESS FIBERS; AXON GUIDANCE; MICROTUBULES; PHOSPHORYLATION	Rho family GTPases have been implicated in neuronal growth cone guidance; however, the underlying cytoskeletal mechanisms are unclear. We have used multimode fluorescent speckle microscopy (FSM) to directly address this problem. We report that actin arcs that form in the transition zone are incorporated into central actin bundles in the C domain. These actin structures are Rho/Rho Kinase (ROCK) effectors. Specifically, LPA mediates growth cone retraction by ROCK-dependent increases in actin arc and central actin bundle contractility and stability. In addition, these treatments had marked effects on MT organization as a consequence of strong MT-actin arc interactions. In contrast, LPA or constitutively active Rho had no effect on P domain retrograde actin flow or filopodium bundle number. This study reveals a novel mechanism for domain-specific spatial control of actin-based motility in the growth cone with implications for understanding chemorepellant growth cone responses and nerve regeneration.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Forscher, P (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		; Zhang, Xiao-Feng/P-7407-2015	Forscher, Paul/0000-0003-1988-5155; Zhang, Xiao-Feng/0000-0001-7240-1397	NINDS NIH HHS [NS1F32 NS11122, R01-NS28695, R01 NS051786] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011122, R01NS028695] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Bridgman PC, 2002, CELL MOTIL CYTOSKEL, V52, P91, DOI 10.1002/cm.10038; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Buck KB, 2002, J NEUROSCI, V22, P9358; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Dergham P, 2002, J NEUROSCI, V22, P6570; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evans LL, 1997, J CELL SCI, V110, P439; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; HEATH JP, 1993, SYM SOC EXP BIOL, V47, P35; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krarup T, 1998, AM J PHYSIOL-CELL PH, V275, pC239, DOI 10.1152/ajpcell.1998.275.1.C239; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Saito S, 1997, NEUROSCI LETT, V229, P73, DOI 10.1016/S0304-3940(97)00397-2; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schmidt JT, 2002, J NEUROBIOL, V52, P175, DOI 10.1002/neu.10083; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takizawa N, 2003, AM J PHYSIOL-CELL PH, V284, pC250, DOI 10.1152/ajpcell.00153.2002; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Welnhofer EA, 1999, J NEUROSCI, V19, P7971; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071	58	128	132	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					931	944		10.1016/S0896-6273(03)00754-2	http://dx.doi.org/10.1016/S0896-6273(03)00754-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659092	Bronze			2022-12-28	WOS:000187042200010
J	Cruz, JC; Tseng, HC; Goldman, JA; Shih, H; Tsai, LH				Cruz, JC; Tseng, HC; Goldman, JA; Shih, H; Tsai, LH			Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; PAIRED HELICAL FILAMENTS; TRANSGENIC MICE; ALZHEIMERS-DISEASE; TAU-PROTEIN; REGULATORY SUBUNIT; NERVOUS-SYSTEM; P35; PHOSPHORYLATION; BRAIN	Cyclin-dependent kinase 5 (Cdk5) and its regulatory subunit p35 are integral players in the proper development of the mammalian central nervous system. Proteolytic cleavage of p35 generates p25, leading to aberrant Cdk5 activation. The accumulation of p25 is implicated in several neurodegenerative diseases. In primary neurons, p25 causes apoptosis and tau hyperphosphorylation. Current mouse models expressing p25, however, fail to rigorously recapitulate these phenotypes in vivo. Here, we generated inducible transgenic mouse lines overexpressing p25 in the postnatal forebrain. Induction of p25 preferentially directed Cdk5 to pathological substrates. These animals exhibited neuronal loss in the cortex and hippocampus, accompanied by forebrain atrophy, astrogliosis, and caspase-3 activation. Endogenous tau was hyperphosphorylated at many epitopes, aggregated tau accumulated, and neurofibrillary pathology developed progressively in these animals. Our cumulative findings provide compelling evidence that in vivo deregulation of Cdk5 by p25 plays a causative role in neurodegeneration and the development of neurofibrillary pathology.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cruz, JC (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.							Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Allen B, 2002, J NEUROSCI, V22, P9340; Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Augustinack JC, 2002, J NEUROPATH EXP NEUR, V61, P557, DOI 10.1093/jnen/61.6.557; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bian F, 2002, J COMP NEUROL, V446, P257, DOI 10.1002/cne.10186; Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; Bu BT, 2002, J NEUROSCI, V22, P6515; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; HISANAGA SI, 1995, CELL MOTIL CYTOSKEL, V31, P283, DOI 10.1002/cm.970310405; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Keshvara L, 2002, J NEUROSCI, V22, P4869, DOI 10.1523/JNEUROSCI.22-12-04869.2002; Ko J, 2001, J NEUROSCI, V21, P6758; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li GB, 2003, J NEUROCHEM, V84, P347, DOI 10.1046/j.1471-4159.2003.01526.x; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Takashima A, 2001, NEUROSCI LETT, V306, P37, DOI 10.1016/S0304-3940(01)01864-X; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Van den Haute C, 2001, NEUROBIOL DIS, V8, P32, DOI 10.1006/nbdi.2000.0333; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146; Zhang FL, 2002, CELL MOTIL CYTOSKEL, V53, P81, DOI 10.1002/cm.10058; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	59	460	507	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					471	483		10.1016/S0896-6273(03)00627-5	http://dx.doi.org/10.1016/S0896-6273(03)00627-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642273	Bronze			2022-12-28	WOS:000186379000008
J	Chung, KKK; Dawson, TM				Chung, KKK; Dawson, TM			Parkin and Hsp70 sacked by BAG5	NEURON			English	Editorial Material							BODY FORMATION; NEURODEGENERATION; PATHOGENESIS	Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, are the major cause of early-onset Parkinson's disease (PD). In this issue of Neuron, Kalia et al. show that the bcl-2-associated athanogene 5 (BAG5) enhances dopamine neuron death in an in vivo model of PD through inhibiting the E3 ligase activity of parkin and the chaperone activity of Hsp70.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chung, KKK (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.							Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bonifati V, 2004, J MOL MED, V82, P163, DOI 10.1007/s00109-003-0512-1; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Shen J, 2004, NEURON, V44, P575, DOI 10.1016/j.neuron.2004.11.008; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200	11	20	21	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					899	901		10.1016/j.neuron.2004.12.007	http://dx.doi.org/10.1016/j.neuron.2004.12.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603730	Bronze			2022-12-28	WOS:000225842300001
J	Washbourne, P				Washbourne, P			Greasing transmission: Palmitoylation at the synapse	NEURON			English	Editorial Material							SNAP-25	Posttranslational modifications such as palmitoylation have the ability to modulate protein localization and function. The reversible addition of the fatty acid palmitate to proteins has been known to occur in neurons for a considerable amount of time and has been noticed to be of particular importance at synapses. In this issue of Neuron, Huang et al. and Fukata et al. describe their studies of palmitoyl transferases and how these enzymes specifically catalyze the modification of a number of synaptic proteins, including the postsynaptic scaffolding protein PSD-95.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Washbourne, P (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.							Bizzozero OA, 1997, NEUROPEDIATRICS, V28, P23, DOI 10.1055/s-2007-973660; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Hering H, 2003, J NEUROSCI, V23, P3262; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Veit M, 2000, MOL CELL NEUROSCI, V15, P408, DOI 10.1006/mcne.1999.0830; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625	8	18	19	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 16	2004	44	6					901	902		10.1016/S0896-6273(04)00799-8	http://dx.doi.org/10.1016/S0896-6273(04)00799-8			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603731	Bronze			2022-12-28	WOS:000225842300002
J	Torsney, C; MacDermott, AB				Torsney, C; MacDermott, AB			AMPA receptors bring on the pain	NEURON			English	Editorial Material								The role of Call-permeable AMPA receptors in pain processing has not been extensively studied. In this issue of Neuron, Hartmann et al. show that altering the levels of these receptors has consequences for inflammatory pain hypersensitivity but not acute pain processing.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University	Torsney, C (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.			Torsney, Carole/0000-0002-2448-3364				Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Engelman HS, 1999, J NEUROSCI, V19, P2081; Garry EA, 2004, PAIN, V109, P210, DOI 10.1016/j.pain.2004.04.002; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	7	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 18	2004	44	4					577	578		10.1016/j.neuron.2004.11.007	http://dx.doi.org/10.1016/j.neuron.2004.11.007			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541304	Bronze			2022-12-28	WOS:000225338100002
J	Mucke, L; Pitas, RE				Mucke, L; Pitas, RE			Food for thought: Essential fatty acid protects against neuronal deficits in transgenic mouse model of AD	NEURON			English	Editorial Material							ALZHEIMERS-DISEASE; GENOTYPE; MICE; BETA	Interactions between environmental and genetic factors may contribute to neurodegenerative disease. In this issue of Neuron, Calon et al. report that a diet low in an essential omega-3 polyunsaturated fatty acid (docosahexaenoic acid) depletes postsynaptic proteins and exacerbates behavioral alterations in a transgenic mouse model of Alzheimer's disease.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mucke, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, POB 419100, San Francisco, CA 94143 USA.							Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7	11	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 2	2004	43	5					596	599		10.1016/j.neuron.2004.08.025	http://dx.doi.org/10.1016/j.neuron.2004.08.025			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339638	Bronze			2022-12-28	WOS:000223691900002
J	Hasegawa, RP; Peterson, BW; Goldberg, ME				Hasegawa, RP; Peterson, BW; Goldberg, ME			Prefrontal neurons coding suppression of specific saccades	NEURON			English	Article							FRONTAL EYE FIELD; GO/NO-GO DISCRIMINATION; LATERAL INTRAPARIETAL AREA; MONKEY SUPERIOR COLLICULUS; INFERIOR TEMPORAL CORTEX; VISUAL-DISCRIMINATION; RHESUS-MONKEYS; ELECTRICAL-STIMULATION; PERCEPTUAL DECISION; PARIETAL CORTEX	The prefrontal cortex has been implicated in the suppression of unwanted behavior, based upon observations of humans and monkeys with prefrontal lesions. Despite this, there has been little direct neurophysiological evidence for a mechanism that suppresses specific behavior. In this study, we used an oculomotor delayed match/nonmatch-to-sample task in which monkeys had to remember a stimulus location either as a marker of where to look or as a marker of where not to look. We found a group of neurons in both the frontal eye field and the caudal prefrontal cortex that carried signals selective for the forbidden stimulus. The activity of these "don't look" neurons correlated with the monkeys' success or failure on the task. These results demonstrate a frontal signal that is related to the active suppression of one action while the subject performs another.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University; Northwestern University; National Institute of Advanced Industrial Science & Technology (AIST); Northwestern University	Hasegawa, RP (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA.	r-hasegawa@aist.go.jp	Hasegawa, Ryohei/Q-4296-2016	Hasegawa, Ryohei/0000-0001-9102-0434	NEI NIH HHS [P30 EY019007, R01 EY017039] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017039, P30EY019007] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIZZI E, 1967, SCIENCE, V157, P1588, DOI 10.1126/science.157.3796.1588; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; GOLDBERG ME, 1986, EXP BRAIN RES, V61, P579; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GUITTON D, 1985, EXP BRAIN RES, V58, P455; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hasegawa RP, 2000, SCIENCE, V290, P1786, DOI 10.1126/science.290.5497.1786; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; HASEGAWA RP, 2004, IN PRESS J NEUROPHYS; Hays AV, 1982, WESCON C P, V2, P1; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Iwabuchi A, 1998, INT J NEUROSCI, V94, P1, DOI 10.3109/00207459808986435; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; KELLER EL, 1974, J NEUROPHYSIOL, V37, P316, DOI 10.1152/jn.1974.37.2.316; KOMATSU H, 1993, J NEUROPHYSIOL, V70, P677, DOI 10.1152/jn.1993.70.2.677; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; LHERMITTE F, 1983, BRAIN, V106, P237, DOI 10.1093/brain/106.2.237; Li BM, 1998, NEUROSCI RES, V31, P83, DOI 10.1016/S0168-0102(98)00027-3; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Pare M, 2003, J NEUROSCI, V23, P6480; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAKAGAMI M, 1994, EXP BRAIN RES, V100, P165; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Sakagami M, 2001, J NEUROSCI, V21, P4801, DOI 10.1523/JNEUROSCI.21-13-04801.2001; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Tsujimoto T, 1997, NEUROSCI LETT, V224, P111, DOI 10.1016/S0304-3940(97)13480-2; van Hooff J.A.R.A.M., 1972, P209; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097	61	69	69	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 5	2004	43	3					415	425		10.1016/j.neuron.2004.07.013	http://dx.doi.org/10.1016/j.neuron.2004.07.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294148	Bronze			2022-12-28	WOS:000223156900014
J	Oddo, S; Billings, L; Kesslak, JP; Cribbs, DH; LaFerla, FM				Oddo, S; Billings, L; Kesslak, JP; Cribbs, DH; LaFerla, FM			A beta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome	NEURON			English	Article							TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; PROTEIN-DEGRADATION; AMYLOID DEPOSITION; MOUSE MODEL; IMMUNIZATION; PATHOLOGY; MICE; ANTIBODIES; INHIBITION	Amyloid-beta (Abeta) plaques and neurofibrillary tangles are the hallmark neuropathological lesions of Alzheimer's disease (AD). Using a triple transgenic model (3xTg-AD) that develops both lesions in AD-relevant brain regions, we determined the consequence of Abeta clearance on the development of tau pathology. Here we show that AD immunotherapy reduces not only extracellular Abeta plaques but also intracellular Abeta accumulation and most notably leads to the clearance of early tau pathology. We find that Abeta deposits are cleared first and subsequently reemerge prior to the tau pathology, indicative of a hierarchical and direct relationship between AD and tau. The clearance of the tau pathology is mediated by the proteasome and is dependent on the phosphorylation state of tau, as hyperphosphorylated tau aggregates are unaffected by the Abeta antibody treatment. These findings indicate that Abeta immunization may be useful for clearing both hallmark lesions of AD, provided that intervention occurs early in the disease course.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferia@uci.edu		Oddo, Salvatore/0000-0001-7304-7430	NIA NIH HHS [AG0212982] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Goldbaum O, 2003, J NEUROSCI, V23, P8872; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Gregori L, 1997, J BIOL CHEM, V272, P58; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; TSENG BT, 2004, IN PRESS CURR ALZHEI; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wilcock DM, 2004, NEUROBIOL DIS, V15, P11, DOI 10.1016/j.nbd.2003.09.015; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003	33	646	692	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					321	332		10.1016/j.neuron.2004.07.003	http://dx.doi.org/10.1016/j.neuron.2004.07.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294141	Bronze			2022-12-28	WOS:000223156900007
J	Kerns, JG; Cohen, JD; Stenger, VA; Carter, CS				Kerns, JG; Cohen, JD; Stenger, VA; Carter, CS			Prefrontal cortex guides context-appropriate responding during language production	NEURON			English	Article							WORKING-MEMORY; COGNITIVE CONTROL; COMPREHENSION; DEFICITS; FMRI; SCHIZOPHRENIA; DISSOCIATION; ORGANIZATION; COMPLETION; REPETITION	Although language processing is thought to frequently require cognitive control, little is known about the cognitive and neural basis of the control of language. Here, we demonstrate that processing of context by the PFC plays an important role in the control of language comprehension and production. Using a missing letter paradigm and fMRI, we found that increased activation in the PFC (but not in posterior regions), while encoding and maintaining context information, predicted context-appropriate responses. Furthermore, greater selection demands increased activity during responding in the same regions engaged during the encoding and maintenance of context. Overall, as in other cognitive task domains, these results suggest that PFC context processing plays an important role in the control of language.	Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; Princeton Univ, Ctr Study Mind Brain & Behav, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; Univ Calif Davis, Dept Psychiat, Dept Psychol, Sacramento, CA 95817 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Missouri System; University of Missouri Columbia; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Carter, CS (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA.	cameron.carter@ucdmc.ucdavis.edu						Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; Barch DM, 2002, J ABNORM PSYCHOL, V111, P478, DOI 10.1037//0021-843X.111.3.478; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BUCKNER RL, 1995, J NEUROSCI, V15, P12; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Cohen Jonathan D., 1992, P99; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; KARNI A, 1995, NATURE, V377, P155; Kerns JG, 2002, J ABNORM PSYCHOL, V111, P211, DOI 10.1037//0021-843X.111.2.211; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Michael EB, 2001, HUM BRAIN MAPP, V13, P239, DOI 10.1002/hbm.1036; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nathaniel-James DA, 2002, NEUROIMAGE, V16, P1094, DOI 10.1006/nimg.2002.1167; Newman SD, 2002, NEUROIMAGE, V15, P810, DOI 10.1006/nimg.2001.0997; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Ojemann JG, 1998, HUM BRAIN MAPP, V6, P203, DOI 10.1002/(SICI)1097-0193(1998)6:4<203::AID-HBM2>3.0.CO;2-7; OReilly R., 1999, MODELS WORKING MEMOR, P375, DOI [10.1017/cbo9781139174909.014, DOI 10.1017/CBO9781139174909.014]; Palmer ED, 2001, NEUROIMAGE, V14, P182, DOI 10.1006/nimg.2001.0779; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; ServanSchreiber D, 1996, ARCH GEN PSYCHIAT, V53, P1105; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	51	55	56	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					283	291		10.1016/j.neuron.2004.06.032	http://dx.doi.org/10.1016/j.neuron.2004.06.032			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260963	Bronze			2022-12-28	WOS:000222905400016
J	Liu, J; Lillo, C; Jonsson, PA; Velde, CV; Ward, CM; Miller, TM; Subramaniam, JR; Rothstein, JD; Marklund, S; Andersen, PM; Brannstrom, T; Gredal, O; Wong, PC; Williams, DS; Cleveland, DW				Liu, J; Lillo, C; Jonsson, PA; Velde, CV; Ward, CM; Miller, TM; Subramaniam, JR; Rothstein, JD; Marklund, S; Andersen, PM; Brannstrom, T; Gredal, O; Wong, PC; Williams, DS; Cleveland, DW			Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; MOLECULAR-WEIGHT COMPLEXES; DEAFNESS DYSTONIA SYNDROME; MOTOR-NEURON DEATH; CU,ZN-SUPEROXIDE DISMUTASE; DISEASE PROGRESSION; COPPER CHAPERONE; MUTATIONS	One cause of amyotrophic lateral sclerosis (ALS) is mutation in ubiquitously expressed copper/zinc superoxide dismutase (SOD1), but the mechanism of toxicity to motor neurons is unknown. Multiple disease-causing mutants, but not wild-type SOD1, are now demonstrated to be recruited to mitochondria, but only in affected tissues. This is independent of the copper chaperone for SOD1 and dismutase activity. Highly preferential association with spinal cord mitochondria is seen in human ALS for a mutant SOD1 that accumulates only to trace cytoplasmic levels. Despite variable proportions that are successfully imported, nearly constant amounts of SOD1 mutants and covalently damaged adducts of them accumulate as apparent import intermediates and/or are tightly aggregated or crosslinked onto integral membrane components on the cytoplasmic face of those mitochondria. These findings implicate damage from action of spinal cord-specific factors that recruit mutant SOD1 to spinal mitochondria as the basis for their selective toxicity in ALS.	Ludwig Inst Canc Res, Dept Neurosci Med & Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Umea Univ, Univ Hosp, Inst Clin Neurosci, Dept Med Biosci, S-90187 Umea, Sweden; Umea Univ, Univ Hosp, Inst Clin Neurosci, Dept Neurol, S-90187 Umea, Sweden; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Bispebjerg Hosp, Dept Neurol, Copenhagen, Denmark	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Umea University; Umea University; Johns Hopkins University; University of Copenhagen; Bispebjerg Hospital	Cleveland, DW (corresponding author), Ludwig Inst Canc Res, Dept Neurosci Med & Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Velde, Christine Vande/AAB-8828-2020; rothstein, jeffrey d/C-9470-2013; Lillo, Concepcion/A-6321-2009; Vande Velde, Christine/F-2721-2016	Lillo, Concepcion/0000-0001-5814-9826; Vande Velde, Christine/0000-0001-5926-1529; Subramaniam, Jamuna R/0000-0003-0343-2469; Cleveland, Don/0000-0002-1934-3682; Jonsson, Andreas/0000-0002-1938-0707	NEI NIH HHS [EY07042, R01 EY007042, EY12598] Funding Source: Medline; NIA NIH HHS [AG 000975] Funding Source: Medline; NINDS NIH HHS [NS40014, R37 NS027036, NS27036] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012598, R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS040014, R01NS027036] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Andrus PK, 1998, J NEUROCHEM, V71, P2041; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Orr HT, 2002, NAT NEUROSCI, V5, P287, DOI 10.1038/nn0402-287; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pfanner N, 2002, CURR OPIN CELL BIOL, V14, P400, DOI 10.1016/S0955-0674(02)00355-1; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Van Landeghem GF, 1999, EUR J NEUROL, V6, P639; Vukosavic S, 2000, J NEUROSCI, V20, P9119; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	62	395	405	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					5	17		10.1016/j.neuron.2004.06.016	http://dx.doi.org/10.1016/j.neuron.2004.06.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233913	Bronze			2022-12-28	WOS:000222549800003
J	Raivich, G; Bohatschek, M; Da Costa, C; Iwata, O; Galiano, M; Hristova, M; Nateri, AS; Makwana, M; Riera-Sans, L; Wolfer, DP; Lipp, HP; Aguzzi, A; Wagner, EF; Behrens, A				Raivich, G; Bohatschek, M; Da Costa, C; Iwata, O; Galiano, M; Hristova, M; Nateri, AS; Makwana, M; Riera-Sans, L; Wolfer, DP; Lipp, HP; Aguzzi, A; Wagner, EF; Behrens, A			The AP-1 transcription factor c-jun is required for efficient axonal regeneration	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; FACIAL MOTOR NUCLEUS; AMYOTROPHIC-LATERAL-SCLEROSIS; IMMUNE SURVEILLANCE; MOUSE DEVELOPMENT; NEURONAL DEATH; SPINAL-CORD; BRAIN; MICE; GENE	Nerve injury triggers numerous changes in the injured neurons and surrounding nonneuronal cells that ultimately result in successful target reinnervation or cell death. c-Jun is a component of the heterodimeric AP-1 transcription factor, and c-Jun is highly expressed in response to neuronal trauma. Here we have investigated the role of c-jun during axonal regeneration using mice lacking c-jun in the central nervous system. After transection of the facial nerve, the absence of c-Jun caused severe defects in several aspects of the axonal response, including perineuronal sprouting, lymphocyte recruitment, and microglial activation. c-Jun-deficient motorneurons were atrophic, resistant to axotomy-induced cell death, and showed reduced target muscle reinnervation. Expression of CD44, galanin, and alpha7beta1 integrin, molecules known to be involved in regeneration, was greatly impaired, suggesting a mechanism for c-Jun-mediated axonal growth. Taken together, our results identify c-Jun as an important regulator of axonal regeneration in the injured central nervous system.	London Res Inst, Mammalian Genet Lab, Canc Res UK, Lincolns Inn Fields Labs, London WC2A 3PX, England; UCL, Dept Obstet & Gynaecol, Perinatal Brain Repair Grp, London WC1E 6HX, England; UCL, Dept Anat, London WC1E 6HX, England; UCL, London WC1E 6JJ, England; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; Univ Spital Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; Res Inst Mol Pathol, A-1030 Vienna, Austria	Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; University of Zurich; University of Zurich; University Zurich Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Behrens, A (corresponding author), London Res Inst, Mammalian Genet Lab, Canc Res UK, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk	Aguzzi, Adriano/A-3351-2008; Raivich, Gennadij/AAL-7229-2021; Wolfer, David P/B-3293-2016; Raivich, Gennadij/A-6770-2011	Wolfer, David P/0000-0002-5957-1401; Makwana, Milan/0000-0002-5198-5466; Aguzzi, Adriano/0000-0002-0344-6708; Behrens, Axel/0000-0002-1557-1143; Wagner, Erwin F/0000-0001-7872-0196; Da Costa, Clive/0000-0002-0435-6747; Shams Nateri, Abdolrahman/0000-0002-6422-6813				ALDSKOGIUS H, 1986, BRAIN RES, V375, P126, DOI 10.1016/0006-8993(86)90965-0; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Anouar Y, 1999, MOL PHARMACOL, V56, P162, DOI 10.1124/mol.56.1.162; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bohatschek M, 2004, J COMP NEUROL, V470, P382, DOI 10.1002/cne.20017; Butterworth NJ, 1996, MOL BRAIN RES, V43, P1, DOI 10.1016/S0169-328X(96)00143-X; Cajal S., 1928, DEGENERATION REGENER; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Galiano M, 2001, EUR J NEUROSCI, V14, P327, DOI 10.1046/j.0953-816x.2001.01647.x; Gass P, 2000, EMBO REP, V1, P447, DOI 10.1093/embo-reports/kvd088; Gendelman HE, 2002, J NEUROVIROL, V8, P474, DOI 10.1080/13550280290168631; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Goldstein LSB, 2001, SCIENCE, V291, P2102, DOI 10.1126/science.1059766; Hai T, 1999, GENE EXPRESSION, V7, P321; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Jones LL, 1997, EUR J NEUROSCI, V9, P1854, DOI 10.1111/j.1460-9568.1997.tb00752.x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; LEE TH, 1993, J BIOL CHEM, V268, P6154; Lin L, 2003, EUR J NEUROSCI, V17, P2299, DOI 10.1046/j.1460-9568.2003.02686.x; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; MAEHLEN J, 1989, J NEUROIMMUNOL, V23, P125, DOI 10.1016/0165-5728(89)90031-3; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Moller JC, 1996, GLIA, V17, P121; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Raivich G, 1998, J NEUROSCI, V18, P5804; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Schwaiger FW, 1998, PROG BRAIN RES, V117, P197; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Serpe CJ, 1999, J NEUROSCI, V19; Stoll G, 1999, BRAIN PATHOL, V9, P313; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Werner A, 2000, J NEUROSCI, V20, P1822; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wynick D, 2001, Curr Opin Pharmacol, V1, P73, DOI 10.1016/S1471-4892(01)00006-6	61	350	358	3	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 8	2004	43	1					57	67		10.1016/j.neuron.2004.06.005	http://dx.doi.org/10.1016/j.neuron.2004.06.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233917	Bronze			2022-12-28	WOS:000222549800007
J	Calakos, N; Schoch, S; Sudhof, TC; Malenka, RC				Calakos, N; Schoch, S; Sudhof, TC; Malenka, RC			Multiple roles for the active zone protein RIM1 alpha in late stages of neurotransmitter release	NEURON			English	Article							RIM-BINDING-PROTEINS; SYNAPTIC-VESICLE FUSION; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; RAB3 EFFECTOR; CA2+ CHANNELS; LIPRIN-ALPHA; FAMILY; MUNC13-1	The active zone protein RIM1alpha interacts with multiple active zone and synaptic vesicle proteins and is implicated in short- and long-term synaptic plasticity, but it is unclear how RIM1alpha's biochemical interactions translate into physiological functions. To address this question, we analyzed synaptic transmission in autaptic neurons cultured from RIM1alpha(-/-) mice. Deletion of RIM1alpha causes a large reduction in the readily releasable pool of vesicles, alters short-term plasticity, and changes the properties of evoked asynchronous release. Lack of RIM1alpha, however, had no effect on synapse formation, spontaneous release, overall Call sensitivity of release, or synaptic vesicle recycling. These results suggest that RIM1alpha modulates sequential steps in synaptic vesicle exocytosis through serial protein-protein interactions and that this modulation is the basis for RIM1alpha's role in synaptic plasticity.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Schoch, Susanne/F-7741-2012		NIMH NIH HHS [MH63394] Funding Source: Medline; NINDS NIH HHS [NS41344] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R01MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS041344] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; NOBLE M, 1998, CULTURING NERVE CELL, P526; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SCHLUTER O, 2004, IN PRESS J NEUROSCI; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200; Sun L, 2002, ANN NY ACAD SCI, V971, P244, DOI 10.1111/j.1749-6632.2002.tb04468.x; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	37	117	120	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					889	896		10.1016/j.neuron.2004.05.014	http://dx.doi.org/10.1016/j.neuron.2004.05.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207234	Bronze			2022-12-28	WOS:000222329300005
J	Cui, ZZ; Wang, HM; Tan, YS; Zaia, KA; Zhang, SQ; Tsien, JZ				Cui, ZZ; Wang, HM; Tan, YS; Zaia, KA; Zhang, SQ; Tsien, JZ			Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain	NEURON			English	Article							FEAR-POTENTIATED STARTLE; PERIRHINAL CORTEX; RETROGRADE-AMNESIA; RECOGNITION MEMORY; CONDITIONED FEAR; CONTEXTUAL FEAR; CONSOLIDATION; HIPPOCAMPUS; LESIONS; EXPRESSION	Long-term storage of information is a hallmark feature of the brain, yet routine turnover of synaptic receptors appears to be intrinsically paradoxical to this capability. To investigate how the brain preserves its delicate synaptic efficacies, we generated inducible and reversible knockout mice in which the NMDA receptor can be temporarily switched off in the forebrain specifically during the storage stage. Retention of 9-month contextual and cued fear memories is severely disrupted by prolonged, but not transient, loss of the NMDA receptor that occurs 6 months after initial training and at least 2 months prior to memory retrieval. Normal learning and memory function in subsequent tasks following the 9-month retention tests suggest that the observed retention deficits did not result from recall or performance impairment. Thus, our study reveals a hitherto unrecognized role of the NMDA receptor in dynamically maintaining the long-term synaptic stability of memory storage circuits in the brain.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Tsien, JZ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jtsien@princeton.edu						Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bucci DJ, 2000, BEHAV NEUROSCI, V114, P882, DOI 10.1037//0735-7044.114.5.882; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; DAVIS M, 1987, ANXIETY AMYGDALA PHA; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FALLS WA, 1992, J NEUROSCI, V12, P854; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frey J U, 2001, Results Probl Cell Differ, V34, P27; Hedou G, 2003, PHILOS T R SOC B, V358, P797, DOI 10.1098/rstb.2002.1245; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lechner HA, 1999, LEARN MEMORY, V6, P77; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maren S, 1996, BEHAV NEUROSCI, V110, P718, DOI 10.1037/0735-7044.110.4.718; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROSEN JB, 1992, J NEUROSCI, V12, P4624; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Squire L. R., 1987, MEMORY BRAIN; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Suzuki WA, 1996, CURR OPIN NEUROBIOL, V6, P179, DOI 10.1016/S0959-4388(96)80071-7; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 2000, SCI AM, V282, P62, DOI 10.1038/scientificamerican0400-62; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V123, P519, DOI 10.1111/j.1748-1716.1985.tb07621.x; Wittenberg GM, 2002, HIPPOCAMPUS, V12, P637, DOI 10.1002/hipo.10102; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Zola SM, 2001, HIPPOCAMPUS, V11, P92, DOI 10.1002/hipo.1027; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	60	133	142	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					781	793		10.1016/S0896-6273(04)00072-8	http://dx.doi.org/10.1016/S0896-6273(04)00072-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003177	Bronze			2022-12-28	WOS:000221458200013
J	Roseberry, AG; Liu, HY; Jackson, AC; Cai, XL; Friedman, JM				Roseberry, AG; Liu, HY; Jackson, AC; Cai, XL; Friedman, JM			Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice	NEURON			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; RECEPTOR MESSENGER-RNA; AGOUTI-RELATED PROTEIN; OBESE GENE-PRODUCT; LEPTIN RECEPTOR; POTASSIUM CONDUCTANCE; MOUSE HYPOTHALAMUS; POMC NEURONS; FOOD-INTAKE; DB/DB MICE	NPY and alphaMSH are expressed in distinct neurons in the arcuate nucleus of the hypothalamus, where alphaMSH decreases and NPY increases food intake and body weight. Here we use patch-clamp electrophysiology from GFP-labeled POMC and NPY neurons to demonstrate that NPY strongly hyperpolarized POMC neurons through the Y1R-mediated activation of GIRK channels, while the alphaMSH analog, MTII, had no effect on activity of NPY neurons. While initially NPY had similar effects on POMC neurons derived from ob/ob mice, further studies revealed a significant increase in desensitization of the NPY-induced currents in POMC neurons from ob/ob mice. This increase in desensitization was specific to NPY, as GABA(B) and muOR agonists showed unaltered desensitization in POMC neurons from ob/ob mice. These data reveal an intricate and asymmetric interplay between NPY and POMC neurons in the hypothalamus and have important implications for the delineation of the neural circuits that regulate feeding behavior.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave,Box 305, New York, NY 10021 USA.	friedj@rockefeller.edu	Friedman, Jeffrey M/E-5784-2011	Roseberry, Aaron/0000-0003-0468-0333	NIDDK NIH HHS [F32 DK61176, R01 DK410096] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK061176] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bagnol D, 1999, J NEUROSCI, V19; BAI FL, 1985, BRAIN RES, V331, P172, DOI 10.1016/0006-8993(85)90730-9; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Broberger C, 1998, J COMP NEUROL, V402, P460; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; LOOSE MD, 1991, NEUROENDOCRINOLOGY, V54, P537, DOI 10.1159/000125979; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Michel MC, 1998, PHARMACOL REV, V50, P143; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; SAWCHENKO PE, 1982, BRAIN RES, V232, P365; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; STANLEY BG, 1986, PEPTIDES, V7, P1189; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	39	147	148	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					711	722		10.1016/S0896-6273(04)00074-1	http://dx.doi.org/10.1016/S0896-6273(04)00074-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003171	Bronze			2022-12-28	WOS:000221458200007
J	Tanaka, T; Serneo, FF; Tseng, HC; Kulkarni, AB; Tsai, LH; Gleeson, JG				Tanaka, T; Serneo, FF; Tseng, HC; Kulkarni, AB; Tsai, LH; Gleeson, JG			Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; MICROTUBULE-ASSOCIATED PROTEIN; DYNEIN HEAVY-CHAIN; DEVELOPMENTAL-CHANGES; TAU-PHOSPHORYLATION; C-ELEGANS; LOCALIZATION; EXPRESSION; LIS1; P35	Mutations in the doublecortin (DCX) gene in human or targeted disruption of the cdk5 gene in mouse lead to similar cortical lamination defects in the developing brain. Here we show that Dcx is phosphorylated by Cdk5. Dcx phosphorylation is developmentally regulated and corresponds to the timing of expression of p35, the major activating subunit for Cdk5. Mass spectrometry and Western blot analysis indicate phosphorylation at Dcx residue Ser297. Phosphorylation of Dcx lowers its affinity to microtubules in vitro, reduces its effect on polymerization, and displaces it from microtubules in cultured neurons. Mutation of Ser297 blocks the effect of Dcx on migration in a fashion similar to pharmacological inhibition of Cdk5 activity. These results suggest that Dcx phosphorylation by Cdk5 regulates its actions on migration through an effect on microtubules.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02115 USA; Natl Inst Dent & Craniofacial Res, Funct Genom Unit, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [R01 NS041537] Funding Source: Medline; PHS HHS [N5047101] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bhaskar K, 2004, NEUROCHEM INT, V44, P35, DOI 10.1016/S0197-0186(03)00099-8; Bix GJ, 1998, J NEUROSCI, V18, P307; BRADY ST, 1984, J CELL BIOL, V99, P1716, DOI 10.1083/jcb.99.5.1716; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Corbo JC, 2002, J NEUROSCI, V22, P7548; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gilmore EC, 2001, J NEUROSCI, V21, P9690, DOI 10.1523/JNEUROSCI.21-24-09690.2001; Glantz SA, 1996, PRIMER BIOSTATISTICS; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Keshvara L, 2002, J NEUROSCI, V22, P4869, DOI 10.1523/JNEUROSCI.22-12-04869.2002; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Ko J, 2001, J NEUROSCI, V21, P6758; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MATSUSHITA M, 1995, NEUROREPORT, V6, P1267, DOI 10.1097/00001756-199506090-00009; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; TSAI LH, 1993, DEVELOPMENT, V119, P1029; VALLEE RB, 1986, METHODS ENZYMOL, V134, P89; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zaman K, 1999, J NEUROSCI, V19, P9821	63	183	192	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					215	227		10.1016/S0896-6273(03)00852-3	http://dx.doi.org/10.1016/S0896-6273(03)00852-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741103	Bronze			2022-12-28	WOS:000221457800008
J	van den Pol, AN				van den Pol, AN			Weighing the role of hypothalamic feeding neurotransmitters	NEURON			English	Review							NEUROPEPTIDE-Y; ARCUATE NUCLEUS; POMC NEURONS; MICE LACKING; BODY-WEIGHT; FOOD-INTAKE; GLUTAMATE; OBESITY; BEHAVIOR; RECEPTOR	Growing health problems related to obesity have focused considerable attention on a number of neurotransmitters, particularly hypothalamic neuropeptides, involved in regulating energy homeostasis and food intake. As the fast-acting transmitters GABA and glutamate underlie the majority of fast synaptic activity in the hypothalamus, understanding neuropeptide modulation of amino acid transmitter actions may be key to a full appreciation of how the brain controls caloric balances.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA	Yale University	van den Pol, AN (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.							Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Belousov AB, 1997, J PHYSIOL-LONDON, V499, P747, DOI 10.1113/jphysiol.1997.sp021966; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DECAVEL C, 1990, J COMP NEUROL, V302, P1019, DOI 10.1002/cne.903020423; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gura T, 2003, SCIENCE, V299, P849, DOI 10.1126/science.299.5608.849; HERKENHAM M, 1987, NEUROSCIENCE, V23, P1, DOI 10.1016/0306-4522(87)90268-5; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; POGGIOLI R, 1986, PEPTIDES, V7, P843, DOI 10.1016/0196-9781(86)90104-X; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; SAWCHENKO PE, 1985, J COMP NEUROL, V241, P138, DOI 10.1002/cne.902410203; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759	23	86	87	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1059	1061		10.1016/S0896-6273(03)00809-2	http://dx.doi.org/10.1016/S0896-6273(03)00809-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687541	Bronze			2022-12-28	WOS:000187503400005
J	Yovel, G; Kanwisher, N				Yovel, G; Kanwisher, N			Face perception: Domain specific, not process specific	NEURON			English	Article							HUMAN FUSIFORM GYRUS; UPSIDE-DOWN FACES; CONFIGURAL INFORMATION; INVERTED FACES; RECOGNITION; INVERSION; OBJECT; AREA; CORTEX; EXPERTISE	Evidence that face perception is mediated by special cognitive and neural mechanisms comes from fMRI studies of the fusiform face area (FFA) and behavioral studies of the face inversion effect. Here, we used these two methods to ask whether face perception mechanisms are stimulus specific, process specific, or both. Subjects discriminated pairs of upright or inverted faces or house stimuli that differed in either the spatial distance among parts (configuration) or the shape of the parts. The FFA showed a much higher response to faces than to houses, but no preference for the configuration task over the part task. Similarly, the behavioral inversion effect was as large in the part task as the configuration task for faces, but absent in both part and configuration tasks for houses. These findings indicate that face perception mechanisms are not process specific for parts or configuration but are domain specific for face stimuli per se.	MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Yovel, G (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Sci, Cambridge, MA 02139 USA.	galit@mit.edu	Yovel, Galit/GPT-4409-2022	Yovel, Galit/0000-0003-0971-2357	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, R01RR016594] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR14075, R01 RR16594-01A1] Funding Source: Medline; NEI NIH HHS [EY13455] Funding Source: Medline; PHS HHS [66696] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, 2003, VISUAL NEUROSCIENCES, P1179; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MALCOM G, 2005, IN PRESS PERCEPTION; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; MCKONE E, 2005, IN PRESS MONKEY BRAI; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; RHODES G, 1994, VIS COGN, V1, P275, DOI DOI 10.1080/13506289408402303; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; RIESENHUBER M, 2004, IN PRESS BIOL LETT; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Tanaka J.W., 2006, PERCEPTION FACES OBJ, P53, DOI [10.1093/acprof:oso/9780195313659.003.0003, DOI 10.1093/ACPROF:OSO/9780195313659.003.0003]; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Wada Y, 2001, J NEUROL NEUROSUR PS, V71, P254, DOI 10.1136/jnnp.71.2.254; Williams MA, 2004, COGNITION, V91, P155, DOI 10.1016/j.cognition.2003.08.002; XU Y, 2005, IN PRESS NEUROPSYCHO; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; YOVEL G, IN PRESS VIS COGN	47	374	383	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					889	898		10.1016/S0896-6273(04)00728-7	http://dx.doi.org/10.1016/S0896-6273(04)00728-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572118	Bronze			2022-12-28	WOS:000225548400015
J	Greene, JD; Nystrom, LE; Engell, AD; Darley, JM; Cohen, JD				Greene, JD; Nystrom, LE; Engell, AD; Darley, JM; Cohen, JD			The neural bases of cognitive conflict and control in moral judgment	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; FMRI; ACTIVATION; INSIGHTS	Traditional theories of moral psychology emphasize reasoning and "higher cognition," while more recent work emphasizes the role of emotion. The present fMRI data support a theory of moral judgment according to which both "cognitive" and emotional processes play crucial and sometimes mutually competitive roles. The present results indicate that brain regions associated with abstract reasoning and cognitive control (including dorsolateral prefrontal cortex and anterior cingulate cortex) are recruited to resolve difficult personal moral dilemmas in which utilitarian values require "personal" moral violations, violations that have previously been associated with increased activity in emotion-related brain regions. Several regions of frontal and parietal cortex predict intertrial differences in moral judgment behavior, exhibiting greater activity for utilitarian judgments. We speculate that the controversy surrounding utilitarian moral philosophy reflects an underlying tension between competing subsystems in the brain.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University; Princeton University	Greene, JD (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	jdgreene@princeton.edu	Engell, Andrew/V-6521-2019	Engell, Andrew/0000-0002-4852-4909	NIMH NIH HHS [MH067410] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH067410] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COLES MGH, 1995, ACTA PSYCHOL, V90, P129, DOI 10.1016/0001-6918(95)00020-U; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio A.R., 2005, DESCARTES ERROR EMOT; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; DeWaal Frans B. M., 1996, GOOD NATURED ORIGINS; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Greene J, 2003, NAT REV NEUROSCI, V4, P846, DOI 10.1038/nrn1224; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; GREENE J, 2004, IN PRESS PHILOS T R; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kant I., 1959, FDN METAPHYSICS MORA; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; MCCLURE SM, 2004, IN PRESS SCIENCE; Mill JohnStuart., 1957, UTILITARIANISM; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Posner M. I., 1975, ATTENTION COGNITIVE, P55, DOI 10.1007/978-1-4613-2985-5; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomson J Jarvis, 1986, RIGHTS RESTITUTION R; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	46	1444	1495	24	340	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					389	400		10.1016/j.neuron.2004.09.027	http://dx.doi.org/10.1016/j.neuron.2004.09.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	864LU	15473975	Bronze			2022-12-28	WOS:000224635800019
J	Rodrigues, SM; Schafe, GE; LeDoux, JE				Rodrigues, SM; Schafe, GE; LeDoux, JE			Molecular mechanisms underlying emotional learning and memory in the lateral amygdala	NEURON			English	Review							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; RAT BASOLATERAL AMYGDALA; METABOTROPIC GLUTAMATE RECEPTORS; ELEMENT-BINDING PROTEIN; D-ASPARTATE RECEPTOR; GATED CALCIUM-CHANNELS; GENE C-FOS; GABAERGIC SYNAPTIC-TRANSMISSION; CONDITIONED FEAR RESPONSES	Fear conditioning is a valuable behavioral paradigm for studying the neural basis of emotional learning and memory. The lateral nucleus of the amygdala (LA) is a crucial site of neural changes that occur during fear conditioning. Pharmacological manipulations of the LA, strategically timed with respect to training and testing, have shed light on the molecular events that mediate the acquisition of fear associations and the formation and maintenance of long-term memories of those associations. Similar mechanisms have been found to underlie long-term potentiation (LTP) in LA, an artificial means of inducing synaptic plasticity and a physiological model of learning and memory. Thus, LTP-like changes in synaptic plasticity may underlie fear conditioning. Given that the neural circuit underlying fear conditioning has been implicated in emotional disorders in humans, the molecular mechanisms of fear conditioning are potential targets for psychotherapeutic drug development.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	New York University; Yale University	LeDoux, JE (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	ledoux@cns.nyu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, K05MH067048, P50MH058911, R37MH038774] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH38774, R01 MH46516, P50 MH58911, K05 MH067048] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Alagarsamy S, 2001, CURR OPIN NEUROBIOL, V11, P357, DOI 10.1016/S0959-4388(00)00219-1; Alberini CM, 1999, J EXP BIOL, V202, P2887; ALBERINI CM, 1995, ANN NY ACAD SCI, V758, P261, DOI 10.1111/j.1749-6632.1995.tb24833.x; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Azad SC, 2003, LEARN MEMORY, V10, P116, DOI 10.1101/lm.53303; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; BARNES CA, 1995, NEURON, V15, P751, DOI 10.1016/0896-6273(95)90166-3; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; BAUER EP, 2004, IN PRESS J NEUROSCI; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BECK CHM, 1995, J NEUROSCI, V15, P709; Bejar R, 2002, J NEUROSCI, V22, P5719; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Berman DE, 1998, J NEUROSCI, V18, P10037; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Blank T, 2002, J NEUROSCI, V22, P3788; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blum S, 1999, J NEUROSCI, V19, P3535; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CAMPEAU S, 1992, BEHAV NEUROSCI, V106, P569, DOI 10.1037/0735-7044.106.3.569; CHAMPMAN PF, 2003, ANN NY ACAD SCI, V985, P114; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; CLUGNET MC, 1990, J NEUROSCI, V10, P1055; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Danober L, 1998, NEUROSCIENCE, V85, P427, DOI 10.1016/S0306-4522(97)00648-9; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; De Blasi A, 2001, TRENDS PHARMACOL SCI, V22, P114, DOI 10.1016/S0165-6147(00)01635-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Dubnau J, 2003, J NEUROBIOL, V54, P238, DOI 10.1002/neu.10170; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Eichenbaum H, 1997, NEURON, V19, P481, DOI 10.1016/S0896-6273(00)80364-5; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Fendt M, 2001, J NEUROSCI, V21, P4111, DOI 10.1523/JNEUROSCI.21-11-04111.2001; Fendt M, 2002, EUR J NEUROSCI, V15, P1535, DOI 10.1046/j.1460-9568.2002.01988.x; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; FLEXNER LB, 1965, J NEUROCHEM, V12, P535, DOI 10.1111/j.1471-4159.1965.tb04246.x; Frankland PW, 2003, NEUROSCIENTIST, V9, P104, DOI 10.1177/1073858403252225; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Fukunaga K, 2000, NEUROSCI RES, V38, P3, DOI 10.1016/S0168-0102(00)00139-5; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Gewirtz JC, 1997, NATURE, V388, P471, DOI 10.1038/41325; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Goosens KA, 2000, BEHAV BRAIN RES, V114, P145, DOI 10.1016/S0166-4328(00)00224-2; Goosens KA, 2002, HIPPOCAMPUS, V12, P592, DOI 10.1002/hipo.10099; GORDON WC, 1994, ANIMAL LEARNING COGN, P255; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heinbockel T, 2000, J NEUROSCI, V20; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOZLL, 2004, PLOS BIOL, V2, pE225, DOI DOI 10.1371/JOURNAL.PB23.0020225; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Jia ZP, 1998, LEARN MEMORY, V5, P331; Johnson TD, 1996, TRENDS PHARMACOL SCI, V17, P22, DOI 10.1016/0165-6147(96)81566-5; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; KANDEL E R, 1986, Neuroscience Research, V3, P498, DOI 10.1016/0168-0102(86)90050-7; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karst H, 2002, EUR J NEUROSCI, V16, P1083, DOI 10.1046/j.1460-9568.2002.02172.x; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kaschel T, 2004, SYNAPSE, V53, P141, DOI 10.1002/syn.20045; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Koyama S, 1999, J PHYSIOL-LONDON, V518, P525, DOI 10.1111/j.1469-7793.1999.0525p.x; Koyama S, 2002, LIFE SCI, V72, P375, DOI 10.1016/S0024-3205(02)02280-4; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Lamprecht R, 1999, CELL MOL LIFE SCI, V55, P554, DOI 10.1007/s000180050314; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee H, 1998, J NEUROSCI, V18, P8444; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Levine ES, 2000, J NEUROSCI RES, V62, P357, DOI 10.1002/1097-4547(20001101)62:3<357::AID-JNR5>3.0.CO;2-6; LI XF, 1995, EXP BRAIN RES, V105, P87; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LYNCH G, 1986, SYNAPSES CIRCUITS BE; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Malkani S, 2000, NEUROSCIENCE, V97, P693, DOI 10.1016/S0306-4522(00)00058-0; Mao LM, 2002, MOL PHARMACOL, V62, P473, DOI 10.1124/mol.62.3.473; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2003, EUR J NEUROSCI, V18, P3080, DOI 10.1111/j.1460-9568.2003.03063.x; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; McDonald AJ, 2002, J COMP NEUROL, V446, P199, DOI 10.1002/cne.10204; McDonald AJ, 2001, NEUROSCIENCE, V107, P641, DOI 10.1016/S0306-4522(01)00380-3; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morales M, 2004, J COMP NEUROL, V468, P205, DOI 10.1002/cne.10968; Moriya T, 2000, EUR J NEUROSCI, V12, P3307, DOI 10.1046/j.1460-9568.2000.00203.x; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pistis M, 2004, NEUROPHARMACOLOGY, V46, P115, DOI 10.1016/j.neuropharm.2003.08.003; Pitman RK, 2001, J CLIN PSYCHIAT, V62, P47; Platenik J, 2000, LIFE SCI, V67, P335, DOI 10.1016/S0024-3205(00)00632-9; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; QUICK J, 1992, BIOCHEM BIOPH RES CO, V187, P657, DOI 10.1016/0006-291X(92)91245-L; QUIRK QJ, 2003, ANN NY ACAD SCI, V985, P263; Rae MG, 2000, J NEUROSCI, V20, P8628; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; Rammes G, 2001, NEUROSCIENCE, V107, P85, DOI 10.1016/S0306-4522(01)00336-0; Rampon C, 2000, HIPPOCAMPUS, V10, P605, DOI 10.1002/1098-1063(2000)10:5<605::AID-HIPO11>3.0.CO;2-3; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosen JB, 1998, BRAIN RES, V796, P132, DOI 10.1016/S0006-8993(98)00294-7; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Rubin MA, 2004, J NEUROSCI, V24, P2328, DOI 10.1523/JNEUROSCI.1622-03.2004; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 1999, LEARN MEMORY, V6, P97; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Scicli AP, 2004, BEHAV NEUROSCI, V118, P5, DOI 10.1037/0735-7044.118.1.5; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Silva AJ, 2003, J NEUROBIOL, V54, P224, DOI 10.1002/neu.10169; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; SOTRESBAYON F, 2004, IN PRESS LEARN MEM; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Stork O, 2002, NEUROSCI LETT, V327, P138, DOI 10.1016/S0304-3940(02)00387-7; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stutzmann GE, 1999, J NEUROSCI, V19; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Szinyei C, 2003, J NEUROSCI, V23, P2549; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Walker DL, 2000, BEHAV NEUROSCI, V114, P1019, DOI 10.1037//0735-7044.114.6.1019; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Weeber EJ, 2000, J NEUROSCI, V20, P5906, DOI 10.1523/JNEUROSCI.20-16-05906.2000; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Woolf NJ, 1998, PROG NEUROBIOL, V55, P59, DOI 10.1016/S0301-0082(97)00094-4; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	231	361	378	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					75	91		10.1016/j.neuron.2004.09.014	http://dx.doi.org/10.1016/j.neuron.2004.09.014			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450161	Bronze			2022-12-28	WOS:000224232600008
J	Polleux, F				Polleux, F			Generation of the cortical area map: Emx2 strikes back	NEURON			English	Editorial Material							NEOCORTEX; IDENTITY; CORTEX	The recent identification of molecular cues involved in the generation of the cortical area map, such as the patterning molecule FGF8 and transcription factors such as Emx2, represents an important breakthrough. In this issue of Neuron, Hamasaki et al. use a genetic approach to explore how these signals interact and propose that Emx2 plays a direct, largely FGF8-independent role in the control of the relative size and position that each area occupies within the cortex.	Univ N Carolina, Dept Pharmacol, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Polleux, F (corresponding author), Univ N Carolina, Dept Pharmacol, Ctr Neurosci, 105 Mason Farm Rd,NRB 8109C, Chapel Hill, NC 27599 USA.		Polleux, Franck/H-9948-2014	Polleux, Franck/0000-0003-4313-0481				Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Dehay C, 2001, J NEUROSCI, V21, P201, DOI 10.1523/JNEUROSCI.21-01-00201.2001; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; LaMantia AS, 2000, NEURON, V28, P411, DOI 10.1016/S0896-6273(00)00121-5; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115	13	3	5	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 5	2004	43	3					295	297		10.1016/j.neuron.2004.07.025	http://dx.doi.org/10.1016/j.neuron.2004.07.025			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294136	Bronze			2022-12-28	WOS:000223156900002
J	Shah, NM; Pisapia, DJ; Maniatis, S; Mendelsohn, MM; Nemes, A; Axel, R				Shah, NM; Pisapia, DJ; Maniatis, S; Mendelsohn, MM; Nemes, A; Axel, R			Visualizing sexual dimorphism in the brain	NEURON			English	Article							MEDIAL PREOPTIC AREA; STRIA TERMINALIS; BED NUCLEUS; MALE-RATS; MICE LACKING; MOUSE-BRAIN; ALKALINE-PHOSPHATASE; AGGRESSIVE-BEHAVIOR; COPULATORY-BEHAVIOR; DIFFERENT PATTERNS	Sexually dimorphic behaviors are likely to involve neural pathways that express the androgen receptor (AR). We have genetically modified the AR locus to visualize dimorphisms in neuronal populations that express AR. Analysis of AR-positive neurons reveals both known dimorphisms in the preoptic area of the hypothalamus and the bed nucleus of the stria terminalis as well as novel dimorphic islands in the basal forebrain with a clarity unencumbered by the vast population of AR-negative neurons. This genetic approach allows the visualization of dimorphic subpopulations of AR-positive neurons along with their projections and may ultimately permit an association between neural circuits and specific dimorphic behaviors.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 701W 168th St,HHSC 1014, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076				ALLEN LS, 1989, J NEUROSCI, V9, P497; BREEDLOVE SM, 1980, SCIENCE, V210, P564, DOI 10.1126/science.7423210; Byne W, 2000, BRAIN RES, V856, P254, DOI 10.1016/S0006-8993(99)02458-0; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; CLARO F, 1995, BRAIN RES BULL, V36, P1, DOI 10.1016/0361-9230(94)00118-K; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; DEVRIES GJ, 1990, J NEUROENDOCRINOL, V2, P1, DOI 10.1111/j.1365-2826.1990.tb00385.x; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; EDWARDS DA, 1969, PHYSIOL BEHAV, V4, P333, DOI 10.1016/0031-9384(69)90185-1; EMERY DE, 1976, PHYSIOL BEHAV, V17, P803, DOI 10.1016/0031-9384(76)90044-5; Eriksson A, 1999, MOL BRAIN RES, V74, P91, DOI 10.1016/S0169-328X(99)00265-X; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; Goy R. W., 1980, SEXUAL DIFFERENTIATI; Greco B, 1998, HORM BEHAV, V33, P125, DOI 10.1006/hbeh.1998.1443; Greco B, 1998, BRAIN RES, V781, P15, DOI 10.1016/S0006-8993(97)01136-0; Gu G, 2003, J COMP NEUROL, V460, P542, DOI 10.1002/cne.10677; HINES M, 1985, J NEUROSCI, V5, P40; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Hutton LA, 1998, J NEUROSCI, V18, P3003; JOPPA MA, 1995, NEUROSCIENCE, V68, P783, DOI 10.1016/0306-4522(95)00179-M; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KELLEY DB, 1986, J NEUROBIOL, V17, P231, DOI 10.1002/neu.480170307; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; KONISHI M, 1982, TRENDS NEUROSCI, V5, P20, DOI 10.1016/0166-2236(82)90011-X; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LAHR G, 1995, MOL BRAIN RES, V33, P179; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Liu YC, 1997, J NEUROSCI, V17, P5245; MACLUSKY NJ, 1987, STEROIDS, V50, P495; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; OHNO S, 1974, CELL, V3, P235, DOI 10.1016/0092-8674(74)90137-8; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; RAISMAN G, 1971, SCIENCE, V173, P731, DOI 10.1126/science.173.3998.731; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; SEGOVIA S, 1993, BRAIN RES REV, V18, P51, DOI 10.1016/0165-0173(93)90007-M; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Simpson ER, 2000, P NATL ACAD SCI USA, V97, P14038, DOI 10.1073/pnas.011526097; Stefanova N, 2000, ADV ANAT EMBRYOL CEL, V158, P1; Tinbergen N, 1951, STUDY INSTINCT; Toda K, 2001, J ENDOCRINOL, V168, P217, DOI 10.1677/joe.0.1680217; Veening JG, 1998, BEHAV BRAIN RES, V92, P181, DOI 10.1016/S0166-4328(97)00190-3; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0	55	129	129	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					313	319		10.1016/j.neuron.2004.07.008	http://dx.doi.org/10.1016/j.neuron.2004.07.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294140	Bronze			2022-12-28	WOS:000223156900006
J	Zervas, M; Millet, S; Ahn, S; Joyner, AL				Zervas, M; Millet, S; Ahn, S; Joyner, AL			Cell behaviors and genetic lineages of the mesencephalon and rhombomere 1	NEURON			English	Article							SITE-SPECIFIC RECOMBINATION; APICAL ECTODERMAL RIDGE; ISTHMIC ORGANIZER; MID/HINDBRAIN ORGANIZER; HINDBRAIN ORGANIZER; BOUNDARY FORMATION; NEURAL PLATE; CAUDAL LIMIT; CHICK; MOUSE	Brain structures derived from the mesencephalon (mes) and rhombomere 1 (0) modulate distinct motor and sensory modalities. The precise origin and cellular behaviors underpinning the cytoarchitectural organization of the mes and r1, however, are unknown. Using a novel inducible genetic fate mapping approach in mouse, we determined the fate and lineage relationships of mes/r1 cells with fine temporal and spatial resolution. We demonstrate that the mes and r1 are neuromeres that along with the isthmic organizer are partitioned along the anterior-posterior axis by lineage restriction boundaries established sequentially between E8.5 and E9.5. Furthermore, a small group of cells originating from the most posterior mes exhibit anterior intracompartmental expansion and contribute throughout the inferior colliculus. Finally, we also uncovered transient and differential genetic lineages of ventral midbrain dopaminergic and ventral hindbrain serotonergic neuronal precursors with respect to Wnt1 and GO expression.	NYU, Sch Med, Howard Hughes Med Inst, Dev Genet Program,Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, Dev Genet Program,Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu		Zervas, Mark/0000-0002-7027-4299	NICHD NIH HHS [1 F32 HD043533-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD043533] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHN S, 2004, IN PRESS CELL, V118; Alexandre P, 2003, DEVELOPMENT, V130, P5331, DOI 10.1242/dev.00756; Altman J, 1997, DEV CEREBELLAR SYSTE; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; BALLYCUIF L, 1995, MECH DEVELOP, V53, P23, DOI 10.1016/0925-4773(95)00421-1; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Brodski C, 2003, J NEUROSCI, V23, P4199; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; CRICK FHC, 1975, SCIENCE, V189, P340, DOI 10.1126/science.806966; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GARCIABELLIDO A, 1979, SCI AM, V241, P102, DOI 10.1038/scientificamerican0779-102; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hidalgo-Sanchez M, 1999, MECH DEVELOP, V81, P175, DOI 10.1016/S0925-4773(98)00224-X; JACOBSON M, 1983, J NEUROSCI, V3, P1019; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Jungbluth S, 2001, CURR BIOL, V11, P204, DOI 10.1016/S0960-9822(01)00049-5; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kimmel RA, 2000, GENE DEV, V14, P1377; Koster RW, 2001, CURR BIOL, V11, P1858, DOI 10.1016/S0960-9822(01)00585-1; Larsen CW, 2001, J NEUROSCI, V21, P4699, DOI 10.1523/JNEUROSCI.21-13-04699.2001; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; Mason I, 2000, BIOCHEM CELL BIOL, V78, P577, DOI 10.1139/bcb-78-5-577; Mathis L, 1997, DEVELOPMENT, V124, P4089; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Millet S, 1996, DEVELOPMENT, V122, P3785; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; NAGY A, 2003, MANIPULATING MMOUSE; Palmgren A., 1921, Acta Zoologica Stockholm, V2, P1; Ramon y Cajal S, 1995, HIST NERVOUS SYSTEM; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; Song DL, 1996, DEVELOPMENT, V122, P627; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tickle C, 2001, CURR OPIN GENET DEV, V11, P476, DOI 10.1016/S0959-437X(00)00220-3; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Vertes RP, 1997, J COMP NEUROL, V378, P411, DOI 10.1002/(SICI)1096-9861(19970217)378:3<411::AID-CNE8>3.0.CO;2-6; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	54	210	213	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					345	357		10.1016/j.neuron.2004.07.010	http://dx.doi.org/10.1016/j.neuron.2004.07.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294143	Bronze			2022-12-28	WOS:000223156900009
J	Katsuno, M; Sobue, G				Katsuno, M; Sobue, G			Polyglutamine diminishes VEGR: Passage to motor neuron death?	NEURON			English	Editorial Material							BULBAR MUSCULAR-ATROPHY; MODEL; NEURODEGENERATION; TOXICITY; DISEASE		Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan	Nagoya University	Katsuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.		KATSUNO, MASAHISA/I-7502-2014	KATSUNO, MASAHISA/0000-0001-9453-9311				Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	12	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 4	2004	41	5					677	679		10.1016/S0896-6273(04)00110-2	http://dx.doi.org/10.1016/S0896-6273(04)00110-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003165	Bronze			2022-12-28	WOS:000221458200001
J	Govindaiah; Cox, CL				Govindaiah; Cox, CL			Synaptic activation of metabotropic glutamate receptors regulates dendritic outputs of thalamic interneurons	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; EXCITATORY POSTSYNAPTIC POTENTIALS; IN-VITRO; THALAMOCORTICAL NEURONS; MESSENGER-RNA; RELAY CELLS; Y-CELLS; X-CELLS; RETINOGENICULATE TRANSMISSION	Information gating through the thalamus is dependent on the output of thalamic relay neurons. These relay neurons receive convergent innervation from a number of sources, including GABA-containing interneurons that provide feed-forward inhibition. These interneurons are unique in that they have two distinct outputs: axonal and dendritic. In addition to conventional axonal outputs, these interneurons have presynaptic dendrites that may provide localized inhibitory influences. Our study indicates that synaptic activation of metabotropic glutamate receptors (mGluRs) increases inhibitory activity in relay neurons by increasing output of presynaptic dendrites of interneurons. Optic tract stimulation increases inhibitory activity in thalamic relay neurons in a frequency- and intensity-dependent manner and is attenuated by mGluR antagonists. Our data suggest that synaptic activation of mGluRs selectively alters dendritic output but not axonal output of thalamic interneurons. This mechanism could serve an important role in focal, feed-forward information processing in addition to dynamic information processing in thalamocortical circuits.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Pharmacol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cox, CL (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	clcox@life.uiuc.edu		Cox, Charles/0000-0002-1179-7014	NATIONAL EYE INSTITUTE [R56EY014024, R01EY014024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS042356] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014024-02, R01 EY014024-03, EY014024, R01 EY014024, R01 EY014024-01A1, R01 EY014024-04] Funding Source: Medline; NINDS NIH HHS [NS42356] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERARDI N, 1984, J PHYSIOL-LONDON, V357, P505, DOI 10.1113/jphysiol.1984.sp015514; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; CLELAND BG, 1973, J PHYSIOL-LONDON, V228, P649, DOI 10.1113/jphysiol.1973.sp010105; Cox CL, 1996, J COMP NEUROL, V366, P416; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 1997, J NEUROSCI, V17, P70, DOI 10.1523/JNEUROSCI.17-01-00070.1997; Cox CL, 1999, J NEUROSCI, V19, P6694; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; Gabriel S, 1996, EXP BRAIN RES, V109, P43; Godwin DW, 1996, J NEUROSCI, V16, P8181; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; HOFFMANN KP, 1972, J NEUROPHYSIOL, V35, P518, DOI 10.1152/jn.1972.35.4.518; HOLDEFER RN, 1989, BRAIN RES, V488, P341, DOI 10.1016/0006-8993(89)90727-0; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUGUENARD JR, 1994, J NEUROPHYSIOL, V71, P2576, DOI 10.1152/jn.1994.71.6.2576; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Jones EG, 1985, THALAMUS; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; LENNIE P, 1981, J PHYSIOL-LONDON, V315, P69, DOI 10.1113/jphysiol.1981.sp013733; LEVAY S, 1977, J COMP NEUROL, V172, P563, DOI 10.1002/cne.901720402; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Neto FL, 2000, BRAIN RES, V854, P93, DOI 10.1016/S0006-8993(99)02326-4; NORTON TT, 1992, PROG BRAIN RES, V90, P193; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; PARE D, 1991, J NEUROPHYSIOL, V66, P1190, DOI 10.1152/jn.1991.66.4.1190; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; RALSTON HJ, 1971, NATURE, V230, P585, DOI 10.1038/230585a0; SALT TE, 1991, EUR J NEUROSCI, V3, P1104, DOI 10.1111/j.1460-9568.1991.tb00045.x; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; SILLITO AM, 1990, J NEUROPHYSIOL, V63, P347, DOI 10.1152/jn.1990.63.2.347; SILLITO AM, 1990, NEUROSCIENCE, V34, P273, DOI 10.1016/0306-4522(90)90137-S; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS, VI; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Turner JP, 1999, J PHYSIOL-LONDON, V519, P481, DOI 10.1111/j.1469-7793.1999.0481m.x; UHLRICH DJ, 1995, J NEUROPHYSIOL, V73, P2428, DOI 10.1152/jn.1995.73.6.2428; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Vidnyanszky Z, 1996, EUR J NEUROSCI, V8, P1061, DOI 10.1111/j.1460-9568.1996.tb01273.x; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WHITE CA, 1992, P NATL ACAD SCI USA, V89, P9850, DOI 10.1073/pnas.89.20.9850; Williams SR, 1996, J PHYSIOL-LONDON, V490, P129, DOI 10.1113/jphysiol.1996.sp021131; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4; Zhu JJ, 1998, J NEUROPHYSIOL, V80, P1122, DOI 10.1152/jn.1998.80.3.1122; Zhu JJ, 1997, NEUROSCIENCE, V80, P191, DOI 10.1016/S0306-4522(97)00095-X	72	52	52	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					611	623		10.1016/S0896-6273(04)00013-3	http://dx.doi.org/10.1016/S0896-6273(04)00013-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980209	Bronze			2022-12-28	WOS:000221458100013
J	LoTurco, J				LoTurco, J			Doublecortin and a tale of two serines	NEURON			English	Editorial Material							SUBCORTICAL LAMINAR HETEROTOPIA; MICROTUBULE-ASSOCIATED PROTEIN; RADIAL MIGRATION; NEURONAL MIGRATION; CEREBRAL-CORTEX; NEOCORTEX		Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	LoTurco, J (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.							Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor S.C., 2004, NAT NEUROSCI; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Tabata H, 2003, J NEUROSCI, V23, P9996; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3	14	26	27	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 22	2004	41	2					175	177		10.1016/S0896-6273(04)00006-6	http://dx.doi.org/10.1016/S0896-6273(04)00006-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741096	Bronze			2022-12-28	WOS:000221457800001
J	Hanz, S; Perlson, E; Willis, D; Zheng, JQ; Massarwa, R; Huerta, JJ; Koltzenburg, M; Kohler, M; van-Minnen, J; Twiss, JL; Fainzilber, M				Hanz, S; Perlson, E; Willis, D; Zheng, JQ; Massarwa, R; Huerta, JJ; Koltzenburg, M; Kohler, M; van-Minnen, J; Twiss, JL; Fainzilber, M			Axoplasmic importins enable retrograde injury signaling in lesioned nerve	NEURON			English	Article							P75 NEUROTROPHIN RECEPTOR; NUCLEAR TRANSPORT FACTOR; PROTEIN-SYNTHESIS; APLYSIA NEURONS; GROWTH CONES; IN-VIVO; AXON; LOCALIZATION; REGENERATION; ALPHA	Axoplasmic proteins containing nuclear localization signals (NLS) signal retrogradely by an unknown mechanism in injured nerve. Here we demonstrate that the importin/karyopherin alpha and beta families underlie this process. We show that importins are found in axons at significant distances from the cell body and that importin beta protein is increased after nerve lesion by local translation of axonal mRNA. This leads to formation of a high-affinity NLS binding complex that traffics retrogradely with the motor protein dynein. Trituration of synthetic NLS peptide at the injury site of axotomized dorsal root ganglion (DRG) neurons delays their regenerative outgrowth, and NLS introduction to sciatic nerve concomitantly with a crush injury suppresses the conditioning lesion induced transition from arborizing to elongating growth in L4/L5 DRG neurons. These data suggest a model whereby lesion-induced upregulation of axonal importin beta may enable retrograde transport of signals that modulate the regeneration of injured neurons.	Weizmann Inst Sci, Mol Neurobiol Grp, Dept Biol Chem, IL-76100 Rehovot, Israel; Alfred I DuPont Hosp Children, Neurosci Res Labs, Nemours Biomed Res, Wilmington, DE 19899 USA; UCL, Inst Child Hlth, London WC1N 1EH, England; HELIOS Franz Volhard Clin, Max Delbrueck Ctr, Charite Med Fac, D-13122 Berlin, Germany; Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Weizmann Institute of Science; Nemours Alfred I. duPont Hospital for Children; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Vrije Universiteit Amsterdam	Fainzilber, M (corresponding author), Weizmann Inst Sci, Mol Neurobiol Grp, Dept Biol Chem, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il	Koltzenburg, Martin/C-1349-2008	Koltzenburg, Martin/0000-0001-9181-5966; Fainzilber, Mike/0000-0001-8173-8557; Perlson, Eran/0000-0001-6047-9613	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41596] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Caroni P, 1998, ESSAYS BIOCHEM, V33, P53, DOI 10.1042/bse0330053; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; Geles KG, 2001, DEVELOPMENT, V128, P1817; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goslin K., 1998, CULTURING NERVE CELL, P339; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenney AM, 1998, J NEUROSCI, V18, P1318; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kumar JP, 2001, DEV BIOL, V240, P315, DOI 10.1006/dbio.2001.0468; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mavlyutov TA, 2002, TRAFFIC, V3, P630, DOI 10.1034/j.1600-0854.2002.30905.x; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; PERLSON E, 2003, IN PRESS J NEUROBIOL; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Schmied R, 1997, J NEUROBIOL, V33, P151, DOI 10.1002/(SICI)1097-4695(199708)33:2<151::AID-NEU4>3.0.CO;2-1; SCHMIED R, 1993, J NEUROSCI, V13, P4064; Smith DS, 1997, J NEUROSCI, V17, P646; Smith HMS, 1998, PLANT CELL, V10, P1791, DOI 10.1105/tpc.10.11.1791; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Zhang XP, 2000, J NEUROBIOL, V45, P84, DOI 10.1002/1097-4695(20001105)45:2<84::AID-NEU3>3.0.CO;2-4; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	41	371	382	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1095	1104		10.1016/S0896-6273(03)00770-0	http://dx.doi.org/10.1016/S0896-6273(03)00770-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687545	Bronze			2022-12-28	WOS:000187503400009
J	Adelman, TL; Bialek, W; Olberg, RM				Adelman, TL; Bialek, W; Olberg, RM			The information content of receptive fields	NEURON			English	Article							INTERNEURONS; RESPONSES; NEURONS	The nervous system must observe a complex world and produce appropriate, sometimes complex, behavioral responses. In contrast to this complexity, neural responses are often characterized through very simple descriptions such as receptive fields or tuning curves. Do these characterizations adequately reflect the true dimensionality reduction that takes place in the nervous system, or are they merely convenient oversimplifications? Here we address this question for the target-selective descending neurons (TSDNs) of the dragonfly. Using extracellular multielectrode recordings of a population of TSDNs, we quantify the completeness of the receptive field description of these cells and conclude that the information in independent instantaneous position and velocity receptive fields accounts for 70%-90% of the total information in single spikes. Thus, we demonstrate that this simple receptive field model is close to a complete description of the features in the stimulus that evoke TSDN response.	Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Union Coll, Dept Sci Biol, Schenectady, NY 12308 USA	Princeton University; Princeton University; Union College	Adelman, TL (corresponding author), Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA.	tadelman@princeton.edu						ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; FRYE MA, 1995, J COMP PHYSIOL A, V177, P569; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; Gordon AD, 1999, CLASSIFICATION; HARTLINE HK, 1958, J GEN PHYSIOL, V41, P1049, DOI 10.1085/jgp.41.5.1049; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KOLTON L, 1995, J COMP PHYSIOL A, V176, P691, DOI 10.1007/BF01021589; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; OLBERG RM, 1986, J COMP PHYSIOL A, V159, P827, DOI 10.1007/BF00603736; Rieke F., 1997, SPIKES EXPLORING NEU; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARPEE T, 2003, IN PRESS ADV NEURAL, V15; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Theunissen FE, 2000, J NEUROSCI, V20, P2315; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379	24	43	44	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					823	833		10.1016/S0896-6273(03)00680-9	http://dx.doi.org/10.1016/S0896-6273(03)00680-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622585	Bronze			2022-12-28	WOS:000186651200016
J	Lee, HC; Wang, JM; Swartz, KJ				Lee, HC; Wang, JM; Swartz, KJ			Interaction between extracellular hanatoxin and the resting conformation of the voltage-sensor paddle in Kv channels	NEURON			English	Article							SHAKER K+ CHANNEL; GATED ION CHANNELS; GATING MODIFIER TOXINS; POTASSIUM CHANNEL; ACTIVATION GATE; CHARGE MOVEMENT; HELICAL STRUCTURE; SENSING DOMAINS; RECEPTOR-SITE; MOVING PARTS	In voltage-activated potassium (Kv) channels, basic residues in S4 enable the voltage-sensing domain to move in response to membrane depolarization and thereby trigger the activation gate to open. In the X-ray structure of the KvAP channel, the S4 helix is located near the intracellular boundary of the membrane where it forms a "voltage-sensor paddle" motif with the S3b helix. It has been proposed that the paddle is lipid-exposed and that it translocates through the membrane as it activates. We studied the interaction of externally applied Hanatoxin with the voltage-sensor paddle in Kv channels and show that the toxin binds tightly even at negative voltages where the paddle is resting and the channel is closed. Moreover, measurements of gating charge movement suggest that Hanatoxin interacts with and stabilizes the resting paddle. These findings point to an extracellular location for the resting conformation of the voltage-sensor paddle and constrain its transmembrane movements during activation.	Natl Inst Neurol Disorders & Stroke, Mol Physiol & Biophys Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), Natl Inst Neurol Disorders & Stroke, Mol Physiol & Biophys Sect, NIH, Bldg 36,Room 2C19,36 Convent Dr,MSC 4066, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; Horn R, 2000, BIOCHEMISTRY-US, V39, P15653, DOI 10.1021/bi0020473; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Marvin L, 1999, EUR J BIOCHEM, V265, P572, DOI 10.1046/j.1432-1327.1999.00726.x; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TAGLIALATELA M, 1993, P NATL ACAD SCI USA, V90, P4758, DOI 10.1073/pnas.90.10.4758; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Wang JL, 2003, BIOPHYS J, V84, p218A; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	58	110	115	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					527	536		10.1016/S0896-6273(03)00636-6	http://dx.doi.org/10.1016/S0896-6273(03)00636-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642277	Bronze			2022-12-28	WOS:000186379000012
J	Emtage, L; Gu, GQ; Hartwieg, E; Chalfie, M				Emtage, L; Gu, GQ; Hartwieg, E; Chalfie, M			Extracellular proteins organize the mechanosensory channel complex in C-elegans touch receptor neurons	NEURON			English	Article							INTEGRIN ADHESION COMPLEXES; MESSENGER-RNA SURVEILLANCE; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEIN; GENE-EXPRESSION; MOLECULAR-BASIS; CELL ADHESION; HAIR-CELLS; MUSCLE; MECHANOTRANSDUCTION	Specialized extracellular matrix (ECM) is associated with virtually every mechanosensory system studied. C. elegans touch receptor neurons have specialized ECM and attach to the surrounding epidermis. The mec-1 gene encodes an ECM protein with multiple EGF and Kunitz domains. MEC-1 is needed for the accumulation of the collagen MEC-5 and other ECM components, attachment, and, separately, for touch sensitivity. MEC-1 and MEC-5 bind to touch processes uniformly and in puncta. These puncta colocalize with and localize the mechanosensory channel complex in the touch neurons. In turn, the production of the MEC-1 and MEC-5 puncta appears to rely on interactions with the neighboring epidermal tissue. These and other observations lead us to propose that extracellular, but not cytoskeletal, tethering of the degenerin channel is needed for mechanosensory transduction. Additionally, our experiments demonstrate an important role of the ECM in organizing the placement of the channel complex.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Massachusetts Institute of Technology (MIT)	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30997, R37 GM030997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1979, J CELL BIOL, V82, P278, DOI 10.1083/jcb.82.1.278; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; GU G, 1998, THESIS COLUMBIA U NE; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; JOE EH, 1992, NATURE, V356, P333, DOI 10.1038/356333a0; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; McMahon L, 2003, MOL BIOL CELL, V14, P1366, DOI 10.1091/mbc.E02-08-0479; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Taniguchi A, 1998, HUM GENET, V102, P197, DOI 10.1007/s004390050677; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vogel BE, 2001, DEVELOPMENT, V128, P883; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; ZHANG S, 2004, THESIS COLUMBIA U NY; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030	48	88	95	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					795	807		10.1016/j.neuron.2004.11.010	http://dx.doi.org/10.1016/j.neuron.2004.11.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572111	Bronze			2022-12-28	WOS:000225548400008
J	Chavas, J; Forero, ME; Collin, T; Llano, I; Marty, A				Chavas, J; Forero, ME; Collin, T; Llano, I; Marty, A			Osmotic tension as a possible link between GABA(A) receptor activation and intracellular calcium elevation	NEURON			English	Article							GLYCINE-INDUCED DEPOLARIZATION; INHIBITORY SYNAPTIC CURRENTS; REGULATORY VOLUME DECREASE; RAT CEREBELLAR SLICES; DORSAL HORN NEURONS; PURKINJE-CELLS; NEUROBLASTOMA-CELLS; RYANODINE RECEPTORS; HIPPOCAMPAL SLICES; CA1 REGION	Intracellular calcium concentration rises have been reported following activation of GABA(A) receptors in neonatal preparations and attributed to activation of voltage-dependent Ca2+ channels. However, we show that, in cerebellar interneurons, GABA(A) agonists induce a somatodendritic Ca2+ rise that persists at least until postnatal day 20 and is not mediated by depolarization-induced Ca2+ entry. A local Ca2+ elevation can likewise be elicited by repetitive stimulation of presynaptic GABAergic afferent fibers. We find that, following GABA(A) receptor activation, bicarbonate-induced Cl- entry leads to cell depolarization, Cl- accumulation, and osmotic tension. We propose that this tension induces the intracellular Ca2+ rise as part of a regulatory volume decrease reaction. This mechanism introduces an unexpected link between activation of GABA(A) receptors and intracellular Call elevation, which could contribute to activity-driven synaptic plasticity.	Univ Paris 05, CNRS UMR 8118, Lab Physiol Cerebrale, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Marty, A (corresponding author), Univ Paris 05, CNRS UMR 8118, Lab Physiol Cerebrale, 45 Rue St Peres, F-75006 Paris, France.	alain.marty@univ-paris5.fr		Chavas, Joel/0000-0002-3559-5919; forero, maria elisa/0000-0002-2604-7013				BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BASAVAPPA S, 1995, J NEUROSCI, V15, P3662; Basavappa S, 2003, BIOCHEM BIOPH RES CO, V308, P759, DOI 10.1016/S0006-291X(03)01481-5; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borgdorff AJ, 2000, J NEUROPHYSIOL, V83, P81, DOI 10.1152/jn.2000.83.1.81; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Chavas J, 2003, J NEUROSCI, V23, P2019; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Eilers J, 2001, J PHYSIOL-LONDON, V536, P429, DOI 10.1111/j.1469-7793.2001.0429c.xd; Franco R, 2000, J NEUROSCI RES, V61, P701, DOI 10.1002/1097-4547(20000915)61:6<701::AID-JNR14>3.3.CO;2-K; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Ishii T, 1996, J PHYSIOL-LONDON, V493, P371, DOI 10.1113/jphysiol.1996.sp021389; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; Kulik A, 2000, J NEUROSCI, V20, P7905; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; Morales-Mulia S, 1998, J NEUROCHEM, V71, P2330; Moran J, 1997, J NEUROSCI RES, V47, P144, DOI 10.1002/(SICI)1097-4547(19970115)47:2<144::AID-JNR3>3.0.CO;2-F; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PASTERNACK M, 1993, ACTA PHYSIOL SCAND, V148, P229, DOI 10.1111/j.1748-1716.1993.tb09553.x; Pouzat C, 1999, J NEUROSCI, V19, P1675; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SOLTESZ I, 1994, J NEUROSCI, V14, P2365; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takagi S, 2002, NEUROSCI RES, V44, P315, DOI 10.1016/S0168-0102(02)00153-0; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; TRAUTMANN A, 1984, P NATL ACAD SCI-BIOL, V81, P611, DOI 10.1073/pnas.81.2.611; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; WANG J, 1994, EUR J NEUROSCI, V6, P1275, DOI 10.1111/j.1460-9568.1994.tb00317.x; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942	49	41	43	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					701	713		10.1016/j.neuron.2004.11.002	http://dx.doi.org/10.1016/j.neuron.2004.11.002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541317	Bronze			2022-12-28	WOS:000225338100015
J	Gao, Y; Deng, KW; Hou, JW; Bryson, JB; Barco, A; Nikulina, E; Spencer, T; Mellado, W; Kandel, ER; Filbin, MT				Gao, Y; Deng, KW; Hou, JW; Bryson, JB; Barco, A; Nikulina, E; Spencer, T; Mellado, W; Kandel, ER; Filbin, MT			Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo	NEURON			English	Article							GILL-WITHDRAWAL REFLEX; NEURITE OUTGROWTH; NOGO RECEPTOR; CORD-INJURY; CYCLIC-AMP; TRANSCRIPTIONAL REGULATION; SENSORY NEURONS; NERVOUS-SYSTEM; GLYCOPROTEIN; GROWTH	Inhibitors in myelin play a major role in preventing spontaneous axonal regeneration after CNS injury. Elevation of cAMP overcomes this inhibition, in a transcription-dependent manner, through the upregulation of Arginase I (Arg I) and increased synthesis of polyamines. Here, we show that the cAMP effect requires activation of the transcription factor cAMP response element binding protein (CREB) to overcome myelin inhibitors; a dominant-negative CREB abolishes the effect, and neurons expressing a constitutively active form of CREB are not inhibited. Activation of CREB is also required for cAMP to upregulate Arg 1, and the ability of constitutively active CREB to overcome inhibition is blocked by an inhibitor of polyamine synthesis. Finally, expression of constitutively active CREB in DRG neurons is sufficient to promote regeneration of subsequently lesioned dorsal column axons. These results indicate that CREB plays a central role in overcoming myelin inhibitors and so encourages regeneration in vivo.	CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	City University of New York (CUNY) System; Hunter College (CUNY); Columbia University; Howard Hughes Medical Institute; Columbia University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Barco, Angel/ABF-1864-2021; Barco, Angel/C-3062-2008; Spencer, Tim/AAK-2094-2020	Barco, Angel/0000-0002-0653-3751; Barco, Angel/0000-0002-0653-3751; Bryson, J. Barney/0000-0001-5486-0258	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037060, U54NS041073, R01NS037060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 37060, NS 41073] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BONIECE IR, 1993, J NEUROSCI, V13, P4220; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; Craig JC, 2001, J BIOL CHEM, V276, P11719, DOI 10.1074/jbc.M010263200; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Esch F, 1998, J NEUROSCI, V18, P4083; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gao Y, 2003, J NEUROSCI, V23, P11770; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; KUPFERMANN I, 1970, SCIENCE, V167, P1743, DOI 10.1126/science.167.3926.1743; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	48	271	287	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					609	621		10.1016/j.neuron.2004.10.030	http://dx.doi.org/10.1016/j.neuron.2004.10.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541310	Bronze			2022-12-28	WOS:000225338100008
J	Nieder, A				Nieder, A			The number domain - Can we count on parietal cortex?	NEURON			English	Review							REPRESENTATIONS; THINKING; OBJECTS; FACES		Univ Tubingen, Primate Neurocognit Lab, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nieder, A (corresponding author), Univ Tubingen, Primate Neurocognit Lab, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Otfried Mueller Str 27, D-72076 Tubingen, Germany.	andreas.nieder@uni-tuebingen.de						Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Fodor J. A, 1983, MODULARITY MIND; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kleinschmidt A, 2004, NEURON, V41, P842, DOI 10.1016/S0896-6273(04)00154-0; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111	16	46	47	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					407	409		10.1016/j.neuron.2004.10.020	http://dx.doi.org/10.1016/j.neuron.2004.10.020			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504322	Bronze			2022-12-28	WOS:000224771700004
J	Hanson, MG; Landmesser, LT				Hanson, MG; Landmesser, LT			Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; SPONTANEOUS RETINAL WAVES; LIM HOMEOBOX GENES; SPINAL-CORD; POLYSIALIC ACID; NEURONAL-ACTIVITY; ORIENTATION SELECTIVITY; GLYCINE TRANSPORTER; ACTION-POTENTIALS	Rhythmic spontaneous electrical activity occurs in many parts of the developing nervous system, where it plays essential roles in the refinement of neural connections. By blocking or slowing this bursting activity, via in ovo drug applications at precise developmental periods, we show that such activity is also required at much earlier stages for spinal motoneurons to accurately execute their first major dorsal-ventral pathfinding decision. Blockade or slowing of rhythmic bursting activity also prevents the normal expression patterns of EphA4 and polysialic acid on NCAM, which may contribute to the pathfinding errors observed. More prolonged (E2-5) blockade resulted in a downregulation of LIM homeodomain transcription factors, but since this occurred only after the pathfinding errors and alterations in guidance molecules, it cannot have contributed to them.	Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Landmesser, LT (corresponding author), Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA.	lynn.landmesser@cwru.edu			NINDS NIH HHS [NS19640, NS23678] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023678, R01NS019640] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bansal A, 2000, J NEUROSCI, V20, P7672; BEHAR TN, 1994, J NEUROSCI, V14, P29; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chub N, 1998, J NEUROSCI, V18, P294; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fueshko SM, 1998, J NEUROSCI, V18, P2560; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LOPEZCORCUERA B, 1989, BIOCHIM BIOPHYS ACTA, V983, P247, DOI 10.1016/0005-2736(89)90240-X; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Milner LD, 1999, J NEUROSCI, V19, P3007; MILNER LD, 1999, THESIS CASE W RESERV; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STOKER AW, 1995, DEVELOPMENT, V121, P1833; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Watt SD, 2000, MOL CELL NEUROSCI, V16, P376, DOI 10.1006/mcne.2000.0871; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976	57	300	305	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					687	701		10.1016/j.neuron.2004.08.018	http://dx.doi.org/10.1016/j.neuron.2004.08.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339650	Bronze			2022-12-28	WOS:000223691900014
J	Richter, JD				Richter, JD			RNA transport (Partly) revealed	NEURON			English	Editorial Material							PROTEIN-SYNTHESIS; MESSENGER-RNA; CAMKII-ALPHA; KINASE-II; LOCALIZATION; TRANSLATION; STAUFEN	Specific mRNAs are transported to dendrites where their translation may modify synaptic plasticity. In this issue of Neuron, Kanai et al. use affinity chromatography and mass spectrometry to identify a large number of new factors that associate with kinesin, a molecular motor, and employ siRNA technology to demonstrate their importance for RNA transport in neurons.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.							Eom T, 2003, J NEUROSCI, V23, P10433; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Ouyang Y, 1999, J NEUROSCI, V19, P7823; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7	11	4	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					442	443		10.1016/j.neuron.2004.08.004	http://dx.doi.org/10.1016/j.neuron.2004.08.004			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312643	Bronze			2022-12-28	WOS:000223436400003
J	Aguiar, PD; Sweadner, KJ; Penniston, JT; Zaremba, J; Liu, L; Caton, M; Linazasoro, G; Borg, M; Tijssen, MAJ; Bressman, SB; Dobyns, WB; Brashear, A; Ozelius, LJ				Aguiar, PD; Sweadner, KJ; Penniston, JT; Zaremba, J; Liu, L; Caton, M; Linazasoro, G; Borg, M; Tijssen, MAJ; Bressman, SB; Dobyns, WB; Brashear, A; Ozelius, LJ			Mutations in the Na+/K+-ATPase alpha 3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; SARCOPLASMIC-RETICULUM; SCANNING MUTAGENESIS; CALCIUM-PUMP; NA,K-ATPASE; SUBUNIT; DOMAIN; CA2+-ATPASE; RESOLUTION; SYSTEM	Rapid-onset dystonia-parkinsonism (RDP, DYT12) is a distinctive autosomal-dominant movement disorder with variable expressivity and reduced penetrance characterized by abrupt onset of dystonia, usually accompanied by signs of parkinsonism. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. We report the finding of six missense mutations in the gene for the Na+/K+-ATPase alpha3 subunit (ATP1A3) in seven unrelated families with RDP. Functional studies and structural analysis of the protein suggest that these mutations impair enzyme activity or stability. This finding implicates the Na+/K+ pump, a crucial protein responsible for the electrochemical gradient across the cell membrane, in dystonia and parkinsonism.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Sao Paulo, Brazil; Massachusetts Gen Hosp, Ctr Neurosci, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Inst Psychiat & Neurol, Dept Genet, PL-02957 Warsaw, Poland; Clin Quiron, Ctr Neurol & Neurocirugia, San Sebastian 20012, Spain; CHU Nice, Neurol Serv, F-06002 Nice, France; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA; Univ Chicago, Dept Human Genet Neurol & Pediat, Chicago, IL 60637 USA; Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA	Yeshiva University; Albert Einstein College of Medicine; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Institute of Psychiatry & Neurology; CHU Nice; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Beth Israel Deaconess Medical Center; University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis	Ozelius, LJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ozelius@aecom.yu.edu	de Carvalho Aguiar, Patricia/B-2350-2013; Dobyns, William/AAI-2768-2020; de Carvalho Aguiar, Patricia/E-8520-2010; Dobyns, William Brian/ABC-6525-2021; Brashear, Allison/G-3853-2015	de Carvalho Aguiar, Patricia/0000-0003-2957-9573; Dobyns, William/0000-0002-7681-2844; de Carvalho Aguiar, Patricia/0000-0003-2957-9573; Zaremba, Jacek/0000-0002-9546-7767	NHLBI NIH HHS [HL36251] Funding Source: Medline; NIA NIH HHS [AG10133] Funding Source: Medline; NIGMS NIH HHS [GM28835] Funding Source: Medline; NINDS NIH HHS [NS26636] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguiar PMD, 2002, LANCET NEUROL, V1, P316, DOI 10.1016/S1474-4422(02)00137-0; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Brashear A, 1998, Adv Neurol, V78, P335; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Grimes DA, 2002, NEUROLOGY, V59, P1183, DOI 10.1212/WNL.59.8.1183; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Hakansson KO, 2003, J MOL BIOL, V332, P1175, DOI 10.1016/j.jmb.2003.07.012; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Ikeda K, 2003, J NEUROSCI, V23, P4667; Ivanov AV, 2002, BIOCHEM J, V364, P293, DOI 10.1042/bj3640293; KAMM C, 2004, IN PRESS MOV DISORD; Kockskamper J, 1997, BBA-BIOMEMBRANES, V1325, P197, DOI 10.1016/S0005-2736(96)00259-3; Kramer PL, 1999, ANN NEUROL, V46, P176, DOI 10.1002/1531-8249(199908)46:2<176::AID-ANA6>3.0.CO;2-2; Linazasoro G, 2002, MOVEMENT DISORD, V17, P608, DOI 10.1002/mds.10103; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Pittock SJ, 2000, NEUROLOGY, V55, P991, DOI 10.1212/WNL.55.7.991; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Taniguchi K, 2001, J BIOCHEM, V129, P335, DOI 10.1093/oxfordjournals.jbchem.a002862; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; ZAREMBA J, 2004, IN PRESS MOV DISORD	34	336	344	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					169	175		10.1016/j.neuron.2004.06.028	http://dx.doi.org/10.1016/j.neuron.2004.06.028			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260953	Bronze			2022-12-28	WOS:000222905400006
J	Stepanyants, A; Tamas, G; Chklovskii, DB				Stepanyants, A; Tamas, G; Chklovskii, DB			Class-specific features of neuronal wiring	NEURON			English	Article							CAT VISUAL-CORTEX; GABAERGIC SYNAPSES; QUANTITATIVE DISTRIBUTION; SYNAPTIC CONNECTIVITY; CORTICAL INTERNEURONS; INHIBITORY SYNAPSES; PYRAMIDAL NEURONS; DENDRITIC SPINES; CEREBRAL-CORTEX; GAP-JUNCTIONS	Brain function relies on specificity of synaptic connectivity patterns among different classes of neurons. Yet, the substrates of specificity in complex neuropil remain largely unknown. We search for imprints of specificity in the layout of axonal and dendritic arbors from the rat neocortex. An analysis of 3D reconstructions of pairs consisting of pyramidal cells (PCs) and GABAergic interneurons (GIs) revealed that the layout of GI axons is specific. This specificity is manifested in a relatively high tortuosity, small branch length of these axons, and correlations of their trajectories with the positions of postsynaptic neuron dendrites. Axons of PCs show no such specificity, usually taking a relatively straight course through neuropil. However, wiring patterns among PCs hold a large potential for circuit remodeling and specificity through growth and retraction of dendritic spines. Our results define distinct class-specific rules in establishing synaptic connectivity, which could be crucial in formulating a canonical cortical circuit.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary	Cold Spring Harbor Laboratory; Northeastern University; Northeastern University; Szeged University	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.edu	Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS047138] Funding Source: NIH RePORTER; NIMH NIH HHS [MH69838] Funding Source: Medline; NINDS NIH HHS [NS047138] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; CAJAL SRY, 1891, CELLULE, V7, P125; Callaway EM, 2002, CURR OPIN NEUROBIOL, V12, P587, DOI 10.1016/S0959-4388(02)00364-1; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DENO RL, 1949, CEREBRAL CORTEX ARCH; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Fiala JC, 1998, J NEUROSCI, V18, P8900; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; JACOBS G, 2002, STRUCTURAL BIOPHYSIC; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A., 1991, FINE STRUCTURE NERVO; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Silberberg G, 2002, TRENDS NEUROSCI, V25, P227, DOI 10.1016/S0166-2236(02)02151-3; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2002, NEUROCOMPUTING, V44, P661, DOI 10.1016/S0925-2312(02)00454-X; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; SZENTAGOTHAI J, 1990, Acta Morphologica Hungarica, V38, P159; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Szentagothai J, 1978, ARCHITECTONICS CEREB, P77; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1998, J NEUROSCI, V18, P4255; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thomassen L, 2002, CONTEMP SOCIOL, V31, P239, DOI 10.2307/3089548; Thomson AM, 1999, J PHYSIOL-LONDON, V519, P57, DOI 10.1111/j.1469-7793.1999.0057o.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395	54	94	96	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					251	259		10.1016/j.neuron.2004.06.013	http://dx.doi.org/10.1016/j.neuron.2004.06.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260960	Bronze			2022-12-28	WOS:000222905400013
J	Davies, AG; Bettinger, JC; Thiele, TR; Judy, ME; McIntire, SL				Davies, AG; Bettinger, JC; Thiele, TR; Judy, ME; McIntire, SL			Natural variation in the npr-1 gene modifies ethanol responses of wild strains of C. elegans	NEURON			English	Article							ACUTE FUNCTIONAL TOLERANCE; NEUROPEPTIDE-Y POLYMORPHISM; CAENORHABDITIS-ELEGANS; ALCOHOL DEPENDENCE; INITIAL SENSITIVITY; SOCIAL-BEHAVIOR; PROTEIN; EXPRESSION; CONSUMPTION; RECEPTOR	Variation in the acute response to ethanol between individuals has a significant impact on determining susceptibility to alcoholism. The degree to which genetics contributes to this variation is of great interest. Here we show that allelic variation that alters the functional level of NPR-1, a neuropeptide Y (NPY) receptor-like protein, can account for natural variation in the acute response to ethanol in wild strains of Caenorhabditis elegans. NPR-1 negatively regulates the development of acute tolerance to ethanol, a neuroadaptive process that compensates for effects of ethanol. Furthermore, dynamic changes in the NPR-1 pathway provide a mechanism for ethanol tolerance in C. elegans. This suggests an explanation for the conserved function of NPY-related pathways in ethanol responses across diverse species. Moreover, these data indicate that genetic variation in the level of NPR-1 function determines much of the phenotypic variation in adaptive behavioral responses to ethanol that are observed in natural populations.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Program Neurosci, Emeryville, CA 94068 USA; Univ Calif San Francisco, Program Biomed Sci, Emeryville, CA 94068 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	McIntire, SL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Program Neurosci, 5858 Horton St,Suite 200, Emeryville, CA 94068 USA.	slm@itsa.ucsf.edu	Davies, Andrew G/AAY-3567-2020	Thiele, Tod/0000-0003-2628-8359				Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Begleiter H, 1995, GENETICS ALCOHOLISM; Bison S, 2003, ALCOHOL CLIN EXP RES, V27, P1173, DOI 10.1097/01.ALC.0000075827.74538.FE; BRENNER S, 1974, GENETICS, V77, P71; Brownlee DJA, 1999, TRENDS NEUROSCI, V22, P16, DOI 10.1016/S0166-2236(98)01281-8; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Colbert HA, 1997, J NEUROSCI, V17, P8259; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; DIAMOND I, 1991, ANN NY ACAD SCI, V625, P473, DOI 10.1111/j.1749-6632.1991.tb33878.x; DIAMOND IF, 2002, DIS NERVOUS SYSTEM C, P1814; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Ehlers CL, 1998, ALCOHOL CLIN EXP RES, V22, P1778, DOI 10.1097/00000374-199811000-00022; Erwin VG, 2000, J PHARMACOL EXP THER, V293, P188; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; GEER BW, 1993, COMP BIOCHEM PHYS B, V105, P203, DOI 10.1016/0305-0491(93)90221-P; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Hiltunen AJ, 2000, ALCOHOL, V22, P69, DOI 10.1016/S0741-8329(00)00107-5; Hodgkin J, 1997, GENETICS, V146, P149; Hwang BH, 1999, ALCOHOL CLIN EXP RES, V23, P1023; Ilveskoski E, 2001, ALCOHOL CLIN EXP RES, V25, P1420, DOI 10.1097/00000374-200110000-00003; KALANT H, 1971, PHARMACOL REV, V23, P135; KAPLAN HL, 1985, J STUD ALCOHOL, V46, P253, DOI 10.15288/jsa.1985.46.253; Kauhanen J, 2000, AM J MED GENET, V93, P117, DOI 10.1002/1096-8628(20000717)93:2<117::AID-AJMG7>3.0.CO;2-#; Kirstein SL, 2002, J PHARMACOL EXP THER, V302, P1238, DOI 10.1124/jpet.302.3.1238; Kubiak TM, 2003, J BIOL CHEM, V278, P33724, DOI 10.1074/jbc.M304861200; Lappalainen J, 2002, ARCH GEN PSYCHIAT, V59, P825, DOI 10.1001/archpsyc.59.9.825; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; LEBLANC AE, 1975, PSYCHOPHARMACOLOGIA, V41, P43, DOI 10.1007/BF00421304; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; LUMENG L, 1995, GENETICS ALCOHOLISM, P165; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P211, DOI 10.1111/j.1530-0277.1993.tb00751.x; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Ponomarev I, 2002, J PHARMACOL EXP THER, V302, P257, DOI 10.1124/jpet.302.1.257; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Rand JB, 1995, METHOD CELL BIOL, V48, P187; RODRIGUEZ LA, 1993, ALCOHOL CLIN EXP RES, V17, P155, DOI 10.1111/j.1530-0277.1993.tb00741.x; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Roy A, 2002, ALCOHOL CLIN EXP RES, V26, P796, DOI 10.1111/j.1530-0277.2002.tb02607.x; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schuckit M.A., 2002, NEUROPSYCHOPHARMACOL, P1399; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; Schumann G, 2003, ALCOHOL CLIN EXP RES, V27, P880, DOI 10.1097/01.ALC.0000065437.18136.86; Shioi G, 2001, GENETICS, V157, P1611; TABAKOFF B, 1979, DRUG ALCOHOL DEPEN, V4, P87, DOI 10.1016/0376-8716(79)90043-7; Thiele TE, 2003, PHYSIOL BEHAV, V79, P95, DOI 10.1016/S0031-9384(03)00109-4; Thiele TE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0006.2002; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; THOMAS JH, 1993, GENETICS, V134, P1105; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Volavka J, 1996, ARCH GEN PSYCHIAT, V53, P258; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilhelmsen KC, 2003, ALCOHOL CLIN EXP RES, V27, P1041, DOI 10.1097/01.ALC.0000075551.02714.63; Woldbye DPD, 2002, ALCOHOL ALCOHOLISM, V37, P318, DOI 10.1093/alcalc/37.4.318; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zhu GS, 2003, ALCOHOL CLIN EXP RES, V27, P19, DOI 10.1097/01.ALC.0000050642-62233.44	63	107	127	10	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					731	743		10.1016/j.neuron.2004.05.004	http://dx.doi.org/10.1016/j.neuron.2004.05.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182714	Bronze			2022-12-28	WOS:000221975000006
J	Bennett, MVL; Zukin, RS				Bennett, MVL; Zukin, RS			Electrical coupling and neuronal synchronization in the mammalian brain	NEURON			English	Review							FUNCTIONAL GAP-JUNCTIONS; IN-VITRO; RAT-BRAIN; HORIZONTAL CELLS; OLFACTORY-BULB; FREQUENCY OSCILLATIONS; SYNAPTIC TRANSMISSION; CONNEXIN EXPRESSION; GAMMA OSCILLATIONS; GABAERGIC SYNAPSES	Certain neurons in the mammalian brain have long been known to be joined by gap junctions, which are the most common type of electrical synapse. More recently, cloning of neuron-specific connexins, increased capability of visualizing cells within brain tissue, labeling of cell types by transgenic methods, and generation of connexin knockouts have spurred a rapid increase in our knowledge of the role of gap junctions in neural activity. This article reviews the many subtleties of transmission mediated by gap junctions and the mechanisms whereby these junctions contribute to synchronous firing.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Bennett, MVL (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	mbennett@aecom.yu.edu	Oka, Yoshitaka/C-9670-2010; Bennett, Michael/A-6958-2009	Oka, Yoshitaka/0000-0002-3482-3051; 	NINDS NIH HHS [NS20752, NS045287] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752, R01NS045287] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrams CK, 2001, BRAIN RES, V900, P9, DOI 10.1016/S0006-8993(00)03327-8; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; ANDERSEN P, 1964, J PHYSIOL-LONDON, V174, P348, DOI 10.1113/jphysiol.1964.sp007492; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; BAKER R, 1971, J PHYSIOL-LONDON, V212, P45, DOI 10.1113/jphysiol.1971.sp009309; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Becker DL, 1998, CELL BIOL INT, V22, P527, DOI 10.1006/cbir.1998.0295; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Benardo LS, 1997, J NEUROPHYSIOL, V77, P3134, DOI 10.1152/jn.1997.77.6.3134; Bennett M., 1977, HDB PHYSL          1, P357; Bennett MVL, 2000, NAT NEUROSCI, V3, P7, DOI 10.1038/71082; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Berthoud VM, 2000, AM J PHYSIOL-LUNG C, V279, pL619, DOI 10.1152/ajplung.2000.279.4.L619; Bou-Flores C, 2001, J NEUROPHYSIOL, V85, P1543, DOI 10.1152/jn.2001.85.4.1543; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Buhl DL, 2003, J NEUROSCI, V23, P1013; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; Cao FL, 1998, J CELL SCI, V111, P31; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; CHRISTIE MJ, 1993, NEUROSCIENCE, V56, P129, DOI 10.1016/0306-4522(93)90568-Z; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; Coleman AM, 2002, J COMP NEUROL, V454, P34, DOI 10.1002/cne.10438; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Condorelli DF, 2003, EUR J NEUROSCI, V18, P1807, DOI 10.1046/j.1460-9568.2003.02910.x; Das Sarma J, 2001, J CELL SCI, V114, P4013; De Zeeuw CI, 2003, J NEUROSCI, V23, P4700; Deans MR, 2001, CELL COMMUN ADHES, V8, P361, DOI 10.3109/15419060109080754; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Demb JB, 2002, NEURON, V36, P551, DOI 10.1016/S0896-6273(02)01062-0; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Elson RC, 2002, J NEUROPHYSIOL, V88, P1166, DOI 10.1152/jn.2002.88.3.1166; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; FINKELSTEIN A, 1994, SCIENCE, V265, P1017, DOI 10.1126/science.265.5175.1017-b; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Fukuda T, 2003, NEUROSCIENCE, V120, P5, DOI 10.1016/S0306-4522(03)00328-2; FURUKAWA T, 1963, J NEUROPHYSIOL, V26, P140, DOI 10.1152/jn.1963.26.1.140; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2000, J NEUROPHYSIOL, V83, P621, DOI 10.1152/jn.2000.83.1.621; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Halliwell JV, 1998, J PHYSIOL-LONDON, V506, P175, DOI 10.1111/j.1469-7793.1998.175bx.x; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HATTON GI, 1994, BRAIN RES, V650, P63, DOI 10.1016/0006-8993(94)90207-0; Hatton GI, 1998, CELL BIOL INT, V22, P765, DOI 10.1006/cbir.1998.0386; Hatton GI, 2001, J NEUROSCI, V21, P2974, DOI 10.1523/JNEUROSCI.21-09-02974.2001; He SG, 2000, J COMP NEUROL, V418, P33, DOI 10.1002/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hua VB, 2003, J MEMBRANE BIOL, V194, P59, DOI 10.1007/s00232-003-2026-8; Jahromi SS, 2002, J NEUROPHYSIOL, V88, P1893, DOI 10.1152/jn.2002.88.4.1893; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; KATSUMARU H, 1988, EXP BRAIN RES, V72, P363; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Kleopa KA, 2002, J NEUROSCI RES, V68, P522, DOI 10.1002/jnr.10255; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; KORN H, 1973, EXP BRAIN RES, V16, P255; KORN H, 1980, P NATL ACAD SCI-BIOL, V77, P6244, DOI 10.1073/pnas.77.10.6244; Kosaka T, 2003, NEUROSCI RES, V45, P189, DOI 10.1016/S0168-0102(02)00222-5; Kwak BR, 1999, J PHYSIOL-LONDON, V516, P679, DOI 10.1111/j.1469-7793.1999.0679u.x; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LeBeau FEN, 2003, BRAIN RES BULL, V62, P3, DOI 10.1016/j.brainresbull.2003.07.004; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Lewis TJ, 2000, NETWORK-COMP NEURAL, V11, P299, DOI 10.1088/0954-898X/11/4/304; Leznik E, 2002, J NEUROSCI, V22, P2804, DOI 10.1523/JNEUROSCI.22-07-02804.2002; LLINAS R, 1974, J NEUROPHYSIOL, V37, P560, DOI 10.1152/jn.1974.37.3.560; Long MA, 2002, J NEUROSCI, V22, P10898; Lowe G, 2003, CURR OPIN NEUROBIOL, V13, P476, DOI 10.1016/S0959-4388(03)00092-8; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Massey SC, 2003, CELL COMMUN ADHES, V10, P425, DOI 10.1080/15419060390264343; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Maxeiner S, 2003, NEUROSCIENCE, V119, P689, DOI 10.1016/S0306-4522(03)00077-0; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Meyer AH, 2002, J NEUROSCI, V22, P7055; Micevych PE, 1996, NEUROENDOCRINOLOGY, V63, P39, DOI 10.1159/000126933; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Miragall F, 1996, NEUROSCI LETT, V216, P199, DOI 10.1016/0304-3940(96)13042-1; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Nagy JI, 2003, GLIA, V44, P205, DOI 10.1002/glia.10278; Nagy JI, 2003, J COMP NEUROL, V464, P356, DOI 10.1002/cne.10797; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Nicholson G, 1996, J NEUROL NEUROSUR PS, V61, P43, DOI 10.1136/jnnp.61.1.43; Nolan MF, 1999, J PHYSIOL-LONDON, V519, P753, DOI 10.1111/j.1469-7793.1999.0753n.x; Ochalski PAY, 1997, NEUROSCIENCE, V76, P931; Odermatt B, 2003, J NEUROSCI, V23, P4549; Onn SP, 1999, SYNAPSE, V33, P1; ONN SP, 1994, J NEUROPHYSIOL, V71, P1917, DOI 10.1152/jn.1994.71.5.1917; Pais I, 2003, J NEUROPHYSIOL, V89, P2046, DOI 10.1152/jn.00549.2002; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Parenti R, 2002, ARCH ITAL BIOL, V140, P101; PATERNOSTRO MA, 1995, DEV BRAIN RES, V84, P1; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; PICCOLINO M, 1984, J NEUROSCI, V4, P2477; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Rash JE, 1998, CELL BIOL INT, V22, P731, DOI 10.1006/cbir.1998.0392; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Rekling JC, 2000, J NEUROSCI, V20, part. no.; REVEL JP, 1967, J CELL BIOL, V33, pC7, DOI 10.1083/jcb.33.3.C7; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Scherer SS, 1999, NOVART FDN SYMP, V219, P175; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; Sotelo C, 1978, Int Rev Cytol, V55, P67; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPIRA ME, 1972, BRAIN RES, V37, P294, DOI 10.1016/0006-8993(72)90674-9; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Srinivas M, 1999, J NEUROSCI, V19, P9848; SRINIVAS M, 2003, SPECIFIC BLOCK CONNE; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tang VW, 2003, BIOPHYS J, V84, P1660, DOI 10.1016/S0006-3495(03)74975-3; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Traub RD, 2000, J NEUROSCI, V20, P2086; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; TRAVAGLI RA, 1995, J NEUROPHYSIOL, V74, P519, DOI 10.1152/jn.1995.74.2.519; Trexler EB, 2001, J COMP NEUROL, V437, P408, DOI 10.1002/cne.1292; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; van den Top M, 2003, J PHYSIOL-LONDON, V549, P809, DOI 10.1113/jphysiol.2002.033290; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Vigmond EJ, 1997, J NEUROPHYSIOL, V78, P3107, DOI 10.1152/jn.1997.78.6.3107; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Xin DY, 2000, VISUAL NEUROSCI, V17, P799, DOI 10.1017/S0952523800175133; Yang QZ, 2002, BRAIN RES, V955, P115, DOI 10.1016/S0006-8993(02)03374-7; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8; Zhang CB, 2000, J COMP NEUROL, V426, P1, DOI 10.1002/1096-9861(20001009)426:1<1::AID-CNE1>3.0.CO;2-Y	155	570	588	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					495	511		10.1016/S0896-6273(04)00043-1	http://dx.doi.org/10.1016/S0896-6273(04)00043-1			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980200	Bronze			2022-12-28	WOS:000221458100004
J	Badre, D; Wagner, AD				Badre, D; Wagner, AD			Selection, integration, and conflict monitoring: Assessing the nature and generality of prefrontal cognitive control mechanisms	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; RESPONSE CONFLICT; FRONTOPOLAR CORTEX; EXECUTIVE CONTROL; FMRI EVIDENCE; MEMORY; RETRIEVAL; TASK; INTERFERENCE; ACTIVATION	Prefrontal cortex (PFC) supports flexible behavior by mediating cognitive control, though the elemental forms of control supported by PFC remain a central debate. Dorsolateral PFC (DLPFC) is thought to guide response selection under conditions of response conflict or, alternatively, may refresh recently active representations within working memory. Lateral frontopolar cortex (FPC) may also adjudicate response conflict, though others propose that FPC supports higher order control processes such as subgoaling and integration. Anterior cingulate cortex (ACC) is hypothesized to upregulate response selection by detecting response conflict; it remains unclear whether ACC functions generalize beyond monitoring response conflict. The present fMRI experiment directly tested these competing theories regarding the functional roles of DLPFC, FPC, and ACC. Results reveal dissociable control processes in PFC, with mid-DLPFC selectively mediating resolution of response conflict and FPC further mediating subgoaling/integration. ACC demonstrated a broad sensitivity to control demands, suggesting a generalized role in modulating cognitive control.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University; Stanford University	Badre, D (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	badred@mit.edu		Wagner, Anthony/0000-0003-0624-4543				Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Barch DM, 1999, NEUROIMAGE, V10, P642, DOI 10.1006/nimg.1999.0500; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; BUNGE SA, 2004, IN PRESS BRAIN COGN; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; Dehaene S, 1995, ANN NY ACAD SCI, V769, P305, DOI 10.1111/j.1749-6632.1995.tb38147.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gehring WJ, 2002, COGNITIVE BRAIN RES, V13, P267, DOI 10.1016/S0926-6410(01)00132-X; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Horn H, 2003, EUR ARCH PSY CLIN N, V253, P154, DOI 10.1007/s00406-003-0419-4; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Johnson MK, 2002, PSYCHOL SCI, V13, P64, DOI 10.1111/1467-9280.00411; Johnson MK, 2003, CEREB CORTEX, V13, P265, DOI 10.1093/cercor/13.3.265; Jonides J, 2002, PRINCIPLES FRONTAL L, P233, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0015; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; KORNBLUM S, 1994, PSYCHOL RES-PSYCH FO, V56, P130, DOI 10.1007/BF00419699; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Michelon P, 2003, NEUROIMAGE, V19, P1612, DOI 10.1016/S1053-8119(03)00111-3; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Passingham R.E., 2002, PRINCIPLES FRONTAL L, P221; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Petrides M, 2000, J NEUROSCI, V20, P7496; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Raye CL, 2002, NEUROIMAGE, V15, P447, DOI 10.1006/nimg.2001.0983; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; SHALLICE T, 1991, FRONTAL LOBE FUNCTIO, P92; Shimamura AP., 2002, PRINCIPLES FRONTAL L, P210, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0013; Shimamura Arthur P., 1995, P803; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1987, FRONTAL LOBES REVIS; Talairach I., 1988, COPLANAR STEREOTACTI; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1	70	323	337	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					473	487		10.1016/S0896-6273(03)00851-1	http://dx.doi.org/10.1016/S0896-6273(03)00851-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766185	Bronze			2022-12-28	WOS:000221457900017
J	Bossy-Wetzel, E; Talantova, MV; Lee, WD; Scholzke, MN; Harrop, A; Mathews, E; Gotz, T; Han, JH; Ellisman, MH; Perkins, GA; Lipton, SA				Bossy-Wetzel, E; Talantova, MV; Lee, WD; Scholzke, MN; Harrop, A; Mathews, E; Gotz, T; Han, JH; Ellisman, MH; Perkins, GA; Lipton, SA			Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels	NEURON			English	Article							METHYL-D-ASPARTATE; P38 MAP KINASE; S-NITROSYLATION; SUPEROXIDE-PRODUCTION; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; VOLUME REGULATION; CASPASE CLEAVAGE; CYTOCHROME-C; APOPTOSIS	Nitric oxide (NO) and zinc (Zn2+) are implicated in the pathogenesis of cerebral ischemia and neurodegenerative diseases. However, their relationship and the molecular mechanism of their neurotoxic effects remain unclear. Here we show that addition of exogenous NO or NMDA (to increase endogenous NO) leads to peroxynitrite (ONOO-) formation and consequent Zn2+ release from intracellular stores in cerebrocortical neurons. Free Zn2+ in turn induces respiratory block, mitochondrial permeability transition (mPT), cytochrome c release, generation of reactive oxygen species (ROS), and p38 MAP kinase activation. This pathway leads to caspase-independent K+ efflux with cell volume loss and apoptotic-like death. Moreover, Zn2+ chelators, ROS scavengers, Bcl-x(L), dominant-interfering p38, or K+ channel blockers all attenuate NO-induced K+ efflux, cell volume loss, and neuronal apoptosis. Thus, these data establish a new form of crosstalk between NO and Zn2+ apoptotic signal transduction pathways that may contribute to neurodegeneration.	Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Bossy-Wetzel, E (corresponding author), Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA.	ebossy-wetzel@bumham.org; slipton@bumham.org	Han, J/G-4671-2010	Lipton, Stuart/0000-0002-3490-1259; Perkins, Guy/0000-0002-1834-6646	NCRR NIH HHS [P41 RR04050] Funding Source: Medline; NEI NIH HHS [R01 EY09024, R01 EY05477] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline; NINDS NIH HHS [R01 NS14718, R01 NS047456, R01 NS41207, R01 NS44314] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014718, R01NS041207, R01NS044314, R01NS047456] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Aiuchi T, 1998, J BIOCHEM-TOKYO, V124, P300, DOI 10.1093/oxfordjournals.jbchem.a022111; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851, DOI 10.1002/jlb.57.6.851; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Berendji D, 1997, FEBS LETT, V405, P37, DOI 10.1016/S0014-5793(97)00150-6; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bonfoco E, 1996, NEUROREPORT, V8, P273, DOI 10.1097/00001756-199612200-00054; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Bossy-Wetzel E, 2000, METHOD ENZYMOL, V322, P235; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Brorson JR, 1999, J NEUROSCI, V19, P147, DOI 10.1523/JNEUROSCI.19-01-00147.1999; Brown AM, 2000, J BIOL CHEM, V275, P13441, DOI 10.1074/jbc.275.18.13441; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Dallaporta B, 1998, J IMMUNOL, V160, P5605; DAWSON TM, 1994, ANN NY ACAD SCI, V738, P76; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dineley KE, 2002, MOL PHARMACOL, V62, P618, DOI 10.1124/mol.62.3.618; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Gomez-Angelats M, 2000, CELL TISSUE RES, V301, P33, DOI 10.1007/s004410000216; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lee JY, 2000, J NEUROSCI, V20; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Montoliu C, 2000, J NEUROCHEM, V75, P266, DOI 10.1046/j.1471-4159.2000.0750266.x; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Pal S, 2003, J NEUROSCI, V23, P4798; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Schieke SM, 1999, FEBS LETT, V448, P301, DOI 10.1016/S0014-5793(99)00372-5; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; SKULACHE.VP, 1967, BIOCHEM BIOPH RES CO, V26, P1, DOI 10.1016/0006-291X(67)90242-2; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X	65	309	319	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					351	365		10.1016/S0896-6273(04)00015-7	http://dx.doi.org/10.1016/S0896-6273(04)00015-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766175	Bronze			2022-12-28	WOS:000221457900007
J	Leissring, MA; Farris, W; Chang, AY; Walsh, DM; Wu, XN; Sun, XY; Frosch, MP; Selkoe, DJ				Leissring, MA; Farris, W; Chang, AY; Walsh, DM; Wu, XN; Sun, XY; Frosch, MP; Selkoe, DJ			Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death	NEURON			English	Article							INSULIN-DEGRADING ENZYME; BRAIN A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; PRECURSOR PROTEIN; IN-VIVO; PEPTIDE; DEGRADATION; EXPRESSION; ANTIBODIES	Converging evidence suggests that the accumulation of cerebral amyloid p-protein (Abeta) in Alzheimer's disease (AD) reflects an imbalance between the production and degradation of this self-aggregating peptide. Upregulation of proteases that degrade Abeta thus represents a novel therapeutic approach to lowering steady-state Abeta levels, but the consequences of sustained upregulation in vivo have not been studied. Here we show that transgenic overexpression of insulin-degrading enzyme (IDE) or neprilysin (NEP) in neurons significantly reduces brain Abeta levels, retards or completely prevents amyloid plaque formation and its associated cytopathology, and rescues the premature lethality present in amyloid precursor protein (APP) transgenic mice. Our findings demonstrate that chronic upregulation of Abeta-degrading proteases represents an efficacious therapeutic approach to combating Alzheimer-type pathology in vivo.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Aging Genet & Neurodegenerat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.		LEISSRING, MALCOLM/AAW-5361-2021; Frosch, Matthew P/ABD-7456-2021	LEISSRING, MALCOLM/0000-0001-7185-4255; Frosch, Matthew P/0000-0002-3940-9861	NIA NIH HHS [AG12749] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012749] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ait-Ghezala G, 2002, NEUROSCI LETT, V325, P87, DOI 10.1016/S0304-3940(02)00243-4; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Caughey B, 2003, ANNU REV NEUROSCI, V9, P9; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Edland SD, 2003, NEUROSCI LETT, V345, P21, DOI 10.1016/S0304-3940(03)00488-9; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FLORENTIN D, 1984, ANAL BIOCHEM, V141, P62, DOI 10.1016/0003-2697(84)90425-1; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45; Lazarov O, 2002, J NEUROSCI, V22, P9785; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Marr RA, 2003, J NEUROSCI, V23, P1992; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; SAITO T, 2003, SCI AGING KNOWLEDGE, pPE1; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; TURNER AJ, 1998, HDB PROEOLYTIC ENZYM; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N	41	577	609	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1087	1093		10.1016/S0896-6273(03)00787-6	http://dx.doi.org/10.1016/S0896-6273(03)00787-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687544	Bronze			2022-12-28	WOS:000187503400008
J	Shea, SD; Margoliash, D				Shea, SD; Margoliash, D			Basal forebrain cholineraic modulation of auditory activity in the zebra finch song system	NEURON			English	Article							VOCAL CONTROL-SYSTEM; NUCLEUS BASALIS; LEARNED VOCALIZATIONS; SOMATOSENSORY CORTEX; MOTOR SYSTEM; BIRD SONG; PLASTICITY; BRAIN; SLEEP; ACETYLCHOLINE	The cholinergic basis of auditory "gating" in the sensorimotor nucleus HVc and its efferent target robustus archistriatalis (RA) was investigated in anesthetized zebra finches. Injections of cholinergic agonists carbachol or muscarine into HVc strongly affected discharge rates and diminished auditory responsiveness in both HVc and its target RA, changes toward an awake-like condition. HVc nicotine injections produced similar strong effects in HVc, but weaker and inconsistent effects in RA. Stimulation of basal forebrain (BF) produced an initial transient network shutdown followed by diminished auditory responsiveness in HVc and RA. All stimulation effects were blocked when preceded by HVc injections of nicotinic or muscarinic antagonists. Thus, BF cholinergic modulation of song system auditory activity acting via functionally distinct HVc circuits can contribute to auditory gating. We hypothesize that wakeful BF activity levels block sensory input to motor systems and adaptively change during behavior to allow sensorimotor feedback such as auditory feedback during singing.	Univ Chicago, Committee Neurobiol, Chicago, IL 60637 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Shea, SD (corresponding author), Univ Chicago, Committee Neurobiol, 1027 E 27th St, Chicago, IL 60637 USA.			Shea, Stephen/0000-0001-6927-0189	NIDCD NIH HHS [DC 05098] Funding Source: Medline; NIMH NIH HHS [MH59831] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005098] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Appeltants D, 2000, J CHEM NEUROANAT, V18, P117, DOI 10.1016/S0891-0618(99)00054-X; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BALL GF, 1990, J COMP NEUROL, V298, P431, DOI 10.1002/cne.902980405; BALL GF, 1994, BRAIN BEHAV EVOLUT, V44, P234, DOI 10.1159/000113579; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARS B, 1993, NEUROSCIENCE, V56, P61, DOI 10.1016/0306-4522(93)90562-T; Janata P, 1999, J NEUROSCI, V19, P5108; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kimpo RR, 2003, J NEUROSCI, V23, P5750; KITT CA, 1981, NEUROSCIENCE, V6, P1551, DOI 10.1016/0306-4522(81)90224-4; Li R, 1999, NEUROREPORT, V10, P165, DOI 10.1097/00001756-199901180-00032; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; Margoliash D, 2002, J COMP PHYSIOL A, V188, P851, DOI 10.1007/s00359-002-0351-5; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; METHERATE R, 1991, BRAIN RES, V559, P163, DOI 10.1016/0006-8993(91)90301-B; Mooney R, 2002, J COMP PHYSIOL A, V188, P879, DOI 10.1007/s00359-002-0353-3; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REINER A, 1983, NEUROSCIENCE, V9, P61, DOI 10.1016/0306-4522(83)90047-7; RYAN SM, 1981, J COMP NEUROL, V202, P211, DOI 10.1002/cne.902020207; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Szymusiak R, 2000, BEHAV BRAIN RES, V115, P171, DOI 10.1016/S0166-4328(00)00257-6; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1212, DOI 10.1152/jn.1990.64.4.1212; Vates GE, 1997, J COMP NEUROL, V380, P275; WATSON JT, 1988, J COMP NEUROL, V274, P255, DOI 10.1002/cne.902740209; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZUSCHRATTER W, 1990, BRAIN RES, V513, P193, DOI 10.1016/0006-8993(90)90457-M	41	42	44	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1213	1226		10.1016/S0896-6273(03)00723-2	http://dx.doi.org/10.1016/S0896-6273(03)00723-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687554	Bronze			2022-12-28	WOS:000187503400018
J	Goosens, KA; Hobin, JA; Maren, S				Goosens, KA; Hobin, JA; Maren, S			Auditory-evoked spike firing in the lateral amygdala and Pavlovian fear conditioning: Mnemonic code or fear bias?	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL NUCLEUS; SYNAPTIC PLASTICITY; NEURONS; STIMULATION; PROJECTIONS; RESPONSES; SENSITIZATION; ACQUISITION; RECORDINGS	Amygdala neuroplasticity has emerged as a candidate substrate for Pavlovian fear memory. By this view, conditional stimulus (CS)-evoked activity represents a mnemonic code that initiates the expression of fear behaviors. However, a fear state may nonassociatively enhance sensory processing, biasing CS-evoked activity in amygdala neurons. Here we describe experiments that dissociate auditory CS-evoked spike firing in the lateral amygdala (LA) and both conditional fear behavior and LA excitability in rats. We found that the expression of conditional freezing and increased LA excitability was neither necessary nor sufficient for the expression of conditional increases in CS-evoked spike firing. Rather, conditioning-related changes in CS-evoked spike firing were solely determined by the associative history of the CS. Thus, our data support a model in which associative activity in the LA encodes fear memory and contributes to the expression of learned fear behaviors.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Maren, S (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	maren@umich.edu	Maren, Stephen/A-7091-2009; Goosens, Ki/ABI-6743-2020; Maren, Stephen/B-6182-2014	Maren, Stephen/0000-0002-9342-7411; Maren, Stephen/0000-0002-9342-7411; Goosens, Ki/0000-0002-5246-2261	NIMH NIH HHS [R01MH065961, R29MH57865] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065961, R29MH057865] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Antoniadis EA, 1999, BEHAV BRAIN RES, V101, P1, DOI 10.1016/S0166-4328(98)00056-4; Antoniadis EA, 2000, BEHAV BRAIN RES, V108, P1, DOI 10.1016/S0166-4328(99)00121-7; APPLEGATE CD, 1982, BRAIN RES, V238, P457, DOI 10.1016/0006-8993(82)90123-8; ASHE JH, 1976, BEHAV BIOL, V16, P45, DOI 10.1016/S0091-6773(76)91108-1; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; GALLAGHER M, 2000, AMYGDALA FUNCTIONAL, P320; Goosens KA, 2002, HIPPOCAMPUS, V12, P592, DOI 10.1002/hipo.10099; HITCHCOCK JM, 1989, BEHAV NEUROSCI, V103, P509, DOI 10.1037/0735-7044.103.3.509; Hobin JA, 2003, J NEUROSCI, V23, P8410; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Holland PC, 2000, J NEUROSCI, V20, P6701, DOI 10.1523/JNEUROSCI.20-17-06701.2000; Jolkkonen E, 1998, J COMP NEUROL, V395, P53, DOI 10.1002/(SICI)1096-9861(19980525)395:1<53::AID-CNE5>3.0.CO;2-G; KAPP B S, 1992, P229; KAPP BS, 1982, BRAIN RES, V234, P251, DOI 10.1016/0006-8993(82)90866-6; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MCECHRON MD, 1995, BRAIN RES, V682, P157, DOI 10.1016/0006-8993(95)00331-J; Pare D, 2002, TRENDS NEUROSCI, V25, P436, DOI 10.1016/S0166-2236(02)02243-9; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; SANANES CB, 1992, BEHAV NEUROSCI, V106, P72, DOI 10.1037/0735-7044.106.1.72; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; Tang JR, 2001, BRAIN RES, V919, P232, DOI 10.1016/S0006-8993(01)03020-7; Vazdarjanova A, 2000, TRENDS NEUROSCI, V23, P345, DOI 10.1016/S0166-2236(00)01599-X; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Weiler HT, 1998, SYNAPSE, V28, P294; WINSON J, 1978, J NEUROPHYSIOL, V41, P716, DOI 10.1152/jn.1978.41.3.716	51	98	98	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1013	1022		10.1016/S0896-6273(03)00728-1	http://dx.doi.org/10.1016/S0896-6273(03)00728-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659099	Bronze			2022-12-28	WOS:000187042200017
J	Moghaddam, B				Moghaddam, B			Bringing order to the glutamate chaos in schizophrenia	NEURON			English	Review							GENETIC-VARIATION; RECEPTOR; KETAMINE; TARGETS; POLYMORPHISMS; ASSOCIATION; MODEL	Recent genetic linkage studies complement the existing evidence that implicates abnormalities in NMDA receptor-mediated neurotransmission in the pathophysiology of schizophrenia. At the same time, advances in our understanding of the complex mechanisms that modulate the function of NMDA receptors suggest several novel sites for pharmacological manipulation of these receptors. This presents exciting opportunities for rational rather than serendipitous discovery of therapeutics for schizophrenia.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Moghaddam, B (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	moghaddam@bns.pitt.edu						Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Clinton SM, 2003, AM J PSYCHIAT, V160, P1100, DOI 10.1176/appi.ajp.160.6.1100; Coyle JT, 2002, CNS NEUROL DISORD-DR, V1, P183, DOI 10.2174/1568007024606212; DEAKIN JFW, 1989, J NEUROCHEM, V52, P1781, DOI 10.1111/j.1471-4159.1989.tb07257.x; Fujii Y, 2003, PSYCHIAT GENET, V13, P71, DOI 10.1097/01.ypg.0000056682.82896.b0; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hirsch S. R., 2003, SCHIZOPHRENIA; Hyman SE, 2003, SCIENCE, V299, P350, DOI 10.1126/science.1077141; Javitt Daniel C, 2002, Curr Opin Investig Drugs, V3, P1067; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kinney GG, 2003, J PHARMACOL EXP THER, V306, P116, DOI 10.1124/jpet.103.048702; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2003, BIOL PSYCHIAT, V53, p111S; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Martucci L, 2003, AM J MED GENET B, V119B, P24, DOI 10.1002/ajmg.b.20014; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Moghaddam B, 2002, BIOL PSYCHIAT, V51, P775, DOI 10.1016/S0006-3223(01)01362-2; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Saugstad JA, 1998, J NEUROSCI, V18, P905; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; TSAI G, 2003, IN PRESS BIOL PSYCHI; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086	29	315	330	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					881	884		10.1016/S0896-6273(03)00757-8	http://dx.doi.org/10.1016/S0896-6273(03)00757-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659087	Bronze			2022-12-28	WOS:000187042200005
J	Zhang, JM; Wang, HK; Ye, CQ; Ge, WP; Chen, YR; Jiang, ZL; Wu, CP; Poo, MM; Duan, SM				Zhang, JM; Wang, HK; Ye, CQ; Ge, WP; Chen, YR; Jiang, ZL; Wu, CP; Poo, MM; Duan, SM			ATP released by Astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression	NEURON			English	Article							RAT SPINAL-CORD; DORSAL-HORN NEURONS; CALCIUM WAVES; HIPPOCAMPAL ASTROCYTES; SYNAPTIC TRANSMISSION; IN-VITRO; RECEPTORS; INHIBITION; ACTIVATION; ADENOSINE	Extracellular ATIP released from axons is known to assist activity-dependent signaling between neurons and Schwann cells in the peripheral nervous system. Here we report that ATP released from astrocytes as a result of neuronal activity can also modulate central synaptic transmission. In cultures of hippocampal neurons, endogenously released ATP tonically suppresses glutamatergic synapses via presynaptic P2Y receptors, an effect that depends on the presence of cocultured astrocytes. Glutamate release accompanying neuronal activity also activates non-NMDA receptors of nearby astrocytes and triggers ATIP release from these cells, which in turn causes homo- and heterosynaptic suppression. In CA1 pyramidal neurons of hippocampal slices, a similar synaptic suppression was also produced by adenosine, an immediate degradation product of ATIP released by glial cells. Thus, neuron-glia crosstalk may participate in activity-dependent synaptic modulation.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.		Wang, Huikun/V-3677-2017	Wang, Huikun/0000-0001-8556-3504				Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Bardoni R, 1997, J NEUROSCI, V17, P5297; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Burnstock G, 1995, J PHYSIOL PHARMACOL, V46, P365; Connolly GP, 2000, EUR J PHARMACOL, V397, P271, DOI 10.1016/S0014-2999(00)00273-9; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Cunha RA, 1998, J NEUROSCI, V18, P1987; Cunha RA, 2000, LIFE SCI, V68, P119, DOI 10.1016/S0024-3205(00)00923-1; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Deuchars SA, 2001, J NEUROSCI, V21, P6308, DOI 10.1523/JNEUROSCI.21-16-06308.2001; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Duan SM, 1999, J NEUROSCI, V19, P10193; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hugel S, 2000, J NEUROSCI, V20, P2121; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Mendoza-Fernandez V, 2000, J PHARMACOL EXP THER, V293, P172; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; NAKAZAWA K, 1995, N-S ARCH PHARMACOL, V351, P202; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Pappas CA, 1996, GLIA, V16, P7, DOI 10.1002/(SICI)1098-1136(199601)16:1<7::AID-GLIA2>3.0.CO;2-2; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Porter JT, 1996, J NEUROSCI, V16, P5073; Queiroz G, 1997, NEUROSCIENCE, V78, P1203, DOI 10.1016/S0306-4522(96)00637-9; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Silinsky EM, 1996, J PHYSIOL-LONDON, V492, P815, DOI 10.1113/jphysiol.1996.sp021348; STENHAUSER C, 1996, TRENDS NEUROSCI, V19, P339; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; SWANSON RA, 1994, BRAIN RES, V664, P94, DOI 10.1016/0006-8993(94)91958-5; SZERB JC, 1987, BRAIN RES, V410, P116, DOI 10.1016/S0006-8993(87)80030-6; Trendelenburg AU, 2000, NEUROSCIENCE, V96, P249, DOI 10.1016/S0306-4522(99)00577-1; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Westfall TD, 1997, EUR J PHARMACOL, V329, P169, DOI 10.1016/S0014-2999(97)89178-9; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	461	494	1	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					971	982		10.1016/S0896-6273(03)00717-7	http://dx.doi.org/10.1016/S0896-6273(03)00717-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659095	Bronze			2022-12-28	WOS:000187042200013
J	Huang, K; Yanai, A; Kang, R; Arstikaitis, P; Singaraja, RR; Metzler, M; Mullard, A; Haigh, B; Gauthier-Campbell, C; Gutekunst, CA; Hayden, MR; El-Husseini, A				Huang, K; Yanai, A; Kang, R; Arstikaitis, P; Singaraja, RR; Metzler, M; Mullard, A; Haigh, B; Gauthier-Campbell, C; Gutekunst, CA; Hayden, MR; El-Husseini, A			Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins	NEURON			English	Article							GABA(A) RECEPTORS; FATTY ACYLATION; SYNAPTOTAGMIN; SNAP-25; PSD-95; SUBSTRATE; MOTIFS	In neurons, posttranslational modification by palmitate regulates the trafficking and function of signaling molecules, neurotransmitter receptors, and associated synaptic scaffolding proteins. However, the enzymatic machinery involved in protein palmitoylation has remained elusive. Here, using biochemical assays, we show that huntingtin (htt) interacting protein, HIP14, is a neuronal palmitoyl transferase (PAT). HIP14 shows remarkable substrate specificity for neuronal proteins, including SNAP-25, PSD-95, GAD65, synaptotagmin I, and htt. Conversely, HIP14 is catalytically invariant toward paralemmin and synaptotagmin VII. Exogenous HIP14 enhances palmitoylation-dependent vesicular trafficking of several acylated proteins in both heterologous cells and neurons. Moreover, interference with endogenous expression of HIP14 reduces clustering of PSD-95 and GAD65 in neurons. These findings define HIP14 as a mammalian palmitoyl transferase involved in the palmitoylation and trafficking of multiple neuronal proteins.	Womens & Childrens Hosp, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; Emory Univ, Dept Neurol, Atlanta, GA 30329 USA	University of British Columbia; Emory University	El-Husseini, A (corresponding author), Womens & Childrens Hosp, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca; alaa@interchange.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867; Yanai, Anat/0000-0002-0792-6901				Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Heindel U, 2003, FEBS LETT, V544, P57, DOI 10.1016/S0014-5793(03)00449-6; HESS DT, 1992, J NEUROSCI, V12, P4634; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; KANG R, 2004, IN PRESS J BIOL CHEM; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kutzleb C, 1998, J CELL BIOL, V143, P795, DOI 10.1083/jcb.143.3.795; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Ueno K, 2000, GENES CELLS, V5, P859, DOI 10.1046/j.1365-2443.2000.00369.x; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625	31	234	245	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					977	986		10.1016/j.neuron.2004.11.027	http://dx.doi.org/10.1016/j.neuron.2004.11.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603740	Bronze			2022-12-28	WOS:000225842300011
J	Paisan-Ruiz, C; Jain, S; Evans, EW; Gilks, WP; Simon, J; van der Brug, M; de Munain, AL; Aparicio, S; Gil, AM; Khan, N; Johnson, J; Martinez, JR; Nicholl, D; Carrera, IM; Pena, AS; de Silva, R; Lees, A; Marti-Masso, JF; Perez-Tur, J; Wood, NW; Singleton, AB				Paisan-Ruiz, C; Jain, S; Evans, EW; Gilks, WP; Simon, J; van der Brug, M; de Munain, AL; Aparicio, S; Gil, AM; Khan, N; Johnson, J; Martinez, JR; Nicholl, D; Carrera, IM; Pena, AS; de Silva, R; Lees, A; Marti-Masso, JF; Perez-Tur, J; Wood, NW; Singleton, AB			Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease	NEURON			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; FAMILIAL ALZHEIMERS-DISEASE; MISSENSE MUTATIONS; SYNUCLEIN; LOCUS	Parkinson's disease (PD; OMIM #168600) is the second most common neurodegenerative disorder in the Western world and presents as a progressive movement disorder. The hallmark pathological features of PD are loss of dopaminergic neurons from the substantia nigra and neuronal intracellular Lewy body inclusions. Parkinsonism is typically sporadic in nature; however, several rare familial forms are linked to genetic loci, and the identification of causal mutations has provided insight into the disease process. PARK8, identified in 2002 by Funayama and colleagues, appears to be a common cause of familial PD. We describe here the cloning of a novel gene that contains missense mutations segregating with PARK8-linked PD in five families from England and Spain. Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor.	CSIC, Inst Biomed, Dept Genom & Proteom, Unitat Genet Mol, E-46010 Valencia, Spain; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Reta Lila Weston Inst Neurol Studies, London W1T 45F, England; NIA, Mol Genet Unit, NIH, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; NIA, Cell Biol & Gene Express Unit, NIH, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; Hosp Donostia, Unidad Expt, E-20014 San Sebastian, Spain; Hosp Donostia, Serv Neurol, E-20014 San Sebastian, Spain; Hosp Ntra Str Antigua Zumarraga, E-20700 Guipuzkao, Spain; Hosp Mendaro, E-20850 Guipuzkao, Spain; Queen Elizabeth Hosp, Birmingham Dept Neurol, Birmingham B15 2TH, W Midlands, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University Hospital Donostia; University Hospital Donostia; University of Birmingham	Perez-Tur, J (corresponding author), CSIC, Inst Biomed, Dept Genom & Proteom, Unitat Genet Mol, E-46010 Valencia, Spain.	jpereztur@ibv.csic.es; nwood@ion.ucl.ac.uk; singleta@mail.nih.gov	Gilks, William/P-9137-2015; Singleton, Andrew B/C-3010-2009; Perez-Tur, Jordi/A-2143-2010; Ruiz, Coro Paisán/C-2912-2009; Sáenz, Amets/E-4761-2019; Johnson, Janel/A-7136-2010; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Martí-Carrera, Itxaso/AGP-5583-2022; de Silva, Rohan/C-1734-2008; Wood, Nicholas W/C-2505-2009; Lees, Andrew J/A-6605-2009; Aparicio, Silvia/K-8563-2014	Gilks, William/0000-0001-7814-3173; Perez-Tur, Jordi/0000-0002-9111-1712; Sáenz, Amets/0000-0002-0704-1150; Martí-Carrera, Itxaso/0000-0003-0578-9568; de Silva, Rohan/0000-0002-5052-5775; Wood, Nicholas W/0000-0002-9500-3348; Lees, Andrew J/0000-0002-2476-4385; Aparicio, Silvia/0000-0002-6664-3768; /0000-0002-9509-4032	Parkinson&apos;s UK [G-4029] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000958, Z01AG000958] Funding Source: NIH RePORTER	Parkinson&apos;s UK(Parkinson&apos;s UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Li JH, 1995, P NATL ACAD SCI USA, V92, P12180, DOI 10.1073/pnas.92.26.12180; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich, 2004, AM J HUM GENET, V75, P534; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	16	1741	1808	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					595	600		10.1016/j.neuron.2004.10.023	http://dx.doi.org/10.1016/j.neuron.2004.10.023			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541308	Bronze			2022-12-28	WOS:000225338100006
J	Berke, JD; Okatan, M; Skurski, J; Eichenbaum, HB				Berke, JD; Okatan, M; Skurski, J; Eichenbaum, HB			Oscillatory entrainment of striatal neurons in freely moving rats	NEURON			English	Review							PARVALBUMIN-IMMUNOREACTIVE NEURONS; THALAMIC RETICULAR NUCLEUS; MEDIUM SPINY NEURONS; ACCUMBENS IN-VIVO; BASAL GANGLIA; GABAERGIC INTERNEURONS; WAVE DISCHARGES; FIRING PATTERNS; GLOBUS-PALLIDUS; HIPPOCAMPAL INTERNEURONS	Oscillations and synchrony in basal ganglia circuits may play a key role in the organization of voluntary actions and habits. We recorded single units and local field potentials from multiple striatal and cortical locations simultaneously, over a range of behavioral states. We observed opposite gradients of oscillatory entrainment, with dorsal/lateral striatal neurons entrained to high-voltage spindle oscillations ("spike wave discharges") and ventral/medial striatal neurons entrained to the hippocampal theta rhythm. While the majority of units were likely medium-spiny projection neurons, a second neuronal population showed characteristic features of fast-spiking GABAergic interneurons, including tonic activity, brief waveforms, and high-frequency bursts. These fired at an earlier spindle phase than the main neuronal population, and their density within striatum corresponded closely to the intensity of spindle oscillations. The orchestration of oscillatory activity by networks of striatal interneurons may be an important mechanism in the pathophysiology of neurological disorders such as Parkinson's disease.	Boston Univ, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Berke, JD (corresponding author), Boston Univ, Lab Cognit Neurobiol, Boston, MA 02215 USA.	jdberke@umich.edu	OKATAN, MURAT/AAP-9572-2020; Okatan, Murat/ABA-7949-2020	OKATAN, MURAT/0000-0002-0064-6747; Okatan, Murat/0000-0002-0064-6747	NIDA NIH HHS [R01 DA014318, R01 DA014318-01] Funding Source: Medline; NIMH NIH HHS [F32 MH012908, F32 MH012908-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014318] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; APICELLA P, 1991, EXP BRAIN RES, V84, P672; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; BENNETT BD, 2003, BASAL GANGLIA, V6; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; Brown LL, 1998, J COMP NEUROL, V392, P468; Brown P, 1998, LANCET, V351, P1801, DOI 10.1016/S0140-6736(97)11225-9; BUCHWALD NA, 1961, ELECTROEN CLIN NEURO, V13, P509, DOI 10.1016/0013-4694(61)90164-X; BUONAMICI M, 1986, NEUROPHARMACOLOGY, V25, P323, DOI 10.1016/0028-3908(86)90259-5; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; BUZSAKI G, 1988, NEUROSCIENCE, V26, P735, DOI 10.1016/0306-4522(88)90095-4; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Courtemanche R, 2003, J NEUROSCI, V23, P11741; COWAN RL, 1990, J COMP NEUROL, V302, P197, DOI 10.1002/cne.903020202; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; DURAND D, 1958, J GEOL, V66, P229, DOI 10.1086/626501; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; GEMERT M, 2000, J NEUROSCI, V20, P7052; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; Goto Y, 2001, J NEUROSCI, V21, P4498, DOI 10.1523/JNEUROSCI.21-12-04498.2001; Goto Y, 2001, J NEUROSCI, V21; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GROENEWEGEN HJ, 1987, NEUROSCIENCE, V23, P103, DOI 10.1016/0306-4522(87)90275-2; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hartmann MJ, 1998, J NEUROPHYSIOL, V80, P1598, DOI 10.1152/jn.1998.80.3.1598; HERKENHAM M, 1981, NATURE, V291, P415, DOI 10.1038/291415a0; Hurtado JM, 1999, P NATL ACAD SCI USA, V96, P1674, DOI 10.1073/pnas.96.4.1674; Ichinohe N, 2001, NEUROSCI LETT, V302, P105, DOI 10.1016/S0304-3940(01)01666-4; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kandel A, 1997, J NEUROSCI, V17, P6783; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KELLEY AE, 1982, NEUROSCIENCE, V7, P2321, DOI 10.1016/0306-4522(82)90198-1; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; KITA H, 1993, PROG BRAIN RES, V99, P51; KITA H, 1990, BRAIN RES, V536, P1, DOI 10.1016/0006-8993(90)90002-S; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; KUBOTA Y, 1993, NEUROREPORT, V5, P205, DOI 10.1097/00001756-199312000-00004; KUBOTA Y, 1993, J COMP NEUROL, V332, P499, DOI 10.1002/cne.903320409; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LAPPER SR, 1992, BRAIN RES, V580, P215, DOI 10.1016/0006-8993(92)90947-8; LENZ S, 1994, SYNAPSE, V18, P55, DOI 10.1002/syn.890180108; LEUNG LS, 1993, CAN J PHYSIOL PHARM, V71, P311, DOI 10.1139/y93-049; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; MacKay WA, 1997, TRENDS COGN SCI, V1, P176, DOI 10.1016/S1364-6613(97)01059-0; Magill PJ, 2000, J NEUROSCI, V20, P820, DOI 10.1523/JNEUROSCI.20-02-00820.2000; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Murer MG, 2002, CELL MOL NEUROBIOL, V22, P611, DOI 10.1023/A:1021840504342; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; ODonnell P, 1997, J NEUROSCI, V17, P2143; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Pare D, 1996, J NEUROSCI, V16, P3334; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Plenz D, 1998, J NEUROSCI, V18, P266; Plenz D, 1996, NEUROSCIENCE, V70, P893, DOI 10.1016/0306-4522(95)00405-X; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; RICHARDSON TL, 1977, BRAIN RES, V127, P219, DOI 10.1016/0006-8993(77)90537-6; Rudkin TM, 1999, NEUROSCIENCE, V88, P1165, DOI 10.1016/S0306-4522(98)00265-6; RYAN LJ, 1984, BRAIN RES BULL, V13, P549, DOI 10.1016/0361-9230(84)90037-6; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SORENSEN KE, 1985, J COMP NEUROL, V238, P308, DOI 10.1002/cne.902380306; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352, DOI 10.1152/jn.1982.48.2.352; STERIADE M, 1984, J COMP NEUROL, V229, P531, DOI 10.1002/cne.902290407; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; VERGNES M, 1990, BRAIN RES, V523, P87, DOI 10.1016/0006-8993(90)91638-W; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; WILSON CJ, 1990, J NEUROSCI, V10, P508; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zar JH, 1974, BIOSTATISTICAL ANAL	102	354	359	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					883	896		10.1016/j.neuron.2004.08.035	http://dx.doi.org/10.1016/j.neuron.2004.08.035			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363398	Bronze			2022-12-28	WOS:000223992000013
J	Hamasaki, T; Leingartner, A; Ringstedt, T; O'Leary, DDM				Hamasaki, T; Leingartner, A; Ringstedt, T; O'Leary, DDM			EMX2 regulates sizes and positioning of the primary sensory and motor areas in neocortex by direct specification of cortical progenitors	NEURON			English	Article							EMBRYONIC CEREBRAL-CORTEX; MUTANT MICE; THALAMOCORTICAL CONNECTIONS; DIFFERENTIAL EXPRESSION; ROSTRAL PROSENCEPHALON; EARLY REGIONALIZATION; DORSAL TELENCEPHALON; CYTOCHROME-OXIDASE; SUBPLATE NEURONS; MOUSE FOREBRAIN	Genetic studies of neocortical area patterning are limited, because mice deficient for candidate regulatory genes die before areas emerge and have other complicating issues. To define roles for the homeodomain transcription factor EMX2, we engineered nestin-Emx2 transgenic mice that overexpress Emx2 in cortical progenitors coincident with expression of endogenous Emx2 and survive postnatally. Cortical size, lamination, thalamus, and thalamocortical pathfinding are normal in homozygous nestin-Emx2 mice. However, primary sensory and motor areas are disproportionately altered in size and shift rostrolaterally. Heterozygous transgenics have similar but smaller changes. Opposite changes are found in heterozygous Emx2 knockout mice. Fgf8 expression in the commissural plate of nestin-Emx2 mice is indistinguishable from wild-type, but Pax6 expression is downregulated in rostral cortical progenitors, suggesting that EMX2 repression of PAX6 specification of rostral identities contributes to reduced rostral areas. We conclude that EMX2 levels in cortical progenitors disproportionately specify sizes and positions of primary cortical areas.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu			NINDS NIH HHS [R37 NS31558] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Grove EA, 1998, DEVELOPMENT, V125, P2315; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; HOGAN B, 1994, MANIPULATING MOUSE E, P217; Huffman KJ, 1999, J NEUROSCI, V19, P9939; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jones L, 2002, DEVELOPMENT, V129, P5041; Kaufman MH, 1994, ATLAS MOUSE DEV; LEINGARTNER A, 1994, J BIOL CHEM, V269, P828; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Liu Q, 2000, J NEUROSCI, V20, P7682; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Theil T, 2002, DEVELOPMENT, V129, P3045; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	52	164	167	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					359	372		10.1016/j.neuron.2004.07.016	http://dx.doi.org/10.1016/j.neuron.2004.07.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294144	Green Submitted, Bronze			2022-12-28	WOS:000223156900010
J	Stoet, G; Snyder, LH				Stoet, G; Snyder, LH			Single neurons in posterior parietal cortex of monkeys encode cognitive set	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; PREFRONTAL CORTEX; NEURAL MECHANISMS; ATTENTIONAL MODULATION; SELECTIVE ATTENTION; VISUAL RESPONSES; TASK; FMRI; ACTIVATION; INTENTION	The primate posterior parietal cortex (PPC), part of the dorsal visual pathway, is best known for its role in encoding salient spatial information. Yet there are indications that neural activity in the PPC can also be modulated by nonspatial task-related information. In this study, we tested whether neurons in the PPC encode signals related to cognitive set, that is, the preparation to perform a particular task. Cognitive set has previously been associated with the frontal cortex but not the PPC. In this study, monkeys performed a cognitive set shifting paradigm in which they were cued in advance to apply one of two different task rules to the subsequent stimulus on every trial. Here we show that a subset of neurons in the PPC, concentrated in the lateral bank of the intraparietal sulcus and on the angular gyrus, responds selectively to cues for different task rules.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stoet, G (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	stoet@pcg.wusti.edu	Snyder, Lawrence H/A-4593-2017; Stoet, Gijsbert/D-6710-2016	Stoet, Gijsbert/0000-0002-7557-483X				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Ben Hamed S, 2003, J NEUROPHYSIOL, V90, P549, DOI 10.1152/jn.00639.2002; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; Dickinson AR, 2003, J NEUROPHYSIOL, V90, P2460, DOI 10.1152/jn.00788.2002; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; FERRERA VP, 1994, J NEUROSCI, V14, P6171; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Gurd JM, 2003, NEUROIMAGE, V20, pS50, DOI 10.1016/j.neuroimage.2003.09.022; Gurd JM, 2002, BRAIN, V125, P1024, DOI 10.1093/brain/awf093; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kimberg DY, 2000, COGNITIVE BRAIN RES, V10, P189, DOI 10.1016/S0926-6410(00)00016-1; Konishi S, 2002, P NATL ACAD SCI USA, V99, P7803, DOI 10.1073/pnas.122644899; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Rao JS., 2001, TOPICS CIRCULAR STAT; ROBINSON DL, 1978, FED PROC, V37, P2258; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Shulman GL, 1999, J NEUROSCI, V19, P9480; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Stoet G, 2003, ANIM COGN, V6, P121, DOI 10.1007/s10071-003-0170-2; Stoet G, 2003, NEUROPSYCHOLOGIA, V41, P1357, DOI 10.1016/S0028-3932(03)00048-4; Sylvester CYC, 2003, NEUROPSYCHOLOGIA, V41, P357, DOI 10.1016/S0028-3932(02)00167-7; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Venables WN., 2002, MODERN APPL STAT S; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	56	125	125	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					1003	1012		10.1016/j.neuron.2004.06.003	http://dx.doi.org/10.1016/j.neuron.2004.06.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207244	Green Submitted, Bronze			2022-12-28	WOS:000222329300015
J	John, J; Wu, MF; Boehmer, LN; Siegel, JM				John, J; Wu, MF; Boehmer, LN; Siegel, JM			Cataplexy-active neurons in the hypothalamus: Implications for the role of histamine in sleep and waking behavior	NEURON			English	Article							LOCUS-COERULEUS NEURONS; IN-VIVO MICRODIALYSIS; VENTROLATERAL PREOPTIC NUCLEUS; MUSCLE TONE SUPPRESSION; AMINO-ACID RELEASE; RAT HYPOTHALAMUS; HUMAN NARCOLEPSY; HYPOCRETIN NEURONS; OREXIN-2 RECEPTOR; REM-SLEEP	Noradrenergic, serotonergic, and histaminergic neurons are continuously active during waking, reduce discharge during NREM sleep, and cease discharge during REM sleep. Cataplexy, a symptom associated with narcolepsy, is a waking state in which muscle tone is lost, as it is in REM sleep, while environmental awareness continues, as in alert waking. In prior work, we reported that, during cataplexy, noradrenergic neurons cease discharge, and serotonergic neurons greatly reduce activity. We now report that, in contrast to these other monoaminergic "REM-off" cell groups, histamine neurons are active in cataplexy at a level similar to or greater than that in quiet waking. We hypothesize that the activity of histamine cells is linked to the maintenance of waking, in contrast to activity in noradrenergic and serotonergic neurons, which is more tightly coupled to the maintenance of muscle tone in waking and its loss in REM sleep and cataplexy.	Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Vet Adm Greater Los Angeles, Neurobiol Res 151A3, Healthcare Syst, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Siegel, JM (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.	jsiegel@ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041370, R37HL041370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014610, R01NS014610] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL041370, HL41370, R37 HL041370] Funding Source: Medline; NIMH NIH HHS [R01 MH064109, MH64109] Funding Source: Medline; NINDS NIH HHS [R37 NS014610, R01 NS014610, NS14610] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldrich MS, 1998, NEUROLOGY, V50, pS2, DOI 10.1212/WNL.50.2_Suppl_1.S2; ANDRE P, 1992, PFLUG ARCH EUR J PHY, V420, P376, DOI 10.1007/BF00374473; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BAUST W, 1972, PFLUG ARCH EUR J PHY, V331, P113, DOI 10.1007/BF00587254; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; Bender BG, 2003, J ALLERGY CLIN IMMUN, V111, P770, DOI 10.1067/mai.2003.1408; BOEHMER LN, 2004, IN PRESS EXPT NEUROL; Bourgin P, 2000, J NEUROSCI, V20, P7760; Chase M. H., 2000, PRINCIPLES PRACTICE, P155; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; D'Ascanio P., 1988, PROG BRAIN RES, P361; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; GUILLEMINAULT C, 1976, NARCOLEPSY, P125; Guilleminault C, 2000, PRINCIPLES PRACTICE, P676; Gulyani S, 2002, NEUROSCIENCE, V112, P355, DOI 10.1016/S0306-4522(02)00089-1; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Horvath TL, 1999, J COMP NEUROL, V415, P145; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Ishizuka T, 2002, NEUROSCI LETT, V323, P93, DOI 10.1016/S0304-3940(01)02552-6; Ivanov A, 2000, NEUROREPORT, V11, P1755, DOI 10.1097/00001756-200006050-00031; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; John J, 2003, J PHYSIOL-LONDON, V548, P557, DOI 10.1113/jphysiol.2002.038729; John J, 2000, Sleep Res Online, V3, P23; Kisanuki YY, 2001, SLEEP, V24, pA22; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Kohyama J, 1998, SLEEP, V21, P695, DOI 10.1093/sleep/21.7.695; KUSHIDA CA, 1985, ELECTROEN CLIN NEURO, V61, P61, DOI 10.1016/0013-4694(85)91073-9; LAI YY, 1991, J NEUROSCI, V11, P2931; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LANTOS TA, 1995, BRAIN RES REV, V20, P209, DOI 10.1016/0165-0173(94)00013-F; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; LIM RKS, 1960, STEROTAXIC ATALS DOG; LIN JS, 1994, EUR J NEUROSCI, V6, P618, DOI 10.1111/j.1460-9568.1994.tb00306.x; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mileykovskiy BY, 2000, J NEUROSCI, V20, P8551, DOI 10.1523/JNEUROSCI.20-22-08551.2000; NISHINO S, 1993, SLEEP, V16, P706, DOI 10.1093/sleep/16.8.706; Nishino S, 2001, NEUROSCI LETT, V313, P125, DOI 10.1016/S0304-3940(01)02270-4; Nishino SS, 2002, SLEEP, V25, pA476; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1990, NEUROSCIENCE, V34, P127, DOI 10.1016/0306-4522(90)90307-P; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PROSPEROGARCIA O, 1993, NEUROSCI LETT, V156, P158, DOI 10.1016/0304-3940(93)90462-T; REINER PB, 1987, NEUROSCI LETT, V73, P43, DOI 10.1016/0304-3940(87)90028-0; SAKAI K, 1990, DIENCEPHALON AND SLEEP, P171; Salin-Pascual R, 2001, NEUROPSYCHOPHARMACOL, V25, pS21, DOI 10.1016/S0893-133X(01)00318-9; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SIEGEL JM, 1983, BRAIN RES, V268, P344, DOI 10.1016/0006-8993(83)90501-2; SIEGEL JM, 1991, SCIENCE, V252, P1315, DOI 10.1126/science.1925546; SIEGEL JM, 1992, J NEUROSCI, V12, P1640; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; SIEGEL JM, 2000, PRINCIPLES PRACTICE, P112; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Thannickal T.C., 2000, SLEEP, V23, pA296; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; Vanni-Mercier G, 2003, BEHAV BRAIN RES, V144, P227, DOI 10.1016/S0166-4328(03)00091-3; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318	71	139	145	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					619	634		10.1016/S0896-6273(04)00247-8	http://dx.doi.org/10.1016/S0896-6273(04)00247-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157423	Green Accepted, Bronze			2022-12-28	WOS:000221708300012
J	Wang, GS; Hong, CJ; Yen, TY; Huang, HY; Ou, Y; Huang, TN; Jung, WG; Kuo, TY; Sheng, M; Wang, TF; Hsueh, YP				Wang, GS; Hong, CJ; Yen, TY; Huang, HY; Ou, Y; Huang, TN; Jung, WG; Kuo, TY; Sheng, M; Wang, TF; Hsueh, YP			Transcriptional modification by a CASK-interacting nucleosome assembly protein	NEURON			English	Article							KINASE-LIKE DOMAIN; NMDA RECEPTOR; RAT-BRAIN; LOCALIZATION; EXPRESSION; BINDING; FAMILY; IDENTIFICATION; HOMOLOG; COMPLEX	CASK acts as a coactivator for Tbr-1, an essential transcription factor in cerebral cortex development. Presently, the molecular mechanism of the CASK co-activation effect is unclear. Here, we report that CASK binds to another nuclear protein, CINAP, which binds histories and facilitates nucleosome assembly. CINAP, via its interaction with CASK, forms a complex with Tbr-1, regulating expression of the genes controlled by Tbr-1 and CASK, such as NR2b and reelin. A knockdown of endogenous CINAP in hippocampal neurons reduces the promoter activity of NR2b. Moreover, NMDA stimulation results in a reduction in the level of CINAP protein, via a proteasomal degradation pathway, correlating with a decrease in NR2b expression in neurons. This study suggests that reduction of the CINAP protein level by synaptic stimulation contributes to regulation of the transcriptional activity of the Tbr-1/CASK/CINAP protein complex and thus modifies expression of the NR2b gene.	Acad Sinica, Inst Mol Biol, Taipei, Taiwan; Acad Sinica, Inst Biol Chem, Taipei, Taiwan; Natl Yang Ming Univ, Grad Inst Microbiol & Immunol, Taipei 112, Taiwan; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Hsueh, YP (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	yph@gate.sinica.edu.tw	Wang, Ting-Fang/ABI-3818-2020; Wang, Guey-Shin/Q-3968-2018; Hsueh, Yi-Ping/ABH-5052-2020; Huang, Tzyy-Nan/AAV-5588-2021	Wang, Ting-Fang/0000-0001-6306-9505; Wang, Guey-Shin/0000-0003-4485-1811; Hsueh, Yi-Ping/0000-0002-0866-6275; Huang, Tzyy-Nan/0000-0002-7509-6305; Sheng, Morgan/0000-0002-8703-5366				Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Asahara H, 2002, MOL CELL BIOL, V22, P2974, DOI 10.1128/MCB.22.9.2974-2983.2002; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; BULGER M, 1995, P NATL ACAD SCI USA, V92, P11726, DOI 10.1073/pnas.92.25.11726; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Follesa P, 1996, J BIOL CHEM, V271, P13297, DOI 10.1074/jbc.271.23.13297; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; GRUSS C, 1992, BIOESSAYS, V14, P1, DOI 10.1002/bies.950140102; Hata Y, 1996, J NEUROSCI, V16, P2488; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; HSUEH YP, 2002, ANN C SOC NEUR ORL F; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Ito T, 2000, GENE DEV, V14, P1899; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Niethammer M, 1998, METHOD ENZYMOL, V293, P104; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pilipuk GP, 2003, J BIOL CHEM, V278, P35668, DOI 10.1074/jbc.M305182200; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Sambrook J., 2001, MOL CLONING LAB MANU; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; STEPHANOVA E, 1988, EXP CELL RES, V179, P545, DOI 10.1016/0014-4827(88)90292-3; WALTER PP, 1995, MOL CELL BIOL, V15, P6178	43	110	119	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					113	128		10.1016/S0896-6273(04)00139-4	http://dx.doi.org/10.1016/S0896-6273(04)00139-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066269	Bronze			2022-12-28	WOS:000221458400012
J	Goadsby, PJ				Goadsby, PJ			Migraine aura: A knockin mouse with a knockout message	NEURON			English	Editorial Material							FAMILIAL HEMIPLEGIC MIGRAINE; CORTICAL SPREADING DEPRESSION; PATHOPHYSIOLOGY; MECHANISMS; CORTEX; TYPE-2		Inst Neurol, Headache Grp, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Goadsby, PJ (corresponding author), Inst Neurol, Headache Grp, Queen Sq, London WC1N 3BG, England.		Goadsby, Peter J/Z-1970-2019; Goadsby, Peter J/B-2267-2009	Goadsby, Peter J/0000-0003-3260-5904; 				De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Giffin NJ, 2003, NEUROLOGY, V60, P935, DOI 10.1212/01.WNL.0000052998.58526.A9; Goadsby PJ, 2003, CEPHALALGIA, V23, P565; Goadsby PJ, 2001, ANN NEUROL, V49, P4, DOI 10.1002/1531-8249(200101)49:1<4::AID-ANA3>3.0.CO;2-W; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658	12	9	11	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 4	2004	41	5					679	680		10.1016/S0896-6273(04)00112-6	http://dx.doi.org/10.1016/S0896-6273(04)00112-6			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003166	Bronze			2022-12-28	WOS:000221458200002
J	Stern-Bach, Y				Stern-Bach, Y			AMPA receptor activation: Not a square dance	NEURON			English	Editorial Material								AMPA receptors are tetramers assembled as a dimer-of-dimers with a 2-fold rotational symmetry in their extracellular domains. Two papers in this issue of Neuron, by Horning and Mayer and Sobolevsky et al., provide complementary data that extend this view and highlight the role of dimers in channel gating.	Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Stern-Bach, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel.							Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BANY MF, 2002, CURR OPIN NEUROBIOL, V12, P279; Dingledine R, 1999, PHARMACOL REV, V51, P7; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; MAYER ML, 2003, ANNU REV PHYSIOL, DOI DOI 10.1146/ANNUREV.PHYSIOL.66.050802.084104.; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a	9	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					309	311		10.1016/S0896-6273(04)00040-6	http://dx.doi.org/10.1016/S0896-6273(04)00040-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766169	Bronze			2022-12-28	WOS:000221457900001
J	Thaler, JP; Koo, SJ; Kania, A; Lettieri, K; Andrews, S; Cox, C; Jessell, TM; Pfaff, SL				Thaler, JP; Koo, SJ; Kania, A; Lettieri, K; Andrews, S; Cox, C; Jessell, TM; Pfaff, SL			A postmitotic role for Isl-class LIM homeodomain proteins in the assignment of visceral spinal motor neuron identity	NEURON			English	Article							PROGENITOR-CELL IDENTITY; HOMEOBOX GENES; CHOLINE-ACETYLTRANSFERASE; TRANSCRIPTIONAL CODES; REPRESSOR ACTIVITY; SUBTYPE IDENTITY; EXPRESSION; FATE; SPECIFICATION; CORD	LIM homeobox genes have a prominent role in the regulation of neuronal subtype identity and distinguish motor neuron subclasses in the embryonic spinal cord. We have investigated the role of IsI-class LIM homeodomain proteins in motor neuron diversification using mouse genetic methods. All spinal motor neuron subtypes initially express both IsI1 and IsI2, but IsI2 is rapidly downregulated by visceral motor neurons, Mouse embryos lacking IsI2 function exhibit defects in the migration and axonal projections of thoracic level motor neurons that appear to reflect a cell-autonomous switch from visceral to somatic motor neuron character. Additional genetic mutations that reduce or eliminate both IsI1 and IsI2 activity result in more pronounced defects in visceral motor neuron generation and erode somatic motor neuron character. Thus, an early phase of high IsI expression and activity in newly generated motor neurons permits the diversification of visceral and somatic motor neuron subtypes in the developing spinal cord.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Salk Institute; Columbia University; Howard Hughes Medical Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	pfaff@salk.edu		Kania, Artur/0000-0002-5209-2520	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037116] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM07198] Funding Source: Medline; NINDS NIH HHS [R01NS37116] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Barber RP, 1998, J COMP NEUROL, V398, P568; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Desai AR, 2000, DEVELOPMENT, V127, P2863; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Koo SJ, 2002, NEURON, V35, P823, DOI 10.1016/S0896-6273(02)00870-X; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; LEVIMONTALCINI R, 1950, J MORPHOL, V86, P253, DOI 10.1002/jmor.1050860203; LICHTMAN JW, 1980, J PHYSIOL-LONDON, V298, P285, DOI 10.1113/jphysiol.1980.sp013081; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; MARKHAM JA, 1991, J NEUROBIOL, V22, P811, DOI 10.1002/neu.480220803; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PHELPS PE, 1988, J COMP NEUROL, V273, P459, DOI 10.1002/cne.902730403; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358	44	136	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					337	350		10.1016/S0896-6273(04)00011-X	http://dx.doi.org/10.1016/S0896-6273(04)00011-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766174	Bronze			2022-12-28	WOS:000221457900006
J	Quinlan, EM; Lebel, D; Brosh, I; Barkai, E				Quinlan, EM; Lebel, D; Brosh, I; Barkai, E			A molecular mechanism for stabilization of learning-induced synaptic modifications	NEURON			English	Article							LONG-TERM POTENTIATION; ASPARTATE RECEPTOR ANTAGONIST; ASSOCIATIVE MEMORY FUNCTION; HETEROMERIC NMDA RECEPTORS; PYRAMIDAL NEURONS; PIRIFORM CORTEX; VISUAL-CORTEX; SELECTIVE IMPAIRMENT; DEPENDENT REGULATION; GLUTAMATE RECEPTORS	Olfaction is a principal sensory modality in rodents, and rats quickly learn to discriminate between odors and to associate odor with reward. Here we show that such olfactory discrimination (OD) learning consists of two phases with distinct cellular mechanisms: an initial NMDAR-sensitive phase in which the animals acquire a successful behavioral strategy (rule learning), followed by an NMDAR-insensitive phase in which the animals learn to distinguish between individual odors (pair learning). Rule learning regulates the composition of synaptic NMDARs in the piriform cortex, resulting in receptors with a higher complement of the NR2a subunit protein relative to NR2b. Rule learning also reduces long-term potentiation (LTP) induced by high-frequency stimulation of the intracortical axons in slices of piriform cortex. As NR2a-containing NMDARs mediate shorter excitatory postsynaptic currents than those containing NR2b, we suggest that learning-induced regulation of NMDAR composition constrains subsequent synaptic plasticity, thereby maintaining the memory encoded by experience.	Univ Maryland, Dept Biol, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Univ Haifa, Fac Sci, Ctr Brain & Behav, IL-31905 Haifa, Israel	University System of Maryland; University of Maryland College Park; Ben Gurion University; Ben Gurion University; University of Haifa	Quinlan, EM (corresponding author), Univ Maryland, Dept Biol, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA.	eq5@umail.umd.edu						BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BARKAI E, 1994, J NEUROPHYSIOL, V72, P659, DOI 10.1152/jn.1994.72.2.659; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Cain DP, 1997, BEHAV BRAIN RES, V84, P179, DOI 10.1016/S0166-4328(96)00149-0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Flint AC, 1997, J NEUROSCI, V17, P2469; HASSELMO ME, 1995, J NEUROSCI, V15, P6592; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Hoh T, 1999, J Neurosci, V19, pRC2; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Knafo S, 2001, EUR J NEUROSCI, V13, P633, DOI 10.1046/j.1460-9568.2001.01422.x; Lebel D, 2001, CEREB CORTEX, V11, P485, DOI 10.1093/cercor/11.6.485; Linster C, 2001, CHEM SENSES, V26, P585, DOI 10.1093/chemse/26.5.585; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Power JM, 1997, J NEUROPHYSIOL, V78, P1184, DOI 10.1152/jn.1997.78.2.1184; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Saar D, 2002, J NEUROPHYSIOL, V87, P2358, DOI 10.1152/jn.2002.87.5.2358; Saar D, 1999, J NEUROSCI, V19, P8616; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; STAUBLI U, 1987, BEHAV NEUROSCI, V101, P757, DOI 10.1037/0735-7044.101.6.757; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555	46	120	128	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					185	192		10.1016/S0896-6273(03)00874-2	http://dx.doi.org/10.1016/S0896-6273(03)00874-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741100	Bronze			2022-12-28	WOS:000221457800005
J	Tricomi, EM; Delgado, MR; Fiez, JA				Tricomi, EM; Delgado, MR; Fiez, JA			Modulation of caudate activity by action contingency	NEURON			English	Article							COCAINE-SEEKING BEHAVIOR; FUNCTIONAL-PROPERTIES; ORBITOFRONTAL CORTEX; DOPAMINE RELEASE; NEURAL RESPONSES; DORSAL STRIATUM; PARIETAL CORTEX; BRAIN ACTIVITY; REWARD; ACTIVATION	Research has increasingly implicated the striatum in the processing of reward-related information in both animals and humans. However, it is unclear whether human striatal activation is driven solely by the hedonic properties of rewards or whether such activation is reliant on other factors, such as anticipation of upcoming reward or performance of an action to earn a reward. We used event-related functional magnetic resonance imaging to investigate hemodynamic responses to monetary rewards and punishments in three experiments that made use of an oddball paradigm. We presented reward and punishment displays randomly in time, following an anticipatory cue, or following a button press response. Robust and differential activation of the caudate nucleus occurred only when a perception of contingency existed between the button press response and the outcome. This finding suggests that the caudate is involved in reinforcement of action potentially leading to reward, rather than in processing reward per se.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; NYU, Dept Psychol, New York, NY 10003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University	Tricomi, EM (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	elt6@pitt.edu		Tricomi, Elizabeth/0000-0002-3659-2656	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014103] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA14103] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; COX W, 1998, COMPUT BIOMED RES, V29, P162; Critchley HD, 2000, J NEUROSCI, V20, P3033; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fissell K, 2003, NEUROINFORMATICS, V1, P111, DOI 10.1385/NI:1:1:111; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hikosaka O, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.43.s.9.4.x; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; KOOB GF, 1992, SEMIN NEUROSCI, V4, P139; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Rolls ET, 1999, NEUROCASE, V5, P301, DOI 10.1080/13554799908411984; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Zink CF, 2003, J NEUROSCI, V23, P8092	53	423	426	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					281	292		10.1016/S0896-6273(03)00848-1	http://dx.doi.org/10.1016/S0896-6273(03)00848-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741108	Bronze			2022-12-28	WOS:000221457800013
J	Stiles, CD				Stiles, CD			Lost in space: Misregulated positional cues create tripotent neural progenitors in cell culture	NEURON			English	Editorial Material								In a widely held view of vertebrate CNS development, neurons, astrocytes, and oligodendrocytes arise from a common tripotent progenitor cell. However, tripotent progenitors have never been detected in developing embryos. In this issue of Neuron, Gabay et al. show that tripotent progenitors can be created in vitro by deregulation of normal dorsoventral positional cues.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Program Neurooncol,Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Stiles, CD (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Program Neurooncol,Dana Farber Canc Inst, Boston, MA 02115 USA.							Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Liu Y, 2003, TRENDS NEUROSCI, V26, P410, DOI 10.1016/S0166-2236(03)00201-7; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Rao MS, 1999, ANAT RECORD, V257, P137; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	12	10	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					447	449		10.1016/S0896-6273(03)00683-4	http://dx.doi.org/10.1016/S0896-6273(03)00683-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642266	Bronze			2022-12-28	WOS:000186379000001
J	Bishop, DL; Misgeld, T; Walsh, MK; Gan, WB; Lichtman, JW				Bishop, DL; Misgeld, T; Walsh, MK; Gan, WB; Lichtman, JW			Axon branch removal at developing synapses by axosome shedding	NEURON			English	Article							DEVELOPING NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; POLYNEURONAL INNERVATION; GLIAL-CELLS; ELECTRON-MICROSCOPY; TRANS-ENDOCYTOSIS; SCHWANN-CELLS; NEWBORN RATS; IN-VIVO; ELIMINATION	In many parts of the developing nervous system, the number of axonal inputs to each postsynaptic cell is dramatically reduced. This synapse elimination has been extensively studied at the neuromuscular junction, but how axons are lost is unknown. Here, we combine time-lapse imaging of fluorescently labeled axons and serial electron microscopy to show that axons at neuromuscular junctions are removed by an unusual cellular mechanism. As axons disappear, they shed numerous membrane bound remnants. These "axosomes" contain a high density of synaptic organelles and are formed by engulfment of axon tips by Schwann cells. After this engulfment, the axosome's contents mix with the cytoplasm of the glial cell. Axosome shedding might underlie other forms of axon loss and may provide a pathway for interactions between axons and glia.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Harvard University; Washington University (WUSTL)	Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu						Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; Broadie K, 2004, CURR BIOL, V14, pR302, DOI 10.1016/j.cub.2004.03.049; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Conradt B, 2002, NAT CELL BIOL, V4, pE139, DOI 10.1038/ncb0602-e139; DENNIS MJ, 1974, J PHYSIOL-LONDON, V237, P431, DOI 10.1113/jphysiol.1974.sp010490; Denzer K, 2000, J CELL SCI, V113, P3365; ECKENHOFF MF, 1979, J NEUROCYTOL, V8, P623, DOI 10.1007/BF01208513; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Gan WB, 1999, J NEUROSCI METH, V93, P13, DOI 10.1016/S0165-0270(99)00096-5; Gillingwater TH, 2003, J ANAT, V203, P265, DOI 10.1046/j.1469-7580.2003.00214.x; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; He Y, 2002, J NEUROSCI, V22, P5982; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; KORNELIUSSEN H, 1976, J NEUROCYTOL, V5, P591, DOI 10.1007/BF01175572; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LICHTMAN JW, 1980, J PHYSIOL-LONDON, V301, P213, DOI 10.1113/jphysiol.1980.sp013200; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; MILEDI R, 1968, PROC R SOC SER B-BIO, V169, P289, DOI 10.1098/rspb.1968.0012; Nakao J, 1997, J NEUROCHEM, V68, P1853; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Parson SH, 2004, J NEUROSCI RES, V76, P64, DOI 10.1002/jnr.20016; Purves, 1985, PRINCIPLES NEURAL DE; Reddy LV, 2003, NEURON, V40, P563, DOI 10.1016/S0896-6273(03)00682-2; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; ROSENTHAL JL, 1977, J PHYSIOL-LONDON, V270, P299, DOI 10.1113/jphysiol.1977.sp011953; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wyatt RM, 2003, J NEUROCYTOL, V32, P777, DOI 10.1023/B:NEUR.0000020623.62043.33	50	197	204	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					651	661		10.1016/j.neuron.2004.10.026	http://dx.doi.org/10.1016/j.neuron.2004.10.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541313	Bronze			2022-12-28	WOS:000225338100011
J	Hartmann, B; Ahmadi, S; Heppenstall, PA; Lewin, GR; Schott, C; Borchardt, T; Seeburg, PH; Zeilhofer, HU; Sprengel, R; Kuner, R				Hartmann, B; Ahmadi, S; Heppenstall, PA; Lewin, GR; Schott, C; Borchardt, T; Seeburg, PH; Zeilhofer, HU; Sprengel, R; Kuner, R			The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain	NEURON			English	Article							DORSAL-HORN NEURONS; UP-REGULATION; CENTRAL SENSITIZATION; THERMAL NOCICEPTION; SPATIAL MEMORY; RAT; CORD; HYPERALGESIA; EXPRESSION; PHOSPHORYLATION	Ca2+-permeable AMPA receptors are densely expressed in the spinal dorsal horn, but their functional significance in pain processing is not understood. By disrupting the genes encoding GluR-A or GluR-B, we generated mice exhibiting increased or decreased numbers of Call-permeable AMPA receptors, respectively. Here, we demonstrate that AMPA receptors are critical determinants of nociceptive plasticity and inflammatory pain. A reduction in the number of Ca2+- permeable AMPA receptors and density of AMPA channel currents in spinal neurons of GluR-A-deficient mice is accompanied by a loss of nociceptive plasticity in vitro and a reduction in acute inflammatory hyperalgesia in vivo. In contrast, an increase in spinal Ca2+- permeable AMPA receptors in GluR-B-deficient mice facilitated nociceptive plasticity and enhanced long-lasting inflammatory hyperalgesia. Thus, AMPA receptors are not mere determinants of fast synaptic transmission underlying basal pain sensitivity as previously thought, but are critically involved in activity-dependent changes in synaptic processing of nociceptive inputs.	Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-61054 Erlangen, Germany; Univ Med Berlin, Charite, Clin Anesthesiol & Operat Intensivemed, D-12200 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Heidelberg Univ, Childrens Hosp, Dept Neonatol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Max Planck Society	Kuner, R (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	rohini.kuner@urz.uni-heidelberg.de	Lewin, Gary R/B-8028-2011; Zeilhofer, Hanns Ulrich/A-4600-2008; Kuner, Rohini/AGU-0204-2022	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Lewin, Gary/0000-0002-2890-6352				Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Albuquerque C, 1999, EUR J NEUROSCI, V11, P2758, DOI 10.1046/j.1460-9568.1999.00691.x; BORCHARDT T, 2002, KONSTRUKTION MAUSEN; Brown KM, 2002, DEV BRAIN RES, V137, P127, DOI 10.1016/S0165-3806(02)00435-2; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CIRINO G, 1989, EUR J PHARMACOL, V166, P505, DOI 10.1016/0014-2999(89)90364-6; DAVIES J, 1983, EXP BRAIN RES, V49, P280; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Engelman HS, 1999, J NEUROSCI, V19, P2081; Fang L, 2003, NEUROSCIENCE, V122, P237, DOI 10.1016/S0306-4522(03)00526-8; Fang L, 2003, MOL BRAIN RES, V118, P160, DOI 10.1016/j.molbrainres.2003.08.002; Flor H, 2002, EMBO REP, V3, P288, DOI 10.1093/embo-reports/kvf080; Flor H, 2000, Prog Brain Res, V129, P313; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heppenstall PA, 2001, P NATL ACAD SCI USA, V98, P8107, DOI 10.1073/pnas.141015098; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; KOLHEKAR R, 1993, NEUROSCIENCE, V57, P385, DOI 10.1016/0306-4522(93)90070-V; Laird JMA, 2001, PAIN, V90, P97, DOI 10.1016/S0304-3959(00)00394-8; Lee CJ, 2002, NEURON, V35, P135, DOI 10.1016/S0896-6273(02)00729-8; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu CR, 2002, J NEUROSCI, V22, P9522; Ma QP, 1996, PAIN, V67, P307, DOI 10.1016/0304-3959(96)03132-6; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sandkuhler J, 2002, LANCET, V360, P426, DOI 10.1016/S0140-6736(02)09683-6; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tinazzi M, 2000, J NEUROSCI, V20, P9277; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; TOLLE TR, 1993, J NEUROSCI, V13, P5009, DOI 10.1523/JNEUROSCI.13-12-05009.1993; VACCARINO AL, 1992, PAIN, V49, P257, DOI 10.1016/0304-3959(92)90150-A; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; Willis WD, 1997, NEUROREPORT, V8, pR3; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou QQ, 2001, MOL BRAIN RES, V88, P186, DOI 10.1016/S0169-328X(01)00041-9	58	166	175	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					637	650		10.1016/j.neuron.2004.10.029	http://dx.doi.org/10.1016/j.neuron.2004.10.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541312	Green Published, Bronze			2022-12-28	WOS:000225338100010
J	Schmucker, D; Flanagan, JG				Schmucker, D; Flanagan, JG			Generation of recognition diversity in the nervous system	NEURON			English	Editorial Material							DROSOPHILA DSCAM; AXON GUIDANCE; RECEPTOR; ADHESION; GENES	For decades, it has been suggested that complex neural wiring might be specified by extensive diversity in receptor isoforms. Dscam is a cell surface protein with 38,016 potential alternatively spliced isoforms in the fly nervous system. Remarkable binding studies now show that Dscam isoform diversity indeed results in an unprecedented level of recognition diversity, showing isoform-specific homophilic binding. In vivo studies have begun to suggest models for use of Dscam diversity in neuron-target recognition, axon fasciculation, and neuron self-recognition.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Schmucker, D (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	dietmar_schmucker@dfci.harvard.edu; flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020					Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; WAG J, 2004, NEURON, V43, P663; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	15	23	26	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					219	222		10.1016/j.neuron.2004.10.004	http://dx.doi.org/10.1016/j.neuron.2004.10.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473961	Bronze			2022-12-28	WOS:000224635800005
J	Zinn, K				Zinn, K			Dendritic tiling: New insights from genetics	NEURON			English	Editorial Material							DROSOPHILA SENSORY NEURONS; NEUROSPORA-CRASSA; KINASE; EXTENSIONS; INTEGRITY; ENCODES; COT-1	Two papers in the current issues of Neuron (Gallegos and Bargmann) and Ceff (Emoto et al.) identify a conserved kinase, SAX-1/Trc, and a large protein required for Trc activity, SAX-2/Fry, as essential elements in the control of dendritic branching and tiling in Drosophila and C. elegans. The tiling and ectopic branching phenotypes of trc mutants appear to be independently generated. Thus, this kinase is the first signaling protein to be associated specifically with tiling.	CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology	Zinn, K (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.							Cong JL, 2001, DEVELOPMENT, V128, P2793; EMOTO K, 2004, IN PRESS CELL; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Geng W, 2000, GENETICS, V156, P1817; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; He B, 2001, MECH DEVELOP, V104, P69, DOI 10.1016/S0925-4773(01)00368-9; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Sugimura K, 2003, J NEUROSCI, V23, P3752; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	12	9	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					211	213		10.1016/j.neuron.2004.09.024	http://dx.doi.org/10.1016/j.neuron.2004.09.024			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473957	Bronze			2022-12-28	WOS:000224635800001
J	Carlson, TA; He, S				Carlson, TA; He, S			Competing global representations fail to initiate binocular rivalry	NEURON			English	Article							MACAQUE VISUAL-CORTEX; MOTION SELECTIVITY; COLOR; PERCEPTION; FORM; INFORMATION; PSYCHOPHYSICS; MECHANISMS; PRECEDENCE; AWARENESS	A longstanding debate in binocular rivalry literature is whether the perceptual competition in rivalry occurs at an early or late stage of visual processing. Central to this debate is the determination of the source of the competition. Overwhelming evidence exists that local interocular differences can lead to binocular rivalry, but it is not yet clear whether interocular conflicts at the global level are sufficient to generate binocular rivalry. The current study adopted a novel stimulus that enabled the introduction of dramatic global differences between the two eyes with compatible local elements. Results show that global differences between the two eyes' images do not result in rivalry if local elements are compatible. The implication of these findings is that the registration of competing interocular information, necessary to generate binocular rivalry, is performed at an early stage of visual processing prior to global analysis of the image.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	sheng@umn.edu	Carlson, Thomas/B-4720-2011	Carlson, Thomas/0000-0002-3953-4195	NEI NIH HHS [R01 EY015261] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015261] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; Andrews TJ, 2004, CURR BIOL, V14, P418, DOI 10.1016/j.cub.2004.02.030; Andrews TJ, 2002, VISION RES, V42, P301, DOI 10.1016/S0042-6989(01)00286-3; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 1998, J COGNITIVE NEUROSCI, V10, P46, DOI 10.1162/089892998563770; BLAKE R, 1985, PERCEPT PSYCHOPHYS, V37, P114, DOI 10.3758/BF03202845; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Bonneh Y, 2001, VISION RES, V41, P981, DOI 10.1016/S0042-6989(01)00013-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carlson TA, 2000, CURR BIOL, V10, P1055, DOI 10.1016/S0960-9822(00)00672-2; CARNEY T, 1987, NATURE, V328, P647, DOI 10.1038/328647a0; DEWEERT CMM, 1988, VISION RES, V28, P1031, DOI 10.1016/0042-6989(88)90080-6; DEWEERT CMM, 1984, VISION RES, V24, P883, DOI 10.1016/0042-6989(84)90162-7; Fry G. A., 1933, AM J OPHTHALMOL, V16, P687; He S, 2001, VISION RES, V41, P835, DOI 10.1016/S0042-6989(00)00315-1; HE S, 2005, IN PRESS BINOCULAR R; Howard I.P., 1995, BINOCULAR VISION STE, V29; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1965, BRIT J PSYCHOL, V56, P1, DOI 10.1111/j.2044-8295.1965.tb00939.x; Levelt WJM, 1965, BINOCULAR RIVALRY; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; Moutoussis K, 2000, P NATL ACAD SCI USA, V97, P8069, DOI 10.1073/pnas.110570897; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; OSHEA RP, 1986, PERCEPT PSYCHOPHYS, V39, P59, DOI 10.3758/BF03207584; OSHEA RP, 1981, VISION RES, V21, P801, DOI 10.1016/0042-6989(81)90177-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1991, SCIENCE, V251, P950, DOI 10.1126/science.2000497; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2001, BRAIN MIND, V2, P55, DOI DOI 10.1023/A:1017942718744; VANDERZWAN R, 1993, VISUAL NEUROSCI, V10, P703, DOI 10.1017/S095252380000540X; WADE NJ, 1986, PERCEPTION, V15, P435, DOI 10.1068/p150435; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Wolfe JM, 1996, NATURE, V380, P587, DOI 10.1038/380587a0	44	35	35	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					907	914		10.1016/j.neuron.2004.08.039	http://dx.doi.org/10.1016/j.neuron.2004.08.039			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363400	Bronze			2022-12-28	WOS:000223992000015
J	Sugimura, K; Satoh, D; Estes, P; Crews, S; Uemura, T				Sugimura, K; Satoh, D; Estes, P; Crews, S; Uemura, T			Development of morphological diversity of dendrites in Drosophila by the BTB-zinc finger protein abrupt	NEURON			English	Article							SENSORY NEURONS; GENE; EXPRESSION; CUT; PATTERNS; DOMAIN; MORPHOGENESIS; CONNECTIONS; SPECIFICITY	Morphological diversity of dendrites contributes to specialized functions of individual neurons. In the present study, we examined the molecular basis that generates distinct morphological classes of Drosophila dendritic arborization (da) neurons. da neurons are classified into classes I to IV in order of increasing territory size and/or branching complexity. We found that Abrupt (Ab), a BTB-zinc finger protein, is expressed selectively in class I cells. Misexpression of ab in neurons of other classes directed them to take the appearance of cells with smaller and/or less elaborated arbors. Loss of ab functions in class I neurons resulted in malformation of their typical comb-like arbor patterns and generation of supernumerary branch terminals. Together with the results of monitoring dendritic dynamics of ab-misexpressing cells or ab mutant ones, all of the data suggested that Ab endows characteristics of dendritic morphogenesis of the class I neurons.	Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Sci, Kyoto 6068507, Japan; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Japan Science & Technology Agency (JST)	Uemura, T (corresponding author), Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan.	tuemura@virus.kyoto-u.ac.jp		Satoh, Daisuke/0000-0002-4039-1670; Sugimura, Kaoru/0000-0002-3076-7347; UEMURA, Tadashi/0000-0001-7204-3606				Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hardiman KE, 2002, GENETICS, V161, P231; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jan Yuh Nung, 1993, P1207; Johannes B, 2002, MECH DEVELOP, V115, P3, DOI 10.1016/S0925-4773(02)00083-7; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sugimura K, 2003, J NEUROSCI, V23, P3752; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	36	85	89	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					809	822		10.1016/j.neuron.2004.08.016	http://dx.doi.org/10.1016/j.neuron.2004.08.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363392	Bronze, Green Published			2022-12-28	WOS:000223992000007
J	Kanai, Y; Dohmae, N; Hirokawa, N				Kanai, Y; Dohmae, N; Hirokawa, N			Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; DENDRITIC TARGETING ELEMENT; IMMEDIATE-EARLY GENE; MESSENGER-RNA; PUR-ALPHA; ORGANELLE TRANSPORT; SUPERFAMILY PROTEIN; AXONAL-TRANSPORT; BINDING PROTEIN; STAUFEN PROTEIN	RNA transport is an important and fundamental event for local protein synthesis, especially in neurons. RNA is transported as large granules, but little is known about them. Here, we isolated a large RNase-sensitive granule (size: 1000Ssimilar to) as a binding partner of conventional kinesin (KIF5). We identified a total of 42 proteins with mRNAs for CaMKIIalpha and Arc in the granule. Seventeen of the proteins (hnRNP-U, Pur alpha and beta, PSF, DDX1, DDX3, SYNCRIP, TLS, NonO, HSPC117, ALY, CGI-99, staufen, three FMRPs, and EF-1alpha) were extensively investigated, including their classification, binding combinations, and necessity for the "transport" of RNA. These proteins and the mRNAs were colocalized to the kinesin-associated granules in dendrites. The granules moved bidirectionally, and the distally directed movement was enhanced by the overexpression of KIF5 and reduced by its functional blockage. Thus, kinesin transports RNA via this granule in dendrites coordinately with opposite motors, such as dynein.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Inst Phys & Chem Res, Biomol Characterizat Div, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Dohmae, Naoshi/C-2040-2011; Kanai, Yoshimitsu/W-3486-2019	Dohmae, Naoshi/0000-0002-5242-9410; Kanai, Yoshimitsu/0000-0002-0375-6853				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; BARBARESE E, 1995, J CELL SCI, V108, P2781; Bardoni B, 2001, BRAIN RES BULL, V56, P375, DOI 10.1016/S0361-9230(01)00647-5; Bassell G J, 2001, Results Probl Cell Differ, V34, P41; Bassell GJ, 1998, J NEUROSCI, V18, P251; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chanas-Sacre G, 1999, J NEUROSCI RES, V57, P62, DOI 10.1002/(SICI)1097-4547(19990701)57:1<62::AID-JNR7>3.0.CO;2-Y; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Fukaya M, 2000, J COMP NEUROL, V426, P572; Gallia GL, 1999, J CELL BIOCHEM, V74, P334, DOI 10.1002/(SICI)1097-4644(19990901)74:3<334::AID-JCB3>3.0.CO;2-O; Gardiol A, 2001, Results Probl Cell Differ, V34, P105; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GODBOUT R, 1993, P NATL ACAD SCI USA, V90, P7578, DOI 10.1073/pnas.90.16.7578; Goslin K., 1998, CULTURING NERVE CELL, P339; Gupta AK, 1998, J VIROL, V72, P8532, DOI 10.1128/JVI.72.11.8532-8540.1998; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KANAI Y, 1995, NEURON, V14, P421, DOI 10.1016/0896-6273(95)90298-8; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kindler S, 2001, Results Probl Cell Differ, V34, P83; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mizutani A, 2000, J BIOL CHEM, V275, P9823, DOI 10.1074/jbc.275.13.9823; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ong LL, 2000, J BIOL CHEM, V275, P32854, DOI 10.1074/jbc.M005650200; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; SOWDEN J, 1995, BIOCHEM J, V308, P839, DOI 10.1042/bj3080839; Steward O, 1998, NEUROREPORT, V9, P477, DOI 10.1097/00001756-199802160-00022; Steward O, 2001, Results Probl Cell Differ, V34, P1; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wallace CS, 1998, J NEUROSCI, V18, P26; WIDNELL CC, 1964, BIOCHEM J, V92, P313, DOI 10.1042/bj0920313; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	77	804	824	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					513	525		10.1016/j.neuron.2004.07.022	http://dx.doi.org/10.1016/j.neuron.2004.07.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312650	Bronze			2022-12-28	WOS:000223436400010
J	Marie, B; Sweeney, ST; Poskanzer, KE; Roos, J; Kelly, RB; Davis, GW				Marie, B; Sweeney, ST; Poskanzer, KE; Roos, J; Kelly, RB; Davis, GW			Dap160/intersectin scaffolds the periactive zone to achieve high-fidelity endocytosis and normal synaptic growth	NEURON			English	Article							ADAPTER PROTEIN; GENETIC-ANALYSIS; EPS15 HOMOLOGY; INTERSECTIN; MACHINERY; ENDOPHILIN; MECHANISMS; PLASTICITY; COMPONENTS; RECEPTORS	Dap160/Intersectin is a multidomain adaptor protein that colocalizes with endocytic machinery in the periactive zone at the Drosophila NMJ. We have generated severe loss-of-function mutations that eliminate Dap160 protein from the NMJ. dap160 mutant synapses have decreased levels of essential endocytic proteins, including dynamin, endophilin, synaptojanin, and AP180, while other markers of the active zone and periactive zone are generally unaltered. Functional analyses demonstrate that dap160 mutant synapses are unable to sustain high-frequency transmitter release, show impaired FM4-64 loading, and show a dramatic increase in presynaptic quantal size consistent with defects in synaptic vesicle recycling. The dap160 mutant synapse is grossly malformed with abundant, highly ramified, small synaptic boutons. We present a model in which Dap160 scaffolds both endocytic machinery and essential synaptic signaling systems to the periactive zone to coordinately control structural and functional synapse development.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St,GDBS 4th Floor N, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu		Sweeney, Sean/0000-0003-2673-9578; Marie, Bruno/0000-0002-6550-3851	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 15927] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Conroy WG, 2003, NEURON, V38, P759, DOI 10.1016/S0896-6273(03)00324-6; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Koh YH, 2002, J NEUROSCI, V22, P2496, DOI 10.1523/JNEUROSCI.22-07-02496.2002; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Preston CR, 1996, GENETICS, V144, P1623; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Sone M, 2000, DEVELOPMENT, V127, P4157; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Torroja L, 1999, J NEUROSCI, V19, P7793; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	44	163	170	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					207	219		10.1016/j.neuron.2004.07.001	http://dx.doi.org/10.1016/j.neuron.2004.07.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260957	Bronze			2022-12-28	WOS:000222905400010
J	Foster, KA; Regehr, WG				Foster, KA; Regehr, WG			Variance-mean analysis in the presence of a rapid antagonist indicates vesicle depletion underlies depression at the climbing fiber synapse	NEURON			English	Article							PAIRED-PULSE DEPRESSION; PURKINJE-CELL SYNAPSES; PROBABILITY FLUCTUATION ANALYSIS; SINGLE HIPPOCAMPAL SYNAPSES; SHORT-TERM DEPRESSION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; HELD SYNAPSE; RECEPTOR DESENSITIZATION; MULTIVESICULAR RELEASE	Many types of synapses throughout the nervous system are transiently depressed during high-frequency stimulation. Several mechanisms have been proposed to account for this depression, including depletion of release-ready vesicles. However, numerous studies have raised doubts about the importance of depletion in depression of central synapses and have implicated alternative mechanisms, such as decreased release probability. We use variance-mean analysis to determine the mechanism of depression at the climbing fiber to Purkinje cell synapse. We find that postsynaptic receptor saturation makes it difficult to distinguish between a decrease in available vesicles and a reduction in release probability. When AMPA receptor saturation is relieved with a low-affinity antagonist, variance-mean analysis reveals that depression arises from a decrease in the number of release-ready vesicles. Vesicle depletion is prominent, despite numerous docked vesicles at each release site, due to multivesicular release. We conclude that vesicle depletion can contribute significantly to depression of central synapses.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NINDS NIH HHS [R01-NS432405] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auger C, 1998, J NEUROSCI, V18, P4532; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Brody DL, 2000, J NEUROSCI, V20, P2480; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chen G, 2004, P NATL ACAD SCI USA, V101, P1063, DOI 10.1073/pnas.0307149101; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Glantz SA., 1997, PRIMER BIOSTATISTICS; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HERRINGTON J, 1995, PULSE CONTROL V4 5 I; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Larramendi LMH, 1969, NEUROBIOLOGY CEREBEL, P803; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matveev V, 2000, J NEUROSCI, V20, P1575; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Palay S.L., 1974, CEREBELLAR CORTEX; Quastel DMJ, 1997, BIOPHYS J, V72, P728, DOI 10.1016/S0006-3495(97)78709-5; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Scheuss V, 2001, BIOPHYS J, V81, P1970, DOI 10.1016/S0006-3495(01)75848-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Thomson AM, 1999, J PHYSIOL-LONDON, V519, P57, DOI 10.1111/j.1469-7793.1999.0057o.x; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VEREJONE.D, 1966, AUST J STAT, V8, P53, DOI 10.1111/j.1467-842X.1966.tb00164.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Watkins J C, 1990, Adv Exp Med Biol, V268, P49; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; ZENGEL JE, 1980, J GEN PHYSIOL, V76, P175, DOI 10.1085/jgp.76.2.175; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	71	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					119	131		10.1016/j.neuron.2004.06.022	http://dx.doi.org/10.1016/j.neuron.2004.06.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233922	Bronze			2022-12-28	WOS:000222549800012
J	Lee, SJ; Montell, C				Lee, SJ; Montell, C			Light-dependent translocation of visual arrestin regulated by the NINAC myosin III	NEURON			English	Article							ROD PHOTORECEPTOR CELLS; RHODOPSIN PHOSPHORYLATION; ACTIN-FILAMENTS; S-ANTIGEN; DROSOPHILA; BINDING; ADAPTATION; PROTEINS; RETINA; PHOTOTRANSDUCTION	The rhodopsin regulatory protein, visual arrestin, undergoes light-dependent trafficking in mammalian and Drosophila photoreceptor cells, though the mechanisms underlying these movements are poorly understood. In Drosophila, the movement of the visual arrestin, Arr2, functions in long-term adaptation and is dependent on interaction with phosphoinositides (PIs). However, the basis for the requirement for PIs for light-dependent shuttling was unclear. Here, we demonstrated that the dynamic trafficking of Arr2 into the phototransducing compartment, the rhabdomere, required the eye-enriched myosin III, NINAC. We showed that defects in ninaC resulted in a long-term adaptation phenotype similar to that which occurred in arr2 mutants. The interaction between Arr2 and NINAC was PI dependent and NINAC bound directly to PIs. These data demonstrate that the light-dependent translocation of Arr2 into the rhabdomeres requires PI-mediated interactions between Arr2 and the NINAC myosin III.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Lee, Seung Jae V/E-2468-2019; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Lee, Seung-Jae/0000-0002-6103-156X	NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NEI NIH HHS [EY08117] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; ARIKAWA K, 1990, J CELL BIOL, V110, P1993, DOI 10.1083/jcb.110.6.1993; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; ARSHAVSKY VY, 2003, SCI STKE, pPE43; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Deng WM, 1999, J CELL SCI, V112, P3677; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2002, GENOMICS, V79, P621, DOI 10.1006/geno.2002.6749; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Hardie RC, 2003, CURR BIOL, V13, pR775, DOI 10.1016/j.cub.2003.09.021; Hicks JL, 1996, CELL MOTIL CYTOSKEL, V35, P367, DOI 10.1002/(SICI)1097-0169(1996)35:4<367::AID-CM8>3.0.CO;2-3; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Komaba S, 2003, J BIOL CHEM, V278, P21352, DOI 10.1074/jbc.M300757200; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Lee SJ, 2001, NEURON, V32, P1097, DOI 10.1016/S0896-6273(01)00538-4; MANGINI NJ, 1994, VISUAL NEUROSCI, V11, P561, DOI 10.1017/S0952523800002467; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2003, J NEUROSCI, V23, P3124; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Zhang HB, 2003, MOL VIS, V9, P231	36	65	67	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					95	103		10.1016/j.neuron.2004.06.014	http://dx.doi.org/10.1016/j.neuron.2004.06.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233920	Bronze			2022-12-28	WOS:000222549800010
J	Wardak, C; Olivier, E; Duhamel, JR				Wardak, C; Olivier, E; Duhamel, JR			A deficit in covert attention after parietal cortex inactivation in the monkey	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; VISUAL-SEARCH; REVERSIBLE INACTIVATION; NEURAL MECHANISMS; NEURONAL-ACTIVITY; SINGLE NEURONS; MACAQUE; REPRESENTATION; SELECTION	Although the parietal cortex has been repeatedly implicated in controlling attention, the nature and importance of this contribution remain unclear. Here we show that inactivating the lateral intraparietal area in monkeys delays the detection of a visual target located in the contralateral visual field. This effect was observed using different visual scene configurations, e.g., with distractors that differ in number or that differ from the target by a conjunction of shape and color or by a single feature. Since eye movements were not allowed during the searching tasks, these results argue for an unambiguous role of the parietal cortex in the top-down control of attentional deployment in space.	UCBL, CNRS, UMR 5015, Inst Cognit Sci, Bron, France; Catholic Univ Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain	Duhamel, JR (corresponding author), UCBL, CNRS, UMR 5015, Inst Cognit Sci, Bron, France.	duhamel@isc.cnrs.fr	Wardak, Claire/P-6222-2016; Duhamel, Jean-René/M-4723-2017	Wardak, Claire/0000-0001-8847-1859; Duhamel, Jean-René/0000-0003-0210-1027				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Bullier J, 1996, BEHAV BRAIN RES, V76, P89, DOI 10.1016/0166-4328(95)00182-4; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CRITCHLEYM, 1953, PARIETAL LOBES; Donner T, 2000, EUR J NEUROSCI, V12, P3407, DOI 10.1046/j.1460-9568.2000.00223.x; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eglin M, 1989, J Cogn Neurosci, V1, P372, DOI 10.1162/jocn.1989.1.4.372; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hays AV, 1982, WESCON C P, V2, P1; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kodaka Y, 1997, NEUROSCI RES, V28, P291, DOI 10.1016/S0168-0102(97)00055-2; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Li CSR, 1999, J NEUROPHYSIOL, V81, P1827, DOI 10.1152/jn.1999.81.4.1827; Malpeli JG, 1999, J NEUROSCI METH, V86, P119, DOI 10.1016/S0165-0270(98)00161-7; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Nobre AC, 2003, NEUROIMAGE, V18, P91, DOI 10.1006/nimg.2002.1329; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vandenberghe R, 2000, CEREB CORTEX, V10, P706, DOI 10.1093/cercor/10.7.706; Wardak C, 2002, J NEUROSCI, V22, P9877; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	37	136	136	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					501	508		10.1016/S0896-6273(04)00185-0	http://dx.doi.org/10.1016/S0896-6273(04)00185-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134645	Bronze			2022-12-28	WOS:000221458700015
J	Marjaux, E; Hartmann, D; De Strooper, B				Marjaux, E; Hartmann, D; De Strooper, B			Presenilins in memory, Alzheimer's disease, and therapy	NEURON			English	Editorial Material							MICE LACKING; NEUROGENESIS; DEFICIENCY; EXPRESSION; NICASTRIN; DEFECTS; PEN-2; SKIN	Presenilins are considered to be the catalytic subunits of the gamma-secretase complex and are therefore drug targets for Alzheimer's disease. They are also essential for the fine tuning of the immunological system and for memory and synaptic plasticity. Genetic ablation in the forebrain results in a progressive neurodegenerative process that is independent from Abeta generation. The question arises as to what extent these observations should influence our thinking on the pathogenesis of Alzheimer's disease and on strategies to further develop gamma-secretase inhibitors.	Katholieke Univ Leuven, UZ Gasthuisberg, Ctr Human Genet, Lab Neuronal Cell Biol & Gene Transfer, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Marjaux, E (corresponding author), Katholieke Univ Leuven, UZ Gasthuisberg, Ctr Human Genet, Lab Neuronal Cell Biol & Gene Transfer, Herestr 49,Vib4, B-3000 Louvain, Belgium.		De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019	De Strooper, Bart/0000-0001-5455-5819; 				De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Handler M, 2000, DEVELOPMENT, V127, P2593; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; KOPAN R, 2004, IN PRESS NAT REV CEL; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; QYANG Y, 2004, IN PRESS BIOCHEMISTR; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; TOURNOY J, 2004, IN PRESS HUM MOL GEN; Wang P, 2003, DEVELOPMENT, V130, P5019, DOI 10.1242/dev.00682; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	21	52	55	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 22	2004	42	2					189	192		10.1016/S0896-6273(04)00218-1	http://dx.doi.org/10.1016/S0896-6273(04)00218-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091335	Bronze			2022-12-28	WOS:000221458500004
J	Beauchamp, MS; Lee, KE; Argall, BD; Martin, A				Beauchamp, MS; Lee, KE; Argall, BD; Martin, A			Integration of auditory and visual information about objects in superior temporal sulcus	NEURON			English	Article							HUMAN CEREBRAL-CORTEX; HUMAN NEURAL SYSTEMS; MACAQUE MONKEY; HUMAN BRAIN; AUDIOVISUAL INTEGRATION; MANIPULATABLE OBJECTS; HEMISPHERIC LESIONS; CROSSMODAL BINDING; PROCESSING STREAMS; PREFRONTAL CORTEX	Two categories of objects in the environment-animals and man-made manipulable objects (tools)-are easily recognized by either their auditory or visual features. Although these features differ across modalities, the brain integrates them into a coherent percept. In three separate fMRI experiments, posterior superior temporal sulcus and middle temporal gyrus (pSTS/MTG) fulfilled objective criteria for an integration site. pSTS/MTG showed signal increases in response to either auditory or visual stimuli and responded more to auditory or visual objects than to meaningless (but complex) control stimuli. pSTS/MTG showed an enhanced response when auditory and visual object features were presented together, relative to presentation in a single modality. Finally, pSTS/MTG responded more to object identification than to other components of the behavioral task. We suggest that pSTS/MTG is specialized for integrating different types of information both within modalities (e.g., visual form, visual motion) and across modalities (auditory and visual).	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.	mbeauchamp@nih.gov	Beauchamp, Michael/AAK-9813-2020; martin, alex/B-6176-2009; Argall, Brenna/G-2543-2011	Beauchamp, Michael/0000-0002-7599-9934; 	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BELLN P, 2002, BRAIN RES COGN BRAIN, V13, P17; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Devlin JT, 2002, NEUROIMAGE, V15, P675, DOI 10.1006/nimg.2001.1002; Engelien A, 1995, BRAIN, V118, P1395, DOI 10.1093/brain/118.6.1395; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Puce A, 2003, NEUROIMAGE, V19, P861, DOI 10.1016/S1053-8119(03)00189-7; Puce A, 1996, J NEUROSCI, V16, P5205; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 1998, J NEUROSCI, V18, P2188; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Saygin AP, 2003, BRAIN, V126, P928, DOI 10.1093/brain/awg082; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SELFRITZ E, 2002, SCIENCE, V297, P1706; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; Stein BE., 1993, MERGING SENSES; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tranel D, 2003, NEUROPSYCHOLOGIA, V41, P847, DOI 10.1016/S0028-3932(02)00223-3; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	90	528	531	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					809	823		10.1016/S0896-6273(04)00070-4	http://dx.doi.org/10.1016/S0896-6273(04)00070-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003179	Bronze			2022-12-28	WOS:000221458200015
J	Guo, H; Liu, D; Gelbard, H; Cheng, T; Insalaco, R; Fernandez, JA; Griffin, JH; Zlokovic, BV				Guo, H; Liu, D; Gelbard, H; Cheng, T; Insalaco, R; Fernandez, JA; Griffin, JH; Zlokovic, BV			Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3	NEURON			English	Article							METHYL-D-ASPARTATE; STAUROSPORINE-INDUCED APOPTOSIS; TISSUE-PLASMINOGEN ACTIVATOR; HUMAN BRAIN ENDOTHELIUM; CELL-DEATH; CEREBROCORTICAL NEURONS; SIGNALING PATHWAYS; THROMBIN RECEPTOR; ISCHEMIC-STROKE; SEVERE SEPSIS	Activated protein C (APC), a serine protease with anticoagulant and anti-inflammatory activities, exerts direct cytoprotective effects on endothelium via endothelial protein C receptor-dependent activation of protease activated receptor 1 (PAR1). Here, we report that APC protects mouse cortical neurons from two divergent inducers of apoptosis, N-methyl-D-aspartate (NMDA) and staurosporine. APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation. Intracerebral APC infusion dose dependently reduced NMDA excitotoxicity in mice. By using different anti-PARs antibodies and mice with single PAR1, PAR3, or PAR4 deletion, we demonstrated that direct neuronal protective effects of APC in vitro and in vivo require PAR1 and PAR3. Thus, PAR1 and PAR3 mediate anti-apoptotic signaling by APC in neurons, which may suggest novel treatments for neurodegenerative disorders.	Socratech Lab, Rochester, NY 14620 USA; Univ Rochester, Med Ctr, Ctr Aging & Dev Biol,Dept Nrurosurg, Div Neurovasc Biol,Frank P Smith Neurosurg Res La, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Rochester; University of Rochester; Scripps Research Institute	Zlokovic, BV (corresponding author), Socratech Lab, Rochester, NY 14620 USA.	berislav_zlokovic@urmc.rochester.edu	Fernandez, Jose A/A-3211-2008; Gelbard, Harris/M-9260-2019	Fernandez, Jose A/0000-0002-0804-1865; Griffin, John/0000-0002-4302-2547; Gelbard, Harris/0000-0001-5095-7976	NHLBI NIH HHS [HL63290] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Ayata C, 1997, J NEUROSCI, V17, P6908; Bahou WF, 2003, CURR TOP DEV BIOL, V54, P343, DOI 10.1016/S0070-2153(03)54014-5; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brune B, 2003, TOXICOL LETT, V139, P119, DOI 10.1016/S0378-4274(02)00426-5; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; da Costa CA, 2003, J BIOL CHEM, V278, P12064, DOI 10.1074/jbc.M212379200; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Djebaili M, 2000, NEUROREPORT, V11, P2973, DOI 10.1097/00001756-200009110-00029; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jordan J, 2003, NEUROSCIENCE, V122, P707, DOI 10.1016/j.neuroscience.2003.08.030; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Le DA, 2001, DRUG AGING, V18, P717, DOI 10.2165/00002512-200118100-00001; Matys T, 2003, NAT MED, V9, P371, DOI 10.1038/nm0403-371; McInnis J, 2002, J PHARMACOL EXP THER, V301, P478, DOI 10.1124/jpet.301.2.478; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Ruf W, 2003, NAT MED, V9, P257, DOI 10.1038/nm0303-258; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sakhi S, 1997, EXP NEUROL, V145, P81, DOI 10.1006/exnr.1997.6451; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; Tieu K, 1999, J NEUROSCI RES, V58, P426, DOI 10.1002/(SICI)1097-4547(19991101)58:3<426::AID-JNR8>3.3.CO;2-6; Uberti D, 1998, EUR J NEUROSCI, V10, P246, DOI 10.1046/j.1460-9568.1998.00042.x; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang XD, 2001, GENE DEV, V15, P2922; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	51	224	232	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					563	572		10.1016/S0896-6273(04)00019-4	http://dx.doi.org/10.1016/S0896-6273(04)00019-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980205	Bronze			2022-12-28	WOS:000221458100009
J	Kaiser, M; Lappe, M				Kaiser, M; Lappe, M			Perisaccadic mislocalization orthogonal to saccade direction	NEURON			English	Article							VISUAL SPACE; SUPERIOR COLLICULUS; APPARENT POSITION; EYE; LOCALIZATION; TARGET; REPRESENTATION; DISPLACEMENT; COMPRESSION; PERCEPTION	Saccadic eye movements transiently distort perceptual space. Visual objects flashed shortly before or during a saccade are mislocalized along the saccade direction, resembling a compression of space around the saccade target. These mislocalizations reflect transient errors of processes that construct spatial stability across eye movements. They may arise from errors of reference signals associated with saccade direction and amplitude or from visual or visuomotor remapping processes focused on the saccade target's position. The second case would predict apparent position shifts toward the target also in directions orthogonal to the saccade. We report that such orthogonal mislocalization indeed occurs. Surprisingly, however, the orthogonal mislocalization is restricted to only part of the visual field. This part comprises distant positions in saccade direction but does not depend on the target's position. Our findings can be explained by a combination of directional and positional reference signals that varies in time course across the visual field.	Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany; Int Jacobs Univ Bremen, D-28759 Bremen, Germany; Univ Munster, Inst Psychol 2, D-48149 Munster, Germany	Ruhr University Bochum; University of Munster	Lappe, M (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany.	mlappe@psy.uni-muenster.de	Kaiser, Marcus/A-7166-2008	Kaiser, Marcus/0000-0002-4654-3110				Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Hamker FH, 2003, J VISION, V3, P808, DOI 10.1167/3.11.14; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1995, VISION RES, V35, P3021, DOI 10.1016/0042-6989(95)00108-C; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; MACH E, 1885, ANAL EMPFINDUNGEN; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Morrone MC, 1997, J NEUROSCI, V17, P7941; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; OSAKA N, 1977, J PSYCHOL, V95, P59, DOI 10.1080/00223980.1977.9915860; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SCHLAG J, 1995, VISION RES, V35, P2347, DOI 10.1016/0042-6989(95)00021-Q; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; VONHELMHOLTZ H, 1966, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988	32	81	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					293	300		10.1016/S0896-6273(03)00849-3	http://dx.doi.org/10.1016/S0896-6273(03)00849-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741109	Green Submitted, Bronze			2022-12-28	WOS:000221457800014
J	Gongidi, V; Ring, C; Moody, M; Brekken, R; Sage, EH; Rakic, P; Anton, ES				Gongidi, V; Ring, C; Moody, M; Brekken, R; Sage, EH; Rakic, P; Anton, ES			SPARC-like 1 regulates the terminal phase of radial glia-guided migration in the cerebral cortex	NEURON			English	Article							NEURONAL MIGRATION; CELL-MIGRATION; LAMINAR ORGANIZATION; NEOCORTEX; SPARC; SC1; PROTEIN; MATRIX; MOUSE; BRAIN	Differential adhesion between migrating neurons and transient radial glial fibers enables the deployment of neurons into appropriate layers in the developing cerebral cortex. The identity of radial glial signals that regulate the termination of migration remains unclear. Here, we identified a radial glial surface antigen, SPARC (secreted protein acidic and rich in cysteine)like 1, distributed predominantly in radial glial fibers passing through the upper strata of the cortical plate (CP) where neurons end their migration. Neuronal migration and adhesion assays indicate that SPARC-like 1 functions to terminate neuronal migration by reducing the adhesivity of neurons at the top of the CP. Cortical neurons fail to achieve appropriate positions in the absence of SPARC-like 1 function in vivo. Together, these data suggest that antiadhesive signaling via SPARC-like 1 on radial glial cell surfaces may enable neurons to recognize the end of migration in the developing cerebral cortex.	Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Hope Heart Inst, Dept Vasc Biol, Seattle, WA 98104 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Yale University	Anton, ES (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	anton@med.unc.edu			NIMH NIH HHS [MH63660] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063660] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ang ESBC, 2003, J NEUROSCI, V23, P5805; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Anton ES, 1997, DEVELOPMENT, V124, P3501; ANTON ES, 1994, DEV BIOL, V164, P133, DOI 10.1006/dbio.1994.1186; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; EMERLING DE, 1994, DEVELOPMENT, V120, P2811; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Friedlander DR, 1998, J NEUROBIOL, V37, P291, DOI 10.1002/(SICI)1097-4695(19981105)37:2<291::AID-NEU8>3.0.CO;2-F; Gilles C, 1998, CANCER RES, V58, P5529; Girard JP, 1996, J BIOL CHEM, V271, P4511; Halfter W, 2002, J NEUROSCI, V22, P6029; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MCCONNELL SK, 1990, EXPERIENTIA, V46, P922, DOI 10.1007/BF01939385; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; McKinnon PJ, 1996, GENOME RES, V6, P1077, DOI 10.1101/gr.6.11.1077; McKinnon PJ, 2000, MOL CELL BIOL, V20, P656, DOI 10.1128/MCB.20.2.656-660.2000; Mendis DB, 1996, BRAIN RES, V713, P53, DOI 10.1016/0006-8993(95)01472-1; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mothe AJ, 2001, BRAIN RES, V892, P27, DOI 10.1016/S0006-8993(00)03141-3; Muneoka K., 1990, POSTIMPLANTATION MAM, P41; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1974, GLIA, V83, P425; RAKIC P, 1988, PROG BRAIN RES, V73, P15; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607; TAKAHASHI T, 1990, J COMP NEUROL, V302, P15, DOI 10.1002/cne.903020103; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	53	94	94	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					57	69		10.1016/S0896-6273(03)00818-3	http://dx.doi.org/10.1016/S0896-6273(03)00818-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715135	Bronze, Green Published			2022-12-28	WOS:000187942800009
J	Llobet, A; Beaumont, V; Lagnado, L				Llobet, A; Beaumont, V; Lagnado, L			Real-time measurement of exocytosis and endocytosis using interference of light	NEURON			English	Article							RETINAL BIPOLAR CELLS; ADRENAL CHROMAFFIN CELLS; SINGLE SYNAPTIC VESICLES; DENSE-CORE VESICLES; REFLECTION MICROSCOPY; SECRETORY GRANULES; ENDOCRINE-CELLS; GOLDFISH RETINA; CALCIUM CURRENT; PC12 CELLS	We describe a new approach for making real-time measurements of exocytosis and endocytosis in neurons and neuroendocrine cells. The method utilizes interference reflection microscopy (IRM) to image surface membrane in close contact with a glass coverslip (the "footprint"). At the synaptic terminal of retinal bipolar cells, the footprint expands during exocytosis and retracts during endocytosis, paralleling changes in total surface area measured by capacitance. In chromaffin cells, IRM detects the fusion of individual granules as the appearance of bright spots within the footprint with spatial and temporal resolution similar to total internal reflection fluorescence microscopy. Advantages of IRM over capacitance are that it can monitor changes in surface area while cells are electrically active and it can be applied to mammalian neurons with relatively small synaptic terminals. IRM reveals that vesicles at the synapse of bipolar cells rapidly collapse into the surface membrane while secretory granules in chromaffin cells do not.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk	Llobet, Artur/D-4339-2014	Llobet, Artur/0000-0001-5797-6782; Beaumont, Vahri/0000-0002-6488-2175				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Angleson JK, 1997, TRENDS NEUROSCI, V20, P281, DOI 10.1016/S0166-2236(97)01083-7; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bader MF, 2002, ANN NY ACAD SCI, V971, P178, DOI 10.1111/j.1749-6632.2002.tb04461.x; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; de Kock CPJ, 2003, J NEUROSCI, V23, P2726; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gillis Kevin D., 1995, P155; GINGELL D, 1979, BIOPHYS J, V26, P507, DOI 10.1016/S0006-3495(79)85268-6; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; IZZARD CS, 1976, J CELL SCI, V21, P129; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; Katz B., 1969, RELEASE NEURAL TRANS; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Llobet A, 2003, J NEUROSCI, V23, P2706; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Pan YV, 2001, BIOMACROMOLECULES, V2, P32, DOI 10.1021/bm0000642; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Ploem J. S., 1975, MONONUCLEAR PHAGOCYT, P405; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Seward EP, 1996, J NEUROSCI, V16, P553; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Weber I, 2003, METHOD ENZYMOL, V361, P34; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538	60	53	55	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1075	1086		10.1016/S0896-6273(03)00765-7	http://dx.doi.org/10.1016/S0896-6273(03)00765-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687543	Bronze			2022-12-28	WOS:000187503400007
J	Greger, IH; Khatri, L; Kong, XP; Ziff, EB				Greger, IH; Khatri, L; Kong, XP; Ziff, EB			AMPA receptor tetramerization is mediated by Q/R editing	NEURON			English	Article							GLUTAMATE-RECEPTOR; ENDOPLASMIC-RETICULUM; ION CHANNELS; SUBUNIT STOICHIOMETRY; POTASSIUM CHANNEL; RECOMBINANT AMPA; K+ CHANNELS; BINDING; GLUR2; SELECTIVITY	AMPA-type glutamate receptors (AMPARs) play a major role in excitatory synaptic transmission and plasticity. Channel properties are largely dictated by their composition of the four subunits, GluR1-4 (or A-D). Here we show that AMPAR assembly and subunit stoichiometry are determined by RNA editing in the pore loop. We demonstrate that editing at the GluR2 Q/R site regulates AMPAR assembly at the step of tetramerization. Specifically, edited R subunits are largely unassembled and ER retained, whereas unedited Q subunits readily tetramerize, and traffic to synapses. This assembly mechanism restricts the number of the functionally critical R subunits in AMPAR tetramers. Therefore, a single amino acid residue affects channel composition and, in turn, controls ion conduction through the majority of AMPARs in the brain.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University	Ziff, EB (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 550 1St Ave, New York, NY 10016 USA.	ig@mrc-imb.cam.ac.uk; edward.ziff@med.nyu.edu		Ziff, Edward/0000-0001-7389-8649; Kong, Xiang-Peng/0000-0001-5773-2681	NATIONAL INSTITUTE ON AGING [R37AG013620, R01AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG13620] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abagyan R, 1997, PROTEINS, P29; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Creighton T. E., 1993, PROTEINS STRUCTURES; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heginbotham L, 1997, BIOCHEMISTRY-US, V36, P10335, DOI 10.1021/bi970988i; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Tikhonov DB, 2002, BIOPHYS J, V82, P1884, DOI 10.1016/S0006-3495(02)75538-0; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	53	235	248	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					763	774		10.1016/S0896-6273(03)00668-8	http://dx.doi.org/10.1016/S0896-6273(03)00668-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622580	Bronze			2022-12-28	WOS:000186651200011
J	Berardi, N; Pizzorusso, T; Maffei, L				Berardi, N; Pizzorusso, T; Maffei, L			Extracellular matrix and visual cortical plasticity: Freeing the synapse	NEURON			English	Review							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; PLASMINOGEN-ACTIVATOR; DENDRITIC SPINES; CRITICAL PERIOD; STRIATE CORTEX; DEPRIVATION; HIPPOCAMPUS; EXPRESSION; INJECTION	The effects of monocular deprivation (MD) on the ocular dominance of visual cortical neurons are a paradigmatic example of experience-dependent plasticity. Here we review recent data showing that extracellular matrix (ECM) plays an important role in the control of experience-dependent plasticity both in the developing and adult visual cortex.	CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Florence, Dipartimento Psicol, I-50100 Florence, Italy; Scuola Normale Super Pisa, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence; Scuola Normale Superiore di Pisa	Maffei, L (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.	lamberto.maffei@in.cnr.it	Pizzorusso, Tommaso/D-1399-2013	Pizzorusso, Tommaso/0000-0001-5614-0668				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BEAR MF, 1990, J NEUROSCI, V10, P909; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Daw NW, 1999, J NEUROPHYSIOL, V81, P204, DOI 10.1152/jn.1999.81.1.204; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Endo A, 1999, NEUROSCI RES, V33, P1, DOI 10.1016/S0168-0102(98)00105-9; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; Mataga N, 1996, NEUROSCI LETT, V218, P149, DOI 10.1016/S0304-3940(96)13139-6; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	32	129	131	4	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					905	908		10.1016/S0896-6273(04)00796-2	http://dx.doi.org/10.1016/S0896-6273(04)00796-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603733	Bronze			2022-12-28	WOS:000225842300004
J	Dudai, Y; Eisenberg, M				Dudai, Y; Eisenberg, M			Rites of passage of the engram: Reconsolidation and the lingering consolidation hypothesis	NEURON			English	Review							LONG-TERM-MEMORY; CONDITIONED TASTE-AVERSION; PASSIVE-AVOIDANCE TASK; REQUIRES NEW-PROTEIN; RETROGRADE-AMNESIA; FEAR MEMORIES; YOUNG CHICKS; RETRIEVAL; EXTINCTION; REACTIVATION	Memory consolidation refers to the progressive stabilization of items in long-term memory as well as to the memory phase(s) during which this stabilization takes place. The textbook account is that, for each item in memory, consolidation starts and ends just once. In recent years, however, the notion that memories reconsolidate upon their reactivation and hence regain sensitivity to amnestic agents has been revitalized. This issue is of marked theoretical and clinical interest. Here we review the recent literature on reconsolidation and infer, on the basis of the majority of the data, that blockade of reconsolidation does not induce permanent amnesia. Further, in several systems, reconsolidation occurs only in relatively fresh memories. We propose a framework model, which interprets reconsolidation as a manifestation of lingering consolidation, rather than recapitulation of a process that had already come to a closure. This model reflects on the nature of consolidation in general and makes predictions that could guide further research.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il		Aizenberg, Mark/0000-0002-0010-0453				Agnihotri NT, 2004, P NATL ACAD SCI USA, V101, P3656, DOI 10.1073/pnas.0400385101; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; Boccia MM, 2004, NEUROSCIENCE, V124, P735, DOI 10.1016/j.neuroscience.2004.01.001; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Burnham WH, 1903, AM J PSYCHOL, V14, P382; Child FM, 2003, BIOL BULL-US, V205, P218, DOI 10.2307/1543261; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Dudai Y., 2002, MEMORY KEYWORDS CONC; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOLD PE, 1973, SCIENCE, V180, P1199, DOI 10.1126/science.180.4091.1199; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Kelly A, 2003, J NEUROSCI, V23, P5354; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Koh MT, 2003, NEUROREPORT, V14, P405, DOI 10.1097/01.wnr.0000058519.74643.df; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lattal KM, 2004, P NATL ACAD SCI USA, V101, P4667, DOI 10.1073/pnas.0306546101; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Litvin O O, 2000, Neurosci Behav Physiol, V30, P671, DOI 10.1023/A:1026698700139; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Marr D., 1982, VISION; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Salinska E, 2004, EUR J NEUROSCI, V19, P3042, DOI 10.1111/j.0953-816X.2004.03407.x; Sangha S, 2003, J NEUROSCI, V23, P8034; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	56	322	331	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					93	100		10.1016/j.neuron.2004.09.003	http://dx.doi.org/10.1016/j.neuron.2004.09.003			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450162	Bronze			2022-12-28	WOS:000224232600009
J	Walsh, DM; Selkoe, DJ				Walsh, DM; Selkoe, DJ			Deciphering the molecular basis of memory failure in Alzheimer's disease	NEURON			English	Review							AMYLOID-BETA-PROTEIN; LONG-TERM POTENTIATION; HEREDITARY CEREBRAL-HEMORRHAGE; CENTRAL-NERVOUS-SYSTEM; A-BETA; TRANSGENIC MICE; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; MOUSE MODEL; IN-VIVO	Acutely developing lesions of the brain have been highly instructive in elucidating the neural systems underlying memory in humans and animal models. Much less has been learned from chronic neurodegenerative disorders that insidiously impair memory. But the advent of a detailed molecular hypothesis for the development of Alzheimer's disease and the creation of compelling mouse models thereof have begun to change this situation. Experiments in rodents suggest that soluble oligomers of the amyloid beta protein (Abeta) may discretely interfere with synaptic mechanisms mediating aspects of learning and memory, including long-term potentiation. In humans, memory impairment correlates strongly with cortical levels of soluble Abeta species, which include oligomers. Local inflammatory changes, neurofibrillary degeneration, and neurotransmitter deficits all contribute to memory impairment, but available evidence suggests that these develop as a consequence of early Abeta accumulation. Accordingly, attempts to slow memory and cognitive loss by decreasing cerebral Abeta levels have entered human trials.	Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Coll Dublin, Conway Inst Biomol, Lab Neurodegenerat Res, Dublin 4, Ireland	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University College Dublin	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	dwalsh@rics.bwh.harvard.edu; dselkoe@rics.bwh.harvard.edu	Blossey, Erich C/A-9696-2011	Blossey, Erich C/0000-0002-8189-766X				Alzheimer A., 1907, Z GESAMTE NEUROL PSY, V18, P177; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BertoniFreddari C, 1996, ANAL QUANT CYTOL, V18, P209; BERTONIFREDDARI C, 1989, PATHOL RES PRACT, V185, P799, DOI 10.1016/S0344-0338(89)80243-2; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; BURDICK D, 1992, J BIOL CHEM, V267, P546; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chang WP, 2004, J NEUROCHEM, V89, P1409, DOI 10.1111/j.1471-4159.2004.02452.x; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLEARY JP, 2004, IN PRESS NAT NEUROSC; CLEMENTS A, 1993, NEUROSCI LETT, V161, P17, DOI 10.1016/0304-3940(93)90129-9; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cras P, 1998, ACTA NEUROPATHOL, V96, P253, DOI 10.1007/s004010050892; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duyckaerts C, 1998, J NEURAL TRANSM-SUPP, P119; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Everall IP, 1997, J NEUROPATH EXP NEUR, V56, P1202, DOI 10.1097/00005072-199711000-00004; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; Funato H, 1999, AM J PATHOL, V155, P23, DOI 10.1016/S0002-9440(10)65094-8; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GILMAN S, 2004, NEUROBIOL AGING, V25, P84; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hebert LE, 2004, NEUROLOGY, V62, P1645, DOI 10.1212/01.WNL.0000123018.01306.10; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KAMINO K, 1992, AM J HUM GENET, V51, P998; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kukull WA, 2002, MED CLIN N AM, V86, P573, DOI 10.1016/S0025-7125(02)00010-X; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lee Hyoung-Gon, 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P293, DOI 10.2174/1568013033483221; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; MAATSCHIEMAN MLC, 1994, ACTA NEUROPATHOL, V88, P371; MAATSCHIEMAN MLC, 1992, ACTA NEUROPATHOL, V84, P674, DOI 10.1007/BF00227745; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; MANN DMA, 1988, HISTOPATHOLOGY, V13, P125, DOI 10.1111/j.1365-2559.1988.tb02018.x; MANN DMA, 1984, NEUROPATH APPL NEURO, V10, P185, DOI 10.1111/j.1365-2990.1984.tb00351.x; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MASLIAH E, 1990, AM J PATHOL, V137, P1293; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; MORRIS JC, 1991, PSYCHIAT CLIN N AM, V14, P223; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; OHare E, 1996, BEHAV PHARMACOL, V7, P742; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; REBECK GW, 1993, NEURON, V11, P575; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Uylings HBM, 2002, BRAIN COGNITION, V49, P268, DOI 10.1006/brcg.2001.1500; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; WALSH DM, 2004, CERTAIN INHIBITORS S; Walsh Dominic M., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P277, DOI 10.2174/1568013033483311; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Westphalen RI, 2003, J NEURAL TRANSM, V110, P1013, DOI 10.1007/s00702-003-0012-z; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu CC, 2004, P NATL ACAD SCI USA, V101, P7141, DOI 10.1073/pnas.0402147101; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060	151	983	1063	2	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					181	193		10.1016/j.neuron.2004.09.010	http://dx.doi.org/10.1016/j.neuron.2004.09.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450169	Bronze			2022-12-28	WOS:000224232600016
J	Larsson, MC; Domingos, AI; Jones, WD; Chiappe, ME; Amrein, H; Vosshall, LB				Larsson, MC; Domingos, AI; Jones, WD; Chiappe, ME; Amrein, H; Vosshall, LB			Or83b encodes a broadly expressed odorant receptor essential for Drosophila olfaction	NEURON			English	Article							VECTOR ANOPHELES-GAMBIAE; C-ELEGANS; SENSORY NEURONS; PHEROMONE RECEPTORS; MAMMALIAN SWEET; GENE-EXPRESSION; MAXILLARY PALP; ANTENNAL LOBE; FLY BRAIN; MELANOGASTER	Fruit flies are attracted by a diversity of odors that signal the presence of food, potential mates, or attractive egg-laying sites. Most Drosophila olfactory neurons express two types of odorant receptor genes: Or83b, a broadly expressed receptor of unknown function, and one or more members of a family of 61 selectively expressed receptors. While the conventional odorant receptors are highly divergent, Or83b is remarkably conserved between insect species. Two models could account for Or83b function: it could interact with specific odor stimuli independent of conventional odorant receptors, or it could act in concert with these receptors to mediate responses to all odors. Our results support the second model. Dendritic localization of conventional odorant receptors is abolished in Or83b mutants. Consistent with this cellular defect, the Or83b mutation disrupts behavioral and electrophysiological responses to many odorants. Or83b therefore encodes an atypical odorant receptor that plays an essential general role in olfaction.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	leslie@mail.rockefeller.edu	Larsson, Mattias C/E-4791-2014; Jones, Walton/A-2417-2011; Amrein, Hubert/AAG-9480-2021	Jones, Walton/0000-0001-8642-627X; Amrein, Hubert/0000-0001-8799-7250; Domingos, Ana/0000-0002-7938-4814; Chiappe, M Eugenia/0000-0003-1761-0457; Vosshall, Leslie/0000-0002-6060-8099	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005036] Funding Source: NIH RePORTER; NIDCD NIH HHS [5 R01 DC05036-03] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hummer TR, 2000, KENYON REV, V22, P1; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; KELLER A, 2003, CURR OPIN NEUROBIOL, V40, P463; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Mukabana WR, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-1; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Park SK, 2002, J NEUROBIOL, V51, P248, DOI 10.1002/neu.10057; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rostelien T, 2000, J COMP PHYSIOL A, V186, P833, DOI 10.1007/s003590000136; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Warr C, 2001, CHEM SENSES, V26, P201, DOI 10.1093/chemse/26.2.201; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	56	884	974	11	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					703	714		10.1016/j.neuron.2004.08.019	http://dx.doi.org/10.1016/j.neuron.2004.08.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339651	Bronze			2022-12-28	WOS:000223691900015
J	Deane, R; Wu, ZH; Sagare, A; Davis, J; Yan, SD; Hamm, K; Xu, F; Parisi, M; LaRue, B; Hu, HW; Spijkers, P; Guo, H; Song, XM; Lenting, PJ; Van Nostrand, WE; Zlokovic, BV				Deane, R; Wu, ZH; Sagare, A; Davis, J; Yan, SD; Hamm, K; Xu, F; Parisi, M; LaRue, B; Hu, HW; Spijkers, P; Guo, H; Song, XM; Lenting, PJ; Van Nostrand, WE; Zlokovic, BV			LRP/amyloid beta-peptide interaction mediates differential brain efflux of A beta isoforms	NEURON			English	Article							RECEPTOR-RELATED PROTEIN; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; BLOOD-BRAIN; MOUSE MODEL; MEMORY DEFICITS; LRP GENE; ASSOCIATION; CLEARANCE	LRP (low-density lipoprotein receptor-related protein) is linked to Alzheimer's disease (AD). Here, we report amyloid beta-peptide Abeta40 binds to immobilized LRP clusters 11 and IV with high affinity (K-d = 0.6-1.2 nM) compared to Abeta42 and mutant Abeta, and LRP-mediated Abeta brain capillary binding, endocytosis, and transcytosis across the mouse blood-brain barrier are substantially reduced by the high beta sheet content in Abeta and deletion of the receptor-associated protein gene. Despite low Abeta production in the brain, transgenic mice expressing low LRP-clearance mutant Abeta develop robust Abeta cerebral accumulations much earlier than Tg-2576 Abeta-overproducing mice. While Abeta does not affect LRP internalization and synthesis, it promotes proteasome-dependent LRP degradation in endothelium at concentrations >1 muM, consistent with reduced brain capillary LRP levels in Abeta-accumulating transgenic mice, AD, and patients with cerebrovascular beta-amyloidosis. Thus, low-affinity LRP/Abeta interaction and/or Abeta-induced LRP loss at the BBB mediate brain accumulation of neurotoxic Abeta.	Univ Rochester, Med Ctr, Frank P Smith Labs Neurosci & Neurosurg Res, Dept Neurosurg,Div Neurovasc Biol, Rochester, NY 14642 USA; Univ Utrecht, Med Ctr, Dept Hematol, Lab Thrombosis & Haemostasis, NL-3584 CX Utrecht, Netherlands; Columbia Univ Coll Phys & Surg, Dept Surg, Dept Pathol, New York, NY 10032 USA; SUNY Stony Brook, Hlth Sci Ctr, Dept Med, Stony Brook, NY 11794 USA	University of Rochester; Utrecht University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Frank P Smith Labs Neurosci & Neurosurg Res, Dept Neurosurg,Div Neurovasc Biol, Arthur Kornberg Med Res Bldg, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu	Lenting, Peter/AAH-5663-2019; Sagare, Abhay/Y-3273-2019; Lenting, Peter/F-8269-2013	Lenting, Peter/0000-0002-7937-3429; Sagare, Abhay/0000-0002-8178-3785; Lenting, Peter/0000-0002-7937-3429	NIA NIH HHS [AG16223, AG23084] Funding Source: Medline; NINDS NIH HHS [NS34467, NS36645] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036645, R01NS034467, R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, P01AG016223, R01AG023084] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bu GJ, 2001, INT REV CYTOL, V209, P79; BURDICK D, 1992, J BIOL CHEM, V267, P546; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Flood DG, 2002, NEUROBIOL AGING, V23, P335, DOI 10.1016/S0197-4580(01)00330-X; Ghiso J, 2002, ADV DRUG DELIVER REV, V54, P1539, DOI 10.1016/S0169-409X(02)00149-7; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Green PS, 2002, CURR OPIN LIPIDOL, V13, P569, DOI 10.1097/00041433-200210000-00013; Guenette SY, 2002, J NEUROCHEM, V82, P755, DOI 10.1046/j.1471-4159.2002.01009.x; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2003, CELL, V112, P289, DOI 10.1016/S0092-8674(03)00073-4; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hollenbach E, 1998, NEUROLOGY, V50, P1905, DOI 10.1212/WNL.50.6.1905; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jordan J, 1998, J NEUROSCI, V18, P195; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lambert JC, 1998, LANCET, V351, P1787, DOI 10.1016/S0140-6736(05)78749-3; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Matsuoka Y, 2003, J NEUROSCI, V23, P29; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; Narita M, 1997, J NEUROCHEM, V69, P1904; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; THORELL JI, 1971, BIOCHIM BIOPHYS ACTA, V251, P363, DOI 10.1016/0005-2795(71)90123-1; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; van der Geer P, 2002, TRENDS CARDIOVAS MED, V12, P160, DOI 10.1016/S1050-1738(02)00154-8; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Van Uden E, 2002, J NEUROSCI, V22, P9298; Veinbergs I, 2001, EXP NEUROL, V170, P15, DOI 10.1006/exnr.2001.7684; Vinters Harry V, 2003, Adv Neurol, V92, P105; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wavrant-DeVrieze F, 1999, HUM GENET, V104, P432, DOI 10.1007/s004390050980; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jbc.M102293200; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Wu ZH, 2003, J NEUROSCI METH, V130, P53, DOI 10.1016/S0165-0270(03)00206-1; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101; Zlokovic B.V., 2003, LANDES BIOSCI, P114; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	59	653	695	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					333	344		10.1016/j.neuron.2004.07.017	http://dx.doi.org/10.1016/j.neuron.2004.07.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294142	Bronze			2022-12-28	WOS:000223156900008
J	Zhang, T; Heuer, HW; Britten, KH				Zhang, T; Heuer, HW; Britten, KH			Parietal area VIP neuronal responses to heading stimuli are encoded in head-centered coordinates	NEURON			English	Article							VENTRAL INTRAPARIETAL AREA; PURSUIT EYE-MOVEMENTS; OPTIC-FLOW STIMULI; SUPERIOR TEMPORAL AREA; MACAQUE MONKEY; MST NEURONS; VISUAL RESPONSE; FIELD STIMULI; DORSAL PART; MOTION	The ventral intraparietal area (VIP) is a multimodal parietal area, where visual responses are brisk, directional, and typically selective for complex optic flow patterns. VIP thus could provide signals useful for visual estimation of heading (self-motion direction). A central problem in heading estimation is how observers compensate for eye velocity, which distorts the retinal motion cues upon which perception depends. To find out if VIP could be useful for heading, we measured its responses to simulated trajectories, both with and without eye movements. Our results showed that most VIP neurons very strongly signal heading direction. Furthermore, the tuning of most VIP neurons was remarkably stable in the presence of eye movements. This stability was such that the population of VIP neurons represented heading very nearly in head-centered coordinates. This makes VIP the most robust source of such signals yet described, with properties ideal for supporting perception.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Britten, KH (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	khbritten@ucdavis.edu	Zhang, Tao/B-5570-2011		NATIONAL EYE INSTITUTE [R01EY010562, P30EY012576] Funding Source: NIH RePORTER; NEI NIH HHS [EY10562, EY12576] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen R A, 2000, Int Rev Neurobiol, V44, P219; Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Ben Hamed S, 2003, J NEUROPHYSIOL, V90, P549, DOI 10.1152/jn.00639.2002; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Hays AV, 1982, WESCON C P, V2, P1; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LAPPE M, 1994, NATURE, V369, P712, DOI 10.1038/369712a0; Lappe M, 1999, EUR J NEUROSCI, V11, P2323, DOI 10.1046/j.1460-9568.1999.00649.x; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Merchant H, 2003, J NEUROPHYSIOL, V90, P675, DOI 10.1152/jn.00331.2003; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Page WK, 1999, J NEUROPHYSIOL, V81, P596, DOI 10.1152/jn.1999.81.2.596; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Paolini M, 2000, J NEUROPHYSIOL, V84, P730, DOI 10.1152/jn.2000.84.2.730; Perrone JA, 1998, J NEUROSCI, V18, P5958; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; Phinney RE, 2000, CEREB CORTEX, V10, P413, DOI 10.1093/cercor/10.4.413; Raffi M, 2002, CEREB CORTEX, V12, P639, DOI 10.1093/cercor/12.6.639; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SAITO H, 1986, J NEUROSCI, V6, P145; Schaafsma SJ, 1996, J NEUROPHYSIOL, V76, P4056; Schlack A, 2003, J PHYSIOL-LONDON, V551, P551, DOI 10.1113/jphysiol.2003.042994; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shenoy KV, 1999, J NEUROPHYSIOL, V81, P2764, DOI 10.1152/jn.1999.81.6.2764; Shenoy KV, 2002, J NEUROPHYSIOL, V88, P2630, DOI 10.1152/jn.00002.2001; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1986, J NEUROSCI, V6, P134; Upadhyay UD, 2000, J NEUROPHYSIOL, V84, P818, DOI 10.1152/jn.2000.84.2.818; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160; ZHANG KC, 1993, NEURAL COMPUT, V5, P597, DOI 10.1162/neco.1993.5.4.597	52	90	94	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					993	1001		10.1016/j.neuron.2004.06.008	http://dx.doi.org/10.1016/j.neuron.2004.06.008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207243	Bronze			2022-12-28	WOS:000222329300014
J	Connor, CE				Connor, CE			Active vision and visual activation in area V4	NEURON			English	Editorial Material							SACCADIC EYE-MOVEMENTS; ATTENTION; NEURONS; CORTEX	During normal vision, the focus of gaze continually jumps from one important image feature to the next. In this issue of Neuron, Mazer and Gallant analyze neural activity in higher-level visual cortex during this kind of active visual exploration, and they demonstrate a localized enhancement of visual responses that predicts the target of the upcoming eye movement.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Dept Neurosci, 3400 N Charles St, Baltimore, MD 21218 USA.							Conner CE, 1997, J NEUROSCI, V17, P3201; FISCHER B, 1981, EXP BRAIN RES, V44, P129; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; KOCH C, 1985, HUM NEUROBIOL, V4, P219; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	12	1	1	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1056	1058		10.1016/S0896-6273(03)00805-5	http://dx.doi.org/10.1016/S0896-6273(03)00805-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687540	Bronze			2022-12-28	WOS:000187503400004
J	Slutsky, I; Sadeghpour, S; Li, B; Liu, GS				Slutsky, I; Sadeghpour, S; Li, B; Liu, GS			Enhancement of synaptic plasticity through chronically reduced Ca2+ flux during uncorrelated activity	NEURON			English	Article							NMDA RECEPTOR; NEUROTRANSMITTER RELEASE; CORTICAL PLASTICITY; HIPPOCAMPAL-NEURONS; CEREBROSPINAL-FLUID; VISUAL EXPERIENCE; ACTION-POTENTIALS; CRITICAL PERIOD; SYNAPSES; MAGNESIUM	The plasticity of synapses within neural circuits is regulated by activity, but the underlying mechanisms remain elusive. Using the dye FM1-43 to directly image presynaptic function, we found that large numbers of presynaptic terminals in hippocampal cultures have a low release probability. While these terminals were not readily modifiable, a transient but not permanent long-term reduction of network activity or Ca2+ influx could increase their modifiability. This modulation of plasticity was mediated by Ca2+ flux through NMDA and voltage-gated calcium channels and was lost within 48 hr. A more permanent enhancement of synaptic plasticity was achieved by selectively reducing the Ca2+ flux associated with uncorrelated activity via adjustment of the voltage-dependent Mg2+ block of the NMDAR. Upregulation of NR2B-containing NMDARs induced by this treatment is an important but not sole contributor to the enhancement of plasticity. Thus, quantity and quality of activity have differential effects on the intrinsic plasticity of neurons.	RIKEN, MIT, Ctr Neurosci, Cambridge, MA 02139 USA; Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN	Liu, GS (corresponding author), Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	liu@mit.edu		Slutsky, Inna/0000-0002-0700-2266	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037342] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58880] Funding Source: Medline; NINDS NIH HHS [NS37342] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CHUTKOW JG, 1974, NEUROLOGY, V24, P780, DOI 10.1212/WNL.24.8.780; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1992, J NEUROSCI, V12, P1826; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KAPAKI E, 1989, ACTA NEUROL SCAND, V79, P373, DOI 10.1111/j.1600-0404.1989.tb03803.x; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Li YX, 1998, J NEUROSCI, V18, P10231; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Murnick JG, 2002, J NEUROSCI METH, V116, P65, DOI 10.1016/S0165-0270(02)00028-6; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Raastad M, 2003, J PHYSIOL-LONDON, V548, P745, DOI 10.1113/jphysiol.2002.032706; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TIMNEY B, 1978, EXP BRAIN RES, V31, P547; Tovar KR, 2000, J NEUROPHYSIOL, V83, P616, DOI 10.1152/jn.2000.83.1.616; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WOODBURY J, 1968, NEUROLOGY, V18, P700, DOI 10.1212/WNL.18.7.700; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	67	98	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					835	849		10.1016/j.neuron.2004.11.013	http://dx.doi.org/10.1016/j.neuron.2004.11.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572114	Bronze			2022-12-28	WOS:000225548400011
J	Preat, T				Preat, T			Diverse mechanisms to remember various odors	NEURON			English	Editorial Material							CONSOLIDATED MEMORY; DROSOPHILA; EXPRESSION; NEURONS		CNRS, Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, Dev Evolut & Plast Syst Nerveux, F-91190 Gif Sur Yvette, France.			Preat, Thomas/0000-0001-9976-1763				BRAND AH, 1993, DEVELOPMENT, V118, P401; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5	9	0	0	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					404	405		10.1016/j.neuron.2004.10.022	http://dx.doi.org/10.1016/j.neuron.2004.10.022			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504321	Bronze			2022-12-28	WOS:000224771700003
J	Shu, TZ; Ayala, R; Nguyen, MD; Xie, ZG; Gleeson, JG; Tsai, LH				Shu, TZ; Ayala, R; Nguyen, MD; Xie, ZG; Gleeson, JG; Tsai, LH			Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning	NEURON			English	Article							DIEKER LISSENCEPHALY GENE; ASPERGILLUS-NIDULANS; NUCLEAR MIGRATION; MICROTUBULE ORGANIZATION; HEAVY-CHAIN; CELL; DYNACTIN; PROTEIN; NUDEL; CENTROSOME	Correct neuronal migration and positioning during cortical development are essential for proper brain function. Mutations of the LIS1 gene result in human lissencephaly (smooth brain), which features misplaced cortical neurons and disarrayed cerebral lamination. However, the mechanism by which LIS1 regulates neuronal migration remains unknown. Using RNA interference (RNAi), we found that the binding partner of LIS1, NudE-like protein (Ndel1, formerly known as NUDEL), positively regulates dynein activity by facilitating the interaction between LIS1 and dynein. Loss of function of Ndel1, LIS1, or dynein in developing neocortex impairs neuronal positioning and causes the uncoupling of the centrosome and nucleus. Overexpression of LIS1 partially rescues the positioning defect caused by Ndel1 RNAi but not dynein RNAi, whereas overexpression of Ndel1 does not rescue the phenotype induced by LIS1 RNAi These results provide strong evidence that Ndel1 interacts with LIS1 to sustain the function of dynein, which in turn impacts microtubule organization, nuclear translocation, and neuronal positioning.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu						Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Clark GD, 2002, NEUROL CLIN, V20, P917, DOI 10.1016/S0733-8619(02)00024-5; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; TIMAUER JS, 2000, J CELL BIOL, V149, P761; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; WILLINS DA, 1995, GENETICS, V141, P1287; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516	57	289	298	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					263	277		10.1016/j.neuron.2004.09.030	http://dx.doi.org/10.1016/j.neuron.2004.09.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473966	Bronze			2022-12-28	WOS:000224635800010
J	Eichenbaum, H				Eichenbaum, H			Hippocampus: Cognitive processes and neural representations that underlie declarative memory	NEURON			English	Review							MEDIAL TEMPORAL-LOBE; IMPAIRED RECOGNITION MEMORY; SYNAPTIC PLASTICITY; EPISODIC MEMORY; PLACE CELLS; CONJUNCTIVE REPRESENTATIONS; OBJECT-RECOGNITION; PERIRHINAL CORTEX; INFORMATION; SEQUENCE	The hippocampus serves a critical role in declarative memory-our capacity to recall everyday facts and events. Recent studies using functional brain imaging in humans and neuropsychological analyses of humans and animals with hippocampal damage have revealed some of the elemental cognitive processes mediated by the hippocampus. In addition, recent characterizations of neuronal firing patterns in behaving animals and humans have suggested how neural representations in the hippocampus underlie those elemental cognitive processes in the service of declarative memory.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu						Addis DR, 2004, HIPPOCAMPUS, V14, P752, DOI 10.1002/hipo.10215; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Agster KL, 2002, J NEUROSCI, V22, P5760; Amaral David G., 1995, P443; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baxter MG, 2001, HIPPOCAMPUS, V11, P61, DOI 10.1002/1098-1063(2001)11:1<61::AID-HIPO1021>3.3.CO;2-Q; Bayley PJ, 2002, J NEUROSCI, V22, P5741; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; BUCKMASTER CA, IN PRESS J NEUROSCI; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burnham WH, 1903, AM J PSYCHOL, V14, P382; BUSSEY TJ, 2002, PARAHIPPOCAMPAL REGI, P239; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; DeCoteau WE, 2000, BEHAV NEUROSCI, V114, P1096, DOI 10.1037//0735-7044.114.6.1096; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Eichenbaum Howard, 1994, P147; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; FORTIN NJ, 2004, IN PRESS NATURE; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Giovanello KS, 2003, COGN AFFECT BEHAV NE, V3, P186, DOI 10.3758/CABN.3.3.186; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; Gothard KM, 1996, J NEUROSCI, V16, P823; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Heckers S, 2004, HIPPOCAMPUS, V14, P153, DOI 10.1002/hipo.10189; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Holscher C, 2003, REV NEUROSCIENCE, V14, P253; Honey RC, 1998, J NEUROSCI, V18, P2226; Keele SW, 2003, PSYCHOL REV, V110, P316, DOI 10.1037/0033-295X.110.2.316; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kesner RP, 1990, NEUROBIOLOGY COMP CO, P179; KIRWAN CB, 2004, IN PERSS HIPPOCAMPUS; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 2004, NEUROIMAGE, V22, P171, DOI 10.1016/j.neuroimage.2003.12.036; Maguire EA, 2000, HIPPOCAMPUS, V10, P475; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; MULLER RU, 1987, J NEUROSCI, V7, P1935; Muller RU, 1999, HIPPOCAMPUS, V9, P413, DOI 10.1002/(SICI)1098-1063(1999)9:4<413::AID-HIPO7>3.0.CO;2-#; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1998, J NEUROSCI, V18, P6568; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nemanic S, 2004, J NEUROSCI, V24, P2013, DOI 10.1523/JNEUROSCI.3763-03.2004; O'Kane G, 2004, HIPPOCAMPUS, V14, P417, DOI 10.1002/hipo.20005; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Pascalis O, 2004, NEUROPSYCHOLOGIA, V42, P1293, DOI 10.1016/j.neuropsychologia.2004.03.005; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Reber PJ, 1998, J COGNITIVE NEUROSCI, V10, P248, DOI 10.1162/089892998562681; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Ribot T. A., 1882, DIS MEMORY; Rivard B, 2004, J GEN PHYSIOL, V124, P9, DOI 10.1085/jgp.200409015; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Ryan JD, 2003, COGN AFFECT BEHAV NE, V3, P168, DOI 10.3758/CABN.3.3.168; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Sohal VS, 1998, NEURAL COMPUT, V10, P869, DOI 10.1162/089976698300017539; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Turriziani P, 2004, NEUROPSYCHOLOGIA, V42, P426, DOI 10.1016/j.neuropsychologia.2003.10.003; Van Elzakker M, 2003, HIPPOCAMPUS, V13, P334, DOI 10.1002/hipo.10083; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P484, DOI 10.1016/S0028-3932(99)00089-5; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Yanike M, 2004, NEURON, V42, P477, DOI 10.1016/S0896-6273(04)00193-X; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775; Zola SM, 2001, HIPPOCAMPUS, V11, P92, DOI 10.1002/hipo.1027; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	123	965	982	2	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					109	120		10.1016/j.neuron.2004.08.028	http://dx.doi.org/10.1016/j.neuron.2004.08.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450164	Bronze			2022-12-28	WOS:000224232600011
J	Yokota, Y; Anton, ES				Yokota, Y; Anton, ES			Calcium waves rule and divide radial glia	NEURON			English	Editorial Material							CA2+ TRANSIENTS; CELLS; PERSPECTIVE; PRECURSORS; MIGRATION; RETINA	Radial glial proliferation is a critical step in the construction of cerebral cortex. In this issue of Neuron, Weissman and colleagues use time-lapse calcium imaging techniques to demonstrate that spontaneous calcium waves sweeping through cohorts of radial glia in the ventricular zone can modulate their proliferation during cerebral cortical development.	Univ N Carolina, Ctr Neurosci, Sch Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Yokota, Y (corresponding author), Univ N Carolina, Ctr Neurosci, Sch Med, Chapel Hill, NC 27599 USA.							Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Kumada T, 2004, P NATL ACAD SCI USA, V101, P8479, DOI 10.1073/pnas.0401000101; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0	14	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 2	2004	43	5					599	601		10.1016/j.neuron.2004.08.030	http://dx.doi.org/10.1016/j.neuron.2004.08.030			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339639	Bronze			2022-12-28	WOS:000223691900003
J	Rosenbaum, T; Gordon, SE				Rosenbaum, T; Gordon, SE			Quickening the pace: Looking into the heart of HCN channels	NEURON			English	Editorial Material							PACEMAKER CHANNELS; ION CHANNELS; MOVEMENT; MODULATION; MECHANISM; CAMP	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels contribute to a wide range of physiological functions and regulate cardiac and neuronal pacemaker activity. Here, we review recent advances in three areas: the polarity of the S4 movement with hyperpolarization, the location of the activation gate, and the structure of the C-terminal C linker and CNBD.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	seg@u.washington.edu		Rosenbaum, Tamara/0000-0002-4791-3195				Accili EA, 2002, NEWS PHYSIOL SCI, V17, P32, DOI 10.1152/physiologyonline.2002.17.1.32; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	15	21	24	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					193	196		10.1016/S0896-6273(04)00199-0	http://dx.doi.org/10.1016/S0896-6273(04)00199-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091336	Bronze			2022-12-28	WOS:000221458500005
J	Sanada, K; Gupta, A; Tsai, LH				Sanada, K; Gupta, A; Tsai, LH			Disabled-1-regulated adhesion of migrating neurons to radial glial fiber contributes to neuronal positioning during early corticogenesis	NEURON			English	Article							REELIN-STIMULATED NEURONS; APOE RECEPTOR 2; EXTRACELLULAR-MATRIX; CELL-MIGRATION; DISABLED 1; TYROSINE PHOSPHORYLATION; NEOCORTICAL DEVELOPMENT; LAMINAR ORGANIZATION; CYTOPLASMIC DOMAIN; BRAIN-DEVELOPMENT	Disabled-1 regulates laminar organization in the developing mammalian brain. Although mutation of the disabled-1 gene in scrambler mice results in abnormalities in neuronal positioning, migratory behavior linked to Disabled-1 signaling is not completely understood. Here we show that newborn neurons in the scrambler cortex remain attached to the process of their parental radial glia during the entire course of radial migration, whereas wild-type neurons detach from the glial fiber in the later stage of migration. This abnormal neuronal-glial adhesion is highly linked to the positional abnormality of scrambler neurons and depends intrinsically on Disabled-1 Tyr220 and Tyr232, potential phosphorylation sites during corticogenesis. Importantly, phosphorylation at those sites regulates alpha3 integrin levels, which is critical for the timely detachment of migrating neurons from radial glia. Altogether, these results outline the molecular mechanism by which Disabled-1 signaling controls the adhesive property of neurons to radial glia, thereby maintaining proper neuronal positioning during corticogenesis.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37007] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Caviness V S Jr, 1982, Brain Res, V256, P293; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hammond V, 2001, J NEUROSCI, V21, P8798, DOI 10.1523/JNEUROSCI.21-22-08798.2001; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Kato T, 2002, EUR J BIOCHEM, V269, P4524, DOI 10.1046/j.1432-1033.2002.03146.x; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Yang HT, 2002, J NEUROSCI, V22, P464, DOI 10.1523/JNEUROSCI.22-02-00464.2002	47	123	133	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					197	211		10.1016/S0896-6273(04)00222-3	http://dx.doi.org/10.1016/S0896-6273(04)00222-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091337	Bronze			2022-12-28	WOS:000221458500006
J	McGee, AW; Nunziato, DA; Maltez, JM; Prehoda, KE; Pitt, GS; Bredt, DS				McGee, AW; Nunziato, DA; Maltez, JM; Prehoda, KE; Pitt, GS; Bredt, DS			Calcium channel function regulated by the SH3-GK module in beta subunits	NEURON			English	Article							GUANYLATE KINASE DOMAINS; CA2+ CHANNELS; INTRAMOLECULAR INTERACTION; SKELETAL-MUSCLE; PROTEIN; INACTIVATION; CALMODULIN; BINDING; PSD-95; MOTIF	beta-subunits of voltage-gated calcium channels (VGCCs) regulate channel trafficking and function, thereby shaping the intensity and duration of intracellular changes in calcium. beta subunits share limited sequence homology with the Src homology 3-guanylate kinase (SH3-GK) module of membrane-associated guanylate kinases (MAGUKs). Here, we show biochemical similarities between beta subunits and MAGUKs, revealing important aspects of P subunit structure and function. Similar to MAGUKs, an SH3-GK interaction within beta subunits can occur both intramolecularly and intermolecularly. Mutations that disrupt the SH3-GK interaction in p subunits alter channel inactivation and can inhibit binding between the alpha(1) and beta subunits. Coexpression of beta subunits with complementary mutations in their SH3 and GK domains rescues these deficits through intermolecular beta subunit assembly. In MAGUKs, the SH3-GK module controls protein scaffolding. In beta subunits, this module regulates the inactivation of VGCCs and provides an additional mechanism for tuning calcium responsiveness.	Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Div Cardiol, Dept Med, New York, NY 10032 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	Columbia University; Columbia University; University of California System; University of California San Francisco; University of Oregon; University of Oregon	Pitt, GS (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	gp2004@columbia.edu	Pitt, Geoffrey/L-4927-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071165] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071165-02, R01 HL071165, R01 HL071165-01, R01 HL071165-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bogdanov Y, 2000, EUR J NEUROSCI, V12, P894, DOI 10.1046/j.1460-9568.2000.00981.x; Brenman JE, 1998, J NEUROSCI, V18, P8805; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Olsen O, 2003, J BIOL CHEM, V278, P6873, DOI 10.1074/jbc.M210165200; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Restituito S, 2000, J NEUROSCI, V20, P9046; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamada Y, 1999, FEBS LETT, V458, P295, DOI 10.1016/S0014-5793(99)01171-0; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200	44	61	62	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					89	99		10.1016/S0896-6273(04)00149-7	http://dx.doi.org/10.1016/S0896-6273(04)00149-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066267	Bronze			2022-12-28	WOS:000221458400010
J	Celie, PHN; van Rossum-Fikkert, SE; van Dijk, WJ; Brejc, K; Smit, AB; Sixma, TK				Celie, PHN; van Rossum-Fikkert, SE; van Dijk, WJ; Brejc, K; Smit, AB; Sixma, TK			Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures	NEURON			English	Article							AGONIST-BINDING; EXTRACELLULAR DOMAIN; PROTEIN; SITE; RESIDUES; IDENTIFICATION; ACTIVATION; AFFINITY; GABA(A); SUBUNIT	Nicotinic acetylcholine receptors are prototypes for the pharmaceutically important family of pentameric ligand-gated ion channels. Here we present atomic resolution structures of nicotine and carbamylcholine binding to AChBP, a water-soluble homolog of the ligand binding domain of nicotinic receptors and their family members, GABA(A), GABA(C), 5HT(3) serotonin, and glycine receptors. Ligand binding is driven by enthalpy and is accompanied by conformational changes in the ligand binding site. Residues in the binding site contract around the ligand, with the largest movement in the C loop. As expected, the binding is characterized by substantial aromatic and hydrophobic contributions, but additionally there are close contacts between protein oxygens and positively charged groups in the ligands. The higher affinity of nicotine is due to a main chain hydrogen bond with the B loop and a closer packing of the aromatic groups. These structures will be useful tools for the development of new drugs involving nicotinic acetylcholine receptor-associated diseases.	Netherlands Canc Inst, Div Mol Carinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Neurosci, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl	Smit, August B/E-8410-2011; Celie, Patrick/AAY-9559-2021	Brejc, Katjusa/0000-0002-4562-6109; Sixma, Titia K/0000-0001-6180-0632				Abreo MA, 1996, J MED CHEM, V39, P817, DOI 10.1021/jm9506884; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; COHEN JB, 1991, J BIOL CHEM, V266, P23354; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; Glennon R A, 2000, Pharm Acta Helv, V74, P103, DOI 10.1016/S0031-6865(99)00022-9; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Le Novere N, 2001, PHILOS T R SOC B, V356, P1121; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Osaka H, 1998, J BIOL CHEM, V273, P12758, DOI 10.1074/jbc.273.21.12758; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Reeves DC, 2002, MOL MEMBR BIOL, V19, P11, DOI 10.1080/09687680110110048; Schapira Matthieu, 2002, BMC Structural Biology, V2, P1, DOI 10.1186/1472-6807-2-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; SINE SM, 1994, J BIOL CHEM, V269, P8808; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Vafa B, 1998, INT REV NEUROBIOL, V42, P285, DOI 10.1016/S0074-7742(08)60613-3; Xie Y, 2001, J BIOL CHEM, V276, P2417, DOI 10.1074/jbc.M009085200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	36	686	709	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					907	914		10.1016/S0896-6273(04)00115-1	http://dx.doi.org/10.1016/S0896-6273(04)00115-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046723	Bronze			2022-12-28	WOS:000221458300010
J	Renteria, RC; Johnson, J; Copenhagen, DR				Renteria, RC; Johnson, J; Copenhagen, DR			Need rods? Get glycine receptors and taurine	NEURON			English	Editorial Material							CELL-FATE DETERMINATION; RETINA	Taurine, a multifunctional amino acid prevalent in developing nervous tissues, regulates the number of rod photoreceptors in developing postnatal rodent retina. In this issue of Neuron, Young and Cepko show that taurine acts via GlyRalpha2 subunit-containing glycine receptors expressed by retinal progenitor cells at birth.	Univ Calif San Francisco, Sch Med, Dept Ophthalmol, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Renteria, RC (corresponding author), Univ Calif San Francisco, Sch Med, Dept Ophthalmol, Dept Physiol, San Francisco, CA 94143 USA.			Renteria, Rene/0000-0002-4490-0735	NATIONAL EYE INSTITUTE [R01EY001869] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY001869-27] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; STURMAN JA, 1986, ANN NY ACAD SCI, V477, P196, DOI 10.1111/j.1749-6632.1986.tb40337.x; Thio LL, 2003, J NEUROPHYSIOL, V90, P89, DOI 10.1152/jn.00612.2002; Young TL, 2004, NEURON, V41, P867, DOI 10.1016/S0896-6273(04)00141-2	8	13	13	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					839	841		10.1016/S0896-6273(04)00153-9	http://dx.doi.org/10.1016/S0896-6273(04)00153-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046714	Bronze			2022-12-28	WOS:000221458300001
J	Alvarez-Buylla, A; Lim, DA				Alvarez-Buylla, A; Lim, DA			For the long run: Maintaining germinal niches in the adult brain	NEURON			English	Editorial Material							NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; MOUSE-BRAIN; PROGENITOR PROLIFERATION; STIMULATES NEUROGENESIS; SONIC HEDGEHOG; SELF-RENEWAL; IN-VITRO; FOREBRAIN; NOTCH1	The adult mammalian brain retains neural stem cells that continually generate new neurons within two restricted regions: the subventricular zone (SVZ) of the lateral ventricle and the dentate gyrus subgranular zone (SGZ) of the hippocampus. Though these cellular populations are spatially isolated and subserve different brain systems, common themes begin to define adult neurogenic niches: (1) astrocytes serve as both stem cell and niche cell, (2) a basal lamina and concomitant vasculogenesis may be essential components of the niche, and (3) "embryonic" molecular morphogens and signals persist in these niches and play critical roles for adult neurogenesis. The adult neurogenic niches can be viewed as "displaced" neuroepithelium, pockets of cells and local signals that preserve enough embryonic character to maintain neurogenesis for life.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.			Lim, Daniel/0000-0001-7221-3425; Alvarez-Buylla, Arturo/0000-0003-4426-8925				Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chambers CB, 2001, DEVELOPMENT, V128, P689; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Imura T, 2003, J NEUROSCI, V23, P2824; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Reynaud-Deonauth S, 2002, DIFFERENTIATION, V69, P198, DOI 10.1046/j.1432-0436.2002.690413.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tropepe V, 1997, J NEUROSCI, V17, P7850; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	28	1040	1104	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					683	686		10.1016/S0896-6273(04)00111-4	http://dx.doi.org/10.1016/S0896-6273(04)00111-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003168	Bronze			2022-12-28	WOS:000221458200004
J	Temereanca, S; Simons, DJ				Temereanca, S; Simons, DJ			Functional topography of corticothalamic feedback enhances thalamic spatial response tuning in the somatosensory whisker/barrel system	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; RAT THALAMUS; CORTICOFUGAL MODULATION; CORTICAL ACTIVATION; RELAY NEURONS; BARREL FIELD; S1 CORTEX; PROJECTIONS; ORGANIZATION	Corticothalamic (CT) projections are similar to10 times more numerous than thalamocortical projections, yet their function in sensory processing is poorly understood. In particular, the functional significance of the topographic precision of CT feedback is unknown. We addressed these issues in the rodent somatosensory whisker/barrel system by deflecting individual whiskers and pharmacologically enhancing activity in layer VI of single whisker-related cortical columns. Enhancement of corticothalamic activity in a cortical column facilitated whisker-evoked responses in topographically aligned thalamic barreloid neurons, while activation of an adjacent column weakly suppressed activity at the same thalamic site. Both effects were more pronounced when stimulating the preferred, or principal, whisker than for adjacent whiskers. Thus, facilitation by homologous CT feedback sharpens thalamic receptive field focus, while suppression by nonhomologous feedback diminishes it. Our findings demonstrate that somatosensory cortex can selectively regulate thalamic spatial response tuning by engaging topographically specific excitatory and inhibitory mechanisms in the thalamus.	Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Temereanca, S (corresponding author), Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA.	temerean@nmr.mgh.harvard.edu		Temereanca, Simona/0000-0002-4671-5971	NIMH NIH HHS [MH61372] Funding Source: Medline; NINDS NIH HHS [NS19950] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019950] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; BARTH DS, 1989, BRAIN RES, V484, P13, DOI 10.1016/0006-8993(89)90344-2; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Bruno RM, 2002, J NEUROSCI, V22, P10966; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Castro-Alamancos MA, 2001, J NEUROPHYSIOL, V85, P1489, DOI 10.1152/jn.2001.85.4.1489; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Desilets-Roy B, 2002, J NEUROSCI, V22; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Eaton SA, 1996, NEUROSCIENCE, V73, P1, DOI 10.1016/0306-4522(96)00123-6; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Ghazanfar AA, 2001, EXP BRAIN RES, V141, P88, DOI 10.1007/s002210100849; GHOSH S, 1994, EXP BRAIN RES, V100, P276; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; GUILLERY RW, 1967, J COMP NEUROL, V130, P197, DOI 10.1002/cne.901300303; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Hartings JA, 2000, J NEUROPHYSIOL, V83, P2791, DOI 10.1152/jn.2000.83.5.2791; He JF, 1997, J NEUROPHYSIOL, V77, P896, DOI 10.1152/jn.1997.77.2.896; He JF, 2003, EXP BRAIN RES, V153, P579, DOI 10.1007/s00221-003-1680-5; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Kao CQ, 1997, J NEUROPHYSIOL, V77, P2661, DOI 10.1152/jn.1997.77.5.2661; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Kelly MK, 2001, SOMATOSENS MOT RES, V18, P202; Kyriazi HT, 1996, BRAIN RES, V712, P325, DOI 10.1016/0006-8993(95)01562-0; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; PESCHANSKI M, 1983, BRAIN RES, V270, P325, DOI 10.1016/0006-8993(83)90607-8; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Rivadulla C, 2002, J NEUROSCI, V22, P2956, DOI 10.1523/JNEUROSCI.22-07-02956.2002; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; SHIN HC, 1990, SOMATOSENS MOT RES, V7, P421, DOI 10.3109/08990229009144717; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; TSUMOTO T, 1978, EXP BRAIN RES, V32, P345; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; YUAN B, 1986, J NEUROSCI, V6, P3611; YUAN B, 1985, J NEUROSCI, V5, P2971; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang ZW, 1997, J NEUROSCI, V17, P6365	57	117	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					639	651		10.1016/S0896-6273(04)00046-7	http://dx.doi.org/10.1016/S0896-6273(04)00046-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980211	Bronze			2022-12-28	WOS:000221458100015
J	Frost, WN; Tian, LM; Hoppe, TA; Mongeluzi, DL; Wang, J				Frost, WN; Tian, LM; Hoppe, TA; Mongeluzi, DL; Wang, J			A cellular mechanism for prepulse inhibition	NEURON			English	Article							CENTRAL PATTERN GENERATOR; DORSAL SWIM INTERNEURONS; ACOUSTIC STARTLE REFLEX; CENTRAL NERVOUS-SYSTEM; TRITONIA ESCAPE SWIM; PRESYNAPTIC INHIBITION; TRANSMITTER RELEASE; INTRINSIC NEUROMODULATION; NEUROLEPTIC MEDICATION; SCHIZOPHRENIA-PATIENTS	In prepulse inhibition (PPI), startle responses to sudden, unexpected stimuli are markedly attenuated if immediately preceded by a weak stimulus of almost any modality. This experimental paradigm exposes a potent inhibitory process, present in nervous systems from invertebrates to humans, that is widely considered to play an important role in reducing distraction during the processing of sensory input. The neural mechanisms mediating PPI are of considerable interest given evidence linking PPI deficits with some of the cognitive disorders of schizophrenia. Here, in the marine mollusk Tritonia diomedea, we describe a detailed cellular mechanism for PPI-a combination of presynaptic inhibition of startle afferent neurons together with distributed postsynaptic inhibition of several downstream interneuronal sites in the startle circuit.	Finch Univ Hlth Sci Chicago Med Sch, Dept Cell Biol & Anat, Abbott Pk, IL 60064 USA; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA	University of Texas System	Frost, WN (corresponding author), Finch Univ Hlth Sci Chicago Med Sch, Dept Cell Biol & Anat, 3333 Green Bay Rd, Abbott Pk, IL 60064 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA016320] Funding Source: NIH RePORTER; NIDA NIH HHS [DA16320] Funding Source: Medline; NINDS NIH HHS [NS36500] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAXTER DA, 1991, SYNAPSE, V7, P244, DOI 10.1002/syn.890070309; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALABRESI P, 1992, ANN NEUROL, V31, P366, DOI 10.1002/ana.410310404; CARPENTER DO, 1977, J NEUROBIOL, V8, P119, DOI 10.1002/neu.480080204; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; Clarac F, 1996, EXP BRAIN RES, V112, P163; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Frost WN, 2001, AM ZOOL, V41, P952, DOI 10.1668/0003-1569(2001)041[0952:SINITD]2.0.CO;2; Frost WN, 1996, P NATL ACAD SCI USA, V93, P422, DOI 10.1073/pnas.93.1.422; FUCHS PA, 1980, J NEUROPHYSIOL, V43, P1547, DOI 10.1152/jn.1980.43.6.1547; GETTING PA, 1976, J COMP PHYSIOL, V110, P271, DOI 10.1007/BF00659144; GETTING PA, 1983, NEURAL ORIGIN RHYTHM, V37, P89; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GRAHAM FK, 1992, ATTENTION INFORMATIO; Hamm AO, 2001, PSYCHOPHARMACOLOGY, V156, P259, DOI 10.1007/s002130100827; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; HOFFMAN HS, 1992, ATTENTION INFORMATIO; HUE B, 1983, J INSECT PHYSIOL, V29, P741, DOI 10.1016/0022-1910(83)90002-1; Kallstrand J, 2002, PSYCHIAT RES, V113, P115, DOI 10.1016/S0165-1781(02)00248-2; KALTENBACH JA, 1993, HEARING RES, V67, P35, DOI 10.1016/0378-5955(93)90229-T; Karper LP, 1996, J NEUROPSYCH CLIN N, V8, P60; Katz PS, 1997, J NEUROSCI, V17, P7703; Katz PS, 1995, J NEUROPHYSIOL, V74, P2281, DOI 10.1152/jn.1995.74.6.2281; KATZ PS, 1994, NATURE, V367, P729, DOI 10.1038/367729a0; KATZ PS, 1995, J NEUROSCI, V15, P6035; KEMENES G, 1991, J NEUROSCI METH, V39, P207, DOI 10.1016/0165-0270(91)90099-L; KRETZ R, 1986, J NEUROPHYSIOL, V55, P113, DOI 10.1152/jn.1986.55.1.113; KRETZ R, 1986, J NEUROPHYSIOL, V55, P131, DOI 10.1152/jn.1986.55.1.131; Leumann L, 2001, BRAIN RES BULL, V56, P101, DOI 10.1016/S0361-9230(01)00607-4; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Martinez ZA, 2002, PSYCHOPHARMACOLOGY, V161, P38, DOI 10.1007/s00213-001-0977-y; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Mongeluzi DL, 1998, J NEUROSCI, V18, P8467; NELSON SB, 1991, J NEUROSCI, V11, P369; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P157, DOI 10.1113/jphysiol.1978.sp012414; Nodal FR, 2003, J COMP NEUROL, V460, P80, DOI 10.1002/cne.10656; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Perry W, 1999, ARCH GEN PSYCHIAT, V56, P277, DOI 10.1001/archpsyc.56.3.277; PERRY W, 1994, AM J PSYCHIAT, V151, P363; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Rudomin P., 1998, PRESYNAPTIC INHIBITI; SCHELL AM, 1995, PSYCHOPHYSIOLOGY, V32, P266, DOI 10.1111/j.1469-8986.1995.tb02955.x; Schicatano EJ, 2000, J NEUROSCI, V20, P4240; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P629, DOI 10.1073/pnas.77.1.629; Shore SE, 1998, J ACOUST SOC AM, V104, P378, DOI 10.1121/1.423294; SIMONS RF, 1992, PSYCHOPHYSIOLOGY, V29, P8, DOI 10.1111/j.1469-8986.1992.tb02004.x; SLAWSKY MT, 1979, THESIS STANFORD U ST; SWERDLOW NR, 1995, BIOL PSYCHIAT, V37, P286, DOI 10.1016/0006-3223(94)00138-S; WATSON AHD, 1992, COMP BIOCHEM PHYS A, V103, P227, DOI 10.1016/0300-9629(92)90573-9; Weike AI, 2000, BIOL PSYCHIAT, V47, P61, DOI 10.1016/S0006-3223(99)00229-2; WILLOWS AOD, 1973, J NEUROBIOL, V4, P207, DOI 10.1002/neu.480040306; Yeomans JS, 2002, NEUROSCI BIOBEHAV R, V26, P1, DOI 10.1016/S0149-7634(01)00057-4; ZOLTAY G, 1990, J NEUROCHEM, V55, P1008, DOI 10.1111/j.1471-4159.1990.tb04590.x	57	46	48	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					991	1001		10.1016/S0896-6273(03)00731-1	http://dx.doi.org/10.1016/S0896-6273(03)00731-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659097	Bronze			2022-12-28	WOS:000187042200015
J	Pascual, O; Haydon, PG				Pascual, O; Haydon, PG			Synaptic inhibition mediated by glia	NEURON			English	Editorial Material							ASTROCYTES; SYNAPSES; NEURONS	It has become increasingly clear over the past several years that astrocytes can release chemical transmitters in response to the activation of neurotransmitter receptors. In this issue of Neuron, Zhang et al. demonstrate that the regulated release of one of these gliotransmitters, ATP, mediates a form of heterosynaptic suppression.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Pascual, O (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.		Pascual, Olivier/E-9533-2017; Pascual, Olivier/AAE-1449-2020	Pascual, Olivier/0000-0002-5730-9880; Pascual, Olivier/0000-0002-5730-9880				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; SUL J, 2004, IN PRESS NEURON GLIA; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	11	12	13	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					873	875		10.1016/S0896-6273(03)00760-8	http://dx.doi.org/10.1016/S0896-6273(03)00760-8			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659084	Bronze			2022-12-28	WOS:000187042200002
J	Gandhi, CS; Clark, E; Loots, E; Pralle, A; Isacoff, EY				Gandhi, CS; Clark, E; Loots, E; Pralle, A; Isacoff, EY			The orientation and molecular movement of a K+ channel voltage-sensing domain	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; GATED ION CHANNELS; S4 SEGMENT; GATING CHARGE; HELICAL STRUCTURE; CRYSTAL-STRUCTURE; PORE DOMAIN; CONFORMATIONS; RESIDUES; REARRANGEMENT	Voltage-gated channels operate through the action of a voltage-sensing domain (membrane segments S1-S4) that controls the conformation of gates located in the pore domain (membrane segments S5-S6). Recent structural studies on the bacterial K(v)AP potassium channel have led to a new model of voltage sensing in which S4 lies in the lipid at the channel periphery and moves through the membrane as a unit with a portion of S3. Here we describe accessibility probing and disulfide scanning experiments aimed at determining how well the K(v)AP model describes the Drosophila Shaker potassium channel. We find that the S1-S3 helices have one end that is externally exposed, S3 does not undergo a transmembrane motion, and S4 lies in close apposition to the pore domain in the resting and activated state.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 271 LSA,MC 3200, Berkeley, CA 94720 USA.		Pralle, Arnd/M-9832-2013; isacoff, ehud/AAP-1459-2020	Pralle, Arnd/0000-0002-6079-109X; Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035549-07, R01 NS35549] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shih TM, 1997, J CELL BIOL, V136, P1037, DOI 10.1083/jcb.136.5.1037; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Wang MH, 1999, J PHYSIOL-LONDON, V521, P315, DOI 10.1111/j.1469-7793.1999.00315.x; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	40	102	106	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					515	525		10.1016/S0896-6273(03)00646-9	http://dx.doi.org/10.1016/S0896-6273(03)00646-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642276	Bronze			2022-12-28	WOS:000186379000011
J	Oray, S; Majewska, A; Sur, M				Oray, S; Majewska, A; Sur, M			Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; TISSUE-PLASMINOGEN ACTIVATOR; CLUSTERED HORIZONTAL CONNECTIONS; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; ACTIN-BASED PLASTICITY; PRIMARY VISUAL-CORTEX; CRITICAL-PERIOD; DEVELOPMENTAL REGULATION; CALCIUM DYNAMICS	The mammalian primary visual cortex (V1) is especially susceptible to changes in visual input over a well-defined critical period, during which closing one eye leads to a loss of responsiveness of neurons to the deprived eye and a shift in response toward the open eye. This functional plasticity can occur rapidly, following even a single day of eye closure, although the structural bases of these changes are unknown. Here, we show that rapid structural changes at the level of dendritic spines occur following brief monocular deprivation. These changes are evident in the supra- and infragranular layers of the binocular zone and can be mimicked by degradation of the extracellular matrix with the tPA/plasmin proteolytic cascade. Further, monocular deprivation occludes a subsequent effect of matrix degradation, suggesting that this mechanism is active in vivo to permit structural remodeling during ocular dominance plasticity.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	msur@mit.edu		Majewska, Ania/0000-0002-2167-6849				Antonini A, 1999, J NEUROSCI, V19, P4388; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fiumelli H, 1999, EUR J NEUROSCI, V11, P1639, DOI 10.1046/j.1460-9568.1999.00580.x; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Majewska A, 2000, J NEUROSCI, V20, P1722; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Sorra KE, 1998, J NEUROSCI, V18, P658; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; SUR M, 1988, J NEUROSCI, V8, P874; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	61	223	232	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					1021	1030		10.1016/j.neuron.2004.12.001	http://dx.doi.org/10.1016/j.neuron.2004.12.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603744	Bronze			2022-12-28	WOS:000225842300015
J	Tarricone, C; Perrina, F; Monzani, S; Massimiliano, L; Kim, MH; Derewenda, ZS; Knapp, S; Tsai, LH; Musacchio, A				Tarricone, C; Perrina, F; Monzani, S; Massimiliano, L; Kim, MH; Derewenda, ZS; Knapp, S; Tsai, LH; Musacchio, A			Coupling PAF signaling to dynein regulation: Structure of LIS1 in complex with PAF-Acetylhydrolase	NEURON			English	Article							PLATELET-ACTIVATING-FACTOR; SUBCORTICAL BAND HETEROTOPIA; DIEKER LISSENCEPHALY GENE; PROTEIN BETA-SUBUNIT; CYTOPLASMIC DYNEIN; MISSENSE MUTATIONS; NEURONAL MIGRATION; CELLULAR FUNCTION; CRYSTAL-STRUCTURE; WD-REPEAT	Mutations in the LIS1 gene cause lissencephaly, a human neuronal migration disorder. LIS1 binds dynein and the dynein-associated proteins Nde1 (formerly known as NudE), Ndel1 (formerly known as NUDEL), and CLIP-170, as well as the catalytic a dimers of brain cytosolic platelet activating factor acetylhydrolase (PAF-AH). The mechanism coupling the two diverse regulatory pathways remains unknown. We report the structure of LIS1 in complex with the (alpha(2)/alpha(2) PAF-AH homodimer. One LIS1 homodimer binds symmetrically to one alpha(2)/alpha(2) homodimer via the highly conserved top faces of the LIS1 beta propellers. The same surface of LIS1 contains sites of mutations causing lissencephaly and overlaps with a putative dynein binding surface. Ndel1 competes with the alpha(2)/alpha(2) homodimer for LIS1, but the interaction is complex and requires both the N- and C-terminal domains of LIS1. Our data suggest that the LIS1 molecule undergoes major conformational rearrangement when switching from a complex with the acetylhydrolase to the one with Ndel1.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Oxford, Struct Genom Consortium, Botnar Res Ctr, Oxford OX3 7LD, England; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	IRCCS European Institute of Oncology (IEO); University of Virginia; University of Oxford; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Musacchio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	andrea.musacchio@ifom-ieo-campus.it	Knapp, Stefan/AAG-2347-2019; Massimiliano, Lucia/AAP-5179-2020	Knapp, Stefan/0000-0001-5995-6494; Massimiliano, Lucia/0000-0001-9128-4317; Musacchio, Andrea/0000-0003-2362-8784	Fondazione Telethon Funding Source: Custom; NINDS NIH HHS [NS36267] Funding Source: Medline; Telethon [GP0097Y01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036267] Funding Source: NIH RePORTER	Fondazione Telethon(Fondazione Telethon); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adachi T, 1997, NEUROSCI LETT, V235, P133, DOI 10.1016/S0304-3940(97)00742-8; Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; BANKS JB, 1988, BIOCHIM BIOPHYS ACTA, V961, P48, DOI 10.1016/0005-2760(88)90129-4; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Caspi M, 2003, J BIOL CHEM, V278, P38740, DOI 10.1074/jbc.M301147200; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gleeson Joseph G., 2000, Current Opinion in Neurology, V13, P121, DOI 10.1097/00019052-200004000-00002; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; HATTORI M, 1993, J BIOL CHEM, V268, P18748; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; HAYASHI H, 1985, J BIOCHEM-TOKYO, V97, P1737, DOI 10.1093/oxfordjournals.jbchem.a135232; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hubbard TJP, 1998, ACTA CRYSTALLOGR D, V54, P1147, DOI 10.1107/S0907444998009172; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kim MH, 2004, STRUCTURE, V12, P987, DOI 10.1016/j.str.2004.03.024; Kitagawa M, 2000, FEBS LETT, V479, P57, DOI 10.1016/S0014-5793(00)01856-1; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Leventer RJ, 2001, NEUROLOGY, V57, P416, DOI 10.1212/WNL.57.3.416; Liu Z, 1999, DEVELOPMENT, V126, P4477; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Pilz DT, 1999, HUM MOL GENET, V8, P1757, DOI 10.1093/hmg/8.9.1757; POLONSKY J, 1980, P NATL ACAD SCI-BIOL, V77, P7019, DOI 10.1073/pnas.77.12.7019; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sheffield PJ, 2001, PROTEIN ENG, V14, P513, DOI 10.1093/protein/14.7.513; Sheffield PJ, 2000, PROTEINS, V39, P1, DOI 10.1002/(SICI)1097-0134(20000401)39:1<1::AID-PROT1>3.0.CO;2-N; Sicca F, 2003, NEUROLOGY, V61, P1042, DOI 10.1212/WNL.61.8.1042; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tokuoka SM, 2003, EUR J NEUROSCI, V18, P563, DOI 10.1046/j.1460-9568.2003.02778.x; Torres FR, 2004, NEUROLOGY, V62, P799, DOI 10.1212/01.WNL.0000113725.46254.FD; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801	50	87	92	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					809	821		10.1016/S0896-6273(04)00751-2	http://dx.doi.org/10.1016/S0896-6273(04)00751-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572112	Bronze			2022-12-28	WOS:000225548400009
J	Zhou, L; Olivier, NB; Yao, H; Young, EC; Siegelbaum, SA				Zhou, L; Olivier, NB; Yao, H; Young, EC; Siegelbaum, SA			A conserved tripeptide in CNG and HCN channels regulates ligand gating by controlling C-terminal oligomerization	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; PACEMAKER CHANNELS; FUNCTIONAL EXPRESSION; OLFACTORY NEURONS; POTASSIUM CHANNEL; BINDING DOMAIN; SUBUNIT STOICHIOMETRY; MOLECULAR MECHANISM; ACTIVATED CHANNEL; CRYSTAL-STRUCTURE	Cyclic nucleotides directly enhance the opening of the tetrameric CNG and HCN channels, although the mechanism remains unclear. We examined why HCN and certain CNG subunits form functional homomeric channels, whereas other CNG subunits only function in heteromeric channels. The "defect" in the CNGA4 subunit that prevents its homomeric expression was localized to its C-linker, which connects the transmembrane domain to the binding domain and contains a tripeptide that decreases the efficacy of ligand gating. Remarkably, replacement of the homologous HCN tripeptide with the CNGA4 sequence transformed cAMP into an inverse agonist that inhibits HCN channel opening. Using analytical ultracentrifugation, we identified the structural basis for this gating switch: whereas cAMP normally enhances the assembly of HCN C-terminal domains into a tetrameric gating ring, inclusion of the CNGA4 tripeptide reversed this action so that cAMP now causes gating ring disassembly. Thus, ligand gating depends on the dynamic oligomerization of C-terminal binding domains.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu		Young, Edgar C./0000-0002-8453-088X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36658] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altomare C, 2003, J PHYSIOL-LONDON, V549, P347, DOI 10.1113/jphysiol.2002.027698; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Bucossi G, 1997, BIOPHYS J, V72, P1165, DOI 10.1016/S0006-3495(97)78765-4; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Cheng KT, 2003, HISTOCHEM CELL BIOL, V120, P475, DOI 10.1007/s00418-003-0596-2; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Gerstner A, 2000, J NEUROSCI, V20, P1324; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Karpen JW, 1997, BIOPHYS J, V72, P986, DOI 10.1016/S0006-3495(97)78749-6; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KRAMER RH, 1994, NEURON, V12, P655, DOI 10.1016/0896-6273(94)90220-8; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Scott SP, 2001, BIOCHEMISTRY-US, V40, P7464, DOI 10.1021/bi002804x; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Young EC, 2001, J GEN PHYSIOL, V118, P523, DOI 10.1085/jgp.118.5.523; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	51	48	48	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					823	834		10.1016/j.neuron.2004.11.012	http://dx.doi.org/10.1016/j.neuron.2004.11.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572113	Bronze			2022-12-28	WOS:000225548400010
J	Hull, C; von Gersdorff, H				Hull, C; von Gersdorff, H			Fast endocytosis is inhibited by GABA-mediated chloride influx at a presynaptic terminal	NEURON			English	Article							RETINAL BIPOLAR CELLS; SYNAPTIC VESICLE ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; FROG NEUROMUSCULAR-JUNCTION; NERVE-TERMINALS; RIBBON SYNAPSE; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; MEMBRANE RETRIEVAL	Although multiple kinetic components of synaptic vesicle endocytosis have been identified, it has remained unclear whether neurons can differentially modulate these components. Using membrane capacitance measurements from isolated goldfish bipolar cell terminals, we found that the kinetics of endocytosis in retinal slices (single exponential decay; tau > 10 s) were significantly slower than those in acutely dissociated terminals (double exponential decay; tau(fast) approximate to 1-2 s; tau(slow) > 10 s). Surprisingly, GABA(A) and/or GABA(C) receptor antagonists restored the fast component of endocytosis to terminals in retinal slices. Blocking GABAergic feedback from reciprocal synapses or removing external Cl- ions also allowed for fast endocytosis. Elevating internal Cl- via the patch pipette invariably slowed endocytosis, even in terminals dialyzed with increased Ca2+ buffer. These results suggest a new role for GABA and Cl- ions in blocking the trigger for fast enclocytosis at this ribbon-type synapse.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	von Gersdorff, H (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	vongersd@ohsu.edu		Hull, Court/0000-0002-0360-8367	NEI NIH HHS [R01 EY014043] Funding Source: Medline; NINDS NIH HHS [F31 NS042506] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS042506] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; Brodin L, 1997, EUR J NEUROSCI, V9, P2503, DOI 10.1111/j.1460-9568.1997.tb01679.x; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Chan SA, 2003, J PHYSIOL-LONDON, V553, P707, DOI 10.1113/jphysiol.2003.053918; Chen Q, 1998, MOL PHARMACOL, V53, P564, DOI 10.1124/mol.53.3.564; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; D'Amico S, 2000, GENE, V253, P95, DOI 10.1016/S0378-1119(00)00229-8; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; De Camilli P, 2001, SYNAPSES, P217; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; Guatimosim C, 2002, J NEUROCHEM, V82, P1047, DOI 10.1046/j.1471-4159.2002.01029.x; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LANIUS RA, 1993, MOL BRAIN RES, V20, P192, DOI 10.1016/0169-328X(93)90041-M; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Lukasiewicz PD, 1998, J NEUROPHYSIOL, V79, P3157, DOI 10.1152/jn.1998.79.6.3157; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MATTHEWS G, 1994, J NEUROSCI, V14, P1079, DOI 10.1523/JNEUROSCI.14-03-01079.1994; McGillem GS, 2000, VISUAL NEUROSCI, V17, P381, DOI 10.1017/S0952523800173067; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Morgan JR, 2002, NEUROMOL MED, V2, P101, DOI 10.1385/NMM:2:2:101; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; Paillart C, 2003, J NEUROSCI, V23, P4092; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Protti DA, 1998, J NEUROSCI, V18, P3715; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rouze NC, 1998, J NEUROSCI, V18, P8614; RUPNIK M, 1995, PFLUG ARCH EUR J PHY, V431, P76, DOI 10.1007/BF00374379; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; SHERRY DM, 1993, J COMP NEUROL, V329, P188, DOI 10.1002/cne.903290204; Singer JH, 2003, J NEUROSCI, V23, P10923; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; Teng HB, 2003, J PHYSIOL-LONDON, V551, P103, DOI 10.1113/jphysiol.2003.041152; Thoreson WB, 2000, VISUAL NEUROSCI, V17, P197, DOI 10.1017/S0952523800172025; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Vu TQ, 2000, J NEUROSCI, V20, P1414; WITKOVSKY P, 1969, Z ZELLFORSCH MIK ANA, V100, P60, DOI 10.1007/BF00343821; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Yao PJ, 2002, J COMP NEUROL, V447, P152, DOI 10.1002/cne.10217; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zhang B, 1999, NEURON, V23, P419, DOI 10.1016/S0896-6273(00)80794-1	79	45	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					469	482		10.1016/j.neuron.2004.10.010	http://dx.doi.org/10.1016/j.neuron.2004.10.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504327	Green Accepted, Bronze			2022-12-28	WOS:000224771700009
J	Matthews, G				Matthews, G			Cycling the synapse: Scenic versus direct routes for vesicles	NEURON			English	Editorial Material							FROG NEUROMUSCULAR-JUNCTION; RIBBON SYNAPSE; FUSION PORE; MEMBRANE RETRIEVAL; EXOCYTOSIS; TERMINALS; TRANSMITTER; DYNAMICS; MODES; POOL	What happens to synaptic vesicles after they release their neurotransmitter content? Recent work on a variety of synaptic systems shows that there is no single answer to this question. Rather, it seems that neurons use a variety of methods to retrieve and reuse synaptic vesicles after they have undergone exocytosis. The challenge now is to establish the molecular mechanisms and to decipher the rules that govern which cycling pathway is used in a given functional context.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Matthews, G (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	gary.g.matthews@sunysb.edu						Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Paillart C, 2003, J NEUROSCI, V23, P4092; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	20	14	14	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					223	226		10.1016/j.neuron.2004.09.025	http://dx.doi.org/10.1016/j.neuron.2004.09.025			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473962	Bronze			2022-12-28	WOS:000224635800006
J	Dolcos, F; LaBar, KS; Cabeza, R				Dolcos, F; LaBar, KS; Cabeza, R			Interaction between the amygdala and the medial temporal lobe memory system predicts better memory for emotional events	NEURON			English	Article							DECLARATIVE MEMORY; FREE-RECALL; LONG-TERM; HIPPOCAMPAL; CONSOLIDATION; AROUSAL; CORTEX; TASK; TEMPOROPOLAR; MODULATION	Emotional events are remembered better than neutral events possibly because the amygdala enhances the function of medial temporal lobe (MTL) memory system (modulation hypothesis). Although this hypothesis has been supported by much animal research, evidence from humans has been scarce and indirect. We investigated this issue using event-related fMRI during encoding of emotional and neutral pictures. Memory performance after scanning showed a retention advantage for emotional pictures. Successful encoding activity in the amygdala and MTL memory structures was greater and more strongly correlated for emotional than for neutral pictures. Moreover, a double dissociation was found along the longitudinal axis of the MTL memory system: activity in anterior regions predicted memory for emotional items, whereas activity in posterior regions predicted memory for neutral items. These results provide direct evidence for the modulation hypothesis in humans and reveal a functional specialization within the MTL regarding the effects of emotion on memory formation.	Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2S2, Canada; Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA	University of Alberta; Duke University	Dolcos, F (corresponding author), Duke Univ, Brain Imaging & Anal Ctr, POB 3918, Durham, NC 27710 USA.	fdolcos@duke.edu	Dolcos, Florin/GZL-8448-2022	Dolcos, Florin/0000-0003-2230-4139	NATIONAL INSTITUTE ON AGING [R01AG019731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014094] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG19731, R01 AG019731] Funding Source: Medline; NIDA NIH HHS [R01 DA14094] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2000, LEARN MEMORY, V7, P180, DOI 10.1101/lm.7.3.180; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; AMARAL D G, 1992, P1; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brierley B, 2002, BRAIN RES REV, V39, P84, DOI 10.1016/S0165-0173(02)00160-1; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Cahill L, 1998, Adv Pharmacol, V42, P964; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Canli T, 2000, J NEUROSCI, V20; Christianson SA., 1992, HDB EMOTION MEMORY R; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Dolcos F, 2002, COGN AFFECT BEHAV NE, V2, P252, DOI 10.3758/CABN.2.3.252; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jha AP, 2000, J COGNITIVE NEUROSCI, V12, P90, DOI 10.1162/089892900564091; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Shields S.A, 1991, INT REV STUDIES EMOT, P227; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Strange BA, 2002, J NEUROSCI, V22, P523, DOI 10.1523/JNEUROSCI.22-02-00523.2002; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499	52	493	513	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					855	863		10.1016/S0896-6273(04)00289-2	http://dx.doi.org/10.1016/S0896-6273(04)00289-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182723	Bronze			2022-12-28	WOS:000221975000015
J	Hughes, SW; Lorincz, M; Cope, DW; Blethyn, KL; Kekesi, KA; Parri, HR; Juhasz, G; Crunelli, V				Hughes, SW; Lorincz, M; Cope, DW; Blethyn, KL; Kekesi, KA; Parri, HR; Juhasz, G; Crunelli, V			Synchronized oscillations at alpha and theta frequencies in the lateral geniculate nucleus	NEURON			English	Article							NEURONS IN-VITRO; THALAMOCORTICAL NEURONS; PYRAMIDAL NEURONS; ELECTRICAL SYNAPSES; CORTICAL-NEURONS; METABOLIC-RATE; ION CHANNELS; NEOCORTEX; RHYTHMS; NETWORKS	In relaxed wakefulness, the EEG exhibits robust rhythms in the a band (8-13 Hz), which decelerate to theta (similar to2-7 Hz) frequencies during early sleep. In animal models, these rhythms occur coherently with synchronized activity in the thalamus. However, the mechanisms of this thalamic activity are unknown. Here we show that, in slices of the lateral geniculate nucleus maintained in vitro, activation of the metabotropic glutamate receptor (mGluR) mGluR1 a induces synchronized oscillations at alpha and theta frequencies that share similarities with thalamic alpha and theta rhythms recorded in vivo. These in vitro oscillations are driven by an unusual form of burst firing that is present in a subset of thalamocortical neurons and are synchronized by gap junctions. We propose that mGluR1a-induced oscillations are a potential mechanism whereby the thalamus promotes EEG alpha and theta rhythms in the intact brain.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; Hungarian Acad Sci, Res Grp Neurobiol, H-1117 Budapest, Hungary	Cardiff University; Hungarian Academy of Sciences	Hughes, SW (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales.	hughessw@cardiff.ac.uk	Crunelli, Vincenzo/A-7258-2010; Juhász, Gábor/I-7781-2017; Kékesi, Katalin Adrienna A/H-3484-2017; Lőrincz, Magor L/C-7746-2012; Parri, Rheinallt/D-1748-2013	Juhász, Gábor/0000-0002-0849-6931; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Lőrincz, Magor L/0000-0001-5240-1904; Hughes, Stuart/0000-0003-0423-777X; Crunelli, Vincenzo/0000-0001-7154-9752; Parri, Rheinallt/0000-0002-1412-2688				Amzica F, 1998, NEUROSCIENCE, V82, P671; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Berger H, 1935, ARCH PSYCHIAT NERVEN, V103, P444, DOI 10.1007/BF02024891; Berman AL, 1982, THALAMUS BASAL TELEN; BOUYER JJ, 1982, ARCH ITAL BIOL, V120, P95; BOUYER JJ, 1983, ELECTROEN CLIN NEURO, V55, P180, DOI 10.1016/0013-4694(83)90186-4; Brumberg JC, 2000, J NEUROSCI, V20, P4829; BUZSAKI G, 1991, NEUROSCIENCE, V41, P351, DOI 10.1016/0306-4522(91)90332-I; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CHATILA M, 1993, CR ACAD SCI III-VIE, V316, P51; CYMBALYUK GS, 1994, BIOL CYBERN, V71, P153, DOI 10.1007/BF00197318; Danos P, 2001, NEUROPSYCHOBIOLOGY, V43, P265, DOI 10.1159/000054901; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Godwin DW, 1996, J NEUROSCI, V16, P8181; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Hughes SW, 2002, NEUROSCIENCE, V110, P395, DOI 10.1016/S0306-4522(01)00577-2; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JUHASZ G, 1985, BRAIN RES BULL, V15, P437, DOI 10.1016/0361-9230(85)90032-2; Kanamori N, 1993, Int J Neurosci, V68, P117; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Liley DTJ, 1999, NETWORK-COMP NEURAL, V10, P79, DOI 10.1088/0954-898X/10/1/005; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Niedermeyer E, 1993, ELECTROENCEPHALOGRAP, P97; NIEDERMEYER E, 1993, ELECTROENCEPHALOGRAP, P153; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; Rozental R, 2001, METH MOL B, V154, P447; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Traub RD, 2000, J NEUROSCI, V20, P2086; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Williams SR, 2000, J NEUROSCI, V20, P1307; Zhan XJ, 2000, J NEUROSCI, V20, P3909, DOI 10.1523/JNEUROSCI.20-10-03909.2000; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P702, DOI 10.1152/jn.1999.81.2.702	48	194	201	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					253	268		10.1016/S0896-6273(04)00191-6	http://dx.doi.org/10.1016/S0896-6273(04)00191-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091341	Bronze			2022-12-28	WOS:000221458500010
J	Uka, T; DeAngelis, GC				Uka, T; DeAngelis, GC			Contribution of area MT to stereoscopic depth perception: Choice-related response modulations reflect task strategy	NEURON			English	Article							STRUCTURE-FROM-MOTION; ATTENTIONAL MODULATION; NEURONAL-ACTIVITY; VISUAL AREA; MONKEY; DECISION; SIGNALS; CORTEX; SENSITIVITY; STRIATE	Due to the diversity of tuning properties in sensory cortex, only a fraction of neurons are engaged in a particular task. Characterizing the tuning properties of neurons that are functionally linked to behavior is essential for understanding how activity is "read out" from sensory maps to guide decisions. We recorded from middle temporal (MT) neurons while monkeys performed a depth discrimination task, and we characterized the linkage between MT responses and behavioral choices. Trial-to-trial response fluctuations of MT neurons with odd-symmetric ("Near," "Far") disparity tuning were predictive of monkeys' choices, whereas responses of neurons with even-symmetric tuning were not. This result cannot be explained by neuronal sensitivity or any other response property of MT neurons that we examined but is simply explained by the task strategy that monkeys learned during training. We suggest that this approach provides a physiological means to explore how task strategies are implemented in the brain.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	gregd@cabernet.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273	NATIONAL EYE INSTITUTE [R01EY013644] Funding Source: NIH RePORTER; NEI NIH HHS [EY-013644] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Basso MA, 1998, J NEUROSCI, V18, P7519; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Grunewald A, 2002, J NEUROSCI, V22, P6195; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; SCHILLER PH, 1976, BRAIN RES, V105, P347, DOI 10.1016/0006-8993(76)90432-7; Seidemann E, 1998, NATURE, V394, P72, DOI 10.1038/27906; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Uka T, 2003, J NEUROSCI, V23, P3515; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	34	159	159	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					297	310		10.1016/S0896-6273(04)00186-2	http://dx.doi.org/10.1016/S0896-6273(04)00186-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091344	Bronze			2022-12-28	WOS:000221458500013
J	Solomon, SG; Peirce, JW; Dhruv, NT; Lennie, P				Solomon, SG; Peirce, JW; Dhruv, NT; Lennie, P			Profound contrast adaptation early in the visual pathway	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; TEMPORAL CONTRAST; GAIN-CONTROL; CORTICAL-NEURONS; MACAQUE; CORTEX; CAT; RESPONSES; PRIMATE	Prior exposure to a moving grating of high contrast led to a substantial and persistent reduction in the contrast sensitivity of neurons in the lateral geniculate nucleus (LGN) of macaque. This slow contrast adaptation was potent in all magnocellular (M) cells but essentially absent in parvocellular (P) cells and neurons that received input from S cones. Simultaneous recordings of M cells and the potentials of ganglion cells driving them showed that adaptation originated in ganglion cells. As expected from the spatiotemporal tuning of M cells, adaptation was broadly tuned for spatial frequency and lacked orientation selectivity. Adaptation could be induced by high temporal frequencies to which cortical neurons do not respond, but not by low temporal frequencies that can strongly adapt cortical neurons. Our observations confirm that contrast adaptation occurs at multiple levels in the visual system, and they provide a new way to reveal the function and perceptual significance of the M pathway.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Lennie, P (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	pl@cns.nyu.edu	Solomon, Samuel/C-8779-2009; Peirce, Jonathan Westley/AAA-8603-2020; Peirce, Jonathan/B-1807-2008	Peirce, Jonathan Westley/0000-0002-9504-4342; Peirce, Jonathan/0000-0002-9504-4342; Solomon, Samuel/0000-0001-5321-0288; Lennie, Peter/0000-0002-2561-6368; Dhruv, Neel/0000-0001-7112-8501	NEI NIH HHS [EY 13079, EY 04440] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004440, R37EY004440, P30EY013079] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Benardete EA, 1997, VISUAL NEUROSCI, V14, P187, DOI 10.1017/S0952523800008865; BISHOP PO, 1962, J PHYSIOL-LONDON, V162, P451, DOI 10.1113/jphysiol.1962.sp006944; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; Forte J, 2002, VISUAL NEUROSCI, V19, P31, DOI 10.1017/S0952523801191030; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Green DM, 1966, SIGNAL DETECTION THE; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; KAPLAN E, 1984, EXP BRAIN RES, V55, P111; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; KELLY DH, 1987, VISION RES, V27, P1527, DOI 10.1016/0042-6989(87)90161-1; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SHADY S, 2004, IN PRESS P NATL ACAD; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SMIMAKIS SM, 1997, NATURE, V386, P69; Solomon SG, 2004, J NEUROSCI, V24, P148, DOI 10.1523/JNEUROSCI.3036-03.2004; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; TROY JB, 1994, VISUAL NEUROSCI, V11, P111, DOI 10.1017/S0952523800011159	37	216	218	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					155	162		10.1016/S0896-6273(04)00178-3	http://dx.doi.org/10.1016/S0896-6273(04)00178-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066272	Green Published, Bronze			2022-12-28	WOS:000221458400015
J	Fadool, DA; Tucker, K; Perkins, R; Fasciani, G; Thompson, RN; Parsons, AD; Overton, JM; Koni, PA; Flavell, RA; Kaczmarek, LK				Fadool, DA; Tucker, K; Perkins, R; Fasciani, G; Thompson, RN; Parsons, AD; Overton, JM; Koni, PA; Flavell, RA; Kaczmarek, LK			Kv1.3 channel gene-targeted deletion produces "super-smeller mice" with altered glomeruli, interacting scaffolding proteins, and biophysics	NEURON			English	Article							GATED POTASSIUM CHANNELS; OLFACTORY-BULB; TYROSINE PHOSPHORYLATION; K+ CHANNELS; NEUROTROPHIC FACTOR; MODULATION; RAT; SUPPRESSION; FAMILY; EXPRESSION	Mice with gene-targeted deletion of the Kv1.3 channel were generated to study its role in olfactory function. Potassium currents in olfactory bulb mitral cells from Kv1.3 null mice have slow inactivation kinetics, a modified voltage dependence, and a dampened C-type inactivation and fail to be modulated by activators of receptor tyrosine signaling cascades. Kv1.3 deletion increases expression of scaffolding proteins that normally regulate the channel through protein-protein interactions. Kv1.3(-/-) mice have a 1,000- to 10,000-fold lower threshold for detection of odors and an increased ability to discriminate between odorants. In accordance with this heightened sense of smell, Kv1.3(-/-) mice have glomeruli or olfactory coding units that are smaller and more numerous than those of wild-type mice. These data suggest that Kv1.3 plays a far more reaching role in signal transduction, development, and olfactory coding than that of the classically defined role of a potassium channel-to shape excitability by influencing membrane potential.	Florida State Univ, Program Neurosci, Dept Sci Biol, Tallahassee, FL 32306 USA; Florida State Univ, Program Mol Biophys, Dept Sci Biol, Tallahassee, FL 32306 USA; Florida State Univ, Biomed Res Facil, Dept Sci Biol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University	Fadool, DA (corresponding author), Florida State Univ, Program Neurosci, Dept Sci Biol, Tallahassee, FL 32306 USA.	dfadool@bio.fsu.edu	Koni, Pandelakis/A-3349-2008	Koni, Pandelakis/0000-0002-0892-4764	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003387, R01DC001919, R01DC003387] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03387, DC01919, R01 DC003387, R01 DC003387-07A1, R01 DC001919, R29 DC003387] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Colacicco G, 2002, BEHAV BRAIN RES, V132, P95, DOI 10.1016/S0166-4328(01)00391-6; Collins NH, 2001, CYTOTHERAPY, V3, P1, DOI 10.1080/146532401753156331; Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Holmes TC, 1996, J NEUROSCI, V16, P1581; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Holmes TC, 1997, J NEUROSCI, V17, P8964; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Koni PA, 2003, J BIOL CHEM, V278, P39443, DOI 10.1074/jbc.M304879200; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Kourrich S, 2001, BEHAV BRAIN RES, V120, P35, DOI 10.1016/S0166-4328(00)00356-9; LAMANTIA AS, 1992, J NEUROSCI, V12, P976; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; MAROM S, 1994, BIOPHYS J, V67, P579, DOI 10.1016/S0006-3495(94)80517-X; McFarlane S, 2000, J NEUROSCI, V20, P1020, DOI 10.1523/JNEUROSCI.20-03-01020.2000; MEISAMI E, 1981, BRAIN RES, V221, P81, DOI 10.1016/0006-8993(81)91065-9; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagao H, 2002, MICROSC RES TECHNIQ, V58, P168, DOI 10.1002/jemt.10146; Nitabach MN, 2002, J NEUROSCI, V22, P7913; POMEROY SL, 1990, J NEUROSCI, V10, P1952; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rogalski SL, 2000, J BIOL CHEM, V275, P25082, DOI 10.1074/jbc.M000183200; Royal SJ, 1999, J NEUROSCI, V19, P9856; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Scannevin RH, 1997, BIOCHEM BIOPH RES CO, V232, P585, DOI 10.1006/bbrc.1997.6333; Schaefer ML, 2001, J COMP NEUROL, V436, P351; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Williams TD, 2003, PHYSIOL BEHAV, V78, P615, DOI 10.1016/S0031-9384(03)00049-0; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Xu JC, 2003, HUM MOL GENET, V12, P551, DOI 10.1093/hmg/ddg049; Yee KK, 2001, PHYSIOL BEHAV, V72, P705, DOI 10.1016/S0031-9384(01)00428-0; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	49	131	133	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					389	404		10.1016/S0896-6273(03)00844-4	http://dx.doi.org/10.1016/S0896-6273(03)00844-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766178	Green Accepted, Bronze			2022-12-28	WOS:000221457900010
J	Ramaswami, M				Ramaswami, M			Specifying the age-sensitive component of a short-term memory	NEURON			English	Editorial Material							DROSOPHILA	Cognitive decline that accompanies aging is believed to arise from alterations in several neuronal mechanisms and neural systems. In this issue of Neuron, Tamura and colleagues make the remarkable observation that age specifically diminishes middle-term memory in Drosophila, a memory phase dependent on expression of the amnesiac gene.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Ramaswami, M (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Box 210106, Tucson, AZ 85721 USA.			Ramaswami, Mani/0000-0001-7631-0468				Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tully T, 1996, COLD SPRING HARB SYM, V61, P207; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	12	1	1	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					877	879		10.1016/S0896-6273(03)00759-1	http://dx.doi.org/10.1016/S0896-6273(03)00759-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659086	Bronze			2022-12-28	WOS:000187042200004
J	Beggs, HE; Schahin-Reed, D; Zang, KL; Goebbels, S; Nave, KA; Gorski, J; Jones, KR; Sretavan, D; Reichardt, LF				Beggs, HE; Schahin-Reed, D; Zang, KL; Goebbels, S; Nave, KA; Gorski, J; Jones, KR; Sretavan, D; Reichardt, LF			FAK deficiency in cells contributing to the basal lamina results in cortical abnormalities resembling congenital muscular dystrophies	NEURON			English	Article							FOCAL ADHESION KINASE; CENTRAL-NERVOUS-SYSTEM; TYROSINE PHOSPHORYLATION; NEURONAL MIGRATION; MATRIX METALLOPROTEINASES; MENINGEAL CELLS; ECTOPIC EXPRESSION; ALPHA-6 INTEGRINS; BETA-DYSTROGLYCAN; BASEMENT-MEMBRANE	Targeted deletion of focal adhesion kinase (fak) in the developing dorsal forebrain resulted in local disruptions of the cortical basement membrane located between the neuroepithelium and pia-meninges. At disruption sites, clusters of neurons invaded the marginal zone. Retraction of radial glial endfeet, midline fusion of brain hemispheres, and gliosis also occurred, similar to type II cobblestone lissencephaly as seen in congenital muscular dystrophy. Interestingly, targeted deletion of fak in neurons alone did not result in cortical ectopias, indicating that fak deletion from glia is required for neuronal mislocalization. Unexpectedly, fak deletion specifically from meningeal fibroblasts elicited similar cortical ectopias in vivo and altered laminin organization in vitro. These observations provide compelling evidence that FAK plays a key signaling role in cortical basement membrane assembly and/or remodeling. In addition, FAK is required within neurons during development because neuron-specific fak deletion alters dendritic morphology in the absence of lamination defects.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Max Planck Society; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Beggs, HE (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA.		Nave, Klaus-Armin/C-8883-2011	JONES, KEVIN/0000-0002-3802-7562	NATIONAL EYE INSTITUTE [R01EY010688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090, F32NS011033] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY10688] Funding Source: Medline; NINDS NIH HHS [R01 NS019090-25, R01 NS11033, F32 NS011033, R01 NS19090, R01 NS019090] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5; Bagri A, 2002, DEVELOPMENT, V129, P4249; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Contestabile A, 2003, INT J DEV NEUROSCI, V21, P83, DOI 10.1016/S0736-5748(02)00126-0; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FURUTA Y, 1995, ONCOGENE, V11, P1989; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gorski JA, 2002, J NEUROSCI, V22, P6309; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; Halfter W, 2002, J NEUROSCI, V22, P6029; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Henry MD, 2001, J CELL SCI, V114, P1137; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Leppert D, 2001, BRAIN RES REV, V36, P249, DOI 10.1016/S0165-0173(01)00101-1; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Ligon KL, 2003, DEVELOPMENT, V130, P2275, DOI 10.1242/dev.00421; Lohikangas L, 2001, EXP CELL RES, V265, P135, DOI 10.1006/excr.2001.5170; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; MARIN O, 2003, ANN REV NEUROSC 0226; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ren XD, 2000, J CELL SCI, V113, P3673; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SANDERSON RD, 1986, J CELL BIOL, V102, P740, DOI 10.1083/jcb.102.3.740; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867; SIEVERS J, 1986, NATURWISSENSCHAFTEN, V73, P188, DOI 10.1007/BF00417722; Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yamamoto T, 1999, PEDIATR NEUROL, V20, P31, DOI 10.1016/S0887-8994(98)00089-7; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	69	242	246	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					501	514		10.1016/S0896-6273(03)00666-4	http://dx.doi.org/10.1016/S0896-6273(03)00666-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642275	Green Accepted, Bronze			2022-12-28	WOS:000186379000010
J	Ormond, J; Hislop, J; Zhao, YL; Webb, N; Vaillaincourt, F; Dyer, JR; Ferraro, G; Barker, P; Martin, KC; Sossin, WS				Ormond, J; Hislop, J; Zhao, YL; Webb, N; Vaillaincourt, F; Dyer, JR; Ferraro, G; Barker, P; Martin, KC; Sossin, WS			ApTrkl, a Trk-like receptor, mediates serotonin-dependent ERK activation and long-term facilitation in Aplysia sensory neurons	NEURON			English	Article							PROTEIN-KINASE-C; SENSORIMOTOR SYNAPSES; SYNAPTIC PLASTICITY; COUPLED RECEPTORS; TYROSINE KINASES; MEMORY STORAGE; EGF RECEPTOR; GROWTH; TRANSACTIVATION; BINDING	The Trk family of receptor tyrosine kinases plays a role in synaptic plasticity and in behavioral memory in mammals. Here, we report the discovery of a Trk-like receptor, ApTrkl, in Aplysia. We show that it is expressed in the sensory neurons, the locus for synaptic facilitation, which is a cellular model for memory formation. Serotonin, the facilitatory neurotransmitter, activates ApTrkl, which, in turn, leads to activation of ERK. Finally, inhibiting the activation of ApTrkl with the Trk inhibitor K252a or using dsRNA to inhibit ApTrkl blocks the serotonin-mediated activation of ERK in the cell body, as well as the cell-wide long-term facilitation induced by 5-HT application to the cell body. Thus, transactivation of the receptor tyrosine kinase ApTrkl by serotonin is an essential step in the biochemical events leading to long-term facilitation in Aplysia.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Univ Calif Los Angeles, Dept Psychiat Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	McGill University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ Ave, Montreal, PQ H3A 2B4, Canada.	wayne.sossin@mcgill.ca		Hislop, Jonathan/0000-0002-5566-183X				Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bhakar AL, 1999, J BIOL CHEM, V274, P21443, DOI 10.1074/jbc.274.30.21443; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dyer JR, 2003, NEUROSCIENCE, V116, P13, DOI 10.1016/S0306-4522(02)00566-3; Dyer JR, 1998, J BIOL CHEM, V273, P29469, DOI 10.1074/jbc.273.45.29469; HASHIMOTO Y, 1991, BIOCHEM BIOPH RES CO, V181, P423, DOI 10.1016/S0006-291X(05)81436-6; Hu JY, 2004, NEURON, V43, P373, DOI 10.1016/j.neuron.2004.07.011; Hu JY, 2003, J NEUROSCI, V23, P1804; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Manseau F, 2001, J NEUROSCI, V21, P1247; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McKay SE, 2001, MOL CELL NEUROSCI, V17, P821, DOI 10.1006/mcne.2001.0977; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; Moreno M, 1998, P NATL ACAD SCI USA, V95, P14997, DOI 10.1073/pnas.95.25.14997; Nakhost A, 1999, J BIOL CHEM, V274, P28944, DOI 10.1074/jbc.274.41.28944; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Purcell AL, 2003, NEURON, V37, P473, DOI 10.1016/S0896-6273(03)00030-8; Purcell AL, 2001, J NEUROPHYSIOL, V85, P2398, DOI 10.1152/jn.2001.85.6.2398; Steffensen I, 1995, INVERTEBR NEUROSCI, V1, P207, DOI 10.1007/BF02211022; Sun ZY, 1998, J NEUROSCI, V18, P3991; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; TAPLEY P, 1992, ONCOGENE, V7, P371; van Kesteren RE, 1998, EMBO J, V17, P2534, DOI 10.1093/emboj/17.9.2534; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yanow SK, 1998, J NEUROCHEM, V70, P572; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000	39	46	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					715	728		10.1016/j.neuron.2004.11.001	http://dx.doi.org/10.1016/j.neuron.2004.11.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541318	Bronze, Green Submitted			2022-12-28	WOS:000225338100016
J	Keene, AC; Stratmann, M; Keller, A; Perrat, PN; Vosshall, LB; Waddell, S				Keene, AC; Stratmann, M; Keller, A; Perrat, PN; Vosshall, LB; Waddell, S			Diverse odor-coonditioned memories require uniquely timed dorsa paired medial neuron output	NEURON			English	Article							PUTATIVE PHEROMONE RECEPTORS; CANDIDATE TASTE RECEPTORS; SHORT-TERM-MEMORY; DROSOPHILA-MELANOGASTER; MUSHROOM BODIES; CHOLINE-ACETYLTRANSFERASE; SYNAPTIC-TRANSMISSION; GENE-EXPRESSION; PREFERENTIAL EXPRESSION; DEFENSIVE SECRETION	Amnesiac mutant flies have an olfactory memory defect. The amn gene encodes a homolog of vertebrate pituitary adenylate cyclase-activating peptide (PACAP), and it is strongly expressed in dorsal paired medial (DPM) neurons. DPM neurons ramify throughout the mushroom bodies in the adult fly brain, and they are required for stable memory. Here, we show that DPM neuron output is only required during the consolidation phase for middle-term odor memory and is dispensable during acquisition and recall. However, we found that DPM neuron output is required during acquisition of a benzaldehyde odor memory. We show that flies sense benzaldehyde by the classical olfactory and a noncanonical route. These results suggest that DPM neurons are required to consolidate memory and are differently involved in memory of a volatile that requires multisensory integration.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	University of Massachusetts System; University of Massachusetts Worcester; Rockefeller University	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@umassmed.edu		Keller, Andreas/0000-0001-5491-2214; Vosshall, Leslie/0000-0002-6060-8099; Waddell, Scott/0000-0003-4503-6229	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH009883, F31MH073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005036] Funding Source: NIH RePORTER; NIDCD NIH HHS [5R01 DC05036-03] Funding Source: Medline; NIMH NIH HHS [F31 MH073311, F31 MH073311-02, MH09883-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BLUM MS, 1969, COMP BIOCHEM PHYSIOL, V29, P461, DOI 10.1016/0010-406X(69)91766-6; BOYNTON S, 1992, GENETICS, V131, P655; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; CHOI KW, 1991, J BIOL CHEM, V266, P15999; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; CONNER WE, 1977, EXPERIENTIA, V33, P206, DOI 10.1007/BF02124069; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DETTNER K, 1992, J APPL ENTOMOL, V113, P128, DOI 10.1111/j.1439-0418.1992.tb00646.x; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; DeZazzo J, 2000, NEURON, V27, P145, DOI 10.1016/S0896-6273(00)00016-7; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gleadow RM, 2002, J CHEM ECOL, V28, P1301, DOI 10.1023/A:1016298100201; GORCZYCA MG, 1987, J NEUROSCI, V7, P1361; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; GURANTZ D, 1994, J NEUROSCI, V14, P3540; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; Ito K, 1998, LEARN MEMORY, V5, P52; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KAWATANI M, 1985, SCIENCE, V229, P879, DOI 10.1126/science.3895438; Keller A, 2003, CURR OPIN NEUROBIOL, V13, P103, DOI 10.1016/S0959-4388(03)00011-4; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; KITAMOTO T, 1995, J NEUROBIOL, V28, P70, DOI 10.1002/neu.480280107; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu DM, 2000, EUR J NEUROSCI, V12, P2243, DOI 10.1046/j.1460-9568.2000.00116.x; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MARGIOTTA JF, 1995, MOL PHARMACOL, V48, P63; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; NAHRSTEDT A, 1988, CIBA F SYMP, V140, P131; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Preat T, 1998, J NEUROSCI, V18, P8534; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Roberto M, 2000, LEARN MEMORY, V7, P303, DOI 10.1101/lm.34200; Roberts HR, 2001, SEMIN HEMATOL, V38, P1; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; THOME N, 2004, CURR BIOL, V14, P1065; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1986, J NEUROGENET, V3, P33, DOI 10.3109/01677068609106893; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; ZHONG Y, 1995, NEURON, V14, P527, DOI 10.1016/0896-6273(95)90309-7	89	102	102	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					521	533		10.1016/j.neuron.2004.10.006	http://dx.doi.org/10.1016/j.neuron.2004.10.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504331				2022-12-28	WOS:000224771700013
J	Surmeier, DJ; Spruston, N				Surmeier, DJ; Spruston, N			Peering into the dendritic machinery of striatal medium spiny neurons	NEURON			English	Editorial Material							NMDA RECEPTORS; CALCIUM; ACTIVATION; CURRENTS; INFLUX		Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Surmeier, DJ (corresponding author), Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA.			Spruston, Nelson/0000-0003-3118-1636				Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chen Q, 1998, NEUROSCIENCE, V83, P749, DOI 10.1016/S0306-4522(97)00452-1; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Kerr JND, 2004, J NEUROSCI, V24, P877, DOI 10.1523/JNEUROSCI.4475-03.2004; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mermelstein PG, 1998, J NEUROSCI, V18, P6650; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; WILSON CJ, 1994, MICROSC RES TECHNIQ, V29, P368, DOI 10.1002/jemt.1070290507; Wilson CJ, 1996, J NEUROSCI, V16, P2397	13	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					401	402		10.1016/j.neuron.2004.10.021	http://dx.doi.org/10.1016/j.neuron.2004.10.021			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504319	Bronze			2022-12-28	WOS:000224771700001
J	Mi, RF; Sia, GM; Rosen, K; Tang, XP; Moghekar, A; Black, JL; McEnery, M; Huganir, RL; O'Brien, RJ				Mi, RF; Sia, GM; Rosen, K; Tang, XP; Moghekar, A; Black, JL; McEnery, M; Huganir, RL; O'Brien, RJ			AMPA receptor-dependent clustering of synaptic NMDA receptors is mediated by stargazin and NR2A/B in spinal neurons and hippocampal interneurons	NEURON			English	Article							POSTSYNAPTICALLY SILENT SYNAPSES; EXCITATORY SYNAPSES; GLUTAMATERGIC SYNAPSES; DENDRITIC SPINES; SUBUNIT GENE; PLASTICITY; PROTEIN; EXPRESSION; LOCALIZATION; MECHANISMS	Under standard conditions, cultured ventral spinal neurons cluster AMPA- but not NMDA-type glutamate receptors at excitatory synapses on their dendritic shafts in spite of abundant expression of the ubiquitous NMDA receptor subunit NRII. We demonstrate here that the NMDA receptor subunits NR2A and NR2B are not routinely expressed in cultured spinal neurons and that transfection with NR2A or NR2B reconstitutes the synaptic targeting of NMDA receptors and confers on exogenous application of the immediate early gene product Narp the ability to cluster both AMPA and NMDA receptors. The use of dominant-negative mutants of GluR2 further showed that the synaptic targeting of NMDA receptors is dependent on the presence of synaptic AMPA receptors and that synaptic AMPA and NMDA receptors are linked by Stargazin and a MAGUK protein. This system of AMPA receptor-dependent synaptic NMDA receptor localization was preserved in hippocampal interneurons but reversed in hippocampal pyramidal neurons.	Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Tufts Univ, Sch Med, Dept Neurol, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA; Mayo Clin & Mayo Grad Sch Med, Dept Psychiat & Psychol, Rochester, MN 55905 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; St. Elizabeth's Medical Center; Tufts University; Mayo Clinic; Case Western Reserve University	O'Brien, RJ (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA.	robrien@jhmi.edu		Sia, Gek Ming/0000-0001-9333-0065	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037694] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS037694] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi SY, 2004, J NEUROCHEM, V88, P708, DOI 10.1046/j.1471-4159.2003.02187.x; Cutforth T, 2002, TRENDS NEUROSCI, V25, P332, DOI 10.1016/S0166-2236(02)02187-2; Desai A, 2002, J BIOL CHEM, V277, P46374, DOI 10.1074/jbc.M203032200; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KALB RG, 1992, P NATL ACAD SCI USA, V89, P8502, DOI 10.1073/pnas.89.18.8502; KONNERTH A, 1990, PFLUG ARCH EUR J PHY, V417, P285, DOI 10.1007/BF00370994; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Mammen AL, 1997, J NEUROSCI, V17, P7351; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; Mi RF, 2002, J NEUROSCI, V22, P7606; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Rao A, 1998, J NEUROSCI, V18, P1217; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sasner M, 1996, J BIOL CHEM, V271, P21316, DOI 10.1074/jbc.271.35.21316; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tao YX, 2003, J NEUROSCI, V23, P6703; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; ZISKINDCONHAIM L, 1990, J NEUROSCI, V10, P125	51	31	34	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					335	349		10.1016/j.neuron.2004.09.029	http://dx.doi.org/10.1016/j.neuron.2004.09.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473971	Bronze			2022-12-28	WOS:000224635800015
J	Schacter, DL; Slotnick, SD				Schacter, DL; Slotnick, SD			The cognitive neuroscience of memory distortion	NEURON			English	Review							FRONTAL-LOBE DAMAGE; PERCEPTUAL FALSE RECOGNITION; EVENT-RELATED FMRI; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; BRAIN POTENTIALS; AMNESIC PATIENTS; ILLUSORY RECOGNITION; OLDER-ADULTS; VISUAL INFORMATION	Memory distortion occurs in the laboratory and in everyday life. This article focuses on false recognition, a common type of memory distortion in which individuals incorrectly claim to have encountered a novel object or event. By considering evidence from neuropsychology, neuroimaging, and electrophysiology, we address three questions. (1) Are there patterns of neural activity that can distinguish between true and false recognition? (2) Which brain regions contribute to false recognition? (3) Which brain regions play a role in monitoring or reducing false recognition? Neuroimaging and electrophysiological studies suggest that sensory activity is greater for true recognition compared to false recognition. Neuropsychological and neuroimaging results indicate that the hippocampus and several cortical regions contribute to false recognition. Evidence from neuropsychology, neuroimaging, and electrophysiology implicates the prefrontal cortex in retrieval monitoring that can limit the rate of false recognition.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Schacter, DL (corresponding author), Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA.	dls@wjh.harvard.edu		Schacter, Daniel/0000-0002-2460-6061	NIA NIH HHS [AG08441] Funding Source: Medline; NIMH NIH HHS [MH-NS60941] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008441, R01AG008441] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBA JW, 1983, PSYCHOL BULL, V93, P203, DOI 10.1037/0033-2909.93.2.203; Arndt J, 2003, J MEM LANG, V48, P1, DOI 10.1016/S0749-596X(02)00518-1; Balota DA, 1999, J INT NEUROPSYCH SOC, V5, P626, DOI 10.1017/S1355617799577060; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; BRAINERD CJ, 1993, PSYCHOL REV, V100, P42, DOI 10.1037/0033-295X.100.1.42; Brainerd CJ, 2003, J MEM LANG, V48, P445, DOI 10.1016/S0749-596X(02)00501-6; Brainerd CJ, 1998, PSYCHOL SCI, V9, P484, DOI 10.1111/1467-9280.00089; Budson AE, 2000, NEUROPSYCHOLOGY, V14, P277, DOI 10.1037//0894-4105.14.2.277; Budson AE, 2003, BRAIN COGNITION, V51, P251, DOI 10.1016/S0278-2626(03)00030-7; Budson AE, 2002, BRAIN, V125, P2750, DOI 10.1093/brain/awf277; Budson AE, 2001, NEUROPSYCHOLOGY, V15, P230, DOI 10.1037/0894-4105.15.2.230; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Curran T, 2001, J COGNITIVE NEUROSCI, V13, P201, DOI 10.1162/089892901564261; Curran T, 1997, NEUROPSYCHOLOGIA, V35, P1035, DOI 10.1016/S0028-3932(97)00029-8; Curran T, 2003, COGNITIVE BRAIN RES, V15, P191, DOI 10.1016/S0926-6410(02)00192-1; Dab S, 1999, COGN NEUROPSYCHOL, V16, P215, DOI 10.1080/026432999380771; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; DELBECQDEROUESNE J, 1990, BRAIN, V113, P1045, DOI 10.1093/brain/113.4.1045; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Endl W, 1999, NEUROSCI LETT, V265, P115, DOI 10.1016/S0304-3940(99)00217-7; Fabiani M, 2000, J COGNITIVE NEUROSCI, V12, P941, DOI 10.1162/08989290051137486; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gallo DA, 2001, PSYCHON B REV, V8, P579, DOI 10.3758/BF03196194; Goldmann RE, 2003, NEUROREPORT, V14, P1717, DOI 10.1097/00001756-200309150-00012; Gonsalves B, 2000, NAT NEUROSCI, V3, P1316, DOI 10.1038/81851; GONSALVES B, 2004, IN PRESS PSYCHOL SCI; Gratton G, 1997, J COGNITIVE NEUROSCI, V9, P92, DOI 10.1162/jocn.1997.9.1.92; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Johnson M. K., 1991, AWARENESS DEFICIT BR, P176; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Koutstaal W, 2003, PSYCHOL SCI, V14, P189, DOI 10.1111/1467-9280.01441; Koutstaal W, 1999, COGNITIVE NEUROPSYCH, V16, P317, DOI 10.1080/026432999380816; LOFTUS EF, 1993, J EXP PSYCHOL GEN, V122, P274, DOI 10.1037/0096-3445.122.2.274; Mather M, 1997, MEM COGNITION, V25, P826, DOI 10.3758/BF03211327; Melo B, 1999, COGNITIVE NEUROPSYCH, V16, P343, DOI 10.1080/026432999380825; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MOSCOVITCH M, 1995, MEMORY DISTORTIONS M, P22; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nessler D, 2001, COGNITIVE BRAIN RES, V10, P283, DOI 10.1016/S0926-6410(00)00049-5; Neuschatz JS, 2003, J EXP PSYCHOL LEARN, V29, P35, DOI 10.1037/0278-7393.29.1.35; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Nyberg L, 2001, NEUROIMAGE, V14, P521, DOI 10.1006/nimg.2001.0801; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Okado Y, 2003, COGN AFFECT BEHAV NE, V3, P323, DOI 10.3758/CABN.3.4.323; Parkin AJ, 1999, COGN NEUROPSYCHOL, V16, P243, DOI 10.1080/026432999380780; Parkin AJ, 1996, BRAIN COGNITION, V32, P14, DOI 10.1006/brcg.1996.0055; Payne DG, 1996, J MEM LANG, V35, P261, DOI 10.1006/jmla.1996.0015; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; Rapcsak SZ, 1996, CORTEX, V32, P593, DOI 10.1016/S0010-9452(96)80033-5; Rapcsak SZ, 1999, COGN NEUROPSYCHOL, V16, P267, DOI 10.1080/026432999380799; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Robinson KJ, 1997, PSYCHOL SCI, V8, P231, DOI 10.1111/j.1467-9280.1997.tb00417.x; Roediger H. L., 1993, HANDB NEUR, P63; Roediger HL, 2000, CURR DIR PSYCHOL SCI, V9, P123, DOI 10.1111/1467-8721.00075; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Roediger HL, 1996, J MEM LANG, V35, P76, DOI 10.1006/jmla.1996.0005; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Schacter DL, 1996, NEUROPSYCHOLOGIA, V34, P793, DOI 10.1016/0028-3932(95)00165-4; Schacter DL, 1997, NEUROPSYCHOLOGY, V11, P331, DOI 10.1037/0894-4105.11.3.331; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 1998, J COGNITIVE NEUROSCI, V10, P668, DOI 10.1162/089892998563086; Schacter DL, 1999, J MEM LANG, V40, P1, DOI 10.1006/jmla.1998.2611; Schacter DL, 2001, PSYCHON B REV, V8, P827, DOI 10.3758/BF03196224; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, J MEM LANG, V35, P319, DOI 10.1006/jmla.1996.0018; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SCHACTER DL, 2004, IN PRESS NAT REV NEU; SCHACTER DL, 2001, 7 SIGNS MEMORY MIND; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; SCHOOLER JW, 1986, J EXP PSYCHOL LEARN, V12, P171, DOI 10.1037/0278-7393.12.2.171; SIMONS JS, 2004, IN PRESS NEUROPSYCHO; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Swick D, 1999, NEUROPSYCHOLOGY, V13, P155, DOI 10.1037/0894-4105.13.2.155; TALLAND GA, 1965, PSYCHIAT NEUROL, V149, P67; Treyer V, 2003, J COGNITIVE NEUROSCI, V15, P610, DOI 10.1162/089892903321662985; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; Verfaellie M, 2004, NEUROPSYCHOLOGY, V18, P94, DOI 10.1037/0894-4105.18.1.94; Verfaellie M, 2002, NEUROPSYCHOLOGIA, V40, P2360, DOI 10.1016/S0028-3932(02)00074-X; von Zerssen GC, 2001, EUR J NEUROSCI, V13, P2148, DOI 10.1046/j.0953-816x.2001.01589.x; Walla P, 2000, COGNITIVE BRAIN RES, V9, P41, DOI 10.1016/S0926-6410(99)00041-5; Ward J, 2003, NEUROPSYCHOLOGIA, V41, P538, DOI 10.1016/S0028-3932(02)00172-0; Ward J, 1999, COGN NEUROPSYCHOL, V16, P293, DOI 10.1080/026432999380807; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Wilding EL, 2000, INT J PSYCHOPHYSIOL, V35, P81, DOI 10.1016/S0167-8760(99)00095-1	108	190	200	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					149	160		10.1016/j.neuron.2004.08.017	http://dx.doi.org/10.1016/j.neuron.2004.08.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	858ZY	15450167	Bronze			2022-12-28	WOS:000224232600014
J	Chevaleyre, V; Castillo, PE				Chevaleyre, V; Castillo, PE			Endocannabinoid-mediated metaplasticity in the hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; CB1 CANNABINOID RECEPTORS; ENDOGENOUS CANNABINOIDS; SYNAPTIC PLASTICITY; RETROGRADE INHIBITION; PATTERNED STIMULATION; RAT HIPPOCAMPUS; THETA-FREQUENCY; PURKINJE-CELLS	Repetitive activation of glutamatergic fibers that normally induces long-term potentiation (LTP) at excitatory synapses in the hippocampus also triggers long-term depression at inhibitory synapses (I-LTD) via retrograde endocannabinoid signaling. Little is known, however, about the physiological significance of I-LTD. Here, we show that synaptic-driven release of endo-cannabinoids is a highly localized and efficient process that strongly depresses cannabinoid-sensitive inhibitory inputs within the dendritic compartment of CA1 pyramidal cells. By removing synaptic inhibition in a restricted area of the dendritic tree, endocannabinoids selectively "primed" nearby excitatory synapses, thereby facilitating subsequent induction of LTP. This induction of local metaplasticity is a novel mechanism by which endocannabinoids can contribute to the storage of information in the brain.	Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.	pcastill@aecom.yu.edu		Chevaleyre, Vivien/0000-0002-3679-4856; Castillo, Pablo/0000-0002-9834-1801				Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bergles DE, 1998, J NEUROSCI, V18, P7709; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bohme GA, 2000, NEUROSCIENCE, V95, P5; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; CHRISTIE BR, 1995, HIPPOCAMPUS, V5, P52, DOI 10.1002/hipo.450050107; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; COLLINS DR, 1995, BRIT J PHARMACOL, V115, P869, DOI 10.1111/j.1476-5381.1995.tb15889.x; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Elphick MR, 2001, PHILOS T R SOC B, V356, P381, DOI 10.1098/rstb.2000.0787; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2004, EUR J NEUROSCI, V19, P2991, DOI 10.1111/j.0953-816X.2004.03433.x; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Katona I, 1999, J NEUROSCI, V19, P4544; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LIU YB, 1993, J NEUROPHYSIOL, V69, P1000, DOI 10.1152/jn.1993.69.3.1000; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin LA, 2001, J PHYSIOL-LONDON, V532, P685, DOI 10.1111/j.1469-7793.2001.0685e.x; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Miura M, 2002, J NEUROSCI, V22, P8379; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; PETROCELLIS LD, 2004, BRIT J PHARMACOL, V141, P765; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PITLER TA, 1992, J NEUROSCI, V12, P4122; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; SHEPHERD GM, 2003, FUNDAMENTAL NEUROSCI, P319; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	64	225	233	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					871	881		10.1016/j.neuron.2004.08.036	http://dx.doi.org/10.1016/j.neuron.2004.08.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363397	Bronze			2022-12-28	WOS:000223992000012
J	Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H				Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H			Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons	NEURON			English	Article							CORTICOSTRIATAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; MONKEY STRIATUM; RAT NEOSTRIATUM; IN-VITRO; CHOLINERGIC INTERNEURONS; MUSCARINIC RECEPTORS; PARKINSONS-DISEASE; PRIMATES STRIATUM; BASAL GANGLIA	Midbrain dopamine and striatal tonically active neurons (TANs, presumed acetylcholine interneurons) signal behavioral significance of environmental events. Since striatal dopamine and acetylcholine affect plasticity of cortico-striatal transmission and are both crucial to learning, they may serve as teachers in the basal ganglia circuits. We recorded from both neuronal populations in monkeys performing a probabilistic instrumental conditioning task. Both neuronal types respond robustly to reward-related events. Although different events yielded responses with different latencies, the responses of the two populations coincided, indicating integration at the target level. Yet, while the dopamine neurons' response reflects mismatch between expectation and outcome in the positive domain, the TANs are invariant to reward predictability. Finally, TAN pairs are synchronized, compared to a minority of dopamine neuron pairs. We conclude that the striatal cholinergic and dopaminergic systems carry distinct messages by different means, which can be integrated differently to shape the basal ganglia responses to reward-related events.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morris, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel.	genela@md.huji.ac.il	Morris, Genela/B-7844-2008; Vaadia, Eilon/E-9347-2011	Morris, Genela/0000-0002-5417-8977				ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS7; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1998, J NEUROPHYSIOL, V80, P3341, DOI 10.1152/jn.1998.80.6.3341; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; ATKINS PT, 1990, NATURE, V344, P240; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Bennett BD, 1999, J NEUROSCI, V19, P5586; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Cragg SJ, 2000, J NEUROSCI, V20, P8209; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P244, DOI 10.1007/BF00238154; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; DRUKARCH B, 1989, J NEUROCHEM, V52, P1680, DOI 10.1111/j.1471-4159.1989.tb07244.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Goodie AS, 2004, J GEN PSYCHOL, V131, P18, DOI 10.3200/GENP.131.1.18-28; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kimura M, 2003, NEUROREPORT, V14, P799, DOI 10.1097/00001756-200305060-00004; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; KITAI ST, 1993, ADV NEUROL, V60, P40; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; KUDERNATSCH M, 1994, NEUROSCI LETT, V181, P107, DOI 10.1016/0304-3940(94)90571-1; LAVOIE B, 1989, J COMP NEUROL, V289, P36, DOI 10.1002/cne.902890104; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Martin RF, 2000, PRIMATE BRAIN MAPS S; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; NISENBAUM LK, 1995, MOL CELLULAR MECH NE, P273; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pisani A, 2003, NEUROPHARMACOLOGY, V45, P45, DOI 10.1016/S0028-3908(03)00137-0; Pisani A, 2000, J NEUROSCI, V20, part. no.; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Ravel S, 2003, J NEUROSCI, V23, P8489; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shimo Y, 2001, J NEUROSCI, V21, P7804, DOI 10.1523/JNEUROSCI.21-19-07804.2001; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R.S., 2017, REINFORCEMENT LEARNI, V2nd, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Tobler PN, 2003, J NEUROSCI, V23, P10402; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wolford G, 2000, J NEUROSCI, V20, part. no.; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	69	399	402	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					133	143		10.1016/j.neuron.2004.06.012	http://dx.doi.org/10.1016/j.neuron.2004.06.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233923	Bronze			2022-12-28	WOS:000222549800013
J	Dani, JA; Zhou, FM				Dani, JA; Zhou, FM			Selective dopamine filter of glutamate striatal afferents	NEURON			English	Editorial Material							RECEPTORS; NEURONS	Corticostriatal glutamate afferents and mesostriatal dopamine afferents commonly converge onto the same postsynaptic spines of medium projection neurons. The consequent synaptic triad provides an ideal configuration for dopamine modulation of glutamatergic transmission. In this issue of Neuron, Bamford et al. report that cloparnine inhibits glutamate release in a selective manner by activating presynaptic D2 receptors.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021229] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS021229] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Haber SN, 2000, J NEUROSCI, V20, P2369; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009	11	35	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					522	524		10.1016/j.neuron.2004.05.008	http://dx.doi.org/10.1016/j.neuron.2004.05.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157413	Bronze			2022-12-28	WOS:000221708300002
J	Shin, KS; Maertens, C; Proenza, C; Rothberg, BS; Yellen, G				Shin, KS; Maertens, C; Proenza, C; Rothberg, BS; Yellen, G			Inactivation in HCN channels results from reclosure of the activation gate: Desensitization to voltage	NEURON			English	Article							CATION CURRENT; PACEMAKER; IDENTIFICATION; MECHANISMS; RECEPTOR; CELLS	Hyperpolarization-activated HCN channels are modulated by direct binding of cyclic nucleotides. For HCN2 channels, cAMP shifts the voltage dependence for activation, with relatively little change in the maximal conductance. By contrast, in spHCN channels, cAMP relieves a rapid inactivation process and produces a large increase in maximum conductance. Our results suggest that these two effects of cAMP represent the same underlying process. We also find that spHCN inactivation occurs not by closure of a specialized inactivation gate, as for other voltage-dependent channels, but by reclosure of the same intracellular gate opened upon activation. Effectively, the activation gate exhibits a "desensitization to voltage," perhaps by slippage of the coupling between the voltage sensors and the gate. Differences in the initial coupling efficiency could allow cAMP to produce either the inactivation or the shift phenotype by strengthening effective coupling: a shift would naturally occur if coupling is already strong in the absence of cAMP.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	gary_yellen@hms.harvard.edu	Rothberg, Brad/AAD-1260-2022	Proenza, Catherine/0000-0003-4324-6206; Rothberg, Brad/0000-0003-1982-2269; Yellen, Gary/0000-0003-4228-7866	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL071365, R01HL070320] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070320, HL71365, HL70320] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Malcolm AT, 2003, BBA-BIOMEMBRANES, V1609, P183, DOI 10.1016/S0005-2736(02)00687-9; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448	21	91	93	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					737	744		10.1016/S0896-6273(04)00083-2	http://dx.doi.org/10.1016/S0896-6273(04)00083-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003173	Bronze			2022-12-28	WOS:000221458200009
J	Ohno, M; Sametsky, EA; Younkin, LH; Oakley, H; Younkin, SG; Citron, M; Vassar, R; Disterhoft, JF				Ohno, M; Sametsky, EA; Younkin, LH; Oakley, H; Younkin, SG; Citron, M; Vassar, R; Disterhoft, JF			BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; LONG-TERM POTENTIATION; A-BETA; TRANSGENIC MICE; SPONTANEOUS-ALTERNATION; CORTICAL-NEURONS; SOCIAL RECOGNITION; KNOCKOUT MICE; IN-VIVO	beta-site APP cleaving enzyme 1 (BACE1) is the beta-secretase enzyme required for generating pathogenic beta-amyloid (Abeta) peptides in Alzheimer's disease (AD). BACE1 knockout mice lack Abeta and are phenotypically normal, suggesting that therapeutic inhibition of BACE1 may be free of mechanism-based side effects. However, direct evidence that BACE1 inhibition would improve cognition is lacking. Here we show that BACE1 null mice engineered to overexpress human APP (BACE1(-/-.)Tg2576(+)) are rescued from Abeta-dependent hippocampal memory deficits. Moreover, impaired hippocampal cholinergic regulation of neuronal excitability found in the Tg2576 AD model is ameliorated in BACE1(-/-.)Tg2576(+) bigenic mice. The behavioral and electrophysiological rescue of deficits in BACE1(-/-.)Tg2576(+) mice is correlated with a dramatic reduction of cerebral Abeta40 and Abeta42 levels and occurs before amyloid deposition in Tg2576 mice. Our gene-based approach demonstrates that lower Abeta levels are beneficial for AD-associated memory impairments, validating BACE1 as a therapeutic target for AD.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Mayo Clin, Jacksonville, FL 32224 USA; Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Amgen	Ohno, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	ohno@northwestern.edu; r-vassar@northwestern.edu; jdisterhoft@northwestern.edu		Disterhoft, John/0000-0002-8817-7913	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008796] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG08796] Funding Source: Medline; NIMH NIH HHS [R01 MH067251] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Auld DS, 1998, TRENDS NEUROSCI, V21, P43, DOI 10.1016/S0166-2236(97)01144-2; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang HM, 2000, NEUROCHEM RES, V25, P303, DOI 10.1023/A:1007592007956; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; John V, 2003, J MED CHEM, V46, P4625, DOI 10.1021/jm030247h; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kelly JF, 1996, P NATL ACAD SCI USA, V93, P6753, DOI 10.1073/pnas.93.13.6753; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lelong V, 2003, N-S ARCH PHARMACOL, V367, P621, DOI 10.1007/s00210-003-0743-2; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; NICOLL JA, 2003, NAT MED, V9, P389; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Saar D, 2001, J NEUROSCI, V21, P1385; Savage LM, 2003, LEARN MEMORY, V10, P242, DOI 10.1101/lm.60003; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Suh YH, 1997, J NEUROCHEM, V68, P1781; Tang J, 2003, J MOL NEUROSCI, V20, P299, DOI 10.1385/JMN:20:3:299; Tran MH, 2002, PEPTIDES, V23, P1271, DOI 10.1016/S0196-9781(02)00062-1; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Wu WW, 2002, AGEING RES REV, V1, P181, DOI 10.1016/S1568-1637(01)00009-5; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhong P, 2003, J BIOL CHEM, V278, P26888, DOI 10.1074/jbc.M302789200	61	424	477	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					27	33		10.1016/S0896-6273(03)00810-9	http://dx.doi.org/10.1016/S0896-6273(03)00810-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715132	Bronze			2022-12-28	WOS:000187942800006
J	Romo, R; Hernandez, A; Zainos, A				Romo, R; Hernandez, A; Zainos, A			Neuronal correlates of a perceptual decision in ventral premotor cortex	NEURON			English	Article							PARAMETRIC WORKING-MEMORY; INFERIOR AREA-6; PSYCHOPHYSICAL MEASUREMENTS; CORTICOSPINAL PROJECTIONS; FUNCTIONAL-ORGANIZATION; PREFRONTAL CORTEX; MACAQUE MONKEY; NEURAL CODES; DISCRIMINATION; FLUTTER	The ventral premotor cortex (VPC) is involved in the transformation of sensory information into action, although the exact neuronal operation is not known. We addressed this problem by recording from single neurons in VPC while trained monkeys report a decision based on the comparison of two mechanical vibrations applied sequentially to the fingertips. Here we report that the activity of VPC neurons reflects current and remembered sensory inputs, their comparison, and motor commands expressing the result; that is, the entire processing cascade linking the evaluation of sensory stimuli with a motor report. These findings provide a fairly complete panorama of the neural dynamics that underlies the transformation of sensory information into an action and emphasize the role of VPC in perceptual decisions.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx		romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; DUM RP, 1991, J NEUROSCI, V11, P667; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HE SQ, 1993, J NEUROSCI, V13, P952; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; KEIZER K, 1989, EXP BRAIN RES, V74, P311; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; McFarland NR, 2000, J NEUROSCI, V20, P3798, DOI 10.1523/JNEUROSCI.20-10-03798.2000; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WISE SP, 1992, J NEUROPHYSIOL, V68, P969, DOI 10.1152/jn.1992.68.3.969; [No title captured]	34	240	240	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					165	173		10.1016/S0896-6273(03)00817-1	http://dx.doi.org/10.1016/S0896-6273(03)00817-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715143	Bronze			2022-12-28	WOS:000187942800017
J	Telgkamp, P; Padgett, DE; Ledoux, VA; Woolley, CS; Raman, IM				Telgkamp, P; Padgett, DE; Ledoux, VA; Woolley, CS; Raman, IM			Maintenance of high-frequency transmission at Purkinje to cerebellar nuclear synapses by spillover from boutons with multiple release sites	NEURON			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; POSTSYNAPTIC GABA(A) RECEPTORS; PAIRED-PULSE DEPRESSION; CALYX-TYPE SYNAPSE; MULTIVESICULAR RELEASE; ASTROCYTIC PROCESSES; GABAERGIC SYNAPSES; QUANTAL RELEASE; MINIATURE IPSCS; MINI AMPLITUDE	Cerebellar Purkinje neurons maintain high firing rates but their synaptic terminals depress only moderately, raising the question of how vesicle depletion is minimized. To identify mechanisms that limit synaptic depression, we evoked 100 Hz trains of GABAergic inhibitory postsynaptic currents (IPSCs) in cerebellar nuclear neurons by stimulating Purkinje axons in mouse brain slices. The paired-pulse ratio (IPSC2/ IPSC1) of the total IPSC was similar to1 and the steady-state ratio (IPSC20/IPSC1) was similar to0.5, suggesting a high response probability of postsynaptic receptors, without an unusually high release probability. Three-dimensional electron microscopic reconstructions of Purkinje boutons revealed multiple active zones without intervening transporters, suggestive of "spillover"-mediated transmission. Simulations of boutons with 10-16 release sites, in which transmitter from any site can reach all receptors opposite the bouton, replicated multiple-pulse depression during normal, high, and low presynaptic Ca influx. These results suggest that release from multiple-site boutons limits depletion-based depression, permitting prolonged, high-frequency inhibition at corticonuclear synapses.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Raman, IM (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.	i-raman@northwestern.edu		Woolley, Catherine/0000-0002-8069-2646	NINDS NIH HHS [NS39395, NS37324] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039395, R01NS037324, R29NS037324] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Chan-Palay V, 1977, CEREBELLAR DENTATE N; CLARK JA, 1994, MOL PHARMACOL, V46, P550; CREPEL F, 1972, EXP BRAIN RES, V14, P463, DOI 10.1007/BF00236588; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1997, J NEUROSCI, V17, P7220; Garin N, 2001, NEUROSCIENCE, V105, P431, DOI 10.1016/S0306-4522(01)00127-0; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Jones MV, 1998, J NEUROSCI, V18, P8590; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Mellor JR, 1998, J PHYSIOL-LONDON, V506, P377, DOI 10.1111/j.1469-7793.1998.377bw.x; Mellor JR, 2001, J NEUROPHYSIOL, V85, P1847, DOI 10.1152/jn.2001.85.5.1847; Minelli A, 1996, J NEUROSCI, V16, P6255, DOI 10.1523/jneurosci.16-19-06255.1996; MORISHITA W, 1995, NEUROSCIENCE, V68, P1127, DOI 10.1016/0306-4522(95)00206-X; MOUGINOT D, 1995, NEUROSCIENCE, V64, P699, DOI 10.1016/0306-4522(94)00456-F; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Park D, 1998, J NEUROSCI, V18, P6757; Pedroarena CM, 2003, J NEUROPHYSIOL, V89, P704, DOI 10.1152/jn.00558.2002; Perrais D, 2000, EUR J NEUROSCI, V12, P400, DOI 10.1046/j.1460-9568.2000.00957.x; Perrais D, 1999, J NEUROSCI, V19, P578; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Ribak CE, 1996, ANAT EMBRYOL, V194, P379; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; Telgkamp P, 2002, J NEUROSCI, V22, P8447; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Varela JA, 1999, J NEUROSCI, V19, P4293; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; WALMSLEY B, 1988, J NEUROPHYSIOL, V60, P889, DOI 10.1152/jn.1988.60.3.889; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	61	91	91	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 8	2004	41	1					113	126		10.1016/S0896-6273(03)00802-X	http://dx.doi.org/10.1016/S0896-6273(03)00802-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715139	Bronze			2022-12-28	WOS:000187942800013
J	Krueger, SR; Kolar, A; Fitzsimonds, RM				Krueger, SR; Kolar, A; Fitzsimonds, RM			The presynaptic release apparatus is functional in the absence of dendritic contact and highly mobile within isolated axons	NEURON			English	Article							HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; MOLECULAR-MECHANISMS; EXCITATORY SYNAPSES; GROWTH CONES; ACTIVE ZONES; DYNAMICS; SYNAPTOGENESIS; PLASTICITY; RAT	Whether contact of an axon with a dendrite is a necessary inductive signal for the assembly of functional presynaptic machinery is controversial. Combining FM1-43 imaging with retrospective immunocytochemistry, we observe many functional synaptic vesicle (SV) release sites lacking postsynaptic specializations in cultured hippocampal neurons. These "orphan" release sites share the same exocytic machinery and mechanisms of endocytic recycling as mature synaptic sites. Moreover, quantitative analysis of FM1-43 destaining at these orphan release sites reveals similar kinetics with slightly lower release probabilities. Time-lapse imaging of FM1-43 reveals that orphans are generated by complete or partial mobilization of synaptic release sites that retain their functionality in transit. Orphan clusters fuse with existing synaptic release sites or form novel release sites onto dendrites. Mobilization and stabilization of orphan boutons to new sites of dendritic contact may represent a necessary presynaptic counterpart to postsynaptic changes observed during development and plasticity in the CNS.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Fitzsimonds, RM (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	reiko.fitzsimonds@yale.edu		Krueger, Stefan/0000-0001-8739-7052; Fitzsimonds, Reiko/0000-0002-0576-9885	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059800] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-59800] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; BURRY RW, 1982, BRAIN RES, V247, P1, DOI 10.1016/0006-8993(82)91022-8; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Craig AM, 1996, J NEUROSCI, V16, P3166; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dailey ME, 1996, J NEUROSCI, V16, P2983; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nikonenko I, 2003, J NEUROSCI, V23, P8498; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PICHITPORNCHAI C, 1994, J COMP NEUROL, V342, P206, DOI 10.1002/cne.903420205; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Rao A, 1998, J NEUROSCI, V18, P1217; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	54	130	134	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					945	957		10.1016/S0896-6273(03)00729-3	http://dx.doi.org/10.1016/S0896-6273(03)00729-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659093	Bronze			2022-12-28	WOS:000187042200011
J	Hirono, M; Denis, CS; Richardson, GP; Gillespie, PG				Hirono, M; Denis, CS; Richardson, GP; Gillespie, PG			Hair cells require phosphatidylinositol 4,5-bisphosphate for mechanical transduction and adaptation	NEURON			English	Article							MYOSIN-I-BETA; BULLFROGS SACCULUS; MEMBRANE-PROTEINS; BINDING; PHOSPHOINOSITIDES; STEREOCILIA; MOTOR; PHOSPHATASE; CALMODULIN; DOMAINS	After opening in response to mechanical stimuli, hair cell transduction channels adapt with fast and slow mechanisms that each depend on Call. We demonstrate here that transduction and adaptation require phosphatidylinositol 4,5-bisphosphate (PIP2) for normal kinetics. PlP(2) has a striking distribution in hair cells, being excluded from the basal region of hair bundles and apical surfaces of frog saccular hair cells. Localization of a phosphatidylinositol lipid phosphatase, Ptprq, to these PlP(2)-free domains suggests that Ptprq maintains low PIP2 levels there. Depletion of PIP2 by inhibition of phosphatidylinositol 4-kinase or sequestration by aminoglycosides reduces the rates of fast and slow adaptation. PIP2 and other anionic phospholipids bind directly to the 10 domains of myosin-1c, the motor that mediates slow adaptation, permitting a strong interaction with membranes and likely regulating the motor's activity. PlP2 depletion also causes a loss in transduction current. PlP2 therefore plays an essential role in hair cell adaptation and transduction.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	Oregon Health & Science University; Oregon Health & Science University; University of Sussex	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gillespp@ohsu.edu		Hirono, Moritoshi/0000-0001-6068-1045; Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC004571] Funding Source: NIH RePORTER; NIDCD NIH HHS [P30 DC005983, R01 DC004571, R01 DC002387] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; AUGERT G, 1989, J BIOL CHEM, V264, P2574; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; CHOQUETTE D, 1984, BIOCHEM BIOPH RES CO, V125, P908, DOI 10.1016/0006-291X(84)91369-X; COCHET C, 1986, BIOCHEM J, V237, P25, DOI 10.1042/bj2370025; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gillespie PG, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-31; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; HILGEMANN DW, 2001, SCI STKE; Hinners I, 1999, ANAL BIOCHEM, V276, P1, DOI 10.1006/abio.1999.4325; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; SCHAEFER T, 1994, ANN NY ACAD SCI, V710, P356, DOI 10.1111/j.1749-6632.1994.tb26642.x; Seifert RA, 2003, EXP CELL RES, V287, P374, DOI 10.1016/S0014-4827(03)00121-6; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; TACHIBANA M, 1984, HISTOCHEMISTRY, V81, P157, DOI 10.1007/BF00490110; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Thomas CL, 1999, BIOCHEM SOC T, V27, P648, DOI 10.1042/bst0270648; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Wagner ML, 2001, BIOPHYS J, V81, P266, DOI 10.1016/S0006-3495(01)75697-4; WANG BM, 1984, BIOCHEM PHARMACOL, V33, P3257, DOI 10.1016/0006-2952(84)90087-X; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	54	135	139	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					309	320		10.1016/j.neuron.2004.09.020	http://dx.doi.org/10.1016/j.neuron.2004.09.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473969	Bronze			2022-12-28	WOS:000224635800013
J	Tanzi, RE; Moir, RD; Wagner, SL				Tanzi, RE; Moir, RD; Wagner, SL			Clearance of Alzheimer's A beta peptide: The many roads to perdition	NEURON			English	Editorial Material							BLOOD-BRAIN-BARRIER; AMYLOID-BETA; TRANSGENIC MICE; DISEASE; PROTEIN; RECEPTOR; NEPRILYSIN; PRECURSOR; INSULIN; ACCUMULATION	The amyloid hypothesis of Alzheimer's disease (AD) maintains that the accumulation of the amyloid beta protein (Abeta) is a critical event in disease pathogenesis. A great deal of both academic and commercial research has focused on the mechanisms by which Abeta is generated. However, investigations into the mechanisms underlying Abeta clearance have blossomed over the last several years. This minireview will summarize pathways involved in the removal of cerebral Abeta, including enzymatic degradation and receptor-mediated efflux out of the brain.	Massachusetts Gen Hosp, Genet & Aging Res Unit, Massgen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA 02129 USA; Neurogenetics Inc, La Jolla, CA 92037 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, Massgen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA 02129 USA.		Moir, Robert D./M-7612-2017; Tanzi, Rudolph/AAE-9622-2019	Moir, Robert D./0000-0001-5431-3553; Tanzi, Rudolph/0000-0002-7032-1454				Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Marr RA, 2003, J NEUROSCI, V23, P1992; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Van Uden E, 2002, J NEUROSCI, V22, P9298; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	26	378	408	0	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 2	2004	43	5					605	608		10.1016/j.neuron.2004.08.024	http://dx.doi.org/10.1016/j.neuron.2004.08.024			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339642	Bronze			2022-12-28	WOS:000223691900006
J	Alarcon, JM; Malleret, G; Touzani, K; Vronskaya, S; Ishii, S; Kandel, ER; Barco, A				Alarcon, JM; Malleret, G; Touzani, K; Vronskaya, S; Ishii, S; Kandel, ER; Barco, A			Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration	NEURON			English	Article							CREB-BINDING-PROTEIN; LONG-TERM POTENTIATION; MEDIATED TRANSCRIPTION; SYNAPTIC PLASTICITY; HUNTINGTONS-DISEASE; GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE MODEL; IN-VIVO; PHOSPHORYLATION	We studied a mouse model of the haploinsufficiency form of Rubinstein-Taybi syndrome (RTS), an inheritable disorder caused by mutations in the gene encoding the CREB binding protein (CBP) and characterized by mental retardation and skeletal abnormalities. In these mice, chromatin acetylation, some forms of long-term memory, and the late phase of hippocampal long-term potentiation (L-LTP) were impaired. We ameliorated the L-LTP deficit in two ways: (1) by enhancing the expression of CREB-dependent genes, and (2) by inhibiting histone deacetyltransferase activity (HDAC), the molecular counterpart of the histone acetylation function of CBP. Inhibition of HDAC also reversed the memory defect observed in fear conditioning. These findings suggest that some of the cognitive and physiological deficits observed on RTS are not simply due to the reduction of CBP during development but may also result from the continued requirement throughout life for both the CREB co-activation and the histone acetylation function of CBP.	Columbia Univ, Ctr Neurobiol & Behav, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; RIKEN, Tsukuba Inst, Genet Mol Lab, Tsukuba, Ibaraki 3050074, Japan	Columbia University; Columbia University; Howard Hughes Medical Institute; RIKEN	Kandel, ER (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Coll Phys & Surg, New York, NY 10032 USA.	erk5@columbia.edu	Barco, Angel/ABF-1864-2021; Ishii, Shunsuke/A-5271-2016; Barco, Angel/C-3062-2008	Barco, Angel/0000-0002-0653-3751; Ishii, Shunsuke/0000-0002-6530-2478; Barco, Angel/0000-0002-0653-3751	NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG08702] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bannister AJ, 1995, ONCOGENE, V11, P2509; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Chan HM, 2001, J CELL SCI, V114, P2363; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Coupry I, 2002, J MED GENET, V39, P415, DOI 10.1136/jmg.39.6.415; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GOTTS EE, 1977, BIOL PSYCHIAT, V12, P413; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; HENNEKAM RCM, 1992, AM J MENT RETARD, V96, P645; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Huang C, 2003, CURR OPIN GENET DEV, V13, P246, DOI 10.1016/S0959-437X(03)00054-6; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kalkhoven E, 2003, HUM MOL GENET, V12, P441, DOI 10.1093/hmg/ddg039; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kouraklis G., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P477, DOI 10.2174/1568011023353921; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; MARAMBAUD P, 1908, CELL, V114, P635; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Myers FA, 2003, J BIOL CHEM, V278, P36315, DOI 10.1074/jbc.M305822200; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Oike Y, 1999, BLOOD, V93, P2771; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Parker D, 1996, MOL CELL BIOL, V16, P694; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Petrij F, 2000, J MED GENET, V37, P168, DOI 10.1136/jmg.37.3.168; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Smith CL, 1997, J BIOL CHEM, V272, P14227, DOI 10.1074/jbc.272.22.14227; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; WIOSDEN W, 1994, IN SITU HYBRIDIZATIO, P9; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829	49	690	724	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					947	959		10.1016/j.neuron.2004.05.021	http://dx.doi.org/10.1016/j.neuron.2004.05.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207239	Bronze			2022-12-28	WOS:000222329300010
J	Bureau, I; Shepherd, GMG; Svoboda, K				Bureau, I; Shepherd, GMG; Svoboda, K			Precise development of functional and anatomical columns in the neocortex	NEURON			English	Article							RAT BARREL CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; SOMATIC SENSORY CORTEX; FERRET VISUAL-CORTEX; CAT STRIATE CORTEX; SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; RECEPTIVE-FIELDS; IN-VIVO; PYRAMIDAL NEURONS	Sensory cortex is ordered into columns, each tuned to a subset of peripheral stimuli. To identify the principles underlying the construction of columnar architecture, we monitored the development of circuits in the rat barrel cortex, using laser-scanning photostimulation analysis of synaptic connectivity, reconstructions of axonal arbors, and in vivo whole-cell recording. Circuits impinging onto layer 2/3 neurons from layers 4 and 2/3 developed in a monotonic, precise progression, with little evidence for transient hyperinnervation at the level of cortical columns. Consistent with this, synaptic currents measured in layer 2/3 neurons at PND 8, just after these neurons ceased to migrate, revealed already spatially well-tuned receptive fields.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.org	Shepherd, Gordon/F-2679-2010; Bureau, Ingrid/O-3941-2016	Bureau, Ingrid/0000-0001-9166-2250				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bender KJ, 2003, J NEUROSCI, V23, P8759; BERNARDO KL, 1987, J COMP NEUROL, V258, P542, DOI 10.1002/cne.902580406; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Borrell V, 2002, J NEUROSCI, V22, P6682; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brennan EM, 1997, J COMP NEUROL, V386, P29, DOI 10.1002/(SICI)1096-9861(19970915)386:1<29::AID-CNE5>3.0.CO;2-F; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; Callaway EM, 1996, J COMP NEUROL, V376, P295; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; DODT HU, 2003, SCI STKE, pE35; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; FOX K, 1992, J NEUROSCI, V12, P1826; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Hamam BN, 2003, J NEUROSCI METH, V123, P61, DOI 10.1016/S0165-0270(02)00341-2; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; IGNACIO MPD, 1995, ANAT EMBRYOL, V191, P89; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1975, BRAIN RES, V86, P469, DOI 10.1016/0006-8993(75)90897-5; Kim U, 1999, J COMP NEUROL, V408, P489; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lev DL, 2002, J COMP NEUROL, V442, P63, DOI 10.1002/cne.1422; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; LU SM, 1992, SOMATOSENS MOT RES, V10, P1; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; MARAVALL M, 2004, IN PRESS J NEUROPHYS, DOI DOI 10.1152/JN.00598.2003; MARAVALL M, 2004, IN PRESS CEREB CORTE, DOI DOI 10.1093/CERCOR/BHH026; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; Roerig B, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0002.1999; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; SHATZ CJ, 1983, J NEUROSCI, V3, P482; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Ullensvang K, 1997, EUR J NEUROSCI, V9, P1646, DOI 10.1111/j.1460-9568.1997.tb01522.x; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WAITE PME, 1978, NATURE, V274, P600, DOI 10.1038/274600a0; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Zigmond MJ, 1999, FUNDAMENTAL NEUROSCI	80	108	128	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					789	801		10.1016/j.neuron.2004.05.002	http://dx.doi.org/10.1016/j.neuron.2004.05.002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182718	Bronze			2022-12-28	WOS:000221975000010
J	Kelley, AE; Schiltz, CA				Kelley, AE; Schiltz, CA			Accessories to addiction: G protein regulators play a key role in cocaine seeking and neuroplasticity	NEURON			English	Editorial Material							REINSTATEMENT; SYSTEMS; CORTEX	The prefrontal cortex mediates many aspects of addiction. In this issue of Neuron, Bowers et al. demonstrate that an activator of G protein signaling (AGS3) is persistently upregulated in the prefrontal cortex after cessation of chronic cocaine treatment. Furthermore, they find that AGS3 is responsible for altered behavior, such as enhanced drug seeking, and altered neurotransmission in cocaine-treated rats, representing a novel therapeutic target.	Univ Wisconsin, Madison Med Sch, Dept Psychiat, Neurosci Training Program, Madison, WI 53705 USA; Univ Wisconsin, Madison Med Sch, Med Scientist Training Program, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kelley, AE (corresponding author), Univ Wisconsin, Madison Med Sch, Dept Psychiat, Neurosci Training Program, 6001 Res Pk Blvd, Madison, WI 53705 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Blumer JB, 2003, RECEPTOR CHANNEL, V9, P195, DOI 10.1080/10606820390203839; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x	11	9	11	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 22	2004	42	2					181	183		10.1016/S0896-6273(04)00223-5	http://dx.doi.org/10.1016/S0896-6273(04)00223-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091332	Bronze			2022-12-28	WOS:000221458500001
J	Powell, CM; Schoch, S; Monteggia, L; Barrot, M; Matos, MF; Feldmann, N; Sudhof, TC; Nestler, EJ				Powell, CM; Schoch, S; Monteggia, L; Barrot, M; Matos, MF; Feldmann, N; Sudhof, TC; Nestler, EJ			The presynaptic active zone protein RIM1 alpha is critical for normal learning and memory	NEURON			English	Article							LONG-TERM POTENTIATION; MOSSY FIBER LTP; CYCLASE MUTANT MICE; NEUROTRANSMITTER RELEASE; RAB3 EFFECTOR; PLASTICITY; FORMS; SYNAPTOTAGMIN; NEUROBIOLOGY; HIPPOCAMPUS	The active zone protein RIM1alpha is required both for maintaining normal probability of neurotransmitter release and for long-term presynaptic potentiation at brain synapses. We now demonstrate that RIM1alpha(-/-) mice exhibit normal coordination and anxiety-related behaviors but display severely impaired learning and memory. Mice with a synaptotagmin 1 mutation, which selectively lowers release probability, and mice with Rab3A deletion, which selectively abolishes presynaptic long-term potentiation, do not exhibit this abnormality. Our data suggest that a decrease in release probability or a loss of presynaptic LTP alone is not sufficient to cause major behavioral alterations, but the combination of presynaptic abnormalities in RIM1alpha(-/-) mice severely alters learning and memory.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Inst Neuropathol, D-53105 Bonn, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Powell, CM (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	craig.powell@utsouthwestern.edu	Schoch, Susanne/F-7741-2012	Powell, Craig/0000-0001-5451-2165	NIMH NIH HHS [K08 MH065975-04, K08 MH065975-03, P50 MH066172, K08 MH065975-05, K08MH65975, K08 MH065975, P50MH66172] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975, P50MH066172] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Dobrunz LE, 2002, NATURE, V415, P277, DOI 10.1038/415277a; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Hensbroek RA, 2003, BEHAV BRAIN RES, V138, P215, DOI 10.1016/S0166-4328(02)00243-7; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lonart G, 2002, TRENDS NEUROSCI, V25, P329, DOI 10.1016/S0166-2236(02)02193-8; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Otto C, 2001, J NEUROSCI, V21, P5520, DOI 10.1523/JNEUROSCI.21-15-05520.2001; Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Sweatt JD, 2003, MECH MEMORY; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	36	109	111	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 8	2004	42	1					143	153		10.1016/S0896-6273(04)00146-1	http://dx.doi.org/10.1016/S0896-6273(04)00146-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066271	Bronze, Green Accepted			2022-12-28	WOS:000221458400014
J	Bandell, M; Story, GM; Hwang, SW; Viswanath, V; Eid, SR; Petrus, MJ; Earley, TJ; Patapoutian, A				Bandell, M; Story, GM; Hwang, SW; Viswanath, V; Eid, SR; Petrus, MJ; Earley, TJ; Patapoutian, A			Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin	NEURON			English	Article							CAPSAICIN RECEPTOR; PAIN; NEURONS; STIMULATION; MECHANISMS; VEINS	Six members of the mammalian transient receptor potential (TRP) ion channels respond to varied temperature thresholds. The natural compounds capsaicin and menthol activate noxious heat-sensitive TRPV1 and cold-sensitive TRPM8, respectively. The burning and cooling perception of capsaicin and menthol demonstrate that these ion channels mediate thermosensation. We show that, in addition to noxious cold, pungent natural compounds present in cinnamon oil, wintergreen oil, clove oil, mustard oil, and ginger all activate TRPA1 (ANKTM1). Bradykinin, an inflammatory peptide acting through its G protein-coupled receptor, also activates TRPA1. We further show that phospholipase C is an important signaling component for TRPA1 activation. Cinnamaldehyde, the most specific TRPA1 activator, excites a subset of sensory neurons highly enriched in cold-sensitive neurons and elicits nociceptive behavior in mice. Collectively, these data demonstrate that TRPA1 activation elicits a painful sensation and provide a potential molecular model for why noxious cold can paradoxically be perceived as burning pain.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480	NINDS NIH HHS [NS046303, NS42822] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042822, R01NS046303] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNDT JO, 1991, J PHYSIOL-LONDON, V440, P467, DOI 10.1113/jphysiol.1991.sp018719; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cliff M., 1992, Journal of Sensory Studies, V7, P279, DOI 10.1111/j.1745-459X.1992.tb00195.x; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kandel E., 2000, PRINCIPLES NEURAL SC; Kasai M, 1998, NEUROSCI RES, V32, P231, DOI 10.1016/S0168-0102(98)00092-3; KLEMENT W, 1991, NEUROSCI LETT, V123, P119, DOI 10.1016/0304-3940(91)90172-P; Kollarik M, 2004, J PHYSIOL-LONDON, V555, P115, DOI 10.1113/jphysiol.2003.054890; LEVINE JD, 1993, J NEUROSCI, V13, P2273, DOI 10.1523/JNEUROSCI.13-06-02273.1993; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minke B, 2001, CELL MOL NEUROBIOL, V21, P629, DOI 10.1023/A:1015191702536; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Prescott J, 2000, CHEM SENSES, V25, P239, DOI 10.1093/chemse/25.3.239; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sullivan E, 1999, METH MOL B, V114, P125; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807	29	1338	1412	5	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					849	857		10.1016/S0896-6273(04)00150-3	http://dx.doi.org/10.1016/S0896-6273(04)00150-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046718	Bronze			2022-12-28	WOS:000221458300005
J	Yao, WD; Gainetdinov, RR; Arbuckle, MI; Sotnikova, TD; Cyr, M; Beaulieu, JM; Torres, GE; Grant, SGN; Caron, MG				Yao, WD; Gainetdinov, RR; Arbuckle, MI; Sotnikova, TD; Cyr, M; Beaulieu, JM; Torres, GE; Grant, SGN; Caron, MG			Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; NMDA RECEPTOR; NITRIC-OXIDE; POSTSYNAPTIC DENSITY-95; MICE LACKING; CHRONIC COCAINE; SENSITIZATION; BRAIN	To identify the molecular mechanisms underlying psychostimulant-elicited plasticity in the brain reward system, we undertook a phenotype-driven approach using genome-wide microarray profiling of striatal transcripts from three genetic and one pharmacological mouse models of psychostimulant or dopamine supersensitivity. A small set of co-affected genes was identified. One of these genes encoding the synaptic scaffolding protein PSD-95 is downregulated in the striatum of all three mutants and in chronically, but not acutely, cocaine-treated mice. At the synaptic level, enhanced long-term potentiation (LTP) of the fronto-cortico-accumbal glutamatergic synapses correlates with PSD-95 reduction in every case. Finally, targeted deletion of PSD-95 in an independent line of mice enhances LTP, augments the acute locomotor-stimulating effects of cocaine, but leads to no further behavioral plasticity in response to chronic cocaine. Our findings uncover a previously unappreciated role of PSD-95 in psychostimulant action and identify a molecular and cellular mechanism shared between drug-related plasticity and learning.	Duke Univ, Howard Hughes Med Inst Labs, Ctr Med, Dept Cell Biol, Durham, NC 27710 USA; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9J2, Midlothian, Scotland; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	Duke University; University of Edinburgh; Wellcome Trust Sanger Institute	Caron, MG (corresponding author), Duke Univ, Howard Hughes Med Inst Labs, Ctr Med, Dept Cell Biol, Durham, NC 27710 USA.	caron002@mc.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011; Jansen, Heiko T./A-5770-2008	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Jansen, Heiko T./0000-0003-0178-396X; Grant, Seth/0000-0001-8732-8735	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013511] Funding Source: NIH RePORTER; NIDA NIH HHS [DA13511] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Beinfeld MC, 2002, J NEUROCHEM, V81, P1021, DOI 10.1046/j.1471-4159.2002.00894.x; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; BURT DR, 1977, SCIENCE, V196, P327, DOI 10.1126/science.847477; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collins SL, 2002, PSYCHOPHARMACOLOGY, V159, P361, DOI 10.1007/s00213-001-0935-8; CREESE I, 1977, SCIENCE, V197, P596, DOI 10.1126/science.877576; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; DAUNAIS JB, 1994, SYNAPSE, V18, P35, DOI 10.1002/syn.890180106; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Garner CC, 1996, TRENDS CELL BIOL, V6, P429, DOI 10.1016/S0962-8924(96)10036-2; Garry EM, 2003, CURR BIOL, V13, P321, DOI 10.1016/S0960-9822(03)00084-8; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gholami A, 2002, EUR J PHARMACOL, V449, P269, DOI 10.1016/S0014-2999(02)02038-1; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Grimm JW, 2003, J NEUROSCI, V23, P742; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KOVOOR KH, 2003, NEURON, V38, P941; Laakso A, 2002, NEURON, V36, P213, DOI 10.1016/S0896-6273(02)00972-8; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; McNamara FN, 2002, SYNAPSE, V46, P19, DOI 10.1002/syn.10108; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nishioku T, 1999, NEUROSCI LETT, V268, P81, DOI 10.1016/S0304-3940(99)00386-9; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; RUBINSTEIN M, 1988, EUR J PHARMACOL, V148, P419, DOI 10.1016/0014-2999(88)90121-5; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SPYRAKI C, 1981, EUR J PHARMACOL, V74, P195, DOI 10.1016/0014-2999(81)90531-8; Stein V, 2003, J NEUROSCI, V23, P5503; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WISE RA, 1993, BEHAV PHARMACOL, V4, P339; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	84	288	294	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					625	638		10.1016/S0896-6273(04)00048-0	http://dx.doi.org/10.1016/S0896-6273(04)00048-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980210	Bronze			2022-12-28	WOS:000221458100014
J	Castro-Alamancos, MA				Castro-Alamancos, MA			Absence of rapid sensory adaptation in neocortex during information processing states	NEURON			English	Article							THALAMOCORTICAL RESPONSE TRANSFORMATION; IN-VIVO; SOMATOSENSORY CORTEX; CORTICAL-NEURONS; BARREL CORTEX; VISUAL-CORTEX; RAT THALAMUS; MODULATION; AROUSAL; RESPONSIVENESS	One prominent feature of sensory responses in neocortex is that they rapidly adapt to increases in frequency, a process called "sensory adaptation." Here we show that sensory adaptation mainly occurs during quiescent states such as anesthesia, slow-wave sleep, and awake immobility. In contrast, during behaviorally activated states, sensory responses are already adapted. For instance, during learning of a behavioral task, when an animal is very alert and expectant, sensory adaptation is mostly absent. After learning occurs, and the task becomes routine, the level of alertness lessens and sensory adaptation becomes robust. The primary sensory thalamocortical pathway of alert and expectant animals is in the adapted state, which may be required for adequate sensory information processing.	Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA	Drexel University	Castro-Alamancos, MA (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA.	manuel.castro@drexel.edu		Castro-Alamancos, Manuel/0000-0002-2916-9585	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046305] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS046305, R01 NS046305-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Bruno RM, 2002, J NEUROSCI, V22, P10966; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; Castro-Alamancos MA, 2001, J NEUROPHYSIOL, V85, P1489, DOI 10.1152/jn.2001.85.4.1489; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; CHAPIN JK, 1981, EXP NEUROL, V72, P164, DOI 10.1016/0014-4886(81)90135-7; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Hartings JA, 1998, J NEUROPHYSIOL, V80, P1016, DOI 10.1152/jn.1998.80.2.1016; HELLWEG FC, 1977, J NEUROPHYSIOL, V40, P463, DOI 10.1152/jn.1977.40.3.463; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Kohn A, 2002, BEHAV BRAIN RES, V135, P119, DOI 10.1016/S0166-4328(02)00139-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEE SM, 1994, J NEUROPHYSIOL, V71, P1716, DOI 10.1152/jn.1994.71.5.1716; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; NELSON RJ, 1984, BRAIN RES, V304, P143, DOI 10.1016/0006-8993(84)90870-9; NELSON SB, 1991, J NEUROSCI, V11, P369; NICHOLSON C, 1979, ELECTROPHYSIOLOGICAL, P93; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Oldford E, 2003, NEUROSCIENCE, V117, P769, DOI 10.1016/S0306-4522(02)00663-2; Paxinos G., 2004, J CHEM INF MODEL, V5th; PURPURA DP, 1959, INT REV NEUROBIOL, V1, P47, DOI 10.1016/S0074-7742(08)60314-1; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; Sheth BR, 1998, J NEUROPHYSIOL, V79, P464, DOI 10.1152/jn.1998.79.1.464; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STERIADE M, 1969, J NEUROPHYSIOL, V32, P251, DOI 10.1152/jn.1969.32.2.251; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Wilson DA, 1998, J NEUROPHYSIOL, V80, P998, DOI 10.1152/jn.1998.80.2.998; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	44	170	171	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					455	464		10.1016/S0896-6273(03)00853-5	http://dx.doi.org/10.1016/S0896-6273(03)00853-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766183	Bronze			2022-12-28	WOS:000221457900015
J	Sterling, P; Smith, RG				Sterling, P; Smith, RG			Design for a binary synapse	NEURON			English	Editorial Material							BIPOLAR CELLS; RETINA; RODS; SENSITIVITY; NOISE; CAT	The mammalian rod transfers a binary signal, the capture of 0 or 1 photon. In this issue of Neuron, Sampath and Rieke show in mouse that the rod's tonic exocytosis in darkness completely saturates a G protein cascade to close nearly all postsynaptic channels. A full-sized photon event supresses exocytosis sufficiently to allow similar to30 postsynaptic channels to open simultaneously. Thus, the synapse behaves like a digital gate, whose hallmark is reliability and resistance to noise.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Sterling, P (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.							Barlow H B, 1971, Vision Res, VSuppl 3, P87; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; NELSON R, 1975, SCIENCE, V189, P137, DOI 10.1126/science.1138370; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rose A., 1973, VISION HUMAN ELECT; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Singer JH, 2003, J NEUROSCI, V23, P10923; van Rossum MCW, 1998, VISUAL NEUROSCI, V15, P809, DOI 10.1017/S0952523898155037; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E	13	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 5	2004	41	3					313	315		10.1016/S0896-6273(04)00044-3	http://dx.doi.org/10.1016/S0896-6273(04)00044-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766171	Bronze			2022-12-28	WOS:000221457900003
J	Gold, DA; Baek, SH; Schork, NJ; Rose, DW; Larsen, DD; Sachs, BD; Rosenfeld, MG; Hamilton, BA				Gold, DA; Baek, SH; Schork, NJ; Rose, DW; Larsen, DD; Sachs, BD; Rosenfeld, MG; Hamilton, BA			ROR alpha coordinates reciprocal signaling in cerebellar development through Sonic hedgehog and calcium-dependent pathways	NEURON			English	Article							STAGGERER MUTANT MICE; ORPHAN NUCLEAR RECEPTOR; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR-TYPE-1; PURKINJE-CELL PROTEIN-2; C-KIT RECEPTOR; UP-REGULATION; THYROID-HORMONE; NEURON PRECURSORS; GENE-EXPRESSION; DEFICIENT MICE	The cerebellum provides an excellent system for understanding how afferent and target neurons coordinate sequential intercellular signals and cell-autonomous genetic programs in development. Mutations in the orphan nuclear receptor RORalpha block Purkinje cell differentiation with a secondary loss of afferent granule cells. We show that early transcriptional targets of RORalpha include both mitogenic signals for afferent progenitors and signal transduction genes required to process their subsequent synaptic input. RORalpha acts through recruitment of gene-specific sets of transcriptional cofactors, including beta-catenin, p300, and Tip60, but appears independent of CBP. One target promoter is Sonic hedgehog, and recombinant Sonic hedgehog restores granule precursor proliferation in RORalpha-deficient cerebellum. Our results suggest a link between RORalpha and beta-catenin pathways, confirm that a nuclear receptor employs distinct coactivator complexes at different target genes, and provide a logic for early RORalpha expression in coordinating expression of genes required for reciprocal signals in cerebellar development.	Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hamilton, BA (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Schork, Nicholas/0000-0003-0920-5013; Larsen, DeLaine/0000-0002-9689-8454; Hamilton, Bruce/0000-0001-5599-9139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059207] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM 008666, T32 GM008666] Funding Source: Medline; NIMH NIH HHS [R01 MH059207-03, R01 MH059207-05, R01 MH059207-06, R01 MH059207-04, R01 MH059207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Brault V, 2001, DEVELOPMENT, V128, P1253; CREPEL F, 1980, NATURE, V283, P483, DOI 10.1038/283483a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GIGUERE V, 1995, MOL CELL BIOL, V15, P2517; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HATTEN ME, 1978, NATURE, V276, P504, DOI 10.1038/276504a0; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; Hirota J, 2003, BIOCHEM J, V372, P435, DOI 10.1042/BJ20030110; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim D, 2003, J NEUROSCI RES, V71, P72, DOI 10.1002/jnr.10466; Koibuchi N, 1998, ENDOCRINOLOGY, V139, P2335, DOI 10.1210/en.139.5.2335; Kuno-Murata M, 2000, ENDOCRINOLOGY, V141, P2275, DOI 10.1210/en.141.6.2275; LANDIS DMD, 1977, J COMP NEUROL, V171, P247, DOI 10.1002/cne.901710208; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; Lau P, 1999, NUCLEIC ACIDS RES, V27, P411, DOI 10.1093/nar/27.2.411; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; MATSUI K, 1993, LIFE SCI, V53, P333, DOI 10.1016/0024-3205(93)90752-O; Nakagawa S, 1997, NEUROSCI RES, V28, P177, DOI 10.1016/S0168-0102(97)00042-4; Nakagawa S, 1996, EUR J NEUROSCI, V8, P1401, DOI 10.1111/j.1460-9568.1996.tb01602.x; Neter J, 1985, APPL LINEAR STAT MET, V2nd; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; SOTELO C, 1974, BRAIN RES, V67, P519, DOI 10.1016/0006-8993(74)90499-5; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; STRAIT KA, 1991, P NATL ACAD SCI USA, V88, P3887, DOI 10.1073/pnas.88.9.3887; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TRENKNER E, 1979, NATURE, V277, P566, DOI 10.1038/277566a0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Vogel MW, 2000, J NEUROBIOL, V42, P323, DOI 10.1002/(SICI)1097-4695(20000215)42:3<323::AID-NEU4>3.0.CO;2-2; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; YOON CH, 1972, NEUROLOGY, V22, P743, DOI 10.1212/WNL.22.7.743; Zhang SC, 1997, J NEUROSCI RES, V47, P1; Zhang XL, 2002, MOL BRAIN RES, V105, P1, DOI 10.1016/S0169-328X(02)00379-0; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zupanc GKH, 2001, NEUROSCI LETT, V309, P149, DOI 10.1016/S0304-3940(01)02061-4; Zupanc GKH, 1999, NEUROSCI LETT, V268, P135, DOI 10.1016/S0304-3940(99)00299-2	63	124	128	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1119	1131		10.1016/S0896-6273(03)00769-4	http://dx.doi.org/10.1016/S0896-6273(03)00769-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687547	Bronze, Green Accepted			2022-12-28	WOS:000187503400011
J	Lerner, Y; Pianka, P; Azmon, B; Leiba, H; Stolovitch, C; Loewenstein, A; Harel, M; Hendler, T; Malach, R				Lerner, Y; Pianka, P; Azmon, B; Leiba, H; Stolovitch, C; Loewenstein, A; Harel, M; Hendler, T; Malach, R			Area-specific amblyopic occipitotemporal object effects in human representations	NEURON			English	Article							FUSIFORM FACE AREA; EARLY VISUAL EXPERIENCE; CORTEX; FMRI; PERCEPTION; ACTIVATION; STRIATE	The role of early visual experience in the establishment of human high-order visual areas is poorly understood. Here we investigated this issue using human amblyopia-a developmental visual disorder, which manifests a central vision (acuity) deficit. Previous fMRI studies of amblyopes have described abnormal functional activations in early retinotopic areas. Here we report the surprising finding of a selective object-related abnormality in high-order occipitotemporal cortex. Specifically, we found that face-related cortical areas show a severe disconnection from the amblyopic eye, while building-related regions remain essentially normal. The selectivity of the deficit highlights the differential computations performed in the different object-related areas and is compatible with the suggested association of face regions with analysis of fine detail.	Weizmann Inst Sci, IL-76100 Rehovot, Israel; Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; Notal Vis Co, IL-63143 Tel Aviv, Israel; Kaplan Med Ctr, IL-76100 Rehovot, Israel; Tel Aviv Univ, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University	Malach, R (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		hendler, talma/C-7677-2012					Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Algaze A, 2002, J AAPOS, V6, P300, DOI 10.1067/mpa.2002.124902; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Demer J L, 1997, J AAPOS, V1, P158, DOI 10.1016/S1091-8531(97)90059-8; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Goodyear BG, 2000, J NEUROPHYSIOL, V84, P1907, DOI 10.1152/jn.2000.84.4.1907; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hess R. F., 1990, VISION CODING EFFICI, P267; HESS RF, 1978, PFLUG ARCH EUR J PHY, V377, P201, DOI 10.1007/BF00584273; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiorpes L, 1996, COLD SPRING HARB SYM, V61, P39; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; LeGrand R, 2001, NATURE, V412, P786; Levi DM, 1993, EARLY VISUAL DEV NOR, P391; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MOVSHON J, 1996, OPHTHALMOL VIS SCI, V37, pS670; Movshon J.A., 1990, P155; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; VONNOORDEN GK, 1988, STRABISMUS AMBLYOPIA, P275	33	67	76	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					1023	1029		10.1016/S0896-6273(03)00720-7	http://dx.doi.org/10.1016/S0896-6273(03)00720-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659100	Bronze			2022-12-28	WOS:000187042200018
J	McCoy, AN; Crowley, JC; Haghighian, G; Dean, HL; Platt, ML				McCoy, AN; Crowley, JC; Haghighian, G; Dean, HL; Platt, ML			Saccade reward signals in posterior cingulate cortex	NEURON			English	Article							MONKEY CAUDATE NEURONS; NIGRA PARS RETICULATA; FUNCTIONAL-PROPERTIES; ANTERIOR CINGULATE; ALZHEIMERS-DISEASE; CORTICAL ATROPHY; PARIETAL CORTEX; RHESUS-MONKEY; EXPECTATION; CONNECTIONS	Movement selection depends on the outcome of prior behavior. Posterior cingulate cortex (CGp) is strongly connected with both limbic and oculomotor circuitry, and CGp neurons respond following saccades, suggesting a role in signaling the motivational outcome of gaze shifts. To test this hypothesis, single CGp neurons were studied in monkeys while they shifted gaze to visual targets for liquid rewards that varied in size or were delivered probabilistically. CGp neurons responded following saccades as well as following reward delivery, and these responses were correlated with reward size. CGp neurons also responded following the omission of predicted rewards. The timing of CGp activation and its modulation by reward could provide signals useful for updating representations of expected saccade value.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Duke University; Carnegie Mellon University	Platt, ML (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	platt@neuro.duke.edu			NEI NIH HHS [EY-013496] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; ARNAULD A, 1562, ART THINKING PORT RO; BALEYDIER C, 1980, BRAIN, V103, P525, DOI 10.1093/brain/103.3.525; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; BERNOUILLI D, 1738, WORKS; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; DEVILLIERS PA, 1976, PSYCHOL BULL, V83, P1131, DOI DOI 10.1037/0033-2909.83.6.1131; FINCH DM, 1984, EXP NEUROL, V83, P468, DOI 10.1016/0014-4886(84)90116-X; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fletcher W A, 1994, Curr Opin Ophthalmol, V5, P38; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GABRIEL M, 1991, BEHAV BRAIN RES, V46, P175, DOI 10.1016/S0166-4328(05)80111-1; Gabriel M, 1996, BEHAV BRAIN RES, V82, P23, DOI 10.1016/S0166-4328(97)81105-9; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hof PR, 1997, VISION RES, V37, P3609, DOI 10.1016/S0042-6989(96)00240-4; HOF PR, 1993, ACTA NEUROPATHOL, V86, P215, DOI 10.1007/BF00304135; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PANDYA DN, 1982, J COMP NEUROL, V204, P196, DOI 10.1002/cne.902040208; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephens D.W., 1986, pi; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208	58	139	143	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1031	1040		10.1016/S0896-6273(03)00719-0	http://dx.doi.org/10.1016/S0896-6273(03)00719-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659101	Bronze			2022-12-28	WOS:000187042200019
J	Ricci, AJ; Crawford, AC; Fettiplace, R				Ricci, AJ; Crawford, AC; Fettiplace, R			Tonotopic variation in the conductance of the hair cell mechanotransducer channel	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; JUNCTION CHANNELS; FAST ADAPTATION; CALCIUM; TURTLE; CURRENTS; COCHLEA; DROSOPHILA; KINETICS; BUNDLE	Hair cells in the vertebrate cochlea are arranged tonotopically with their characteristic frequency (CF), the sound frequency to which they are most sensitive, changing systematically with position. Single mechanotransducer channels of hair cells were characterized at different locations in the turtle cochlea. In 2.8 mM external Ca2+, the channel's chord conductance was 118 pS (range 80-163 pS), which nearly doubled (range 149-300 pS) on reducing Ca2+ to 50 muM. In both Ca2+ concentrations, the conductance was positively correlated with hair cell CF. Variation in channel conductance can largely explain the increases in size of the macroscopic transducer current and speed of adaptation with CF. It suggests diversity of transducer channel structure or environment along the cochlea that may be an important element of its tonotopic organization.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.			ricci, anthony/0000-0002-1706-8904	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362, R01DC003896] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 03896, R01 DC 01362] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashcroft FM, 2000, ION CHANNELS DIS; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bonigk W, 1999, J NEUROSCI, V19, P5332; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Fettiplace R, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P65, DOI 10.1142/9789812704931_0007; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HACKNEY CM, 1995, ACTIVE HEARING, P103; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Marty A., 1983, SINGLE CHANNEL RECOR, P107; Meyer J, 1998, J NEUROSCI, V18, P6748; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Verselis V.K., 2000, ADV MOL CEL, V30, P129; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	45	145	152	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					983	990		10.1016/S0896-6273(03)00721-9	http://dx.doi.org/10.1016/S0896-6273(03)00721-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659096	Bronze			2022-12-28	WOS:000187042200014
J	Geschwind, DH				Geschwind, DH			Tau phosphorylation, tangles, and neurodegeneration: The chicken or the egg?	NEURON			English	Review							NEUROFIBRILLARY TANGLES; BETA; P25; HYPERPHOSPHORYLATION; AGGREGATION; CDK5	Pathological aggregation of the microtubule-associated protein tau is a common feature of many neurodegenerative diseases. Although tau aggregation is associated with abnormal tau phosphorylation, the role of phosphorylation in the initiation of neurodegeneration has been unclear. Now, several animal models and data from human patients provide converging evidence that aberrant tau phosphorylation can cause a neurodegenerative phenotype similar to that seen in human neurodegenerative diseases.	Univ Calif Los Angeles, Neurogenet Program, Dept Neurol,David Geffen Sch Med, Ctr Neurobehav Genet,Neuropsychiat Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Neurogenet Program, Dept Neurol,David Geffen Sch Med, Ctr Neurobehav Genet,Neuropsychiat Inst, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	dhg@ucla.edu						Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Allen B, 2002, J NEUROSCI, V22, P9340; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bian F, 2002, J COMP NEUROL, V446, P257, DOI 10.1002/cne.10186; Bird T, 2003, ANN NEUROL, V54, pS29, DOI 10.1002/ana.10572; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kins S, 2001, J BIOL CHEM, V276, P38193; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9	25	111	116	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					457	460		10.1016/S0896-6273(03)00681-0	http://dx.doi.org/10.1016/S0896-6273(03)00681-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642270	Bronze			2022-12-28	WOS:000186379000005
J	Mataga, N; Mizuguchi, Y; Hensch, TK				Mataga, N; Mizuguchi, Y; Hensch, TK			Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator	NEURON			English	Article							LONG-TERM POTENTIATION; OCULAR DOMINANCE PLASTICITY; HEPATOCYTE GROWTH-FACTOR; CRITICAL-PERIOD; MONOCULAR DEPRIVATION; SYNAPTIC PLASTICITY; CORTICAL PLASTICITY; HIPPOCAMPAL-NEURONS; PROTEOLYTIC ACTIVITY; NEUROTROPHIC FACTOR	Sensory experience physically rewires the brain in early postnatal life through unknown processes. Here, we identify a robust anatomical consequence of monocular deprivation (MD) in layer II/III of visual cortex that corresponds to the rapid, functional loss of responsiveness preceding any changes in axonal input. Protrusions on pyramidal cell apical dendrites increased steadily after eye opening, but were transiently lost through competitive mechanisms after brief MD only during the physiological critical period. Proteolysis by tissue-type plasminogen activator (tPA) conversely declined with age and increased with MD only in young mice. Targeted disruption of tPA release or its upstream regulation by glutamic acid decarboxylase (GAD65) prevented MD-induced spine loss that was pharmacologically rescued concomitant with critical period plasticity. An extracellular mechanism for structural remodeling that is limited to the binocular zone upon proper detection of competing inputs thus links early sensory experience to visual function.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan	RIKEN	Hensch, TK (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hensch@riken.jp	Hensch, Takao/L-4182-2019; Mataga, Nobuko/N-5531-2015	Mataga, Nobuko/0000-0003-0991-4354				Antonini A, 1999, J NEUROSCI, V19, P4388; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; Bidoia C, 2004, SCIENCE, V303; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Endo A, 1999, NEUROSCI RES, V33, P1, DOI 10.1016/S0168-0102(98)00105-9; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fiumelli H, 1999, EUR J NEUROSCI, V11, P1639, DOI 10.1046/j.1460-9568.1999.00580.x; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hoffman KB, 1998, BRAIN RES, V811, P29, DOI 10.1016/S0006-8993(98)00906-8; Horwood JM, 2004, BEHAV BRAIN RES, V150, P127, DOI 10.1016/S0166-4328(03)00248-1; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jiang B, 2003, J NEUROSCI, V23, P3761; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; LIU Y, 1994, J NEUROBIOL, V25, P325, DOI 10.1002/neu.480250312; Lochner JE, 1998, MOL BIOL CELL, V9, P2463, DOI 10.1091/mbc.9.9.2463; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; MARS WM, 1993, AM J PATHOL, V143, P949; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; Mataga N, 1996, NEUROSCI LETT, V218, P149, DOI 10.1016/S0304-3940(96)13139-6; Mataga N, 2001, J NEUROSCI, V21, P9724, DOI 10.1523/JNEUROSCI.21-24-09724.2001; MATAGA N, 2002, PROTEASES BRAIN PROT, V3; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matys T, 2003, NAT MED, V9, P371, DOI 10.1038/nm0403-371; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murphy DD, 1998, J NEUROSCI, V18, P2550; Murphy DD, 1998, P NATL ACAD SCI USA, V95, P11412, DOI 10.1073/pnas.95.19.11412; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; PARNAVELAS JG, 1973, EXP NEUROL, V40, P742, DOI 10.1016/0014-4886(73)90108-8; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Quattrocchi CC, 2003, SCIENCE, V301, P1849; Quattrocchi CC, 2003, SCIENCE, V301, P649, DOI 10.1126/science.1082690; RICCIO RV, 1985, DEV BRAIN RES, V19, P173, DOI 10.1016/0165-3806(85)90189-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Seeds NW, 2003, J NEUROSCI, V23, P7368; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shiosaka S, 2000, NEUROSCI RES, V37, P85, DOI 10.1016/S0168-0102(00)00115-2; Silver MA, 1999, J NEUROSCI, V19, P10829, DOI 10.1523/JNEUROSCI.19-24-10829.1999; SUMI Y, 1992, DEVELOPMENT, V116, P625; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Thewke DP, 1996, J NEUROSCI, V16, P6933; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tsirka SE, 1997, J NEUROSCI, V17, P543; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; VALVERDE F, 1967, EXP BRAIN RES, V3, P337; VALVERDE F, 1971, BRAIN RES, V33, P1, DOI 10.1016/0006-8993(71)90302-7; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Wannier-Morino P, 2003, EUR J NEUROSCI, V17, P1853, DOI 10.1046/j.1460-9568.2003.02628.x; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	90	270	283	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					1031	1041		10.1016/j.neuron.2004.11.028	http://dx.doi.org/10.1016/j.neuron.2004.11.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603745	Bronze			2022-12-28	WOS:000225842300016
J	Menon, KP; Sanyal, S; Habara, Y; Sanchez, R; Wharton, RP; Ramaswami, M; Zinn, K				Menon, KP; Sanyal, S; Habara, Y; Sanchez, R; Wharton, RP; Ramaswami, M; Zinn, K			The translational repressor Pumilio regulates presynaptic morphology and controls postsynaptic accumulation of translation factor elF-4E	NEURON			English	Article							CYTOPLASMIC POLYADENYLATION ELEMENT; DROSOPHILA NEUROMUSCULAR-JUNCTION; HUNCHBACK MESSENGER-RNA; GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; BINDING PROTEIN; AXON GUIDANCE; STEM-CELLS; NANOS; EXPRESSION	Translational repression by Drosophila Pumilio (Pum) protein controls posterior patterning during embryonic development. Here, we show that Pum is an important mediator of synaptic growth and plasticity at the neuromuscular junction (NMJ). Pum is localized to the postsynaptic side of the NMJ in third instar larvae and is also expressed in larval neurons. Neuronal Pum regulates synaptic growth. In its absence, NMJ boutons are larger and fewer in number, while Pum overexpression increases bouton number and decreases bourton size. Postsynaptic Pum negatively regulates expression of the translation factor elF-4E at the NMJ, and Pum binds selectively to the 3'UTR of elF-4E mRNA. The GluRlla glutamate receptor is upregulated in pum mutants. These results, together with genetic epistasis studies, suggest that postsynaptic Pum modulates synaptic function via direct control of elF-4E expression.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85716 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85716 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	California Institute of Technology; University of Arizona; University of Arizona; Duke University; Howard Hughes Medical Institute	Zinn, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu		Ramaswami, Mani/0000-0001-7631-0468; Sanyal, Subhabrata/0000-0003-2590-2732	NCI NIH HHS [T32 CA09213] Funding Source: Medline; NIDA NIH HHS [DA15495, DA15383] Funding Source: Medline; NINDS NIH HHS [R01 NS043416, R37 NS028182, R01 NS028182-15, R01 NS028182, R01 NS43416, R01 NS043416-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182, R01NS043416, R37NS028182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015383, R01DA015495] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; Forbes A, 1998, DEVELOPMENT, V125, P679; Jiang CG, 2002, TRENDS BIOCHEM SCI, V27, P506, DOI 10.1016/S0968-0004(02)02190-4; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Menon KP, 1998, DEVELOPMENT, V125, P4121; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Parisi M, 1999, GENETICS, V153, P235; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rorth P, 1998, DEVELOPMENT, V125, P1049; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schweers BA, 2002, GENETICS, V161, P1177; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; STERN M, 1990, GENETICS, V124, P133; STERN M, 1989, J NEUROGENET, V5, P215, DOI 10.3109/01677068909066209; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Stimson DT, 1998, J NEUROSCI, V18, P9638; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	38	119	122	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					663	676		10.1016/j.neuron.2004.10.028	http://dx.doi.org/10.1016/j.neuron.2004.10.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541314	Bronze			2022-12-28	WOS:000225338100012
J	Carter, AG; Sabatini, BL				Carter, AG; Sabatini, BL			State-dependent calcium signaling in dendritic spines of striatal medium spiny neurons	NEURON			English	Article							RAT NEOSTRIATAL NEURONS; LONG-TERM POTENTIATION; GATED CA2+ CHANNELS; NMDA RECEPTORS; PYRAMIDAL NEURONS; SINGLE SPINES; HIPPOCAMPAL-NEURONS; IN-VIVO; CREB PHOSPHORYLATION; SYNAPTIC EFFICACY	Striatal medium spiny neurons (MSNs) in vivo undergo large membrane depolarizations known as state transitions. Calcium (Ca) entry into MSNs triggers diverse downstream cellular processes. However, little is known about Ca signals in MSN dendrites and spines and how state transitions influence these signals. Here, we develop a novel approach, combining 2-photon Ca imaging and 2-photon glutamate uncaging, to examine how voltage-sensitive Ca channels (VSCCs) and ionotropic glutamate receptors contribute to Ca signals in MSNs. We find that upstate transitions switch the VSCCs available in dendrites and spines, decreasing T-type while enhancing L-type channels. Moreover, these transitions change the dominant synaptic Ca source from Ca-permeable AMPA receptors to NMDA receptors. Finally, pairing bAPs with synaptic inputs generates additional synaptic Ca signals due to enhanced Ca influx through NMDA receptors. By altering the sources, amplitude, and kinetics of spine Ca signals, state transitions may gate synaptic plasticity and gene expression in MSNs.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, T32NS007484] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS07484, R01 NS046579-01A] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akopian G, 2002, J NEUROPHYSIOL, V87, P157, DOI 10.1152/jn.00115.2001; BARGAS J, 1994, J NEUROSCI, V14, P6667; Bernard V, 1997, J NEUROSCI, V17, P819; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Cepeda C, 1998, J NEUROPHYSIOL, V79, P82, DOI 10.1152/jn.1998.79.1.82; Chen Q, 1998, NEUROSCIENCE, V83, P749, DOI 10.1016/S0306-4522(97)00452-1; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Egger V, 2003, J NEUROSCI, V23, P7551; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Foehring RC, 2000, J NEUROPHYSIOL, V84, P2225, DOI 10.1152/jn.2000.84.5.2225; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; HOEHN K, 1993, J NEUROSCI, V13, P1244; JAHR CE, 1990, J NEUROSCI, V10, P1830; Jimenez C, 2000, NEUROPHARMACOLOGY, V39, P1, DOI 10.1016/S0028-3908(99)00153-7; Kerr JND, 2004, J NEUROSCI, V24, P877, DOI 10.1523/JNEUROSCI.4475-03.2004; Kerr JND, 2002, J NEUROSCI, V22, P1499, DOI 10.1523/JNEUROSCI.22-05-01499.2002; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Konradi C, 1996, J NEUROSCI, V16, P4231; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Plenz D, 1998, J NEUROSCI, V18, P266; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Song WJ, 1996, J NEUROPHYSIOL, V76, P2290, DOI 10.1152/jn.1996.76.4.2290; Stefani A, 1998, DEV NEUROSCI-BASEL, V20, P242, DOI 10.1159/000017318; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; Waters J, 2003, J NEUROSCI, V23, P8558; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	60	245	251	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					483	493		10.1016/j.neuron.2004.10.013	http://dx.doi.org/10.1016/j.neuron.2004.10.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504328	Bronze			2022-12-28	WOS:000224771700010
J	Peigneux, P; Laureys, S; Fuchs, S; Collette, F; Perrin, F; Reggers, J; Phillips, C; Degueldre, C; Del Fiore, G; Aerts, J; Luxen, A; Maquet, P				Peigneux, P; Laureys, S; Fuchs, S; Collette, F; Perrin, F; Reggers, J; Phillips, C; Degueldre, C; Del Fiore, G; Aerts, J; Luxen, A; Maquet, P			Are spatial memories strengthened in the human hippocampus during slow wave sleep?	NEURON			English	Article							LATE NOCTURNAL SLEEP; CEREBRAL-BLOOD-FLOW; EYE-MOVEMENT SLEEP; DECLARATIVE MEMORY; SUBSEQUENT SLEEP; REM-SLEEP; EXPERIENCE; SYSTEMS; REACTIVATION; BRAIN	In rats, the firing sequences observed in hippocampal ensembles during spatial learning are replayed during subsequent sleep, suggesting a role for posttraining sleep periods in the offline processing of spatial memories. Here, using regional cerebral blood flow measurements, we show that, in humans, hippocampal areas that are activated during route learning in a virtual town are likewise activated during subsequent slow wave sleep. Most importantly, we found that the amount of hippocampal activity expressed during slow wave sleep positively correlates with the improvement of performance in route retrieval on the next day. These findings suggest that learning-dependent modulation in hippocampal activity during human sleep reflects the offline processing of recent episodic and spatial memory traces, which eventually leads to the plastic changes underlying the subsequent improvement in performance.	Univ Liege, Cyclotron Res Ctr, B-4000 Cointe Ougree, Belgium; Univ Liege, Neuropsychol Unit, Fac Psychol & Sci Educ, B-4000 Liege, Belgium; Univ Liege, Ctr Hosp Univ, Dept Neurol, B-4000 Cointe Ougree, Belgium	University of Liege; University of Liege; University of Liege	Peigneux, P (corresponding author), Univ Liege, Cyclotron Res Ctr, B-4000 Cointe Ougree, Belgium.	philippe.peigneux@ulg.ac.be	Laureys, Steven/A-3349-2011; luxen, andre/C-2116-2009; Laureys, Steven/AAN-2097-2021; Phillips, Christophe/M-3025-2017	Laureys, Steven/0000-0002-3096-3807; , Pierre/0000-0003-3106-3357; , Fabien/0000-0002-1444-3414; Phillips, Christophe/0000-0002-4990-425X; Peigneux, Philippe/0000-0003-4745-1434				Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BRETT M, 1999, NEUROIMAGE, V9, pS56; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FOGEL S, 2001, ACTAS FISIOLOGIA, V7, P123; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; Hofle N, 1997, J NEUROSCI, V17, P4800; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2001, NEUROIMAGE, V13, P743, DOI 10.1006/nimg.2000.0712; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2000, J SLEEP RES, V9, P207; Maquet P., 2003, SLEEP BRAIN PLASTICI; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; OKEEFE J, 1978, HIPPOCAMPUS COGNIIVE; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Plihal W, 1999, PSYCHONEUROENDOCRINO, V24, P313, DOI 10.1016/S0306-4530(98)00080-8; QIN YL, 1999, HIPPOCAMPAL PARIETAL, P305; Rauch SL, 1995, HUM BRAIN MAPP, V3, P271, DOI 10.1002/hbm.460030403; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; RIBEIRO S, 2004, LONG LASTING NOVELTY; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shelton AL, 2002, J NEUROSCI, V22, P2711, DOI 10.1523/JNEUROSCI.22-07-02711.2002; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Staba RJ, 2002, HIPPOCAMPUS, V12, P724, DOI 10.1002/hipo.10026; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; TULVING E, 1987, HUM NEUROBIOL, V6, P67; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	63	503	510	2	78	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 28	2004	44	3					535	545		10.1016/j.neuron.2004.10.007	http://dx.doi.org/10.1016/j.neuron.2004.10.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504332	Bronze, Green Submitted			2022-12-28	WOS:000224771700014
J	Hutter-Paier, B; Huttunen, HJ; Puglielli, L; Eckman, CB; Kim, DY; Hofmeister, A; Moir, RD; Domnitz, SB; Frosch, MP; Windisch, M; Kovacs, DM				Hutter-Paier, B; Huttunen, HJ; Puglielli, L; Eckman, CB; Kim, DY; Hofmeister, A; Moir, RD; Domnitz, SB; Frosch, MP; Windisch, M; Kovacs, DM			The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease	NEURON			English	Article							SECRETASE-LIKE CLEAVAGE; PRECURSOR-PROTEIN; TRANSGENIC MICE; BETA-PROTEIN; IN-VITRO; CHOLESTEROL; PRESENILIN-1; DEPOSITION; APP; PURIFICATION	Amyloid beta-peptide (Abeta) accumulation in specific brain regions is a pathological hallmark of Alzheimer's disease (AD). We have previously reported that a well characterized acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor, CP-113,818, inhibits Abeta production in cell-based experiments. Here, we assessed the efficacy of CP-113,818 in reducing AD-like pathology in the brains of transgenic mice expressing human APP(751) containing the London (V7171) and Swedish (K670M/N671L) mutations. Two months of treatment with CP-113,818 reduced the accumulation of amyloid plaques by 88%-99% and membrane/insoluble Abeta levels by 83%-96%, while also decreasing brain cholesteryl-esters by 86%. Additionally, soluble Abeta(42) was reduced by 34% in brain homogenates. Spatial learning was slightly improved and correlated with decreased Abeta levels. In nontransgenic littermates, CP-113,818 also reduced ectodomain shedding of endogenous APP in the brain. Our results suggest that ACAT inhibition may be effective in the prevention and treatment of AD by inhibiting generation of the Abeta peptide.	Harvard Univ, Sch Med, Neurobiol Dis Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; JSW Res Forsch Labor GmbH, Inst Expt Pharmacol, A-8020 Graz, Austria	Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Mayo Clinic	Kovacs, DM (corresponding author), Harvard Univ, Sch Med, Neurobiol Dis Lab, Charlestown, MA 02129 USA.	dora_kovacs@hms.harvard.edu	Frosch, Matthew P/ABD-7456-2021; Moir, Robert D./M-7612-2017	Frosch, Matthew P/0000-0002-3940-9861; Moir, Robert D./0000-0001-5431-3553; Huttunen, Henri/0000-0002-9867-4438				Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Champagne D, 2003, NEUROSCIENCE, V121, P99, DOI 10.1016/S0306-4522(03)00361-0; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2001, J LIPID RES, V42, P1933; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Harter D, 2001, BEHAV BRAIN SCI, V24, P45, DOI 10.1017/S0140525X01303916; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; MARZETTA CA, 1994, J LIPID RES, V35, P1829; Park IH, 2003, NEUROBIOL AGING, V24, P637, DOI 10.1016/S0197-4580(02)00155-0; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shah Prediman K, 2003, Rev Cardiovasc Med, V4, P136; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651	45	199	210	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					227	238		10.1016/j.neuron.2004.08.043	http://dx.doi.org/10.1016/j.neuron.2004.08.043			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473963	Bronze			2022-12-28	WOS:000224635800007
J	Duchaine, BC; Dingle, K; Butterworth, E; Nakayama, K				Duchaine, BC; Dingle, K; Butterworth, E; Nakayama, K			Normal greeble learning in a severe case of developmental prosopagnosia	NEURON			English	Article							FUSIFORM FACE AREA; EXPERT OBJECT RECOGNITION; PERCEPTION; MECHANISMS; RESPONSES	A central question in cognitive neuroscience is whether mechanisms exist that are specialized for particular domains. One of the most commonly cited examples of a domain-specific competence is the human ability to recognize upright faces. However, according to a widely discussed alternative hypothesis, face recognition is instead performed by mechanisms specialized for processing any object class for which an individual has expertise. Faces, according to this domain-general hypothesis, are just one example of an expert class. Nonface object expertise has been intensively investigated using a training procedure involving an artificial stimulus class known as greebles. A key prediction of this hypothesis is that individuals with face recognition impairments will also have impairments with other categories that control subjects have expertise with. Our results show that a man with severe prosopagnosia performed normally throughout the standard greeble training procedure. These findings indicate that face recognition and greeble recognition rely on separate mechanisms.	Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA; Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA	Harvard University; Vanderbilt University	Duchaine, BC (corresponding author), Harvard Univ, Dept Psychol, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.		Duchaine, Brad/A-3207-2010		NEI NIH HHS [R01 EY13602] Funding Source: Medline; NIMH NIH HHS [F32 MH64246-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH064246] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CAREY S, 1992, PHILOS T ROY SOC B, V335, P95, DOI 10.1098/rstb.1992.0012; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; DUCHAINE B, 2004, IN PRESS J COGN NEUR; Duchaine BC, 2003, NEUROCASE, V9, P380, DOI 10.1076/neur.9.5.380.16556; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; Farah MJ, 1996, BEHAV BRAIN RES, V76, P181, DOI 10.1016/0166-4328(95)00198-0; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; GROSS CG, 1972, J NEUROPHYSIOL, V80, P324; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCKONE E, 2004, MONKEY BRAIN HUMAN B; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; SERGENT J, 1992, CEREB CORTEX, V2, P375, DOI 10.1093/cercor/2.5.375; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	27	54	58	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 19	2004	43	4					469	473		10.1016/j.neuron.2004.08.006	http://dx.doi.org/10.1016/j.neuron.2004.08.006			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312646	Bronze			2022-12-28	WOS:000223436400006
J	Logan, MA; Vetter, ML				Logan, MA; Vetter, ML			Do-it-yourself tiling: Dendritic growth in the absence of homotypic contacts	NEURON			English	Editorial Material							RETINAL GANGLION-CELLS	Many subtypes of neurons are precisely arranged with little overlap of their dendritic arbors, which has been suggested to arise due to homotypic dendritic repulsion. In this issue of Neuron, Lin et al. demonstrate that subtypes of retinal ganglion cells establish normal dendritic field sizes and morphologies in the absence of contact with cells of the same class.	Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 83142 USA; Univ Utah, Interdept Neurosci Program, Salt Lake City, UT 83142 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Logan, MA (corresponding author), Univ Utah, Dept Neurobiol & Anat, 20 N 1900 E, Salt Lake City, UT 83142 USA.			Vetter, Monica/0000-0001-6262-8504				BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; HITCHCOCK PF, 1989, DEVELOPMENT, V106, P589; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jeyarasasingam G, 1998, J COMP NEUROL, V394, P335; KIRBY MA, 1986, J COMP NEUROL, V251, P532, DOI 10.1002/cne.902510408; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301	11	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 19	2004	43	4					439	440		10.1016/j.neuron.2004.08.010	http://dx.doi.org/10.1016/j.neuron.2004.08.010			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312641	Bronze			2022-12-28	WOS:000223436400001
J	Godement, P; Mason, C				Godement, P; Mason, C			It's all in the assay: A new model for retinotectal topographic mapping	NEURON			English	Editorial Material							GROWTH CONES; EPH RECEPTOR; AXONS; GRADIENTS; GUIDANCE	Ephrin-As have been implicated as topographic mapping labels in the retinotectal system, but the underlying molecular mechanisms for their activities in this context remain somewhat mysterious. Hansen et al. (this issue of Neuron) developed an assay that reveals new mechanisms for ephrins in topographic mapping and suggest a model whereby retinal axons grow and terminate in the tectum via a balance of growth promotion and repulsion, with the balance point depending on retinal position and concentration of ephrin-As.	Univ Paris 05, CNRS, UMR 7060,UFR Biomed, Lab Neurobiol Reseaux Sensorimoteurs, Paris, France; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Pathol, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Columbia University	Godement, P (corresponding author), Univ Paris 05, CNRS, UMR 7060,UFR Biomed, Lab Neurobiol Reseaux Sensorimoteurs, Paris, France.							Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Llirbat B, 1999, EUR J NEUROSCI, V11, P2103, DOI 10.1046/j.1460-9568.1999.00628.x; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; WALTER J, 1987, DEVELOPMENT, V101, P685; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341	13	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 10	2004	42	5					697	699		10.1016/j.neuron.2004.05.018	http://dx.doi.org/10.1016/j.neuron.2004.05.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182709	Bronze			2022-12-28	WOS:000221975000001
J	Long, H; Sabatier, C; Ma, L; Plump, A; Yuan, WL; Ornitz, DM; Tamada, A; Murakami, F; Goodman, CS; Tessier-Lavigne, M				Long, H; Sabatier, C; Ma, L; Plump, A; Yuan, WL; Ornitz, DM; Tamada, A; Murakami, F; Goodman, CS; Tessier-Lavigne, M			Conserved roles for slit and robo proteins in midline commissural axon guidance	NEURON			English	Article							LONG-RANGE GUIDANCE; DORSOVENTRAL POSITION; LATERAL POSITION; SPINAL-CORD; FLOOR PLATE; CNS MIDLINE; RECEPTORS; DROSOPHILA; ROUNDABOUT; EXPRESSION	In Drosophila, Slit at the midline activates Robo receptors on commissural axons, thereby repelling them out of the midline into distinct longitudinal tracts on the contralateral side of the central nervous system. In the vertebrate spinal cord, Robo1 and Robo2 are expressed by commissural neurons, whereas all three Slit homologs are expressed at the ventral midline. Previous analysis of Slit1;Slit2 double mutant spinal cords failed to reveal a defect in commissural axon guidance. We report here that when all six Slit alleles are removed, many commissural axons fail to leave the midline, while others recross it. In addition, Robo1 and Robo2 single mutants show guidance defects that reveal a role for these two receptors in guiding commissural axons to different positions within the ventral and lateral funiculi. These results demonstrate a key role for Slit/Robo signaling in midline commissural axon guidance in vertebrates.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Natl Inst Basic Biol, Div Behav & Neurobiol, Okazaki, Aichi 4448585, Japan; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Washington University (WUSTL); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com	Ma, Le/A-3733-2013	Tamada, Atsushi/0000-0003-3677-6102; Ornitz, David/0000-0003-1592-7629; Ma, Le/0000-0003-2769-9416	NIDCD NIH HHS [DCO4289] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004289] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; GRIESHAMMER U, 2004, IN PRESS DEV CELL, V6; Imondi R, 2000, DEVELOPMENT, V127, P1397; Imondi R, 2001, DEVELOPMENT, V128, P4859; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; SABATIER C, 2004, IN PRESS CELL, V117; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	28	335	346	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					213	223		10.1016/S0896-6273(04)00179-5	http://dx.doi.org/10.1016/S0896-6273(04)00179-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091338	Bronze			2022-12-28	WOS:000221458500007
J	Verderio, C; Pozzi, D; Pravettoni, E; Inverardi, F; Schenk, U; Coco, S; Proux-Gillardeaux, V; Galli, T; Rossetto, O; Frassoni, C; Matteoli, M				Verderio, C; Pozzi, D; Pravettoni, E; Inverardi, F; Schenk, U; Coco, S; Proux-Gillardeaux, V; Galli, T; Rossetto, O; Frassoni, C; Matteoli, M			SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; PROTEIN SNAP-25; CA2+ CHANNELS; SYNAPTOTAGMIN-I; SNARE PROTEIN; TETANUS TOXIN; RELEASE; MEMBRANE; CELLS	SNAP-25 is a component of the SNARE complex implicated in synaptic vesicle exocytosis. In this study, we demonstrate that hippocampal GABAergic synapses, both in culture and in brain, lack SNAP-25 and are resistant to the action of botulinum toxins type A and E, which cleave this SNARE protein. Relative to glutamatergic neurons, which express SNAP-25, GABAergic cells were characterized by a higher calcium responsiveness to depolarization. Exogenous expression of SNAP-25 in GABAergic interneurons lowered calcium responsiveness, and SNAP-25 silencing in glutamatergic neurons increased calcium elevations evoked by depolarization. Expression of SNAP-25(1-197) but not of SNAP-25(1-180) inhibited calcium responsiveness, pointing to the involvement of the 180-197 residues in the observed function. These data indicate that SNAP-25 is crucial for the regulation of intracellular calcium dynamics and, possibly, of network excitability. SNAP-25 is therefore a multifunctional protein that participates in exocytotic function both at the mechanistic and at the regulatory level.	Univ Milan, CNR Inst Neurosci, Ctr Excellence Neurodegenerat Dis, Dept Med Pharmacol, I-20129 Milan, Italy; Inst Nacl Neurol C Besta, Dip Neurofisiol Sperimentale, I-20133 Milan, Italy; INSERM, U536, Inst Fer Moulin, F-75005 Paris, France; Univ Padua, Dip Sci Biomed Sperimentali, I-35121 Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Padua	Matteoli, M (corresponding author), Univ Milan, CNR Inst Neurosci, Ctr Excellence Neurodegenerat Dis, Dept Med Pharmacol, Via Vanvitelli 32, I-20129 Milan, Italy.	m.matteoli@in.cnr.it	Coco, Silvia/AAD-6719-2022; Galli, Thierry/Q-2249-2019; Pozzi, Davide/A-7021-2016; Galli, Thierry/G-8842-2011; rossetto, ornella/AAC-3866-2022; Frassoni, Carolina CF/J-8337-2016; Matteoli, Michela/K-4526-2018; verderio, claudia/K-4415-2016	Galli, Thierry/0000-0001-8514-7455; Pozzi, Davide/0000-0001-6436-0556; Galli, Thierry/0000-0001-8514-7455; rossetto, ornella/0000-0002-6113-3857; Frassoni, Carolina CF/0000-0002-9300-5139; Matteoli, Michela/0000-0002-3569-7843; verderio, claudia/0000-0001-7216-5873; COCO, SILVIA/0000-0002-3883-9472				[Anonymous], 1977, HDB PHYSL NERVOUS SY; Armano S, 2002, J BIOL CHEM, V277, P10467, DOI 10.1074/jbc.M110942200; ASHTON AC, 1988, J NEUROCHEM, V50, P1808, DOI 10.1111/j.1471-4159.1988.tb02482.x; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Benson DL, 1998, J NEUROSCI, V18, P6892; BIGALKE H, 1981, N-S ARCH PHARMACOL, V316, P244, DOI 10.1007/BF00505657; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; CHIEREGATTI E, 2004, IN PRESS MOL BIOL CE; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; Ji JZ, 2002, J BIOL CHEM, V277, P20195, DOI 10.1074/jbc.M201034200; JONES EG, 1994, J NEUROSCI, V14, P611; Kavalali ET, 2002, BIOESSAYS, V24, P926, DOI 10.1002/bies.10165; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Nonet ML, 1998, J NEUROSCI, V18, P70; Ortino B, 2003, EUR J NEUROSCI, V18, P323, DOI 10.1046/j.1460-9568.2003.02748.x; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Proux-Gillardeaux V, 2003, BIOCHEM J, V370, P213, DOI 10.1042/BJ20021309; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Schenk U, 2003, EMBO J, V22, P558, DOI 10.1093/emboj/cdg059; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Sheng ZH, 1998, J BIOENERG BIOMEMBR, V30, P335, DOI 10.1023/A:1021985521748; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Takamori S, 2000, J NEUROSCI, V20, P4904; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	42	161	167	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					599	610		10.1016/S0896-6273(04)00077-7	http://dx.doi.org/10.1016/S0896-6273(04)00077-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980208	Bronze			2022-12-28	WOS:000221458100012
J	de Lafuente, V; Romo, R				de Lafuente, V; Romo, R			Language abilities of motor cortex	NEURON			English	Editorial Material							VENTRAL PREMOTOR CORTEX; MOVEMENT		Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	de Lafuente, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.		de la Fuente, Javier/GQP-6328-2022	romo, ranulfo/0000-0003-3529-3635; de Lafuente, Victor/0000-0002-1047-1354				Georgopoulos AP, 1999, NEWS PHYSIOL SCI, V14, P64; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Salinas E, 1998, J NEUROSCI, V18, P499; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239	12	25	25	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 22	2004	41	2					178	180		10.1016/S0896-6273(04)00004-2	http://dx.doi.org/10.1016/S0896-6273(04)00004-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741098	Bronze			2022-12-28	WOS:000221457800003
J	Kuromi, H; Honda, A; Kidokoro, Y				Kuromi, H; Honda, A; Kidokoro, Y			Ca2+ influx through distinct routes controls exocytosis and endocytosis at Drosophila presynaptic terminals	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE EXOCYTOSIS; CALCIUM-CHANNEL; TRANSMITTER RELEASE; NERVE-TERMINALS; LANTHANUM IONS; MULTIPLE FORMS; MUTANT; LOCALIZATION; DYNAMIN	Endocytosis of synaptic vesicles follows exocytosis, and both processes require external Ca2+. However, it is not known whether Ca2+ influx through one route initiates both processes. At larval Drosophila neuromuscular junctions, we separately measured exocytosis and endocytosis using FM1-43. In a temperature-sensitive Ca2+ channel mutant, cacophony(TS2), exocytosis induced by high K+ decreased at nonpermissive temperatures, while endocytosis remained unchanged. In wild-type larvae, a spider toxin, PLTXII, preferentially inhibited exocytosis, whereas the Ca2+ channel blockers flunarizine and La3+ selectively depressed endocytosis. None of these blockers affected exocytosis or endocytosis induced by a Ca2+ ionophore. Evoked synaptic potentials were depressed regardless of stimulus frequency in cacophony(TS2) at nonpermissive temperatures and in wild-type by PLTXII, whereas flunarizine or La3+ gradually depressed synaptic potentials only during high-frequency stimulation, suggesting depletion of synaptic vesicles due to blockade of endocytosis. In shibire(ts1), a dynamin mutant, flunarizine or La3+ inhibited assembly of clathrin at the plasma membrane during stimulation without affecting dynamin function.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	kuromi@med.gunma-u.ac.jp						BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BRANTON WD, 1987, J NEUROSCI, V7, P4195; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COHEN MW, 1991, J NEUROSCI, V11, P1032; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Estes PS, 1996, J NEUROSCI, V16, P5443; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1971, PROC R SOC SER B-BIO, V179, P247, DOI 10.1098/rspb.1971.0096; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Kawasaki F, 2000, J NEUROSCI, V20, P4885; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; KRIEBEL ME, 1983, NEUROSCIENCE, V9, P535, DOI 10.1016/0306-4522(83)90172-0; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; MUNDIGL O, 1995, EUR J CELL BIOL, V66, P246; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sand O, 2001, J PHYSIOL-LONDON, V536, P21, DOI 10.1111/j.1469-7793.2001.00021.x; Santi CM, 2002, J NEUROSCI, V22, P396, DOI 10.1523/JNEUROSCI.22-02-00396.2002; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Smith LA, 1996, J NEUROSCI, V16, P7868; Sone M, 2000, DEVELOPMENT, V127, P4157; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Teng HB, 2000, J NEUROSCI, V20, P7986; Thaler C, 2001, J NEUROSCI, V21, P412, DOI 10.1523/JNEUROSCI.21-02-00412.2001; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wu LG, 1999, J NEUROSCI, V19, P726	44	48	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					101	111		10.1016/S0896-6273(03)00815-8	http://dx.doi.org/10.1016/S0896-6273(03)00815-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715138	Bronze			2022-12-28	WOS:000187942800012
J	Eglen, SJ; Demas, J; Wong, ROL				Eglen, SJ; Demas, J; Wong, ROL			Mapping by waves: Patterned spontaneous activity regulates retinotopic map refinement	NEURON			English	Editorial Material							RETINAL WAVES; CIRCUITS; COLUMNS	A role for spontaneous spiking activity in shaping neuronal circuits has frequently been debated. Analyses of retinotopy in mutant mice with reduced correlated firing among neighboring retinal cells by Grubb et al. and McLaughlin et al. in this issue of Neuron indicate the importance of patterned spontaneous activity for retinotopic map refinement in subcortical visual targets.	Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh EH1 2QL, Midlothian, Scotland; Washington Univ, Sch Med, Dept Neurobiol & Anat, St Louis, MO 63110 USA	University of Edinburgh; Washington University (WUSTL)	Eglen, SJ (corresponding author), Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, 5 Forrest Hill, Edinburgh EH1 2QL, Midlothian, Scotland.			Eglen, Stephen/0000-0001-8607-8025; Demas, Jay/0000-0001-7678-1905				Bansal A, 2000, J NEUROSCI, V20, P7672; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Huberman AD, 2002, J NEUROSCI, V22, P9419; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29	12	19	19	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1053	1055		10.1016/S0896-6273(03)00808-0	http://dx.doi.org/10.1016/S0896-6273(03)00808-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687538	Bronze			2022-12-28	WOS:000187503400002
J	Ferbinteanu, J; Shapiro, ML				Ferbinteanu, J; Shapiro, ML			Prospective and retrospective memory coding in the hippocampus	NEURON			English	Article							EPISODIC-LIKE MEMORY; COMPLEX-SPIKE CELLS; UNIT-ACTIVITY; PLACE CELLS; SPATIAL MEMORY; NETWORK MODEL; PATH-INTEGRATION; NEURONS; TASK; SEQUENCES	The effect of memory on hippocampal neuronal activity was assessed as rats performed a spatial task that was impaired by fornix lesions. The influences of current location, recently entered places, and places about to be entered were compared. Three new findings emerged. (1) Current, retrospective, and prospective coding were common and recorded simultaneously in neural ensembles. (2) The origin of journeys influenced firing even when rats made detours, showing that recent memory could modulate neuronal activity more than spatial trajectory. (3) Diminished retrospective coding and, more markedly, reduced prospective coding in error trials suggested that the neuronal signal was important for task performance. The population of hippocampal neurons thus encoded information about the recent past, the present, and the imminent future, consistent with a neuronal mechanism for episodic memory.	Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Kastor Neurobiol Aging Labs, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Shapiro, ML (corresponding author), Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Kastor Neurobiol Aging Labs, 1 Gustave L Levy Pl, New York, NY 10029 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014166] Funding Source: NIH RePORTER; NIDA NIH HHS [DA14166] Funding Source: Medline; NIMH NIH HHS [MH65658] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agster KL, 2002, J NEUROSCI, V22, P5760; Burgess N, 2000, BIOL CYBERN, V83, P301, DOI 10.1007/s004220000172; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; CLAYTON NS, 1998, EPISODIC LIKE MEMORY; DONOVICK PJ, 1974, STAIN TECHNOL, V49, P49, DOI 10.3109/10520297409116937; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Gallistel C. R., 1990, ORG LEARNING; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hampson RE, 2000, J NEUROSCI, V20, P8932; HETHERINGTON PA, 1993, BEHAV NEUROSCI, V107, P434, DOI 10.1037/0735-7044.107.3.434; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Lenck-Santini PP, 2001, EUR J NEUROSCI, V13, P1055, DOI 10.1046/j.0953-816x.2001.01481.x; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 1996, J EXP BIOL, V199, P173; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1978, EXP NEUROL, V58, P387, DOI 10.1016/0014-4886(78)90096-1; OLTON DS, 1984, WORKING MEMORY SERIA, P171; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RANCK JB, 1982, BEHAV CONTRIBUTIONS; REDISH AD, 1999, BEYOND COGNITIVE MAP; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SHAPIRO ML, 1993, BEHAV NEUROSCI, V107, P34, DOI 10.1037/0735-7044.107.1.34; SHARP PE, 1991, PSYCHOBIOLOGY, V19, P103; Skaggs WE, 1998, J NEUROSCI, V18, P8455; TONKISS J, 1990, BEHAV BRAIN RES, V36, P113, DOI 10.1016/0166-4328(90)90166-C; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; WHITE NM, 1986, NEUROBIOL LEARN MEM, V399, P97; WIBLE CG, 1986, BRAIN RES, V399, P97, DOI 10.1016/0006-8993(86)90604-9; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	50	363	370	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1227	1239		10.1016/S0896-6273(03)00752-9	http://dx.doi.org/10.1016/S0896-6273(03)00752-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687555	Bronze			2022-12-28	WOS:000187503400019
J	Fukata, M; Fukata, Y; Adesnik, H; Nicoll, RA; Bredt, DS				Fukata, M; Fukata, Y; Adesnik, H; Nicoll, RA; Bredt, DS			Identification of PSD-95 palmitoylating enzymes	NEURON			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN PALMITOYLATION; MEMBRANE ATTACHMENT; SIGNALING FUNCTIONS; LIPID MODIFICATIONS; FATTY ACYLATION; RAS PROTEINS; SNAP-25; DOMAIN; LOCALIZATION	Palmitoylation is a lipid modification that plays a critical role in protein trafficking and function throughout the nervous system. Palmitoylation of PSD-95 is essential for its regulation of AMPA receptors and synaptic plasticity. The enzymes that mediate palmitoyl acyl transfer to PSD-95 have not yet been identified; however, proteins containing a DHHC cysteine-rich domain mediate palmitoyl acyl transferase activity in yeast. Here, we isolated 23 mammalian DHHC proteins and found that a subset specifically palmitoylated PSD-95 in vitro and in vivo. These PSD-95 palmitoyl transferases (P-PATs) showed substrate specificity, as they did not all enhance palmitoylation of Lck, SNAP-25b, Galpha(s), or H-Ras in cultured cells. Inhibition of P-PAT activity in neurons reduced palmitoylation and synaptic clustering of PSD-95 and diminished AMPA receptor-mediated neurotransmission. This study suggests that P-PATs regulate synaptic function through PSD-95 palmitoylation.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	bredt@itsa.ucsf.edu	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643				Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; BOUVIER M, 1995, BIOCHEM SOC T, V23, P577, DOI 10.1042/bst0230577; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HESS DT, 1992, J NEUROSCI, V12, P4634; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Lane SR, 1997, J NEUROCHEM, V69, P1864; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; ROSS EM, 1995, CURR BIOL, V5, P107, DOI 10.1016/S0960-9822(95)00026-1; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stein V, 2003, J NEUROSCI, V23, P5503; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	38	379	399	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					987	996		10.1016/j.neuron.2004.12.005	http://dx.doi.org/10.1016/j.neuron.2004.12.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603741	Bronze			2022-12-28	WOS:000225842300012
J	Guzowski, JF; Knierim, JJ; Moser, EI				Guzowski, JF; Knierim, JJ; Moser, EI			Ensemble dynamics of hippocampal regions CA3 and CA1	NEURON			English	Editorial Material							PLACE CELLS; MEMORY; COMPLEMENTARY; SUBFIELDS; DISTINCT; STORAGE; SYSTEM	Computational models based on hippocampal connectivity have proposed that CA3 is uniquely positioned as an autoassociative memory network, capable of performing the competing functions of pattern completion and pattern separation. Recently, three independent studies, two using parallel neurophysiological recording methods and one using immediate-early gene imaging, have examined the responses of CA3 and CA1 ensembles to alterations of environmental context in rats. The results provide converging evidence that CA3 is capable of performing nonlinear transformations of sensory input patterns, whereas CA1 may represent changes in input in a more linear fashion.	Univ New Mexico, HSC, Dept Neurosci, Albuquerque, NM 87131 USA; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway	University of New Mexico; University of Texas System; Norwegian University of Science & Technology (NTNU)	Guzowski, JF (corresponding author), Univ New Mexico, HSC, Dept Neurosci, Albuquerque, NM 87131 USA.	jguzowski@salud.unm.edu; james.j.knierim@uth.tmc.edu; edvard.moser@cbm.ntnu.no		Knierim, James/0000-0002-1796-2930				[Anonymous], 1998, NEURAL NETWORKS BRAI; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; JARRARD LE, 1975, J COMP PHYSIOL PSYCH, V89, P400, DOI 10.1037/h0077049; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Knierim J.J., 2003, NEUROBIOLOGY SPATIAL, P226; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	19	244	247	2	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 18	2004	44	4					581	584		10.1016/j.neuron.2004.11.003	http://dx.doi.org/10.1016/j.neuron.2004.11.003			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541306	Bronze			2022-12-28	WOS:000225338100004
J	Atanasoski, S; Notterpek, L; Lee, HY; Castagner, F; Young, P; Ehrengruber, MU; Meijer, D; Sommer, L; Stavnezer, E; Colmenares, C; Suter, U				Atanasoski, S; Notterpek, L; Lee, HY; Castagner, F; Young, P; Ehrengruber, MU; Meijer, D; Sommer, L; Stavnezer, E; Colmenares, C; Suter, U			The protooncogene Ski Schwann cell proliferation controls and myelination	NEURON			English	Article							TRANSFORMING-GROWTH-FACTOR; IN-VITRO; PERIPHERAL MYELIN; C-SKI; TRANSCRIPTIONAL REPRESSION; MUSCLE DIFFERENTIATION; ONCOPROTEIN INTERACTS; GENE-EXPRESSION; SMAD PROTEINS; MESSENGER-RNA	Schwann cell proliferation and subsequent differentiation to nonmyelinating and myelinating cells are closely linked processes. Elucidating the molecular mechanisms that control these events is key to the understanding of nerve development, regeneration, nerve-sheath tumors, and neuropathies. We define the protooncogene Ski, an inhibitor of TGF-beta signaling, as an essential component of the machinery that controls Schwarm cell proliferation and myelination. Functional Ski overexpression inhibits TGF-beta-mediated proliferation and prevents growth-arrested Schwarm cells from reentering the cell cycle. Consistent with these findings, myelinating Schwarm cells upregulate Ski during development and remyelination after injury. Myelination is blocked in myelin-competent cultures derived from Ski-deficient animals, and genes encoding myelin components are downregulated in Ski-deficient nerves. Conversely, overexpression of Ski in Schwann cells causes an upregulation of myelin-related genes. The myelination-regulating transcription factor Oct6 is involved in a complex modulatory relationship with Ski. We conclude that Ski is a crucial signal in Schwarm cell development and myelination.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, Zurich, Switzerland; Univ Florida, McKnight Brain Inst, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; Univ Munster, Dept Neurol, D-4400 Munster, Germany; Univ Zurich, Inst Brain Res, CH-8029 Zurich, Switzerland; Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; State University System of Florida; University of Florida; University of Munster; University of Zurich; Erasmus University Rotterdam; Erasmus MC; Case Western Reserve University; Cleveland Clinic Foundation	Suter, U (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, Zurich, Switzerland.	usuter@cell.biol.ethz.ch	Meijer, Dies/C-7786-2012; Suter, Ueli/A-1624-2010; Atanasoski, Suzana/A-3275-2011	Meijer, Dies/0000-0002-8461-6341; Atanasoski, Suzana/0000-0001-7340-0775; Castagner, Francois/0000-0002-9830-0057	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD030728, R55HD030728] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043600] Funding Source: NIH RePORTER; NCI NIH HHS [CA43600] Funding Source: Medline; NICHD NIH HHS [HD30728] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADIKOFER K, 1995, NAT GENET, V11, P274; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Atanasoski S, 1997, ONCOGENE, V14, P1287, DOI 10.1038/sj.onc.1200953; Atanasoski S, 2002, J NEUROSCI RES, V67, P443, DOI 10.1002/jnr.10133; Atanasoski S, 2001, MOL CELL NEUROSCI, V18, P581, DOI 10.1006/mcne.2001.1055; Awatramani R, 2002, MOL CELL NEUROSCI, V19, P307, DOI 10.1006/mcne.2001.1094; Berger Alan R., 1995, P648; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Carenini S, 1998, GLIA, V22, P213, DOI 10.1002/(SICI)1098-1136(199803)22:3<213::AID-GLIA1>3.0.CO;2-6; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COLMENARES C, 1991, MOL CELL BIOL, V11, P1167, DOI 10.1128/MCB.11.2.1167; COLMENARES C, 1990, CANC BIOL, V1, P383; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; Day WA, 2003, EXP NEUROL, V184, P857, DOI 10.1016/S0014-4886(03)00308-X; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; Dyck P.J, 1993, PNP, P1094; Ehrengruber MU, 2000, GENE, V258, P63, DOI 10.1016/S0378-1119(00)00445-5; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ENGERT JC, 1995, NUCLEIC ACIDS RES, V23, P2988, DOI 10.1093/nar/23.15.2988; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; GUENARD V, 1995, J NEUROSCI, V15, P419; Ichikawa K, 1997, BIOCHEM J, V328, P607, DOI 10.1042/bj3280607; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kokura K, 2003, J BIOL CHEM, V278, P20133, DOI 10.1074/jbc.M210855200; Kulkarni Ashok B., 2002, Current Molecular Medicine (Hilversum), V2, P303; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LEMKE GE, 1984, J NEUROSCI, V4, P75; Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X; LYONS GE, 1994, DEV DYNAM, V201, P354, DOI 10.1002/aja.1002010407; Magyar JP, 1996, J NEUROSCI, V16, P5351; MEIJER D, 1992, NUCLEIC ACIDS RES, V20, P2241, DOI 10.1093/nar/20.9.2241; MEWS M, 1993, GLIA, V8, P208, DOI 10.1002/glia.440080308; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORGAN L, 1994, DEVELOPMENT, V120, P1399; Mosser DD, 1997, BIOTECHNIQUES, V22, P150, DOI 10.2144/97221rr02; Moustakas A, 2001, J CELL SCI, V114, P4359; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Notterpek L, 1999, GLIA, V25, P358, DOI 10.1002/(SICI)1098-1136(19990215)25:4<358::AID-GLIA5>3.0.CO;2-K; Paratore C, 1999, HISTOCHEM CELL BIOL, V111, P435, DOI 10.1007/s004180050379; Parkinson DB, 2001, J NEUROSCI, V21, P8572, DOI 10.1523/JNEUROSCI.21-21-08572.2001; RIDLEY AJ, 1989, J CELL BIOL, V109, P3419, DOI 10.1083/jcb.109.6.3419; Sancho S, 1999, BRAIN, V122, P1563, DOI 10.1093/brain/122.8.1563; Sancho S, 2001, BRAIN, V124, P2177, DOI 10.1093/brain/124.11.2177; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Stoll G, 1999, BRAIN PATHOL, V9, P313; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1994, J BIOL CHEM, V269, P25795; Tarapore P, 1997, NUCLEIC ACIDS RES, V25, P3895, DOI 10.1093/nar/25.19.3895; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Yang ZY, 1996, P NATL ACAD SCI USA, V93, P7905, DOI 10.1073/pnas.93.15.7905; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	67	53	65	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					499	511		10.1016/j.neuron.2004.08.001	http://dx.doi.org/10.1016/j.neuron.2004.08.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312649	Bronze			2022-12-28	WOS:000223436400009
J	Cooke, DF; Graziano, MSA				Cooke, DF; Graziano, MSA			Super-flinchers and nerves of steel: Defensive movements altered by chemical manipulation of a cortical motor area	NEURON			English	Article							VENTRAL INTRAPARIETAL AREA; PREMOTOR CORTEX; MACAQUE MONKEY; REVERSIBLE INACTIVATION; RESPONSE PROPERTIES; PRECENTRAL GYRUS; NEURONS; MICROSTIMULATION; COLLICULUS; MUSCIMOL	In a restricted zone of the monkey motor cortex, neurons respond to objects near, approaching, or touching the body. This polysensory zone was hypothesized to play a role in monitoring nearby stimuli for the guidance of defensive movements. To test this hypothesis, we chemically manipulated sites within that zone by injecting bicuculline (increasing neuronal activity) or muscimol (decreasing neuronal activity). Bicuculline caused the monkey to react in an exaggerated fashion to an air puff on the face and to objects approaching the face, whereas muscimol caused the monkey to react in a reduced fashion. The effects were expressed partly as a motor abnormality (affecting movement of the musculature contralateral to the injection site) but also partly as a sensory enhancement or sensory neglect (affecting responses to stimuli contralateral to the injection site). These findings suggest that the polysensory zone contributes to the ethologically important function of defense of the body.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Graziano, MSA (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	graziano@princeton.edu	Cooke, Dylan F./O-9954-2019	Cooke, Dylan F./0000-0002-5976-705X	NEI NIH HHS [EY-11347] Funding Source: Medline; NINDS NIH HHS [NS-41878] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS041878] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRANDAO ML, 1993, BEHAV BRAIN RES, V58, P49, DOI 10.1016/0166-4328(93)90089-9; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hediger H., 1955, STUDIES PSYCHOL BEHA; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KING SM, 1992, PERCEPTION, V21, P245, DOI 10.1068/p210245; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Landis C, 1939, STARTLE PATTERN; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Malpeli JG, 1999, J NEUROSCI METH, V86, P119, DOI 10.1016/S0165-0270(98)00161-7; MATELLI M, 1985, BEHAV BRAIN RES, V18, P125, DOI 10.1016/0166-4328(85)90068-3; MATSUMURA M, 1991, J NEUROPHYSIOL, V65, P1542, DOI 10.1152/jn.1991.65.6.1542; Rind FC, 2002, MICROSC RES TECHNIQ, V56, P256, DOI 10.1002/jemt.10029; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1983, BRAIN, V106, P655, DOI 10.1093/brain/106.3.655; Schaafsma SJ, 1996, J NEUROPHYSIOL, V76, P4056; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Schuster S, 2002, CURR BIOL, V12, P1591, DOI 10.1016/S0960-9822(02)01141-7; Strauss H, 1929, J PSYCHOL NEUROL, V39, P111; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Tammero LF, 2002, J EXP BIOL, V205, P2785; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Yeomans JS, 2002, NEUROSCI BIOBEHAV R, V26, P1, DOI 10.1016/S0149-7634(01)00057-4	43	41	43	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					585	593		10.1016/j.neuron.2004.07.029	http://dx.doi.org/10.1016/j.neuron.2004.07.029			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312656	Bronze			2022-12-28	WOS:000223436400016
J	Xu, YL; Reinscheid, RK; Huitron-Resendiz, S; Clark, SD; Wang, ZW; Lin, SH; Brucher, FA; Zeng, JA; Ly, NK; Henriksen, SJ; Lecea, LC; Civelli, O				Xu, YL; Reinscheid, RK; Huitron-Resendiz, S; Clark, SD; Wang, ZW; Lin, SH; Brucher, FA; Zeng, JA; Ly, NK; Henriksen, SJ; Lecea, LC; Civelli, O			Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects	NEURON			English	Article							PROTEIN-COUPLED RECEPTORS; LOCUS-CERULEUS NEURONS; BARRINGTONS NUCLEUS; COERULEUS; ANXIETY; SLEEP; STRESS; MICE; SUSCEPTIBILITY; PROJECTIONS	Arousal and anxiety are behavioral responses that involve complex neurocircuitries and multiple neurochemical components. Here, we report that a neuropeptide, neuropeptide S (NPS), potently modulates wakefulness and could also regulate anxiety. NIPS acts by activating its cognate receptor (NPSR) and inducing mobilization of intracellular Ca2+. The NPSR mRNA is widely distributed in the brain, including the amygdala and the midline thalamic nuclei. Central administration of NPS increases locomotor activity in mice and decreases paradoxical (REM) sleep and slow wave sleep in rats. NPS was further shown to produce anxiolytic-like effects in mice exposed to four different stressful paradigms. Interestingly, NPS is expressed in a previously undefined cluster of cells located between the locus coeruleus (LC) and Barrington's nucleus. These results indicate that NIPS could be a new modulator of arousal and anxiety. They also show that the LC region encompasses distinct nuclei expressing different arousal-promoting neurotransmitters.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute; Scripps Research Institute	Reinscheid, RK (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	rreinsch@uci.edu	Civelli, Olivier/A-8392-2012; de Lecea, Luis/B-3171-2009; de Lecea, Luis/ABE-4005-2021	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942				ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BING O, 1993, NEUROSCI LETT, V164, P17, DOI 10.1016/0304-3940(93)90846-D; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Bourgin P, 2000, J NEUROSCI, V20, P7760; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419; Chojnacka-Wojcik E, 2001, Curr Opin Investig Drugs, V2, P1112; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Hunsley MS, 2003, SLEEP, V26, P521; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; JONES BE, 1991, PROG BRAIN RES, V88, P533; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohayon MM, 1998, COMPR PSYCHIAT, V39, P185, DOI 10.1016/S0010-440X(98)90059-1; Paine TA, 2002, BEHAV PHARMACOL, V13, P511, DOI 10.1097/00008877-200211000-00001; Paxinos G., 1998, RAT BRAIN STEROTAXIC; REDMOND DE, 1979, LIFE SCI, V25, P2149, DOI 10.1016/0024-3205(79)90087-0; Reinscheid RK, 2002, NEUROPEPTIDES, V36, P72, DOI 10.1054/npep.2002.0901; RIZVI TA, 1994, J COMP NEUROL, V347, P1, DOI 10.1002/cne.903470102; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sato S, 2002, World Patent Application, Patent No. [WO 02/ 31145 A1, 0231145]; Shimomura Y, 2002, J BIOL CHEM, V277, P35826, DOI 10.1074/jbc.M205337200; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; SUTIN EL, 1988, J COMP NEUROL, V270, P243, DOI 10.1002/cne.902700206; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Ursin R, 2002, SLEEP MED REV, V6, P57, DOI 10.1053/smrv.2001.0174; Valentino RJ, 1995, J COMP NEUROL, V363, P402, DOI 10.1002/cne.903630306; Valentino RJ, 2000, J COMP NEUROL, V417, P399; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Wilson S, 1998, BRIT J PHARMACOL, V125, P1387, DOI 10.1038/sj.bjp.0702238	49	424	443	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					487	497		10.1016/j.neuron.2004.08.005	http://dx.doi.org/10.1016/j.neuron.2004.08.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312648	Bronze			2022-12-28	WOS:000223436400008
J	Pasinelli, P; Belford, ME; Lennon, N; Bacskai, BJ; Hyman, BT; Trotti, D; Brown, RH				Pasinelli, P; Belford, ME; Lennon, N; Bacskai, BJ; Hyman, BT; Trotti, D; Brown, RH			Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria	NEURON			English	Article							TRANSGENIC MOUSE MODEL; SUPEROXIDE-DISMUTASE GENE; PROGRAMMED CELL-DEATH; MOTOR-NEURON DEATH; ALS-LINKED SOD1; OXIDATIVE DAMAGE; APOPTOTIC DEATH; DEGENERATION; MUTATIONS; MICE	Familial amyotrophic lateral sclerosis (ALS)-linked mutations in the copper-zinc superoxide dismutase (SOD1) gene cause motor neuron death in about 3% of ALS cases. While the wild-type (wt) protein is anti-apoptotic, mutant SOD1 promotes apoptosis. We now demonstrate that both wt and mutant SOD1 bind the anti-apoptotic protein Bcl-2, providing evidence of a direct link between SOD1 and an apoptotic pathway. This interaction is evident in vitro and in vivo in mouse and human spinal cord. We also demonstrate that in mice and humans, Bcl-2 binds to high molecular weight SIDS-resistant mutant SOD1 containing aggregates that are present in mitochondria from spinal cord but not liver. These findings provide new insights into the anti-apoptotic function of SOD1 and suggest that entrapment of Bcl-2 by large SOD1 aggregates may deplete motor neurons of this anti-apoptotic protein.	Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Day Lab Neuromusc Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Dept Neurol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Pasinelli, P (corresponding author), Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Day Lab Neuromusc Res, Charlestown, MA 02129 USA.	ppasinelli@partners.org; rhbrown@partners.org	Bacskai, Brian/AAE-9583-2021	Trotti, Davide/0000-0001-6338-6404; Pasinelli, Piera/0000-0002-3385-2707	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012406, R43AG022252, P01AG012992, R44AG022252] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG12406, P01 AG12992-9, R03-AG022252] Funding Source: Medline; NIBIB NIH HHS [EB00768] Funding Source: Medline; NINDS NIH HHS [R01-NS44292] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Appel SH, 2001, AMYOTROPH LATERAL SC, V2, pS47; Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Ekegren T, 1999, ACTA NEUROL SCAND, V100, P317; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Ghadge GD, 1997, J NEUROSCI, V17, P8756; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Hzecka J, 2001, ACTA NEUROL SCAND, V103, P255; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; Schimmer AD, 2001, BLOOD, V98, P3541, DOI 10.1182/blood.V98.13.3541; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; Vukosavic S, 2000, J NEUROSCI, V20, P9119; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yachnis AT, 1998, EXP NEUROL, V150, P82, DOI 10.1006/exnr.1997.6746; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	43	381	399	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					19	30		10.1016/j.neuron.2004.06.021	http://dx.doi.org/10.1016/j.neuron.2004.06.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233914	Bronze			2022-12-28	WOS:000222549800004
J	Beckstead, MJ; Grandy, DK; Wickman, K; Williams, JT				Beckstead, MJ; Grandy, DK; Wickman, K; Williams, JT			Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons	NEURON			English	Article							SUBSTANTIA-NIGRA NEURONS; VENTRAL TEGMENTAL AREA; MEDIATED VOLUME TRANSMISSION; DENDRO-DENDRITIC SYNAPSES; MEMBRANE-PROPERTIES; POTASSIUM CHANNELS; SYNAPTIC INPUTS; DEFICIENT MICE; FIRING PATTERN; QUANTAL SIZE	Synchronous activation of dopamine neurons, for instance upon presentation of an unexpected rewarding stimulus, results in the release of dopamine from both terminals in projection areas and somatodendritic sites within the ventral midbrain. This report describes an inhibitory postsynaptic current (IPSC) that was elicited by dopamine in slices from mouse midbrain. The IPSC was tetrodotoxin sensitive, calcium dependent, and blocked by a D2 receptor antagonist. Inhibition of monoamine transporters prolonged the IPSC, indicating that the time course of dopamine neurotransmission is tightly regulated by reuptake. Changing the stimulus intensity altered the amplitude but not the time course of the IPSC, whose onset was faster than could be reproduced with iontophoresis. The results indicate a rapid rise in dopamine concentration at the D2 receptors, suggesting that dopamine that is released by a train of action potentials acts in a localized area rather than in a manner consistent with volume transmission.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Oregon Health & Science University; Oregon Health & Science University; University of Minnesota System; University of Minnesota Twin Cities	Williams, JT (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97239 USA.	williamj@ohsu.edu		Wickman, Kevin/0000-0002-5179-9540	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066360, R01MH061933, R01MH067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012062, F32DA016467, R01DA004523] Funding Source: NIH RePORTER; NIDA NIH HHS [DA4523, DA16467, F32 DA016467, DA12062] Funding Source: Medline; NIDDK NIH HHS [T32 DK007680, DK7680] Funding Source: Medline; NIMH NIH HHS [MH66360, R01 MH061933, MH61933, MH67497] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; Cragg SJ, 2001, J NEUROPHYSIOL, V85, P1761, DOI 10.1152/jn.2001.85.4.1761; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Davila V, 2003, J NEUROSCI, V23, P5693; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Fuxe K, 1991, VOLUME TRANSMISSION; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grillner P, 2002, BEHAV BRAIN RES, V130, P149, DOI 10.1016/S0166-4328(01)00418-1; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; GROVES PM, 1983, EXP BRAIN RES, V49, P209; Hoffman AF, 1999, J PHARMACOL EXP THER, V289, P455; Jaffe EH, 1998, J NEUROSCI, V18, P3548; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1991, J NEUROCHEM, V56, P961, DOI 10.1111/j.1471-4159.1991.tb02015.x; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; Kuzhikandathil EV, 1998, MOL CELL NEUROSCI, V12, P390, DOI 10.1006/mcne.1998.0722; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Pothos EN, 2002, BEHAV BRAIN RES, V130, P203, DOI 10.1016/S0166-4328(01)00419-3; Pothos EN, 1998, J NEUROSCI, V18, P4106; PUCAK ML, 1994, J PHARMACOL EXP THER, V271, P1181; Rice ME, 2000, PROG BRAIN RES, V125, P277; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Sodickson DL, 1998, J NEUROSCI, V18, P8153; TEPPER JM, 1991, BRAIN RES, V559, P283, DOI 10.1016/0006-8993(91)90013-L; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; WILLIAMS JT, 1984, NEUROSCIENCE, V13, P137, DOI 10.1016/0306-4522(84)90265-3; WILSON CJ, 1977, EXP BRAIN RES, V30, P161; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	48	261	266	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					939	946		10.1016/j.neuron.2004.05.019	http://dx.doi.org/10.1016/j.neuron.2004.05.019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207238	Bronze			2022-12-28	WOS:000222329300009
J	Nielsen, TA; DiGregorio, DA; Silver, RA				Nielsen, TA; DiGregorio, DA; Silver, RA			Modulation of glutamate mobility reveals the mechanism underlying slow-rising AMPAR EPSCs and the diffusion coefficient in the synaptic cleft	NEURON			English	Article							EXTRACELLULAR CA2+ DEPLETION; CEREBELLAR MOSSY FIBER; MULTIPLE RELEASE SITES; RECEPTOR DESENSITIZATION; TIME-COURSE; RAT; SYNAPSES; VESICLES; SINGLE; TRANSMISSION	Fast- and slow-rising AMPA receptor-mediated EPSCs occur at central synapses. Fast-rising EPSCs are thought to be mediated by rapid local release of glutamate. However, two controversial mechanisms have been proposed to underlie slow-rising EPSCs: prolonged local release of transmitter via a fusion pore, and spillover of transmitter released rapidly from distant sites. We have investigated the mechanism underlying slow-rising EPSCs and the diffusion coefficient of glutamate in the synaptic cleft (D(glut)) at cerebellar mossy fiber-granule cell synapses using a combination of diffusion modeling and patch-clamp recording. Simulations show that modulating D(glut) has different effects on the peak amplitudes and time courses of EPSCs mediated by these two mechanisms. Slowing diffusion with the macromolecule dextran slowed slow-rising EPSCs and had little effect on their amplitude, indicating that glutamate spillover underlies these currents. Our results also suggest that under control conditions D(glut) is approximately 3-fold lower than in free solution.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Boyce W.E., 2012, ELEMENTARY DIFFERENT, V10th; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Crank J., 1975, MATH DIFFUSION; Diamond JS, 1997, J NEUROSCI, V17, P4672; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; FABER DS, 1985, P NATL ACAD SCI USA, V82, P3504, DOI 10.1073/pnas.82.10.3504; FINKEL AS, 1983, J PHYSIOL-LONDON, V342, P615, DOI 10.1113/jphysiol.1983.sp014872; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Hrabetova S, 2003, J NEUROSCI, V23, P8351; Jahr CE, 2003, TRENDS NEUROSCI, V26, P7, DOI 10.1016/S0166-2236(02)00003-6; JAKAB R L, 1989, Acta Morphologica Hungarica, V37, P11; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Katz B., 1969, RELEASE NEURAL TRANS; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; LAND BR, 1984, P NATL ACAD SCI-BIOL, V81, P1594, DOI 10.1073/pnas.81.5.1594; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; NICHOLSON C, 1993, BIOPHYS J, V65, P2277, DOI 10.1016/S0006-3495(93)81324-9; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palay S.L., 1974, CEREBELLAR CORTEX; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Perrais D, 2000, EUR J NEUROSCI, V12, P400, DOI 10.1046/j.1460-9568.2000.00957.x; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; RAMAN IM, 1994, J NEUROSCI, V14, P4998; Ravindranathan A, 2000, J PHYSIOL-LONDON, V523, P667, DOI 10.1111/j.1469-7793.2000.00667.x; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; RICE ME, 1993, J NEUROPHYSIOL, V70, P2035, DOI 10.1152/jn.1993.70.5.2035; RIVEROS N, 1986, BRAIN RES, V386, P405, DOI 10.1016/0006-8993(86)90181-2; Robert A, 2003, J NEUROSCI, V23, P847; Robinson R.A., 2002, ELECTROLYTE SOLUTION; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sykova E, 2001, Prog Brain Res, V132, P339; TORRITARELLI F, 1985, J CELL BIOL, V101, P1386, DOI 10.1083/jcb.101.4.1386; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Watanabe T, 1996, MAGNET RESON MED, V35, P697, DOI 10.1002/mrm.1910350511; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	73	156	159	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 10	2004	42	5					757	771		10.1016/j.neuron.2004.04.003	http://dx.doi.org/10.1016/j.neuron.2004.04.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182716	Bronze			2022-12-28	WOS:000221975000008
J	McMains, SA; Somers, DC				McMains, SA; Somers, DC			Multiple spotlights of attentional selection in human visual cortex	NEURON			English	Article							HUMAN CEREBRAL-CORTEX; MACAQUE AREA V4; SPATIAL ATTENTION; FUNCTIONAL MRI; PHYSIOLOGICAL CORRELATE; EXTRASTRIATE CORTEX; NEURAL MECHANISMS; TARGET DETECTION; FOCAL ATTENTION; CORTICAL AREAS	Spatially directed attention strongly enhances visual perceptual processing. The metaphor of the "spotlight" has long been used to describe spatial attention; however, there has been considerable debate as to whether spatial attention must be unitary or may be split between discrete regions of space. This question was addressed here through functional MR imaging of human subjects as they performed a task that required simultaneous attention to two briefly displayed and masked targets at locations separated by distractor stimuli. These data reveal retinotopically specific enhanced activation in striate and extrastriate visual cortical representations of the two attended stimuli and no enhancement at the intervening representation of distractor stimuli. This finding of two spotlights was obtained within a single cortical hemisphere and across the two hemispheres. This provides direct evidence that spatial attention can select, in parallel, multiple low-level perceptual representations.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Boston Univ, Program Neurosci, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Radiol, Hillsborough 02129, North Ireland	Boston University; Boston University	Somers, DC (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	somers@bu.edu	Somers, David C./G-5802-2010	Somers, David C./0000-0002-4169-5895	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; COMTOIS R, 1999, VISIONSHELL MACINTOS; Conner CE, 1997, J NEUROSCI, V17, P3201; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corchs S, 2002, CEREB CORTEX, V12, P339, DOI 10.1093/cercor/12.4.339; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hahn S, 1998, VIS COGN, V5, P217, DOI 10.1080/713756781; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McCormick PA, 1998, J EXP PSYCHOL HUMAN, V24, P350, DOI 10.1037/0096-1523.24.1.350; MCLEAN JP, 1983, Q J EXP PSYCHOL-A, V35, P171, DOI 10.1080/14640748308402123; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Neisser U., 1967, COGNITIVE PSYCHOL; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pashler HE, 1998, PSYCHOL ATTENTION; Peterson MS, 2000, J GEN PSYCHOL, V127, P6, DOI 10.1080/00221300009598568; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHAW ML, 1978, J EXP PSYCHOL HUMAN, V4, P586, DOI 10.1037/0096-1523.4.4.586; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; SHULMAN GL, 1979, J EXP PSYCHOL HUMAN, V5, P522, DOI 10.1037/0096-1523.5.3.522; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; TSAL Y, 1983, J EXP PSYCHOL HUMAN, V9, P523, DOI 10.1037/0096-1523.9.4.523; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wolfe JM, 2000, NATURE, V406, P691, DOI 10.1038/35021132; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	63	214	216	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					677	686		10.1016/S0896-6273(04)00263-6	http://dx.doi.org/10.1016/S0896-6273(04)00263-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157427	Bronze			2022-12-28	WOS:000221708300016
J	Bulow, HE; Boulin, T; Hobert, O				Bulow, HE; Boulin, T; Hobert, O			Differential functions of the C. elegans FGF receptor in axon outgrowth and maintenance of axon position	NEURON			English	Article							CAENORHABDITIS-ELEGANS; GROWTH; SPECIFICITY; SYSTEM; DOMAIN	Wiring of the nervous system requires that axons navigate to their targets and maintain their correct positions in axon fascicles after termination of axon outgrowth. We show here that the C. elegans fibroblast growth factor receptor (FGFR), EGL-15, affects both processes in fundamentally distinct manners. FGF-dependent activation of the EGL-15 tyrosine kinase and subsequently the GTPase LET-60/ras is required within epidermal cells, the substratum for most outgrowing axon, for appropriate outgrowth of specific axon classes to their target area. In contrast, genetic elimination of the FGFR isoform EGL-15(5A), defined by the inclusion of an alternative extracellular interimmunoglobulin domain, has no consequence for axon outgrowth but leads to a failure to postembryonically maintain axon position within defined axon fascicles. An engineered, secreted form of EGL-15(5A) containing only its ectodomain is sufficient for maintenance of axon position, thus providing novel insights into receptor tyrosine kinase function and the process of maintaining axon position.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	or38@columbia.edu	Boulin, Thomas/D-6907-2011	Boulin, Thomas/0000-0002-1734-1915; Hobert, Oliver/0000-0002-7634-2854				Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DRAGO J, 1991, EXP CELL RES, V196, P246, DOI 10.1016/0014-4827(91)90258-V; DURBIN RM, 1987, THESIS U CAMBIDGE CA; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goodman SJ, 2003, DEVELOPMENT, V130, P3757, DOI 10.1242/dev.00604; Hobert O, 2003, CURR OPIN NEUROBIOL, V13, P70, DOI 10.1016/S0959-4388(03)00002-3; HUANG P, 2004, IN PRESS DEVELOPMENT; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Letourneau PC, 1992, CURR OPIN GENET DEV, V2, P625, DOI 10.1016/S0959-437X(05)80183-2; Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Roubin R, 1999, ONCOGENE, V18, P6741, DOI 10.1038/sj.onc.1203074; Viollet C, 1997, CELL TISSUE RES, V290, P451, DOI 10.1007/s004410050952; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	24	76	82	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					367	374		10.1016/S0896-6273(04)00246-6	http://dx.doi.org/10.1016/S0896-6273(04)00246-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134634	Bronze			2022-12-28	WOS:000221458700004
J	Fernandez-Chacon, R; Wolfel, M; Nishimune, H; Tabares, L; Schmitz, F; Castellano-Munoz, M; Rosenmund, C; Montesinos, ML; Sanes, JR; Schneggenburger, R; Sudhof, TC				Fernandez-Chacon, R; Wolfel, M; Nishimune, H; Tabares, L; Schmitz, F; Castellano-Munoz, M; Rosenmund, C; Montesinos, ML; Sanes, JR; Schneggenburger, R; Sudhof, TC			The synaptic vesicle protein CSP alpha prevents presynaptic degeneration	NEURON			English	Article							CYSTEINE-STRING PROTEIN; CALCIUM-CHANNEL TYPES; TRANSMITTER RELEASE; TRAPEZOID BODY; GLUTAMATE RECEPTORS; MEDIAL NUCLEUS; NEUROTRANSMITTER EXOCYTOSIS; DEVELOPMENTAL-CHANGES; MUTANT DROSOPHILA; GABA(B) RECEPTOR	Cysteine string protein a (CSPalpha)-an abundant synaptic vesicle protein that contains a DNA-J domain characteristic of Hsp40 chaperones-is thought to regulate Ca2+ channels and/or synaptic vesicle exocytosis. We now show that, in young mice, deletion of CSPa does not impair survival and causes no significant changes in presynaptic Ca2+ currents or synaptic vesicle exocytosis as measured in the Calyx of Held synapse. At 2-4 weeks of age, however, CSPalpha-deficient mice develop a progressive, fatal sensorimotor disorder. The neuromuscular junctions and Calyx synapses of CSPa-deficient mice exhibit increasing neurodegenerative changes, synaptic transmission becomes severely impaired, and the mutant mice die at similar to2 months of age. Our data suggest that CSPa is not essential for the normal operation of Ca2+ channels or exocytosis but acts as a presynaptic chaperone that maintains continued synaptic function, raising the possibility that enhanced CSPalpha function could attenuate neurodegenerative diseases.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Sevilla, Dept Fisiol Med & Biofis, E-41009 Seville, Spain; Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; Univ Saarland, Inst Anat & Zellbiol, D-66421 Homburg, Germany; MPI Biophys Chem, AG Synapt Dynam & Modulat, D-37070 Gottingen, Germany; MPI Biophys Chem, AG Synapt Physiol, Dept Membrane Biophys, D-37070 Gottingen, Germany; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Sevilla; Leipzig University; Saarland University; Max Planck Society; Max Planck Society; Washington University (WUSTL)	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	IBIS, FISIOLOGIA/O-9485-2015; Nishimune, Hiroshi/B-7226-2013; Fernandez-Chacon, Rafael/E-6303-2010; Rosenmund, Christian/AAC-3596-2020; Tabares, Lucia/K-8768-2015; Montesinos, María Luz/H-3251-2015; IBIS, SINAPTICA/C-2547-2016	Rosenmund, Christian/0000-0002-3905-2444; Tabares, Lucia/0000-0002-4027-4044; Montesinos, María Luz/0000-0003-3525-5874; Fernandez-Chacon, Rafael/0000-0002-9845-9885				Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Graham ME, 2000, J NEUROSCI, V20, P1281; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heckmann M, 1997, NEUROSCI LETT, V228, P167, DOI 10.1016/S0304-3940(97)00390-X; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; JIRMANOVA I, 1975, J NEUROCYTOL, V4, P141, DOI 10.1007/BF01098779; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; Katz B., 1969, RELEASE NEURAL TRANS; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Matos MF, 2000, EUR J CELL BIOL, V79, P377, DOI 10.1078/0171-9335-00063; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; Morales M, 1999, EUR J NEUROSCI, V11, P1818, DOI 10.1046/j.1460-9568.1999.00604.x; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Nie ZP, 1999, J NEUROSCI, V19, P10270; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Ranjan R, 1998, J NEUROSCI, V18, P956; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Satzler K, 2002, J NEUROSCI, V22, P10567; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Takahashi T, 1998, J NEUROSCI, V18, P3138; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, J NEUROSCI, V19, P726; YAWO H, 1994, J PHYSIOL-LONDON, V477, P437, DOI 10.1113/jphysiol.1994.sp020205; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	60	215	219	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					237	251		10.1016/S0896-6273(04)00190-4	http://dx.doi.org/10.1016/S0896-6273(04)00190-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091340	Bronze			2022-12-28	WOS:000221458500009
J	Fernandez-Alfonso, T; Ryan, TA				Fernandez-Alfonso, T; Ryan, TA			The kinetics of synaptic vesicle pool depletion at CNS synaptic terminals	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; RELEASABLE POOL; ENDOCYTOSIS; SINGLE; RAT; TRANSMISSION; MOBILIZATION; NEURONS; REPLENISHMENT	During sustained action potential (AP) firing at nerve terminals, the rates of endocytosis compared to exocytosis determine how quickly the available synaptic vesicle pool is depleted, in turn influencing presynaptic efficacy. Mechanisms, including rapid kiss-and-run endocytosis as well as local, preferential recycling of docked vesicles, have been proposed as a means to allow endocytosis and recycling to keep up with stimulation. We show here that, for CNS nerve terminals at physiological temperatures, endocytosis is sufficiently fast to avoid vesicle pool depletion during continuous AP firing at 10 Hz. This endocytosis-exocytosis balance persists for turnover of the entire releasable pool of vesicles and allows for efficient escape of FM 4-64, indicating that it is a non-kiss-and-run endocytic event. Thus, under physiological conditions, the sustained speed of vesicle membrane retrieval for the entire releasable pool appears to be sufficiently fast to compensate for exocytosis, avoiding significant vesicle pool depletion during robust synaptic activity.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Fernandez Alfonso, Tomas/0000-0002-9339-6678; Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS036942] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 1996, J NEUROSCI, V16, P5661; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Hardingham NR, 1998, J PHYSIOL-LONDON, V507, P249, DOI 10.1111/j.1469-7793.1998.249bu.x; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Taschenberger H, 2000, J NEUROSCI, V20, P9162; TENG H, 2000, J PHYSL, V551, P103; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wiener SI, 1996, PROG NEUROBIOL, V49, P335, DOI 10.1016/0301-0082(96)00019-6; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	36	174	176	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					943	953		10.1016/S0896-6273(04)00113-8	http://dx.doi.org/10.1016/S0896-6273(04)00113-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046726	Bronze			2022-12-28	WOS:000221458300013
J	DeMattos, RB; Cirrito, JR; Parsadanian, M; May, PC; O'Dell, MA; Taylor, JW; Harmony, JAK; Aronow, BJ; Bales, KR; Paul, SM; Holtzman, DM				DeMattos, RB; Cirrito, JR; Parsadanian, M; May, PC; O'Dell, MA; Taylor, JW; Harmony, JAK; Aronow, BJ; Bales, KR; Paul, SM; Holtzman, DM			ApoE and clusterin cooperatively suppress A beta levels and deposition: Evidence that ApoE regulates extracellular A beta metabolism in vivo	NEURON			English	Article							ALZHEIMERS AMYLOID-BETA; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; HUMAN APOLIPOPROTEIN-E; PLAQUE-FORMATION; BLOOD-BRAIN; PROTEIN; DISEASE; PEPTIDE; PLASMA	Apolipoprotein E (apoE) and clusterin can influence structure, toxicity, and accumulation of the amyloid-P (Abeta) peptide in brain. Both molecules may also be involved in Abeta metabolism prior to its deposition. To assess this possibility, we compared PDAPP transgenic mice that develop age-dependent Abeta accumulation in the absence of apoE or clusterin as well as in the absence of both proteins. apoE(-/-) and clusterin(-/-) mice accumulated similar Abeta levels but much less fibrillar Abeta. In contrast, apoE(-/-)/clusterin(-/-) mice had both earlier onset and markedly increased Abeta and amyloid deposition. Both apoE(-/-) and apoE(-/-)/clusterin(-/-) mice had elevated CSF and brain interstitial fluid Abeta, as well as significant differences in the elimination half-life of interstitial fluid Abeta measured by in vivo microdialysis. These findings demonstrate additive effects of apoE and clusterin on influencing Abeta deposition and that apoE plays an important role in regulating extracellular CNS Abeta metabolism independent of Abeta synthesis.	Eli Lilly & Co, Lilly Res Lab, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45627 USA; Childrens Hosp Res Fdn, Div Mol & Dev Biol, Cincinnati, OH 45229 USA; Indiana Univ, Sch Med, Dept Pharmacol, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Toxicol, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46285 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA	Eli Lilly; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Eli Lilly & Co, Lilly Res Lab, Neurosci Discovery Res, Indianapolis, IN 46285 USA.	demattos_ronald-bradley@lilly.com; holtzman@neuro.wustl.edu	Aronow, Bruce J/F-8438-2012; Paul, Steve/ABE-5400-2020		NIA NIH HHS [AG11355, AG13956, AG05681] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG011355, R37AG013956, P50AG005681, R01AG013956] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Beffert U, 1999, MOL BRAIN RES, V68, P181, DOI 10.1016/S0169-328X(99)00073-X; Biere AL, 1995, NEUROBIOL DIS, V2, P177, DOI 10.1006/nbdi.1995.0019; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fryer JD, 2003, J NEUROSCI, V23, P7889; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Hammad SM, 1997, J BIOL CHEM, V272, P18644, DOI 10.1074/jbc.272.30.18644; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; JOACHIM CL, 1988, BRAIN RES, V474, P100, DOI 10.1016/0006-8993(88)90673-7; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; MAY PC, 1992, TRENDS NEUROSCI, V15, P391, DOI 10.1016/0166-2236(92)90190-J; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; MENACHERRY S, 1992, ANAL CHEM, V64, P577, DOI 10.1021/ac00030a003; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Strittmatter WJ, 2002, CURR OPIN LIPIDOL, V13, P119, DOI 10.1097/00041433-200204000-00002; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sun YL, 1998, J NEUROSCI, V18, P3261; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Urmoneit B, 1997, LAB INVEST, V77, P157; WILLIAMS DL, 1995, J LIPID RES, V36, P745; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wisniewski T, 1997, NEUROBIOL DIS, V4, P313, DOI 10.1006/nbdi.1997.0147; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	59	342	357	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					193	202		10.1016/S0896-6273(03)00850-X	http://dx.doi.org/10.1016/S0896-6273(03)00850-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741101	Bronze			2022-12-28	WOS:000221457800006
J	Eriksen, JL; Dawson, TM; Dickson, DW; Petrucelli, L				Eriksen, JL; Dawson, TM; Dickson, DW; Petrucelli, L			Caught in the act: alpha-synuclein is the culprit in Parkinson's disease	NEURON			English	Review							SYSTEM; MICE; NEURODEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; MECHANISM; PATHWAYS; MODEL	Previous reports on Parkinson's disease indicate that genetic mutations in alpha-synuclein result in the aberrant accumulation of this protein, causing toxic gain of function leading to the development of Parkinson's. A recent report on the Iowan kindred, an extended pedigree with an autosomal dominant form of this disease, provides new mechanistic insight into Parkinson's disease by showing that an elevation in wildtype alpha-synuclein protein is sufficient to develop the early-onset form of the disorder. This review discusses how insights gained from these studies of alpha-synuclein may direct future research into Parkinson's disease.	Mayo Clin Jacksonville, Dept Neurogenet, Jacksonville, FL 32224 USA; Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21287 USA	Mayo Clinic; Johns Hopkins University	Petrucelli, L (corresponding author), Mayo Clin Jacksonville, Dept Neurogenet, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.		Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Dickson, Dennis W/0000-0001-7189-7917				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Gwinn-Hardy K, 2000, ACTA NEUROPATHOL, V99, P663, DOI 10.1007/s004010051177; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; SINGLETON A, 2003, IN PRESS SCIENCE, V302; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	25	126	133	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					453	456		10.1016/S0896-6273(03)00684-6	http://dx.doi.org/10.1016/S0896-6273(03)00684-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642269	Bronze			2022-12-28	WOS:000186379000004
J	Wicker, B; Keysers, C; Plailly, J; Royet, JP; Gallese, V; Rizzolatti, G				Wicker, B; Keysers, C; Plailly, J; Royet, JP; Gallese, V; Rizzolatti, G			Both of us disgusted in My Insula: The common neural basis of seeing and feeling disgust	NEURON			English	Article							OLD-WORLD MONKEY; HUMAN CINGULATE CORTEX; FACIAL EXPRESSIONS; TEMPORAL CORTEX; HUMAN AMYGDALA; PREMOTOR CORTEX; NEURONS; RECOGNITION; PAIN; EMOTION	What neural mechanism underlies the capacity to understand the emotions of others? Does this mechanism involve brain areas normally involved in experiencing the same emotion? We performed an fMRI study in which participants inhaled odorants producing a strong feeling of disgust. The same participants observed video clips showing the emotional facial expression of disgust. Observing such faces and feeling disgust activated the same sites in the anterior insula and to a lesser extent in the anterior cingulate cortex. Thus, as observing hand actions activates the observer's motor representation of that action, observing an emotion activates the neural representation of that emotion. This finding provides a unifying mechanism for understanding the behaviors of others.	Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy; CNRS, Inst Neurosci Physiol & Cognit, F-13402 Marseille 20, France; Univ Groningen Hosp, BCN Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands; Univ Lyon 1, CNR, UMR 5020, Lab Neurosci & Syst Sensoriels, F-69007 Lyon 07, France	University of Parma; Centre National de la Recherche Scientifique (CNRS); University of Groningen; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rizzolatti, G (corresponding author), Univ Parma, Dept Neurosci, Physiol Sect, Via Volturno 39, I-43100 Parma, Italy.	giacomo.rizzolatti@unipr.it	Keysers, Christian/H-6251-2013; Plailly, Jane/G-8417-2017; Gallese, Vittorio/ABD-5097-2021; Royet, Jean-Pierre/N-9812-2017	Keysers, Christian/0000-0002-2845-5467; Plailly, Jane/0000-0003-4189-1631; Gallese, Vittorio/0000-0003-4815-3607; Royet, Jean-Pierre/0000-0003-1158-7225				Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Brodmann K, 1909, VERGLEICHENDE LOKALI; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Goldman A, 2000, TRENDS COGN SCI, V4, P255, DOI 10.1016/S1364-6613(00)01505-9; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Hess U., 1999, SOCIAL CONTEXT NONVE, P213; Hudry J, 2001, CEREB CORTEX, V11, P619, DOI 10.1093/cercor/11.7.619; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Lipps Theodor., 1907, PSYCHOL UNTERSUCHUNG, V1, P694; Lozano AM, 1995, ADV STER F, V11, P30; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Royet JP, 2000, J NEUROSCI, V20, P7752; ROYET JP, 2003, IN PRESS NEUROIMAGE; ROZIN R, 2000, HDB EMOTIONS, P637; Schienle A, 2002, NEUROREPORT, V13, P2023, DOI 10.1097/00001756-200211150-00006; SCOTT TR, 1991, J NEUROPHYSIOL, V65, P76, DOI 10.1152/jn.1991.65.1.76; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Stanislavsky Constantin, 1936, ACTOR PREPARES; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; YAXLEY S, 1990, J NEUROPHYSIOL, V63, P689, DOI 10.1152/jn.1990.63.4.689; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 1998, J CEREBR BLOOD F MET, V18, P896, DOI 10.1097/00004647-199808000-00010; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5	64	1441	1491	5	179	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					655	664		10.1016/S0896-6273(03)00679-2	http://dx.doi.org/10.1016/S0896-6273(03)00679-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642287	Bronze			2022-12-28	WOS:000186379000022
J	Corlett, PR; Aitken, MRF; Dickinson, A; Shanks, DR; Honey, GD; Honey, RAE; Robbins, TW; Bullmore, ET; Fletcher, PC				Corlett, PR; Aitken, MRF; Dickinson, A; Shanks, DR; Honey, GD; Honey, RAE; Robbins, TW; Bullmore, ET; Fletcher, PC			Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning	NEURON			English	Article							WITHIN-COMPOUND ASSOCIATIONS; FALSE DISCOVERY RATE; CONTINGENCY JUDGMENT; FRONTAL-CORTEX; RESPONSES	Associative learning theory assumes that prediction error is a driving force in learning. A competing view, probabilistic contrast (PC) theory, is that learning and prediction error are unrelated. We tested a learning phenomenon that has proved troublesome for associative theory-retrospective revaluation-to evaluate these two models. We previously showed that activation in right lateral prefrontal cortex (PFC) provides a reliable signature for the presence of prediction error. Thus, if the associative view is correct, retrospective revaluation should be accompanied by right lateral PFC activation. PC theory would be supported by the absence of this activation. Right PFC and ventral striatal activation occurred during retrospective revaluation, supporting the associative account. Activations appeared to reflect the degree of revaluation, predicting later brain responses to revalued cues. Our results support a modified associative account of retrospective revaluation and demonstrate the potential of functional neuroimaging as a tool for evaluating competing learning models.	Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Psychiat,Brain Mapping Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; UCL, Dept Psychol, London WC1E 6BT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London	Fletcher, PC (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Psychiat,Brain Mapping Unit, Cambridge CB2 2QQ, England.	pcf22@cam.ac.uk	Shanks, David/A-1510-2015; Bullmore, Ed/C-1706-2012; Robbins, Trevor W/A-7551-2008; Fletcher, Paul/F-5380-2011	Shanks, David/0000-0002-4600-6323; Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Robbins, Trevor/0000-0003-0642-5977; Aitken Deakin, Michael/0000-0001-9763-8999; Corlett, Philip/0000-0002-5368-1992	Medical Research Council [G9439390, G0001237] Funding Source: Medline; Wellcome Trust [064351] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AITKEN MR, 2004, IN PRESS LEARN BEHAV; Aitken MRF, 2001, Q J EXP PSYCHOL-B, V54, P27, DOI 10.1080/02724990042000029; ALLAN LG, 1993, PSYCHOL BULL, V114, P435, DOI 10.1037/0033-2909.114.3.435; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; CHENG PW, 1992, PSYCHOL REV, V99, P83; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; Denniston JC, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P65; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; DICKINSON A, 1996, J EXP PSYCHOL B, V37, P397; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Larkin MJW, 1998, J EXP PSYCHOL LEARN, V24, P1331, DOI 10.1037/0278-7393.24.6.1331; Macho S, 2002, J EXP PSYCHOL LEARN, V28, P1171, DOI 10.1037//0278-7393.28.6.1171; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Melchers KG, 2004, Q J EXP PSYCHOL-B, V57, P25, DOI 10.1080/02724990344000042; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PRICE PC, 1995, J EXP PSYCHOL LEARN, V21, P1639, DOI 10.1037/0278-7393.21.6.1639; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SHANKS DR, 1985, Q J EXP PSYCHOL-B, V37, P1, DOI 10.1080/14640748508402082; Talairach J, 1988, CO PLANAR STEREOTAXI; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046; VANHAMME LJ, 1994, LEARN MOTIV, V25, P127, DOI 10.1006/lmot.1994.1008; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Zink CF, 2003, J NEUROSCI, V23, P8092	32	122	124	3	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 2	2004	44	5					877	888		10.1016/j.neuron.2004.11.022	http://dx.doi.org/10.1016/j.neuron.2004.11.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572117	Bronze			2022-12-28	WOS:000225548400014
J	Drouot', X; Oshino, S; Jarraya, B; Besret, L; Kishima, H; Remy, P; Dauguet, J; Lefaucheur, JP; Dolle, F; Conde, F; Bottlaender, M; Peschanski, M; Keravel, Y; Hantraye, P; Palfi, S				Drouot', X; Oshino, S; Jarraya, B; Besret, L; Kishima, H; Remy, P; Dauguet, J; Lefaucheur, JP; Dolle, F; Conde, F; Bottlaender, M; Peschanski, M; Keravel, Y; Hantraye, P; Palfi, S			Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation	NEURON			English	Article							HIGH-FREQUENCY STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS; GLOBUS-PALLIDUS; BASAL GANGLIA; NEURONAL-ACTIVITY; DOPAMINE; OSCILLATIONS; INHIBITION	A concept in Parkinson's disease postulates that motor cortex may pattern abnormal rhythmic activities in the basal ganglia, underlying the genesis of observed motor symptoms. We conducted a preclinical study of electrical interference in the primary motor cortex using a chronic MPTP primate model in which dopamine depletion was progressive and regularly documented using F-18-DOPA positron tomography. High-frequency motor cortex stimulation significantly reduced akinesia and bradykinesia. This behavioral benefit was associated with an increased metabolic activity in the supplementary motor area as assessed with 18-F-deoxyglucose PET, a normalization of mean firing rate in the internal globus pallidus (GPi) and the subthalamic nucleus (STN), and a reduction of synchronized oscillatory neuronal activities in these two structures. Motor cortex stimulation is a simple and safe procedure to modulate subthalamo-pallido-cortical loop and alleviate parkinsonian symptoms without requiring deep brain stereotactic surgery.	Serv Hosp Frederic Joliot, CEA, CNRS, URA 2210, F-91401 Orsay, France; Serv Hosp Frederic Joliot, Isotop Imaging Biochem & Pharmacol Unit, F-91401 Orsay, France; Serv Hosp Frederic Joliot, Imagene Program, F-91401 Orsay, France; Univ Paris 12, UPVM U 421, INSERM, F-94010 Creteil, France; Univ Paris 12, Serv Physiol, F-94010 Creteil, France; Univ Paris 12, Serv Neurol, F-94010 Creteil, France; Univ Paris 12, Serv Neurochirurg, Hop Henri Mondor, AP HP, F-94010 Creteil, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Palfi, S (corresponding author), Serv Hosp Frederic Joliot, CEA, CNRS, URA 2210, F-91401 Orsay, France.	stephane.palfi@hmn.ap-hop-paris.fr	Oshino, Satoru/AAS-1647-2020; Dollé, Frédéric/R-5756-2017; Jarraya, Bechir/R-6023-2019; Peschanski, Marc/N-5769-2017	Jarraya, Bechir/0000-0003-0878-763X; Remy, Philippe/0000-0003-2150-2563; Drouot, Xavier/0000-0002-3940-4825; Oshino, Satoru/0000-0002-4248-2322				Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bezard Erwan, 2001, FASEB Journal, V15, P1092; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Escola L, 2003, BRAIN, V126, P95, DOI 10.1093/brain/awg004; Fukuda M, 2001, ANN NEUROL, V49, P155, DOI 10.1002/1531-8249(20010201)49:2<155::AID-ANA35>3.0.CO;2-9; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; GRAFTON ST, 1995, ANN NEUROL, V37, P776, DOI 10.1002/ana.410370611; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Hashimoto T, 2002, J NEUROSCI METH, V113, P181, DOI 10.1016/S0165-0270(01)00491-5; Heimer G, 2002, J NEUROSCI, V22, P7850; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; JENKINS IH, 1992, ANN NEUROL, V32, P749, DOI 10.1002/ana.410320608; Krack P, 1998, BRAIN, V121, P451, DOI 10.1093/brain/121.3.451; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Magill PJ, 2001, NEUROSCIENCE, V106, P313, DOI 10.1016/S0306-4522(01)00281-0; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Ribeiro MJ, 2002, ARCH NEUROL-CHICAGO, V59, P580, DOI 10.1001/archneur.59.4.580; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89; Wichmann T, 1999, NATURE, V400, P621, DOI 10.1038/23148	34	132	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					769	778		10.1016/j.neuron.2004.11.023	http://dx.doi.org/10.1016/j.neuron.2004.11.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572109	Bronze			2022-12-28	WOS:000225548400006
J	Enomoto, H; Hughes, I; Golden, J; Baloh, RH; Yonemura, S; Heuckeroth, RO; Johnson, EM; Milbrandt, J				Enomoto, H; Hughes, I; Golden, J; Baloh, RH; Yonemura, S; Heuckeroth, RO; Johnson, EM; Milbrandt, J			GFR alpha 1 expression in cells lacking RET is dispensable for organogenesis and nerve regeneration	NEURON			English	Article							GDNF FAMILY LIGANDS; MOTOR-NEURON POOLS; NEUROTROPHIC FACTOR; MICE LACKING; RECEPTOR COMPONENTS; PERIPHERAL-NERVE; SURVIVAL FACTOR; OLFACTORY-BULB; ENTERIC NEURON; AXONAL GROWTH	The GDNF family ligands signal through a receptor complex composed of a ligand binding subunit, GFRalpha, and a signaling subunit, the RET tyrosine kinase. GFRalphas are expressed not only in RET-expressing cells, but also in cells lacking RET. A body of evidence suggests that RET-independent GFRalphas are important for (1) modulation of RET signaling in a non-cell-autonomous fashion (trans-signaling) and (2) regulation of NCAM function. To address the physiological significance of these roles, we generated mice specifically lacking RET-independent GFRalpha1. These mice exhibited no deficits in regions where trans-signaling has been implicated in vitro, including enteric neurons, motor neurons, kidney, and regenerating nerves. Furthermore, no abnormalities were found in the olfactory bulb, which requires proper NCAM function for its formation and is putatively a site of GDNF-GFRalpha-NCAM signaling. Thus RET-independent GFRalpha1 is dispensable for organogenesis and nerve regeneration in vivo, indicating that trans-signaling and GFRalpha-dependent NCAM signaling play a minor role physiologically.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; RIKEN, Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Lab Cellular Morphogenesis, Kobe, Hyogo 6500047, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); RIKEN; RIKEN	Enomoto, H (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	enomoto@cdb.riken.jp; jeff@pathology.wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689; Golden, Judith/0000-0002-5168-8525; Heuckeroth, Robert/0000-0002-3282-1765	NIA NIH HHS [AG01373, AG13729] Funding Source: Medline; NIDDK NIH HHS [R01 DK57038, R01 DK64592] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057038, R01DK064592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chazal G, 2000, J NEUROSCI, V20, P1446; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Ehrenfels CW, 1999, DEV GENET, V24, P263, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<263::AID-DVG9>3.0.CO;2-D; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hoke A, 2003, J NEUROSCI, V23, P561; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mikaels-Edman A, 2003, DEV DYNAM, V227, P27, DOI 10.1002/dvdy.10280; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pot C, 2002, J CELL BIOL, V159, P29, DOI 10.1083/jcb.200206068; Rossi J, 2000, EUR J NEUROSCI, V12, P3944, DOI 10.1046/j.1460-9568.2000.00292.x; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Sagot Y, 1998, J NEUROSCI, V18, P1132; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Worley DS, 2000, DEVELOPMENT, V127, P4383; Yu T, 1998, J NEUROSCI, V18, P4684	50	56	59	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					623	636		10.1016/j.neuron.2004.10.032	http://dx.doi.org/10.1016/j.neuron.2004.10.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541311	Bronze			2022-12-28	WOS:000225338100009
J	Grishanin, RN; Kowalchyk, JA; Klenchin, VA; Kyougsook, A; Earles, CA; Chapman, ER; Gerona, RRL; Martin, TFJ				Grishanin, RN; Kowalchyk, JA; Klenchin, VA; Kyougsook, A; Earles, CA; Chapman, ER; Gerona, RRL; Martin, TFJ			CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein	NEURON			English	Article							CA2+-DEPENDENT ACTIVATOR PROTEIN; CHROMAFFIN CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; REGULATED EXOCYTOSIS; SECRETORY GRANULES; PLASMA-MEMBRANE; C2 DOMAINS; CALCIUM; RELEASE; SYNAPTOTAGMIN	CAPS-1 is required for Ca2+-triggered fusion of dense-core vesicles with the plasma membrane, but its site of action and mechanism are unknown. We analyzed the kinetics of Ca2+-triggered exocytosis reconstituted in permeable PC12 cells. CAPS-1 increased the initial rate of Ca2+-triggered vesicle exocytosis by acting at a rate-limiting, Ca2+-dependent prefusion step. CAPS-1 activity depended upon prior ATP-dependent priming during which PIP2 synthesis occurs. CAPS-1 activity and binding to the plasma membrane depended upon PIP2- Call Was ineffective in triggering vesicle fusion in the absence of CAPS-1 but instead promoted desensitization to CAPS-1 resulting from decreased plasma membrane PIP2. We conclude that CAPS-1 functions following ATP-dependent priming as a PIP2 binding protein to enhance Ca2+-dependent DCV exocytosis. Essential prefusion steps in dense-core vesicle exocytosis involve sequential ATP-dependent synthesis of PIP2 and the subsequent PIP2-dependent action of CAPS-1. Regulation of PIP2 levels and CAPS-1 activity would control the secretion of neuropeptides and monoaminergic transmitters.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@facstaff.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40428] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; AVERY L, 1993, GENETICS, V134, P454; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Barg S, 2001, J CELL SCI, V114, P2145; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Earles C, 1998, ANAL BIOCHEM, V264, P191, DOI 10.1006/abio.1998.2850; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Elhamdani A, 2000, J NEUROSCI, V20, P2495; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES PM, 1992, BIOCHEM J, V285, P973, DOI 10.1042/bj2850973; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; Krause M, 1995, METHOD CELL BIOL, V48, P513; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Ng YK, 2002, J NEUROSCI, V22, P3890, DOI 10.1523/JNEUROSCI.22-10-03890.2002; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SEWARD EP, 1995, J NEUROSCI, V15, P3390; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VANDERMERWE PA, 1990, BIOCHEM J, V268, P493, DOI 10.1042/bj2680493; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	64	133	137	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					551	562		10.1016/j.neuron.2004.07.028	http://dx.doi.org/10.1016/j.neuron.2004.07.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312653	Bronze			2022-12-28	WOS:000223436400013
J	Lin, B; Wang, SW; Masland, RH				Lin, B; Wang, SW; Masland, RH			Retinal ganglion cell type, size, and spacing can be specified independent of homotypic dendritic contacts	NEURON			English	Article							DOMAIN FACTOR BRN-3B; MAMMALIAN RETINA; SENSORY NEURONS; MOUSE RETINA; CAT RETINA; SPATIAL-ORGANIZATION; RECEPTIVE-FIELDS; NERVOUS-SYSTEM; AXON OUTGROWTH; VISUAL-SYSTEM	In Brn3b(-/-) mice, where 80% of retinal ganglion cells degenerate early in development, the remaining 20% include most or all ganglion cell types. Cells of the same type cover the retinal surface evenly but tile it incompletely, indicating that a regular mosaic and normal dendritic field size can be maintained in the absence of contact among homotypic cells. In Math5(-/-) mice, where only similar to5% of ganglion cells are formed, the dendritic arbors of at least two types among the residual ganglion cells are indistinguishable from normal in shape and size, even though throughout development they are separated by millimeters from the nearest neighboring ganglion cell of the same type. It appears that the primary phenotype of retinal ganglion cells can develop without homotypic contact; dendritic repulsion may be an end-stage mechanism that fine-tunes the dendritic arbors for more efficient coverage of the retinal surface.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Masland, RH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	masland@helix.mgh.harvard.edu	Lin, Bin/E-9871-2010	Lin, Bin/0000-0003-1309-3480				AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; EYSEL UT, 1985, J COMP NEUROL, V242, P134, DOI 10.1002/cne.902420109; Farajian R, 2004, VISUAL NEUROSCI, V21, P13, DOI 10.1017/S0952523804041021; Galli-Resta L, 2000, EUR J NEUROSCI, V12, P3819, DOI 10.1046/j.1460-9568.2000.00280.x; Galli-Resta L, 1999, EUR J NEUROSCI, V11, P1461, DOI 10.1046/j.1460-9568.1999.00555.x; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HITCHCOCK PF, 1989, DEVELOPMENT, V106, P589; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KIRBY MA, 1986, J COMP NEUROL, V251, P532, DOI 10.1002/cne.902510408; Lin B, 2000, EUR J NEUROSCI, V12, P4155, DOI 10.1111/j.1460-9568.2000.01311.x; Lohmann C, 2001, J NEUROBIOL, V48, P150, DOI 10.1002/neu.1048; Masland RH, 2000, ANNU REV NEUROSCI, V23, P249, DOI 10.1146/annurev.neuro.23.1.249; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; NICHOLLS JG, 1968, J NEUROPHYSIOL, V31, P740, DOI 10.1152/jn.1968.31.5.740; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Raven MA, 2002, J COMP NEUROL, V454, P168, DOI 10.1002/cne.10444; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Rockhill RL, 2002, J NEUROSCI, V22, P3831; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; TAUCHI M, 1985, J NEUROSCI, V5, P2494; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; VANEY DI, 1994, J NEUROSCI, V14, P6301; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang SW, 2000, MOL CELL NEUROSCI, V16, P141, DOI 10.1006/mcne.2000.0860; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1983, PROG BRAIN RES, V58, P183, DOI 10.1016/S0079-6123(08)60019-9; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1983, VISION RES, V23, P1151, DOI 10.1016/0042-6989(83)90029-9; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	53	142	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					475	485		10.1016/j.neuron.2004.08.002	http://dx.doi.org/10.1016/j.neuron.2004.08.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312647	Bronze			2022-12-28	WOS:000223436400007
J	Tischkau, SA; Mitchell, JW; Pace, LA; Barnes, JW; Barnes, JA; Gillette, MU				Tischkau, SA; Mitchell, JW; Pace, LA; Barnes, JW; Barnes, JA; Gillette, MU			Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock	NEURON			English	Article							CYCLIN-DEPENDENT KINASES; SUPRACHIASMATIC NUCLEUS; DROSOPHILA CLOCK; CELL-CYCLE; GENE-EXPRESSION; DOUBLE-TIME; S-PHASE; CGMP; LIGHT; CAMP	Circadian clocks comprise a cyclic series of dynamic cellular states, characterized by the changing availability of substrates that alter clock time when activated. To determine whether circadian clocks, like the cell cycle, exhibit regulation by key phosphorylation events, we examined endogenous kinase regulation of timekeeping in the mammalian suprachiasmatic nucleus (SCN). Short-term inhibition of PKG-II but not PKG-Ibeta using antisense oligodeoxynucleotides delayed rhythms of electrical activity and Bmal1 mRNA. Phase resetting was rapid and dynamic; inhibition of PKG-II forced repetition of the last 3.5 hr of the cycle. Chronic inhibition of PKG-II disrupted electrical activity rhythms and tonically increased Bmal1 mRNA. PKG-II-like immunoreactivity was detected after coimmunoprecipitation with CLOCK, and CLOCK was phosphorylated in the presence of active PKG-II. PKG-II activation may define a critical control point for temporal progression into the daytime domain by acting on the positive arm of the transcriptional/translational feedback loop.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Cell & Struct Biol, B107 CLSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	mgillett@uiuc.edu		Pace, Laura/0000-0002-3311-8342	NHLBI NIH HHS [HL67007, R01 HL067007] Funding Source: Medline; NIGMS NIH HHS [GM07143] Funding Source: Medline; NINDS NIH HHS [NS35859, R01 NS035859, R01 NS022155, NS22155, NS11158, NS10170] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011158, R01NS022155, R01NS035859, F32NS010170] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; BUTT E, 1993, NEUROCHEM RES, V18, P27, DOI 10.1007/BF00966920; Comolli AC, 1999, J BIOL RHYTHM, V14, P11, DOI 10.1177/074873099129000399; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; ESKIN A, 1984, J NEUROSCI, V4, P2466; Ferreyra GA, 2001, AM J PHYSIOL-REG I, V280, pR1348, DOI 10.1152/ajpregu.2001.280.5.R1348; Gambaryan S, 1996, J CLIN INVEST, V98, P662, DOI 10.1172/JCI118837; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; GILLETTE MU, 1987, BRAIN RES BULL, V19, P135, DOI 10.1016/0361-9230(87)90176-6; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Gillette MU, 1996, PROG BRAIN RES, V111, P121, DOI 10.1016/S0079-6123(08)60404-5; GILLETTE MU, 1988, BRAIN RES, V474, P348, DOI 10.1016/0006-8993(88)90449-0; GILLETTE MU, 1995, CIRCADIAN CLOCKS THE, P134; Gitig DM, 2001, MOL BIOTECHNOL, V19, P179, DOI 10.1385/MB:19:2:179; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Krucher NA, 1997, CELL MOL NEUROBIOL, V17, P495, DOI 10.1023/A:1026358821640; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Liu C, 1997, J NEUROSCI, V17, P659; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mathur A, 1996, AM J PHYSIOL-REG I, V270, pR1031, DOI 10.1152/ajpregu.1996.270.5.R1031; Merrow MW, 1997, P NATL ACAD SCI USA, V94, P3877, DOI 10.1073/pnas.94.8.3877; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Okamura H, 2002, CELL TISSUE RES, V309, P47, DOI 10.1007/s00441-002-0572-5; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; POHLER D, 1995, FEBS LETT, V374, P419, DOI 10.1016/0014-5793(95)01168-E; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; PROSSER RA, 1989, P NATL ACAD SCI USA, V86, P6812, DOI 10.1073/pnas.86.17.6812; PROSSER RA, 1989, J NEUROSCI, V9, P1073; Ripperger JA, 2001, CURR OPIN CELL BIOL, V13, P357, DOI 10.1016/S0955-0674(00)00220-9; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; WEBER ET, 1995, NEUROSCI LETT, V197, P227, DOI 10.1016/0304-3940(95)11961-U; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yang YH, 2001, J BIOL CHEM, V276, P41064, DOI 10.1074/jbc.M106905200; Yew PR, 2001, J CELL PHYSIOL, V187, P1, DOI 10.1002/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO;2-O; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	52	45	47	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					539	549		10.1016/j.neuron.2004.07.027	http://dx.doi.org/10.1016/j.neuron.2004.07.027			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312652	Bronze, Green Submitted			2022-12-28	WOS:000223436400012
J	Voermans, NC; Petersson, KM; Daudey, L; Weber, B; van Spaendonck, KP; Kremer, HPH; Fernandez, G				Voermans, NC; Petersson, KM; Daudey, L; Weber, B; van Spaendonck, KP; Kremer, HPH; Fernandez, G			Interaction between the human hippocampus and the caudate nucleus during route recognition	NEURON			English	Article							MEMORY-SYSTEMS; SPATIAL MEMORY; MAZE TASKS; LESIONS; ORGANIZATION; STRIATUM; DEFICITS; FORNIX; PLACE; BRAIN	Navigation through familiar environments can rely upon distinct neural representations that are related to different memory systems with either the hippocampus or the caudate nucleus at their core. However, it is a fundamental question whether and how these systems interact during route recognition. To address this issue, we combined a functional neuroimaging approach with a naturally occurring, well-controlled human model of caudate nucleus dysfunction (i.e., preclinical and early-stage Huntington's disease). Our results reveal a noncompetitive interaction so that the hippocampus compensates for gradual caudate nucleus dysfunction with a gradual activity increase, maintaining normal behavior. Furthermore, we revealed an interaction between medial temporal and caudate activity in healthy subjects, which was adaptively modified in Huntington patients to allow compensatory hippocampal processing. Thus, the two memory systems contribute in a noncompetitive, cooperative manner to route recognition, which enables the hippocampus to compensate seamlessly for the functional degradation of the caudate nucleus.	Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Cognit Neurol & Memory Res Grp, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; Karolinska Hosp, Dept Clin Neurosci, Cognit Neurophysiol Res Grp, Karolinska Inst, S-17176 Stockholm, Sweden; Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; University of Bonn	Fernandez, G (corresponding author), Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Cognit Neurol & Memory Res Grp, POB 9101, NL-6500 HB Nijmegen, Netherlands.	guillen.fernandez@fcdonders.kun.nl	Voermans, N.C./L-4724-2015; Petersson, Karl Magnus/E-8188-2012; GNC, GNC/B-5716-2013; Petersson, Karl Magnus/HDO-0143-2022; Weber, Bernd/H-5244-2012; Fernandez, Guillen/B-3771-2009	Petersson, Karl Magnus/0000-0002-8245-0392; Petersson, Karl Magnus/0000-0002-8245-0392; Weber, Bernd/0000-0002-7811-9605; Fernandez, Guillen/0000-0002-5522-0604				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AYLWARD EH, 1991, AM J NEURORADIOL, V12, P1217; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bohbot VD, 2000, ANN NY ACAD SCI, V911, P355; BUYTENHUIJS EL, 1994, NEUROPSYCHOLOGIA, V32, P335, DOI 10.1016/0028-3932(94)90135-X; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Delis DC., 2000, CALIFORNIA VERBAL LE; Devan BD, 1999, J NEUROSCI, V19, P2789; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; HARPER P. S., 1996, HUNTINGTONS DIS; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Iaria G, 2003, J NEUROSCI, V23, P5945; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; MCDONALD RJ, 1995, BEHAV NEUROSCI, V109, P579, DOI 10.1037/0735-7044.109.4.579; Money J., 1976, STANDARDIZED ROAD MA; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; POTEGAL M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P479; Ramos JMJ, 2000, EUR J NEUROSCI, V12, P3375, DOI 10.1046/j.1460-9568.2000.00206.x; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wechsler D., 2000, WAIS 3 NEDERLANDSTAL; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	41	189	190	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					427	435		10.1016/j.neuron.2004.07.009	http://dx.doi.org/10.1016/j.neuron.2004.07.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294149	Green Published, Bronze			2022-12-28	WOS:000223156900015
J	Martin, KC; Sun, YE				Martin, KC; Sun, YE			To learn better, keep the HAT on	NEURON			English	Editorial Material							RUBINSTEIN-TAYBI-SYNDROME; LONG-TERM-MEMORY	Long-lasting memories are known to require new transcription. Recent studies have highlighted a role for epigenetic alterations, including histone acetylation, in regulating gene expression. In this issue of Neuron, Alarcon et al. and Korzus et al. use two different mouse models of Rubinstein-Taybi syndrome to elucidate a role for the histone acetyltransferase activity of CREB binding protein (CBP) in long-term memory and plasticity.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Inst Neuropsychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Inst Neuropsychiat, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.							Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215	9	16	18	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 24	2004	42	6					879	881		10.1016/j.neuron.2004.06.007	http://dx.doi.org/10.1016/j.neuron.2004.06.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207231	Bronze			2022-12-28	WOS:000222329300002
J	Zhou, FQ; Zhou, J; Dedhar, S; Wu, YH; Snider, WD				Zhou, FQ; Zhou, J; Dedhar, S; Wu, YH; Snider, WD			NGF-induced axon growth is mediated by localized inactivation of GSK-30 and functions of the microtubule plus end binding protein APC	NEURON			English	Article							ADENOMATOUS-POLYPOSIS-COLI; GLYCOGEN-SYNTHASE KINASE-3-BETA; TUMOR-SUPPRESSOR PROTEIN; INTEGRIN-LINKED KINASE; CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; CELL POLARITY; COMPARTMENTALIZED CULTURES	Little is known about how nerve growth factor (NGF) signaling controls the regulated assembly of microtubules that underlies axon growth. Here we demonstrate that a tightly regulated and localized activation of phosphatidylinositol 3-kinase (PI3K) at the growth cone is essential for rapid axon growth induced by NGF. This spatially activated PI3K signaling is conveyed downstream through a localized inactivation of glycogen synthase kinase 3P (GSK-3beta). These two spatially coupled kinases control axon growth via regulation of a microtubule plus end binding protein, adenomatous polyposis coli (APC). Our results demonstrate that NGF signals are transduced to the axon cytoskeleton via activation of a conserved cell polarity signaling pathway.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Jack Bell Res Ctr, BC Canc Agcy, Vancouver, BC V6H 3Z6, Canada	University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of British Columbia	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu		Dedhar, Shoukat/0000-0003-4355-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS031768] Funding Source: NIH RePORTER; NINDS NIH HHS [P30 NS045892, NS031768] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Baas Peter W., 2001, Neuron, V32, P981, DOI 10.1016/S0896-6273(01)00556-6; BHAT RV, 1994, J NEUROSCI, V14, P3059; Brakeman JSF, 1999, NEUROSCIENCE, V91, P661, DOI 10.1016/S0306-4522(98)00605-8; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; CAMPENOT RB, 1982, DEV BIOL, V93, P13, DOI 10.1016/0012-1606(82)90233-0; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Goold RG, 2001, J CELL SCI, V114, P4273; Goold RG, 1999, J CELL SCI, V112, P3373; GORDONWEEKS PR, 1991, BIOESSAYS, V13, P235, DOI 10.1002/bies.950130506; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; He Y, 2002, J NEUROSCI, V22, P5982; Hetman M, 2000, J NEUROSCI, V20, P2567; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mills J, 2003, J NEUROSCI, V23, P1638; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mimori-Kiyosue Y, 2001, J CELL BIOL, V154, P1105, DOI 10.1083/jcb.200106113; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Morrison EE, 1997, NEUROSCI LETT, V235, P129, DOI 10.1016/S0304-3940(97)00739-8; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sayas CL, 2002, J NEUROSCI, V22, P6863; Schindelholz B, 1999, METHODS, V18, P487, DOI 10.1006/meth.1999.0817; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Smith DS, 1997, J NEUROSCI, V17, P646; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wagner U, 1996, J CELL SCI, V109, P1537; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; WOODGETT JR, 2001, SCI STKE, pRE12; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	71	431	451	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					897	912		10.1016/j.neuron.2004.05.011	http://dx.doi.org/10.1016/j.neuron.2004.05.011			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207235	Bronze, Green Published			2022-12-28	WOS:000222329300006
J	Thoreson, WB; Rabl, K; Townes-Anderson, E; Heidelberger, R				Thoreson, WB; Rabl, K; Townes-Anderson, E; Heidelberger, R			A highly Ca2+-sensitive pool of vesicles contributes to linearity at the rod photoreceptor ribbon synapse	NEURON			English	Article							TRANSMITTER RELEASE; GLUTAMATE RELEASE; CALCIUM-DEPENDENCE; BIPOLAR CELLS; SYNAPTOTAGMIN-III; HORIZONTAL CELLS; CHROMAFFIN CELLS; INNER SEGMENTS; SALAMANDER; EXOCYTOSIS	Studies of the properties of synaptic transmission have been carried out at only a few synapses. We analyzed exocytosis from rod photoreceptors with a combination of physiological and ultrastructural techniques. As at other ribbon synapses, we found that rods exhibited rapid kinetics of release, and the number of vesicles in the releasable pool is comparable to the number of vesicles tethered at ribbon-style active zones. However, unlike other previously studied neurons, we identified a highly Call-sensitive pool of releasable vesicles with a relatively shallow relationship between the rate of exocytosis and [Ca2+], that is nearly linear over a presumed physiological range of intra-terminal [Ca2+]. The low-order [Ca2+] dependence of release promotes a linear relationship between Ca2+ entry and exocytosis that permits rods to relay information about small changes in illumination with high fidelity at the first synapse in vision.	Univ Nebraska, Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA; Univ Med & Dent New Jersey, Dept Neurol & Neurosci, Sch Med, Newark, NJ 07103 USA; Univ Texas, Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Health Science Center Houston	Thoreson, WB (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol, 600 S 42nd St, Omaha, NE 68198 USA.	wbthores@unmc.edu	Thoreson, Wallace B./F-6172-2010	Thoreson, Wallace B./0000-0001-7104-042X; Heidelberger, Ruth/0000-0002-8033-2050	NATIONAL EYE INSTITUTE [R29EY010542, P30EY010608, R01EY012128, R29EY012128, R55EY010542, R01EY012031, R01EY010542] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY010608, EY-12031, R29 EY010542, EY-10542, R01 EY012031, R01 EY012128, R29 EY012128, R01 EY010542-08, EY-10608, R01 EY010542, EY-12128] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABE H, 1984, J ULTRA MOL STRUCT R, V86, P246, DOI 10.1016/S0022-5320(84)90104-7; Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DONNELLY DF, 1994, BIOPHYS J, V66, P873, DOI 10.1016/S0006-3495(94)80863-X; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gillis Kevin D., 1995, P155; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; Heidelberger R, 2003, VISUAL NEUROSCI, V20, P37, DOI 10.1017/S095252380320105X; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Heidelberger R, 2001, REV PHYSIOL BIOCH P, V143, P1, DOI 10.1007/BFb0115592; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KIM HG, 1991, BRAIN RES, V538, P141, DOI 10.1016/0006-8993(91)90388-C; KIM HG, 1993, J NEUROPHYSIOL, V69, P352, DOI 10.1152/jn.1993.69.2.352; Kits KS, 1999, BIOPHYS J, V76, P1693, DOI 10.1016/S0006-3495(99)77328-5; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Messler P, 1996, J NEUROSCI METH, V69, P137, DOI 10.1016/S0165-0270(96)00032-5; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAKA KI, 1987, J GEN PHYSIOL, V89, P321, DOI 10.1085/jgp.89.2.321; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PIERANTONI RL, 1981, PHOTORECEPTORS, P255; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROHLICEK V, 1994, PFLUG ARCH EUR J PHY, V428, P30, DOI 10.1007/BF00374749; Rouze NC, 1998, J NEUROSCI, V18, P8614; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1329, DOI 10.1152/jn.1987.58.6.1329; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Thoreson WB, 2003, NEUROSCIENCE, V122, P785, DOI 10.1016/j.neuroscience.2003.08.012; TOWNESANDERSON E, 1985, J CELL BIOL, V100, P175, DOI 10.1083/jcb.100.1.175; TOWNESANDERSON E, 1988, J NEUROSCI, V8, P320; TRANCHINA D, 1981, P NATL ACAD SCI-BIOL, V78, P6540, DOI 10.1073/pnas.78.10.6540; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wu LG, 1999, J NEUROSCI, V19, P726; WU SM, 1985, P NATL ACAD SCI USA, V82, P3944, DOI 10.1073/pnas.82.11.3944; WU SM, 1988, VISION RES, V28, P1; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	82	148	148	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					595	605		10.1016/S0896-6273(04)00254-5	http://dx.doi.org/10.1016/S0896-6273(04)00254-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157421	Green Accepted, Bronze			2022-12-28	WOS:000221708300010
J	Gomez, TM; Robles, E				Gomez, TM; Robles, E			The great escape: Phosphorylation of Ena/VASP by PKA promotes filopodial formation	NEURON			English	Editorial Material							AXON GUIDANCE; PROTEINS; RECEPTOR; OUTGROWTH; MOTILITY	The Ena/VASP family of proteins consists of adaptor molecules that localize to subcellular sites of actin polymerization. The role of Ena/VASP proteins in the regulation of cell motility and axon outgrowth has been controversial. Recently, these proteins have been proposed to function as "anticapping" factors, which may have differential effects on filopodial versus lammelipodial actin-based protrusions. A study by Lebrand et al. in this issue of Neuron supports this model and identifies PKA as a key regulator of Ena/VASP function downstream of the chemoattractant Netrin.	Univ Wisconsin, Sch Med, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Gomez, TM (corresponding author), Univ Wisconsin, Sch Med, Dept Anat, Madison, WI 53706 USA.			Gomez, Timothy/0000-0002-1515-8228; Robles, Estuardo/0000-0002-1202-2050	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041564] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041564-04, R01 NS041564] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Coppolino MG, 2001, J CELL SCI, V114, P4307; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; SONG HJ, 2001, NAT CELL BIL, V23, P81; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113	13	15	15	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 8	2004	42	1					1	3		10.1016/S0896-6273(04)00188-6	http://dx.doi.org/10.1016/S0896-6273(04)00188-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066258	Bronze			2022-12-28	WOS:000221458400001
J	Pasley, BN; Mayes, LC; Schultz, RT				Pasley, BN; Mayes, LC; Schultz, RT			Subcortical discrimination of unperceived objects during binocular rivalry	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; MACAQUE MONKEY AMYGDALA; MEDIAL TEMPORAL-LOBE; SUPERIOR COLLICULUS; VISUAL AWARENESS; TOPOGRAPHIC ORGANIZATION; PATTERN-DISCRIMINATION; PREFRONTAL CORTEX; EMOTIONAL FACES; CORTICAL INPUTS	Rapid identification of behaviorally relevant objects is important for survival. In humans, the neural computations for visually discriminating complex objects involve inferior temporal cortex (IT). However, less detailed but faster form processing may also occur in a phylogenetically older subcortical visual system that terminates in the amygdala. We used binocular rivalry to present stimuli without conscious awareness, thereby eliminating the IT object representation and isolating subcortical visual input to the amygdala. Functional magnetic resonance imaging revealed significant brain activation in the left amygdala but not in object-selective IT in response to unperceived fearful faces compared to unperceived nonface objects. These findings indicate that, for certain behaviorailly relevant stimuli, a high-level cortical representation in IT is not required for object discrimination in the amygdala.	Yale Univ, Dev Neuroimaging Lab, Ctr Child Study, New Haven, CT 06520 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Yale University; University of California System; University of California Berkeley	Schultz, RT (corresponding author), Yale Univ, Dev Neuroimaging Lab, Ctr Child Study, New Haven, CT 06520 USA.	robert.schultz@yale.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD003008, P01HD035482] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD/DC35482, P01 HD 03008] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bar M, 1999, P NATL ACAD SCI USA, V96, P1790, DOI 10.1073/pnas.96.4.1790; Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; BENEVENTO LA, 1975, J COMP NEUROL, V160, P339, DOI 10.1002/cne.901600306; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Cave CB, 1998, PSYCHOL SCI, V9, P299, DOI 10.1111/1467-9280.00059; CHALUPA LM, 1976, J NEUROPHYSIOL, V39, P354, DOI 10.1152/jn.1976.39.2.354; Dailey MN, 1999, NEURAL NETWORKS, V12, P1053, DOI 10.1016/S0893-6080(99)00050-7; Dawkins MS, 2000, NATURE, V403, P652, DOI 10.1038/35001064; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GALLANT JL, 2000, SEEING, P311; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; GOREN CC, 1975, PEDIATRICS, V56, P544; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; IWAI E, 1987, J COMP NEUROL, V261, P362, DOI 10.1002/cne.902610304; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Kraemer M, 1999, DOC OPHTHALMOL, V97, P189, DOI 10.1023/A:1002041122449; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Linke R, 1999, J COMP NEUROL, V403, P158; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Lomber SG, 2002, P NATL ACAD SCI USA, V99, P4049, DOI 10.1073/pnas.062551899; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MILLER M, 1980, J NEUROPHYSIOL, V43, P1510, DOI 10.1152/jn.1980.43.6.1510; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; NAKAMURA K, 1992, J NEUROPHYSIOL, V67, P1447, DOI 10.1152/jn.1992.67.6.1447; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Rolls E. T., 2000, AMYGDALA FUNCTIONAL, P447; ROLLS ET, 1994, EXP BRAIN RES, V101, P473; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; ROLLS ET, 1999, BRAIN EMOTION; Romanski LM, 1997, J COMP NEUROL, V379, P313; ROSA MGP, 1994, VISUAL NEUROSCI, V11, P1037, DOI 10.1017/S0952523800006878; SCHILLER PH, 1977, J NEUROPHYSIOL, V40, P428, DOI 10.1152/jn.1977.40.2.428; SCHILLER PH, 1999, J NEUROPHYSIOL, V69, P243; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Sewards TV, 2002, COMP BIOCHEM PHYS A, V132, P861, DOI 10.1016/S1095-6433(02)00119-8; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Simion F, 1998, J EXP PSYCHOL HUMAN, V24, P1399, DOI 10.1037/0096-1523.24.5.1399; Stefanacci L, 2000, J COMP NEUROL, V421, P52, DOI 10.1002/(SICI)1096-9861(20000522)421:1<52::AID-CNE4>3.0.CO;2-O; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Stepniewska I, 2000, VISUAL NEUROSCI, V17, P529, DOI 10.1017/S0952523800174048; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2001, BRAIN MIND, V2, P55, DOI DOI 10.1023/A:1017942718744; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WEBSTER MJ, 1991, J NEUROSCI, V11, P1095; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; Whalen PJ, 1998, J NEUROSCI, V18, P411; ZIMBA LD, 1983, J EXP PSYCHOL HUMAN, V9, P807, DOI 10.1037/0096-1523.9.5.807	70	220	231	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					163	172		10.1016/S0896-6273(04)00155-2	http://dx.doi.org/10.1016/S0896-6273(04)00155-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066273	Bronze			2022-12-28	WOS:000221458400016
J	De Rosa, E; Desmond, JE; Anderson, AK; Pfefferbaum, A; Sullivan, EV				De Rosa, E; Desmond, JE; Anderson, AK; Pfefferbaum, A; Sullivan, EV			The human basal forebrain integrates the old and the new	NEURON			English	Article							CHRONIC ETHANOL-CONSUMPTION; ANTERIOR CINGULATE CORTEX; STORED ODOR MEMORIES; WORKING-MEMORY; CHOLINERGIC MODULATION; PROACTIVE-INTERFERENCE; ORBITOFRONTAL CORTEX; COGNITIVE FUNCTIONS; BRAIN; SYSTEMS	Acquisition of new learning is challenged by the phenomenon of proactive interference (PI), which occurs when previous learning disrupts later learning. Whereas human neuroimaging studies have focused on the cortical contributions to interference resolution, animal studies demonstrate that efficient resolution of PI depends on cholinergic modulation from basal forebrain (BF). Whether the BF promotes PI resolution in humans is unknown. Here, we adapted a PI paradigm from animal studies for use in a functional MRI experiment. During PI resolution, neurologically intact subjects recruited a BF network that included afferent anterior and posterior cortical sites associated with efficient memory acquisition and perceptual processing. Despite normal performance, nonamnesic patients with alcoholism, which is known to disrupt BF function, did not activate a BF network but instead invoked anterior cortical sites traditionally associated with executive function. These results provide evidence for parallel neural systems, each with the potential to resolve interference in the face of competing information.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; SRI Int, Program Neurosci, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; Stanford University; Stanford University; SRI International	De Rosa, E (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	derosa@psych.utoronto.ca	De Rosa, Eve/B-5888-2014; Sullivan, Edith V/ABD-5684-2021	Sullivan, Edith V/0000-0001-6739-3716	NIAAA NIH HHS [AA 10723, AA 05965] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005965, R37AA005965, R01AA010723, R37AA010723] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Arendt T, 1994, J Neural Transm Suppl, V44, P173; ARENDT T, 1988, BRAIN RES BULL, V21, P563, DOI 10.1016/0361-9230(88)90193-1; ASHE JH, 1989, SYNAPSE, V4, P44, DOI 10.1002/syn.890040106; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; CASAMENTI F, 1993, NEUROSCIENCE, V56, P465, DOI 10.1016/0306-4522(93)90346-H; CERMAK LS, 1972, NEUROPSYCHOLOGIA, V10, P89, DOI 10.1016/0028-3932(72)90045-0; Courtney SM, 1997, CURR OPIN NEUROBIOL, V7, P554, DOI 10.1016/S0959-4388(97)80036-0; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; De Rosa E, 2000, BEHAV NEUROSCI, V114, P32, DOI 10.1037/0735-7044.114.1.32; De Rosa E, 2001, BEHAV NEUROSCI, V115, P314, DOI 10.1037/0735-7044.115.2.314; Desmond JE, 2003, NEUROIMAGE, V19, P1510, DOI 10.1016/S1053-8119(03)00102-2; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; EBLEN F, 1995, J NEUROSCI, V15, P5999; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Ghashghaei HT, 2001, NEUROSCIENCE, V103, P593, DOI 10.1016/S0306-4522(00)00585-6; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; LOSIER BJ, 1993, BRAIN RES, V604, P41, DOI 10.1016/0006-8993(93)90350-V; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MAI JK, 1987, ATLAS HUMAN BRAIN; Matttews DB, 2000, ALCOHOL CLIN EXP RES, V24, P1427, DOI 10.1111/j.1530-0277.2000.tb02113.x; McGeoch JA., 1942, PSYCHOL HUMAN LEARNI; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Miasnikov AA, 2001, NEUROREPORT, V12, P1537, DOI 10.1097/00001756-200105250-00047; Miller R, 2002, BRAIN RES, V950, P137, DOI 10.1016/S0006-8993(02)03014-7; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; NODBERG A, 1982, DRUG ALCOHOL DEPEN, V10, P333; NORDBERG A, 1983, PHARMACOL BIOCHEM BE, V18, P397, DOI 10.1016/0091-3057(83)90206-X; OSCARBERMAN M, 1980, NEUROPSYCHOLOGIA, V18, P513, DOI 10.1016/0028-3932(80)90153-0; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2001, NEUROIMAGE, V14, P7, DOI 10.1006/nimg.2001.0785; ROTHBERG BS, 1991, NEUROSCI LETT, V132, P243, DOI 10.1016/0304-3940(91)90311-G; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; Sakai K, 1998, J NEUROSCI, V18, P1827; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; SULLIVAN EV, 1993, PSYCHIAT RES, V46, P175, DOI 10.1016/0165-1781(93)90019-D; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; WICKENS DD, 1970, PSYCHOL REV, V77, P1, DOI 10.1037/h0028569; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x	61	52	52	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					825	837		10.1016/S0896-6273(04)00080-7	http://dx.doi.org/10.1016/S0896-6273(04)00080-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003180	Bronze			2022-12-28	WOS:000221458200016
J	Marin-Teva, JL; Dusart, I; Colin, C; Gervais, A; van Rooijen, N; Mallat, M				Marin-Teva, JL; Dusart, I; Colin, C; Gervais, A; van Rooijen, N; Mallat, M			Microglia promote the death of developing Purkinje cells	NEURON			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; NADPH OXIDASE; NEUROTROPHIC FACTOR; BRAIN MACROPHAGES; SUPEROXIDE GENERATION; OXIDATIVE STRESS; APOPTOTIC CELLS; MICE LACKING	The loss of neuronal cells, a prominent event in the development of the nervous system, involves regulated triggering of programmed cell death, followed by efficient removal of cell corpses. Professional phagocytes, such as microglia, contribute to the elimination of dead cells. Here we provide evidence that, in addition to their phagocytic activity, microglia promote the death of developing neurons engaged in synaptogenesis. In the developing mouse cerebellum, Purkinje cells die, and 60% of these neurons that already expressed activated caspase-3 were engulfed or contacted by spreading processes emitted by microglial cells. Apoptosis of Purkinje cells in cerebellar slices was strongly reduced by selective elimination of microglia. Superoxide ions produced by microglial respiratory bursts played a major role in this Purkinje cell death. Our study illustrates a mammalian form of engulfment-promoted cell death that links the execution of neuron death to the scavenging of dead cells.	INSERM, U495, IFR 70, UPMC, F-75654 Paris 13, France; Hop La Pitie Salpetriere, INSERM, U106, IFR 70, F-75013 Paris, France; Vrije Univ Amsterdam Med Ctr, Dept Mol & Cell Biol, NL-1081 BT Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mallat, M (corresponding author), INSERM, U495, IFR 70, UPMC, F-75654 Paris 13, France.	michel.mallat@infobiogen.fr	Van Rooijen, Nico/Z-1578-2019; Mallat, Michel/J-3609-2017	Dusart, Isabelle/0000-0002-3211-4323				Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; ASHWELL K, 1990, DEV BRAIN RES, V55, P219, DOI 10.1016/0165-3806(90)90203-B; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; BERTOSSI M, 1986, ANAT EMBRYOL, V175, P25, DOI 10.1007/BF00315453; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CHAMAK B, 1995, NEUROSCIENCE, V69, P177, DOI 10.1016/0306-4522(95)00236-C; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHAO CC, 1992, J IMMUNOL, V149, P2736; Combs CK, 2001, J NEUROSCI, V21, P1179; CUADROS MA, 1991, J ANAT, V177, P145; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; Dusart I, 1997, J NEUROSCI, V17, P3710; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fan HB, 2001, J COMP NEUROL, V436, P82; Flavin MP, 2000, GLIA, V29, P347, DOI 10.1002/(SICI)1098-1136(20000215)29:4<347::AID-GLIA5>3.3.CO;2-#; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; GARDETTE R, 1985, DEV BRAIN RES, V19, P47, DOI 10.1016/0165-3806(85)90230-5; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Ghoumari AM, 2002, J NEUROSCI, V22, P3531; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; HENDELMAN WJ, 1980, J COMP NEUROL, V193, P1063, DOI 10.1002/cne.901930417; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kaal ECA, 1998, J NEUROSCI RES, V54, P778, DOI 10.1002/(SICI)1097-4547(19981215)54:6<778::AID-JNR5>3.0.CO;2-0; Kim SH, 2002, J CELL BIOL, V159, P821, DOI 10.1083/jcb.200112131; LARKFORS L, 1994, EUR J NEUROSCI, V6, P1015, DOI 10.1111/j.1460-9568.1994.tb00596.x; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; Lindholm D, 1997, PERSPECT DEV NEUROBI, V5, P83; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416, DOI 10.1002/jlb.56.3.416; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Morrison ME, 1998, J NEUROSCI, V18, P3563; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Murakami K, 1998, J NEUROSCI, V18, P205; NAVSCUES J, 2002, MICROGLIA DEGENERATI; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Noh KM, 2000, J NEUROSCI, V20; OPPENHEIM RW, 1999, FUNDAMENTAL NEUROSCI, P581; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rakic S, 2000, EUR J NEUROSCI, V12, P2721, DOI 10.1046/j.1460-9568.2000.00153.x; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; Sankarapandi S, 1998, ARCH BIOCHEM BIOPHYS, V353, P312, DOI 10.1006/abbi.1998.0658; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schneider SD, 1997, GENE THER, V4, P524, DOI 10.1038/sj.gt.3300432; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Tammariello SP, 2000, J NEUROSCI, V20; THANOS S, 1993, J NEUROSCI, V13, P455; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; TORRESALEMAN I, 1992, EUR J NEUROSCI, V4, P864, DOI 10.1111/j.1460-9568.1992.tb00196.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Upender MB, 1999, DEV NEUROSCI-BASEL, V21, P491, DOI 10.1159/000017416; vanRooijen N, 1997, TRENDS BIOTECHNOL, V15, P178, DOI 10.1016/S0167-7799(97)01019-6; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2	80	510	526	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					535	547		10.1016/S0896-6273(04)00069-8	http://dx.doi.org/10.1016/S0896-6273(04)00069-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980203	Bronze			2022-12-28	WOS:000221458100007
J	Sobolevsky, AI; Yelshansky, MV; Wollmuth, LP				Sobolevsky, AI; Yelshansky, MV; Wollmuth, LP			The outer pore of the glutamate receptor channel has 2-fold rotational symmetry	NEURON			English	Article							LIGAND-BINDING; ION CHANNELS; K+ CHANNELS; EXTRACELLULAR VESTIBULE; SUBSTITUTED CYSTEINES; POTASSIUM CHANNELS; SELECTIVITY FILTER; CRYSTAL-STRUCTURES; AMPA RECEPTORS; NMDAR CHANNELS	The ligand binding domain of glutamate receptors (GluRs) has 2-fold rotational symmetry. The structure including the symmetry of the GluR ion channel remains undefined. Here we used substituted cysteines in the pore-lining M3 segment of the AMPAR GluR-A subunit and various cysteine-reactive agents to study the structure of the channel during gating. We find that cysteines substituted at A+6, located in the highly conserved SYTANLAAF motif, are grouped in pairs consistent with a 2-fold symmetry in the extracellular part of the pore. To account for this symmetry and cross-linking, we propose that the M3 segments in two neighboring GluR subunits are kinked within SYTANLAAF in opposite directions relative to the central axis of the pore. Our results extend the 2-fold rotational symmetry from the ligand binding domain to at minimum the extracellular part of the channel and suggest a model of gating movements in GluR pore-forming domains.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sobolevsky, AI (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	asobolevsky@notes2.cc.sunysb.edu		Wollmuth, Lonnie/0000-0002-8179-1259	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039102] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066892] Funding Source: Medline; NINDS NIH HHS [R01 NS39102] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonov SM, 1996, J PHYSIOL-LONDON, V493, P425, DOI 10.1113/jphysiol.1996.sp021394; Antonov SM, 1998, NAT NEUROSCI, V1, P451, DOI 10.1038/2167; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Bahring R, 1998, J PHYSIOL-LONDON, V509, P635, DOI 10.1111/j.1469-7793.1998.635bm.x; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; Bowie D, 1998, J NEUROSCI, V18, P8175; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; COSTA ACS, 1994, J PHARMACOL EXP THER, V268, P503; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dingledine R, 1999, PHARMACOL REV, V51, P7; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LORING RH, 1992, MOL BRAIN RES, V15, P113, DOI 10.1016/0169-328X(92)90158-8; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; NARULA SS, 1995, BIOCHEMISTRY-US, V34, P620, DOI 10.1021/bi00002a029; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sobolevsky A.I., 2003, RECENT RES DEV PHYSL, P1; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 1999, J NEUROSCI, V19, P10611, DOI 10.1523/JNEUROSCI.19-24-10611.1999; Sobolevsky AI, 2002, BIOPHYS J, V83, P3304, DOI 10.1016/S0006-3495(02)75331-9; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	45	70	74	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 5	2004	41	3					367	378		10.1016/S0896-6273(04)00008-X	http://dx.doi.org/10.1016/S0896-6273(04)00008-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766176	Bronze			2022-12-28	WOS:000221457900008
J	Tuch, DS; Reese, TG; Wiegell, MR; Wedeen, VJ				Tuch, DS; Reese, TG; Wiegell, MR; Wedeen, VJ			Diffusion MRI of complex neural architecture	NEURON			English	Article							BRAIN WHITE-MATTER; MAGNETIC-RESONANCE; WATER DIFFUSION; IN-VIVO; AXONAL PROJECTIONS; PROPAGATOR REPRESENTATION; TENSOR; NMR; SPACE; ANISOTROPY	While functional brain imaging methods can locate the cortical regions subserving particular cognitive functions, the connectivity between the functional areas of the human brain remains poorly understood. Recently, investigators have proposed a method to image neural connectivity noninvasively using a magnetic resonance imaging method called diffusion tensor imaging (DTI). DTI measures the molecular diffusion of water along neural pathways. Accurate reconstruction of neural connectivity patterns from DTI has been hindered, however, by the inability of DTI to resolve more than a single axon direction within each imaging voxel. Here, we present a novel magnetic resonance imaging technique that can resolve multiple axon directions within a single voxel. The technique, called q-ball imaging, can resolve intravoxel white matter fiber crossing as well as white matter insertions into cortex. The ability of q-ball imaging to resolve complex intravoxel fiber architecture eliminates a key obstacle to mapping neural connectivity in the human brain noninvasively.	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University	Tuch, DS (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, 149 13th St,Room 2301, Charlestown, MA 02129 USA.	dtuch@mit.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064044, R56MH064044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS046532] Funding Source: NIH RePORTER; NCRR NIH HHS [RR14075] Funding Source: Medline; NIMH NIH HHS [MH64044] Funding Source: Medline; NINDS NIH HHS [NS46532] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfken G.B., 1985, MATH METHODS PHYS, Vthird, P957; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 1999, NMR BIOMED, V12, P335, DOI 10.1002/(SICI)1099-1492(199910)12:6<335::AID-NBM581>3.0.CO;2-A; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bracewell R., 1999, FOURIER TRANSFORM IT, P62; Callaghan, 1993, PRINCIPLES NUCL MAGN; Callaghan PT, 1999, REP PROG PHYS, V62, P599, DOI 10.1088/0034-4885/62/4/003; CALLAGHAN PT, 1988, J PHYS E SCI INSTRUM, V21, P820, DOI 10.1088/0022-3735/21/8/017; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; De Boor C., 2001, PRACTICAL GUIDE SPLI; Deans S R, 1993, RADON TRANSFORM SOME; DOUEK P, 1991, J COMPUT ASSIST TOMO, V15, P923, DOI 10.1097/00004728-199111000-00003; Fasshauer GE, 1998, INNOV APPL MATH, P117; Fisher N. I., 1987, STAT ANAL SPHERICAL; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Funk P, 1915, MATH ANN, V77, P129, DOI 10.1007/BF01456824; HARDY RL, 1986, GEOPHYS RES LETT, V13, P18, DOI 10.1029/GL013i001p00018; Helgason S, 1999, RADON TRANSFORM, V5; Hoehn-Berlage M, 1999, NMR BIOMED, V12, P45, DOI 10.1002/(SICI)1099-1492(199902)12:1<45::AID-NBM545>3.0.CO;2-6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; KARGER J, 1983, J MAGN RESON, V51, P1, DOI 10.1016/0022-2364(83)90094-X; KIMMICH R, 1993, PHYS REV B, V47, P11788, DOI 10.1103/PhysRevB.47.11788; King MD, 1997, MAGN RESON MED, V38, P930, DOI 10.1002/mrm.1910380612; KING MD, 1994, MAGNET RESON MED, V32, P707, DOI 10.1002/mrm.1910320605; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; Kuchel PW, 2000, J MAGN RESON, V145, P291, DOI 10.1006/jmre.2000.2093; LEBIHAN D, 1993, NEUROREPORT, V4, P887; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Mangin JF, 2002, NMR BIOMED, V15, P481, DOI 10.1002/nbm.780; Mardia KV, 2000, DIRECTIONAL STAT; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Niewenhuys R., 1996, HUMAN CENTRAL NERVOU; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; TUCH DS, 2002, THESIS HARVARD U MAS; TURNER R, 1990, J MAGN RESON, V86, P445, DOI 10.1016/0022-2364(90)90023-3; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Zavada T, 1999, PHYS REV E, V60, P1292, DOI 10.1103/PhysRevE.60.1292; Zavada T, 1999, PHYS REV E, V59, P5848, DOI 10.1103/PhysRevE.59.5848	61	533	552	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					885	895		10.1016/S0896-6273(03)00758-X	http://dx.doi.org/10.1016/S0896-6273(03)00758-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659088	Bronze			2022-12-28	WOS:000187042200006
J	Claeys, KG; Lindsey, DT; De Schutter, E; Orban, GA				Claeys, KG; Lindsey, DT; De Schutter, E; Orban, GA			A higher order motion region in human inferior parietal lobule: Evidence from fMRI	NEURON			English	Article							HUMAN VISUAL-CORTEX; APPARENT MOTION; 2ND-ORDER MOTION; HUMAN BRAIN; FUNCTIONAL SPECIALIZATION; ATTENTIONAL LOAD; TEMPORAL CORTEX; MACAQUE MONKEY; OPTIC FLOW; PERCEPTION	The proposal that motion is processed by multiple mechanisms in the human brain has received little anatomical support so far. Here, we compared higher and lower-level motion processing in the human brain using functional magnetic resonance imaging. We observed activation of an inferior parietal lobule (IPL) motion region by isoluminant red-green gratings when saliency of one color was increased and by long-range apparent motion at 7 Hz but not 2 Hz. This higher order motion region represents the entire visual field, while traditional motion regions predominantly process contralateral motion. Our results suggest that there are two motion-processing systems in the human brain: a contralateral lower-level luminance-based system, extending from hMT/V5+ into dorsal IPS and STS, and a bilateral higher-level saliency-based system in IPL.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; Univ Instelling Antwerp, Lab Theoret Neurobiol, B-2610 Wilrijk, Belgium; Ohio State Univ, Dept Psychol, Mansfield, OH 44906 USA	KU Leuven; University of Antwerp; University System of Ohio; Ohio State University	Orban, GA (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.		De Schutter, Erik/G-8460-2011	De Schutter, Erik/0000-0001-8618-5138; Orban, Guy/0000-0002-8179-9584; Claeys, Kristl/0000-0001-9937-443X				Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Cavanagh P, 1991, Spat Vis, V5, P303, DOI 10.1163/156856891X00065; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Duffy CJ, 1997, J NEUROSCI, V17, P2839; Dupont P, 2003, EUR J NEUROSCI, V17, P1509, DOI 10.1046/j.1460-9568.2003.02571.x; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Exner S., 1875, PFLUGERS ARCH GESAMT, V11, P403, DOI [10.1007/BF01659311, DOI 10.1007/BF01659311]; FOSTER DH, 1991, PSYCHOL BULL, V109, P152, DOI 10.1037/0033-2909.109.1.152; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gibson JJ, 1950, PERCEPTION VISUAL WO; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; GULDIN WO, 1992, J COMP NEUROL, V326, P375, DOI 10.1002/cne.903260306; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kriegeskorte N, 2003, J NEUROSCI, V23, P1451, DOI 10.1523/JNEUROSCI.23-04-01451.2003; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; Le S, 2002, BRAIN, V125, P58, DOI 10.1093/brain/awf004; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; LU ZL, 1995, NATURE, V377, P237, DOI 10.1038/377237a0; Lu ZL, 1999, P NATL ACAD SCI USA, V96, P8289, DOI 10.1073/pnas.96.14.8289; Lu ZL, 1999, P NATL ACAD SCI USA, V96, P15374, DOI 10.1073/pnas.96.26.15374; Muckli L, 2002, NEUROIMAGE, V16, P843, DOI 10.1006/nimg.2002.1085; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; ORBAN GA, 2003, IN PRESS NEUROPSYCHO; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; Puce A, 1998, J NEUROSCI, V18, P2188; QIAN N, 1994, J NEUROSCI, V14, P7367; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; SAITO H, 1986, J NEUROSCI, V6, P145; Schubotz RI, 2002, NEUROIMAGE, V16, P920, DOI 10.1006/nimg.2002.1183; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; Seiffert AE, 2003, CEREB CORTEX, V13, P340, DOI 10.1093/cercor/13.4.340; Seiffert AE, 1999, VISION RES, V39, P4172, DOI 10.1016/S0042-6989(99)00129-7; Smith AT, 1998, J NEUROSCI, V18, P3816; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Talairach J., 1988, COPLANAR STEREOTAXIC; Ternus J, 1938, SOURCE BOOK GESTALT, DOI [10.1037/11496-011, DOI 10.1037/11496-011]; Thiele A, 2001, NEURON, V32, P351, DOI 10.1016/S0896-6273(01)00463-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Vaina LM, 1999, HUM BRAIN MAPP, V7, P67, DOI 10.1002/(SICI)1097-0193(1999)7:1<67::AID-HBM6>3.0.CO;2-K; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0; Zhuo Y, 2003, SCIENCE, V299, P417, DOI 10.1126/science.1077091	63	105	105	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					631	642		10.1016/S0896-6273(03)00590-7	http://dx.doi.org/10.1016/S0896-6273(03)00590-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642285	Green Published, Bronze			2022-12-28	WOS:000186379000020
J	Chambers, CD; Stokes, MG; Mattingley, JB				Chambers, CD; Stokes, MG; Mattingley, JB			Modality-specific control of strategic spatial attention in parietal cortex	NEURON			English	Article							CROSSMODAL LINKS; VISUOSPATIAL ATTENTION; MAGNETIC STIMULATION; MECHANISMS; NEGLECT; VISION; LOCALIZATION; AWARENESS; DEFICIT; SHIFTS	The neural basis of selective spatial attention presents a significant challenge to cognitive neuroscience. Recent neuroimaging studies have suggested that regions of the parietal and temporal cortex constitute a "supramodal" network that mediates goal-directed attention in multiple sensory modalities. Here we used transcranial magnetic stimulation (TMS) to determine which cortical subregions control strategic attention in vision and touch. Healthy observers undertook an orienting task in which a central arrow cue predicted the location of a subsequent visual or somatosensory target. To determine the attentional role of cortical subregions at different stages of processing, TMS was delivered to the right hemisphere during cue or target events. Results indicated a critical role of the inferior parietal cortex in strategic orienting to visual events, but not to somatosensory events. These findings are inconsistent with the existence of a supramodal attentional network and instead provide direct evidence for modality-specific attentional processing in parietal cortex.	Univ Melbourne, Sch Behav Sci, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia	University of Melbourne	Chambers, CD (corresponding author), Univ Melbourne, Sch Behav Sci, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia.	c.chambers@psych.unimelb.edu.au	Mattingley, Jason/J-1537-2014; Chambers, Chris/E-7827-2010	Mattingley, Jason/0000-0003-0929-9216; Chambers, Chris/0000-0001-6058-4114				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BUTTER CM, 1989, NEUROPSYCHOLOGIA, V27, P1231, DOI 10.1016/0028-3932(89)90035-3; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Critchley M., 1953, PARIETAL LOBES; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Eimer M, 2001, NEUROSCI BIOBEHAV R, V25, P497, DOI 10.1016/S0149-7634(01)00029-X; Eimer M, 2002, PSYCHOPHYSIOLOGY, V39, P437, DOI 10.1017/S0048577201393162; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; Macaluso E, 2000, J NEUROPHYSIOL, V83, P3062, DOI 10.1152/jn.2000.83.5.3062; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; Pavani F, 2002, NEUROPSYCHOLOGIA, V40, P291, DOI 10.1016/S0028-3932(01)00091-4; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C, 2001, EXP BRAIN RES, V141, P324, DOI 10.1007/s002210100883; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; SPENCE CJ, 1994, J EXP PSYCHOL HUMAN, V20, P555, DOI 10.1037/0096-1523.20.3.555; Stein BE., 1993, MERGING SENSES; Townsend JT, 1983, STOCHASTIC MODELLING; Walsh V, 1998, TRENDS COGN SCI, V2, P103, DOI 10.1016/S1364-6613(98)01134-6; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; YAMAGUCHI S, 1994, BRAIN, V117, P553, DOI 10.1093/brain/117.3.553; [No title captured]	29	96	97	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 16	2004	44	6					925	930		10.1016/j.neuron.2004.12.009	http://dx.doi.org/10.1016/j.neuron.2004.12.009			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603736	Bronze			2022-12-28	WOS:000225842300007
J	Kantor, DB; Chivatakarn, O; Peer, KL; Oster, SF; Inatani, M; Hansen, MJ; Flanagan, JG; Yamaguchi, Y; Sretavan, DW; Giger, RJ; Kolodkin, AL				Kantor, DB; Chivatakarn, O; Peer, KL; Oster, SF; Inatani, M; Hansen, MJ; Flanagan, JG; Yamaguchi, Y; Sretavan, DW; Giger, RJ; Kolodkin, AL			Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans	NEURON			English	Article							RAT-BRAIN; NEURITE OUTGROWTH; DEVELOPING MOUSE; GROWTH CONES; N-SYNDECAN; EXPRESSION; SYSTEM; RECEPTOR; BINDING; NETRIN-1	The response of neuronal growth cones to axon guidance cues depends on the developmental context in which these cues are encountered. We show here that the transmembrane protein semaphorin 5A (Sema5A) is a bifunctional guidance cue exerting both attractive and inhibitory effects on developing axons of the fasciculus retroflexus, a diencephalon fiber tract associated with limbic function. The thrombospondin repeats of Sema5A physically interact with the glycosaminoglycan portion of both chondroitin sulfate proteoglycans (CSPGs) and heparan sulfate proteoglycans (HSPGs). CSPGs function as precisely localized extrinsic cues that convert Sema5A from an attractive to an inhibitory guidance cue. Therefore, glycosaminoglycan bound guidance cues provide a molecular mechanism for CSPG-mediated inhibition of axonal extension. Further, axonal HSPGs are required for Sema5A-mediated attraction, suggesting that HSPGs are components of functional Sema5A receptors. Thus, neuronal responses to Sema5A are proteoglycan dependent and interpreted according to the biological context in which this membrane bound guidance cue is presented.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Rochester, Sch Med & Dent, Rochester, NY 14645 USA; Univ Calif San Francisco, Dept Ophthalmol, Dept Physiol,Neurosci Program, Program Biomed Sci, San Francisco, CA 94143 USA; Burnham Inst, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Cell Biol, Program Neurosci, Boston, MA 02115 USA	Johns Hopkins University; University of Rochester; University of California System; University of California San Francisco; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Flanagan, John/AAM-2995-2020; Thompson-Peer, Katherine/AAC-1051-2020	Thompson-Peer, Katherine/0000-0002-4200-3870; Kantor, David/0000-0002-0466-1012	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035165, R01NS035165, R01NS047333, R01NS049641, R56NS047333] Funding Source: NIH RePORTER; NINDS NIH HHS [NS047333, NS049641, NS35165] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JC, 2000, DEV DYNAM, V218, P280; Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Anderson RB, 1998, DEV BIOL, V202, P235, DOI 10.1006/dbio.1998.9006; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; BRITTIS PA, 1994, P NATL ACAD SCI USA, V91, P7539, DOI 10.1073/pnas.91.16.7539; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Condic ML, 1999, J NEUROSCI, V19, P10036; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; Emerling DE, 1996, NEURON, V17, P1089, DOI 10.1016/S0896-6273(00)80242-1; ERNST H, 1995, J CELL SCI, V108, P3807; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Funato H, 2000, MOL CELL NEUROSCI, V16, P206, DOI 10.1006/mcne.2000.0870; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Inatani M, 2002, INVEST OPHTH VIS SCI, V43, P1616; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Irie A, 2002, DEVELOPMENT, V129, P61; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Jones L, 2002, DEVELOPMENT, V129, P5041; Kinnunen A, 1998, EUR J NEUROSCI, V10, P635, DOI 10.1046/j.1460-9568.1998.00082.x; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; MIAO HQ, 1995, J CELL BIOCHEM, V57, P173, DOI 10.1002/jcb.240570202; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; Oster SF, 2003, DEVELOPMENT, V130, P775, DOI 10.1242/dev.00299; Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sahay A, 2003, J NEUROSCI, V23, P6671; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Skaliora I, 1998, EUR J NEUROSCI, V10, P1215, DOI 10.1046/j.1460-9568.1998.00128.x; SNOW DM, 1992, J NEUROBIOL, V23, P322, DOI 10.1002/neu.480230311; Snow DM, 2003, EXP NEUROL, V182, P310, DOI 10.1016/S0014-4886(03)00034-7; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; TUTTLE R, 1995, J NEUROSCI, V15, P3039; WALTER J, 1987, DEVELOPMENT, V101, P685; Walz A, 1997, DEVELOPMENT, V124, P2421; WANG LS, 1992, NEURON, V8, P701, DOI 10.1016/0896-6273(92)90091-Q; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	56	297	307	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					961	975		10.1016/j.neuron.2004.12.002	http://dx.doi.org/10.1016/j.neuron.2004.12.002			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603739	Bronze			2022-12-28	WOS:000225842300010
J	Abraham, NM; Spors, H; Carleton, A; Margrie, TW; Kuner, T; Schaefer, AT				Abraham, NM; Spors, H; Carleton, A; Margrie, TW; Kuner, T; Schaefer, AT			Maintaining accuracy at the expense of speed: Stimulus similarity defines odor discrimination time in mice	NEURON			English	Article							MAMMALIAN OLFACTORY-BULB; LATERAL INHIBITION; GLOMERULAR LAYER; REPRESENTATIONS; RAT; DYNAMICS; NEURONS; SYSTEM; ORGANIZATION; INCREASES	Odor discrimination times and their dependence on stimulus similarity were evaluated to test temporal and spatial models of odor representation in mice. In a go/ no-go operant conditioning paradigm, discrimination accuracy and time were determined for simple monomolecular odors and binary mixtures of odors. Mice discriminated simple odors with an accuracy exceeding 95%. Binary mixtures evoking highly overlapping spatiotemporal patterns of activity in the olfactory bulb were discriminated equally well. However, while discriminating simple odors in less than 200 ms, mice required 70-100 ms more time to discriminate highly similar binary mixtures. We conclude that odor discrimination in mice is fast and stimulus dependent. Thus, the underlying neuronal mechanisms act on a fast timescale, requiring only a brief epoch of odor-specific spatiotemporal representations to achieve rapid discrimination of dissimilar odors. The fine discrimination of highly similar stimuli, however, requires temporal integration of activity, suggesting a tradeoff between accuracy and speed.	Heidelberger Akad Wissensch, WIN Grp Olfact Dynam, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Schaefer, AT (corresponding author), Heidelberger Akad Wissensch, WIN Grp Olfact Dynam, Jahnstr 29, D-69120 Heidelberg, Germany.	schaefer@mpimf-heidelberg.mpg.de	Abraham, Nixon/R-8381-2016; Carleton, Alan/C-9721-2010	Abraham, Nixon/0000-0001-8523-716X; Carleton, Alan/0000-0001-5633-9159; Schaefer, Andreas/0000-0002-4677-8788; Spors, Hartwig/0000-0003-3153-9001				ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; BEIDLER LM, 1953, J NEUROPHYSIOL, V16, P595, DOI 10.1152/jn.1953.16.6.595; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FREEMAN WJ, 1981, PERSPECT BIOL MED, V24, P561; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 2000, J INSECT PHYSIOL, V46, P877, DOI 10.1016/S0022-1910(99)00194-8; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; HALPERN BP, 1971, SCIENCE, V171, P1256, DOI 10.1126/science.171.3977.1256; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 1996, J NEUROSCI, V16, P3837; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Linster C, 2002, J NEUROSCI, V22, P6842; Luce R. D., 1986, RESPONSE TIMES; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Meister M, 2001, J NEUROSCI, V21, P1351; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Rabinovich M., 2001, PHYS REV LETT, V87; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; ROSPARS JP, 1994, NETWORK-COMP NEURAL, V5, P121, DOI 10.1088/0954-898X/5/2/001; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Slotnick B.M., 1990, COMP PERCEPT, V1, P155; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; TAYLOR DA, 1976, PSYCHOL BULL, V83, P161, DOI 10.1037/0033-2909.83.2.161; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VONHELMHOLTZ H, 1850, MITTH PHYS GESELLSCH, P1; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	52	276	277	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					865	876		10.1016/j.neuron.2004.11.017	http://dx.doi.org/10.1016/j.neuron.2004.11.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572116	Bronze			2022-12-28	WOS:000225548400013
J	Zhou, Q; Homma, KJ; Poo, MM				Zhou, Q; Homma, KJ; Poo, MM			Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses	NEURON			English	Article							AREA CA1; RAT HIPPOCAMPUS; DENTATE GYRUS; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; MOLECULAR LAYER; KNOCKOUT MICE; POTENTIATION; DENSITY; CORTEX	Activity-induced modification of neuronal connections is essential for the development of the nervous system and may also underlie learning and memory functions of mature brain. Previous studies have shown an increase in dendritic spine density and/or enlargement of spines after the induction of long-term potentiation (LTP). Using two-photon time-lapse imaging of dendritic spines in acute hippocampal slices from neonatal rats, we found that the induction of long-term depression (LTD) by low-frequency stimulation is accompanied by a marked shrinkage of spines, which can be reversed by subsequent high-frequency stimulation that induces LTP. The spine shrinkage requires activation of NMDA receptors and calcineurin, similar to that for LTD. However, spine shrinkage is mediated by cofilin, but not by protein phosphatase 1 (PP1), which is essential for LTD, suggesting that different downstream pathways are involved in spine shrinkage and LTD. This activity-induced spine shrinkage may contribute to activity-dependent elimination of synaptic connections.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Will Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Will Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999, R01NS037831] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37831, NS36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Dailey ME, 1996, J NEUROSCI, V16, P2983; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; DESMOND NL, 1986, J COMP NEUROL, V253, P476, DOI 10.1002/cne.902530405; DESMOND NL, 1986, J COMP NEUROL, V253, P466, DOI 10.1002/cne.902530404; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; FIFKOVA E, 1981, EXP NEUROL, V74, P621, DOI 10.1016/0014-4886(81)90197-7; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; Jacobs B, 1997, J COMP NEUROL, V386, P661; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Malley A, 2000, NEUROSCIENCE, V99, P229, DOI 10.1016/S0306-4522(00)00182-2; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sorra KE, 1998, J NEUROSCI, V18, P658; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; UEMURA E, 1980, EXP NEUROL, V69, P164, DOI 10.1016/0014-4886(80)90151-X; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHITE EL, 1997, MOTOR RES, V14, P34; WISE SP, 1979, NEUROSCIENCE, V4, P1275, DOI 10.1016/0306-4522(79)90157-X; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	53	750	771	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					749	757		10.1016/j.neuron.2004.11.011	http://dx.doi.org/10.1016/j.neuron.2004.11.011			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572107	Bronze			2022-12-28	WOS:000225548400004
J	Zimprich, A; Biskup, S; Leitner, P; Lichtner, P; Farrer, M; Lincoln, S; Kachergus, J; Hulihan, M; Uitti, RJ; Calne, DB; Stoessl, AJ; Pfeiffer, RF; Patenge, N; Carbajal, IC; Vieregge, P; Asmus, F; Muller-Myhsok, B; Dickson, DW; Meitinger, T; Strom, TM; Wszolek, ZK; Gasser, T				Zimprich, A; Biskup, S; Leitner, P; Lichtner, P; Farrer, M; Lincoln, S; Kachergus, J; Hulihan, M; Uitti, RJ; Calne, DB; Stoessl, AJ; Pfeiffer, RF; Patenge, N; Carbajal, IC; Vieregge, P; Asmus, F; Muller-Myhsok, B; Dickson, DW; Meitinger, T; Strom, TM; Wszolek, ZK; Gasser, T			Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology	NEURON			English	Article							ALPHA-SYNUCLEIN; TAU-SYNUCLEIN; DISEASE; LOCUS; GENE; PROTEIN; DEGENERATION; LINKAGE; REPEAT; MAPS	We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.	GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Memphis, TN 38103 USA; Klinikum Lemgo, Dept Neurol, D-32657 Lemgo, Germany; Max Planck Inst Psychiat, Computat Genet Grp, D-80804 Munich, Germany; Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Medical University of Vienna; Mayo Clinic; Mayo Clinic; University of British Columbia; University of Tennessee System; University of Tennessee Health Science Center; Max Planck Society; Technical University of Munich	Meitinger, T (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany.	meitinger@gsf.de; wszolek.zbigniew@mayo.edu; thomas.gasser@med.uni-tuebingen.de	Wszolek, Zbigniew K./AAB-1431-2019; Stoessl, A Jon/J-9661-2015; Gasser, Thomas/GNH-5293-2022; Carballo-Carbajal, Iria/F-5312-2016; Zimprich, Alexander/A-5232-2017; Müller-Myhsok, Bertram/A-3289-2013; Meitinger, Thomas/O-1318-2015	Stoessl, A Jon/0000-0002-9778-7246; Gasser, Thomas/0000-0002-1069-1146; Carballo-Carbajal, Iria/0000-0002-4403-8006; Zimprich, Alexander/0000-0002-1668-5177; Farrer, Matthew/0000-0003-1159-5321; Dickson, Dennis W/0000-0001-7189-7917; Meitinger, Thomas/0000-0002-8838-8403	NINDS NIH HHS [P50-NS40256-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvanitakis Z, 2001, CURR OPIN NEUROL, V14, P491, DOI 10.1097/00019052-200108000-00010; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Dickson DW, 1999, J NEUROL, V246, P6; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; GHETTI B, 2003, NEURODEGENERATION MO, P86; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pankratz N, 2003, AM J HUM GENET, V72, P1053, DOI 10.1086/374383; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	31	2109	2178	2	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					601	607		10.1016/j.neuron.2004.11.005	http://dx.doi.org/10.1016/j.neuron.2004.11.005			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541309	Bronze			2022-12-28	WOS:000225338100007
J	Gallegos, ME; Bargmann, CI				Gallegos, ME; Bargmann, CI			Mechanosensory neurite termination and tiling depend on SAX-2 and the SAX-1 kinase	NEURON			English	Article							MULTIDENDRITIC SENSORY NEURONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; ACTIN-FILAMENTS; NERVOUS-SYSTEM; CELL MORPHOGENESIS; IN-VIVO; DROSOPHILA; MICROTUBULES; FAMILY	Mechanosensory neurons provide accurate information about stimulus location by restricting their sensory dendrites to nonoverlapping regions, a pattern called tiling. Here, we show that C. elegans sax-1 and sax-2 regulate mechanosensory tiling by controlling the termination point of sensory dendrites. During development, the posterior PLM mechanosensory dendrite overlaps transiently with the anterior ALM mechanosensory neuron. This overlap is eliminated during a discrete period of paused or slowed PLM process growth, between an early period of rapid outgrowth and a later period of maintenance growth. In sax-2 mutants, the PLM sensory dendrite fails to slow between the active growth and maintenance growth phases, leading to sustained overlap of anterior and posterior mechanosensory processes. sax-2 encodes a large conserved protein with HEAT/Armadillo repeats that functions with sax-1, an NDR cell morphology-regulating kinase. High-level expression of sax-2 leads to premature neurite termination, suggesting that SAX-2 can directly inhibit neurite growth.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat & Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	cori@itsa.ucsf.edu		Bargmann, Cornelia/0000-0002-8484-0618				Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Buck KB, 2002, J NEUROSCI, V22, P9358; CHALFIE M, 1985, J NEUROSCI, V5, P956; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Cong JL, 2001, DEVELOPMENT, V128, P2793; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Geng W, 2000, GENETICS, V156, P1817; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Grueber WB, 2001, J COMP NEUROL, V440, P271, DOI 10.1002/cne.1385; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; He B, 2002, DEV GENES EVOL, V212, P218, DOI 10.1007/s00427-002-0229-0; He Y, 2002, J NEUROSCI, V22, P5982; Hirata D, 2002, EMBO J, V21, P4863, DOI 10.1093/emboj/cdf495; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; KITSON DL, 1983, PROC R SOC SER B-BIO, V218, P49, DOI 10.1098/rspb.1983.0025; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Maloof JN, 1998, DEVELOPMENT, V125, P181; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wrischnik LA, 1997, DEVELOPMENT, V124, P2875; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278	48	89	93	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					239	249		10.1016/j.neuron.2004.09.021	http://dx.doi.org/10.1016/j.neuron.2004.09.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473964	Bronze			2022-12-28	WOS:000224635800008
J	Phelps, EA; Delgado, MR; Nearing, KI; LeDoux, JE				Phelps, EA; Delgado, MR; Nearing, KI; LeDoux, JE			Extinction learning in humans: Role of the amygdala and vmPFC	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; FEAR-POTENTIATED STARTLE; PROJECTIONS; MODULATION; RESPONSES; MEMORY; MONKEY	Understanding how fears are acquired is an important step in translating basic research to the treatment of fear-related disorders. However, understanding how learned fears are diminished may be even more valuable. We explored the neural mechanisms of fear extinction in humans. Studies of extinction in nonhuman animals have focused on two interconnected brain regions: the amygdala and the ventral medial prefrontal cortex (vmPFC). Consistent with animal models suggesting that the amygdala is important for both the acquisition and extinction of conditioned fear, amygdala activation was correlated across subjects with the conditioned response in both acquisition and early extinction. Activation in the vmPFC (subgenual anterior cingulate) was primarily linked to the expression of fear learning during a delayed test of extinction, as might have been expected from studies demonstrating this region is critical for the retention of extinction. These results provide evidence that the mechanisms of extinction learning may be preserved across species.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neurosci, New York, NY 10003 USA	New York University; New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, New York, NY 10003 USA.	liz.phelps@nyu.edu	anand, amit/A-7222-2009		NIMH NIH HHS [P50 MH8911, MH62104] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL D G, 1992, P1; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; FALLS WA, 1992, J NEUROSCI, V12, P854; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Gewirtz JC, 1997, BEHAV NEUROSCI, V111, P712, DOI 10.1037/0735-7044.111.4.712; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J.E., 2002, SYNAPTIC SELF OUR BR; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; PORRINO LJ, 1981, J COMP NEUROL, V230, P465; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; ROSE JE, 1948, J COMP NEUROL, V89, P279, DOI 10.1002/cne.900890307; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; VOGT BA, 1987, J COMP NEUROL, V262, P256, DOI 10.1002/cne.902620207; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	32	1274	1293	3	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					897	905		10.1016/j.neuron.2004.08.042	http://dx.doi.org/10.1016/j.neuron.2004.08.042			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363399	Bronze			2022-12-28	WOS:000223992000014
J	Krapivinsky, G; Medina, I; Krapivinsky, L; Gapon, S; Clapham, DE				Krapivinsky, G; Medina, I; Krapivinsky, L; Gapon, S; Clapham, DE			SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor dependent synaptic AMPA receptor potentiation	NEURON			English	Article							GTPASE-ACTIVATING PROTEIN; DOMAIN-CONTAINING PROTEINS; RAS-GTPASE; CEREBRAL-CORTEX; MOLECULAR-BASIS; PDZ DOMAINS; SYNGAP; CAMKII; MUPP1; LTP	The synapse contains densely localized and interacting proteins that enable it to adapt to changing inputs. We describe a Ca2+-sensitive protein complex involved in the regulation of AMPA receptor synaptic plasticity. The complex is comprised of MUPPI, a multi-PDZ domain-containing protein; SynGAP, a synaptic GTPase-activating protein; and the Ca2+/calmodulin-dependent kinase CaMKII. In synapses of hippocampal neurons, SynGAP and CaMKII are brought together by direct physical interaction with the PDZ domains of MUPP1, and in this complex, SynGAP is phosphorylated. Ca2+/CaM binding to CaMKII dissociates it from the MUPPI complex, and Ca2+ entering via the NMDAR drives the dephosphorylation of SynGAP. Specific peptide-induced SynGAP dissociation from the MUPP1-CaMKII complex results in SynGAP dephosphorylation accompanied by P38 MAPK inactivation, potentiation of synaptic AMPA responses, and an increase in the number of AMPAR-containing clusters in hippocampal neuron synapses. siRNA-mediated SynGAP knockdown confirmed these results. These data implicate SynGAP in NMDAR- and CaMKII-dependent regulation of AMPAR trafficking.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; INMED, INSERM, Unite 29, F-13009 Marseille, France	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Medina, Igor/O-5532-2016; Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Medina, Igor/0000-0001-6839-5414; Clapham, David/0000-0002-4459-9428; 				Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gomes AR, 2003, NEUROCHEM RES, V28, P1459, DOI 10.1023/A:1025610122776; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iida N, 2001, J NEUROSCI, V21, P6459, DOI 10.1523/JNEUROSCI.21-17-06459.2001; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Komiyama NH, 2002, J NEUROSCI, V22, P9721; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Li WD, 2001, J BIOL CHEM, V276, P21417, DOI 10.1074/jbc.M010744200; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Oh JS, 2002, NEURON, V33, P151; Palsson EM, 2000, J BIOL CHEM, V275, P7818, DOI 10.1074/jbc.275.11.7818; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Parker LL, 2003, J BIOL CHEM, V278, P21576, DOI 10.1074/jbc.M210973200; Pei L, 2001, J CEREBR BLOOD F MET, V21, P955, DOI 10.1097/00004647-200108000-00008; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Platenik J, 2000, LIFE SCI, V67, P335, DOI 10.1016/S0024-3205(00)00632-9; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Salojin KV, 1999, J IMMUNOL, V163, P844; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sitek B, 2003, BRAIN RES, V970, P178, DOI 10.1016/S0006-8993(03)02338-2; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	48	198	220	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					563	574		10.1016/j.neuron.2004.08.003	http://dx.doi.org/10.1016/j.neuron.2004.08.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312654	Bronze			2022-12-28	WOS:000223436400014
J	Maier, JX; Neuhoff, JG; Logothetis, NK; Ghazanfar, AA				Maier, JX; Neuhoff, JG; Logothetis, NK; Ghazanfar, AA			Multisensory integration of looming signals by Rhesus monkeys	NEURON			English	Article							VENTRAL INTRAPARIETAL AREA; TEMPORAL POLYSENSORY AREA; IMPENDING COLLISION; PERCEPTION; MACAQUE; RESPONSES; MOTION; DISTANCE; INFANTS; CORTEX	Looming objects produce ecologically important signals that can be perceived in both the visual and auditory domains. Using a preferential looking technique with looming and receding visual and auditory stimuli, we examined the multisensory integration of looming stimuli by rhesus monkeys. We found a strong attentional preference for coincident visual and auditory looming but no analogous preference for coincident stimulus recession. Consistent with previous findings, the effect occurred only with tonal stimuli and not with broadband noise. The results suggest an evolved capacity to integrate multisensory looming objects.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Coll Wooster, Dept Psychol, Wooster, OH 44691 USA	Max Planck Society; College of Wooster	Ghazanfar, AA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	asifg@tuebingen.mpg.de	Neuhoff, John G/A-2955-2016; Logothetis, Nikos/U-9282-2019	Neuhoff, John/0000-0003-1123-9044				Anderson KC, 1999, J NEUROSCI, V19, P2681; ASHMEAD DH, 1995, J EXP PSYCHOL HUMAN, V21, P239, DOI 10.1037/0096-1523.21.2.239; BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; ETTLINGER G, 1990, BEHAV BRAIN RES, V40, P169, DOI 10.1016/0166-4328(90)90075-P; Freiberg K, 2001, BRIT J DEV PSYCHOL, V19, P1, DOI 10.1348/026151001165903; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Gil-da-Costa R, 2003, P ROY SOC B-BIOL SCI, V270, P605, DOI 10.1098/rspb.2002.2281; Hietanen JK, 1996, EXP BRAIN RES, V108, P341; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; ROSENBLUM LD, 1993, PERCEPTION, V22, P1467, DOI 10.1068/p221467; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; SPELKE ES, 1983, PERCEPTION, V12, P719, DOI 10.1068/p120719; Stecker GC, 2000, J ACOUST SOC AM, V107, P3358, DOI 10.1121/1.429407; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Tinbergen N, 1951, STUDY INSTINCT; Walker-Andrews AS, 1994, DEV INTERSENSORY PER, P39; WALKERANDREWS AS, 1985, CHILD DEV, V56, P544	36	123	125	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					177	181		10.1016/j.neuron.2004.06.027	http://dx.doi.org/10.1016/j.neuron.2004.06.027			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260954	Bronze			2022-12-28	WOS:000222905400007
J	Ilg, UJ; Schumann, S; Thier, P				Ilg, UJ; Schumann, S; Thier, P			Posterior parietal cortex neurons encode target motion in world-centered coordinates	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; VISUAL-TRACKING NEURONS; CORTICAL AREAS MT; FUNCTIONAL-PROPERTIES; RESPONSE PROPERTIES; MACAQUE MONKEY; MST; REPRESENTATION; CONNECTIONS; SELECTIVITY	The motion areas of posterior parietal cortex extract information on visual motion for perception as well as for the guidance of movement. It is usually assumed that neurons in posterior parietal cortex represent visual motion relative to the retina. Current models describing action guided by moving objects work successfully based on this assumption. However, here we show that the pursuit-related responses of a distinct group of neurons in area MST of monkeys are at odds with this view. Rather than signaling object image motion on the retina, they represent object motion in world-centered coordinates. This representation may simplify the coordination of object-directed action and ego motion-invariant visual perception.	Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ilg, UJ (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	uwe.ilg@uni-tuebingen.de		Ilg, Uwe/0000-0003-2623-1627; Schumann, Stefan/0000-0003-0773-7489; Thier, Peter/0000-0001-5909-4222				ALLMAN JM, 1971, BRAIN RES, V35, P89, DOI 10.1016/0006-8993(71)90596-8; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Ilg UJ, 1999, VISION RES, V39, P2143, DOI 10.1016/S0042-6989(98)00321-6; Ilg UJ, 2003, J NEUROPHYSIOL, V90, P1489, DOI 10.1152/jn.00272.2003; KAWANO K, 1984, J NEUROPHYSIOL, V51, P352, DOI 10.1152/jn.1984.51.2.352; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Krauzlis RJ, 1989, NEURAL COMPUT, V1, P116, DOI 10.1162/neco.1989.1.1.116; Lappe M, 1996, J NEUROSCI, V16, P6265; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; SAKATA H, 1983, J NEUROPHYSIOL, V49, P1364, DOI 10.1152/jn.1983.49.6.1364; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	23	92	92	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 8	2004	43	1					145	151		10.1016/j.neuron.2004.06.006	http://dx.doi.org/10.1016/j.neuron.2004.06.006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233924	Bronze, Green Submitted			2022-12-28	WOS:000222549800014
J	Strasser, GA; Rahim, NA; VanderWaal, KE; Gertler, FB; Lanier, LM				Strasser, GA; Rahim, NA; VanderWaal, KE; Gertler, FB; Lanier, LM			Arp2/3 is a negative regulator of growth cone translocation	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN DEPOLYMERIZING FACTOR; AXON GUIDANCE; N-WASP; LISTERIA-MONOCYTOGENES; ENA/VASP PROTEINS; CULTURED NEURONS; IN-VITRO; F-ACTIN; REQUIRES INTERACTIONS	Arp2/3 is an actin binding complex that is enriched in the peripheral lamellipodia of fibroblasts, where it forms a network of short, branched actin filaments, generating the protrusive force that extends lamellipodia and drives fibroblast motility. Although it has been assumed that Arp2/3 would play a similar role in growth cones, our studies indicate that Arp2/3 is enriched in the central, not the peripheral, region of growth cones and that the growth cone periphery contains few branched actin filaments. Arp2/3 inhibition in fibroblasts severely disrupts actin organization and membrane protrusion. In contrast, Arp2/3 inhibition in growth cones minimally affects actin organization and does not inhibit lamellipodia protrusion or de novo filopodia formation. Surprisingly, Arp2/3 inhibition significantly enhances axon elongation and causes defects in growth cone guidance. These results indicate that Arp2/3 is a negative regulator of growth cone translocation.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT)	Lanier, LM (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	lanie002@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049178] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049178-01, R01 NS049178-02] Funding Source: Medline; PHS HHS [6895154] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; ARCE CA, 1978, J NEUROCHEM, V31, P205, DOI 10.1111/j.1471-4159.1978.tb12449.x; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 2003, J HISTOCHEM CYTOCHEM, V51, P407, DOI 10.1177/002215540305100401; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Buck KB, 2002, J NEUROSCI, V22, P9358; CALDWELL JE, 1989, J BIOL CHEM, V264, P12648; Challacombe JF, 1997, J NEUROSCI, V17, P3085; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DENT EW, 2004, IN PRESS J NEUROSCI; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Goslin K., 1998, CULTURING NERVE CELL, P339; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hufner K, 2002, FEBS LETT, V514, P168, DOI 10.1016/S0014-5793(02)02358-X; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; Kim MD, 2002, J NEUROSCI, V22, P1794, DOI 10.1523/JNEUROSCI.22-05-01794.2002; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koleske Anthony J, 2003, Sci STKE, V2003, ppe20; Kuhn TB, 1998, J NEUROSCI, V18, P184; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LETOURNEAU PC, 1983, J CELL BIOL, V97, P963, DOI 10.1083/jcb.97.4.963; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Machesky LM, 1997, BIOCHEM J, V328, P105; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2002, NAT CELL BIOL, V4, pE191, DOI 10.1038/ncb0802-e191a; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; TANAKA E, 1995, J CELL BIOL, V128, P127, DOI 10.1083/jcb.128.1.127; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	91	135	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					81	94		10.1016/j.neuron.2004.05.015	http://dx.doi.org/10.1016/j.neuron.2004.05.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233919	Green Published, Bronze			2022-12-28	WOS:000222549800009
J	Oliver, TG; Wechsler-Reya, RJ				Oliver, TG; Wechsler-Reya, RJ			Getting at the root and stem of brain tumors	NEURON			English	Review							SONIC-HEDGEHOG; MOUSE MODEL; CELL; GROWTH; CANCER; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	Brain tumors are among the most aggressive and intractable types of cancer. Recent studies indicate that brain tumor cells resemble neural stem cells in terms of phenotype, signaling, and behavior in vitro. In light of these similarities, it has been suggested that brain tumors arise from stem cells, that they co-opt stem cell strategies for self-renewal, and even that they contain "cancer stem cells" that are critical for tumor maintenance. We will examine these possibilities and discuss their implications for the understanding and treatment of brain tumors.	Duke Univ, Ctr Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Wechsler-Reya, RJ (corresponding author), Duke Univ, Ctr Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	rw.reya@duke.edu		Oliver, Trudy/0000-0003-2082-2397				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Ding H, 2001, CANCER RES, V61, P3826; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Goldman S, 2003, TRENDS NEUROSCI, V26, P590, DOI 10.1016/j.tins.2003.09.011; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Johnson R.A., 2004, ORGANIC REACTIONS; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2003, CANCER RES, V63, P5821; Wechsler-Reya RJ, 2003, RECENT PROG HORM RES, V58, P227, DOI 10.1210/rp.58.1.227; Weiss WA, 2003, CANCER RES, V63, P1589; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	25	85	92	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					885	888		10.1016/j.neuron.2004.06.011	http://dx.doi.org/10.1016/j.neuron.2004.06.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207233	Bronze			2022-12-28	WOS:000222329300004
J	Lustig, C; Buckner, RL				Lustig, C; Buckner, RL			Preserved neural correlates of priming in old age and dementia	NEURON			English	Article							EVENT-RELATED POTENTIALS; INFERIOR PREFRONTAL CORTEX; IMPLICIT MEMORY; FUNCTIONAL MRI; DIFFERENTIAL VULNERABILITY; INDIVIDUAL-DIFFERENCES; HEMODYNAMIC-RESPONSE; SEMANTIC MEMORY; EPISODIC MEMORY; SENILE DEMENTIA	Implicit memory, including priming, can be preserved in aging and dementia despite impairment of explicit memory. To explore the neural correlates of preserved memory ability, whole-brain functional MRI (fMRI) was used during a repetition priming paradigm to study 34 young adults, 33 older adults without dementia, and 24 older adults in the early stages of dementia of the Alzheimer type (DAT). Both older adult groups showed repetition-based response time benefits (priming) and changes in activation along inferior frontal gyrus similar to those shown by young adults. Across all three groups, repetition-related response time reductions correlated with prefrontal activity reductions, demonstrating a direct relation between priming and fMRI-measured activity change. These results suggest that despite difficulties with deliberate memory, both older adults without dementia and those with early-stage DAT can modify behavior mediated by prefrontal contributions, making these preserved abilities an attractive target for cognitive training and rehabilitation.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	clustig@artsci.wustl.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026	NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681, F32AG005886] Funding Source: NIH RePORTER; NIA NIH HHS [AG03991, AG00030, AG05681, AG05886, P50 AG05681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Backman L, 2000, J COGNITIVE NEUROSCI, V12, P134, DOI 10.1162/089892900561922; Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; Badgaiyan RD, 1999, J COGNITIVE NEUROSCI, V11, P337, DOI 10.1162/089892999563463; BERG L, 1982, J NEUROL NEUROSUR PS, V45, P962, DOI 10.1136/jnnp.45.11.962; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; BOTWINICK J, 1986, ARCH NEUROL-CHICAGO, V43, P1124, DOI 10.1001/archneur.1986.00520110024008; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buckner RL, 2003, J NEUROSCI, V23, P3999; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Craik F. I. M., 1992, HDB AGING COGNITION, P51, DOI DOI 10.1016/S0022-5371(72)80001-X; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEMB JB, 1995, J NEUROSCI, V15, P5870; DOBBINS IG, 2004, IN PRESS NATURE; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Fleischman DA, 1998, PSYCHOL AGING, V13, P88, DOI 10.1037/0882-7974.13.1.88; Fleischman DA, 1999, CURR OPIN NEUROBIOL, V9, P240, DOI 10.1016/S0959-4388(99)80034-8; Gabrieli JDE, 1999, J EXP PSYCHOL GEN, V128, P479, DOI 10.1037/0096-3445.128.4.479; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Gershberg FB, 1997, J COGNITIVE NEUROSCI, V9, P105, DOI 10.1162/jocn.1997.9.1.105; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; JENNINGS JM, 1993, PSYCHOL AGING, V8, P283, DOI 10.1037/0882-7974.8.2.283; Jennings JM, 2003, NEUROPSYCHOL REHABIL, V13, P417, DOI 10.1080/09602010244000390; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; KARAYANIDIS F, 1993, COGNITIVE BRAIN RES, V1, P123, DOI 10.1016/0926-6410(93)90017-Y; KAUSLER DH, 1988, AM J PSYCHOL, V101, P207, DOI 10.2307/1422835; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; LAVOIE D, 1994, PSYCHOL AGING, V9, P539, DOI 10.1037/0882-7974.9.4.539; Lazzara MM, 2001, NEUROPSYCHOLOGY, V15, P483, DOI 10.1037//0894-4105.15.4.483; Lazzara MM, 2002, AGING NEUROPSYCHOL C, V9, P145, DOI 10.1076/anec.9.2.145.9545; Light LL, 2000, DEBATES PSYCHOL, P238; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; Light LL, 2000, MEM COGNITION, V28, P856, DOI 10.3758/BF03198421; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maccotta L, 2001, NEUROIMAGE, V14, P1105, DOI 10.1006/nimg.2001.0912; MACCOTTA L, 2004, IN PRESS J COGN NEUR; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; Pfutze EM, 2002, PSYCHOL AGING, V17, P140, DOI 10.1037//0882-7974.17.1.140; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RAJARAM S, 1993, J EXP PSYCHOL LEARN, V19, P765, DOI 10.1037/0278-7393.19.4.765; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Reuter-Lorenz PA, 2001, EUR J COGN PSYCHOL, V13, P257, DOI 10.1080/09541440125972; Roediger H. L., 1993, HANDB NEUR, P63; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; RYBASH JM, 1996, DEV NEUROPSYCHOL, V12, P251; SALAT DH, 2004, IN PRESS CEREB CORTE; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 1999, NEUROREPORT, V10, P2061, DOI 10.1097/00001756-199907130-00013; Snyder AL, 2002, NEUROBIOL AGING, V23, pS362; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Swick D, 1997, J EXP PSYCHOL LEARN, V23, P123, DOI 10.1037/0278-7393.23.1.123; Swick D, 1996, NEUROPSYCHOLOGIA, V34, P1019, DOI 10.1016/0028-3932(96)00011-5; Swick D, 1998, COGNITIVE BRAIN RES, V7, P143, DOI 10.1016/S0926-6410(98)00019-6; TALARAICH J, 1988, CO PLANAR STEREOTAXI; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Trott CT, 1999, PSYCHOL AGING, V14, P390, DOI 10.1037/0882-7974.14.3.390; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Winocur G, 1996, NEUROPSYCHOLOGY, V10, P57, DOI 10.1037/0894-4105.10.1.57; ZACKS RT, 2000, HDB AGING COGNITION, P2093; Zheng YY, 2000, PSYCHON B REV, V7, P113, DOI 10.3758/BF03210729	90	102	105	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					865	875		10.1016/j.neuron.2004.04.002	http://dx.doi.org/10.1016/j.neuron.2004.04.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	828LO	15182724	Bronze			2022-12-28	WOS:000221975000016
J	Moser, EI				Moser, EI			Hippocampal place cells demand attention	NEURON			English	Editorial Material							PREFRONTAL CORTEX; TASK; RATS; PERFORMANCE; NEURONS	Hippocampal representations of the environment are thought to play a fundamental role in the encoding, storage, and retrieval of declarative memory. In this issue of Neuron, Kentros and coworkers show that new hippocampal representations stabilize only when animals are attentive.	NTNU, Ctr Biol Memory, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), NTNU, Ctr Biol Memory, NO-7489 Trondheim, Norway.							Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCGAUGHY J, 1995, PSYCHOPHARMACOLOGY, V117, P340, DOI 10.1007/BF02246109; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; QUIRK GJ, 1990, J NEUROSCI, V10, P2008	11	6	6	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					183	185		10.1016/S0896-6273(04)00219-3	http://dx.doi.org/10.1016/S0896-6273(04)00219-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091333	Bronze			2022-12-28	WOS:000221458500002
J	Saura, CA; Choi, SY; Beglopoulos, V; Malkani, S; Zhang, DW; Rao, BSS; Chattarji, S; Kelleher III, RJ; Kandel, ER; Duff, K; Kirkwood, A; Shen, J				Saura, CA; Choi, SY; Beglopoulos, V; Malkani, S; Zhang, DW; Rao, BSS; Chattarji, S; Kelleher III, RJ; Kandel, ER; Duff, K; Kirkwood, A; Shen, J			Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration	NEURON			English	Article							LONG-TERM POTENTIATION; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; MICE LACKING; N-CADHERIN; APP; HIPPOCAMPAL; MUTATION; NOTCH; CREB	Mutations in presenilins are the major cause of familial Alzheimer's disease, but the pathogenic mechanism by which presenilin mutations cause memory loss and neurodegeneration remains unclear. Here we demonstrate that conditional double knockout mice lacking both presenilins in the postnatal forebrain exhibit impairments in hippocampal memory and synaptic plasticity. These deficits are associated with specific reductions in NMDA receptor-mediated responses and synaptic levels of NMDA receptors and alphaCaMKII. Furthermore, loss of presenilins causes reduced expression of CBP and CREB/CBP target genes, such as c-fos and BDNF. With increasing age, mutant mice develop striking neurodegeneration of the cerebral cortex and worsening impairments of memory and synaptic function. Neurodegeneration is accompanied by increased levels of the Cdk5 activator p25 and hyperphosphorylated tau. These results define essential roles and molecular targets of presenilins in synaptic plasticity, learning and memory, and neuronal survival in the adult cerebral cortex.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA; Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA; Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Nathan S Kline Inst, Orangeburg, NY 10962 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Massachusetts Institute of Technology (MIT); Columbia University; Howard Hughes Medical Institute; Nathan Kline Institute for Psychiatric Research	Shen, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Duff, Karen EK/C-2510-2009; Shen, Jie/GXH-9449-2022; Saura, Carlos A/AFM-9239-2022; Saura, Carlos A/D-2727-2011	Saura, Carlos A/0000-0003-3692-5657; Duff, Karen/0000-0002-6177-868X; Choi, Se-Young/0000-0001-7534-5167	NINDS NIH HHS [NS41783] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amtul Z, 2002, NEUROBIOL DIS, V9, P269, DOI 10.1006/nbdi.2001.0473; Baumeister R, 1997, Genes Funct, V1, P149; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Braak E, 1997, ACTA NEUROPATHOL, V93, P323, DOI 10.1007/s004010050622; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Davidsson P, 2001, DEMENT GERIATR COGN, V12, P243, DOI 10.1159/000051266; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Handler M, 2000, DEVELOPMENT, V127, P2593; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; IRIZARRY M, 1997, J NEUROPATHOL EXP NE, V56, P173; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kemp N, 1997, NEUROPHARMACOLOGY, V36, P397, DOI 10.1016/S0028-3908(96)90015-5; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Lewis PA, 2000, BIOCHEM BIOPH RES CO, V277, P261, DOI 10.1006/bbrc.2000.3646; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mitsuda N, 2001, J BIOL CHEM, V276, P9688, DOI 10.1074/jbc.M006153200; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Theuns J, 2003, HUM MOL GENET, V12, P869, DOI 10.1093/hmg/ddg098; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; Uemura K, 2003, J NEUROSCI RES, V74, P184, DOI 10.1002/jnr.10753; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Vyas A, 2002, J NEUROSCI, V22, P6810; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	53	582	626	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					23	36		10.1016/S0896-6273(04)00182-5	http://dx.doi.org/10.1016/S0896-6273(04)00182-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066262	Bronze, Green Accepted			2022-12-28	WOS:000221458400005
J	Kennedy, MJ; Dunn, FA				Kennedy, MJ; Dunn, FA			Visual pigment phosphorylation but not transducin translocation can contribute to light adaptation in zebrafish cones	NEURON			English	Article							CYTOPLASMIC CALCIUM-CONCENTRATION; ROD OUTER SEGMENTS; RHODOPSIN-KINASE; RETINAL RODS; G-PROTEIN; IN-VIVO; MULTIPLE PHOSPHORYLATION; BOVINE RHODOPSIN; VERTEBRATE RODS; DARK-ADAPTATION	The ability of cone photoreceptors to adapt to light is extraordinary. In this study we evaluated two biochemical processes, visual pigment phosphorylation and transducin translocation, for their ability to contribute to light adaptation in zebrafish cones. Since cytoplasmic Ca2+ regulates light adaptation, the sensitivities of these processes to both light and Ca2+ were examined. Cytoplasmic Ca2+ regulates the sites of light-stimulated phosphorylation. Unexpectedly, we found that Ca2+ also regulates the extent of phosphorylation of unbleached cone pigments. Immunocytochemical analyses revealed that neither light nor cytoplasmic Ca2+ influences the localization of transducin in zebrafish cones.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dunn, FA (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	jbhhh@u.washington.edu			NEI NIH HHS [EY06641] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams RA, 2003, BIOCHEM J, V374, P537, DOI 10.1042/BJ20030408; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BINDER BM, 1990, J BIOL CHEM, V265, P15333; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; BURNSIDE B, 1983, INVEST OPHTH VIS SCI, V24, P16; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Calvert PD, 2002, ADV EXP MED BIOL, V514, P37; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chinen A, 2003, GENETICS, V163, P663; CRESCITELLI F, 1988, EXP EYE RES, V46, P239, DOI 10.1016/S0014-4835(88)80081-2; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; Kutuzov MA, 1996, EUR J BIOCHEM, V238, P613, DOI 10.1111/j.1432-1033.1996.0613w.x; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; MAHROO O, 2003, IN PRESS J PHYSL; MALCHOW RP, 1986, VISION RES, V26, P1655, DOI 10.1016/0042-6989(86)90053-2; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MATTHEWS HR, 2000, J PHYSL, V420, P4479; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; McGinnis JF, 1997, J NEUROSCI RES, V50, P487, DOI 10.1002/(SICI)1097-4547(19971101)50:3<487::AID-JNR15>3.0.CO;2-3; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; Otto-Bruce AE, 1998, P NATL ACAD SCI USA, V95, P15014, DOI 10.1073/pnas.95.25.15014; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; Parry JWL, 2000, VISION RES, V40, P2241, DOI 10.1016/S0042-6989(00)00101-2; RUSHTON WAH, 1977, BIOPHYS STRUCT MECH, V3, P159, DOI 10.1007/BF00535812; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Senin II, 1997, BIOCHEM J, V321, P551, DOI 10.1042/bj3210551; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	64	58	59	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					915	928		10.1016/S0896-6273(04)00086-8	http://dx.doi.org/10.1016/S0896-6273(04)00086-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046724	Bronze			2022-12-28	WOS:000221458300011
J	Pinel, P; Piazza, M; Le Bihan, D; Dehaene, S				Pinel, P; Piazza, M; Le Bihan, D; Dehaene, S			Distributed and overlapping cerebral representations of number, size, and luminance during comparative judgments	NEURON			English	Article							MENTAL ROTATION; PARIETAL CORTEX; ACTIVATION; ORGANIZATION; SUBTRACTION; OBJECTS; AREAS; TASK; TIME	How are comparative judgments performed in the human brain? We scanned subjects with fMRI while they compared stimuli for size, luminance, or number. Regions involved in comparative judgments were identified using three criteria: task-related activation, presence of a distance effect, and interference of one dimension onto the other. We observed considerable overlap in the neural substrates of the three comparison tasks. Interestingly, the amount of overlap predicted the amount of cross-dimensional interference: in both behavior and fMRI, number interfered with size and size with luminance, but number did not interfere with luminance. The results suggest that during comparative judgments, the relevant continuous quantities are represented in distributed and overlapping neural populations, with number and size engaging a common parietal spatial code, while size and luminance engage shared occipito-temporal perceptual representations.	Serv Hosp Frederic Joliot, INSERM U562, CEA, DRM,DSV, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Pinel, P (corresponding author), Serv Hosp Frederic Joliot, INSERM U562, CEA, DRM,DSV, 4 Pl Gen Leclerc, F-91401 Orsay, France.	pinel@shfj.cea.fr	pinel, philippe/AAJ-3768-2020; Piazza, Manuela/D-2028-2010	pinel, philippe/0000-0001-6945-1369; Piazza, Manuela/0000-0003-2557-9701				BANKS WP, 1977, J EXP PSYCHOL HUMAN, V3, P278, DOI 10.1037/0096-1523.3.2.278; Burbaud P, 1999, NEUROSCI LETT, V273, P195, DOI 10.1016/S0304-3940(99)00641-2; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Faillenot I, 1999, NEUROIMAGE, V10, P114, DOI 10.1006/nimg.1999.0449; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fias W, 2001, COGNITIVE BRAIN RES, V12, P415, DOI 10.1016/S0926-6410(01)00078-7; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; JOHNSON DM, 1939, ARCH PSYCHOL, V241, P1; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Lammertyn J., 2002, CORTEX, V38, P878, DOI [DOI 10.1016/S0010-9452(08)70061-3, 10.1016/S0010-9452(08)70061-3]; Lauwereyns J, 2001, J NEUROPHYSIOL, V86, P2001, DOI 10.1152/jn.2001.86.4.2001; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; LINK S, 1990, J MATH PSYCHOL, V34, P2, DOI 10.1016/0022-2496(90)90010-7; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; MOYER RS, 1973, PERCEPT PSYCHOPHYS, V13, P180, DOI 10.3758/BF03214124; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; PAIVIO A, 1975, MEM COGNITION, V3, P635, DOI 10.3758/BF03198229; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Thioux M, 2001, NEUROIMAGE, V13, pS617; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	43	523	529	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					983	993		10.1016/S0896-6273(04)00107-2	http://dx.doi.org/10.1016/S0896-6273(04)00107-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046729	Bronze, Green Submitted			2022-12-28	WOS:000221458300016
J	Koyama, M; Hasegawa, I; Osada, T; Adachi, Y; Nakahara, K; Miyashita, Y				Koyama, M; Hasegawa, I; Osada, T; Adachi, Y; Nakahara, K; Miyashita, Y			Functional magnetic resonance imaging of macaque monkeys performing visually guided saccade tasks: Comparison of cortical eye fields with humans	NEURON			English	Article							POSTERIOR PARIETAL; PREFRONTAL CORTEX; INTRAPARIETAL SULCUS; SPATIAL ATTENTION; WORKING-MEMORY; COVERT SHIFTS; REPRESENTATION; AREAS; FMRI; PREMOTOR	The frontal and parietal eye fields serve as functional landmarks of the primate brain, although their correspondences between humans and macaque monkeys remain unclear. We conducted fMRI at 4.7 T in monkeys performing visually-guided saccade tasks and compared brain activations with those in humans using identical paradigms. Among multiple parietal activations, the dorsal lateral intraparietal area in monkeys and an area in the posterior superior parietal lobule in humans exhibited the highest selectivity to saccade directions. In the frontal cortex, the selectivity was highest at the junction of the precentral and superior frontal sulci in humans and in the frontal eye field (FEF) in monkeys. BOLD activation peaks were also found in premotor areas (BA6) in monkeys, which suggests that the apparent discrepancy in location between putative human FEF (BA6, suggested by imaging studies) and monkey FEF (BA8, identified by microstimulation studies) partly arose from methodological differences.	Univ Tokyo, Sch Med, Dept Physiol, Tokyo, Japan; Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	ADACHI, Yusuke/O-5316-2016; Miyashita, Yasushi/B-7171-2019; Osada, Takahiro/GLU-9088-2022; Hasegawa, Isao/AAW-5682-2021	ADACHI, Yusuke/0000-0001-8697-994X; Miyashita, Yasushi/0000-0003-3496-8637; Osada, Takahiro/0000-0002-3743-3200; Hasegawa, Isao/0000-0002-8633-2502; Koyama, Minoru/0000-0002-9774-9223; Nakahara, Kiyoshi/0000-0001-6701-6216				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brewer AA, 2002, J NEUROSCI, V22, P10416; Brodmann K, 1904, J PSYCHOL NEUROL, V4, P177; Brodmann K, 1909, VERGLEICHENDE LOKALI; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Burgund ED, 2003, NEUROIMAGE, V19, P29, DOI 10.1016/S1053-8119(03)00061-2; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Fujii N, 1998, P NATL ACAD SCI USA, V95, P12034, DOI 10.1073/pnas.95.20.12034; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gitelman DR, 2002, NEUROIMAGE, V15, P970, DOI 10.1006/nimg.2001.1006; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Hayashi T, 1999, EUR J NEUROSCI, V11, P4451, DOI 10.1046/j.1460-9568.1999.00892.x; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Liu TT, 2001, NEUROIMAGE, V13, P759, DOI 10.1006/nimg.2000.0728; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 2002, NEURON, V35, P227, DOI 10.1016/S0896-6273(02)00775-4; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; Menon RS, 1999, TRENDS COGN SCI, V3, P207, DOI 10.1016/S1364-6613(99)01329-7; Merriam EP, 2001, NEUROIMAGE, V13, P794, DOI 10.1006/nimg.2000.0742; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Petit L, 1997, J NEUROPHYSIOL, V77, P3386, DOI 10.1152/jn.1997.77.6.3386; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rosano C, 2003, BRAIN RES, V972, P16, DOI 10.1016/S0006-8993(03)02431-4; Sakai K, 1998, J NEUROSCI, V18, P1827; Schall JD, 1997, CEREBR CORT, V12, P527; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; Schmitt F., 1998, ECHO PLANAR IMAGING; SELTZER B, 1980, BRAIN RES, V192, P339, DOI 10.1016/0006-8993(80)90888-4; SELTZER B, 1986, EXP BRAIN RES, V62, P459; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Snedecor G.W., 1989, AMES IOWA STATE U PR; Snyder LH, 2000, J NEUROPHYSIOL, V83, P1099, DOI 10.1152/jn.2000.83.2.1099; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Talairach J., 1988, COPLANAR STEREOTAXIC; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; von Bonin G., 1947, NEOCORTEX MACACA MUL; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; ZEKI SM, 1977, PROC R SOC SER B-BIO, V195, P517, DOI 10.1098/rspb.1977.0024	78	210	210	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					795	807		10.1016/S0896-6273(04)00047-9	http://dx.doi.org/10.1016/S0896-6273(04)00047-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003178	Bronze			2022-12-28	WOS:000221458200014
J	Alcedo, J; Kenyon, C				Alcedo, J; Kenyon, C			Regulation of C-elegans longevity by specific gustatory and olfactory neurons	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; LIFE-SPAN; CHEMOSENSORY NEURONS; INSULIN-RECEPTOR; LARVAL DEVELOPMENT; GENE; ENCODES; PROTEIN; DAF-16	The life span of C. elegans is extended by mutations that inhibit the function of sensory neurons. In this study, we show that specific subsets of sensory neurons influence longevity. We find that certain gustatory neurons inhibit longevity, whereas others promote longevity, most likely by influencing insulin/IGF-1 signaling. Olfactory neurons also influence life span, and they act in a distinct pathway that involves the reproductive system. In addition, we find that a putative chemosensory G protein-coupled receptor that is expressed in some of these sensory neurons inhibits longevity. Together our findings imply that the life span of C. elegans is regulated by environmental cues and that these cues are perceived and integrated in a complex and sophisticated fashion by specific chemosensory neurons.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Alcedo, Joy/0000-0002-5279-6640; Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [AG11816, F32 AG05860] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F32AG005860, R37AG011816, R01AG011816] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BRAND JG, 1982, ANNU REV NUTR, V2, P249, DOI 10.1146/annurev.nu.02.070182.001341; Chou JH, 2001, GENETICS, V157, P211; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DRISCOLL M, 1997, NEMATODE C ELEGANS, V2, P645; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; EPSTEIN HF, ANAL ORGANISM, P225; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1995, GENETICS, V139, P1567; LAWLESS JF, 1982, MODELS METHODS LIFET; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Riddle DL, 1997, C ELEGANS, P739; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Weindruch R., 1988, RETARDATION AGING DI; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	67	265	292	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					45	55		10.1016/S0896-6273(03)00816-X	http://dx.doi.org/10.1016/S0896-6273(03)00816-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715134	Bronze			2022-12-28	WOS:000187942800008
J	Niu, S; Renfro, A; Quattrocchi, CC; Sheldon, M; D'Arcangelo, G				Niu, S; Renfro, A; Quattrocchi, CC; Sheldon, M; D'Arcangelo, G			Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway	NEURON			English	Article							RADIAL GLIAL SCAFFOLD; APOE RECEPTOR 2; DENTATE GYRUS; BRAIN-DEVELOPMENT; TYROSINE PHOSPHORYLATION; NEURONAL MIGRATION; DOWN-REGULATION; CELL-MIGRATION; NERVOUS-SYSTEM; KNOCKOUT MICE	Reelin is a secreted glycoprotein that regulates neuronal positioning in cortical brain structures through the VLDLR and ApoER2 receptors and the adaptor protein Dab1. In addition to cellular disorganization, dendrite abnormalities are present in the brain of reeler mice lacking Reelin. It is unclear whether these defects are due primarily to cellular ectopia or the absence of Reelin. Here we examined dendrite development in the hippocampus of normal and mutant mice and in dissociated cultures. We found that dendrite complexity is severely reduced in homozygous mice deficient in Reelin signaling both in vivo and in vitro, and it is also reduced in heterozygous mice in the absence of cellular ectopia. Addition of Reelin interfering antibodies, receptor antagonists, and Dab1 phosphorylation inhibitors prevented dendrite outgrowth from normal neurons, whereas addition of recombinant Reelin rescued the deficit in reeler cultures. Thus, the same signaling pathway controls both neuronal migration and dendrite maturation.	Cain Fdn Labs, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Univ Brescia, Program Neurosci, I-25123 Brescia, Italy; Texas Childrens Canc Ctr, Div Hematol Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Brescia; Texas Children's Cancer Center	D'Arcangelo, G (corresponding author), Cain Fdn Labs, Houston, TX 77030 USA.	gangelo@bcm.tmc.edu		Quattrocchi, Carlo Cosimo/0000-0001-6823-7707; D'Arcangelo, Gabriella/0000-0003-1575-1010	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042616] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042616] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Costa E, 2001, NEUROBIOL DIS, V8, P723, DOI 10.1006/nbdi.2001.0436; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Drakew A, 2002, EXP NEUROL, V176, P12, DOI 10.1006/exnr.2002.7918; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Fatemi S, 2002, MOL PSYCHIATR, V7, P919, DOI 10.1038/sj.mp.4001248; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hammond V, 2001, J NEUROSCI, V21, P8798, DOI 10.1523/JNEUROSCI.21-22-08798.2001; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; MARIANI J, 1982, J NEUROBIOL, V13, P119, DOI 10.1002/neu.480130204; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Quattrocchi CC, 2003, SCIENCE, V301, P649, DOI 10.1126/science.1082690; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rodriguez MA, 2000, P NATL ACAD SCI USA, V97, P3550, DOI 10.1073/pnas.050589797; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; STANFIELD BB, 1979, J COMP NEUROL, V185, P461, DOI 10.1002/cne.901850304; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Yang HT, 2002, J NEUROSCI, V22, P464, DOI 10.1523/JNEUROSCI.22-02-00464.2002	50	282	294	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					71	84		10.1016/S0896-6273(03)00819-5	http://dx.doi.org/10.1016/S0896-6273(03)00819-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715136	Bronze			2022-12-28	WOS:000187942800010
J	McLaughlin, T; Torborg, CL; Feller, MB; O'Leary, DDM				McLaughlin, T; Torborg, CL; Feller, MB; O'Leary, DDM			Retinotopic map refinement requires spontaneous retinal waves during a brief critical period of development	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; VISUAL-SYSTEM DEVELOPMENT; EYE-SPECIFIC SEGREGATION; FACTOR MESSENGER-RNA; ACTIVITY IN-VIVO; RETINOTECTAL PROJECTION; NEUROTROPHIC FACTOR; IMPULSE ACTIVITY; GANGLION-CELLS; POSTNATAL-DEVELOPMENT	During retinocollicular map development, spontaneous waves of action potentials spread across the retina, correlating activity among neighboring retinal ganglion cells (RGCs). To address the role of retinal waves in topographic map development, we examined wave dynamics and retinocollicular projections in mice lacking the beta2 subunit of the nicotinic acetylcholine receptor. beta2(-/-) mice lack waves during the first postnatal week, but RGCs have high levels of uncorrelated firing. By P8, the wild-type retinocollicular projection remodels into a refined map characterized by axons of neighboring RGCs forming focal termination zones (TZs) of overlapping arbors. In contrast, in P8 beta2(-/-) mice, neighboring RGC axons form large TZs characterized by broadly distributed arbors. At P8, glutamatergic retinal waves appear in beta2(-/-) mice, and later, visually patterned activity appears, but the diffuse TZs fail to remodel. Thus, spontaneous retinal waves that correlate RGC activity are required for retinotopic map remodeling during a brief early critical period.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Feller, MB (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	mfeller@ucsd.edu; doleary@salk.edu			NATIONAL EYE INSTITUTE [R01EY007025, R01EY013528] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY07025, R01 EY13528] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Bansal A, 2000, J NEUROSCI, V20, P7672; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Burden S. J., 2003, FUNDAMENTALS NEUROSC, P469; Butt CM, 2000, J COMP NEUROL, V423, P603, DOI 10.1002/1096-9861(20000807)423:4<603::AID-CNE6>3.0.CO;2-F; Butts DA, 2002, NEUROSCIENTIST, V8, P243; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Demas J, 2003, J NEUROSCI, V23, P2851; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; HARRIS WA, 1984, J NEUROSCI, V4, P1153; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOBAYASHI T, 1990, DEV BRAIN RES, V57, P29, DOI 10.1016/0165-3806(90)90181-W; Lein ES, 2000, J NEUROSCI, V20, P1470; Marks MJ, 2002, J NEUROCHEM, V81, P1102, DOI 10.1046/j.1471-4159.2002.00910.x; Mason CA, 1997, CURR OPIN NEUROBIOL, V7, P647, DOI 10.1016/S0959-4388(97)80084-0; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Montague PR, 1991, CEREB CORTEX, V1, P199, DOI 10.1093/cercor/1.3.199; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Ravary A, 2003, J NEUROSCI, V23, P2228; REID RC, 2003, FUNDAMENTALS NEUROSC, P469; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xu W, 1999, J NEUROSCI, V19, P9298; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yu CJ, 2003, EUR J NEUROSCI, V17, P1253, DOI 10.1046/j.1460-9568.2003.02557.x; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1992, J NEUROSCI, V12, P4793	70	307	310	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1147	1160		10.1016/S0896-6273(03)00790-6	http://dx.doi.org/10.1016/S0896-6273(03)00790-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687549	Bronze			2022-12-28	WOS:000187503400013
J	Ulens, C; Siegelbaum, SA				Ulens, C; Siegelbaum, SA			Regulation of hyperpolarization-activated HCN channels by cAMP through a gating switch in binding domain symmetry	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; MOLECULAR MECHANISM; PACEMAKER CHANNELS; CRYSTAL-STRUCTURE; NICOTINIC RECEPTORS; POTASSIUM CHANNEL; CYCLIC-AMP; LIGAND; MODULATION; PROTEIN	Recent X-ray structures show that the binding domains of tetrameric ligand-gated channels form either a 4-fold symmetric gating ring or a 2-fold symmetric dimer of dimers. To determine how such structures function to coordinate the binding of multiple ligands during channel activation, we examined the action of cAMP to enhance the opening of the hyperpolarization-activated HCN2 channels, whose cytoplasmic C terminus forms a gating ring in the presence of cAMP. Using tandem dimers and tetramers; in which cAMP binding to selected HCN2 subunits was prevented by a point mutation or deletion, we provide the first direct determination of the energetic effects on gating of each of four ligand binding events and demonstrate the importance of the gating ring for cAMP regulation. We suggest that cAMP binding enhances channel opening by promoting assembly of the gating ring from an unliganded state in which the four subunits interact as a 2-fold symmetric dimer of dimers.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Pharmacol, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu			NINDS NIH HHS [NS 036658] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Scott SP, 2001, BIOCHEMISTRY-US, V40, P7464, DOI 10.1021/bi002804x; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	28	87	89	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					959	970		10.1016/S0896-6273(03)00753-0	http://dx.doi.org/10.1016/S0896-6273(03)00753-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659094	Green Published, Bronze			2022-12-28	WOS:000187042200012
J	Bamji, SX; Shimazu, K; Kimes, N; Huelsken, J; Birchmeier, W; Lu, B; Reichardt, LF				Bamji, SX; Shimazu, K; Kimes, N; Huelsken, J; Birchmeier, W; Lu, B; Reichardt, LF			Role of beta-catenin in synaptic vesicle localization and presynaptic assembly	NEURON			English	Article							LONG-TERM POTENTIATION; TYROSINE KINASE SUBSTRATE; CELL-CELL JUNCTIONS; E-CADHERIN; N-CADHERIN; EXCITATORY SYNAPSES; TRANSMITTER RELEASE; ADHESION MOLECULE; ALPHA-CATENIN; PHOSPHATIDYLINOSITOL 3-KINASE	Cadherins and catenins are thought to promote adhesion between pre and postsynaptic elements in the brain. Here we show a role for beta-catenin in localizing the reserved pool of vesicles at presynaptic sites. Deletion of P-catenin in hippocampal pyramidal neurons in vivo resulted in a reduction in the number of reserved pool vesicles per synapse and an impaired response to prolonged repetitive stimulation. This corresponded to a dispersion of vesicles along the axon in cultured neurons. Interestingly, these effects are not due to beta-catenin's involvement in cadherin-mediated adhesion or wnt signaling. Instead, beta-catenin modulates vesicle localization via its PDZ binding domain to recruit PDZ proteins such as Veli to cadherin at synapses. This study defines a specific role for cadherins and catenins in synapse organization beyond their roles in mediating cell adhesion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; NICHHD, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Huelsken, Joerg/AAC-9581-2021; Lu, Bai/A-4018-2012	Huelsken, Joerg/0000-0003-3105-9606; Lu, Bai/0000-0001-5418-9759	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-21] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iida J, 2002, EUR J NEUROSCI, V15, P1493, DOI 10.1046/j.1460-9568.2002.01987.x; Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Izawa I, 2002, GENES CELLS, V7, P475, DOI 10.1046/j.1365-2443.2002.00533.x; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; LYNCH MA, 1994, NEUROSCIENCE, V60, P1, DOI 10.1016/0306-4522(94)90197-X; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Mok H, 2002, J NEUROSCI, V22, P5253; Montonen O, 2001, J HISTOCHEM CYTOCHEM, V49, P1487, DOI 10.1177/002215540104901202; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; PAPA M, 1995, J NEUROSCI, V15, P1; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ranscht B, 2000, INT J DEV NEUROSCI, V18, P643, DOI 10.1016/S0736-5748(00)00030-7; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Robinson TE, 1997, J NEUROSCI, V17, P8491; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Saegusa C, 2002, J BIOL CHEM, V277, P24499, DOI 10.1074/jbc.M202767200; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Serafini T, 1997, TRENDS NEUROSCI, V20, P322; Shan WS, 2002, J NEUROSCI RES, V69, P292, DOI 10.1002/jnr.10305; SHIBAMOTO S, 1995, J CELL BIOL, V128, P949, DOI 10.1083/jcb.128.5.949; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sorra KE, 1998, J COMP NEUROL, V398, P225; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wang CY, 2002, J BIOL CHEM, V277, P10614, DOI 10.1074/jbc.M106116200; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Xu YR, 1997, J BIOL CHEM, V272, P13463, DOI 10.1074/jbc.272.21.13463; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	87	251	264	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					719	731		10.1016/S0896-6273(03)00718-9	http://dx.doi.org/10.1016/S0896-6273(03)00718-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622577	Green Accepted, Bronze			2022-12-28	WOS:000186651200008
J	Turrigiano, G				Turrigiano, G			A competitive game of synaptic tag	NEURON			English	Editorial Material							LONG-TERM POTENTIATION; DEPRESSION	LTP maintenance is thought to require an activity-dependent "synaptic tag" that allows potentiated synapses to sequester factors necessary for maintenance. In a paper in this issue of Neuron, Fonseca et al. show that synapses can compete with each other for such maintenance factors, so that additional potentiation of one input results in loss of potentiation of another. These data suggest that UP maintenance is a dynamic and competitive process.	Brandeis Univ, Dept Biol, Waltham, MA 02493 USA	Brandeis University	Turrigiano, G (corresponding author), Brandeis Univ, Dept Biol, Mailstop 008, Waltham, MA 02493 USA.							Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327	8	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 16	2004	44	6					903	904		10.1016/j.neuron.2004.12.011	http://dx.doi.org/10.1016/j.neuron.2004.12.011			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603732	Bronze			2022-12-28	WOS:000225842300003
J	Shuman, M; Kanwisher, N				Shuman, M; Kanwisher, N			Numerical magnitude in the human parietal lobe: Tests of representational generality and domain specificity	NEURON			English	Article							RHESUS MACAQUES; NUMBER; BRAIN; ACTIVATION; NUMEROSITY; SHAPE; MULTIPLICATION; MECHANISMS; DISTANCE; THINKING	Behavioral evidence suggests that human adults have a single system for representing the numerical magnitude of both symbolic numbers (e.g., Arabic digits) and nonsymbolic number stimuli (e.g., dot arrays). Brain imaging studies have implicated a specific parietal region in symbolic number processing, leading to the influential hypothesis that this region is the locus of a dedicated, domain-specific number system. Here we evaluated a prediction of this hypothesis, that this region should be activated not only by symbolic but also nonsymbolic number processing. Using nonsymbolic stimuli, we tested for higher parietal activations for number than for nonnumber comparison tasks (experiment 1), fMRI adaptation for numerosity repetition (experiment 2), and greater fMRI increases with increasing task difficulty for number than nonnumber tasks (experiment 3). None of these predictions were supported by the data, posing a serious challenge to the hypothesis that a single, domain-specific parietal region underlies both symbolic and nonsymbolic number representation.	Harvard Univ, Sch Med, Dept Psychol, Cambridge, MA 02138 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Martinos Ctr Biol Imaging, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Shuman, M (corresponding author), Harvard Univ, Sch Med, Dept Psychol, Cambridge, MA 02138 USA.	mshuman@fas.harvard.edu						Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fias W, 2002, J COGNITIVE NEUROSCI, V14, P646, DOI 10.1162/08989290260045873; Fink GR, 2001, NEUROIMAGE, V13, P46, DOI 10.1006/nimg.2000.0673; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Hauser MD, 2003, COGNITIVE PSYCHOL, V47, P367, DOI 10.1016/S0010-0285(03)00050-1; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1095, DOI 10.1162/089892903322598076; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kazui H, 2000, PSYCHIAT CLIN NEUROS, V54, P479, DOI 10.1046/j.1440-1819.2000.00739.x; Kleinschmidt A, 2004, NEURON, V41, P842, DOI 10.1016/S0896-6273(04)00154-0; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Pansky A, 2002, J EXP PSYCHOL LEARN, V28, P259, DOI 10.1037//0278-7393.28.2.259; Pavese A, 1998, J EXP PSYCHOL HUMAN, V24, P1535, DOI 10.1037/0096-1523.24.5.1535; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Piazza M, 2003, P ROY SOC B-BIOL SCI, V270, P1237, DOI 10.1098/rspb.2003.2356; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Sathian K, 1999, J COGNITIVE NEUROSCI, V11, P36, DOI 10.1162/089892999563238; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	48	130	130	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					557	569		10.1016/j.neuron.2004.10.008	http://dx.doi.org/10.1016/j.neuron.2004.10.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504334	Bronze			2022-12-28	WOS:000224771700016
J	Bramblett, DE; Pennesi, ME; Wu, SM; Tsai, MJ				Bramblett, DE; Pennesi, ME; Wu, SM; Tsai, MJ			The transcription factor Bhlhb4 is required for rod bipolar cell maturation	NEURON			English	Article							STATIONARY NIGHT BLINDNESS; DEVELOPMENTAL EXPRESSION; SYNAPTIC CONNECTIONS; PLEXIFORM LAYER; ALPHA-SUBUNIT; MOUSE MODEL; GENE; PHOTORECEPTOR; HOMEOBOX; RETINA	Retinal bipolar cells are essential to the transmission of light information. Although bipolar cell dysfunction can result in blindness, little is known about the factors required for bipolar cell development and functional maturation. The basic helix-loop-helix (bHLH) transcription factor Bhlhb4 was found to be expressed in rod bipolar cells (RB). Electroretinograms (ERGS) in the adult Bhlhb4 knockout (Bhlhb4(-/-)) showed that the loss of Bhlhb4 resulted in disrupted rod signaling and profound retinal dysfunction resembling human congenital stationary night blindness (CSNB), characterized by the loss of the scotopic ERG b-wave. A depletion of inner nuclear layer (INL) cells in the adult Bhlhb4 knockout has been ascribed to the abolishment of the RB cell population during postnatal development. Other retinal cell populations including photoreceptors were unaltered. The timing of RB cell depletion in the Bhlhb4(-/-) mouse suggests that Bhlhb4 is essential for RB cell maturation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bramblett, DE (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	debrab@bcm.tmc.edu	Bramblett, Debra/ABA-3362-2021	Bramblett, Debra/0000-0002-3072-3862	NATIONAL EYE INSTITUTE [P30EY002520, R01EY004446] Funding Source: NIH RePORTER; NEI NIH HHS [EY04446, EY02520] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akagi T, 2004, J BIOL CHEM, V279, P28492, DOI 10.1074/jbc.M400871200; Ball SL, 2003, VISUAL NEUROSCI, V20, P267, DOI 10.1017/S0952523803203059; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, HUM GENET, V103, P124, DOI 10.1007/s004390050794; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Bramblett DE, 2002, GENOMICS, V79, P402, DOI 10.1006/geno.2002.6708; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dhingra A, 2000, J NEUROSCI, V20, P9053; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; Fitzgerald KM, 2001, AM J OPHTHALMOL, V131, P495, DOI 10.1016/S0002-9394(00)00849-7; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Jansen HG, 1997, MICROSC RES TECHNIQ, V36, P96, DOI 10.1002/(SICI)1097-0029(19970115)36:2<96::AID-JEMT3>3.0.CO;2-T; Leconte L, 2000, INVEST OPHTH VIS SCI, V41, P917; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; MANCINI MA, 1986, INVEST OPHTH VIS SCI, V27, P336; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Nawy S, 1999, J NEUROSCI, V19, P2938; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Peachey NS, 2003, DOC OPHTHALMOL, V107, P13, DOI 10.1023/A:1024448314608; PENG JJ, 2004, J PHYSL, V558, P897; Pennesi ME, 2003, P NATL ACAD SCI USA, V100, P6783, DOI 10.1073/pnas.1130102100; Pennesi ME, 2003, J NEUROSCI, V23, P453; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; STERLING P, 1998, RETINA SYNAPTIC ORG, P205; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tagawa Y, 1999, J NEUROSCI, V19, P2568; Vardi N, 1998, J COMP NEUROL, V395, P43; VARDI N, 1993, VISUAL NEUROSCI, V10, P473, DOI 10.1017/S0952523800004697; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	48	82	83	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					779	793		10.1016/j.neuron.2004.08.032	http://dx.doi.org/10.1016/j.neuron.2004.08.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363390	Bronze			2022-12-28	WOS:000223992000005
J	Marillat, V; Sabatier, C; Failli, V; Matsunaga, E; Sotelo, C; Tessier-Lavigne, M; Chedotal, A				Marillat, V; Sabatier, C; Failli, V; Matsunaga, E; Sotelo, C; Tessier-Lavigne, M; Chedotal, A			The slit receptor Rig-1/Robo3 controls midline crossing by hindbrain precerebellar neurons and axons	NEURON			English	Article							INFERIOR OLIVARY NEURONS; FLOOR PLATE; NEURITIC DIFFERENTIATION; MOLECULAR-MECHANISMS; CEREBELLAR SYSTEM; COMMISSURAL AXONS; MIGRATORY STREAM; CAUDAL MEDULLA; RETINAL AXONS; CNS MIDLINE	During development, precerebellar neurons migrate dorsoventrally from the rhombic lip to the floor plate. Some of these neurons cross the midline while others stop. We have identified a role for the slit receptor Rig-1/Robo3 in directing this process. During their tangential migration, neurons of all major hindbrain precerebellar nuclei express high levels of Rig-1 mRNA. Rig-1 expression is rapidly downregulated as their leading process crosses the floor plate. Interestingly, most precerebellar nuclei do not develop normally in Rig-1-deficient mice, as they fail to cross the midline. In addition, inferior olivary neurons, which normally send axons into the contralateral cerebellum, project ipsilaterally in Rig-1 mutant mice. Similarly, neurons of the lateral reticular nucleus and basilar pons are unable to migrate across the floor plate and instead remain ipsilateral. These results demonstrate that Rig-1 controls the ability of both precerebellar neuron cell bodies and their axons to cross the midline.	Univ Paris 06, CNRS, UMR7102, F-75005 Paris, France; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; Stanford University	Chedotal, A (corresponding author), Univ Paris 06, CNRS, UMR7102, Bat B,Case 12,9 Quai St Bernard, F-75005 Paris, France.	chedotal@infobiogen.fr	Chedotal, Alain/F-2750-2017; Sotelo, Constantino/G-3397-2015	Chedotal, Alain/0000-0001-7577-3794; Sotelo, Constantino/0000-0001-8051-2492				Alcantara S, 2000, DEVELOPMENT, V127, P1359; ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; ALTMAN J, 1987, J COMP NEUROL, V257, P490, DOI 10.1002/cne.902570403; ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P300; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; BOURRAT F, 1990, ARCH ITAL BIOL, V128, P151; BOURRAT F, 1991, J COMP NEUROL, V313, P509, DOI 10.1002/cne.903130311; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Causeret F, 2002, DEV BIOL, V246, P429, DOI 10.1006/dbio.2002.0681; Chedotal A, 1996, J NEUROSCI, V16, P3296; de Diego I, 2002, DEVELOPMENT, V129, P297; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Gilthorpe JD, 2002, DEVELOPMENT, V129, P4719; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kyriakopoulou K, 2002, DEVELOPMENT, V129, P287; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; ONO K, 1990, ANAT EMBRYOL, V182, P11; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Stoeckli ET, 1998, PROG BRAIN RES, V117, P105; TABERPIERCE E, 1973, PROG BRAIN RES, V40, P53; Taniguchi H, 2002, DEV BIOL, V249, P321, DOI 10.1006/dbio.2002.0763; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Wong MS, 2002, NANO LETT, V2, P583, DOI 10.1021/nl020244c; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zhu Y, 2002, DEV DYNAM, V225, P365, DOI 10.1002/dvdy.10166; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	52	143	144	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					69	79		10.1016/j.neuron.2004.06.018	http://dx.doi.org/10.1016/j.neuron.2004.06.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233918	Bronze			2022-12-28	WOS:000222549800008
J	Kalil, K; Dent, EW				Kalil, K; Dent, EW			Hot +TIPS: Guidance cues signal directly to microtubules	NEURON			English	Editorial Material							GROWTH CONE; ACTIN-FILAMENTS; MECHANISMS; MOTILITY	Plus end tracking proteins (+TIPS) bind to microtubules. Results reported by Lee et al. and Zhou et al. in this issue of Neuron demonstrate that, via intracellular pathways signaling to +TIPs, microtubules can be a direct target of guidance cues in steering growth cones and regulating axon elongation.	Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT)	Kalil, K (corresponding author), Univ Wisconsin, Dept Anat, Madison, WI 53706 USA.		Dent, Erik/L-6208-2019; Kalil, Katherine/B-4413-2009	Dent, Erik/0000-0001-8525-7136; 				Buck KB, 2002, J NEUROSCI, V22, P9358; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	12	11	11	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 24	2004	42	6					877	879		10.1016/j.neuron.2004.06.009	http://dx.doi.org/10.1016/j.neuron.2004.06.009			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207230	Bronze			2022-12-28	WOS:000222329300001
J	Pawlu, C; DiAntonio, A; Heckmann, M				Pawlu, C; DiAntonio, A; Heckmann, M			Postfusional control of quantal current shape	NEURON			English	Article							TRANSMITTER RELEASE; SYNAPTIC VESICLES; SYNAPTOTAGMIN-I; TIME-COURSE; GLUTAMATE; SIZE; NEUROTRANSMITTER; KINETICS; ACETYLCHOLINE; VARIABILITY	Whether glutamate is released rapidly, in an all-or-none manner, or more slowly, in a regulated manner, is a matter of debate. We analyzed the time course of excitatory postsynaptic currents (EPSCs) at glutamatergic neuromuscular junctions of Drosophila and found that the decay phase of EPSCs was protracted to a variable extent. The protraction was more pronounced in evoked and spontaneous quantal EPSCs than in action potential-evoked multiquantal EPSCs; reduced in quantal EPSCs from endophilin null mutants, which maintain release via kiss-and-run; and dependent on synaptotagmin isoform, calcium, and protein phosphorylation. Our data indicate that glutamate is released from individual synaptic vesicles for milliseconds through a fusion pore. Quantal glutamate discharge time course depends on presynaptic calcium inflow and the molecular composition of the release machinery.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Freiburg; Washington University (WUSTL)	Heckmann, M (corresponding author), Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany.	manfred.heckmann@physiologie.uni-freiburg.de		DiAntonio, Aaron/0000-0002-7262-0968; Heckmann, Manfred/0000-0002-4874-1735	NINDS NIH HHS [R01 NS043171] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043171] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almers W, 2001, NATURE, V409, P567, DOI 10.1038/35054637; ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; Behrends JC, 1998, J NEUROPHYSIOL, V79, P2999, DOI 10.1152/jn.1998.79.6.2999; Burgoyne RD, 2002, TRENDS NEUROSCI, V25, P176, DOI 10.1016/S0166-2236(00)02126-3; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CRAWFORD AC, 1977, J PHYSIOL-LONDON, V268, P711, DOI 10.1113/jphysiol.1977.sp011878; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P514, DOI 10.1113/jphysiol.1961.sp006644; DUDEL J, 1992, PFLUG ARCH EUR J PHY, V422, P129, DOI 10.1007/BF00370412; Dudel J, 2000, PFLUG ARCH EUR J PHY, V441, P175, DOI 10.1007/s004240000407; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; Franks KM, 2003, J NEUROSCI, V23, P3186; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Geiger JRP, 1999, HANDB EXP PHARM, V141, P363; GOVIND CK, 1994, SYNAPSE, V16, P45, DOI 10.1002/syn.890160106; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Heckmann M, 1997, BIOPHYS J, V72, P2160, DOI 10.1016/S0006-3495(97)78859-3; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Karunanithi S, 2002, J NEUROSCI, V22, P10267; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; KATZ B, 1963, J PHYSIOL-LONDON, V168, P389, DOI 10.1113/jphysiol.1963.sp007199; KHANIN R, 1994, BIOPHYS J, V67, P966, DOI 10.1016/S0006-3495(94)80562-4; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V244, P467, DOI 10.1113/jphysiol.1975.sp010808; NEHER E, 1993, NATURE, V363, P497, DOI 10.1038/363497a0; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PARNAS I, 1991, J NEUROSCI, V11, P1309; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stiles JR, 2001, SYNAPSES, P681; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wong K, 1999, J NEUROPHYSIOL, V82, P1497, DOI 10.1152/jn.1999.82.3.1497; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	58	86	88	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					607	618		10.1016/S0896-6273(04)00269-7	http://dx.doi.org/10.1016/S0896-6273(04)00269-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157422	Bronze			2022-12-28	WOS:000221708300011
J	Kruman, II; Wersto, RP; Cardozo-Pelaez, F; Smilenov, L; Chan, SL; Chrest, FJ; Emokpae, R; Gorospe, M; Mattson, MP				Kruman, II; Wersto, RP; Cardozo-Pelaez, F; Smilenov, L; Chan, SL; Chrest, FJ; Emokpae, R; Gorospe, M; Mattson, MP			Cell cycle activation linked to neuronal cell death initiated by DNA damage	NEURON			English	Article							BASE-EXCISION-REPAIR; DEPENDENT KINASE INHIBITORS; INDUCED APOPTOSIS; POSTMITOTIC NEURONS; STRAND BREAKS; ATM; REPLICATION; PROTEIN; PHOSPHATASE; CDC25A	Increasing evidence indicates that neurodegeneration involves the activation of the cell cycle machinery in postmitotic neurons. However, the purpose of these cell cycle-associated events in neuronal apoptosis remains unknown. Here we tested the hypothesis that cell cycle activation is a critical component of the DNA damage response in postmitotic neurons. Different genotoxic compounds (etoposide, methotrexate, and homocysteine) induced apoptosis accompanied by cell cycle reentry of terminally differentiated cortical neurons. In contrast, apoptosis initiated by stimuli that do not target DNA (staurosporine and colchicine) did not initiate cell cycle activation. Suppression of the function of ataxia telangiectasia mutated (ATM), a proximal component of DNA damage-induced cell cycle checkpoint pathways, attenuated both apoptosis and cell cycle reentry triggered by DNA damage but did not change the fate of neurons exposed to staurosporine and colchicine. Our data suggest that cell cycle activation is a critical element of the DNA damage response of postmitotic neurons leading to apoptosis.	NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; NIA, Cellular & Mol Biol Lab, Intramural Res Program, Baltimore, MD 21224 USA; Univ Montana, Environm Hlth Sci Ctr, Dept Pharmaceut Sci, Missoula, MT 59812 USA; Columbia Univ, Sch Med, Ctr Radiol Res, New York, NY 10032 USA; Sun Hlth Res Inst, Thomas H Christopher Ctr Parkinsons Dis Res, Sun City, AZ 85351 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Montana System; University of Montana; Columbia University; Banner Research; Banner Health; Banner Sun Health Research Institute; Johns Hopkins University	Kruman, II (corresponding author), NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	inna.kruman@sunhealth.org	Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE ON AGING [ZIAAG000312, Z01AG000312, Z01AG000511, ZIAAG000511, Z01AG000313, ZIAAG000313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Beck WT, 2001, BIOCHEM SOC T, V29, P702, DOI 10.1042/0300-5127:0290702; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174; Cardozo-Pelaez F, 1998, NEUROBIOL AGING, V19, P311, DOI 10.1016/S0197-4580(98)00067-0; Cardozo-Pelaez F, 2000, FREE RADICAL BIO MED, V28, P779, DOI 10.1016/S0891-5849(00)00172-6; Choi EK, 2002, J PATHOL, V198, P121, DOI 10.1002/path.1164; Chong MJ, 2000, P NATL ACAD SCI USA, V97, P889, DOI 10.1073/pnas.97.2.889; COMFORTH MN, 1985, SCIENCE, V227, P1589; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Ding XL, 2000, AM J PATHOL, V157, P1983, DOI 10.1016/S0002-9440(10)64837-7; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Gobbel GT, 1998, J NEUROSCI, V18, P147; Gorman AM, 1999, EUR J NEUROSCI, V11, P1067, DOI 10.1046/j.1460-9568.1999.00512.x; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; HANAWALT PC, 1992, ANN NY ACAD SCI, V663, P17, DOI 10.1111/j.1749-6632.1992.tb38644.x; Hayashi T, 2000, NEUROPATH APPL NEURO, V26, P390, DOI 10.1046/j.1365-2990.2000.00264.x; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; HUSCHTSCHA LI, 1994, EXP CELL RES, V212, P161, DOI 10.1006/excr.1994.1131; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kruman I, 1997, J NEUROSCI, V17, P5089; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Li X, 1996, EXP CELL RES, V222, P28, DOI 10.1006/excr.1996.0004; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lovell MA, 1999, J NEUROCHEM, V72, P771, DOI 10.1046/j.1471-4159.1999.0720771.x; Macleod MR, 2003, NEUROREPORT, V14, P215, DOI 10.1097/00001756-200302100-00011; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MCCOMBE P, 1976, INT J RADIAT BIOL, V29, P523, DOI 10.1080/09553007614550621; McShea A, 1999, MED HYPOTHESES, V52, P525, DOI 10.1054/mehy.1997.0680; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Morris EJ, 1999, BIOTECHNIQUES, V26, P282, DOI 10.2144/99262st02; Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Nagy Z, 1998, NEUROSCIENCE, V87, P731; Neugroschl J, 2002, AM J GERIAT PSYCHIAT, V10, P660, DOI 10.1176/appi.ajgp.10.6.660; Ninomiya Y, 1997, J CELL PHYSIOL, V172, P25, DOI 10.1002/(SICI)1097-4652(199707)172:1<25::AID-JCP3>3.3.CO;2-P; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; Rideout HJ, 2003, J NEUROSCI, V23, P1237, DOI 10.1523/JNEUROSCI.23-04-01237.2003; Rolig RL, 2000, TRENDS NEUROSCI, V23, P417, DOI 10.1016/S0166-2236(00)01625-8; Roser S, 2001, MUTAT RES-GEN TOX EN, V497, P169, DOI 10.1016/S1383-5718(01)00255-8; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Ruggiero A, 2001, PEDIATR DRUGS, V3, P237, DOI 10.2165/00128072-200103040-00001; Sakakura C, 1997, SURG TODAY, V27, P773, DOI 10.1007/BF02384996; Sarkaria JN, 1999, CANCER RES, V59, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1999, ONCOGENE, V18, P573; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Smith DS, 2000, CELL GROWTH DIFFER, V11, P625; Smith MZ, 1999, NEUROSCI LETT, V271, P45, DOI 10.1016/S0304-3940(99)00509-1; Smith ND, 2003, J UROLOGY, V169, P1219, DOI 10.1097/01.ju.0000056085.58221.80; Stedeford T, 2001, FREE RADICAL BIO MED, V31, P1272, DOI 10.1016/S0891-5849(01)00715-8; Uberti D, 2003, TOXICOL LETT, V139, P99, DOI 10.1016/S0378-4274(02)00423-X; UPPULURI S, 1993, P NATL ACAD SCI USA, V90, P11598, DOI 10.1073/pnas.90.24.11598; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WALLACE SS, 1997, OXIDATIVE STRESS MOL, P49; WALSH MJ, 1995, J BIOL CHEM, V270, P5289, DOI 10.1074/jbc.270.10.5289; Yamasaki F, 2003, CANCER CHEMOTH PHARM, V51, P271, DOI 10.1007/s00280-002-0562-z; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001	80	284	299	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					549	561		10.1016/S0896-6273(04)00017-0	http://dx.doi.org/10.1016/S0896-6273(04)00017-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980204	Bronze			2022-12-28	WOS:000221458100008
J	Hauk, O; Johnsrude, I; Pulvermuller, F				Hauk, O; Johnsrude, I; Pulvermuller, F			Somatotopic representation of action words in human motor and premotor cortex	NEURON			English	Article							FUNCTIONAL NEUROANATOMY; BRAIN; NOUNS	Since the early days of research into language and the brain, word meaning was assumed to be processed in specific brain regions, which most modern neuroscientists localize to the left temporal lobe. Here we use event-related fMRI to show that action words referring to face, arm, or leg actions (e.g., to lick, pick, or kick), when presented in a passive reading task, differentially activated areas along the motor strip that either were directly adjacent to or overlapped with areas activated by actual movement of the tongue, fingers, or feet. These results demonstrate that the referential meaning of action words has a correlate in the somatotopic activation of motor and premotor cortex. This rules out a unified "meaning center" in the human brain and supports a dynamic view according to which words are processed by distributed neuronal assemblies with cortical topographies that reflect word semantics.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England		Pulvermuller, F (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	friedemann.pulvermuller@mrc-cbu.cam.ac.uk	Johnsrude, Ingrid S/G-4694-2011	Johnsrude, Ingrid S/0000-0002-7810-1333; pulvermuller, friedemann/0000-0003-3210-7112	MRC [MC_U105579212] Funding Source: UKRI; Medical Research Council [MC_U105579212] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRAITENBERG V, 1992, NATURWISSENSCHAFTEN, V79, P103, DOI 10.1007/BF01131538; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Brett M, 2002, NEUROIMAGE, V16; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cusack R, 2003, NEUROIMAGE, V18, P127, DOI 10.1006/nimg.2002.1281; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; DEHAENE S, 1995, NEUROREPORT, V6, P2153, DOI 10.1097/00001756-199511000-00014; Devlin JT, 2002, NEUROIMAGE, V15, P675, DOI 10.1006/nimg.2001.1002; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kellenbach ML, 2002, J COGNITIVE NEUROSCI, V14, P561, DOI 10.1162/08989290260045819; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; Neininger B, 2001, NEUROCASE, V7, P303, DOI 10.1093/neucas/7.4.303; Penfield W., 1950, CEREBRAL CORTEX MAN; PREISSL H, 1995, NEUROSCI LETT, V197, P81, DOI 10.1016/0304-3940(95)11892-Z; Price CJ, 2001, J COGNITIVE NEUROSCI, V13, P419, DOI 10.1162/08989290152001853; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Pulvermuller F, 1996, EUR J NEUROSCI, V8, P937, DOI 10.1111/j.1460-9568.1996.tb01580.x; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 1996, PSYCHOPHYSIOLOGY, V33, P317, DOI 10.1111/j.1469-8986.1996.tb01057.x; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 2003, NEUROSCIENCE LANGUAG; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Talairach J., 1988, COPLANAR STEREOTAXIC; TSUMOTO T, 1992, PROG NEUROBIOL, V39, P209, DOI 10.1016/0301-0082(92)90011-3; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; Wernicke C., 1874, APHASISCHE SYMPTOMEN	42	1295	1320	5	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					301	307		10.1016/S0896-6273(03)00838-9	http://dx.doi.org/10.1016/S0896-6273(03)00838-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741110	Bronze			2022-12-28	WOS:000221457800015
J	Seung, HS				Seung, HS			Learning in spiking neural networks by reinforcement of stochastic synaptic transmission	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; PLASTICITY; SYNAPSES; FACILITATION; INTELLIGENCE; FEEDFORWARD; RELIABILITY; DEPRESSION	It is well-known that chemical synaptic transmission is an unreliable process, but the function of such unreliability remains unclear. Here I consider the hypothesis that the randomness of synaptic transmission is harnessed by the brain for learning, in analogy to the way that genetic mutation is utilized by Darwinian evolution. This is possible if synapses are "hedonistic," responding to a global reward signal by increasing their probabilities of vesicle release or failure, depending on which action immediately preceded reward. Hedonistic synapses learn by computing a stochastic approximation to the gradient of the average reward. They are compatible with synaptic dynamics such as short-term facilitation and depression and with the intricacies of dendritic integration and action potential generation. A network of hedonistic synapses can be trained to perform a desired computation by administering reward appropriately, as illustrated here through numerical simulations of integrate-and-fire model neurons.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Seung, HS (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Bartlett P. L., 2000, BIOL PLAUSIBLE LOCAL; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Baum EB, 1999, MACH LEARN, V35, P155, DOI 10.1023/A:1007593124513; Baxter J, 2001, J ARTIF INTELL RES, V15, P319, DOI 10.1613/jair.806; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Buchs NJ, 2002, J COMPUT NEUROSCI, V13, P167, DOI 10.1023/A:1020210230751; CAUWENBERGHS G, 1993, ADV NEURAL INFORMATI, V5, P244; Chance FS, 1998, J NEUROSCI, V18, P4785; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; Davison M., 1988, ERLBAUM; DAYAN P, 1990, P 1990 CONN MOD SUMM, P45; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; GALLISTEL CR, 1994, COGNITION, V50, P151, DOI 10.1016/0010-0277(94)90026-4; HERMSTEIN RJ, 1991, J ECON PERSPECT, V5, P137; HINTON GE, 1989, ARTIF INTELL, V40, P185, DOI 10.1016/0004-3702(89)90049-0; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; JABRI M, 1992, IEEE T NEURAL NETWOR, V3, P154, DOI 10.1109/72.105429; Johnson F, 2002, BEHAV BRAIN RES, V131, P57, DOI 10.1016/S0166-4328(01)00374-6; KIMURA H, 1995, P 12 INT C MACH LEAR, P295; KLOPF AH, 1982, HEDONISTIC NEURON; Kushner H., 1978, STOCHASTIC APPROXIMA; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Minsky M., 1954, THESIS PRINCETON U P; Minsky M., 1988, SOC MIND; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NARENDRA KS, 1989, LEARNING AUTOMATA IN; Raymond JL, 1998, J NEUROSCI, V18, P9112; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sutton Rs, 1984, TEMPORAL CREDIT ASSI; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; UNNIKRISHNAN KP, 1994, NEURAL COMPUT, V6, P469, DOI 10.1162/neco.1994.6.3.469; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; WERFEL JK, IN PRESS ADV NEURAL; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696	47	209	228	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1063	1073		10.1016/S0896-6273(03)00761-X	http://dx.doi.org/10.1016/S0896-6273(03)00761-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	756UZ	14687542	Green Published, Bronze			2022-12-28	WOS:000187503400006
J	Suzuki, WA				Suzuki, WA			Episodic memory signals in the rat hippocampus	NEURON			English	Editorial Material								How does the hippocampus signal memory for episodes? In this issue of Neuron, Ferbinteanu and Shapiro show that classic place cell activity in the rat hippocampus together with robust retrospective and prospective memory signals reflects the sequence of past, present, and future events that make up an episode.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Suzuki, WA (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Room 809, New York, NY 10003 USA.							Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	9	5	6	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1055	1056		10.1016/S0896-6273(03)00806-7	http://dx.doi.org/10.1016/S0896-6273(03)00806-7			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687539	Bronze			2022-12-28	WOS:000187503400003
J	Formisano, E; Kim, DS; Di Salle, F; van de Moortele, PF; Ugurbil, K; Goebel, R				Formisano, E; Kim, DS; Di Salle, F; van de Moortele, PF; Ugurbil, K; Goebel, R			Mirror-symmetric tonotopic maps in human primary auditory cortex	NEURON			English	Article							LEVEL-DEPENDENT REPRESENTATION; MIDDLE LATENCY COMPONENTS; TIME-RESOLVED FMRI; EVENT-RELATED FMRI; VOLUME MEASUREMENT; INTRINSIC SIGNALS; EVOKED-POTENTIALS; MACAQUE MONKEY; TONE INTENSITY; HUMAN BRAIN	Understanding the functional organization of the human primary auditory cortex (PAC) is an essential step in elucidating the neural mechanisms underlying the perception of sound, including speech and music. Based on invasive research in animals, it is believed that neurons in human PAC that respond selectively with respect to the spectral content of a sound form one or more maps in which neighboring patches on the cortical surface respond to similar frequencies (tonotopic maps). The number and the cortical layout of such tonotopic maps in the human brain, however, remain unknown. Here we use silent, event-related functional magnetic resonance imaging at 7 Tesla and a cortex-based analysis of functional data to delineate with high spatial resolution the detailed topography of two tonotopic maps in two adjacent subdivisions of PAC. These maps share a low-frequency border, are mirror symmetric, and clearly resemble those of presumably homologous fields in the macaque monkey.	Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Univ Minnesota, Sch Med, Ctr Magnet Resonance Res CMRR, Minneapolis, MN 55455 USA; Univ Naples Federico II, Dept Neuroradiol, Nuovo Policlin, I-80131 Naples, Italy	Maastricht University; University of Minnesota System; University of Minnesota Twin Cities; University of Naples Federico II	Goebel, R (corresponding author), Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, Postbus 616, NL-6200 MD Maastricht, Netherlands.		Ugurbil, Kamil/AAD-6058-2022; Van de Moortele, Pierre-François/H-5087-2011; Kim, Dae-Shik/C-2071-2011	Van de Moortele, Pierre-François/0000-0002-6941-5947; Formisano, Elia/0000-0001-5008-2460; Goebel, Rainer/0000-0003-1780-2467; Di Salle, Francesco/0000-0002-0226-8460	NCRR NIH HHS [RR08079] Funding Source: Medline; NIBIB NIH HHS [EB00331] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; BRODMANN K, 1809, VERGLEICHENDE LOCALI; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; Di Salle F, 2001, NEUROIMAGE, V13, P328, DOI 10.1006/nimg.2000.0683; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; Engelien A, 2002, NEUROIMAGE, V16, P944, DOI 10.1006/nimg.2002.1149; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Harel N, 2000, NEUROIMAGE, V11, P302, DOI 10.1006/nimg.1999.0537; Harrison RV, 1996, HEARING RES, V100, P157, DOI 10.1016/0378-5955(96)00120-7; HEIL P, 1994, HEARING RES, V76, P188, DOI 10.1016/0378-5955(94)90099-X; Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0; HUOTILAINEN M, 1995, NEUROREPORT, V6, P841, DOI 10.1097/00001756-199504190-00004; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; LIEGEOISCHAUVEL C, 1991, BRAIN, V114, P139; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luo Y, 2001, MAGNET RESON MED, V45, P1095, DOI 10.1002/mrm.1144; Lutkenhoner B, 2003, NEUROIMAGE, V19, P935, DOI 10.1016/S1053-8119(03)00172-1; Lutkenhoner B, 2003, NEUROIMAGE, V18, P58, DOI 10.1006/nimg.2002.1325; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scheich H, 1991, Curr Opin Neurobiol, V1, P236, DOI 10.1016/0959-4388(91)90084-K; Scherg M, 1989, ADV BIOMAGNETISM, P97, DOI 10.1007/978-1-4613-0581-1_11; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ugurbil K, 2003, TRENDS NEUROSCI, V26, P108, DOI 10.1016/S0166-2236(02)00039-5; Versnel H, 2002, J NEUROPHYSIOL, V88, P1545, DOI 10.1152/jn.2002.88.3.1545; von Economo C, 1925, CYTOARCHITEKTONIK HI; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; YAMAMOTO T, 1992, ACTA OTOLARYNGOL STO, V112, P210; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	69	324	331	0	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					859	869		10.1016/S0896-6273(03)00669-X	http://dx.doi.org/10.1016/S0896-6273(03)00669-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622588	Bronze, Green Published			2022-12-28	WOS:000186651200019
J	Henley, JR; Huang, KH; Wang, D; Poo, MM				Henley, JR; Huang, KH; Wang, D; Poo, MM			Calcium mediates bidirectional growth cone turning induced by myelin-associated glycoprotein	NEURON			English	Article							NERVE GROWTH; AXONAL REGENERATION; SARCOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; CA2+ CHANNELS; NOGO RECEPTOR; CYCLIC-AMP; CAMP; GUIDANCE; PHOSPHORYLATION	Cytoplasmic second messengers, Ca2+ and cAMP, regulate nerve growth cone turning responses induced by many guidance cues, but the causal relationship between these signaling pathways has been unclear. We here report that, for growth cone turning induced by a gradient of myelin-associated glycoprotein (MAG), cAMP acts by modulating MAG-induced Ca2+ signaling. Growth cone repulsion induced by MAG was accompanied by localized Ca2+ signals on the side of the growth cone facing the MAG source, due to Ca2+ release from intracellular stores. Elevating cAMP signaling activity or membrane depolarization enhanced MAG-induced Ca2+ signals and converted growth cone repulsion to attraction. Directly imposing high- or low-amplitude Ca2+ signals with an extracellular gradient of Ca2+ ionophore was sufficient to trigger either attractive or repulsive turning, respectively. Thus, distinct Ca2+ signaling, which can be modulated by cAMP, mediates the bidirectional turning responses induced by MAG.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu	Huang, Kuo-Hua/AAA-4107-2021; Henley, John/D-7171-2011	Huang, Kuo-Hua/0000-0001-6232-296X; Henley, John/0000-0003-1846-5941	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764, F32NS010875] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS022764, R01 NS022764-18, F32 NS010875-03, F32 NS010875] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CHOI EJ, 1992, J BIOL CHEM, V267, P12440; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; KATER SB, 1991, J NEUROSCI, V11, P891; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LIU CM, 1978, J BIOL CHEM, V253, P5892; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Loschinger J, 1997, J NEUROBIOL, V33, P825, DOI 10.1002/(SICI)1097-4695(19971120)33:6<825::AID-NEU9>3.0.CO;2-B; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; SATO S, 1982, J NEUROCHEM, V39, P97, DOI 10.1111/j.1471-4159.1982.tb04706.x; Schafer M, 1996, NEURON, V16, P1107, DOI 10.1016/S0896-6273(00)80137-3; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; TANG WJ, 1991, J BIOL CHEM, V266, P8595; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zucchi R, 1997, PHARMACOL REV, V49, P1	40	100	101	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					909	916		10.1016/j.neuron.2004.11.030	http://dx.doi.org/10.1016/j.neuron.2004.11.030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603734	Green Accepted, Bronze			2022-12-28	WOS:000225842300005
J	Martinez-Trujillo, JC; Medendorp, WP; Wang, HY; Crawford, JD				Martinez-Trujillo, JC; Medendorp, WP; Wang, HY; Crawford, JD			Frames of reference for eye-head gaze commands in primate supplementary eye fields	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; SUPERIOR COLLICULUS; RHESUS-MONKEYS; COORDINATE SYSTEMS; ELECTRICAL-STIMULATION; 3-DIMENSIONAL EYE; FRONTAL-CORTEX; NEURAL-CONTROL; MACAQUE SEF; MOVEMENTS	The supplementary eye field (SEF) is a region within medial frontal cortex that integrates complex visuospatial information and controls eye-head gaze shifts. Here, we test if the SEF encodes desired gaze directions in a simple retinal (eye-centered) frame, such as the superior colliculus, or in some other, more complex frame. We electrically stimulated 55 SEF sites in two head-unrestrained monkeys to evoke 3D eye-head gaze shifts and then mathematically rotated these trajectories into various reference frames. Each stimulation site specified a specific spatial goal when plotted in its intrinsic frame. These intrinsic frames varied site by site, in a continuum from eye-, to head-, to space/body-centered coding schemes. This variety of coding schemes provides the SEF with a unique potential for implementing arbitrary reference frame transformations.	CSB York Univ, Lab Visuomotor Neurosci, Ctr Vis Res, Canadian Inst Hlth Res,Grp Act & Percept, N York, ON M3J 1P3, Canada; CSB York Univ, Dept Psychol, N York, ON M3J 1P3, Canada; CSB York Univ, Dept Biol, N York, ON M3J 1P3, Canada; CSB York Univ, Dept Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada; McGill Univ, Fac Med, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Radboud Univ Nijmegen, Nijmegen Inst Cognit & Informat, NL-6500 HE Nijmegen, Netherlands; Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6500 HE Nijmegen, Netherlands	Institute for Work & Health; York University - Canada; York University - Canada; York University - Canada; York University - Canada; McGill University; Radboud University Nijmegen; Radboud University Nijmegen	Martinez-Trujillo, JC (corresponding author), CSB York Univ, Lab Visuomotor Neurosci, Ctr Vis Res, Canadian Inst Hlth Res,Grp Act & Percept, N York, ON M3J 1P3, Canada.	julio.martinez@mcgill.ca	Martinez-Trujillo, Julio C/M-2146-2015; Medendorp, W. Pieter/A-7369-2010	Martinez-Trujillo, Julio C/0000-0003-3338-578X; Medendorp, W. Pieter/0000-0001-9615-4220; Crawford, Doug/0000-0003-2288-1286				Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Crawford JD, 2003, CURR OPIN NEUROBIOL, V13, P655, DOI 10.1016/j.conb.2003.10.009; Crawford JD, 1997, J NEUROPHYSIOL, V78, P2811, DOI 10.1152/jn.1997.78.5.2811; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; FULLER JH, 1992, EXP BRAIN RES, V92, P152; GLENN B, 1992, J NEUROPHYSIOL, V68, P309, DOI 10.1152/jn.1992.68.1.309; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Klier EM, 2003, PROG BRAIN RES, V142, P109; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Martinez-Trujillo JC, 2003, J NEUROPHYSIOL, V90, P2770, DOI 10.1152/jn.00330.2003; Martinez-Trujillo JC, 2003, J NEUROPHYSIOL, V89, P2961, DOI 10.1152/jn.01065.2002; Olson CR, 1999, J NEUROPHYSIOL, V81, P2340, DOI 10.1152/jn.1999.81.5.2340; PARE M, 1994, EXP BRAIN RES, V101, P123; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Russo GS, 1996, J NEUROPHYSIOL, V76, P825, DOI 10.1152/jn.1996.76.2.825; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P530, DOI 10.1152/jn.1991.66.2.530; SCHALL JD, 1993, VISUAL NEUROSCI, V10, P385, DOI 10.1017/S0952523800003771; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; Scherberger H, 2003, J NEUROPHYSIOL, V89, P1456, DOI 10.1152/jn.00883.2002; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; Smith MA, 2001, J COMPUT NEUROSCI, V10, P127, DOI 10.1023/A:1011264913465; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; STANTON GB, 1993, J COMP NEUROL, V330, P286, DOI 10.1002/cne.903300209; STRASCHILL M, 1973, BRAIN RES, V59, P211, DOI 10.1016/0006-8993(73)90262-X; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Tehovnik EJ, 1998, BRAIN RES, V795, P287, DOI 10.1016/S0006-8993(98)00302-3; Tehovnik EJ, 1999, EUR J NEUROSCI, V11, P2431, DOI 10.1046/j.1460-9568.1999.00665.x; Tremblay L, 2002, J NEUROPHYSIOL, V87, P333, DOI 10.1152/jn.00356.2001; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D; Tweed D, 1997, J NEUROPHYSIOL, V77, P654, DOI 10.1152/jn.1997.77.2.654; VANOPSTAL AJ, 1991, SCIENCE, V252, P1313, DOI 10.1126/science.1925545; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	41	61	61	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					1057	1066		10.1016/j.neuron.2004.12.004	http://dx.doi.org/10.1016/j.neuron.2004.12.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603747	Bronze			2022-12-28	WOS:000225842300018
J	Piazza, M; Izard, V; Pinel, P; Le Bihan, D; Dehaene, S				Piazza, M; Izard, V; Pinel, P; Le Bihan, D; Dehaene, S			Tuning curves for approximate numerosity in the human intraparietal sulcus	NEURON			English	Article							PRIMATE PREFRONTAL CORTEX; NUMBER REPRESENTATION; NUMERICAL INFORMATION; MODEL; AREAS; DISCRIMINATION; ACTIVATION; NEURONS; MEMORY; MONKEY	Number, like color or movement, is a basic property of the environment. Recently, single neurons tuned to number have been observed in animals. We used both psychophysics and neuroimaging to examine whether a similar neural coding scheme is present in humans. When participants viewed sets of items with a variable number, the bilateral intraparietal sulci responded selectively to number change. Functionally, the shape of this response indicates that humans, like other animal species, encode approximate number on a compressed internal scale. Anatomically, the intraparietal site coding for number in humans is compatible with that observed in macaque monkeys. Our results therefore suggest an evolutionary basis for human elementary arithmetic.	CEA, Unite INSERM 562 Cognit Neuroimaging, F-91401 Orsay, France; CEA, DSV, Serv Hosp Frederic Joliot, Unite Neuroimagerie Anatomo Fonct, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), CEA, Unite INSERM 562 Cognit Neuroimaging, F-91401 Orsay, France.	dehaene@shfj.cea.fr	pinel, philippe/AAJ-3768-2020; Piazza, Manuela/D-2028-2010	pinel, philippe/0000-0001-6945-1369; Piazza, Manuela/0000-0003-2557-9701				ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 1997, NUMBER SENSE; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; MILLER EK, 1993, J NEUROSCI, V13, P1460; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120	30	744	753	4	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					547	555		10.1016/j.neuron.2004.10.014	http://dx.doi.org/10.1016/j.neuron.2004.10.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504333	Bronze			2022-12-28	WOS:000224771700015
J	Feng, YY; Walsh, CA				Feng, YY; Walsh, CA			Mitotic spindle regulation by Nde1 controls cerebral cortical size	NEURON			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; CELL-DIVISION; ASYMMETRIC DISTRIBUTION; LISSENCEPHALY GENE; TUMOR-SUPPRESSOR; PRECURSOR CELLS; PROTEIN; LIS1	Ablation of the LIS1-interacting protein Nde1 (formerly mNudE) in mouse produces a small brain (microcephaly), with the most dramatic reduction affecting the cerebral cortex. While cortical lamination is mostly preserved, the mutant cortex has fewer neurons and very thin superficial cortical layers (II to IV). BrdU birthdating revealed retarded and modestly disorganized neuronal migration; however, more dramatic defects on mitotic progression, mitotic orientation, and mitotic chromosome localization in cortical progenitors were observed in Nde1 mutant embryos. The small cerebral cortex seems to reflect both reduced progenitor cell division and altered neuronal cell fates. In vitro analysis demonstrated that Nde1 is essential for centrosome duplication and mitotic spindle assembly. Our data show that mitotic spindle function and orientation are essential for normal development of mammalian cerebral cortex.	Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr,Howard Hughes Med I, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr,Howard Hughes Med I, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu		Walsh, Christopher/0000-0002-0156-2238	NICHD NIH HHS [P30HD18655] Funding Source: Medline; NIMH NIH HHS [K01MH065338] Funding Source: Medline; NINDS NIH HHS [P01 NS40043, R01 NS032457] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH065338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043, R01NS032457] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; BARKOVICH AJ, 1991, ANN NEUROL, V30, P139, DOI 10.1002/ana.410300204; Barkovich AJ, 1996, NEUROPEDIATRICS, V27, P59, DOI 10.1055/s-2007-973750; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOE CQ, 1995, NEURON, V15, P991, DOI 10.1016/0896-6273(95)90088-8; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hattori M, 1995, J BIOL CHEM, V270, P31345, DOI 10.1074/jbc.270.52.31345; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; NIETO M, 2004, IN PRESS J COMP NEUR; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RAKIC P, 1988, PROG BRAIN RES, V73, P15; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shen Q, 2002, DEVELOPMENT, V129, P4843; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Sweeney KJ, 2001, MECH DEVELOP, V101, P21, DOI 10.1016/S0925-4773(00)00543-8; Takahashi T, 1996, J NEUROSCI, V16, P5762; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	57	273	282	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					279	293		10.1016/j.neuron.2004.09.023	http://dx.doi.org/10.1016/j.neuron.2004.09.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473967	Bronze			2022-12-28	WOS:000224635800011
J	Trimmer, JS				Trimmer, JS			Peering into the birth canal during ion channel parturition	NEURON			English	Editorial Material							KV1.1 POTASSIUM CHANNEL; K+-CHANNEL; SUBUNIT	Recent studies have provided detailed structures of the N-terminal T1 domain of Kv channel alpha subunits that mediates contranslational subunit assembly. In this issue of Neuron, Kosolapov et al. probe T1 domain structure within the ribosomal tunnel. They find that the T1 domain forms secondary structure within the tunnel, in preparation for its immediate role in governing channel assembly upon exit.	Univ Calif Davis, Dept Pharmacol, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Pharmacol, Sch Med, Davis, CA 95616 USA.							DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Manganas LN, 2001, J BIOL CHEM, V276, P49427, DOI 10.1074/jbc.M109325200; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; Ptacek L, 2002, NOVART FDN SYMP, V241, P87; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286	13	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					214	216		10.1016/j.neuron.2004.10.001	http://dx.doi.org/10.1016/j.neuron.2004.10.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473959	Bronze			2022-12-28	WOS:000224635800003
J	Brunel, N; Hakim, V; Isope, P; Nadal, JP; Barbour, B				Brunel, N; Hakim, V; Isope, P; Nadal, JP; Barbour, B			Optimal information storage and the distribution of synaptic weights: Perceptron versus Purkinje cell	NEURON			English	Article							FIBER RECEPTIVE-FIELDS; RAT VISUAL-CORTEX; PYRAMIDAL NEURONS; SILENT SYNAPSES; NEURAL-NETWORKS; POSTSYNAPTIC EXPRESSION; CEREBELLAR CORTEX; PLASTICITY; GRANULE; AMPA	It is widely believed that synaptic modifications underlie learning and memory. However, few studies have examined what can be deduced about the learning process from the distribution of synaptic weights. We analyze the perceptron, a prototypical feedforward neural network, and obtain the optimal synaptic weight distribution for a perceptron with excitatory synapses. It contains more than 50% silent synapses, and this fraction increases with storage reliability: silent synapses are therefore a necessary byproduct of optimizing learning and reliability. Exploiting the classical analogy between the perceptron and the cerebellar Purkinje cell, we fitted the optimal weight distribution to that measured for granule cell-Purkinje cell synapses. The two distributions agreed well, suggesting that the Purkinje cell can learn up to 5 kilobytes of information, in the form of 40,000 input-output associations.	Ecole Normale Super, Neurobiol Lab, F-75230 Paris 05, France; Univ Paris 05, F-75270 Paris 06, France; Ecole Normale Super, Phys Stat Lab, F-75231 Paris 05, France; Kinsmen Lab Neurol Res, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of British Columbia	Barbour, B (corresponding author), Ecole Normale Super, Neurobiol Lab, 46 Rue Ulm, F-75230 Paris 05, France.	barbour@ens.fr	Nadal, Jean-Pierre/HHM-8804-2022	Barbour, Boris/0000-0002-1911-0539; hakim, vincent/0000-0001-7505-8192; Isope, Philippe/0000-0002-0630-5935; Nadal, Jean-Pierre/0000-0003-0022-0647				Albus JS, 1971, MATH BIOSCI, V10, P26, DOI DOI 10.1016/0025-5564(71)90051-4; ARNIT D, 1989, MODELING BRAIN FUNCT; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Coenen OJMD, 2001, AUTON ROBOT, V11, P291, DOI 10.1023/A:1012403510221; COVER TM, 1965, IEEE TRANS ELECTRON, VEC14, P326, DOI 10.1109/PGEC.1965.264137; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; Efron B., 1994, MONOGRAPHS STAT APPL; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Engel A., 2001, STAT MECH LEARNING; FATT P, 1953, J PHYSIOL-LONDON, V121, P374, DOI 10.1113/jphysiol.1953.sp004952; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P271, DOI 10.1088/0305-4470/21/1/031; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P257, DOI 10.1088/0305-4470/21/1/030; GRINIASTY M, 1991, J PHYS A-MATH GEN, V24, P715, DOI 10.1088/0305-4470/24/3/030; GUTFREUND H, 1990, J PHYS A-MATH GEN, V23, P2613, DOI 10.1088/0305-4470/23/12/036; Gutig R, 2003, J NEUROSCI, V23, P3697; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hebb Donald O., 1949, ORG BEHAV; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Isope P, 2002, ANN NY ACAD SCI, V978, P164, DOI 10.1111/j.1749-6632.2002.tb07564.x; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; KOHLER HM, 1991, J PHYS A-MATH GEN, V24, pL495, DOI 10.1088/0305-4470/24/9/008; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lubke J, 1996, J NEUROSCI, V16, P3209; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MASON A, 1991, J NEUROSCI, V11, P72; Mezard M., 1987, WORLD SCI LECT NOT P, V9; Minsky M., 1988, PERCEPTRONS INTRO CO; MONASSON R, 1992, J PHYS A-MATH GEN, V25, P3701, DOI 10.1088/0305-4470/25/13/019; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Nadal JP, 1990, NETWORK-COMP NEURAL, V1, P61, DOI 10.1088/0954-898X/1/1/005; Nadal JP, 1990, NETWORK-COMP NEURAL, V1, P463, DOI 10.1088/0954-898X/1/4/006; NAPPER RMA, 1988, J COMP NEUROL, V274, P158, DOI 10.1002/cne.902740203; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; PRESS WH, 1992, NUMERICAL RECIPES; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Rumpel S, 1998, J NEUROSCI, V18, P8863; SAYER RJ, 1990, J NEUROSCI, V10, P826; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; 1999, NAT NEUROSCI, V2, P618	67	186	186	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					745	757		10.1016/S0896-6273(04)00528-8	http://dx.doi.org/10.1016/S0896-6273(04)00528-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339654	Bronze			2022-12-28	WOS:000223691900018
J	Knutson, B; Bjork, JM; Fong, GW; Hommer, D; Mattay, VS; Weinberger, DR				Knutson, B; Bjork, JM; Fong, GW; Hommer, D; Mattay, VS; Weinberger, DR			Amphetamine modulates human incentive processing	NEURON			English	Article							NUCLEUS-ACCUMBENS; FUNCTIONAL MRI; BRAIN ACTIVITY; CORTICAL ACTIVATION; PREFRONTAL CORTEX; NEURAL RESPONSES; REWARD; DOPAMINE; FMRI; ANTICIPATION	Research suggests that psychostimulants can physiologically alter dopamine kinetics in the ventral striatum (VS) and psychologically enhance mood and attention. Using event-related functional magnetic resonance imaging (fMRI), we conducted a within-subject, double-blind, placebo (PLAC)-controlled study of the effects of oral dextroamphetamine (AMPH, 0.25 mg/kg) treatment on brain activity and affect during incentive processing. In two counterbalanced scanning sessions 60-180 min after ingesting AMPH or PLAC, 8 healthy volunteers played a game involving anticipation and receipt of monetary gains and losses. Group and volume of interest analyses suggested that by enhancing tonic over phasic activation, AMPH treatment "equalized" levels of VS activity and positive arousal during anticipation of both gain and loss. These findings suggest that therapeutic effects of amphetamine on incentive processing may involve reducing the difference between anticipation of gains and losses.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; NIAAA, Clin Studies Lab, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Knutson, B (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	knutson@psych.stanford.edu	Bjork, James/Q-5108-2019	Bjork, James/0000-0003-0593-3291; Knutson, Brian/0000-0002-7669-426X	NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH066923, ZIAMH002716, Z01MH002716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000081, ZIAAA000081] Funding Source: NIH RePORTER; NIMH NIH HHS [MH066923] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*APA, 1998, STRUCT CLIN INT DSM; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Bloom AS, 1999, HUM BRAIN MAPP, V8, P235, DOI 10.1002/(SICI)1097-0193(1999)8:4<235::AID-HBM7>3.0.CO;2-3; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; CADOR M, 1991, PSYCHOPHARMACOLOGY, V104, P377, DOI 10.1007/BF02246039; CALDWELL JA, 1995, AVIAT SPACE ENVIR MD, V66, P930; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig W, 1918, BIOL BULL-US, V34, P91, DOI 10.2307/1536346; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; GARRIS PA, 1994, J NEUROSCI, V14, P442; Hariri AR, 2002, NEUROPSYCHOPHARMACOL, V27, P1036, DOI 10.1016/S0893-133X(02)00373-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, BIOL PSYCHIAT, V50, P685, DOI 10.1016/S0006-3223(01)01220-3; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; Neter J., 1996, APPL LINEAR STAT MOD; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Rao SM, 2000, AM J PSYCHIAT, V157, P1697, DOI 10.1176/appi.ajp.157.10.1697; Salmeron Betty Jo, 2002, Psychopharmacol Bull, V36, P102; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sell LA, 1997, DRUG ALCOHOL DEPEN, V49, P55, DOI 10.1016/S0376-8716(97)00140-3; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Uftring SJ, 2001, NEUROPSYCHOPHARMACOL, V25, P925, DOI 10.1016/S0893-133X(01)00311-6; Wachtel SR, 1999, BEHAV PHARMACOL, V10, P271, DOI 10.1097/00008877-199905000-00004; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Young AMJ, 1998, NEUROSCIENCE, V83, P1175, DOI 10.1016/S0306-4522(97)00483-1	39	128	131	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 22	2004	43	2					261	269		10.1016/j.neuron.2004.06.030	http://dx.doi.org/10.1016/j.neuron.2004.06.030			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260961	Bronze			2022-12-28	WOS:000222905400014
J	van Atteveldt, N; Formisano, E; Goebel, R; Blomert, L				van Atteveldt, N; Formisano, E; Goebel, R; Blomert, L			Integration of letters and speech sounds in the human brain	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; AUDITORY-CORTEX; AUDIOVISUAL INTEGRATION; CROSSMODAL BINDING; VISUAL INFORMATION; PERCEPTION; ACTIVATION; GRAPHEME; MACAQUE; AREA	Most people acquire literacy skills with remarkable ease, even though the human brain is not evolutionarily adapted to this relatively new cultural phenomenon. Associations between letters and speech sounds form the basis of reading in alphabetic scripts. We investigated the functional neuroanatomy of the integration of letters and speech sounds using functional magnetic resonance imaging (fMRI). Letters and speech sounds were presented unimodally and bimodally in congruent or incongruent combinations. Analysis of single-subject data and group data aligned on the basis of individual cortical anatomy revealed that letters and speech sounds are integrated in heteromodal superior temporal cortex. Interestingly, responses to speech sounds in a modality-specific region of the early auditory cortex were modified by simultaneously presented letters. These results suggest that efficient processing of culturally defined associations between letters and speech sounds relies on neural mechanisms similar to those naturally evolved for integrating audiovisual speech.	Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Maastricht University	van Atteveldt, N (corresponding author), Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	n.vanatteveldt@psychology.unimaas.nl	van Atteveldt, Nienke M/K-2124-2014	van Atteveldt, Nienke M/0000-0002-3387-6151; Goebel, Rainer/0000-0003-1780-2467; Formisano, Elia/0000-0001-5008-2460				BAYLIS GC, 1987, J NEUROSCI, V7, P330; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BLOMERT L, 2002, DYSLEXIE STAND ZAKEN; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DIJKSTRA T, 1993, J EXP PSYCHOL HUMAN, V19, P931, DOI 10.1037/0096-1523.19.5.931; DIJKSTRA T, 1989, LANG SPEECH, V32, P89, DOI 10.1177/002383098903200201; Duvemoy H. M., 1999, HUMAN BRAIN SURFACE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Fort A, 2002, CEREB CORTEX, V12, P1031, DOI 10.1093/cercor/12.10.1031; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; FROST R, 1988, J MEM LANG, V27, P741, DOI 10.1016/0749-596X(88)90018-6; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gros H, 2001, J CEREBR BLOOD F MET, V21, P1330, DOI 10.1097/00004647-200111000-00009; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; HARDY M, 1972, J EDUC PSYCHOL, V63, P433, DOI 10.1037/h0033240; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Hinton G. E., 1986, FOUNDATIONS, V1, P77; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Jones JA, 2003, NEUROREPORT, V14, P1129, DOI 10.1097/00001756-200306110-00006; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kim JJ, 2000, NEUROIMAGE, V11, P271, DOI 10.1006/nimg.2000.0543; King AJ, 2001, CURR BIOL, V11, pR322, DOI 10.1016/S0960-9822(01)00175-0; Liberman A. M., 1992, ADV PSYCHOL, P167; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MASSARO DW, 1988, VISIBLE LANGUAGE SPE, V22; MCGURK H, 1976, NATURE, V263, P747; Meredith MA, 2002, COGNITIVE BRAIN RES, V14, P31, DOI 10.1016/S0926-6410(02)00059-9; Olson IR, 2002, COGNITIVE BRAIN RES, V14, P129, DOI 10.1016/S0926-6410(02)00067-8; Paulesu E, 2003, J NEUROPHYSIOL, V90, P2005, DOI 10.1152/jn.00926.2002; Perfetti C A, 2000, J Deaf Stud Deaf Educ, V5, P32, DOI 10.1093/deafed/5.1.32; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Shah NJ, 2000, NEUROIMAGE, V12, P100, DOI 10.1006/nimg.2000.0588; Snow C., 1998, PREV READ DIFF YOUNG; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Suzuki M, 2002, HEARING RES, V163, P37, DOI 10.1016/S0378-5955(01)00367-7; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	54	375	376	1	47	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 22	2004	43	2					271	282		10.1016/j.neuron.2004.06.025	http://dx.doi.org/10.1016/j.neuron.2004.06.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260962	Green Published, Bronze			2022-12-28	WOS:000222905400015
J	Moulder, KL; Meeks, JP; Shute, AA; Hamilton, CK; de Erausquin, G; Mennerick, S				Moulder, KL; Meeks, JP; Shute, AA; Hamilton, CK; de Erausquin, G; Mennerick, S			Plastic elimination of functional glutamate release sites by depolarization	NEURON			English	Article							EXCITATORY SYNAPTIC CURRENTS; HIPPOCAMPAL-NEURONS; SILENT SYNAPSES; NEUROTRANSMITTER RELEASE; PRESYNAPTIC RELEASE; QUANTAL AMPLITUDE; CALCIUM CURRENTS; TIME-COURSE; TRANSPORTERS; ACTIVATION	To examine persisting effects of depolarizing rises in extracellular potassium concentration ([K+](o)) on synapses, we depolarized cells to simulate ischemia-like rises in [K+](o). Elevated [K+](o) for 1-16 hr severely depressed glutamate signaling, while mildly depressing GABA transmission. The glutamate-specific changes were plastic over several hours and involved a decrease in the size of the pool of releasable vesicles. Rather than a reduction of the number of vesicles per release site, the change involved functional elimination of release sites. This change was clearly dissociable from a second effect, depressed probability of transmitter release, which was common to both glutamate and GABA transmission. Thus, while other recent evidence links alteration of the releasable pool size with changes in p(r), our results suggest the two can be independently manipulated. Selective depression of glutamate release may provide an adaptive mechanism by which neurons limit excitotoxicity.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave, St Louis, MO 63110 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017; Meeks, Julian/ABE-4361-2020; de Erausquin, Gabriel A./Z-1952-2019; de Erausquin, Gabriel A/G-5840-2010	Mennerick, Steven/0000-0003-0868-0664; de Erausquin, Gabriel A./0000-0001-6423-4461; de Erausquin, Gabriel A/0000-0001-6423-4461; Meeks, Julian/0000-0002-7537-4491	NIAAA NIH HHS [AA 12592] Funding Source: Medline; NIDA NIH HHS [5T32 DA 07261, 1F32 DA 15948] Funding Source: Medline; NINDS NIH HHS [NS 40488] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, F32DA015948] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; ATLROCK WD, 2003, NEURON, V37, P787; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Gido G, 1997, STROKE, V28, P206, DOI 10.1161/01.STR.28.1.206; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; He YJ, 2002, J NEUROPHYSIOL, V87, P925, DOI 10.1152/jn.00225.2001; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Linden DJ, 1998, J NEUROPHYSIOL, V79, P3151, DOI 10.1152/jn.1998.79.6.3151; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1999, J NEUROSCI, V19, P9242; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Mennerick S, 1996, J NEUROSCI, V16, P55; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Moulder KL, 2003, J NEUROSCI, V23, P1825; Moulder KL, 2002, NEUROBIOL DIS, V10, P396, DOI 10.1006/nbdi.2002.0523; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; SHARPLESS SK, 1975, DEV NEUROPSYCHOL, P125; Shi J, 2001, J NEUROSCI, V21, P6233, DOI 10.1523/JNEUROSCI.21-16-06233.2001; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Xu WY, 2000, J NEUROSCI, V20, P3147, DOI 10.1523/JNEUROSCI.20-09-03147.2000; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	64	49	50	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					423	435		10.1016/S0896-6273(04)00184-9	http://dx.doi.org/10.1016/S0896-6273(04)00184-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134639	Bronze			2022-12-28	WOS:000221458700009
J	Yu, DH; Ponomarev, A; Davis, RL				Yu, DH; Ponomarev, A; Davis, RL			Altered representation of the spatial code for Odors after olfactory classical conditioning: Memory trace formation by synaptic recruitment	NEURON			English	Article							SHORT-TERM-MEMORY; ANTENNAL LOBE; DROSOPHILA; MAP; NEURONS; IDENTIFICATION; TRANSMISSION; ORGANIZATION; EXPRESSION; RECEPTORS	In the olfactory bulb of vertebrates or the homologous antennal lobe of insects, odor quality is represented by stereotyped patterns of neuronal activity that are reproducible within and between individuals. Using optical imaging to monitor synaptic activity in the Drosophila antennal lobe, we show here that classical conditioning rapidly alters the neural code representing the learned odor by recruiting new synapses into that code. Pairing of an odor-conditioned stimulus with an electric shock-unconditioned stimulus causes new projection neuron synapses to respond to the odor along with those normally activated prior to conditioning. Different odors recruit different groups of projection neurons into the spatial code. The change in odor representation after conditioning appears to be intrinsic to projection neurons. The rapid recruitment by conditioning of new synapses into the representation of sensory information may be a general mechanism underlying many forms of short-term memory.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIAAA NIH HHS [AA 13476] Funding Source: Medline; NINDS NIH HHS [NS 19904] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013476] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Beck CDO, 2000, J NEUROSCI, V20, P2944; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dudai Y., 2002, MEMORY KEYWORDS CONC; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lessing D, 1999, CURR OPIN NEUROBIOL, V9, P766, DOI 10.1016/S0959-4388(99)00035-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mcguire S.E., 2001, SCIENCE, V10, P1126; Meller VH, 1996, INSECT BIOCHEM MOLEC, V26, P327, DOI 10.1016/0965-1748(95)00100-X; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ponomarev AL, 2003, BIOINFORMATICS, V19, P1431, DOI 10.1093/bioinformatics/btg176; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Squire L. R., 1987, MEMORY BRAIN; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Sun XJ, 1997, J COMP NEUROL, V379, P2, DOI 10.1002/(SICI)1096-9861(19970303)379:1<2::AID-CNE2>3.0.CO;2-8; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	45	181	183	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					437	449		10.1016/S0896-6273(04)00217-X	http://dx.doi.org/10.1016/S0896-6273(04)00217-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134640	Bronze			2022-12-28	WOS:000221458700010
J	Li, HS; Wang, DN; Shen, Q; Schonemann, MD; Gorski, JA; Jones, KR; Temple, S; Jan, LY; Jan, YN				Li, HS; Wang, DN; Shen, Q; Schonemann, MD; Gorski, JA; Jones, KR; Temple, S; Jan, LY; Jan, YN			Inactivation of numb and numblike in embryonic dorsal forebrain impairs neurogenesis and disrupts cortical morphogenesis	NEURON			English	Article							ASYMMETRIC CELL-DIVISION; MAMMALIAN NUMB; STEM-CELLS; NERVOUS-SYSTEM; INTRACELLULAR DOMAIN; CEREBRAL-CORTEX; NEURAL TISSUE; MOUSE NUMB; PROTEIN; FATE	Numb and Numblike, conserved homologs of Drosophila Numb, have been implicated in cortical neurogenesis; however, analysis of their involvement in later stages of cortical development has been hampered by early lethality of double mutants in previous studies. Using Emx1(IREScre) to induce more restricted inactivation of Numb in the dorsal forebrain of numblike null mice beginning at E9.5, we have generated viable double mutants that displayed striking brain defects. It was thus possible to examine neurogenesis during the later peak phase (El 2.5-E16.5). Loss of Numb and Numblike in dorsal forebrain resulted in neural progenitor hyper-proliferation, delayed cell cycle exit, impaired neuronal differentiation, and concomitant defects in cortical morphogenesis. These findings reveal novel and essential function of Numb and Numblike during the peak period of cortical neurogenesis. Further, these double mutant mice provide an unprecedented viable animal model for severe brain malformations due to defects in neural progenitor cells.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Albany Medical College; University of Colorado System; University of Colorado Boulder	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	ynjan@itsa.ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; JONES, KEVIN/0000-0002-3802-7562				Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bayer S.A., 1991, NEOCORTICAL DEV; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Gorski JA, 2002, J NEUROSCI, V22, P6309; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; Lele Z, 2002, DEVELOPMENT, V129, P3281; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Takahashi T, 1999, J NEUROSCI, V19, P10357; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	62	160	166	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1105	1118		10.1016/S0896-6273(03)00755-4	http://dx.doi.org/10.1016/S0896-6273(03)00755-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687546	Bronze			2022-12-28	WOS:000187503400010
J	Lu, CS; Hodge, JJL; Mehren, J; Sun, XX; Griffith, LC				Lu, CS; Hodge, JJL; Mehren, J; Sun, XX; Griffith, LC			Regulation of the Ca2+/CaM-responsive pool of CaMKII by scaffold-dependent autophosphorylation	NEURON			English	Article							PROTEIN-KINASE-II; SITE-DIRECTED MUTAGENESIS; CALMODULIN-BINDING; NMDA RECEPTOR; INHIBITORY AUTOPHOSPHORYLATION; POSTSYNAPTIC DENSITY-95; AUTOINHIBITORY DOMAIN; SYNAPTIC PLASTICITY; DROSOPHILA; TRANSLOCATION	CaMKII is critical for structural and functional plasticity. Here we show that Camguk (Cmg), the Drosophila homolog of CASK/Lin-2, associates in an ATP-regulated manner with CaMKII to catalyze formation of a pool of calcium-insensitive CaMKII. In the presence of Ca2+/CaM, CaMKII complexed to Cmg can auto-phosphorylate at T287 and become constitutively active. In the absence of Ca2+/CaM, ATP hydrolysis results in phosphorylation of T306 and inactivation of CaMKII. Cmg coexpression suppresses CaMKII activity in transfected cells, and the level of Cmg expression in Drosophila modulates postsynaptic T306 phosphorylation. These results suggest that Cmg, in the presence of Ca2+/CaM, can provide a localized source of active kinase. When Ca2+/CaM or synaptic activity is low, Cmg promotes inactivating autophosphorylation, producing CaMKII that requires phosphatase to reactivate. This interaction provides a mechanism by which the active postsynaptic pool of CaMKII can be controlled locally to differentiate active and inactive synapses.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.		Lu, Cecilia S./ABD-3989-2020; Lu, Cecilia S/G-2467-2015	Lu, Cecilia S./0000-0002-0685-2859; Lu, Cecilia S/0000-0002-0685-2859; Griffith, Leslie/0000-0003-3164-9876; Hodge, James/0000-0003-4741-2363	NCRR NIH HHS [S10 RR16780] Funding Source: Medline; NIGMS NIH HHS [R01 GM54408, R01 GM054408-07, R01 GM054408] Funding Source: Medline; NINDS NIH HHS [P01 NS44232, F32NS43024] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS043024, P01NS044232] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Dimitratos SD, 1997, MECH DEVELOP, V63, P127, DOI 10.1016/S0925-4773(97)00668-0; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; GAILEY DA, 1982, GENETICS, V102, P771; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hata Y, 1996, J NEUROSCI, V16, P2488; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; LOU LL, 1989, J NEUROSCI, V9, P2020; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Park D, 2002, J NEUROBIOL, V52, P24, DOI 10.1002/neu.10066; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PATTON BL, 1991, METHODS NEUROSCI, V6, P158; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Sambrook J., 2002, MOL CLONING LAB MANU; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P565; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Snaith HA, 1996, J CELL SCI, V109, P3001; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang Z, 1998, J NEUROCHEM, V71, P378; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; YOUNG JZ, 1979, J ROY SOC MED, V72, P801	58	85	89	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1185	1197		10.1016/S0896-6273(03)00786-4	http://dx.doi.org/10.1016/S0896-6273(03)00786-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687552	Bronze			2022-12-28	WOS:000187503400016
J	Gomeza, J; Ohno, K; Hulsmann, S; Armsen, W; Eulenburg, V; Richter, DW; Laube, B; Betz, H				Gomeza, J; Ohno, K; Hulsmann, S; Armsen, W; Eulenburg, V; Richter, DW; Laube, B; Betz, H			Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality	NEURON			English	Article							RECEPTOR-BETA-SUBUNIT; RAT SPINAL-CORD; NEUROTRANSMITTER TRANSPORTERS; HEREDITARY HYPEREKPLEXIA; DOPAMINE TRANSPORTER; FRAMESHIFT MUTATION; STARTLE DISEASE; SPASTIC MOUSE; BRAIN-STEM; GENE GLRA1	The glycine transporter subtype 2 (GlyT2) is localized in the axon terminals of glycinergic neurons. Mice deficient in GlyT2 are normal at birth but during the second postnatal week develop a lethal neuromotor deficiency that resembles severe forms of human hyperekplexia (hereditary startle disease) and is characterized by spasticity, tremor, and an inability to right. Histological and immunological analyses failed to reveal anatomical or biochemical abnormalities, but the amplitudes of glycinergic miniature inhibitory currents (mIPSCs) were strikingly reduced in hypoglossal motoneurons and dissociated spinal neurons from GlyT2-deficient mice. Thus, postnatal GlyT2 function is crucial for efficient transmitter loading of synaptic vesicles in glycinergic nerve terminals, and the GlyT2 gene constitutes a candidate disease gene in human hyperekplexia patients.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de	Eulenburg, Volker/B-7263-2013; Hülsmann, Swen/F-7169-2010; Eulenburg, Volker/B-7263-2013	Eulenburg, Volker/0000-0002-4878-5746; Hülsmann, Swen/0000-0001-5042-8724; Eulenburg, Volker/0000-0001-6314-566X				AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Andrew M, 1997, BRIT J PSYCHIAT, V170, P106, DOI 10.1192/bjp.170.2.106; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Becker L, 2000, EUR J NEUROSCI, V12, P27, DOI 10.1046/j.1460-9568.2000.00877.x; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Breitinger HG, 1998, CURR PHARM DESIGN, V4, P315; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dumoulin A, 1999, J CELL SCI, V112, P811; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Friauf E, 1999, J COMP NEUROL, V412, P17; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; Hartenstein B, 1996, EMBO J, V15, P1275, DOI 10.1002/j.1460-2075.1996.tb00469.x; Hulsmann S, 2000, EUR J NEUROSCI, V12, P239, DOI 10.1046/j.1460-9568.2000.00902.x; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; Laube B, 2002, EUR J NEUROSCI, V16, P1025, DOI 10.1046/j.1460-9568.2002.02170.x; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Mahendrasingam S, 2000, BRAIN RES, V887, P477, DOI 10.1016/S0006-8993(00)03054-7; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Milani N, 1996, AM J HUM GENET, V58, P420; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Nelson N, 1998, J NEUROCHEM, V71, P1785; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Poyatos I, 1997, MOL BRAIN RES, V49, P63, DOI 10.1016/S0169-328X(97)00124-1; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Rajendra Sundran, 1995, Trends in Neurosciences, V18, P80, DOI 10.1016/0166-2236(95)93880-7; REES MI, 1994, HUM MOL GENET, V3, P2175, DOI 10.1093/hmg/3.12.2175; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sakata Y, 2001, MOL BRAIN RES, V94, P119, DOI 10.1016/S0169-328X(01)00225-X; SAUL B, 1994, FEBS LETT, V350, P1; SCHLOSS P, 1994, CURR OPIN CELL BIOL, V6, P595, DOI 10.1016/0955-0674(94)90081-7; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Tijssen MAJ, 1997, ARCH NEUROL-CHICAGO, V54, P388, DOI 10.1001/archneur.1997.00550160034012; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Vergouwe MN, 1997, CLIN NEUROL NEUROSUR, V99, P172, DOI 10.1016/S0303-8467(97)00022-X; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; ZAFRA F, 1995, J NEUROSCI, V15, P3952	55	242	248	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					797	806		10.1016/S0896-6273(03)00673-1	http://dx.doi.org/10.1016/S0896-6273(03)00673-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622583	Green Published, hybrid			2022-12-28	WOS:000186651200014
J	Verstreken, P; Koh, TW; Schulze, KL; Zhai, RG; Hiesinger, PR; Zhou, Y; Mehta, SQ; Cao, Y; Roos, J; Bellen, HJ				Verstreken, P; Koh, TW; Schulze, KL; Zhai, RG; Hiesinger, PR; Zhou, Y; Mehta, SQ; Cao, Y; Roos, J; Bellen, HJ			Synaptojanin is recruited by Endophilin to promote synaptic vesicle uncoating	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; MUTANT DROSOPHILA; NERVE-TERMINALS; SH3 DOMAIN; PROTEIN; MUTATIONS; DYNAMIN; SINGLE	We describe the isolation and characterization of Drosophila synaptojanin (synj) mutants. synj encodes a phosphatidylinositol phosphatase involved in clathrin-mediated endocytosis. We show that Synj is specifically localized to presynaptic terminals and is associated with synaptic vesicles. The electrophysiological and ultrastructural defects observed in synj mutants are strikingly similar to those found in endophilin mutants, and Synj and Endo colocalize and interact biochemically. Moreover, synj; endo double mutant synaptic terminals exhibit properties that are very similar to terminals of each single mutant, and overexpression of Endophilin can partially rescue the functional defects in partial loss-of-function synj mutants. Interestingly, Synj is mislocalized and destabilized at synapses devoid of Endophilin, suggesting that Endophilin recruits and stabilizes Synj on newly formed vesicles to promote vesicle uncoating. Our data also provide further evidence that kiss-and-run is able to maintain neurotransmitter release when synapses are not extensively challenged.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		Koh, Tong-Wey/M-3774-2013; Verstreken, Patrik/AAC-7591-2022; Zhai, R. Grace/AGZ-3936-2022	Koh, Tong-Wey/0000-0001-9136-3189; Verstreken, Patrik/0000-0002-5073-5393; Zhai, Rong/0000-0002-7599-1430; Bellen, Hugo/0000-0001-5992-5989; Mehta, Sunil/0000-0003-3020-4939	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15927] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Cousin MA, 2001, J NEUROCHEM, V76, P105, DOI 10.1046/j.1471-4159.2001.00049.x; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; FABIANFINE R, 2003, IN PRESS J NEUROSCI; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hurley JH, 2002, CELL, V111, P143, DOI 10.1016/S0092-8674(02)01044-9; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Kjaerulff O, 2002, NAT CELL BIOL, V4, pE245, DOI 10.1038/ncb1102-e245; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; Newsome TP, 2000, DEVELOPMENT, V127, P851; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qualmann B, 2002, INT REV CYTOL, V220, P93; Rikhy R, 2002, J NEUROSCI, V22, P7478; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stowers RS, 1999, GENETICS, V152, P1631; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	44	280	289	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					733	748		10.1016/S0896-6273(03)00644-5	http://dx.doi.org/10.1016/S0896-6273(03)00644-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622578	Bronze			2022-12-28	WOS:000186651200009
J	Fonseca, R; Nagerl, UV; Morris, RGM; Bonhoeffer, T				Fonseca, R; Nagerl, UV; Morris, RGM; Bonhoeffer, T			Competing for memory: Hippocampal LTP under regimes of reduced protein synthesis	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; LATE MAINTENANCE; CA1 REGION; AREA CA1; DEPRESSION; ANISOMYCIN; SLICES; RAT; BLOCKADE	The persistence of synaptic potentiation in the hippocampus is known to depend on transcription and protein synthesis. We report here that, under regimes of reduced protein synthesis, competition between synapses for the relevant intracellular proteins can be demonstrated. Under such circumstances, the induction of additional protein synthesis-dependent long-term potentiation for a given set of postsynaptic neurons occurs at the expense of the maintenance of prior potentiation on an independent pathway. This new phenomenon, which we call "competitive maintenance," has important functional consequences, and it may be explained in terms of dynamic interactions between synapses and "plasticity factors" over extended periods of time.	Max Planck Inst Neurobiol, D-82152 Munich, Germany; Univ Edinburgh, Ctr Neurosci, Cognit Neurosci Lab, Edinburgh EH8 9LE, Midlothian, Scotland	Max Planck Society; University of Edinburgh	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009; Fonseca, Rosalina/AAS-1117-2020; Nägerl, Valentin/AAD-2575-2022; Morris, Richard G M/C-9982-2013; Fonseca, Rosalina/I-1715-2012	Bonhoeffer, Tobias/0000-0001-7897-6634; Fonseca, Rosalina/0000-0003-0884-6441; Nägerl, Valentin/0000-0001-6831-9008; MORRIS, Richard G M/0000-0001-8661-1520				ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; Baddeley AD., 1990, HUMAN MEMORY THEORY; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bliss TVP, 2003, PHILOS T ROY SOC B, V358, P607, DOI 10.1098/rstb.2003.1282; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; KATZ LC, 1987, J NEUROSCI, V7, P1223; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; REYMANN KG, 1985, BRAIN RES BULL, V15, P249, DOI 10.1016/0361-9230(85)90147-9; Sajikumar S, 2003, NEUROSCI LETT, V338, P147, DOI 10.1016/S0304-3940(02)01400-3; Scanziani M, 1996, J PHYSIOLOGY-PARIS, V90, P165, DOI 10.1016/S0928-4257(97)81416-7; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; STANTON PK, 1984, J NEUROSCI, V4, P3080; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Woo NH, 2003, J NEUROSCI, V23, P1125, DOI 10.1523/JNEUROSCI.23-04-01125.2003	31	119	120	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					1011	1020		10.1016/j.neuron.2004.10.033	http://dx.doi.org/10.1016/j.neuron.2004.10.033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603743	Bronze			2022-12-28	WOS:000225842300014
J	Thompson, KR; Otis, KO; Chen, DY; Zhao, Y; O'Dell, TJ; Martin, KC				Thompson, KR; Otis, KO; Chen, DY; Zhao, Y; O'Dell, TJ; Martin, KC			Synapse to nucleus signaling during long-term synaptic plasticity: a role for the classical active nuclear import pathway	NEURON			English	Article							APLYSIA SENSORY NEURONS; GENE-EXPRESSION; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN-SYNTHESIS; CRITICAL PERIOD; PORE COMPLEX; MEMORY; ALPHA; FACILITATION; HIPPOCAMPUS	The requirement for transcription during long-lasting plasticity indicates that signals generated at the synapse must be transported to the nucleus. We have investigated whether the classical active nuclear import pathway mediates intracellular retrograde signal transport in Aplysia sensory neurons and rodent hippocampal neurons. We found that importins localize to distal neuronal processes, including synaptic compartments, where they are well positioned to mediate synapse to nucleus signaling. In Aplysia, stimuli known to produce long-lasting but not short-lasting facilitation triggered importin nuclear translocation. In hippocampal neurons, NMDA receptor activation but not depolarization induced importin nuclear translocation. We further showed that LTP-inducing stimuli recruited active nuclear import in hippocampal slices. Together with our finding that long-term facilitation of Aplysia sensory-motor synapses required active nuclear import, our results indicate that regulation of the active nuclear import pathway plays a critical role in transporting synaptically generated signals into the nucleus during learning-related forms of plasticity.	Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdepartmental Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martin, KC (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu						Alberini CM, 1999, J EXP BIOL, V202, P2887; AMBRON RT, 1992, J NEUROSCI, V12, P2813; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Cassany A, 2004, TRAFFIC, V5, P10, DOI 10.1046/j.1398-9219.2003.0143.x; CHIN GJ, 1989, J NEUROSCI, V9, P38; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; CLEVER J, 1991, P NATL ACAD SCI USA, V88, P7333, DOI 10.1073/pnas.88.16.7333; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; FEATHERSTONE C, 1988, J CELL BIOL, V107, P1289, DOI 10.1083/jcb.107.4.1289; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Makhinson M, 1999, J NEUROSCI, V19, P2500; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Prieve MG, 1996, J BIOL CHEM, V271, P7654, DOI 10.1074/jbc.271.13.7654; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Suzuki WA, 2000, CURR OPIN NEUROBIOL, V10, P768, DOI 10.1016/S0959-4388(00)00148-3; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	43	120	123	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					997	1009		10.1016/j.neuron.2004.11.025	http://dx.doi.org/10.1016/j.neuron.2004.11.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603742	Bronze			2022-12-28	WOS:000225842300013
J	Koirala, S; Ko, CP				Koirala, S; Ko, CP			Pruning an axon piece by piece: A new mode of synapse elimination	NEURON			English	Editorial Material							NEUROMUSCULAR-JUNCTION; GLIAL-CELLS; MUSCLE; RAT; INNERVATION	The process by which excess axons are pruned during development has remained unclear. In this issue of Neuron, Bishop et al. use time-lapse imaging and serial electron microscopy of developing neuromuscular junctions to describe a novel cellular mechanism in which retracting axon branches shed fragments rich in normal synaptic organelles. These "axosomes" are engulfed by adjacent Schwann cells and may be assimilated into the glial cytoplasm. Shedding of axosomes and glial engulfment may represent a widespread mechanism of synapse elimination.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Southern California	Koirala, S (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA.							Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; BIXBY JL, 1981, J NEUROCYTOL, V10, P81, DOI 10.1007/BF01181746; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Kang H, 2003, J NEUROCYTOL, V32, P975, DOI 10.1023/B:NEUR.0000020636.27222.2d; Koirala S, 2003, J NEUROCYTOL, V32, P987, DOI 10.1023/B:NEUR.0000020637.71452.3c; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; ROSENTHAL JL, 1977, J PHYSIOL-LONDON, V270, P299, DOI 10.1113/jphysiol.1977.sp011953; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035	12	8	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					578	580		10.1016/S0896-6273(04)00718-4	http://dx.doi.org/10.1016/S0896-6273(04)00718-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541305	Bronze			2022-12-28	WOS:000225338100003
J	Weissman, TA; Riquelme, PA; Ivic, L; Flint, AC; Kriegstein, AR				Weissman, TA; Riquelme, PA; Ivic, L; Flint, AC; Kriegstein, AR			Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex	NEURON			English	Article							CORTICAL PROGENITOR CELLS; GAP-JUNCTION HEMICHANNELS; VENTRICULAR ZONE; CEREBRAL-CORTEX; DNA-SYNTHESIS; EMBRYONIC NEOCORTEX; PRECURSOR CELLS; NEURONS ARISE; ATP RELEASE; ASTROCYTES	The majority of neurons in the adult neocortex are produced embryonically during a brief but intense period of neuronal proliferation. The radial glial cell, a transient embryonic cell type known for its crucial role in neuronal migration, has recently been shown to function as a neuronal progenitor cell and appears to produce most cortical pyramidal neurons. Radial glial cell modulation could thus affect neuron production, neuronal migration, and overall cortical architecture; however, signaling mechanisms among radial glia have not been studied directly. We demonstrate here that calcium waves propagate through radial glial cells in the proliferative cortical ventricular zone (VZ). Radial glial calcium waves occur spontaneously and require connexin hemichannels, P2Y(1) ATP receptors, and intracellular IP3-mediated calcium release. Furthermore, we show that wave disruption decreases VZ proliferation during the peak of embryonic neurogenesis. Taken together, these results demonstrate a radial glial signaling mechanism that may regulate cortical neuronal production.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kriegstein, AR (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	ark17@columbia.edu		Flint, Alexander/0000-0002-3721-2694; Weissman, Tamily/0000-0001-9361-6071	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21223] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Bayer S.A., 1991, NEOCORTICAL DEV; Behar TN, 1996, J NEUROSCI, V16, P1808; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bittman K, 1997, J NEUROSCI, V17, P7037; Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Cai L, 1997, J NEUROSCI, V17, P2088; Campbell K, 2003, GLIA, V43, P44, DOI 10.1002/glia.10247; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goto T, 2002, J NEUROSCI RES, V69, P714, DOI 10.1002/jnr.10361; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Grafstein B, 2000, ANN NEUROL, V47, P18, DOI 10.1002/1531-8249(200001)47:1<18::AID-ANA6>3.3.CO;2-E; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moll V, 2002, INVEST OPHTH VIS SCI, V43, P766; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Neary JT, 1996, TRENDS NEUROSCI, V19, P13, DOI 10.1016/0166-2236(96)81861-3; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Pearson R, 2002, J NEUROSCI, V22, P7569; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Ralevic V, 1998, PHARMACOL REV, V50, P413; Sanches G, 2002, INT J DEV NEUROSCI, V20, P21, DOI 10.1016/S0736-5748(02)00004-7; Scemes E, 2003, J NEUROSCI, V23, P11444; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sugioka M, 1999, INT J DEV NEUROSCI, V17, P135, DOI 10.1016/S0736-5748(98)00066-5; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Uckermann O, 2002, J NEUROSCI RES, V70, P209, DOI 10.1002/jnr.10406; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zanotti S, 1997, J NEUROCHEM, V69, P594; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236	67	409	413	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					647	661		10.1016/j.neuron.2004.08.015	http://dx.doi.org/10.1016/j.neuron.2004.08.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339647	Bronze			2022-12-28	WOS:000223691900011
J	Szumlinski, KK; Dehoff, MH; Kang, SH; Frys, KA; Lominac, KD; Klugmann, M; Rohrer, J; Griffin, W; Toda, S; Champtiaux, NP; Berry, T; Tu, JC; Shealy, SE; During, MJ; Middaugh, LD; Worley, PF; Kalivas, PW				Szumlinski, KK; Dehoff, MH; Kang, SH; Frys, KA; Lominac, KD; Klugmann, M; Rohrer, J; Griffin, W; Toda, S; Champtiaux, NP; Berry, T; Tu, JC; Shealy, SE; During, MJ; Middaugh, LD; Worley, PF; Kalivas, PW			Homer proteins regulate sensitivity to cocaine	NEURON			English	Article							POSTSYNAPTIC DENSITY PROTEINS; CONDITIONED PLACE PREFERENCE; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; GLUTAMATE TRANSMISSION; EXPRESSION; RECEPTORS; HIPPOCAMPAL; SEEKING; MICE	Drug addiction involves complex interactions between pharmacology and learning in genetically susceptible individuals. Members of the Homer gene family are regulated by acute and chronic cocaine administration. Here, we report that deletion of Homer1 or Homer:2 in mice caused the same increase in sensitivity to cocaine-induced locomotion, conditioned reward, and augmented extracellular glutamate in nucleus accumbens as that elicited by withdrawal from repeated cocaine administration. Moreover, adeno-associated virus-mediated restoration of Homer2 in the accumbens of Homer2 KO mice reversed the cocaine-sensitized phenotype. Further analysis of Homer2 KO mice revealed extensive additional behavioral and neurochemical similarities to cocaine-sensitized animals, including accelerated acquisition of cocaine self-administration and altered regulation of glutamate by metabotropic glutamate receptors and cystine/glutamate exchange. These data show that Homer deletion mimics the behavioral and neurochemical phenotype produced by repeated cocaine administration and implicate Homer in regulating addiction to cocaine.	Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA; Med Univ S Carolina, Ctr Drug & Alcohol Programs, Dept Psychiat, Charleston, SC 29425 USA; Univ Auckland, Dept Mol Med & Pathol, Auckland 1020, New Zealand; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Medical University of South Carolina; Medical University of South Carolina; University of Auckland; Johns Hopkins University	Szumlinski, KK (corresponding author), Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA.	szumlink@musc.edu	Jansen, Heiko T./A-5770-2008; During, Matthew/AAC-1388-2020; Szumlinski, Karen K./J-9617-2015	Jansen, Heiko T./0000-0003-0178-396X; Szumlinski, Karen K./0000-0003-1078-1077; Lominac, Kevin/0000-0003-2397-1451	NIDA NIH HHS [DA-03906, DA-10309, DA-11742, DA-14185-01, DA-14185] Funding Source: Medline; NIMH NIH HHS [KO2-MH01152, MH-40817] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040817, K02MH001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014185, R01DA011742, R37DA010309, R01DA010309, R37DA003906, R01DA003906] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Avgeropoulos N, 1998, J ACQ IMMUN DEF SYND, V18, P13, DOI 10.1097/00042560-199805010-00003; Baker DA, 2002, J NEUROSCI, V22, P9134; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5; Bohn LM, 2003, J NEUROSCI, V23, P10265; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Cunningham CL, 1999, PSYCHOPHARMACOLOGY, V146, P73, DOI 10.1007/s002130051090; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; During Matthew J, 2003, Methods Mol Med, V76, P221; Ebihara T, 2003, J NEUROSCI, V23, P2170; Everitt BJ, 2002, J NEUROSCI, V22, P3312; FRANKLIN BJK, 1997, MOUSE BRAIN STEREOTA; Ghasemzadeh MB, 2003, EUR J NEUROSCI, V18, P1645, DOI 10.1046/j.1460-9568.2003.02880.x; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Griffin WC, 2003, PHARMACOL BIOCHEM BE, V76, P543, DOI 10.1016/j.pbb.2003.09.010; Groseclose CH, 1998, J NEUROSCI METH, V79, P31, DOI 10.1016/S0165-0270(97)00158-1; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Hennou S, 2003, EUR J NEUROSCI, V18, P811, DOI 10.1046/j.1460-9568.2003.02812.x; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; HORGER BA, 1990, PHARMACOL BIOCHEM BE, V37, P707, DOI 10.1016/0091-3057(90)90552-S; Hotsenpiller G, 2001, EUR J NEUROSCI, V14, P1843, DOI 10.1046/j.0953-816x.2001.01804.x; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; Middaugh LD, 2003, ALCOHOL CLIN EXP RES, V27, P1892, DOI 10.1097/01.ALC.0000099264.36220.48; Middaugh LD, 1998, PSYCHOPHARMACOLOGY, V136, P44, DOI 10.1007/s002130050537; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; PATRICK KS, 1993, J CHROMATOGR-BIOMED, V621, P89, DOI 10.1016/0378-4347(93)80080-N; Pierce RC, 1996, J NEUROSCI, V16, P1550; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Reid MS, 1996, NEUROREPORT, V7, P1325, DOI 10.1097/00001756-199605170-00022; Sala C, 2003, J NEUROSCI, V23, P6327; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shih AY, 2001, BIOCHEM BIOPH RES CO, V282, P1132, DOI 10.1006/bbrc.2001.4703; Shimosato K, 2000, PHARMACOL BIOCHEM BE, V66, P285, DOI 10.1016/S0091-3057(00)00185-4; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; Shippenberg TS, 1998, EUR J PHARMACOL, V345, P27, DOI 10.1016/S0014-2999(97)01614-2; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Swanson CJ, 2001, J NEUROSCI, V21, P9043, DOI 10.1523/JNEUROSCI.21-22-09043.2001; Szumlinski KK, 2003, PSYCHOPHARMACOLOGY, V165, P329, DOI 10.1007/s00213-002-1274-0; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Usui S, 2003, J BIOL CHEM, V278, P10619, DOI 10.1074/jbc.M210802200; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	64	190	195	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					401	413		10.1016/j.neuron.2004.07.019	http://dx.doi.org/10.1016/j.neuron.2004.07.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294147	Bronze			2022-12-28	WOS:000223156900013
J	Xiang, JZ; Brown, MW				Xiang, JZ; Brown, MW			Neuronal responses related to long-term recognition memory processes in prefrontal cortex	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; ANTERIOR CINGULATE; HIPPOCAMPAL-FORMATION; PERIRHINAL CORTEX; WORKING-MEMORY; FAMILIARITY; RETRIEVAL; RECENCY; OBJECT; PET	Much evidence indicates that prefrontal cortex plays an important role in long-term recognition memory processes. Here, we report primate prefrontal neuronal responses carrying information necessary for long-term visual recognition memory. The responses of many neurons signaled stimulus familiarity even when the period over which stimuli had to be remembered extended to 24 hr. Such responses occurred frequently in ventromedial, orbitofrontal, and anterior cingulate but not dorsolateral prefrontal cortex. Prefrontal information processing, as indicated by the response latencies, started after that in inferior temporal cortex and might be related to retrieval processes, as responses were typically larger for familiar than for novel stimuli.	Univ Bristol, Bristol BS8 1TD, Avon, England; MRC, Ctr Synapt Plast, Sch Med, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Brown, MW (corresponding author), Univ Bristol, Univ Walk, Bristol BS8 1TD, Avon, England.	m.w.brown@bris.ac.uk						BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; BAKER RJ, 1978, GLIM GEN LINEAR INTE; Bogacz R, 2003, HIPPOCAMPUS, V13, P494, DOI 10.1002/hipo.10093; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cadoret G, 2001, EUR J NEUROSCI, V14, P1164, DOI 10.1046/j.0953-816x.2001.01737.x; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; FAHY FL, 1993, EXP BRAIN RES, V96, P457; Funahashi S, 2002, REV NEUROSCIENCE, V13, P313; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 1995, MEMORY CEREBRAL CORT; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Konishi S, 2002, J NEUROSCI, V22, P9549; Kopelman MD, 1998, NEUROPSYCHOLOGIA, V36, P785, DOI 10.1016/S0028-3932(97)00167-X; Lee Andy C. H., 2000, Critical Reviews in Neurobiology, V14, P165; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Miller EK, 1996, J NEUROSCI, V16, P5154; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Parker A, 1998, EUR J NEUROSCI, V10, P3044, DOI 10.1046/j.1460-9568.1998.00306.x; Parkin AJ, 1996, BRAIN COGNITION, V32, P14, DOI 10.1006/brcg.1996.0055; Paxinos G., 2000, RHESUS MONKEY BRAIN; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; RANGANATH C, 2002, COGNITIVE NEUROSCIEN, P83; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; RICHES IP, 1991, J NEUROSCI, V11, P1763; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Schacter DL, 1996, NEUROPSYCHOLOGIA, V34, P793, DOI 10.1016/0028-3932(95)00165-4; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SNIDER RS, 1963, STEREOTAXIC ATLAS MO; SOBOTKA S, 1994, BRAIN RES, V646, P95, DOI 10.1016/0006-8993(94)90061-2; SOBOTKA S, 1993, EXP BRAIN RES, V96, P28, DOI 10.1007/BF00230436; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6	51	61	62	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					817	829		10.1016/j.neuron.2004.05.013	http://dx.doi.org/10.1016/j.neuron.2004.05.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182720	Bronze			2022-12-28	WOS:000221975000012
J	Bamford, NS; Zhang, H; Schmitz, Y; Wu, NP; Cepeda, C; Levine, MS; Schmauss, C; Zakharenko, SS; Zablow, L; Sulzer, D				Bamford, NS; Zhang, H; Schmitz, Y; Wu, NP; Cepeda, C; Levine, MS; Schmauss, C; Zakharenko, SS; Zablow, L; Sulzer, D			Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals	NEURON			English	Article							NUCLEUS-ACCUMBENS; IN-VIVO; SYNAPTIC PLASTICITY; STRIATAL NEURONS; MICE LACKING; ULTRASTRUCTURAL-LOCALIZATION; PRESYNAPTIC INHIBITION; RECEPTOR ACTIVATION; TRANSMITTER RELEASE; DORSAL STRIATUM	Dopamine input to the striatum is required for voluntary motor movement, behavioral reinforcement, and responses to drugs of abuse. It is speculated that these functions are dependent on either excitatory or inhibitory modulation of corticostriatal synapses onto medium spiny neurons (MSNs). While dopamine modulates MSN excitability, a direct presynaptic effect on the corticostriatal input has not been clearly demonstrated. We combined optical monitoring of synaptic vesicle exocytosis from motor area corticostriatal afferents and electrochemical recordings of striatal dopamine release to directly measure effects of dopamine at the level of individual presynaptic terminals. Dopamine released by either electrical stimulation or amphetamine acted via D2 receptors to inhibit the activity of subsets of corticostriatal terminals. Optical and electrophysiological data suggest that heterosynaptic inhibition was enhanced by higher frequency stimulation and was selective for the least active terminals. Thus, dopamine, by filtering less active inputs, appears to reinforce specific sets of corticostriatal synaptic connections.	Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Univ Washington, Childrens Hosp & Reg Med Ctr, Dept Neurol, Dept Pediat, Seattle, WA 98105 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Calif Los Angeles, Mental Retardat Res Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.	ds43@columbia.edu	Zakharenko, Stanislav/D-3287-2013; Bamford, Nigel/S-9141-2019; Schmitz, Yvonne/L-6183-2013	Zakharenko, Stanislav/0000-0001-8115-202X; Bamford, Nigel/0000-0003-3375-1022; 	NIDA NIH HHS [DA07418] Funding Source: Medline; NIMH NIH HHS [MH056123] Funding Source: Medline; NINDS NIH HHS [NS33538] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R55DA007418, R01DA007418, R29DA007418] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Brager DH, 2003, J NEUROSCI, V23, P10475; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; CALABRESI P, 1993, BRAIN, V116, P433; Calabresi P, 1997, J NEUROSCI, V17, P4536; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; FISHER RS, 1994, J NEUROSCI RES, V38, P551, DOI 10.1002/jnr.490380508; FloresHernandez J, 1997, SYNAPSE, V25, P185, DOI 10.1002/(SICI)1098-2396(199702)25:2<185::AID-SYN9>3.0.CO;2-8; GARCIAMUNOZ M, 1991, BRAIN RES, V551, P195, DOI 10.1016/0006-8993(91)90933-M; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gonon F, 1997, J NEUROSCI, V17, P5972; GRAYBIEL AM, 1981, NEUROSCIENCE, V6, P377, DOI 10.1016/0306-4522(81)90131-7; Harvey J, 1996, J PHYSIOL-LONDON, V492, P143, DOI 10.1113/jphysiol.1996.sp021296; HERSCH SM, 1995, J NEUROSCI, V15, P5222; HSU KS, 1995, BRAIN RES, V690, P264, DOI 10.1016/0006-8993(95)00734-8; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Jones SR, 1998, J NEUROSCI, V18, P1979; Jung MY, 1999, NEUROSCIENCE, V91, P911, DOI 10.1016/S0306-4522(98)00705-2; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lin YQ, 2001, AUTON NEUROSCI-BASIC, V88, P16, DOI 10.1016/S1566-0702(00)00287-3; MAURA G, 1988, J PHARMACOL EXP THER, V247, P680; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicola SM, 1996, J NEUROSCI, V16, P1591; Nicola SM, 1998, J NEUROPHYSIOL, V79, P1768, DOI 10.1152/jn.1998.79.4.1768; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; ODONNELL P, 1994, BRAIN RES, V634, P105, DOI 10.1016/0006-8993(94)90263-1; Robinson DL, 2001, NEUROREPORT, V12, P2549, DOI 10.1097/00001756-200108080-00051; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; SESACK SR, 1994, J NEUROSCI, V14, P88; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhang H, 2003, J NEUROSCI, V23, P10585	40	275	287	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					653	663		10.1016/S0896-6273(04)00265-X	http://dx.doi.org/10.1016/S0896-6273(04)00265-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157425	Bronze			2022-12-28	WOS:000221708300014
J	Guirland, C; Suzuki, S; Kojima, M; Lu, B; Zheng, JQ				Guirland, C; Suzuki, S; Kojima, M; Lu, B; Zheng, JQ			Lipid rafts mediate chemotropic guidance of nerve growth cones	NEURON			English	Article							PHOSPHOLIPASE C-GAMMA; NOGO RECEPTOR; LIGAND; SIGNAL; TRANSMEMBRANE; LOCALIZATION; GANGLIOSIDES; GLYCOPROTEIN; MICRODOMAINS; ASSOCIATION	Axon guidance requires signal transduction of extracellular cues through the plasma membrane for directional motility. Here we present evidence that cholesterol- and sphingolipid-enriched membrane microdomains (lipid rafts) mediate specific guidance responses of nerve growth cones. Disruption of lipid rafts by various approaches targeting cholesterol or gangliosides selectively abolished growth cone attraction and repulsion in BDNF and netrin-1 gradients, respectively, without affecting glumamate-induced attraction. Interestingly, local raft disruption on one side of the growth cone in bath BDNF or netrin-1 produced opposite turning responses to that induced by the gradients. Raft manipulation also blocked Semaphorin 3A-induced growth cone repulsion, inhibition, and collapse. Finally, guidance responses appeared to involve raft-dependent activation of p42/p44 MAPK and ligand-induced receptor recruitment to lipid rafts. Together with the observation of asymmetric receptor-raft associations at the growth cone in guidance gradients, our findings indicate that localized signaling through membrane rafts plays a role in mediating guidance actions of extracellular cues on developing axons.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Natl Inst Adv Ind Sci & Technol, Div Life Sci Technol, Ikeda, Osaka 5638577, Japan; NICHHD, Sect Synapse Dev & Plast, NIH, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zheng, JQ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	james.zheng@umdnj.edu	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAIRD DH, 1992, J NEUROBIOL, V23, P579, DOI 10.1002/neu.480230511; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Buck KB, 2002, J NEUROSCI, V22, P9358; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Guirland C, 2003, J NEUROSCI, V23, P2274; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hering H, 2003, J NEUROSCI, V23, P3262; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Inoue H, 2002, EUR J IMMUNOL, V32, P2188, DOI 10.1002/1521-4141(200208)32:8<2188::AID-IMMU2188>3.0.CO;2-T; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Ma L, 2003, J NEUROSCI, V23, P3164; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; McKerracher L, 2002, NEURON, V36, P345, DOI 10.1016/S0896-6273(02)01018-8; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 1997, J NEUROSCI, V17, P7860; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Paratcha G, 2002, CURR OPIN NEUROBIOL, V12, P542, DOI 10.1016/S0959-4388(02)00363-X; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Rabacchi SA, 1999, J NEUROSCI, V19, P4437; ROBINSON JM, 1980, J HISTOCHEM CYTOCHEM, V28, P161, DOI 10.1177/28.2.6766487; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Suzuki T, 2001, MOL BRAIN RES, V89, P20, DOI 10.1016/S0169-328X(01)00051-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	51	211	214	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					51	62		10.1016/S0896-6273(04)00157-6	http://dx.doi.org/10.1016/S0896-6273(04)00157-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066264	Bronze			2022-12-28	WOS:000221458400007
J	Anthony, TE; Klein, C; Fishell, G; Heintz, N				Anthony, TE; Klein, C; Fishell, G; Heintz, N			Radial glia serve as neuronal progenitors in all regions of the central nervous system	NEURON			English	Article							FETAL MONKEY NEOCORTEX; CELL MIGRATION; STEM-CELLS; CEREBRAL CORTEX; BASAL FOREBRAIN; EXPRESSION; MOUSE; BRAIN; FATE; GENES	Radial glial cells function during CNS development as neural progenitors, although their precise contribution to neurogenesis remains controversial. Recent work has argued that regional differences may exist regarding the neurogenic potential of radial glia. Here, we show that the vast majority of neurons in all brain regions derive from radial glia. Cre/IoxP fate mapping and clonal analysis demonstrate that radial glia throughout the CNS serve as neuronal progenitors and that radial glia within different regions of the CNS pass through their neurogenic stage of development at distinct time points. Thus, radial glial populations within different CNS regions are not heterogeneous with regard to their potential to generate neurons versus glia.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; NYU, Ctr Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University; New York University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu		Fishell, Gordon/0000-0002-9640-9278				Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bayer S.A., 1991, NEOCORTICAL DEV; Bisconte J C, 1975, J Hirnforsch, V16, P55; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; Hogan B, 1994, MANIPULATING MOUSE E; Kaech S, 1997, J NEUROSCI, V17, P9565; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MCSHERRY GM, 1984, J EMBRYOL EXP MORPH, V81, P239; MCSHERRY GM, 1986, J ANAT, V144, P1; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Nomes H. O., 1978, BRAIN RES, V159, P1; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi T, 1999, J NEUROSCI, V19, P10357; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	39	599	618	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					881	890		10.1016/S0896-6273(04)00140-0	http://dx.doi.org/10.1016/S0896-6273(04)00140-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046721	Bronze			2022-12-28	WOS:000221458300008
J	Rajimehr, R				Rajimehr, R			Unconscious orientation processing	NEURON			English	Article							MONKEY VISUAL-CORTEX; INVISIBLE PATTERNS; BINOCULAR-RIVALRY; COLOR; ADAPTATION; MOTION; ATTENTION; AWARENESS; SYSTEM; PERCEPTION	Recent findings have shown that certain attributes of visual stimuli, like orientation, are registered in cortical areas when the stimulus is unresolvable or perceptually invisible; however, there is no evidence to show that complex forms of orientation processing (e.g., modulatory effects of orientation on the processing of other features) could occur in the absence of awareness. To address these questions, different psychophysical paradigms were designed in six experiments to probe unconscious orientation processing. First we demonstrated orientation-selective adaptation and color-contingent orientation adaptation for peripheral unresolvable Gabor patches. The next experiments showed the modulatory effects of perceptually indiscriminable orientations on apparent motion processing and attentional mechanisms. Finally we investigated disappearance patterns of unresolvable Gabor stimuli during motion-induced blindness (MIB). Abrupt changes in local unresolvable orientations truncated MIB; however, orientation-based grouping failed to affect the MIB pattern when the orientations were unresolvable. Overall results revealed that unresolvable orientations substantially influence perception at multiple levels.	Iranian Inst Studies Theoret Phys & Math Niavaran, Sch Intelligent Syst, Dept Cognit Neurosci, Tehran, Iran		Rajimehr, R (corresponding author), Iranian Inst Studies Theoret Phys & Math Niavaran, Sch Intelligent Syst, Dept Cognit Neurosci, POB 19395-5746, Tehran, Iran.	rajimehr@ipm.ir						Blake R, 1999, PSYCHOL SCI, V10, P145, DOI 10.1111/1467-9280.00122; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BRADLEY A, 1988, VISION RES, V28, P841, DOI 10.1016/0042-6989(88)90031-4; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Fernandez-Duque D, 2000, VIS COGN, V7, P323, DOI 10.1080/135062800394838; Francis G, 1999, PERCEPTION, V28, P1243, DOI 10.1068/p2980; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; HELD R, 1971, SCIENCE, V174, P314, DOI 10.1126/science.174.4006.314; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Ives HE, 1912, PHILOS MAG, V24, P149, DOI 10.1080/14786440708637317; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; Kaneoke Y, 1997, NEUROREPORT, V8, P677, DOI 10.1097/00001756-199702100-00020; Kentridge RW, 1999, P ROY SOC B-BIOL SCI, V266, P1805, DOI 10.1098/rspb.1999.0850; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Posner MI, 1978, MODES PERCEIVING PRO, P137; SCHALL JD, 1993, VISION RES, V33, P2057, DOI 10.1016/0042-6989(93)90004-G; Shady S, 2002, NAT NEUROSCI, V5, P729, DOI 10.1038/nn894; Shioiri S, 2000, VISION RES, V40, P1365, DOI 10.1016/S0042-6989(99)00249-7; Sobel KV, 2002, PERCEPTION, V31, P813, DOI 10.1068/p3279; Tanaka Y, 1998, P NATL ACAD SCI USA, V95, P12729, DOI 10.1073/pnas.95.21.12729; THEEUWES J, 1995, PERCEPT PSYCHOPHYS, V57, P637, DOI 10.3758/BF03213269; Thibos L. N., 1995, VISION MODELS TARGET, P338; WAGNER G, 1972, J OPT SOC AM, V62, P1508, DOI 10.1364/JOSA.62.001508; Wolfe J. M., 1996, BASIC CLIN APPL VISI, P189	33	43	45	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 19	2004	41	4					663	673		10.1016/S0896-6273(04)00041-8	http://dx.doi.org/10.1016/S0896-6273(04)00041-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980213	Bronze			2022-12-28	WOS:000221458100017
J	Nagy, G; Reim, K; Matti, U; Brose, N; Binz, T; Rettig, J; Neher, E; Sorensen, JB				Nagy, G; Reim, K; Matti, U; Brose, N; Binz, T; Rettig, J; Neher, E; Sorensen, JB			Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; SYNAPTOSOME-ASSOCIATED PROTEIN; CYSTEINE STRING PROTEIN; LONG-TERM POTENTIATION; CATECHOLAMINE SECRETION; CYCLIC-AMP; GLUTAMATE RELEASE; SYNAPTOTAGMIN-I; SNARE COMPLEX; 25 KDA	Protein kinase A (PKA) is a key regulator of neurosecretion, but the molecular targets remain elusive. We combined pharmacological manipulations of kinase and phosphatase activities with mutational studies on the exocytotic machinery driving fusion of catecholamine-containing vesicles from chromaffin cells. We found that constitutive PKA activity was necessary to maintain a large number of vesicles in the release-ready, so-called primed, state, whereas calcineurin (protein phosphatase 2B) activity antagonized this effect. Overexpression of the SNARE protein SNAP-25a mutated in a PKA phosphorylation site (Thr-138) eliminated the effect of PKA inhibitors on the vesicle priming process. Another, unidentified, PKA target regulated the relative size of two different primed vesicle pools that are distinguished by their release kinetics. Overexpression of the SNAP-25b isoform increased the size of both primed vesicle pools by a factor of two, and mutations in the conserved Thr-138 site had similar effects as in the a isoform.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Hannover Med Sch, Inst Physiol Chem, D-30625 Hannover, Germany	Max Planck Society; Max Planck Society; Hannover Medical School	Sorensen, JB (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	jsoeren@gwdg.de	Neher, Erwin/A-2109-2013; Rettig, Jens/K-5103-2013	Rettig, Jens/0000-0001-6160-3954; Sorensen, Jakob/0000-0001-5465-3769; Matti, Ulf/0000-0001-5548-1081				ANTONI FA, 1993, BIOCHEM BIOPH RES CO, V194, P226, DOI 10.1006/bbrc.1993.1808; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BAKER EM, 1985, BIOCHIM BIOPHYS ACTA, V846, P388, DOI 10.1016/0167-4889(85)90010-2; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; BITTNER MA, 1986, J BIOL CHEM, V261, P182; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Chan SA, 2001, J PHYSIOL-LONDON, V537, P871; CHEEK TR, 1987, J BIOL CHEM, V262, P11663; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Gil A, 2000, NEUROSCIENCE, V98, P605, DOI 10.1016/S0306-4522(00)00132-9; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; GUTIERREZ LM, 1995, EUR J CELL BIOL, V68, P88; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; HESS DT, 1992, J NEUROSCI, V12, P4634; Hilfiker S, 1999, J NEUROCHEM, V73, P921, DOI 10.1046/j.1471-4159.1999.0730921.x; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; KEOGH R, 1991, J NEUROCHEM, V57, P1721, DOI 10.1111/j.1471-4159.1991.tb06373.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MALHOTRA RK, 1989, J NEUROSCI, V9, P4150; MORGAN A, 1993, EMBO J, V12, P3747, DOI 10.1002/j.1460-2075.1993.tb06052.x; MORITA K, 1987, J NEUROCHEM, V48, P243, DOI 10.1111/j.1471-4159.1987.tb13154.x; Nagy G, 2002, J NEUROSCI, V22, P9278; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; PARRAMON M, 1995, BRIT J PHARMACOL, V114, P517, DOI 10.1111/j.1476-5381.1995.tb13257.x; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; SIHRA TS, 1995, BIOCHEM BIOPH RES CO, V212, P609, DOI 10.1006/bbrc.1995.2013; Sistiaga A, 2000, NEUROPHARMACOLOGY, V39, P1544, DOI 10.1016/S0028-3908(00)00034-4; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Warashina A, 1998, BIOL SIGNAL RECEPT, V7, P307; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699	61	152	158	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					417	429		10.1016/S0896-6273(04)00038-8	http://dx.doi.org/10.1016/S0896-6273(04)00038-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766180	Bronze, Green Published			2022-12-28	WOS:000221457900012
J	Gold, JI; Kalwani, RM				Gold, JI; Kalwani, RM			Context matters	NEURON			English	Editorial Material							REWARD; DOPAMINE		Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Gold, JI (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.			Gold, Joshua/0000-0002-6018-0483				Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	9	0	0	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 22	2004	41	2					177	178		10.1016/S0896-6273(04)00009-1	http://dx.doi.org/10.1016/S0896-6273(04)00009-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741097	Bronze			2022-12-28	WOS:000221457800002
J	Han, WP; Rhee, JS; Maximov, A; Lao, Y; Mashimo, T; Rosenmund, C; Sudhof, TC				Han, WP; Rhee, JS; Maximov, A; Lao, Y; Mashimo, T; Rosenmund, C; Sudhof, TC			N-glycosylation is essential for vesicular targeting of synaptotagmin 1	NEURON			English	Article							CORE VESICLE EXOCYTOSIS; PHOSPHOLIPID-BINDING; SYNAPTIC VESICLES; PLASMA-MEMBRANE; DISTINCT CA2+; SR2+ BINDING; I FUNCTIONS; PROTEIN; RELEASE; COMPONENTS	Synaptotagmins 1 and 7 are candidate Call sensors for exocytosis localized to synaptic vesicles and plasma membranes, respectively. We now show that the N-terminal intraluminal sequence of synaptotagmin 1, when transplanted onto synaptotagmin 7, redirects synaptotagmin 7 from the plasma membrane to secretory vesicles. Conversely, mutation of the N-terminal N-glycosylation site of synaptotagmin 1 redirects synaptotagmin 1 from vesicles to the plasma membrane. In cultured hippocampal neurons, the plasma membrane-localized mutant of synaptotagmin 1 suppressed the readily releasable pool of synaptic vesicles, whereas wild-type synaptotagmin 1 did not. In addition to the intraluminal N-glycosylation site, the cytoplasmic C-2 domains of synaptotagmin 1 were required for correct targeting but could be functionally replaced by the C-2 domains of synaptotagmin 7. Our data suggest that the intravesicular N-glycosylation site of synaptotagmin I collaborates with its cytoplasmic C-2 domains in directing synaptotagmin 1 to synaptic vesicles via a novel N-glycosylation-dependent mechanism.	Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci, Dallas, TX 75390 USA; Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dasgupta S, 2003, J CELL SCI, V116, P1327, DOI 10.1242/jcs.00290; Emanuelsson O, 2001, BBA-MOL CELL RES, V1541, P114, DOI 10.1016/S0167-4889(01)00145-8; FEANY MB, 1993, J CELL BIOL, V123, P575, DOI 10.1083/jcb.123.3.575; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Harris TW, 2001, TRAFFIC, V2, P597, DOI 10.1034/j.1600-0854.2001.002009597.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Prudovsky I, 2002, J CELL BIOL, V158, P201, DOI 10.1083/jcb.200203084; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Saegusa C, 2002, J BIOL CHEM, V277, P24499, DOI 10.1074/jbc.M202767200; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Tokuoka H, 2003, NEURON, V38, P521, DOI 10.1016/S0896-6273(03)00290-3; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	58	83	85	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					85	99		10.1016/S0896-6273(03)00820-1	http://dx.doi.org/10.1016/S0896-6273(03)00820-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715137	Green Published, Bronze			2022-12-28	WOS:000187942800011
J	Wolozin, B				Wolozin, B			Cholesterol and the biology of Alzheimer's disease	NEURON			English	Review							TRANSGENIC MOUSE MODEL; REDUCTASE INHIBITORS; AMYLOID PATHOLOGY; BETA PEPTIDE; PROTEIN GENE; IN-VIVO; RISK; SIMVASTATIN; EXPRESSION; SECRETASE	Recent results implicating cholesterol metabolism in the pathophysiology of Alzheimer's disease (AD) bring cholesterol to the forefront of AD research. Research from genetics, epidemiology, and cell biology all converge, suggesting that cholesterol plays a central role in the biology of amyloid precursor protein and the toxic peptide generated by its cleavage, beta-amyloid (Abeta). The ability of cholesterol to modulate Abeta production suggests opportunities for therapeutic intervention, although the functional significance underlying the connection between cholesterol and Abeta remains to be investigated.	Loyola Univ, Med Ctr, Dept Pharmacol, Maywood, IL 60153 USA	Loyola University Chicago	Wolozin, B (corresponding author), Loyola Univ, Med Ctr, Dept Pharmacol, Bldg 102,Room 3634,2160 S 1st Ave, Maywood, IL 60153 USA.	bwolozi@lumc.edu		Wolozin, Benjamin/0000-0003-2068-1475				Burns M, 2003, J NEUROSCI, V23, P5645; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Desai P, 2002, NEUROSCI LETT, V328, P9, DOI 10.1016/S0304-3940(02)00443-3; Eckert GP, 2001, NEUROREPORT, V12, P883, DOI 10.1097/00001756-200104170-00003; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Friedhoff LT, 2001, INT J NEUROPSYCHOPH, V4, P127, DOI 10.1017/S1461145701002310; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Kolsch H, 2003, AM J MED GENET B, V121B, P128, DOI 10.1002/ajmg.b.20043; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sanchez L, 2001, AM J MED GENET, V105, P76, DOI 10.1002/1096-8628(20010108)105:1<76::AID-AJMG1066>3.0.CO;2-R; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Sun Y, 2003, J BIOL CHEM, V278, P27688, DOI 10.1074/jbc.M300760200; Vega GL, 2003, ARCH NEUROL-CHICAGO, V60, P510, DOI 10.1001/archneur.60.4.510; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wollmer MA, 2003, NEUROBIOL AGING, V24, P421, DOI 10.1016/S0197-4580(02)00094-5; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	26	215	231	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 8	2004	41	1					7	10		10.1016/S0896-6273(03)00840-7	http://dx.doi.org/10.1016/S0896-6273(03)00840-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715130	Bronze			2022-12-28	WOS:000187942800004
J	Hausser, M; Monsivais, P				Hausser, M; Monsivais, P			Less means more: Inhibition of spontaneous firing triggers persistent increases in excitability	NEURON			English	Editorial Material							INTRINSIC EXCITABILITY; PURKINJE NEURONS; SODIUM CURRENT; MODULATION; GAIN	Modulation of intrinsic excitability is an alternative to classical synaptic plasticity for implementing activity-dependent changes in neuronal networks. In this issue of Neuron, Nelson et al. reveal a new form of plasticity of intrinsic excitability that can be triggered rapidly when synaptic inhibition reduces spontaneous firing, resulting in persistent enhancement of firing rate and neuronal gain.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.		Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Monsivais, Pablo/0000-0002-7088-6674				Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; AVANZINI G, 1989, J PHYSIOL-LONDON, V416, P111, DOI 10.1113/jphysiol.1989.sp017752; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Smith SL, 2003, J NEUROSCI, V23, P367, DOI 10.1523/JNEUROSCI.23-02-00367.2003; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3	14	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					449	451		10.1016/S0896-6273(03)00686-X	http://dx.doi.org/10.1016/S0896-6273(03)00686-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642267	Bronze			2022-12-28	WOS:000186379000002
J	Nagerl, UV; Eberhorn, N; Cambridge, SB; Bonhoeffer, T				Nagerl, UV; Eberhorn, N; Cambridge, SB; Bonhoeffer, T			Bidirectional activity-dependent morphological plasticity in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPINES; AREA CA1; STIMULATION; DEPRESSION; EXPERIENCE; INDUCTION; SYNAPSES; LTP	Dendritic spines on pyramidal neurons receive the vast majority of excitatory input and are considered electrobiochemical processing units, integrating and compartmentalizing synaptic input. Following synaptic plasticity, spines can undergo morphological plasticity, which possibly forms the structural basis for long-term changes in neuronal circuitry. Here, we demonstrate that spines on CA1 pyramidal neurons from organotypic slice cultures show bidirectional activity-dependent morphological plasticity. Using two-photon time-lapse microscopy, we observed that low-frequency stimulation induced NMDA receptor-dependent spine retractions, whereas theta burst stimulation led to the formation of new spines. Moreover, without stimulation the number of spine retractions was on the same order of magnitude as the stimulus-induced spine gain or loss. Finally, we found that the ability of neurons to eliminate spines in an activity-dependent manner decreased with developmental age. Taken together, our data show that hippocampal neurons can undergo bidirectional morphological plasticity; spines are formed and eliminated in an activity-dependent way.	Max Planck Inst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Am Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de	Cambridge, Sidney/GYQ-5764-2022; Bonhoeffer, Tobias/B-9481-2009; Nägerl, Valentin/AAD-2575-2022	Bonhoeffer, Tobias/0000-0001-7897-6634; Nägerl, Valentin/0000-0001-6831-9008				BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; Cooper L. N., 1973, P NOBEL S COLLECTIVE, P252; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; PALM G, 1982, CYBERNETICS SYSTEM R; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	22	430	440	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					759	767		10.1016/j.neuron.2004.11.016	http://dx.doi.org/10.1016/j.neuron.2004.11.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572108	Bronze			2022-12-28	WOS:000225548400005
J	Leitges, M; Kovac, J; Plomann, M; Linden, DJ				Leitges, M; Kovac, J; Plomann, M; Linden, DJ			A unique PDZ ligand in PKC alpha confers induction of cerebellar long-term synaptic depression	NEURON			English	Article							PROTEIN-KINASE-C; PURKINJE-CELLS; CELLULAR-DISTRIBUTION; EXPRESSION; GLUR2; PHOSPHORYLATION; MULTIPLE; FAMILY; PICK1; LTD	Induction of cerebellar long-term depression (LTD) requires a postsynaptic cascade involving activation of mGluR1 and protein kinase C (PKC). Our understanding of this process has been limited by the fact that PKC is a large family of molecules, many isoforms of which are expressed in the relevant postsynaptic compartment, the cerebellar Purkinje cell. Here, we report that LTD is absent in Purkinje cells in which the alpha isoform of PKC has been reduced by targeted RNA interference or in cells derived from PKCalpha null mice. In both of these cases, LTD could be rescued by expression of PKCalpha but not other PKC isoforms. The special role of PKCa in cerebellar LTD is likely to derive from its unique PDZ ligand (OSAV). When this motif is mutated, PKCalpha no longer supports LTD. Conversely, when this PDZ ligand is inserted in a nonpermissive isoform, PKCgamma, it confers the capacity for LTD induction.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Max Planck Inst Expt Endokrinol, D-30625 Hannover, Germany; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany	Johns Hopkins University; Max Planck Society; University of Cologne	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R29MH051106, R01MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bareggi R, 1996, BIOL CELL, V87, P55, DOI 10.1016/S0248-4900(97)89837-1; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Bear MF, 2001, SYNAPSES, P455; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; Garcia MM, 1997, J COMP NEUROL, V385, P26; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; Hirono M, 2001, J BIOL CHEM, V276, P45236, DOI 10.1074/jbc.M105413200; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Nishizuka Y, 2001, ALCOHOL CLIN EXP RES, V25, p3S, DOI 10.1111/j.1530-0277.2001.tb02367.x; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SHIMOHAMA S, 1990, J CHEM NEUROANAT, V3, P367; Shutoh F, 2003, EUR J NEUROSCI, V18, P134, DOI 10.1046/j.1460-9568.2003.02717.x; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	34	95	98	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					585	594		10.1016/j.neuron.2004.10.024	http://dx.doi.org/10.1016/j.neuron.2004.10.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541307	Bronze			2022-12-28	WOS:000225338100005
J	Bailey, CH; Kandel, ER; Si, KS				Bailey, CH; Kandel, ER; Si, KS			The persistence of long-term memory: A molecular approach to self-sustaining changes in learning-induced synaptic growth	NEURON			English	Review							APLYSIA SENSORY NEURONS; LOCAL PROTEIN-SYNTHESIS; CELL-ADHESION MOLECULES; GILL-WITHDRAWAL REFLEX; STRUCTURAL-CHANGES; CYTOPLASMIC POLYADENYLATION; PRESYNAPTIC FACILITATION; RHO-GTPASES; HETEROSYNAPTIC FACILITATION; BEHAVIORAL SENSITIZATION	Recent cellular and molecular studies of both implicit and explicit memory storage suggest that experience-dependent modulation of synaptic strength and structure is a fundamental mechanism by which these diverse forms of memory are encoded and stored. For both forms of memory storage, some type of synaptic growth is thought to represent the stable cellular change that maintains the long-term process. In this review, we discuss recent findings on the molecular events that underlie learning-related synaptic growth in Aplysia and discuss the possibility that an active, prion-based mechanism is important for the maintenance of the structural change and for the persistence of long-term memory.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu			NIMH NIH HHS [MH37134] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH037134] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1989, J NEUROSCI, V9, P1774; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Benfenati F, 1999, PHILOS T R SOC B, V354, P243, DOI 10.1098/rstb.1999.0376; Bliss TVP, 2003, PHILOS T ROY SOC B, V358, P607, DOI 10.1098/rstb.2003.1282; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Byrne JH, 1996, J NEUROSCI, V16, P425; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1986, J PHYSIOL-PARIS, V81, P349; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; DALE N, 1987, J NEUROSCI, V7, P2232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Han JH, 2004, LEARN MEMORY, V11, P421, DOI 10.1101/lm.61104; Hatada Y, 1999, J NEUROBIOL, V41, P242, DOI 10.1002/(SICI)1097-4695(19991105)41:2<242::AID-NEU7>3.0.CO;2-#; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Huntley GW, 2002, CELL, V108, P1, DOI 10.1016/S0092-8674(01)00631-6; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Liu JM, 2003, BRAIN RES, V959, P68, DOI 10.1016/S0006-8993(02)03729-0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; SCHWARTZ JH, 1971, J NEUROPHYSIOL, V34, P939, DOI 10.1152/jn.1971.34.6.939; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	69	204	212	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					49	57		10.1016/j.neuron.2004.09.017	http://dx.doi.org/10.1016/j.neuron.2004.09.017			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450159	Bronze			2022-12-28	WOS:000224232600006
J	Bildl, W; Strassmaier, T; Thurm, H; Andersen, J; Eble, S; Oliver, D; Knipper, M; Mann, M; Schulte, U; Adelman, JP; Fakler, B				Bildl, W; Strassmaier, T; Thurm, H; Andersen, J; Eble, S; Oliver, D; Knipper, M; Mann, M; Schulte, U; Adelman, JP; Fakler, B			Protein kinase CK2 is coassembled with small conductance Ca2+-activated K+ channels and regulates channel gating	NEURON			English	Article							INNER HAIR-CELLS; PHOSPHORYLATION; CALMODULIN; ACTIVATION; EXPRESSION; CA2+; INTERMEDIATE; INHIBITION; SUBUNITS; PRESTIN	Small conductance Ca2+-activated K+ channels (SK channels) couple the membrane potential to fluctuations in intracellular Ca2+ concentration in many types of cells. SK channels are gated by Ca2+ ions via calmodulin that is constitutively bound to the intracellular C terminus of the channels and serves as the Ca2+ sensor. Here we show that, in addition, the cytoplasmic N and C termini of the channel protein form a polyprotein complex with the catalytic and regulatory subunits of protein kinase CK2 and protein phosphatase 2A. Within this complex, CK2 phosphorylates calmodulin at threonine 80, reducing by 5-fold the apparent Ca2+ sensitivity and accelerating channel deactivation. The results show that native SK channels are polyprotein complexes and demonstrate that the balance between kinase and phosphatase activities within the protein complex shapes the hyperpolarizing response mediated by SK channels.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Freiburg, Dept Physiol, D-79104 Freiburg, Germany; Complexio GmbH Labor, D-79104 Freiburg, Germany; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Tubingen Hearing Res Ctr, Dept Otolaryngol, D-72076 Tubingen, Germany	Oregon Health & Science University; University of Freiburg; University of Southern Denmark; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fakler, B (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.	bernd.fakler@physiologie.uni-freiburg.de	Andersen, Jens S/L-2100-2015; Mann, Matthias/A-3454-2013; Oliver, Dominik/F-5845-2013	Andersen, Jens S/0000-0002-6091-140X; Mann, Matthias/0000-0003-1292-4799; Oliver, Dominik/0000-0002-8368-0923				ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; Doughty JM, 1999, AM J PHYSIOL-HEART C, V276, pH1107, DOI 10.1152/ajpheart.1999.276.3.H1107; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Guinan J.J., 1996, COCHLEA EDITED, P435; Herrera GM, 2000, AM J PHYSIOL-REG I, V279, pR60, DOI 10.1152/ajpregu.2000.279.1.R60; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Marin O, 1999, BIOCHEM BIOPH RES CO, V256, P442, DOI 10.1006/bbrc.1999.0348; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1992, EUR J BIOCHEM, V205, P939, DOI 10.1111/j.1432-1033.1992.tb16860.x; MEGGIO F, 1987, FEBS LETT, V215, P241, DOI 10.1016/0014-5793(87)80154-0; NAKAJO S, 1988, J BIOCHEM-TOKYO, V104, P946, DOI 10.1093/oxfordjournals.jbchem.a122588; Naraghi M, 1997, J NEUROSCI, V17, P6961; Oliver D, 2003, J NEUROSCI, V23, P2141; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; SACKS DB, 1992, BIOCHEM J, V283, P21, DOI 10.1042/bj2830021; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Syme CA, 2000, AM J PHYSIOL-CELL PH, V278, pC570, DOI 10.1152/ajpcell.2000.278.3.C570; TSE A, 1992, SCIENCE, V255, P462, DOI 10.1126/science.1734523; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; Westmark CJ, 2002, BIOCHEM J, V362, P375, DOI 10.1042/0264-6021:3620375; WILHELM V, 1995, EUR J BIOCHEM, V232, P671, DOI 10.1111/j.1432-1033.1995.tb20859.x; Wissmann R, 2002, J BIOL CHEM, V277, P4558, DOI 10.1074/jbc.M109240200; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Womack MD, 2003, J NEUROSCI, V23, P2600; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406	44	154	155	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					847	858		10.1016/j.neuron.2004.08.033	http://dx.doi.org/10.1016/j.neuron.2004.08.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363395	Bronze			2022-12-28	WOS:000223992000010
J	Calon, F; Lim, GP; Yang, FS; Morihara, T; Teter, B; Ubeda, O; Rostaing, P; Triller, A; Salem, N; Ashe, KH; Frautschy, SA; Cole, GM				Calon, F; Lim, GP; Yang, FS; Morihara, T; Teter, B; Ubeda, O; Rostaing, P; Triller, A; Salem, N; Ashe, KH; Frautschy, SA; Cole, GM			Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model	NEURON			English	Article							AMYLOID-PRECURSOR-PROTEIN; POLYUNSATURATED FATTY-ACIDS; NICOTINIC ACETYLCHOLINE-RECEPTOR; LONG-TERM POTENTIATION; TRANSGENIC MICE; A-BETA; COGNITIVE IMPAIRMENT; LIPID-PEROXIDATION; PHOSPHATIDYLINOSITOL 3-KINASE; POSTSYNAPTIC DENSITY-95	Learning and memory depend on dendritic spine actin assembly and docosahexaenoic acid (DHA), an essential n-3 (omega-3) polyunsaturated fatty acid (PFA). High DHA consumption is associated with reduced Alzheimer's disease (AD) risk, yet mechanisms and therapeutic potential remain elusive. Here, we report that reduction of dietary n-3 PFA in an AD mouse model resulted in 80%-90% losses of the p85alpha subunit of phosphatidylinositol 3-kinase and the postsynaptic actin-regulating protein drebrin, as in AD brain. The loss of postsynaptic proteins was associated with increased oxidation, without concomitant neuron or presynaptic protein loss. N-3 PFA depletion increased caspase-cleaved actin, which was localized in dendrites ultrastructurally. Treatment of n-3 PFA-restricted mice with DHA protected against these effects and behavioral deficits and increased antiapoptotic BAD phosphorylation. Since n-3 PFAs are essential for p85-mediated CNS insulin signaling and selective protection of postsynaptic proteins, these findings have implications for neurodegenerative diseases where synaptic loss is critical, especially AD.	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Greater Los Angeles Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr, Sepulveda, CA 91343 USA; INSERM, Lab Biol Cellulaire Synapse Normale & Pathol, U497, Ecole Normale Super, F-75005 Paris, France; NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, Div Intramural Clin & Biol Res, Rockville, MD 20852 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cole, GM (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	gmcole@ucla.edu	Morihara, Takashi/AAK-2709-2021; Calon, Frederic/AAF-4390-2020	TRILLER, Antoine/0000-0002-7530-1233; Frautschy, Sally A./0000-0003-0194-0363; Calon, Frederic/0000-0002-4203-0887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142, P50AG016570, R01AG010685, R01AG016793, R01AG013741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000235] Funding Source: NIH RePORTER; NIA NIH HHS [AG10685, P50 AG005142, P50 AG05142, R01 AG010685, P01 AG16570, AG16793, P50 AG016570, R01 AG013741, R01 AG016793, R01 AG13741, P50 AG 16570] Funding Source: Medline; NINDS NIH HHS [R01 NS043946, NS43946] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbar M, 2002, J NEUROCHEM, V82, P655, DOI 10.1046/j.1471-4159.2002.01015.x; Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007; Cole GM, 1999, ALZHEIMER'S DISEASE AND RELATED DISORDERS, P363; Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; El-Hussein AE, 2000, SCIENCE, V290, P1364; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Everall IP, 1997, J NEUROPATH EXP NEUR, V56, P1202, DOI 10.1097/00005072-199711000-00004; Favreliere S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Grant WB, 2002, J ALZHEIMERS DIS, V4, P179, DOI 10.3233/JAD-2002-4308; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; JOLLES J, 1992, J NEUROCHEM, V58, P2326, DOI 10.1111/j.1471-4159.1992.tb10981.x; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kyle DJ, 1999, LIPIDS, V34, pS245, DOI 10.1007/BF02562306; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liolitsa D, 2002, J NEUROL NEUROSUR PS, V73, P261, DOI 10.1136/jnnp.73.3.261; Mattson MP, 1999, J NEUROSCI RES, V58, P152, DOI 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Opazo P, 2003, J NEUROSCI, V23, P3679; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rossiter JP, 2000, NEUROPATH APPL NEURO, V26, P342, DOI 10.1046/j.1365-2990.2000.00252.x; SAJI M, 2002, SOC NEUR M; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024; Shoop RD, 2000, J NEUROSCI, V20, P4021; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stein TD, 2002, J NEUROSCI, V22, P7380; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Taouis M, 2002, AM J PHYSIOL-ENDOC M, V282, pE664, DOI 10.1152/ajpendo.00320.2001; Taubes G, 2003, SCIENCE, V301, P40, DOI 10.1126/science.301.5629.40; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yang FS, 1998, AM J PATHOL, V152, P379; Yavin E, 2002, NUTR NEUROSCI, V5, P149, DOI 10.1080/10284150290003159; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zubenko GS, 1999, BIOL PSYCHIAT, V45, P731, DOI 10.1016/S0006-3223(98)00073-0	81	566	604	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					633	645		10.1016/j.neuron.2004.08.013	http://dx.doi.org/10.1016/j.neuron.2004.08.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339646	Green Accepted, Bronze			2022-12-28	WOS:000223691900010
J	Lu, W; Constantine-Paton, M				Lu, W; Constantine-Paton, M			Eye opening rapidly induces synaptic potentiation and refinement	NEURON			English	Article							LONG-TERM POTENTIATION; NMDA-RECEPTOR; SUPERIOR COLLICULUS; VISUAL-CORTEX; POSTSYNAPTIC DENSITY; HIPPOCAMPAL SYNAPSES; SUBUNIT COMPOSITION; RAT-BRAIN; IN-VIVO; EXPERIENCE	NMDA receptor (NMDAR)-mediated increases in AMPA receptor (AMPAR) currents are associated with long-term synaptic potentiation (LTP). Here, we provide evidence that similar changes occur in response to normal increases in sensory stimulation during development. Experiments discriminated between eye opening-induced and age-dependent changes in synaptic currents. At 6 hr after eye opening (AEO), a transient population of currents mediated by NR2B-rich NMDARs increase significantly, and silent synapses peak. Sustained increases in evoked and miniature AMPAR currents occur at 12 hr AEO. Significant changes in AMPAR:NMDAR evoked current ratios, contacts per axon, and inputs per cell are present at 24 hr AEO. The AMPAR current changes are those seen in vitro during NMDAR-dependent LTP. Here, they are a consequence of eye opening and are associated with a new wave of synaptic refinement. These data also suggest that new NR2B-rich NMDAR currents precede and may initiate this developmental synaptic potentiation and functional tuning.	MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Constantine-Paton, M (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol, Cambridge, MA 02139 USA.	mcpaton@mit.edu			NEI NIH HHS [EY014074] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014074] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bansal A, 2000, J NEUROSCI, V20, P7672; BEAR MF, 1990, J NEUROSCI, V10, P909; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Binns KE, 1997, DEV BRAIN RES, V99, P263, DOI 10.1016/S0165-3806(97)00004-7; Binns KE, 1998, EXP BRAIN RES, V120, P335, DOI 10.1007/s002210050407; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Hohnke CD, 2000, J NEUROSCI, V20, P8051; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Komiyama NH, 2002, J NEUROSCI, V22, P9721; LANGER TP, 1974, J COMP NEUROL, V158, P405, DOI 10.1002/cne.901580404; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; LUND RD, 1972, INVEST OPHTH VISUAL, V11, P434; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Purves, 1985, PRINCIPLES NEURAL DE; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rodieck R.W., 1998, 1 STEPS SEEING; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Savidge JR, 1999, NEUROPHARMACOLOGY, V38, P375, DOI 10.1016/S0028-3908(98)00202-0; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Shi J, 1997, J NEUROSCI, V17, P6264; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stein V, 2003, J NEUROSCI, V23, P5503; THONG IG, 1986, DEV BRAIN RES, V25, P227, DOI 10.1016/0165-3806(86)90212-9; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tovar KR, 1999, J NEUROSCI, V19, P4180; TOWNSEND M, 2003, P NATL ACAD SCI USA, V89, P10593; VANZUNDERT B, 2004, IN PRESS TRENDS NEUR; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	60	74	76	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					237	249		10.1016/j.neuron.2004.06.031	http://dx.doi.org/10.1016/j.neuron.2004.06.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260959	Bronze			2022-12-28	WOS:000222905400012
J	Barker, PA				Barker, PA			p75NTR is positively promiscuous: Novel partners and new insights	NEURON			English	Editorial Material							MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; NEUROTROPHIN RECEPTOR; NERVOUS-SYSTEM; NOGO RECEPTOR; SORTILIN; PROTEIN; RHO; REGENERATION; APOPTOSIS	Although identified almost 20 years ago, the precise physiological role of the p75 neurotrophin receptor (p75NTR) has remained elusive. Recent studies have revealed that p75NTR is a component of three distinct receptor platforms that bind different ligands and that, under differing circumstances, facilitate cell survival, cell death, or growth inhibition. These recent developments provide new insights into the functions of this enigmatic receptor.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ Ave, Montreal, PQ H3A 2B4, Canada.							Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Fainzilber M, 1996, SCIENCE, V274, P1540, DOI 10.1126/science.274.5292.1540; Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2; HARRINGTON AW, 2004, IN PRESS P NATL ACAD; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Murray SS, 2004, J NEUROSCI, V24, P2742, DOI 10.1523/JNEUROSCI.3960-03.2004; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004; Shonukan T, 2003, ONCOGENE, V22, P3616, DOI 10.1038/sj.onc.1206561; Song XY, 2004, J NEUROSCI, V24, P542, DOI 10.1523/JNEUROSCI.4281-03.2004; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	26	250	267	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					529	533		10.1016/j.neuron.2004.04.001	http://dx.doi.org/10.1016/j.neuron.2004.04.001			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157416	Bronze			2022-12-28	WOS:000221708300005
J	Gottfried, JA; Smith, APR; Rugg, MD; Dolan, RJ				Gottfried, JA; Smith, APR; Rugg, MD; Dolan, RJ			Remembrance of odors past: Human olfactory cortex in cross-modal recognition memory	NEURON			English	Article							ORBITOFRONTAL CORTEX; EPISODIC MEMORY; BRAIN ACTIVITY; HIPPOCAMPAL; RETRIEVAL; AMYGDALA; FMRI; REPRESENTATIONS; LOCALIZATION; ORGANIZATION	Episodic memory is often imbued with multisensory richness, such that the recall of an event can be endowed with the sights, sounds, and smells of its prior occurrence. While hippocampus and related medial temporal structures are implicated in episodic memory retrieval, the participation of sensory-specific cortex in representing the qualities of an episode is less well established. We combined functional magnetic resonance imaging (fMRI) with a cross-modal paradigm, where objects were presented with odors during memory encoding. We then examined the effect of odor context on neural responses at retrieval when these same objects were presented alone. Primary olfactory (piriform) cortex, as well as anterior hippocampus, was activated during the successful retrieval of old (compared to new) objects. Our findings indicate that sensory features of the original engram are preserved in unimodal olfactory cortex. We suggest that reactivation of memory traces distributed across modality-specific brain areas underpins the sensory qualities of episodic memories.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Univ Calif Irvine, Ctr Neurobiol Learning & Mem, Irvine, CA 92697 USA	University of London; University College London; University of London; University College London; University of California System; University of California Irvine	Gottfried, JA (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	j.gottfried@fil.ion.ucl.ac.uk	Ying, Hua/D-8724-2012; Smith-Collins, Adam/C-6946-2009	Smith-Collins, Adam/0000-0002-5620-6169; Dolan, Ray/0000-0001-9356-761X				Alvarez P, 2001, LEARN MEMORY, V8, P79, DOI 10.1101/lm.38201; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 1983, CANADIAN PSYCHOL; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Buckley MJ, 1998, NEUROPSYCHOLOGIA, V36, P535, DOI 10.1016/S0028-3932(97)00120-6; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Cohen NJ, 1997, MEMORY, V5, P131, DOI 10.1080/741941149; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Elmes DG, 1998, CHEM SENSES, V23, P443, DOI 10.1093/chemse/23.4.443; Erk S, 2003, NEUROIMAGE, V18, P439, DOI 10.1016/S1053-8119(02)00015-0; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Henson RNA, 1999, J NEUROSCI, V19, P3962; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; Maratos EJ, 2001, J COGNITIVE NEUROSCI, V13, P877, DOI 10.1162/089892901753165809; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mayes AR, 1999, BEHAV BRAIN SCI, V22, P460, DOI 10.1017/S0140525X99372034; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; RAUSCH R, 1977, CORTEX, V13, P445, DOI 10.1016/S0010-9452(77)80024-5; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Saar D, 1999, J NEUROSCI, V19, P8616; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith APR, 2004, J COGNITIVE NEUROSCI, V16, P760, DOI 10.1162/089892904970816; SMITH APR, 2004, IN PRESS NEUROIMAGE; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Stark CEL, 2000, HIPPOCAMPUS, V10, P329, DOI 10.1002/1098-1063(2000)10:3<329::AID-HIPO13>3.0.CO;2-Z; Stark CEL, 2001, LEARN MEMORY, V8, P190, DOI 10.1101/lm.40701; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	59	172	173	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					687	695		10.1016/S0896-6273(04)00270-3	http://dx.doi.org/10.1016/S0896-6273(04)00270-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157428	Bronze			2022-12-28	WOS:000221708300017
J	Peng, CH; Rich, ED; Varnum, MD				Peng, CH; Rich, ED; Varnum, MD			Subunit configuration of heteromeric cone cyclic nucleotide-gated channels	NEURON			English	Article							ION CHANNELS; FUNCTIONAL EXPRESSION; RETINAL ROD; PHOTORECEPTOR CELLS; MOLECULAR-CLONING; OLFACTORY NEURONS; CATION CHANNEL; BETA-SUBUNIT; STOICHIOMETRY; ADAPTATION	Cone photoreceptor cyclic nucleotide-gated (CNG) channels are thought to be tetrameric assemblies of CNGB3 (B3) and CNGA3 (A3) subunits. We have used functional and biochemical approaches to investigate the stoichiometry and arrangement of these subunits in recombinant channels. First, tandem dimers of linked subunits were used to constrain the order of CNGB3 and CNGA3 subunits; the properties of channels formed by B3/B3 + A3/A3 dimers, or A3/B3 + B3/ A3 dimers, closely resembled those of channels arising from B3 + A3 monomers. Functional markers in B3/ B3 (or A3/A3) dimers confirmed that both B3 subunits (and both A3 subunits) gained membership into the pore-forming tetramer and that like subunits were positioned adjacent to each other. Second, chemical crosslinking and co-immunoprecipitation studies using epitope-tagged monomer subunits both demonstrated the presence of two CNGB3 subunits in cone channels. Together, these data support a preferred subunit arrangement for cone CNG channels (B3-B3-A3-A3) that is distinct from the 3A:1B configuration of rod channels.	Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Varnum, MD (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, POB 646520, Pullman, WA 99164 USA.	varnum@wsu.edu			NEI NIH HHS [EY 12836] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012836] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAUER PJ, 1992, J PHYSIOL-LONDON, V451, P109, DOI 10.1113/jphysiol.1992.sp019156; Bonigk W, 1999, J NEUROSCI, V19, P5332; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Gerstner A, 2000, J NEUROSCI, V20, P1324; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Hackos DH, 1997, J GEN PHYSIOL, V110, P515, DOI 10.1085/jgp.110.5.515; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Miller James L., 1994, Current Opinion in Neurobiology, V4, P488, DOI 10.1016/0959-4388(94)90048-5; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Peng CH, 2003, J BIOL CHEM, V278, P34533, DOI 10.1074/jbc.M305102200; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; PICONES A, 1995, BIOPHYS J, V69, P120, DOI 10.1016/S0006-3495(95)79881-2; PICONES A, 1992, J GEN PHYSIOL, V100, P647, DOI 10.1085/jgp.100.4.647; Rebrik TI, 2004, J GEN PHYSIOL, V123, P63, DOI 10.1085/jgp.200308952; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Shapiro MS, 2000, BIOPHYS J, V78, P2307, DOI 10.1016/S0006-3495(00)76777-4; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V14, P407, DOI 10.1016/0896-6273(95)90296-1; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WP, 1996, FEBS LETT, V393, P211, DOI 10.1016/0014-5793(96)00889-7; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	62	96	106	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					401	410		10.1016/S0896-6273(04)00225-9	http://dx.doi.org/10.1016/S0896-6273(04)00225-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134637	Bronze			2022-12-28	WOS:000221458700007
J	Born, RT				Born, RT			Taking strategies to task	NEURON			English	Editorial Material							PERCEPTION; DEPTH; AREA; MT	In this issue of Neuron, Uka and DeAngelis report a neural signature of the strategy that monkeys' brains developed to solve a visual discrimination task by training them on one version of the task and testing them on another. Extensive training on one version caused decision networks in the animals' brains to ignore certain classes of neurons whose signals would have been useful on the modified version of the task used to test them.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Born, RT (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X				Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515	7	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 22	2004	42	2					185	187		10.1016/S0896-6273(04)00220-X	http://dx.doi.org/10.1016/S0896-6273(04)00220-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091334	Bronze			2022-12-28	WOS:000221458500003
J	Zhang, C; Xiong, W; Zheng, H; Wang, LC; Lu, B; Zhou, Z				Zhang, C; Xiong, W; Zheng, H; Wang, LC; Lu, B; Zhou, Z			Calcium- and dynamin-independent endocytosis in dorsal root ganglion neurons	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; TEMPERATURE-SENSITIVE MUTANT; SYNAPTIC VESICLE ENDOCYTOSIS; TRANSMITTER RELEASE; RECEPTOR INTERNALIZATION; DROSOPHILA-MELANOGASTER; HIPPOCAMPAL SYNAPSES; REVERSIBLE BLOCKAGE; NEUROTROPHIC FACTOR; MEMBRANE RETRIEVAL	Synaptic vesicle endocytosis is believed to require calcium and the GTPase dynamin. We now report a form of rapid endocytosis (RE) in dorsal root ganglion (DRG) neurons that, unlike previously described forms of endocytosis, is independent of calcium and dynamin. The RE is tightly coupled to calcium-independent but voltage-dependent secretion (CIVDS). Using FM dye and capacitance measurements, we show that membrane depolarization induces RE in the absence of calcium. Inhibition of dynamin function does not affect RE. The magnitude of RE is proportional to that of preceding CIVDS and stimulation frequency. Inhibitors of protein kinase A (PKA) suppress RE induced by high-frequency depolarization, while PKA activators enhance RE induced by low-frequency depolarization. Biochemical experiments demonstrate that depolarization directly upregulates PKA activity in calcium-free medium. These results reveal a calcium- and dynamin-independent form of endocytosis, which is controlled by neuronal activity and PKA-dependent phosphorylation, in DRG neurons.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; NICHHD, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zhou, Z (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	zzhou@ion.ac.cn	zhou, zhuan/A-8285-2011; zheng, Hui/I-3573-2013; Xiong, Wei/AAY-5944-2020; Xiong, Wei/A-6170-2012; Wang, Shirong/G-1698-2011	zheng, Hui/0000-0002-2504-9092; Xiong, Wei/0000-0002-2784-7696; Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Amir R, 1997, J PHYSIOL-LONDON, V501, P183, DOI 10.1111/j.1469-7793.1997.183bo.x; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; Chan SA, 2003, PFLUG ARCH EUR J PHY, V445, P540, DOI 10.1007/s00424-002-0966-y; Cooper DMF, 1998, J BIOL CHEM, V273, P27703, DOI 10.1074/jbc.273.42.27703; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pu L, 2002, J NEUROSCI, V22, P1914, DOI 10.1523/JNEUROSCI.22-05-01914.2002; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; VIEIRA AV, 1996, SCIENCE, V274, P86; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wang CY, 2002, J BIOL CHEM, V277, P10614, DOI 10.1074/jbc.M106116200; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	51	43	44	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					225	236		10.1016/S0896-6273(04)00189-8	http://dx.doi.org/10.1016/S0896-6273(04)00189-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091339	Bronze			2022-12-28	WOS:000221458500008
J	Watt, WC; Sakano, H; Lee, ZY; Reusch, JE; Trinh, K; Storm, DR				Watt, WC; Sakano, H; Lee, ZY; Reusch, JE; Trinh, K; Storm, DR			Odorant stimulation enhances survival of olfactory sensory neurons via MAPK and CREB	NEURON			English	Article							ELEMENT-BINDING PROTEIN; CELL-DEATH; RECEPTOR; KINASE; PHOSPHORYLATION; TRANSCRIPTION; GENE; BULB; INDUCTION; CYCLASE	Olfactory sensory neurons (OSNs) can be sensitized to odorants by repeated exposure, suggesting that an animal's responsiveness to olfactory cues can be enhanced at the initial stage of detection. However, because OSNs undergo a regular cycle of apoptosis and replacement by ostensibly naive, precursor-derived neurons, the advantage of sensitization would be lost in the absence of a mechanism for odorant-enhanced survival of OSNs. Using recombinant adenoviruses in conjunction with surgical and electrophysiological techniques, we monitored OSN survival and function in vivo and find that odorant exposure selectively rescues populations of OSNs from apoptosis. We further demonstrate that odorant stimuli rescue OSNs in a cAMP-dependent manner by activating the MAPK/CREB-dependent transcriptional pathway, possibly as a result of expression of Bcl-2.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Med Genet, Seattle, WA 98195 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Cardiovasc Pulm Res Sect, Denver, CO 80220 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu		Sakano, Hitomi/0000-0002-7471-8352; Reusch, Jane/0000-0001-8620-1003	NIDCD NIH HHS [DC04156, R01 DC004156-09] Funding Source: Medline; NIGMS NIH HHS [GM07270] Funding Source: Medline; NINDS NIH HHS [R01 NS020498-25, NS357056] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BOOTH WD, 1981, Q J EXP PHYSIOL CMS, V66, P533, DOI 10.1113/expphysiol.1981.sp002594; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Dittman AH, 1997, NEURON, V19, P381, DOI 10.1016/S0896-6273(00)80947-2; Fiske BK, 2001, J NEUROBIOL, V47, P223, DOI 10.1002/neu.1029; Fiske BK, 2001, J COMP NEUROL, V431, P311; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Jourdan F, 1998, NEUROREPORT, V9, P921, DOI 10.1097/00001756-199803300-00029; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MICHEL D, 1994, NEUROREPORT, V5, P1329, DOI 10.1097/00001756-199406000-00009; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moon C, 1999, P NATL ACAD SCI USA, V96, P14605, DOI 10.1073/pnas.96.25.14605; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; RONNETT GV, 1991, P NATL ACAD SCI USA, V88, P2366, DOI 10.1073/pnas.88.6.2366; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Watt WC, 2001, J BIOL CHEM, V276, P2047, DOI 10.1074/jbc.M006703200; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	35	95	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					955	967		10.1016/S0896-6273(04)00075-3	http://dx.doi.org/10.1016/S0896-6273(04)00075-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046727	Bronze			2022-12-28	WOS:000221458300014
J	Schuske, KR; Richmond, JE; Matthies, DS; Davis, WS; Runz, S; Rube, DA; van der Bliek, AM; Jorgensen, EM				Schuske, KR; Richmond, JE; Matthies, DS; Davis, WS; Runz, S; Rube, DA; van der Bliek, AM; Jorgensen, EM			Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin	NEURON			English	Article							BINDING PARTNERS; SH3 DOMAIN; IDENTIFICATION; MEMBRANE; DYNAMIN; AMPHIPHYSIN; MUTATIONS; PROTEINS; DISTINCT; HOMOLOG	Endophilin is a membrane-associated protein required for endocytosis of synaptic vesicles. Two models have been proposed for endophilin: that it alters lipid composition in order to shape membranes during endocytosis, or that it binds the polyphosphoinositide phosphatase synaptojanin and recruits this phosphatase to membranes. In this study, we demonstrate that the unc-57 gene encodes the Caenorhabditis elegans ortholog of endophilin A. We demonstrate that endophilin is required in C. elegans for synaptic vesicle recycling. Furthermore, the defects observed in endophilin mutants closely resemble those observed in synaptojanin mutants. The electrophysiological phenotype of endophilin and synaptojanin double mutants are virtually identical to the single mutants, demonstrating that endophilin and synaptojanin function in the same pathway. Finally, endophilin is required to stabilize expression of synaptojanin at the synapse. These data suggest that endophilin is an adaptor protein required to localize and stabilize synaptojanin at membranes during synaptic vesicle recycling.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60606 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58166, T32-GM07104] Funding Source: Medline; NINDS NIH HHS [R01 NS041477-01A1, R01 NS041477-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balguerie A, 1999, J CELL SCI, V112, P2529; Bamber BA, 1999, J NEUROSCI, V19, P5348; CLARK SG, 1994, GENETICS, V137, P987; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; De Camilli P, 2001, SYNAPSES, P217; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Harris TW, 2001, TRAFFIC, V2, P597, DOI 10.1034/j.1600-0854.2001.002009597.x; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yook KJ, 2001, GENETICS, V158, P209	38	199	209	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					749	762		10.1016/S0896-6273(03)00667-6	http://dx.doi.org/10.1016/S0896-6273(03)00667-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622579	Bronze			2022-12-28	WOS:000186651200010
J	Etkin, A; Klemenhagen, KC; Dudman, JT; Rogan, MT; Hen, R; Kandel, ER; Hirsch, J				Etkin, A; Klemenhagen, KC; Dudman, JT; Rogan, MT; Hen, R; Kandel, ER; Hirsch, J			Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces	NEURON			English	Article							EMOTIONAL FACIAL EXPRESSIONS; PREFRONTAL CORTEX; BENZODIAZEPINE RECEPTORS; SPATIAL ATTENTION; FUNCTIONAL MRI; VISUAL-CORTEX; AREA V4; ACTIVATION; FMRI; PERCEPTION	Responses to threat-related stimuli are influenced by conscious and unconscious processes, but the neural systems underlying these processes and their relationship to anxiety have not been clearly delineated. Using fMRI, we investigated the neural responses associated with the conscious and unconscious (backwardly masked) perception of fearful faces in healthy volunteers who varied in threat sensitivity (Spielberger trait anxiety scale). Unconscious processing modulated activity only in the basolateral subregion of the amygdala, while conscious processing modulated activity only in the dorsal amygdala (containing the central nucleus). Whereas activation of the dorsal amygdala by conscious stimuli was consistent across subjects and independent of trait anxiety, activity in the basolateral amygdala to unconscious stimuli, and subjects' reaction times, were predicted by individual differences in trait anxiety. These findings provide a biological basis for the unconscious emotional vigilance characteristic of anxiety and a means for investigating the mechanisms and efficacy of treatments for anxiety.	Columbia Univ, Med Ctr, fMRI Res Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Kavli Inst Brain Sci, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Dept Radiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, fMRI Res Ctr, Dept Psychol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Etkin, A (corresponding author), Columbia Univ, Med Ctr, fMRI Res Ctr, Ctr Neurobiol & Behav, 170 W 168th St,Box 108, New York, NY 10032 USA.	ae157@columbia.edu; jh2155@columbia.edu	Etkin, Amit/ABD-5761-2021	Hirsch, Joy/0000-0002-1418-6489; Dudman, Joshua/0000-0002-4436-1057	NICHD NIH HHS [HD 07430] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; AMARAL D G, 1992, P1; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Brewin CR, 1996, ANNU REV PSYCHOL, V47, P33, DOI 10.1146/annurev.psych.47.1.33; CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Di Russo F, 1999, NEUROREPORT, V10, P2755; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman P., 1976, PICTURES FACIAL AFFE; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; First M. D., 1996, USERS GUIDE STRUCTUR; Fisher PL, 1999, PSYCHOL MED, V29, P1425, DOI 10.1017/S0033291799001336; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gabbard GO, 2003, INT J PSYCHOANAL, V84, P823, DOI 10.1516/N4T0-4D5G-NNPL-H7NL; Gabbard GO, 2000, BRIT J PSYCHIAT, V177, P117, DOI 10.1192/bjp.177.2.117; GABBARD GO, 2000, BASIC PRINCIPLES DYN; Green DM, 1966, SIGNAL DETECTION THE; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; JAPEE S, 2004, 10 ANN M ORG HUM BRA; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macovski A, 1996, MAGNET RESON MED, V36, P494, DOI 10.1002/mrm.1910360327; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Merboldt KD, 2001, NEUROIMAGE, V14, P253, DOI 10.1006/nimg.2001.0802; MERIKLE PM, 1992, AM PSYCHOL, V47, P792, DOI 10.1037/0003-066X.47.6.792; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MOTTER BC, 1994, J NEUROSCI, V14, P2178; NIEHOFF DL, 1983, BRAIN RES, V276, P237, DOI 10.1016/0006-8993(83)90730-8; NIEHOFF DL, 1983, J NEUROSCI, V3, P2091; Paxinos G., 1990, HUMAN NERVOUS SYSTEM; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2003, J NEUROSCI, V23, P3990; PESSOA L, 2005, IN PRESS CURR OPIN N; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Pierce C.S., 1884, MEMOIRS NATL ACAD SC, V3, P73; Pitkanen A., 2000, CONNECTIVITY RAT AMY; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rousseeuw P.J., 2003, REGRESSION OUTLIER D; Shevrin H., 1996, CONSCIOUS UNCONSCIOU; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Snodgrass M, 2004, PERCEPT PSYCHOPHYS, V66, P846, DOI 10.3758/BF03194978; Spielberger CD, 1970, MANUAL STATE TRAIT A; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wong PS, 1999, J AM PSYCHOANAL ASS, V47, P817, DOI 10.1177/00030651990470031901; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	67	461	478	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					1043	1055		10.1016/j.neuron.2004.12.006	http://dx.doi.org/10.1016/j.neuron.2004.12.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603746	Bronze, Green Published			2022-12-28	WOS:000225842300017
J	Shen, J				Shen, J			Protein kinases linked to the pathogenesis of Parkinson's disease	NEURON			English	Editorial Material							GENOME	Two papers (by Paisan-Ruiz et al. and by Zimprich et al.) in this issue of Neuron identify a causative gene, LRRK2, for familial parkinsonism. Several dominantly inherited missense mutations have been identified in a number of families that exhibit a broad spectrum of neuropathological features, including deposition of alpha-synuclein and tau proteins. The LRRK2 gene is predicted to encode a large protein containing leucine-rich repeats and Ras/GTPase, tyrosine kinase-like, and WD40 domains.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shen, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.							Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gwinn-Hardy K, 2002, MOVEMENT DISORD, V17, P645, DOI 10.1002/mds.10173; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	12	38	43	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 18	2004	44	4					575	577		10.1016/j.neuron.2004.11.008	http://dx.doi.org/10.1016/j.neuron.2004.11.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541303	Bronze			2022-12-28	WOS:000225338100001
J	Ducommun, CY; Michel, CM; Clarke, S; Adriani, M; Seeck, M; Landis, T; Blanke, O				Ducommun, CY; Michel, CM; Clarke, S; Adriani, M; Seeck, M; Landis, T; Blanke, O			Cortical motion deafness	NEURON			English	Article							MONKEY AUDITORY-CORTEX; HUMAN CEREBRAL-CORTEX; SOUND MOVEMENT; RIGHT-HEMISPHERE; BRAIN-DAMAGE; ELECTRICAL-STIMULATION; SPATIAL LOCALIZATION; HORIZONTAL PLANE; VISUAL-CORTEX; LESIONS	The extent to which the auditory system, like the visual system, processes spatial stimulus characteristics such as location and motion in separate specialized neuronal modules or in one homogenously distributed network is unresolved. Here we present a patient with a selective deficit for the perception and discrimination of auditory motion following resection of the right anterior temporal lobe and the right posterior superior temporal gyrus (STG). Analysis of stimulus identity and location within the auditory scene remained intact. In addition, intracranial auditory evoked potentials, recorded preoperatively, revealed motion-specific responses selectively over the resected right posterior STG, and electrical cortical stimulation of this region was experienced by the patient as incoming moving sounds. Collectively, these data present a patient with cortical motion deafness, providing evidence that cortical processing of auditory motion is performed in a specialized module within the posterior STG.	Univ Hosp Geneva, Funct Brain Mapping Lab, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Presurg Epilepsy Unit, CH-1211 Geneva, Switzerland; Univ Lausanne Hosp, Neuropsychol Div, CH-1011 Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ducommun, CY (corresponding author), Univ Hosp Geneva, Funct Brain Mapping Lab, CH-1211 Geneva, Switzerland.	christine.ducommun@hcuge.ch	Clarke, Stephanie/A-2845-2009	Clarke, Stephanie/0000-0001-9393-5718; Michel, Christoph/0000-0003-3426-5739				Adriani M, 2003, EXP BRAIN RES, V153, P591, DOI 10.1007/s00221-003-1616-0; AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; ALTMAN JA, 1987, NEUROPSYCHOLOGIA, V25, P435, DOI 10.1016/0028-3932(87)90031-5; ALTMAN JA, 1986, HEARING RES, V24, P243, DOI 10.1016/0378-5955(86)90023-7; ALTMAN JA, 1979, NEUROPSYCHOLOGIA, V17, P295, DOI 10.1016/0028-3932(79)90075-7; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; BARTON JJS, 1995, ANN NEUROL, V37, P665, DOI 10.1002/ana.410370517; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; BELLMANN A, 1998, SWISS ARCH NEUROLOGY, V149, P80; BISIACH E, 1984, BRAIN, V107, P37, DOI 10.1093/brain/107.1.37; Blanke O, 1999, NEUROREPORT, V10, P925, DOI 10.1097/00001756-199904060-00006; Blanke O, 2000, EPILEPSY BEHAV, V1, P356, DOI 10.1006/ebeh.2000.0109; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Ducommun CY, 2002, NEUROIMAGE, V16, P76, DOI 10.1006/nimg.2002.1062; GIRVIN JP, 1979, SENS PROCESS, V3, P66; GRANTHAM DW, 1986, J ACOUST SOC AM, V79, P1939, DOI 10.1121/1.393201; Grantham DW, 1998, ACUSTICA, V84, P337; Griffiths TD, 1997, J NEUROL NEUROSUR PS, V62, P522, DOI 10.1136/jnnp.62.5.522; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; GRIFFITHS TD, 1994, CURR BIOL, V4, P892, DOI 10.1016/S0960-9822(00)00198-6; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; Jiang H, 2000, HEARING RES, V139, P69, DOI 10.1016/S0378-5955(99)00176-8; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kaiser J, 2000, J NEUROSCI, V20, P6631, DOI 10.1523/JNEUROSCI.20-17-06631.2000; Lessard N, 1999, BEHAV BRAIN RES, V104, P37, DOI 10.1016/S0166-4328(99)00048-0; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MULLAN S, 1959, AMA ARCH NEUROL PSYC, V8, P1269; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; PAAVILAINEN P, 1989, ELECTROEN CLIN NEURO, V73, P129, DOI 10.1016/0013-4694(89)90192-2; Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0; Perrott D.R., 1997, BINAURAL SPATIAL HEA, P275; PERROTT DR, 1989, J ACOUST SOC AM, V85, P1773, DOI 10.1121/1.397968; POIRIER P, 1994, NEUROPSYCHOLOGIA, V32, P541, DOI 10.1016/0028-3932(94)90143-0; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romansk LM, 2000, NAT NEUROSCI, V3, P966, DOI 10.1038/79892; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; SHU ZJ, 1993, NATURE, V364, P721, DOI 10.1038/364721a0; Thiran AB, 2003, NEUROPSYCHOLOGIA, V41, P1254, DOI 10.1016/S0028-3932(03)00014-9; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; TORONCHUK JM, 1992, EXP BRAIN RES, V88, P169, DOI 10.1007/BF02259138; Vaina LM, 2001, BRAIN, V124, P310, DOI 10.1093/brain/124.2.310; Wade NJ, 1996, VISION RES, V36, P2167, DOI 10.1016/0042-6989(95)00266-9; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Xiang J, 2002, CLIN NEUROPHYSIOL, V113, P1, DOI 10.1016/S1388-2457(01)00709-X; Yabe H, 1999, EEG CL N SU, P166; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; ZEKI S, 1991, BRAIN, V114, P811, DOI 10.1093/brain/114.2.811; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	58	34	34	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					765	777		10.1016/j.neuron.2004.08.020	http://dx.doi.org/10.1016/j.neuron.2004.08.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363389	Bronze, Green Published			2022-12-28	WOS:000223992000004
J	Wen, ZX; Guirland, C; Ming, GL; Zheng, JQ				Wen, ZX; Guirland, C; Ming, GL; Zheng, JQ			A CaMKII/calcineurin switch controls the direction of Ca2+-dependent growth cone guidance	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; LONG-TERM POTENTIATION; NERVE GROWTH; KINASE-II; ADENYLYL-CYCLASE; TAU-FACTOR; CALCIUM; CALCINEURIN; ATTRACTION; ACTIVATION	Axon pathfinding depends on attractive and repulsive turning of growth cones to extracellular cues. Localized cytosolic Ca2+ signals are known to mediate the bidirectional responses, but downstream mechanisms remain elusive. Here, we report that calcium-calmodulin-dependent protein kinase II (CaMKII) and calcineurin (CaN) phosphatase provide a switch-like mechanism to control the direction of Ca2+-dependent growth cone turning. A relatively large local Ca2+ elevation preferentially activates CaMKII to induce attraction, while a modest local Ca2+ signal predominately acts through CaN and phosphatase-1 (PP1) to produce repulsion. The resting level of intracellular Call concentrations also affects CaMKII/CaN operation: a normal baseline allows distinct turning responses to different local Ca2+ signals, while a low baseline favors CaN-PP1 activation for repulsion. Moreover, the CAMP pathway negatively regulates CaN-PP1 signaling to inhibit repulsion. Finally, CaMKII/CaN-PP1 also mediates netrin-1 guidance. Together, these findings establish a complex Ca2+ mechanism that targets the balance of CaMKII/CaN-PP1 activation to control distinct growth cone responses.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol, Baltimore, MD 21205 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University	Zheng, JQ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	james.zheng@umdnj.edu	Ming, Guo-li/J-7880-2013; Wen, Zhexing/L-1228-2018; Wen, Zhexing/B-9313-2014	Wen, Zhexing/0000-0002-1518-3845; Ming, Guo-li/0000-0002-2517-6075				BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; Buck KB, 2002, J NEUROSCI, V22, P9358; Chang C, 2004, SCIENCE, V305, P103, DOI 10.1126/science.1096983; CHANG HY, 1995, NATURE, V376, P686, DOI 10.1038/376686a0; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2003, J NEUROSCI, V23, P2274; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Isaac J, 2001, NEURON, V32, P963, DOI 10.1016/S0896-6273(01)00545-1; ISHIDA A, 1995, J BIOL CHEM, V270, P2163, DOI 10.1074/jbc.270.5.2163; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Uezu A, 2002, J NEUROCHEM, V82, P585, DOI 10.1046/j.1471-4159.2002.00984.x; WALAAS SI, 1983, NATURE, V301, P69; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; YAMAMOTO H, 1985, J NEUROCHEM, V44, P759, DOI 10.1111/j.1471-4159.1985.tb12880.x; YOVELL Y, 1992, J NEUROCHEM, V59, P1736, DOI 10.1111/j.1471-4159.1992.tb11005.x; Zheng JQ, 1996, PERSPECT DEV NEUROBI, V4, P205; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	53	149	150	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					835	846		10.1016/j.neuron.2004.08.037	http://dx.doi.org/10.1016/j.neuron.2004.08.037			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363394	Bronze			2022-12-28	WOS:000223992000009
J	Meyer-Lindenberg, A; Kohn, P; Mervis, CB; Kippenhan, JS; Olsen, RK; Morris, CA; Berman, KF				Meyer-Lindenberg, A; Kohn, P; Mervis, CB; Kippenhan, JS; Olsen, RK; Morris, CA; Berman, KF			Neural basis of genetically determined visuospatial construction deficit in Williams syndrome	NEURON			English	Article							SYNDROME COGNITIVE PROFILE; HUMAN BRAIN; CORTEX; FACE; MRI; ABNORMALITIES; DISSOCIATION; PERCEPTION; PHENOTYPE; DELETIONS	A unique opportunity to understand genetic determinants of cognition is offered by Williams syndrome (WS), a well-characterized hemideletion on chromosome 7q11.23 that causes extreme, specific weakness in visuospatial construction (the ability to visualize an object as a set of parts or construct a replica). Using multimodal neuroimaging, we identified a neural mechanism underlying the WS visuoconstructive deficit. Hierarchical assessment of visual processing with fMRI showed isolated hypoactivation in WS in the parietal portion of the dorsal stream. In the immediately adjacent parietooccipital/intraparietat sulcus, structural neuroimaging showed a gray matter volume reduction in participants with WS. Path analysis demonstrated that the functional abnormalities could be attributed to impaired input from this structurally altered region. Our observations confirm a longstanding hypothesis about dorsal stream dysfunction in WS, demonstrate effects of a localized abnormality on visual information processing in humans, and define a systems-level phenotype for mapping genetic determinants of visuoconstructive function.	NIMH, Unit Integrat Neuroimaging, Clin Brain Disorders Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Louisville, Neurodev Sci Lab, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Meyer-Lindenberg, A (corresponding author), NIMH, Unit Integrat Neuroimaging, Clin Brain Disorders Branch, NIH,Dept Hlth & Human Serv, 10-4C101,9000 Rockville Pike, Bethesda, MD 20892 USA.	andreasml@nih.gov	; Meyer-Lindenberg, Andreas/H-1076-2011	Olsen, Rosanna/0000-0002-2918-4152; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002652, Z01MH002863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35102, R01 NS035102] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Bellugi U., 1988, LANGUAGE DEV EXCEPTI, P177; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Cammareri V, 1999, AM J MED GENET, V85, P491, DOI 10.1002/(SICI)1096-8628(19990827)85:5<491::AID-AJMG11>3.0.CO;2-Z; Danoff SK, 2004, NEUROSCIENCE, V123, P931, DOI 10.1016/j.neuroscience.2003.08.038; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Galaburda AM, 2002, ARCH NEUROL-CHICAGO, V59, P1461, DOI 10.1001/archneur.59.9.1461; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grice SJ, 2003, NEUROREPORT, V14, P1773, DOI 10.1097/00001756-200310060-00003; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Jordan H, 2002, PSYCHOL SCI, V13, P162, DOI 10.1111/1467-9280.00429; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LOWERY MC, 1995, AM J HUM GENET, V57, P49; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Mervis CB, 2000, MENT RETARD DEV D R, V6, P148; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; MISSAR CD, 1994, SCHIZOPHR RES, V12, P247, DOI 10.1016/0920-9964(94)90034-5; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Nakamura M, 2001, DEV MED CHILD NEUROL, V43, P617, DOI 10.1017/S0012162201001128; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355; Paul BM, 2002, NEUROREPORT, V13, P1115, DOI 10.1097/00001756-200207020-00009; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Schmitt JE, 2002, DEV MED CHILD NEUROL, V44, P292; Schmitt JE, 2001, ARCH NEUROL-CHICAGO, V58, P283, DOI 10.1001/archneur.58.2.283; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII	44	234	241	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					623	631		10.1016/j.neuron.2004.08.014	http://dx.doi.org/10.1016/j.neuron.2004.08.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339645	Bronze			2022-12-28	WOS:000223691900009
J	Tager-Flusberg, H				Tager-Flusberg, H			Fulfilling the promise of the cognitive Neurosciences	NEURON			English	Editorial Material							WILLIAMS-SYNDROME; LANGUAGE; FACE; MIND	The paper by Meyer-Lindenberg and colleagues in this issue of Neuron provides strong evidence that the absence of one or more genes in Williams syndrome leads to highly circumscribed pathology in the dorsal visual stream. This program of research demonstrates that neurocognitive architecture follows the same principles in typical and atypical development.	Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Boston University	Tager-Flusberg, H (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.		Tager-Flusberg, Helen B/D-5265-2009	Tager-Flusberg, Helen/0000-0002-8768-5414				Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/089892900561940; BELLUGI U, 1992, MINN SYM CHILD PSYCH, V24, P201; Grant J, 2002, J CHILD LANG, V29, P403, DOI 10.1017/S030500090200510X; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; KARMILOFFSMITH A, 1995, J COGNITIVE NEUROSCI, V7, P196, DOI 10.1162/jocn.1995.7.2.196; Laws G, 2004, INT J LANG COMM DIS, V39, P45, DOI 10.1080/13682820310001615797; Mervis CB, 1999, DEV COGN NEUROSCI, P65; Mobbs D, 2004, NEUROLOGY, V62, P2070, DOI 10.1212/01.WNL.0000129536.95274.DC; Morris CA, 1999, HANDBOOK OF NEURODEVELOPMENTAL AND GENETIC DISORDERS IN CHILDREN, P555; Pinker Steven, 1994, LANGUAGE INSTINCT; Tager-Flusberg H, 2000, COGNITION, V76, P59, DOI 10.1016/S0010-0277(00)00069-X	11	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					595	596		10.1016/j.neuron.2004.08.026	http://dx.doi.org/10.1016/j.neuron.2004.08.026			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339637	Bronze			2022-12-28	WOS:000223691900001
J	Sato, TK; Panda, S; Miraglia, LJ; Reyes, TM; Rudic, RD; McNamara, P; Naik, KA; Fitzgerald, GA; Kay, SA; Hogenesch, JB				Sato, TK; Panda, S; Miraglia, LJ; Reyes, TM; Rudic, RD; McNamara, P; Naik, KA; Fitzgerald, GA; Kay, SA; Hogenesch, JB			A functional genomics strategy reveals rora as a component of the mammalian circadian clock	NEURON			English	Article							NUCLEAR ORPHAN RECEPTOR; ALPHA-DEFICIENT MICE; GENE-EXPRESSION; TRANSCRIPTION; MOUSE; STAGGERER; OSCILLATOR; DISRUPTION; PHENOTYPE; RHYTHMS	The mammalian circadian clock plays an integral role in timing rhythmic physiology and behavior, such as locomotor activity, with anticipated daily environmental changes. The master oscillator resides within the suprachiasmatic nucleus (SCN), which can maintain circadian rhythms in the absence of synchronizing light input. Here, we describe a genomics-based approach to identify circadian activators of Bmal1, itself a key transcriptional activator that is necessary for core oscillator function. Using cell-based functional assays, as well as behavioral and molecular analyses, we identified Rora as an activator of Bmal1 transcription within the SCN. Rora is required for normal Bmal1 expression and consolidation of daily locomotor activity and is regulated by the core clock in the SCN. These results suggest that opposing activities of the orphan nuclear receptors Rora and Rev-erb alpha, which represses Bmal1 expression, are important in the maintenance of circadian clock function.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Lab Neuronal Struct, La Jolla, CA 92037 USA; Funct Salk Inst, La Jolla, CA 92037 USA; Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Phenomix Corp, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute; Scripps Research Institute; University of Pennsylvania	Hogenesch, JB (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA.	hogenesch@gnf.org	Panda, Satchidananda/J-6891-2012; Reyes, Teresa M/D-1147-2009; Kay, Steve A/F-6025-2011; FitzGerald, Garret A/A-4222-2010; Reyes, Teresa/GYI-8942-2022; Rudic, Dan/B-3432-2016	Kay, Steve A/0000-0002-0402-2878; Reyes, Teresa/0000-0003-3009-3749; Rudic, Dan/0000-0001-9122-3127				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Greiner EF, 1996, P NATL ACAD SCI USA, V93, P10105, DOI 10.1073/pnas.93.19.10105; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PITTENDR.CS, 1972, P NATL ACAD SCI USA, V69, P1537, DOI 10.1073/pnas.69.6.1537; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300	33	737	773	3	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					527	537		10.1016/j.neuron.2004.07.018	http://dx.doi.org/10.1016/j.neuron.2004.07.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312651	Bronze			2022-12-28	WOS:000223436400011
J	Shen, J; Cookson, MR				Shen, J; Cookson, MR			Mitochondria and dopamine: New insights into recessive parkinsonism	NEURON			English	Editorial Material							OXIDATIVE DAMAGE; CELL-DEATH; PROTEASOME; DISEASE; DYSFUNCTION; MUTATIONS; DJ-1; DEFICITS	Recessively inherited mutations in parkin, DJ-1, and PINK1 have recently been linked to familial forms of parkinsonism. These syndromes are often clinically indistinguishable from Parkinson's disease, as similar neuronal groups, notably dopaminergic neurons, are selectively affected. Studies of the functions of these gene products may provide insights into the pathogenic mechanisms underlying the selective degeneration of dopaminergic neurons. Emerging evidence that one or several of these genes play important roles in mitochondrial function and the dopaminergic system suggests that these events may be early steps of the pathophysiological changes of the disease. This review will summarize recent advances in our understanding of these gene products, with emphasis on the surprising convergence of their functions.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Neurosci Program,Ctr Neurol Dis, Boston, MA 02115 USA; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Neurosci Program,Ctr Neurol Dis, Boston, MA 02115 USA.	cookson@mail.nih.gov	Cookson, Mark/AAW-2516-2021	Cookson, Mark/0000-0002-1058-3831	NATIONAL INSTITUTE ON AGING [ZIAAG000953, Z01AG000953] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lorenzetti D, 2004, MAMM GENOME, V15, P210, DOI 10.1007/s00335-003-2333-5; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056	23	88	95	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					301	304		10.1016/j.neuron.2004.07.012	http://dx.doi.org/10.1016/j.neuron.2004.07.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294138	Bronze			2022-12-28	WOS:000223156900004
J	Zhou, FQ; Walzer, MA; Snider, WD				Zhou, FQ; Walzer, MA; Snider, WD			Turning on the machine: Genetic control of axon regeneration by c-jun	NEURON			English	Editorial Material							TRANSCRIPTION FACTOR; EXPRESSION; MEDIATOR; DEATH	Upregulation of the transcription factor c-Jun has been correlated with axon regeneration after injury in multiple types of neurons. In this issue of Neuron, Raivich et al. use a nervous system-specific mutant to provide genetic evidence that c-Jun is necessary for efficient axon regeneration.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Zhou, FQ (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.							Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; EFERL R, 2003, NAT REV CANCER, V3, P589; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Werner A, 2000, J NEUROSCI, V20, P1822	14	19	21	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					1	2		10.1016/j.neuron.2004.06.020	http://dx.doi.org/10.1016/j.neuron.2004.06.020			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233911	Bronze			2022-12-28	WOS:000222549800001
J	Niu, XW; Qian, X; Magleby, KL				Niu, XW; Qian, X; Magleby, KL			Linker-gating ring complex as passive spring and Ca2+-dependent machine for a voltage- and Ca2+-activated potassium channel	NEURON			English	Article							DEPENDENT ION CHANNELS; SHAKER K+ CHANNEL; BK CHANNELS; RAT MUSCLE; CALCIUM SENSITIVITY; MOLECULAR MECHANISM; CA-2&-ACTIVATED K; CAMP MODULATION; CHARGE MOVEMENT; XENOPUS-OOCYTES	Ion channels are proteins that control the flux of ions across cell membranes by opening and closing (gating) their pores. It has been proposed that channels gated by internal agonists have an intracellular gating ring that extracts free energy from agonist binding to open the gates using linkers that directly connect the gating ring to the gates. Here we find for a voltageand Ca2+-activated K+ (BK) channel that shortening the linkers increases channel activity and lengthening the linkers decreases channel activity, both in the presence and absence of intracellular Ca2+. These observations are consistent with a mechanical model in which the linker-gating ring complex forms a passive spring that applies force to the gates in the absence of Ca2+ to modulate the voltage-dependent gating. Adding Ca2+ then changes the force to further activate the channel. Both the passive and Ca2+-induced forces contribute to the gating of the channel.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA	University of Miami	Magleby, KL (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, POB 016430, Miami, FL 33101 USA.	kmagleby@miami.edu			NIAMS NIH HHS [R01AR32805] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032805] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; ARMSTRONG CM, 2003, SCI STKE, V188, pRE10, DOI DOI 10.1126/STKE.2003.188.RE10; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Brejc K, 2002, NOVART FDN SYMP, V245, P22; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Diaz L, 1998, J BIOL CHEM, V273, P32430, DOI 10.1074/jbc.273.49.32430; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fisher TE, 2000, NEURON, V27, P435, DOI 10.1016/S0896-6273(00)00055-6; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Howard J., 2001, MECH MOTOR PROTEINS; Hu L, 2003, P NATL ACAD SCI USA, V100, P10488, DOI 10.1073/pnas.1834300100; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Larsson HP, 2002, J GEN PHYSIOL, V120, P475, DOI 10.1085/jgp.20028657; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Meera P, 1996, FEBS LETT, V385, P127; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Nimigean CM, 2000, J GEN PHYSIOL, V115, P719, DOI 10.1085/jgp.115.6.719; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Patlak JB, 1999, J GEN PHYSIOL, V113, P385, DOI 10.1085/jgp.113.3.385; Piskorowski R, 2002, NATURE, V420, P499, DOI 10.1038/nature01199; Qian X, 2003, P NATL ACAD SCI USA, V100, P10061, DOI 10.1073/pnas.1731650100; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; SUKHAREV S, 2004, SCI STKE, V219, pRE4; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zagotta WN, 1996, J BIOENERG BIOMEMBR, V28, P269, DOI 10.1007/BF02110700; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhang B, 2001, BIOPHYS J, V80, P597, DOI 10.1016/S0006-3495(01)76040-7	80	129	134	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					745	756		10.1016/j.neuron.2004.05.001	http://dx.doi.org/10.1016/j.neuron.2004.05.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182715	Bronze			2022-12-28	WOS:000221975000007
J	Hashimoto, R; Sakai, KL				Hashimoto, R; Sakai, KL			Learning letters in adulthood: Direct visualization of cortical plasticity for forming a new link between orthography and phonology	NEURON			English	Article							HUMAN COLOR-CENTER; DEVELOPMENTAL DYSLEXIA; FUNCTIONAL CONNECTIVITY; NEURAL MECHANISMS; VISUAL-CORTEX; ANGULAR GYRUS; BRAIN; WORD; SLEEP; ACTIVATION	To identify which brain regions in adults show plasticity for learning letters, Hangul letters were experimentally associated with either speech sounds (HS condition) or nonspeech sounds (HN condition) in fMRI sessions over two consecutive days. Selective activations under the HS condition were found in several regions including the left posterior inferior temporal gyrus (PITG) and the parieto-occipital cortex (PO), as compared with activations under a condition for familiar letters and speech sounds, and with those under the HN condition. The left PITG showed a selective activation increase under the HS condition over two days, the degree of which predicted individual performance improvement. Further, functional connectivity between the left PITG and the left PO was selectively enhanced under the HS condition. These results demonstrate that a new link between orthography and phonology is formed by the plasticity of a functional system involving the left PITG in association with the left PO.	Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, 3-8-1 Komba, Tokyo 1538902, Japan.	sakai@mind.c.u-tokyo.ac.jp		Hashimoto, Ryu-ichiro/0000-0002-9661-3412				Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; GESCHWIND N, 1979, SCI AM, V241, P180, DOI 10.1038/scientificamerican0979-180; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hashimoto R, 2000, NEUROIMAGE, V12, P147, DOI 10.1006/nimg.2000.0603; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jonides J, 1998, J NEUROSCI, V18, P5026; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Lee HS, 2003, NEUROIMAGE, V20, P1, DOI 10.1016/S1053-8119(03)00254-4; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Puce A, 1996, J NEUROSCI, V16, P5205; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Shaywitz SE, 1996, SCI AM, V275, P98, DOI 10.1038/scientificamerican1196-98; Soon CS, 2003, HUM BRAIN MAPP, V20, P1, DOI 10.1002/hbm.10122; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267	53	94	97	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					311	322		10.1016/S0896-6273(04)00196-5	http://dx.doi.org/10.1016/S0896-6273(04)00196-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091345	Bronze			2022-12-28	WOS:000221458500014
J	Zhao, Y; Yarov-Yarovoy, V; Scheuer, T; Catterall, WA				Zhao, Y; Yarov-Yarovoy, V; Scheuer, T; Catterall, WA			A gating hinge in Na+ channels: A molecular switch for electrical signaling	NEURON			English	Article							GATED SODIUM-CHANNELS; K+ CHANNEL; POTASSIUM CHANNEL; TRANSMEMBRANE HELICES; TRANSFECTED CELLS; ION CHANNELS; PROLINE; ACTIVATION; DISTORTIONS; SELECTIVITY	Voltage-gated sodium channels are members of a large family with similar pore structures. The mechanism of opening and closing is unknown, but structural studies suggest gating via bending of the inner pore helix at a glycine hinge. Here we provide functional evidence for this gating model for the bacterial sodium channel NaChBac. Mutation of glycine 219 to proline, which would strongly favor bending of the alpha helix, greatly enhances activation by shifting its voltage dependence -51 mV and slowing deactivation by 2000-fold. The mutation also slows voltage-dependent inactivation by 1200-fold. The effects are specific because substitutions of proline at neighboring positions and substitutions of other amino acids at position 219 have much smaller functional effects. Our results fit a model in which concerted bending at glycine 219 in the S6 segments of NaChBac serves as a gating hinge. This gating motion may be conserved in most members of this large ion channel protein family.	Univ Washington, Dept Pharmacol, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98105 USA.	wcatt@u.washington.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH067625-01, K01 MH67625] Funding Source: Medline; NINDS NIH HHS [R01 NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 2002, IUPHAR COMPENDIUM VO; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HURLEY JH, 1992, BIOPOLYMERS, V32, P1443, DOI 10.1002/bip.360321104; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KOISHI R, 2003, IN PRESS J BIOL CHEM; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Meisler MH, 2002, NOVART FDN SYMP, V241, P72; MEISLER MH, 2002, NOVART FDN SYMP, V241, P226; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	38	114	117	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					859	865		10.1016/S0896-6273(04)00116-3	http://dx.doi.org/10.1016/S0896-6273(04)00116-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046719	Bronze			2022-12-28	WOS:000221458300006
J	Kalyvas, A; David, S				Kalyvas, A; David, S			Cytosolic phospholipase A(2) plays a key role in the pathogenesis of multiple sclerosis-like disease	NEURON			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CHEMOKINE RECEPTOR EXPRESSION; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MOUSE SPINAL-CORD; TRIFLUOROMETHYL KETONES; DEMYELINATING DISEASE; CEREBROSPINAL-FLUID; MICROARRAY ANALYSIS	Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) that results in motor and sensory deficits. Although MS and its animal model, experimental autoimmune encephalomyelitis (EAE), are thought to be T cell-mediated diseases, the mechanisms underlying the lesions in the CNS are not fully understood. We propose that a strong candidate as a central mediator in evoking the complex pathological changes seen in MS and EAE is the enzyme cytosolic phospholipase A(2) (cPLA(2)). One of the metabolic products of this enzyme is proinflammatory, while the other induces myelin breakdown, demyelination, and chemokine/cytokine expression. We provide evidence that cPLA(2) is highly expressed in EAE lesions and show that blocking this enzyme leads to a remarkable reduction in the onset and progression of EAE.	McGill Univ, Inst Res, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University	David, S (corresponding author), McGill Univ, Inst Res, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	sam.david@mcgill.ca						ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Asensio VC, 1999, AM J PATHOL, V154, P1181, DOI 10.1016/S0002-9440(10)65370-9; Bettelli Estelle, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P389; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; BOLTON C, 1984, J NEUROIMMUNOL, V6, P151, DOI 10.1016/0165-5728(84)90002-X; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Carmody RJ, 2002, J NEUROIMMUNOL, V133, P95, DOI 10.1016/S0165-5728(02)00366-1; Caughey GE, 1997, J IMMUNOL, V158, P351; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DENNIS EA, 1991, FASEB J, V5, P2068, DOI 10.1096/fasebj.5.7.1901288; DOREDUFFY P, 1986, NEUROLOGY, V36, P1587, DOI 10.1212/WNL.36.12.1587; DOREDUFFY P, 1991, NEUROLOGY, V41, P322, DOI 10.1212/WNL.41.2_Part_1.322; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; Fischer FR, 2000, J NEUROIMMUNOL, V110, P195, DOI 10.1016/S0165-5728(00)00351-9; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Ghomashchi F, 1999, BBA-BIOMEMBRANES, V1420, P45, DOI 10.1016/S0005-2736(99)00056-5; Glabinski AR, 2003, SCAND J IMMUNOL, V58, P81, DOI 10.1046/j.1365-3083.2003.01285.x; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; HULKOWER K, 1993, J IMMUNOL, V150, P2525; Huterer SJ, 1995, NEUROCHEM RES, V20, P1335, DOI 10.1007/BF00992509; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; James MJ, 2001, INFLAMM RES, V50, P249, DOI 10.1007/s000110050750; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Jiang Y, 1998, J NEUROIMMUNOL, V86, P1, DOI 10.1016/S0165-5728(98)00005-8; JOHNS TG, 1995, J IMMUNOL, V154, P5536; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Kawai K, 1996, CELL IMMUNOL, V171, P262, DOI 10.1006/cimm.1996.9989; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Leger Olivier J. P., 1997, Human Antibodies, V8, P3; Liu X, 1998, GLIA, V24, P390, DOI 10.1002/(SICI)1098-1136(199812)24:4<390::AID-GLIA4>3.0.CO;2-1; Locati M, 1996, J BIOL CHEM, V271, P6010, DOI 10.1074/jbc.271.11.6010; LOCATI M, 1994, J BIOL CHEM, V269, P4746; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Mead RJ, 2002, J IMMUNOL, V168, P458, DOI 10.4049/jimmunol.168.1.458; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Murphy P, 2002, J NEUROSCI RES, V67, P461, DOI 10.1002/jnr.10139; NARUO K, 1993, J BIOL CHEM, V268, P2857; Nomiyama H, 2001, INT IMMUNOL, V13, P1021, DOI 10.1093/intimm/13.8.1021; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; OWENS T, 1995, NEUROL CLIN, V13, P51, DOI 10.1016/S0733-8619(18)30061-6; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Polman CH, 2000, WESTERN J MED, V173, P398, DOI 10.1136/ewjm.173.6.398; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; RACKE MK, 1993, J NEUROIMMUNOL, V46, P175, DOI 10.1016/0165-5728(93)90247-V; Rajan AJ, 2000, J IMMUNOL, V164, P2120, DOI 10.4049/jimmunol.164.4.2120; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; REDER AT, 1994, J NEUROIMMUNOL, V54, P117, DOI 10.1016/0165-5728(94)90238-0; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Rocha PN, 2003, SPRINGER SEMIN IMMUN, V25, P215, DOI 10.1007/s00281-003-0132-4; Rolak LA, 2001, NEUROL CLIN, V19, P107, DOI 10.1016/S0733-8619(05)70007-4; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; RYBORG AK, 1994, ARCH DERMATOL RES, V286, P462, DOI 10.1007/BF00371572; Ryborg AK, 2000, ACTA DERM-VENEREOL, V80, P242; Selmaj K, 1998, EUR J IMMUNOL, V28, P2035, DOI 10.1002/(SICI)1521-4141(199806)28:06<2035::AID-IMMU2035>3.3.CO;2-1; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Subramanian S, 2003, J IMMUNOL, V170, P1548, DOI 10.4049/jimmunol.170.3.1548; Sundstrom E, 2002, J NEUROTRAUM, V19, P257, DOI 10.1089/08977150252806992; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Teuscher C, 1999, J IMMUNOL, V163, P2262; Tran EH, 1998, J IMMUNOL, V161, P3767; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TRAUGOTT U, 1989, J NEUROPATH EXP NEUR, V48, P321, DOI 10.1097/00005072-198905000-00068; Trigueros SDA, 2003, MOL CELL NEUROSCI, V24, P753, DOI 10.1016/S1044-7431(03)00241-0; TRIMBLE LA, 1993, BIOCHEMISTRY-US, V32, P12560, DOI 10.1021/bi00210a002; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WEBER F, 1991, INT ARCH ALLER A IMM, V95, P136, DOI 10.1159/000235418; Whitney LW, 2001, J NEUROIMMUNOL, V121, P40, DOI 10.1016/S0165-5728(01)00438-6; WOELK H, 1974, J NEUROL, V207, P319, DOI 10.1007/BF00312585; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421	93	152	162	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					323	335		10.1016/S0896-6273(04)00003-0	http://dx.doi.org/10.1016/S0896-6273(04)00003-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766173	Bronze			2022-12-28	WOS:000221457900005
J	Schaar, BT; Kinoshita, K; McConnell, SK				Schaar, BT; Kinoshita, K; McConnell, SK			Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons	NEURON			English	Article							NERVE GROWTH CONES; C-ELEGANS PAR-1; PROTEIN-KINASE; CEREBRAL-CORTEX; DIRECTIONAL GUIDANCE; AXONAL MICROTUBULES; LISSENCEPHALY GENE; CELL-CYCLE; DYNAMICS; PHOSPHORYLATION	Doublecortin (Dcx) is a microtubule-associated protein that is mutated in X-linked lissencephaly (X-LIS), a neuronal migration disorder associated with epilepsy and mental retardation. Although Dcx can bind ubiquitously to microtubules in nonneuronal cells, Dcx is highly enriched in the leading processes of migrating neurons and the growth cone region of differentiating neurons. We present evidence that Dcx/microtubule interactions are negatively controlled by Protein Kinase A (PKA) and the MARK/PAR-1 family of protein kinases. In addition to a consensus MARK site, we identified a serine within a novel sequence that is crucial for the PKA- and MARK-dependent regulation of Dcx's microtubule binding activity in vitro. This serine is mutated in two families affected by X-LIS. Immunostaining neurons with an antibody that recognizes phosphorylated substrates of MARK supports the conclusion that Dcx localization and function are regulated at the leading edge of migrating cells by a balance of kinase and phosphatase activity.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Stanford University; Max Planck Society	McConnell, SK (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	suemcc@stanford.edu		Kinoshita, Kazuhisa/0000-0002-0882-4296	NIMH NIH HHS [MH51864] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864, R37MH051864] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; BROWN A, 1993, J CELL SCI, V104, P339; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, CELL, V92, P51; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson Joseph G., 2000, Current Opinion in Neurology, V13, P121, DOI 10.1097/00019052-200004000-00002; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Mandell JW, 1998, J NEUROBIOL, V35, P17, DOI 10.1002/(SICI)1097-4695(199804)35:1<17::AID-NEU2>3.0.CO;2-E; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Merrick SE, 1996, J BIOL CHEM, V271, P5589, DOI 10.1074/jbc.271.10.5589; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moores CA, 2003, NAT STRUCT BIOL, V10, P314, DOI 10.1038/nsb0503-314; Nelson WJ, 1997, CURR BIOL, V7, pR562, DOI 10.1016/S0960-9822(06)00282-X; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; SUN HJ, 2001, NAT CELL BIOL, V3, P81; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Ward M, 2003, J NEUROSCI, V23, P5170; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yoshiura K, 2000, J NEUROBIOL, V43, P132, DOI 10.1002/(SICI)1097-4695(200005)43:2<132::AID-NEU3>3.3.CO;2-9; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077	59	167	173	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					203	213		10.1016/S0896-6273(03)00843-2	http://dx.doi.org/10.1016/S0896-6273(03)00843-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741102	Bronze			2022-12-28	WOS:000221457800007
J	Cirelli, C; Gutierrez, CM; Tononi, G				Cirelli, C; Gutierrez, CM; Tononi, G			Extensive and divergent effects of sleep and wakefulness on brain gene expression	NEURON			English	Article							CEREBRAL PROTEIN-SYNTHESIS; CIRCADIAN-RHYTHMS; MESSENGER-RNAS; WAKING; DEPRIVATION; PLASTICITY; LIVER; TRANSCRIPTION; HOMEOSTASIS; MICROARRAY	Sleep is present in all species where it has been studied, but its functions remain unknown. To investigate what benefits sleep may bring at the cellular level, we profiled gene expression in awake and sleeping rats by using high-density microarrays. We find that similar to10% of the transcripts in the cerebral cortex change their expression between day and night and demonstrate that half of them are modulated by sleep and wakefulness independent of time of day. We also show that molecular correlates of sleep are found in the cerebellum, a structure not known for generating sleep rhythms. Finally, we show that different functional categories of genes are selectively associated with sleep and wakefulness. The similar to100 known genes whose expression increases during sleep provide molecular support for the proposed involvement of sleep in protein synthesis and neural plasticity and point to a novel role for sleep in membrane trafficking and maintenance.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	ccirelli@wisc.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cirelli C, 2002, J APPL PHYSIOL, V92, P394, DOI 10.1152/jappl.2002.92.1.394; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hobson J.A., 1989, SLEEP; HOBSON JA, 1972, ELECTROEN CLIN NEURO, V33, P457, DOI 10.1016/0013-4694(72)90210-6; HORNE JA, 1988, WHY SLEEP FUNCTIONS; Jurevics H, 2000, J LIPID RES, V41, P1048; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; LI WWF, 1993, J BIOL CHEM, V268, P12003; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; MAQUET P, 1995, BEHAV BRAIN RES, V69, P75, DOI 10.1016/0166-4328(95)00017-N; Maquet P, 2000, J SLEEP RES, V9, P207; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meuth SG, 2003, J NEUROSCI, V23, P6460; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; Ogawa A, 1997, HEPATOLOGY, V26, P1580, DOI 10.1002/hep.510260628; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Petit JM, 2002, EUR J NEUROSCI, V16, P1163, DOI 10.1046/j.1460-9568.2002.02145.x; RAMM P, 1990, PHYSIOL BEHAV, V48, P749, DOI 10.1016/0031-9384(90)90220-X; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RHYNER TA, 1990, EUR J NEUROSCI, V2, P1063, DOI 10.1111/j.1460-9568.1990.tb00018.x; Shaffery JP, 2002, NEUROSCIENCE, V110, P431, DOI 10.1016/S0306-4522(01)00589-9; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Terao A, 2003, NEUROSCIENCE, V116, P187, DOI 10.1016/S0306-4522(02)00695-4; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2001, ARCH ITAL BIOL, V139, P221; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Yamada M, 2000, BIOL CHEM, V381, P1149, DOI 10.1515/BC.2000.142	60	439	445	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					35	43		10.1016/S0896-6273(03)00814-6	http://dx.doi.org/10.1016/S0896-6273(03)00814-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715133	Bronze			2022-12-28	WOS:000187942800007
J	Cayouette, M; Barres, BA; Raff, M				Cayouette, M; Barres, BA; Raff, M			Importance of intrinsic mechanisms in cell fate decisions in the developing rat retina	NEURON			English	Article							ROD PHOTORECEPTOR DEVELOPMENT; PROGENITOR CELLS; AMACRINE CELLS; DROSOPHILA NEUROBLASTS; DEVELOPMENT INVITRO; MAMMALIAN RETINA; TADPOLE RETINA; XENOPUS RETINA; BIPOLAR CELLS; FROG RETINA	Cell diversification in the developing nervous system is thought to involve both cell-intrinsic mechanisms and extracellular signals, but their relative importance in particular cell fate decisions remains uncertain. In the mammalian retina, different cell types develop on a predictable schedule from multipotent retinal neuroepithelial cells (RNECs). A current view is that RNECs pass through a series of competence states, progressively changing their responsiveness to instructive extracellular cues, which also change over time. We show here, however, that embryonic day 16-17 (E16-17) rat RNECs develop similarly in serum-free clonal-density cultures and in serum-containing retinal explants-in the number of times they divide, the cell types they generate, and the order in which they generate these cell types. These surprising results suggest that extracellular signals may be less important than currently believed in determining when RNECs stop dividing and what cell types they generate when they withdraw from the cell cycle, at least from E16-17 onward.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	University of London; University College London; University of London; University College London; Stanford University	Cayouette, M (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,299 Campus Dr,D231, Stanford, CA 94305 USA.	m.cayouefte@stanford.edu		Cayouette, Michel/0000-0003-4655-9048	NEI NIH HHS [R01 EY113110] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAGAWA K, 1986, BRAIN RES, V383, P110, DOI 10.1016/0006-8993(86)90012-0; AKAGAWA K, 1987, BRAIN RES, V437, P298, DOI 10.1016/0006-8993(87)91644-1; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; FURST A, 1985, DEV BIOL, V112, P467, DOI 10.1016/0012-1606(85)90419-1; GalliResta L, 1997, J NEUROSCI, V17, P7831; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUANG S, 1995, J COMP NEUROL, V360, P442, DOI 10.1002/cne.903600306; Huang S, 1997, J COMP NEUROL, V387, P42; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jensen AM, 1997, DEV BIOL, V188, P267, DOI 10.1006/dbio.1997.8645; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LUER K, 1992, DEVELOPMENT, V116, P377; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Moody SA, 2000, J NEUROSCI, V20, P3244, DOI 10.1523/JNEUROSCI.20-09-03244.2000; Morrow EM, 1998, J NEUROSCI, V18, P3738; NEGISHI K, 1982, SCIENCE, V216, P747, DOI 10.1126/science.7079736; Neophytou C, 1997, DEVELOPMENT, V124, P2345; ONODA N, 1987, BRAIN RES, V416, P359, DOI 10.1016/0006-8993(87)90919-X; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rapaport DH, 1996, PERSPECT DEV NEUROBI, V3, P147; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; Sheedlo HJ, 1996, J NEUROSCI RES, V44, P519; Shen Q, 2002, DEVELOPMENT, V129, P4843; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Waid DK, 1998, DEVELOPMENT, V125, P1059; WATANABE T, 1992, DEVELOPMENT, V114, P899; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS RW, 1992, TRENDS NEUROSCI, V15, P368, DOI 10.1016/0166-2236(92)90181-7; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	46	131	133	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					897	904		10.1016/S0896-6273(03)00756-6	http://dx.doi.org/10.1016/S0896-6273(03)00756-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659089	Bronze			2022-12-28	WOS:000187042200007
J	Kruger, GM; Mosher, JT; Tsai, TH; Yeager, KJ; Iwashita, T; Gariepy, CE; Morrison, SJ				Kruger, GM; Mosher, JT; Tsai, TH; Yeager, KJ; Iwashita, T; Gariepy, CE; Morrison, SJ			Temporally distinct requirements for endothelin receptor B in the generation and migration of gut neural crest stem cells	NEURON			English	Article							ENTERIC NERVOUS-SYSTEM; PRESUMPTIVE AGANGLIONIC BOWEL; HIRSCHSPRUNG-DISEASE; SPOTTING LETHAL; CONGENITAL AGANGLIONOSIS; SYMPATHETIC NEURONS; SELF-RENEWAL; COAT COLOR; AVIAN GUT; IN-VITRO	Loss of Endothelin-3/Endothelin receptor B (EDNRB) signaling leads to aganglionosis of the distal gut (Hirschsprung's disease), but it is unclear whether it is required primarily for neural crest progenitor maintenance or migration. Ednrb-deficient gut neural crest stem cells (NCSCs) were reduced to 40% of wild-type levels by embryonic day 12.5 (E12.5), but no further depletion of NCSCs was subsequently observed. Undifferentiated NCSCs persisted in the proximal guts of Ednrb-deficient rats throughout fetal and postnatal development but exhibited migration defects after E12.5 that prevented distal gut colonization. EDNRB signaling may be required to modulate the response of neural crest progenitors to migratory cues, such as glial cell line-derived neurotrophic factor (GDNF). This migratory defect could be bypassed by transplanting wild-type NCSCs directly into the aganglionic region of the Ednrb(sl/sl) gut, where they engrafted and formed neurons as efficiently as in the wild-type gut.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.		Gariepy, Cheryl/AAQ-3441-2021; Crane, Genevieve M/AAK-9224-2020; Morrison, Sean/ABD-5326-2021; Gariepy, Cheryl/C-6141-2012	Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [T32CA009676, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310, P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09676, CA46592] Funding Source: Medline; NIAMS NIH HHS [P30 AR48310, AR20557] Funding Source: Medline; NIA NIH HHS [AG00114-18] Funding Source: Medline; NIDDK NIH HHS [P60DK-20572] Funding Source: Medline; NINDS NIH HHS [R01 NS040750-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Conner PJ, 2003, DEV DYNAM, V226, P91, DOI 10.1002/dvdy.10219; COVENTRY S, 1994, LAB INVEST, V71, P82; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FONTAINEPERUS J, 1981, HISTOCHEMISTRY, V71, P313, DOI 10.1007/BF00495878; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Gershon MD, 1999, CLIN EXP PHARMACOL P, V26, P985, DOI 10.1046/j.1440-1681.1999.03176.x; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; JACOBSCOHEN RJ, 1987, J COMP NEUROL, V255, P425, DOI 10.1002/cne.902550309; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; Kapur RP, 2000, DEV BIOL, V227, P146, DOI 10.1006/dbio.2000.9886; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; KAPUR RP, 1993, DEVELOPMENT, V117, P993; KAPUR RP, 1992, DEVELOPMENT, V116, P167; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leibl MA, 1999, GUT, V44, P246, DOI 10.1136/gut.44.2.246; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; MEIJERS JHC, 1987, PEDIATR RES, V21, P466, DOI 10.1203/00006450-198705000-00009; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; NAGAHAMA M, 1985, ANAT EMBRYOL, V171, P285, DOI 10.1007/BF00347017; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P224, DOI 10.1007/s10024-001-0142-y; PARIKH DH, 1992, GASTROENTEROLOGY, V102, P1236; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Reid K, 1996, DEVELOPMENT, V122, P3911; Reissmann E, 1996, DEVELOPMENT, V122, P2079; ROTHMAN TP, 1993, DEV BIOL, V159, P559, DOI 10.1006/dbio.1993.1264; Rothman TP, 1996, DEV BIOL, V178, P498, DOI 10.1006/dbio.1996.0234; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Sidebotham EL, 2002, J PEDIATR SURG, V37, P145, DOI 10.1053/jpsu.2002.30239; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; von Boyen GBT, 2002, GUT, V51, P414, DOI 10.1136/gut.51.3.414; Watanabe Y, 1997, J PEDIATR SURG, V32, P1229, DOI 10.1016/S0022-3468(97)90688-6; Woodward MN, 2003, J PEDIATR SURG, V38, P1322, DOI 10.1016/S0022-3468(03)00389-0; Woodward MN, 2000, J PEDIATR SURG, V35, P25, DOI 10.1016/S0022-3468(00)80007-X; Wu JJ, 1999, DEVELOPMENT, V126, P1161; Young HM, 2002, J NEUROSCI, V22, P6005; Young HM, 1999, MICROSC RES TECHNIQ, V47, P303, DOI 10.1002/(SICI)1097-0029(19991201)47:5<303::AID-JEMT1>3.0.CO;2-T; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100	57	99	105	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					917	929		10.1016/S0896-6273(03)00727-X	http://dx.doi.org/10.1016/S0896-6273(03)00727-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659091	Bronze			2022-12-28	WOS:000187042200009
J	Mobbs, D; Greicius, MD; Abdel-Azim, E; Menon, V; Reiss, AL				Mobbs, D; Greicius, MD; Abdel-Azim, E; Menon, V; Reiss, AL			Humor modulates the mesolimbic reward centers	NEURON			English	Article							FACIAL EXPRESSION; DOPAMINE RELEASE; NEURAL BASIS; LAUGHTER; BRAIN; FMRI; AMYGDALA; COMPREHENSION; ACTIVATION; NUCLEUS	Humor plays an essential role in many facets of human life including psychological, social, and somatic functioning. Recently, neuroimaging has been applied to this critical human attribute, shedding light on the affective, cognitive, and motor networks involved in humor processing. To date, however, researchers have failed to demonstrate the subcortical correlates of the most fundamental feature of humor-reward. In an effort to elucidate the neurobiological substrate that subserves the reward components of humor, we undertook a high-field (3 Tesla) event-related functional MRI study. Here we demonstrate that humor modulates activity in several cortical regions, and we present new evidence that humor engages a network of subcortical regions including the nucleus accumbens, a key component of the mesolimbic dopaminergic reward system. Further, the degree of humor intensity was positively correlated with BOLD signal intensity in these regions. Together, these findings offer new insight into the neural basis of salutary aspects of humor.	Stanford Univ, Sch Med, Stanford Psychiat Neuroimaging Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Brain Res Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Reiss, AL (corresponding author), Stanford Univ, Sch Med, Stanford Psychiat Neuroimaging Lab, Stanford, CA 94305 USA.	reiss@stanford.edu	Abdel-Azim, Eman/M-2675-2019; anand, amit/A-7222-2009; Menon, Vinod/J-6402-2013	Abdel-Azim, Eman/0000-0002-2899-863X; Azim, Eiman/0000-0002-1015-1772; Menon, Vinod/0000-0003-1622-9857	NIMH NIH HHS [MH01142] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ARROYO S, 1993, BRAIN, V116, P757, DOI 10.1093/brain/116.4.757; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bennett MP, 2003, ALTERN THER HEALTH M, V9, P38; BERK LS, 1989, AM J MED SCI, V298, P390, DOI 10.1097/00000441-198912000-00006; Braver TS, 2003, NEURON, V38, P150, DOI 10.1016/S0896-6273(03)00230-7; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BROWNELL HH, 1983, BRAIN LANG, V18, P20, DOI 10.1016/0093-934X(83)90002-0; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chassagnon S, 2003, EPILEPSIA, V44, P859, DOI 10.1046/j.1528-1157.2003.60802.x; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DEROGATIS LR, 1977, SCL 90 ADM SCORING P, V1; Devous MD, 2001, J NUCL MED, V42, P535; Dixon NF, 1980, STRESS ANXIETY, V7, P281; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Dum RP, 1993, NEUROBIOLOGY CINGULA, P415, DOI 10.1007/978-1-4899-6704-6_15; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Fredrickson BL, 1998, COGNITION EMOTION, V12, P191; Fried I, 1998, NATURE, V391, P650, DOI 10.1038/35536; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fry W F Jr, 1992, JAMA, V267, P1857, DOI 10.1001/jama.267.13.1857; GARDNER H, 1975, BRAIN, V98, P399, DOI 10.1093/brain/98.3.399; GAVRILOVIC J, 2003, EPIDEMIOLOGY, V38, P128; Geday J, 2003, NEUROIMAGE, V18, P675, DOI 10.1016/S1053-8119(02)00038-1; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; GOEL V, 2003, IN PRESS PSYCHOLOGIC, V32; HERZOG TR, 1988, J PSYCHOL, V122, P597, DOI 10.1080/00223980.1988.9915534; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Iwase M, 2002, NEUROIMAGE, V17, P758, DOI 10.1006/nimg.2002.1225; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; LEFCOURT HM, 1990, HUMOR INT J HUMOR RE, V3, P305; Mai J.K., 1997, ATLAS HUMAN BRAIN; Martin RA, 2001, PSYCHOL BULL, V127, P504, DOI 10.1037//0033-2909.127.4.504; MCGHEE PE, 1971, PSYCHOL BULL, V76, P328, DOI 10.1037/h0031670; Mummery CJ, 2000, ANN NEUROL, V47, P36; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Neuhoff CC, 2002, PSYCHOL REP, V91, P1079, DOI 10.2466/PR0.91.7.1079-1080; Nezlek JB, 2001, HUMOR, V14, P395, DOI 10.1515/humr.2001.011; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osaka N, 2003, NEUROSCI LETT, V340, P127, DOI 10.1016/S0304-3940(03)00093-4; Ozawa F, 2000, NEUROREPORT, V11, P1141, DOI 10.1097/00001756-200004270-00001; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Pratt WE, 1998, BEHAV NEUROSCI, V112, P554, DOI 10.1037/0735-7044.112.3.554; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; PRICE JL, 1981, J NEUROSCI, V1, P1242; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SULS J, 1972, PSYCHOL HUMOR; Talairach J., 1988, COPLANAR STEREOTAXIC; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Toyokura M, 2002, J NEUROIMAGING, V12, P172, DOI 10.1111/j.1552-6569.2002.tb00116.x; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	65	273	279	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1041	1048		10.1016/S0896-6273(03)00751-7	http://dx.doi.org/10.1016/S0896-6273(03)00751-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	751FM	14659102	Bronze			2022-12-28	WOS:000187042200020
J	Schaar, BT				Schaar, BT			Cortical development deNUDEd	NEURON			English	Editorial Material							NEOCORTICAL DEVELOPMENT; CELL-DIVISION; DYNEIN	The development of the cerebral cortex is a highly orchestrated process of cell division and migration. In this issue of Neuron, Feng and Walsh and Shu et al. examine the roles of two related proteins, Nde1 (mNudE) and Ndel1 (NUDEL), in cortical development. These proteins play a crucial role in centrosome positioning, with Nde1 functioning mainly during progenitor cell divisions and Ndel1 functioning in neuronal migration.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Schaar, BT (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297	15	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					213	214		10.1016/j.neuron.2004.10.002	http://dx.doi.org/10.1016/j.neuron.2004.10.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473958	Bronze			2022-12-28	WOS:000224635800002
J	Cheng, HYM; Obrietan, K; Cain, SW; Lee, BY; Agostino, PV; Joza, NA; Harrington, ME; Ralph, MR; Penninger, JM				Cheng, HYM; Obrietan, K; Cain, SW; Lee, BY; Agostino, PV; Joza, NA; Harrington, ME; Ralph, MR; Penninger, JM			Dexras1 potentiates photic and suppresses nonphotic responses of the circadian clock	NEURON			English	Article							NMDA RECEPTOR ANTAGONISTS; PHASE-SHIFTS; SUPRACHIASMATIC NUCLEUS; NEUROPEPTIDE-Y; GOLDEN-HAMSTER; HYPOTHALAMIC TRACT; KINASE ACTIVATION; ACTIVITY RHYTHMS; GENE-EXPRESSION; IN-VITRO	Circadian rhythms of physiology and behavior are generated by biological clocks that are synchronized to the cyclic environment by photic or nonphotic cues. The interactions and integration of various entrainment pathways to the clock are poorly understood. Here, we show that the Ras-like G protein Dexras1 is a critical modulator of the responsiveness of the master clock to photic and nonphotic inputs. Genetic deletion of Dexras1 reduces photic entrainment by eliminating a pertussis-sensitive circadian response to NMDA. Mechanistically, Dexras1 couples NMDA and light input to G(i/o) and ERK activation. In addition, the mutation greatly potentiates nonphotic responses to neuropeptide Y and unmasks a nonphotic response to arousal. Thus, Dexras1 modulates the responses of the master clock to photic and nonphotic stimuli in opposite directions. These results identify a signaling molecule that serves as a differential modulator of the gated photic and nonphotic input pathways to the circadian timekeeping system.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; Smith Coll, Dept Psychol, Northampton, MA 01063 USA; Smith Coll, Program Neurosci, Northampton, MA 01063 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University System of Ohio; Ohio State University; University of Toronto; Smith College; Smith College	Cheng, HYM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	hymcheng@yahoo.ca; josef.penninger@oeaw.ac.at	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Cain, Sean/0000-0002-8385-1550				Aschoff, 1965, CIRCADIAN CLOCKS, P95; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; BIELLO SM, 1995, P ROY SOC B-BIOL SCI, V259, P179, DOI 10.1098/rspb.1995.0026; Biello SM, 1997, NEUROSCIENCE, V77, P1049, DOI 10.1016/S0306-4522(96)00547-7; Butcher GQ, 2003, J NEUROPHYSIOL, V90, P3854, DOI 10.1152/jn.00524.2003; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Coogan AN, 2003, J NEUROSCI, V23, P3085; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; HARRINGTON ME, 1988, PHYSIOL BEHAV, V42, P183, DOI 10.1016/0031-9384(88)90296-X; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Lall GS, 2003, NEUROSCIENCE, V120, P915, DOI 10.1016/S0306-4522(03)00396-8; Maywood E. S., 2001, Gene Expression Patterns, V1, P27, DOI 10.1016/S1567-133X(01)00005-9; Mintz EM, 1999, J NEUROSCI, V19, P5124; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Mrosovsky N, 1996, CHRONOBIOL INT, V13, P387, DOI 10.3109/07420529609012662; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pickard G E, 1987, J Biol Rhythms, V2, P35, DOI 10.1177/074873048700200104; PICKARD GE, 1993, PHYSIOL BEHAV, V54, P1, DOI 10.1016/0031-9384(93)90035-E; RALPH MR, 1992, J BIOL RHYTHM, V7, P353, DOI 10.1177/074873049200700408; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REEBS SG, 1989, J COMP PHYSIOL A, V165, P819, DOI 10.1007/BF00610880; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 2001, PHYSIOL BEHAV, V74, P101, DOI 10.1016/S0031-9384(01)00546-7; Roenneberg T, 2000, CURR BIOL, V10, pR742, DOI 10.1016/S0960-9822(00)00739-9; SHIBATA S, 1992, BRAIN RES, V582, P353, DOI 10.1016/0006-8993(92)90156-4; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Takesono A, 2002, J BIOL CHEM, V277, P13827, DOI 10.1074/jbc.M201064200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yannielli PC, 2001, J NEUROSCI, V21, P5367, DOI 10.1523/JNEUROSCI.21-14-05367.2001	48	84	85	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					715	728		10.1016/j.neuron.2004.08.021	http://dx.doi.org/10.1016/j.neuron.2004.08.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339652	Bronze			2022-12-28	WOS:000223691900016
J	Chan, JR; Watkins, TA; Cosgaya, JM; Zhang, CZ; Chen, L; Reichardt, LF; Shooter, EM; Barres, BA				Chan, JR; Watkins, TA; Cosgaya, JM; Zhang, CZ; Chen, L; Reichardt, LF; Shooter, EM; Barres, BA			NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes	NEURON			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; ACTION-POTENTIALS; SENSORY NEURONS; SPINAL-CORD; SYSTEM; ACTIVATION; SURVIVAL; CALIBER	Axons dictate whether or not they will become myelinated in both the central and peripheral nervous systems by providing signals that direct the development of myelinating glia. Here we identify the neurotrophin nerve growth factor (NGF) as a potent regulator of the axonal signals that control myelination of TrkA-expressing dorsal root ganglion neurons (DRGs). Unexpectedly, these NGF-regulated axonal signals have opposite effects on peripheral and central myelination, promoting myelination by Schwann cells but reducing myelination by oligodendrocytes. These findings indicate a novel role for growth factors in regulating the receptivity of axons to myelination and reveal that different axonal signals control central and peripheral myelination.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Watkins, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Sci Bldg D235, Stanford, CA 94305 USA.	trentw@stanford.edu	Cosgaya, Jose M/B-4936-2008	Cosgaya, Jose Miguel/0000-0002-6005-2916	NEI NIH HHS [R01 EY10257, R01 EY010257] Funding Source: Medline; NINDS NIH HHS [NS04270, P01 NS016033-20, R01 NS004270, P01 NS016033] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270, P01NS016033] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; BAHR M, 1991, GLIA, V4, P529, DOI 10.1002/glia.440040512; BANSAL R, 1985, J NEUROSCI RES, V14, P21, DOI 10.1002/jnr.490140103; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Berthold CH., 1993, PERIPHERAL NEUROPATH, P73; Blakemore WF, 2000, CELL TRANSPLANT, V9, P289, DOI 10.1177/096368970000900214; BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0; CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Colello RJ, 1997, MOL NEUROBIOL, V15, P83, DOI 10.1007/BF02740617; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; Fraher J, 1998, J ANAT, V193, P195, DOI 10.1046/j.1469-7580.1998.19320195.x; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hoke A, 2003, J NEUROSCI, V23, P561; Kleitman N, 1991, CULTURING NERVE CELL, P337; KORSCHING S, 1985, NEUROSCI LETT, V54, P201, DOI 10.1016/S0304-3940(85)80079-3; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LucidiPhillipi CA, 1996, NEURON, V16, P653, DOI 10.1016/S0896-6273(00)80084-7; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; Raval-Fernandes S, 1998, MICROSC RES TECHNIQ, V41, P379, DOI 10.1002/(SICI)1097-0029(19980601)41:5<379::AID-JEMT5>3.0.CO;2-L; RETHELYI M, 1982, J COMP NEUROL, V207, P381; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WEINBERG EL, 1979, BRAIN RES, V162, P273, DOI 10.1016/0006-8993(79)90289-0; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100	44	244	258	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					183	191		10.1016/j.neuron.2004.06.024	http://dx.doi.org/10.1016/j.neuron.2004.06.024			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260955	Green Accepted, Bronze			2022-12-28	WOS:000222905400008
J	Sanyal, S; Kim, SM; Ramaswami, M				Sanyal, S; Kim, SM; Ramaswami, M			Retrograde regulation in the CNS: Neuron-specific interpretations of TGF-beta signaling	NEURON			English	Editorial Material							SYNAPTIC GROWTH; NERVOUS-SYSTEM; II RECEPTOR; DROSOPHILA; EXPRESSION; MORPHOLOGY; MECHANISMS; EFFICACY; MEMBRANE; RELEASE	Retrograde signals influence neuronal survival, differentiation, synaptogenesis, and plasticity. Several recent papers describe novel roles for the well-studied TGF-beta pathway in retrograde synaptic signaling. While each dissects spatial and molecular aspects of TGF-beta signaling in a specific synaptic context, together these studies demonstrate that a specific retrograde signal may be interpreted in diverse, neuron-specific ways. Thus, a neuron's intrinsic properties and its other extrinsic signaling inputs determine its cellular and genomic response to TGF-beta.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Ramaswami, M (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Box 210106, Tucson, AZ 85721 USA.	mani@u.arizona.edu		Sanyal, Subhabrata/0000-0003-2590-2732; Ramaswami, Mani/0000-0001-7631-0468				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Nolan KM, 2002, GENE DEV, V16, P3061, DOI 10.1101/gad.1027702; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stewart BA, 1996, J NEUROSCI, V16, P3877; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	24	52	54	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					845	848		10.1016/S0896-6273(04)00152-7	http://dx.doi.org/10.1016/S0896-6273(04)00152-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046717	Bronze			2022-12-28	WOS:000221458300004
J	Bastian, J; Chacron, MJ; Maler, L				Bastian, J; Chacron, MJ; Maler, L			Plastic and nonplastic pyramidal cells perform unique roles in a network capable of adaptive redundancy reduction	NEURON			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; CENTRAL-NERVOUS-SYSTEM; ELECTROSENSORY SYSTEM; MESSENGER-RNA; NMDA RECEPTOR; NEURONS; MORPHOLOGY; LOCALIZATION; ORGANIZATION	Pyramidal cells show marked variation in their morphology, including dendritic structure, which is correlated with physiological diversity; however, it is not known how this variation is related to a cell's role within neural networks. In this report, we describe correlations among electrosensory lateral line lobe (ELL) pyramidal cells' highly variable dendritic morphology and their ability to adaptively cancel redundant inputs via an anti-Hebbian form of synaptic plasticity. A subset of cells, those with the largest apical dendrites, are plastic, but those with the smallest dendrites are not. A model of the network's connectivity predicts that efficient redundancy reduction requires that nonplastic cells provide feedback input to those that are plastic. Anatomical results confirm the model's prediction of optimal network architecture. These results provide a demonstration of different roles for morphological/physiological variants of a single cell type within a neural network performing a well-defined function.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada	University of Oklahoma System; University of Oklahoma - Norman; University of Ottawa; University of Ottawa	Bastian, J (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	jbastian@ou.edu		Chacron, Maurice/0000-0002-3032-452X				ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, P331; BASTIAN J, 1993, J COMP PHYSIOL A, V172, P409, DOI 10.1007/BF00213523; Bastian J, 1999, J EXP BIOL, V202, P1327; BASTIAN J, 1986, J NEUROSCI, V6, P553; BASTIAN J, 1995, J COMP PHYSIOL A, V176, P63; Bastian J., 1986, P577; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1991, J COMP PHYSIOL A, V168, P393, DOI 10.1007/BF00199600; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Bastian J, 1996, J NEUROPHYSIOL, V76, P2483, DOI 10.1152/jn.1996.76.4.2483; Bastian J, 1998, J NEUROPHYSIOL, V80, P3352, DOI 10.1152/jn.1998.80.6.3352; Bastian J, 1996, J NEUROPHYSIOL, V76, P2497, DOI 10.1152/jn.1996.76.4.2497; Batschelet E., 1981, CIRCULAR STAT BIOL; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; Berman N, 2001, J NEUROPHYSIOL, V86, P1612, DOI 10.1152/jn.2001.86.4.1612; BERMAN NJ, 1995, J COMP NEUROL, V361, P512, DOI 10.1002/cne.903610313; Bottai D, 1998, J NEUROSCI, V18, P5191, DOI 10.1523/JNEUROSCI.18-14-05191.1998; Bottai D, 1997, J COMP NEUROL, V389, P65, DOI 10.1002/(SICI)1096-9861(19971208)389:1<65::AID-CNE5>3.0.CO;2-C; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Dayan P, 2001, COMPUTATIONAL NEUROS; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; Frank K, 1964, PHYS TECHNIQUES BIOL, P23, DOI DOI 10.1016/B978-0-12-514105-5.50009-5; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; Hardingham N, 2003, J NEUROSCI, V23, P4428; Harvey-Girard E, 2003, J NEUROPHYSIOL, V89, P822, DOI 10.1152/jn.00629.2002; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; HAUSSER M, 1999, CONCLUSION FUTURE DE, P365; Heiligenberg W., 1991, NEURAL NETS ELECT FI; JONES EG, 1994, J NEUROSCI, V14, P611; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; LARKMAN A, 1990, J NEUROSCI, V10, P1407; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519, DOI 10.1152/jn.2000.84.3.1519; LEWIS J, 2003, IN PRESS J NEUROPHYS; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; MALER L, 1991, J CHEM NEUROANAT, V4, P1, DOI 10.1016/0891-0618(91)90030-G; MALER L, 1982, J COMP NEUROL, V211, P154, DOI 10.1002/cne.902110205; MALER L, 1979, J COMP NEUROL, V183, P323, DOI 10.1002/cne.901830208; NELSON ME, 1995, J COMP PHYSIOL A, V177, P723; Nelson ME, 1999, J EXP BIOL, V202, P1195; SAS E, 1987, ANAT EMBRYOL, V177, P55, DOI 10.1007/BF00325290; SAUNDERS J, 1984, J COMP PHYSIOL, V154, P199, DOI 10.1007/BF00604985; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; ZUPANC GKH, 1992, J COMP NEUROL, V325, P135, DOI 10.1002/cne.903250202	49	106	106	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					767	779		10.1016/S0896-6273(04)00071-6	http://dx.doi.org/10.1016/S0896-6273(04)00071-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003176	Bronze, Green Published			2022-12-28	WOS:000221458200012
J	Sopher, BL; Thomas, PS; LaFevre-Bernt, MA; Holm, IE; Wilke, SA; Ware, CB; Jin, LW; Libby, RT; Ellerby, LM; La Spada, AR				Sopher, BL; Thomas, PS; LaFevre-Bernt, MA; Holm, IE; Wilke, SA; Ware, CB; Jin, LW; Libby, RT; Ellerby, LM; La Spada, AR			Androgen receptor YAC Transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration	NEURON			English	Article							BULBAR MUSCULAR-ATROPHY; CREB-BINDING PROTEIN; MOUSE MODEL; CAG-REPEAT; TRINUCLEOTIDE REPEAT; HETEROZYGOUS FEMALES; HUNTINGTONS-DISEASE; STRUCTURAL BASIS; CELL-DEATH; LATE-ONSET	X-linked spinal and bulbar muscular atrophy (SBMA) is an inherited neuromuscular disorder characterized by lower motor neuron degeneration. SBMA is caused by polyglutamine repeat expansions in the androgen receptor (AR). To determine the basis of AR polyglutamine neurotoxicity, we introduced human AR yeast artificial chromosomes carrying either 20 or 100 CAGs into mouse embryonic stem cells. The AR100 transgenic mice developed a late-onset, gradually progressive neuromuscular phenotype accompanied by motor neuron degeneration, indicating striking recapitulation of the human disease. We then tested the hypothesis that polyglutamine-expanded AR interferes with CREB binding protein (CBP)-mediated transcription of vascular endothelial growth factor (VEGF) and observed altered CBP-AR binding and VEGF reduction in AR100 mice. We found that mutant AR-induced death of motor neuron-like cells could be rescued by VEGF. Our results suggest that SBMA motor neuronopathy involves altered expression of VEGF, consistent with a role for VEGF as a neurotrophic/survival factor in motor neuron disease.	Univ Washington, Ctr Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Ctr Med, Dept Neurol Neurogenet, Seattle, WA 98195 USA; Buck Inst Age Res, Novato, CA 94945 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Buck Institute for Research on Aging	La Spada, AR (corresponding author), Univ Washington, Ctr Med, Dept Lab Med, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020		NINDS NIH HHS [R01 NS40251, R01 NS41648] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041648, R01NS040251] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gosztonyi G, 2001, MICROSC RES TECHNIQ, V55, P187, DOI 10.1002/jemt.1170; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Marbini A, 2002, BRAIN DEV-JPN, V24, P63, DOI 10.1016/S0387-7604(01)00394-1; Mariotti C, 2000, NEUROMUSCULAR DISORD, V10, P391, DOI 10.1016/S0960-8966(99)00132-7; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; RINGEL SP, 1978, MUSCLE NERVE, V1, P297, DOI 10.1002/mus.880010406; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SOBUE G, 1993, J NEUROL SCI, V117, P74, DOI 10.1016/0022-510X(93)90157-T; Sopher BL, 2000, GENE, V261, P383, DOI 10.1016/S0378-1119(00)00508-4; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor MD, 2001, J COMP NEUROL, V432, P244, DOI 10.1002/cne.1100; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	47	140	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					687	699		10.1016/S0896-6273(04)00082-0	http://dx.doi.org/10.1016/S0896-6273(04)00082-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003169	Bronze, Green Submitted			2022-12-28	WOS:000221458200005
J	Scannevin, RH; Wang, KW; Jow, F; Megules, J; Kopsco, DC; Edris, W; Carroll, KC; Lu, Q; Xu, WX; Xu, ZB; Katz, AH; Olland, S; Lin, L; Taylor, M; Stahl, M; Malakian, K; Somers, W; Mosyak, L; Bowlby, MR; Chanda, P; Rhodes, KJ				Scannevin, RH; Wang, KW; Jow, F; Megules, J; Kopsco, DC; Edris, W; Carroll, KC; Lu, Q; Xu, WX; Xu, ZB; Katz, AH; Olland, S; Lin, L; Taylor, M; Stahl, M; Malakian, K; Somers, W; Mosyak, L; Bowlby, MR; Chanda, P; Rhodes, KJ			Two N-terminal domains of Kv4 K+ channels regulate binding to and modulation by KChIP1	NEURON			English	Article							POTASSIUM CHANNELS; PYRAMIDAL NEURONS; CRYSTAL-STRUCTURE; T1 DOMAIN; PROTEIN; EXPRESSION; SUBUNIT; TETRAMERIZATION; INACTIVATION; CALSENILIN	The family of calcium binding proteins called KChlPs associates with Kv4 family K+ channels and modulates their biophysical properties. Here, using mutagenesis and X-ray crystallography, we explore the interaction between Kv4 subunits and KChlP1. Two regions in the Kv4.2 N terminus, residues 7-11 and 71-90, are necessary for KChlP1 modulation and interaction with Kv4.2. When inserted into the Kv1.2 N terminus, residues 71-90 of Kv4.2 are also sufficient to confer association with KChlP1. To provide a structural framework for these data, we solved the crystal structures of Kv4.3N and KChlP1 individually. Taken together with the mutagenesis data, the individual structures suggest that that the Kv4 N terminus is required for stable association with KChlP1, perhaps through a hydrophobic surface interaction, and that residues 71-90 in Kv4 subunits form a contact loop that mediates the specific association of KChlPs with Kv4 subunits.	Wyeth Ayerst Res, Neurosci Discovery Res, Princeton, NJ 08543 USA; Wyeth Ayerst Res, Struct Biol Chem & Screening Sci, Cambridge, MA 02140 USA	Pfizer; Pfizer	Wang, KW (corresponding author), Wyeth Ayerst Res, Neurosci Discovery Res, CN-8000, Princeton, NJ 08543 USA.	wangk@wyeth.com		Scannevin, Robert/0000-0002-5749-2785				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Holmqvist MH, 2001, J NEUROSCI, V21, P4154, DOI 10.1523/JNEUROSCI.21-12-04154.2001; Jahng AW, 2002, J BIOL CHEM, V277, P47885, DOI 10.1074/jbc.M208416200; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; McPherson A Jr, 1976, Methods Biochem Anal, V23, P249, DOI 10.1002/9780470110430.ch4; Nakamura TY, 1997, AM J PHYSIOL-HEART C, V273, pH1775, DOI 10.1152/ajpheart.1997.273.4.H1775; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Tsaur ML, 1997, FEBS LETT, V400, P215, DOI 10.1016/S0014-5793(96)01388-9; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; WU RL, 1992, J NEUROSCI, V12, P2235; Zaidi NF, 2002, NEUROSCIENCE, V114, P247, DOI 10.1016/S0306-4522(02)00251-8	34	94	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					587	598		10.1016/S0896-6273(04)00049-2	http://dx.doi.org/10.1016/S0896-6273(04)00049-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980207	Bronze			2022-12-28	WOS:000221458100011
J	Kiehn, O; Kullander, K				Kiehn, O; Kullander, K			Central pattern generators deciphered by molecular genetics	NEURON			English	Editorial Material							SPINAL-CORD; CORTICOSPINAL TRACT; NEURONAL CIRCUITS; NEURAL PATHWAYS; ION CHANNELS; LOCOMOTION; RECEPTOR; EXPRESSION; DROSOPHILA; TRANSGENE	Central pattern generators (CPGs) are localized neuronal networks that have the ability to produce rhythmic movements even in the absence of movement-related sensory feedback. They are found in all animals, including man, and serve as informative model systems for understanding how neuronal networks produce behavior. Traditionally, CPGs have been investigated with electrophysiological techniques. Here we review recent molecular and genetic approaches for dissecting the organization and development of CPGs.	Karolinska Inst, Mammalian Locomotor Lab, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Gothenburg, Dept Biochem Med, S-40530 Gothenburg, Sweden	Karolinska Institutet; University of Gothenburg	Kiehn, O (corresponding author), Karolinska Inst, Mammalian Locomotor Lab, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.		Kiehn, Ole/C-4679-2008; kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019	Kullander, Klas/0000-0001-6418-5460				Cohen A., 1988, NEURAL CONTROL RHYTH; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Granato M, 1996, DEVELOPMENT, V123, P399; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Yoshihara Y, 2002, NEUROSCI RES, V44, P133, DOI 10.1016/S0168-0102(02)00130-X; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang Y, 2003, J NEUROSCI, V23, P9059; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	25	77	78	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 5	2004	41	3					317	321		10.1016/S0896-6273(04)00042-X	http://dx.doi.org/10.1016/S0896-6273(04)00042-X			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766172	Bronze			2022-12-28	WOS:000221457900004
J	Grubb, MS; Rossi, FM; Changeux, JP; Thompson, ID				Grubb, MS; Rossi, FM; Changeux, JP; Thompson, ID			Abnormal functional organization in the dorsal lateral geniculate nucleus of mice lacking the beta 2 subunit of the nicotinic acetylcholine receptor	NEURON			English	Article							EYE-SPECIFIC SEGREGATION; RETINAL GANGLION-CELLS; OPTIC-NERVE TERMINALS; RETINOCOLLICULAR PROJECTION; TOPOGRAPHIC SPECIFICITY; SYNAPTIC TRANSMISSION; POSTNATAL-DEVELOPMENT; SUPERIOR COLLICULUS; BINDING-SITES; RETINOGENICULATE	Spontaneous activity patterns in the developing retina appear important for the functional organization of the visual system. We show here that an absence of early retinal waves in mice lacking the beta2 subunit of the nicotinic acetylcholine receptor (nAChR) is associated with both gain and loss of functional organization in the dorsal lateral geniculate nucleus (dLGN). Anatomical studies show normal gross retinotopy in the beta2(-/-) dLGN but suggest reduced topographic precision in the retinogeniculate projection. Physiological recordings reveal normal topography in the dorsoventral visual axis but a lack of fine-scale mapping in the nasotemporal visual plane. In contrast, unlike wildtype mice, on- and off-center cells in the beta2(-/-) dLGN are spatially segregated. The presence of the beta2 subunit of the nAChR in the CNS is therefore important for normal functional organization in the retinogeniculate projection.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Inst Pasteur, CNRS, URA 2182, Dept Biotechnol, F-75724 Paris 15, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thompson, ID (corresponding author), Univ Oxford, Physiol Lab, Pks Rd, Oxford OX1 3PT, England.		Thompson, Ian D/C-5785-2009; Grubb, Matthew S/B-4939-2008; Rossi, Francesco Mattia/K-6544-2015	Grubb, Matthew S/0000-0002-2673-274X; Rossi, Francesco Mattia/0000-0001-9855-5925				Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bansal A, 2000, J NEUROSCI, V20, P7672; BONAVENTURE N, 1968, CR SOC BIOL, V162, P553; Butts DA, 2002, NEUROSCIENTIST, V8, P243; Chalupa LM, 1998, J COMP NEUROL, V392, P35, DOI 10.1002/(SICI)1096-9861(19980302)392:1<35::AID-CNE3>3.0.CO;2-Q; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; EYSEL UT, 1986, J PHYSIOL-LONDON, V370, P233, DOI 10.1113/jphysiol.1986.sp015932; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FRANCESCONI W, 1988, J NEUROPHYSIOL, V59, P1690, DOI 10.1152/jn.1988.59.6.1690; FRAUNFEL.FT, 1970, EXP EYE RES, V10, P19, DOI 10.1016/S0014-4835(70)80005-7; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GRANT S, 1992, EUR J NEUROSCI, V4, P37, DOI 10.1111/j.1460-9568.1992.tb00107.x; GRUBB MS, 2003, IN PRESS J NEUROPHYS, V27; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; King AJ, 1998, J NEUROSCI, V18, P9394; KING WM, 1990, BRAIN RES, V527, P150; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; Lena C, 1997, J NEUROSCI, V17, P576; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; METIN C, 1983, CR ACAD SCI III-VIE, V296, P157; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; NAEFF B, 1992, DEV BRAIN RES, V68, P163, DOI 10.1016/0165-3806(92)90058-5; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; PRUSKY GT, 1988, VISUAL NEUROSCI, V1, P245, DOI 10.1017/S0952523800001504; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SILLITO AM, 1983, BRAIN RES, V280, P299, DOI 10.1016/0006-8993(83)90059-8; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; SIMON DK, 1991, J COMP NEUROL, V307, P393, DOI 10.1002/cne.903070305; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; STRYKER MP, 1983, J NEUROSCI, V3, P1943; SWANSON LW, 1987, J NEUROSCI, V7, P3334; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Yu CJ, 2003, EUR J NEUROSCI, V17, P1253, DOI 10.1046/j.1460-9568.2003.02557.x; Zar JH., 1999, BIOSTAT ANAL; Zhu JJ, 1997, NEUROSCIENCE, V80, P191, DOI 10.1016/S0306-4522(97)00095-X; Zoli M, 1998, J NEUROSCI, V18, P4461	52	147	149	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1161	1172		10.1016/S0896-6273(03)00789-X	http://dx.doi.org/10.1016/S0896-6273(03)00789-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687550	Bronze			2022-12-28	WOS:000187503400014
J	Goldberg, JH; Tamas, G; Aronov, D; Yuste, R				Goldberg, JH; Tamas, G; Aronov, D; Yuste, R			Calcium microdomains in aspiny dendrites	NEURON			English	Article							NEOCORTICAL INTERNEURON DENDRITES; ANTEROVENTRAL COCHLEAR NUCLEUS; GLUTAMATE-RECEPTOR ACTIVATION; AII AMACRINE CELLS; CAT VISUAL-CORTEX; AMPA RECEPTORS; NMDA RECEPTORS; CA2+-PERMEABLE AMPA; PYRAMIDAL NEURONS; HIPPOCAMPAL INTERNEURONS	Dendritic spines receive excitatory synapses and serve as calcium compartments, which appear to be necessary for input-specific synaptic plasticity. Dendrites of GABAergic interneurons have few or no spines and thus do not possess a clear morphological basis for synapse-specific compartmentalization. We demonstrate using two-photon calcium imaging that activation of single synapses on aspiny dendrites of neocortical fast spiking (FS) interneurons creates highly localized calcium microdomains, often restricted to less than 1 mum of dendritic space. We confirm using ultrastructural reconstruction of imaged dendrites the absence of any morphological basis for this compartmentalization and show that it is dependent on the fast kinetics of calcium-permeable (CP) AMPA receptors and fast local extrusion via. the Na+/Ca2+ exchanger. Because aspiny dendrites throughout the CNS express CP-AMPA receptors, we propose that CP-AMPA receptors mediate a spine-free mechanism of input-specific calcium compartmentalization.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary	Columbia University; Szeged University	Goldberg, JH (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.		Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001; Goldberg, Jesse/0000-0003-0422-8902	NEI NIH HHS [EY11787] Funding Source: Medline; NINDS NIH HHS [NS40726] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albuquerque C, 1999, EUR J NEUROSCI, V11, P2758, DOI 10.1046/j.1460-9568.1999.00691.x; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CATAL SRY, 1999, TEXTURA SISERNA NERI; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; DELANEY KR, 1989, J NEUROSCI, V9, P3558; FAIREN A, 1984, NONPYRAMIDICAL NEURO, P201; GABRIEL R, 1992, BRAIN RES, V595, P133, DOI 10.1016/0006-8993(92)91462-N; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Gardner SM, 2001, J NEUROSCI, V21, P7428, DOI 10.1523/JNEUROSCI.21-18-07428.2001; Gardner SM, 1999, J NEUROSCI, V19, P8721, DOI 10.1523/JNEUROSCI.19-20-08721.1999; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Gotz T, 1997, J NEUROSCI, V17, P204; Gulyas AI, 1999, J NEUROSCI, V19, P10082; HAMANO K, 1990, J COMP NEUROL, V302, P417, DOI 10.1002/cne.903020217; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HELMCHEN F, 1999, DENDRITES, P161; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KOCH C, 1993, J NEUROSCI, V13, P413; Koch C., 1998, BIOPHYSICS COMPUTATI; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P1722; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; MUGNAINI E, 1985, J COMP NEUROL, V235, P61, DOI 10.1002/cne.902350106; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; OHSHIMA T, 1991, J NEUROL, V238, P320, DOI 10.1007/BF00315329; Otis T. S., 1995, Biophysical Journal, V68, pA397; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Prince HC, 2000, SYNAPSE, V38, P489, DOI 10.1002/1098-2396(20001215)38:4<489::AID-SYN15>3.0.CO;2-N; Ranciat-McComb NS, 2000, NEUROSCI LETT, V294, P13, DOI 10.1016/S0304-3940(00)01524-X; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; SIK A, 1995, J NEUROSCI, V15, P6651; Smith Y, 1998, J COMP NEUROL, V391, P164, DOI 10.1002/(SICI)1096-9861(19980209)391:2<164::AID-CNE2>3.0.CO;2-0; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; SOMOGYI P, 1983, NEUROSCIENCE, V9, P475, DOI 10.1016/0306-4522(83)90167-7; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1997, J NEUROSCI, V17, P6352; Teskey GC, 1999, CEREB CORTEX, V9, P675, DOI 10.1093/cercor/9.7.675; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3031, DOI 10.1016/0306-4522(82)90228-7; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3053, DOI 10.1016/0306-4522(82)90229-9; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Yuste R, 2001, NEUROSCIENTIST, V7, P387, DOI 10.1177/107385840100700508; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	91	161	164	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					807	821		10.1016/S0896-6273(03)00714-1	http://dx.doi.org/10.1016/S0896-6273(03)00714-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622584	Bronze			2022-12-28	WOS:000186651200015
J	Colledge, M; Snyder, EM; Crozier, RA; Soderling, JA; Jin, YT; Langeberg, LK; Lu, H; Bear, MF; Scott, JD				Colledge, M; Snyder, EM; Crozier, RA; Soderling, JA; Jin, YT; Langeberg, LK; Lu, H; Bear, MF; Scott, JD			Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression	NEURON			English	Article							LONG-TERM DEPRESSION; BIDIRECTIONAL SYNAPTIC PLASTICITY; D-ASPARTATE RECEPTORS; PROTEIN-KINASE-A; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; PROTEASOME SYSTEM; ADENOVIRUS E4-ORF1; TUMOR-SUPPRESSOR; E6 ONCOPROTEINS	PSD-95 is a major scaffolding protein of the postsynaptic density, tethering NMDA- and AMPA-type glutamate receptors to signaling proteins and the neuronal cytoskeleton. Here we show that PSD-95 is regulated by the ubiquitin-proteasome pathway. PSD-95 interacts with and is ubiquitinated by the E3 ligase Mdm2. In response to NMDA receptor activation, PSD-95 is ubiquitinated and rapidly removed from synaptic sites by proteasome-dependent degradation. Mutations that block PSD-95 ubiquitination prevent NMDA-induced AMPA receptor endocytosis. Likewise, proteasome inhibitors prevent NMDA-induced AMPA receptor internalization and synaptically induced long-term depression. This is consistent with the notion that PSD-95 levels are an important determinant of AMPA receptor number at the synapse. These data suggest that ubiquitination of PSD-95 through an Mdm2-mediated pathway is critical in regulating AMPA receptor surface expression during synaptic plasticity.	Oregon Hlth Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Scott, JD (corresponding author), Oregon Hlth Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97239 USA.			Bear, Mark/0000-0002-9903-2541	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048231, R37 GM048231, GM48231] Funding Source: Medline; NINDS NIH HHS [NS39321, P01 NS039321] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Ehlers M.D., 2003, NAT NEUROSCI, V10, P10; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; LUNA RMD, 1995, NATURE, V378, P203; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moss A, 2002, J NEUROSCI, V22, P1363, DOI 10.1523/JNEUROSCI.22-04-01363.2002; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stein V, 2003, J NEUROSCI, V23, P5503; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	62	415	435	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					595	607		10.1016/S0896-6273(03)00687-1	http://dx.doi.org/10.1016/S0896-6273(03)00687-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642282	Bronze, Green Accepted			2022-12-28	WOS:000186379000017
J	Nelson, AB; Krispel, CM; Sekirnjak, C; du Lac, S				Nelson, AB; Krispel, CM; Sekirnjak, C; du Lac, S			Long-lasting increases in intrinsic excitability triggered by inhibition	NEURON			English	Article							VESTIBULAR NUCLEUS NEURONS; BRAIN-STEM NEURONS; ELECTRO-PHYSIOLOGICAL OBSERVATIONS; PRIMATE VESTIBULOOCULAR REFLEX; ACTIVATED POTASSIUM CHANNELS; DEEP CEREBELLAR NUCLEI; TERM ADAPTIVE-CHANGES; UNILATERAL LABYRINTHECTOMY; SQUIRREL-MONKEY; PURKINJE-CELLS	Although experience-dependent changes in neural circuits are commonly assumed to be mediated by synaptic plasticity, modifications of intrinsic excitability may serve as a complementary mechanism. In whole-cell recordings from spontaneously firing vestibular nucleus neurons, brief periods of inhibitory synaptic stimulation or direct membrane hyperpolarization triggered long-lasting increases in spontaneous firing rates and firing responses to intracellular depolarization. These increases in excitability, termed firing rate potentiation, were induced by decreases in intracellular calcium and expressed as reductions in the sensitivity to the BK-type calcium-activated potassium channel blocker iberiotoxin. Firing rate potentiation is a novel form of cellular plasticity that could contribute to motor learning in the vestibulo-ocular reflex.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	du Lac, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NEI NIH HHS [EY11027] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011027] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Bennett BD, 1999, J NEUROSCI, V19, P5586; Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Cameron SA, 1997, NEUROREPORT, V8, P2595, DOI 10.1097/00001756-199707280-00035; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Darlington CL, 2002, EUR J NEUROSCI, V15, P1719, DOI 10.1046/j.1460-9568.2002.02024.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DIERINGER N, 1979, EXP BRAIN RES, V36, P329, DOI 10.1007/BF00238915; DIERINGER N, 1979, EXP BRAIN RES, V36, P311, DOI 10.1007/BF00238914; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; DULAC S, 1995, J COMP PHYSIOL A, V176, P641; duLac S, 1996, ANN NY ACAD SCI, V781, P489; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUCHS AF, 1975, J NEUROPHYSIOL, V38, P1140, DOI 10.1152/jn.1975.38.5.1140; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P242, DOI 10.1152/jn.1984.51.2.242; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Graham BP, 2001, EXP BRAIN RES, V137, P387, DOI 10.1007/s002210100677; Him A, 2001, BRAIN RES, V908, P58, DOI 10.1016/S0006-8993(01)02600-2; Hirata Y, 2002, J NEUROPHYSIOL, V88, P3194, DOI 10.1152/jn.00698.2001; Hirata Y, 2001, J NEUROPHYSIOL, V85, P2267, DOI 10.1152/jn.2001.85.5.2267; ITO M, 1982, EXP BRAIN RES, V45, P233; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; Johnston AR, 2002, J PHYSIOL-LONDON, V545, P903, DOI 10.1113/jphysiol.2002.024281; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; LISBERGER SG, 1992, NATURE, V360, P159, DOI 10.1038/360159a0; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P954, DOI 10.1152/jn.1994.72.2.954; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P928, DOI 10.1152/jn.1994.72.2.928; LISBERGER SG, 1984, J NEUROPHYSIOL, V52, P1140, DOI 10.1152/jn.1984.52.6.1140; LISBERGER SG, 1988, SCIENCE, V242, P771, DOI 10.1126/science.3142040; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; Mahon S, 2003, J PHYSIOL-LONDON, V550, P947, DOI 10.1113/jphysiol.2003.043125; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McElligott JG, 1998, J NEUROPHYSIOL, V79, P1286, DOI 10.1152/jn.1998.79.3.1286; MILES FA, 1980, J NEUROPHYSIOL, V43, P1477, DOI 10.1152/jn.1980.43.5.1477; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; NAGAO S, 1983, EXP BRAIN RES, V53, P36; NEWLANDS SD, 1990, EXP BRAIN RES, V82, P359, DOI 10.1007/BF00231255; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P615, DOI 10.1152/jn.1995.73.2.615; PRECHT W, 1966, J NEUROPHYSIOL, V29, P996, DOI 10.1152/jn.1966.29.6.996; Raman IM, 2000, J NEUROSCI, V20, P9004; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; REINHART PH, 1991, J NEUROSCI, V11, P1627; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; SCHAIRER JO, 1986, BRAIN RES, V373, P164, DOI 10.1016/0006-8993(86)90327-6; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; Sekirnjak C, 2003, J NEUROSCI, V23, P6392; Sekirnjak C, 2002, J NEUROSCI, V22, P2083, DOI 10.1523/JNEUROSCI.22-06-02083.2002; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Smith PF, 1996, TRENDS PHARMACOL SCI, V17, P421, DOI 10.1016/S0165-6147(96)10050-X; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Smith SL, 2003, J NEUROSCI, V23, P367, DOI 10.1523/JNEUROSCI.23-02-00367.2003; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; van Alphen AM, 2002, EUR J NEUROSCI, V16, P486, DOI 10.1046/j.1460-9568.2002.02094.x; WATANABE E, 1984, BRAIN RES, V297, P169, DOI 10.1016/0006-8993(84)90555-9; Yamanaka T, 2000, J PHYSIOL-LONDON, V523, P413, DOI 10.1111/j.1469-7793.2000.t01-1-00413.x	66	181	184	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					609	620		10.1016/S0896-6273(03)00641-X	http://dx.doi.org/10.1016/S0896-6273(03)00641-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642283	Bronze			2022-12-28	WOS:000186379000018
J	Sejnowski, TJ				Sejnowski, TJ			In memoriam: Francis H.C. Crick	NEURON			English	Biographical-Item									Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Sejnowski, Terrence/AAV-5558-2021						0	2	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 2	2004	43	5					619	621		10.1016/S0896-6273(04)00532-X	http://dx.doi.org/10.1016/S0896-6273(04)00532-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339644	Bronze			2022-12-28	WOS:000223691900008
J	Emery, P; Reppert, SM				Emery, P; Reppert, SM			A rhythmic ror	NEURON			English	Editorial Material							DROSOPHILA CIRCADIAN OSCILLATOR; CLOCK; TRANSCRIPTION; VRILLE; ALPHA; EXPRESSION; ELEMENT; LOOPS; GENE	The circadian clock mechanism in mammals involves two interlocking transcriptional feedback loops. Reverb alpha, through its role as a transcriptional repressor, was thought to be the primary determinant of the feedback loop that regulates Bmal1 transcription. Results reported by Sato et al. in this issue of Neuron now show that the transactivator Rora acts coordinately with Rev-erb alpha and that their competing activities on the same promoter element drive the rhythm in Bmal1 transcription. This finding defines the second feedback loop in mammals.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.							Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906	15	97	98	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 19	2004	43	4					443	446		10.1016/j.neuron.2004.08.009	http://dx.doi.org/10.1016/j.neuron.2004.08.009			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312644	Bronze			2022-12-28	WOS:000223436400004
J	Cao, YQ; Piedras-Renteria, ES; Smith, GB; Chen, G; Harata, NC; Tsien, RW				Cao, YQ; Piedras-Renteria, ES; Smith, GB; Chen, G; Harata, NC; Tsien, RW			Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; EXCITATORY SYNAPTIC-TRANSMISSION; CALCIUM-CHANNEL; TRANSMITTER RELEASE; N-TYPE; NERVE-TERMINALS; EPISODIC ATAXIA; CURRENT-DENSITY; MUTATIONS; EXPRESSION	Several human channelopathies result from mutations in alpha(1A), the pore-forming subunit of P/Q-type Ca2+ channels, conduits of presynaptic Ca2+ entry for evoked neurotransmission. We found that wild-type human alpha(1A) subunits supported transmission between cultured mouse hippocampal neurons equally well as endogenous mouse alpha(1A), whereas introduction of impermeant human alpha(1A) hampered the effect of endogenous subunits. Thus, presynaptic P/Q-type channels may compete for channel type-preferring "slots" that limit their synaptic effectiveness. The existence of slots generates predictions for how neurotransmission might be affected by changes in Ca2+ channel properties, which we tested by studying alpha(1A) mutations that are associated with familial hemiplegic migraine type 1 (FHM1). Mutant human P/Q-type channels were impaired in contributing to neurotransmission in precise accord with their deficiency in supporting whole-cell Ca2+ channel activity. Expression of mutant channels in wild-type neurons reduced the synaptic contribution of P/Q-type channels, suggesting that competition for type-preferring slots might support the dominant inheritance of FHM1.	Stanford Univ, Sch Med, Beckman Ctr, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Harata, N. Charles/0000-0003-3287-4549; Chen JNU, Gong/0000-0002-1857-3670; Piedras-Renteria, Erika/0000-0001-7983-585X	NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambrosini A, 2001, NEUROLOGY, V56, P1038, DOI 10.1212/WNL.56.8.1038; Ashcroft F. M., 2000, ION CHANNELS DIS CHA; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Currie KPM, 2002, J PHYSIOL-LONDON, V539, P419, DOI 10.1113/jphysiol.2001.013206; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Denier C, 2001, ARCH NEUROL-CHICAGO, V58, P292, DOI 10.1001/archneur.58.2.292; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hans M, 1999, J NEUROSCI, V19, P1610; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Jen J, 1999, NEUROLOGY, V53, P34, DOI 10.1212/WNL.53.1.34; Jen J, 2001, NEUROLOGY, V57, P1843, DOI 10.1212/WNL.57.10.1843; Jen J, 1999, CURR OPIN NEUROBIOL, V9, P274, DOI 10.1016/S0959-4388(99)80040-3; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Knight YE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0002.2002; Kors EE, 2002, CURR OPIN NEUROL, V15, P311, DOI 10.1097/00019052-200206000-00014; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; Krovetz HS, 2000, J NEUROSCI, V20, P7564; Kullmann DM, 2002, LANCET NEUROL, V1, P157, DOI 10.1016/S1474-4422(02)00071-6; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Maximov A, 2002, J NEUROSCI, V22, P6939; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pagani R, 2004, NEUROSCIENCE, V123, P75, DOI 10.1016/j.neuroscience.2003.09.019; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; RAHAMIMOFF R, 1969, ELECTROEN CLIN NEURO, V27, P219; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Reid CA, 1997, J NEUROSCI, V17, P2738; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Soong TW, 2002, J NEUROSCI, V22, P10142; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Tsien RW, 1999, CALCIUM AS A CELLULAR REGULATOR, P171; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Wheeler DB, 1996, J NEUROSCI, V16, P2226; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, J NEUROSCI, V14, P645; Wu LG, 1999, J NEUROSCI, V19, P726; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zhou YD, 2003, J PHYSIOL-LONDON, V547, P497, DOI 10.1113/jphysiol.2002.033415	64	129	134	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					387	400		10.1016/j.neuron.2004.07.014	http://dx.doi.org/10.1016/j.neuron.2004.07.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294146	Bronze			2022-12-28	WOS:000223156900012
J	Strissel, KJ; Arshavsky, VY				Strissel, KJ; Arshavsky, VY			Myosin III illuminates the mechanism of arrestin translocation	NEURON			English	Editorial Material							LIGHT ADAPTATION; PHOTORECEPTORS; DROSOPHILA; ROD	Recent studies have revealed that light adaptation of both vertebrate and invertebrate photoreceptors; is accompanied by massive translocations of major signaling proteins in and out of the cellular compartments where visual signal transduction takes place. In this issue of Neuron, Lee and Montell report a breakthrough in understanding the mechanism of arrestin translocation in Drosophila. They show that arrestin is carried into the light-sensitive microvilli by phosphoinositide-enriched vesicles driven by a myosin motor.	Harvard Univ, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Strissel, KJ (corresponding author), Harvard Univ, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA.							ARSHAVSKY VY, 2003, SCI STKE E, V43; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Hardie RC, 2003, CURR BIOL, V13, pR775, DOI 10.1016/j.cub.2003.09.021; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0	12	9	10	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 8	2004	43	1					2	4		10.1016/j.neuron.2004.06.026	http://dx.doi.org/10.1016/j.neuron.2004.06.026			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233912	Bronze			2022-12-28	WOS:000222549800002
J	Sacchetti, B; Scelfo, B; Tempia, F; Strata, P				Sacchetti, B; Scelfo, B; Tempia, F; Strata, P			Long-term synaptic changes induced in the cerebellar cortex by fear conditioning	NEURON			English	Article							PURKINJE-CELLS; GLUTAMATE-RECEPTOR; EYELID RESPONSES; NITRIC-OXIDE; HEART-RATE; IN-VITRO; RAT; CONSOLIDATION; POTENTIATION; DEPRESSION	To better understand learning mechanisms, one needs to study synaptic plasticity induced by behavioral training. Recently, it has been demonstrated that the cerebellum is involved in the consolidation of fear memory. Nevertheless, how the cerebellum contributes to emotional behavior is far from known. In cerebellar slices at 10 min and 24 hr following fear conditioning, we found a long-lasting potentiation of the synapse between parallel fibers and Purkinje cells in vermal lobules V-VI, but not in the climbing fiber synapses. The mechanism is postsynaptic, due to an increased AMPA response. In addition, in hotfoot mice with a primary deficiency of the parallel fiber to Purkinje cell synapse, cued (but not contextual) fear conditioning is affected. We propose that this synapse plays an important role in the learned fear and that its long-term potentiation may represent a contribution to the neural substrate of fear memory.	Univ Turin, Rita Levi Montalcini Ctr Brain Repair, Dept Neurosci, I-10125 Turin, Italy; Univ Perugia, Sect Human Physiol, Dept Internal Med, I-06126 Perugia, Italy; Rehabil Hosp & Res Inst, Santa Lucia Fdn, I-00179 Rome, Italy	University of Turin; University of Perugia; IRCCS Santa Lucia	Strata, P (corresponding author), Univ Turin, Rita Levi Montalcini Ctr Brain Repair, Dept Neurosci, Corso Raffaello 30, I-10125 Turin, Italy.	piergiorgio.strata@unito.it	Sacchetti, Benedetto/AFK-4141-2022; Tempia, Filippo/A-5883-2012; Sacchetti, Benedetto/AAG-2916-2022; Scelfo, Bibiana/B-5997-2017	Tempia, Filippo/0000-0003-2778-0943; Scelfo, Bibiana/0000-0002-2261-8683; Sacchetti, Benedetto/0000-0002-8695-8310				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bures J, 1998, CONDITIONED TASTE AV; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Cesa R, 2003, J NEUROSCI, V23, P2363; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Heath R G, 1981, Curr Psychiatr Ther, V20, P329; HOLLMANN H, 1994, ANNU REV NEUROSCI, V17, P31; HUANG CM, 1982, BRAIN RES, V244, P1, DOI 10.1016/0006-8993(82)90897-6; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kleim JA, 1997, J NEUROSCI, V17, P717; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Mediavilla C, 1999, NEUROBIOL LEARN MEM, V72, P13, DOI 10.1006/nlme.1998.3899; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; MOYE TB, 1987, DEV PSYCHOBIOL, V20, P405, DOI 10.1002/dev.420200405; Moyer JR, 1996, J NEUROSCI, V16, P5536; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Saab CY, 2003, BRAIN RES REV, V42, P85, DOI 10.1016/S0165-0173(03)00151-6; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P86, DOI 10.1152/jn.1997.77.1.86; SEBASTIANI L, 1992, EXP BRAIN RES, V88, P193, DOI 10.1007/BF02259141; Snider RS, 1944, J NEUROPHYSIOL, V7, P331, DOI 10.1152/jn.1944.7.6.331; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Strata Piergiorgio, 2002, Cerebellum, V1, P230, DOI 10.1080/147342202320883533; SUPPLE WF, 1990, BEHAV NEUROSCI, V104, P934; SUPPLE WF, 1988, PHYSIOL BEHAV, V42, P145, DOI 10.1016/0031-9384(88)90290-9; SUPPLE WF, 1987, PHYSIOL BEHAV, V39, P579, DOI 10.1016/0031-9384(87)90156-9; SUPPLE WF, 1993, J NEUROSCI, V13, P3705; Tempia F, 1996, J NEUROSCI, V16, P456; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1	61	132	133	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					973	982		10.1016/j.neuron.2004.05.012	http://dx.doi.org/10.1016/j.neuron.2004.05.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207241	Bronze			2022-12-28	WOS:000222329300012
J	Tsujikawa, M; Malicki, J				Tsujikawa, M; Malicki, J			Intraflagellar transport genes are essential for differentiation and survival of vertebrate sensory neurons	NEURON			English	Article							POLYCYSTIC KIDNEY-DISEASE; MUTATIONS AFFECTING DEVELOPMENT; BARDET-BIEDL-SYNDROME; EAR DEVELOPMENT; ZEBRAFISH; HOMOLOG; CILIA; CELLS; TRANSDUCTION; PROTEIN	Cilia play diverse roles in vertebrate and invertebrate sensory neurons. We show that a mutation of the zebrafish oval (ovl) locus affects a component of the ciliary transport (IFT) mechanism, the IFT88 polypeptide. In mutant retina, cilia are generated but not maintained, producing the absence of photoreceptor outer segments. A loss of cilia also occurs in auditory hair cells and olfactory sensory neurons. In all three sense organs, cilia defects are followed by degeneration of sensory cells. Similar phenotypes are induced by the absence of the IFT complex B polypeptides, ift52 and ift57, but not by the loss of complex A protein, ift140. The degeneration of mutant photoreceptor cells is caused, at least partially, by the ectopic accumulation of opsins. These studies reveal an essential role for IFT genes in vertebrate sensory neurons and implicate the molecular components of intraflagellar transport in degenerative disorders of these cells.	Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02110 USA	Harvard University; Harvard Medical School	Malicki, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02110 USA.	jarema_malicki@meei.harvard.edu	malicki, jarema/G-8611-2014	malicki, jarema/0000-0002-5947-8805	NATIONAL EYE INSTITUTE [R01EY011882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005103] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY11882] Funding Source: Medline; NIDCD NIH HHS [R01DC005103] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Brand M, 1996, DEVELOPMENT, V123, P129; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Ghadami M, 2000, AM J MED GENET, V94, P433, DOI 10.1002/1096-8628(20001023)94:5<433::AID-AJMG17>3.0.CO;2-X; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; HANSEN A, 1993, J COMP NEUROL, V333, P289, DOI 10.1002/cne.903330213; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Malicki J, 1999, METHODS CELL BIOL, V59, P273; Malicki J, 1996, DEVELOPMENT, V123, P263; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; Meyer M, 1996, J MOL BIOL, V264, P199, DOI 10.1006/jmbi.1996.0634; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pujic Z, 2001, DEV BIOL, V234, P454, DOI 10.1006/dbio.2001.0251; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Rosenbaum JL, 1999, J CELL BIOL, V144, P385, DOI 10.1083/jcb.144.3.385; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SCHRICK JJ, 1995, HUM MOL GENET, V4, P559, DOI 10.1093/hmg/4.4.559; SOBKOWICZ HM, 1995, J NEUROCYTOL, V24, P633, DOI 10.1007/BF01179815; STREISINGER G, 1986, GENETICS, V112, P311; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yoshida T, 2002, J NEUROSCI, V22, P4964, DOI 10.1523/JNEUROSCI.22-12-04964.2002; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	39	210	213	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					703	716		10.1016/S0896-6273(04)00268-5	http://dx.doi.org/10.1016/S0896-6273(04)00268-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182712	Bronze			2022-12-28	WOS:000221975000004
J	Ninan, I; Arancio, O				Ninan, I; Arancio, O			Presynaptic CaMKII is necessary for synaptic plasticity in cultured hippocampal neurons	NEURON			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; CALMODULIN-DEPENDENT KINASE; NITRIC-OXIDE; SYNAPSIN-I; NEUROTRANSMITTER RELEASE; GLUTAMATE RECEPTORS; AUTOPHOSPHORYLATION; ALPHA; EXPRESSION	Calcium/calmodulin-dependent protein kinase II (CaMKII) is a multifunctional enzyme that is very critical for synaptic plasticity and memory formation. Although significant progress has been made in understanding the role of postsynaptic CaMKII in synaptic plasticity, very little is known about its presynaptic function during plasticity changes. Here we report that KN-93, a membrane-permeable CaMKII inhibitor, blocked glutamate-induced increases in the frequency of miniature excitatory postsynaptic currents (mEPSCs) and the number of presynaptic functional boutons in cultured hippocampal pyramidal neurons. In addition, presynaptic injection of the membrane-impermeable CaMKII inhibitor peptide 281-309 blocked synaptic plasticity induced by tetanus, glutamate, or NO/cGMP pathway activation as expressed by long-lasting increases in EPSC amplitude and functional presynaptic boutons. Presynaptic injection of CaMKII itself coupled with weak tetanus produced an immediate and long-lasting enhancement of EPSC amplitude. Thus, the present results conclusively prove that presynaptic CaMKII is essential for synaptic plasticity in cultured hippocampal neurons.	NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; Nathan S Kline Inst Psychiat Res, Dementia Res Ctr, Orangeburg, NY 10962 USA	New York University; New York University; Nathan Kline Institute for Psychiatric Research	Arancio, O (corresponding author), Columbia Univ, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	oa1@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X; Ninan, Ipe/0000-0001-9774-6455	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040045] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 40045] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Benfenati F, 1996, MOL BRAIN RES, V40, P297, DOI 10.1016/0169-328X(96)00053-8; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carlier E, 2000, BIOCHEM BIOPH RES CO, V274, P394, DOI 10.1006/bbrc.2000.3145; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GORELICK FS, 1988, J BIOL CHEM, V263, P17209; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Jin I, 2003, J NEUROSCI, V23, P7288; JOHNSTON HM, 1995, MOL BRAIN RES, V31, P141, DOI 10.1016/0169-328X(95)00046-U; Jourdain P, 2003, J NEUROSCI, V23, P10645; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lissin DV, 1999, J NEUROSCI, V19, P1263; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; OCORR KA, 1991, NEURON, V6, P907, DOI 10.1016/0896-6273(91)90231-N; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Ohyama A, 2002, J NEUROSCI, V22, P3342; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; RICH DP, 1989, J NEUROCHEM, V53, P807, DOI 10.1111/j.1471-4159.1989.tb11777.x; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	62	90	101	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					129	141		10.1016/S0896-6273(04)00143-6	http://dx.doi.org/10.1016/S0896-6273(04)00143-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066270	Bronze			2022-12-28	WOS:000221458400013
J	Bentley, P; Husain, M; Dolan, RJ				Bentley, P; Husain, M; Dolan, RJ			Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory	NEURON			English	Article							ACETYLCHOLINE-RELEASE; SUSTAINED ATTENTION; CORTICAL ACETYLCHOLINE; ALZHEIMERS-DISEASE; TOP-DOWN; CORTEX; PERFORMANCE; SCOPOLAMINE; MODULATION; NICOTINE	We compared behavioral and neural effects of cholinergic enhancement between spatial attention, spatial working memory (WM), and visual control tasks, using fMRI and the anticholinesterase physostigmine. Physostigmine speeded responses nonselectively but increased accuracy selectively for attention. Physostigmine also decreased activations to visual stimulation across all tasks within primary visual cortex, increased extrastriate occipital cortex activation selectively during maintained attention and WM encoding, and decreased parietal activation selectively during maintained attention. Finally, lateralization of occipital activation as a function of the visual hemifield toward which attention or memory was directed was decreased under physostigmine. In the case of attention, this effect correlated strongly with a decrease in a behavioral measure of selective spatial processing. Our results suggest that, while cholinergic enhancement facilitates visual attention by increasing activity in extrastriate cortex generally, it accomplishes this in a manner that reduces expectation-driven selective biasing of extrastriate cortex.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Charing Cross Hosp, Dept Neurol, London W6 8RF, England; Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; Imperial College London; University of London; University College London	Bentley, P (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	p.bentley@fil.ion.ucl.ac.uk	Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Dolan, Ray/0000-0001-9356-761X; Bentley, Paul/0000-0001-8036-7010				Acquas E, 1996, J NEUROSCI, V16, P3089; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Baxter MG, 1996, NEUROREPORT, V7, P1417, DOI 10.1097/00001756-199605310-00019; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Berntson GG, 1998, BEHAV BRAIN RES, V94, P225, DOI 10.1016/S0166-4328(98)00041-2; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Chappell J, 1998, NEUROPHARMACOLOGY, V37, P481, DOI 10.1016/S0028-3908(98)00032-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; Davidson MC, 2000, J NEUROPHYSIOL, V83, P1536, DOI 10.1152/jn.2000.83.3.1536; Ernst M, 2001, NEUROPSYCHOPHARMACOL, V25, P313, DOI 10.1016/S0893-133X(01)00257-3; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Furey ML, 2000, PHARMACOL BIOCHEM BE, V66, P475, DOI 10.1016/S0091-3057(00)00186-6; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Glaser DE, 2001, NEUROIMAGE, V13, pS127; GRASBY PM, 1995, EXP BRAIN RES, V104, P337; Hasselmo ME, 1996, BEHAV BRAIN RES, V79, P153, DOI 10.1016/0166-4328(96)00010-1; Heishman SJ, 1994, EXP CLIN PSYCHOPHARM, V2, P345, DOI 10.1037/1064-1297.2.4.345; Herremans AHJ, 1996, BRAIN RES, V711, P102, DOI 10.1016/0006-8993(95)01404-7; Himmelheber AM, 2000, COGNITIVE BRAIN RES, V9, P313, DOI 10.1016/S0926-6410(00)00012-4; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MASH DC, 1988, J COMP NEUROL, V278, P265, DOI 10.1002/cne.902780209; McGaughy J, 1998, BEHAV NEUROSCI, V112, P1519, DOI 10.1037/0735-7044.112.6.1519; Mentis MJ, 2001, NEUROPSYCHOPHARMACOL, V25, P555, DOI 10.1016/S0893-133X(01)00264-0; MURPHY PC, 1991, NEUROSCIENCE, V40, P13, DOI 10.1016/0306-4522(91)90170-S; Park S, 2000, NEUROPSYCHOPHARMACOL, V22, P200, DOI 10.1016/S0893-133X(99)00098-6; Phillips JM, 2000, PSYCHOPHARMACOLOGY, V150, P112, DOI 10.1007/s002130000437; PHILLIS JW, 1965, NATURE, V207, P1253, DOI 10.1038/2071253a0; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Prusky G T, 1988, Brain Res, V467, P161; Robbins TW, 1998, ATTENTIVE BRAIN, P189; Robbins TW, 1997, PSYCHOPHARMACOLOGY, V134, P95, DOI 10.1007/s002130050430; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; RUSTED JM, 1988, PSYCHOPHARMACOLOGY, V96, P145; SAHAKIAN BJ, 1993, PSYCHOPHARMACOLOGY, V110, P395, DOI 10.1007/BF02244644; Sarter M, 2003, NEUROBIOL LEARN MEM, V80, P245, DOI 10.1016/S1074-7427(03)00070-4; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Stewart C, 2001, PSYCHOPHARMACOLOGY, V155, P210, DOI 10.1007/s002130100692; Thiel CM, 2002, EUR J NEUROSCI, V16, P2199, DOI 10.1046/j.1460-9568.2002.02272.x; Thiel CM, 2001, J NEUROSCI, V21, P6846, DOI 10.1523/JNEUROSCI.21-17-06846.2001; VOYTKO ML, 1994, J NEUROSCI, V14, P167; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	54	134	136	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 25	2004	41	6					969	982		10.1016/S0896-6273(04)00145-X	http://dx.doi.org/10.1016/S0896-6273(04)00145-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046728	Bronze, Green Published			2022-12-28	WOS:000221458300015
J	Walker, DL; Davis, M				Walker, DL; Davis, M			Are fear memories made and maintained by the same NMDA receptor-dependent mechanisms?	NEURON			English	Editorial Material							ANTAGONISTS; ACQUISITION; EXPRESSION; BLOCKING; AMYGDALA		Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Ctr Mol & Behav Neurosci, Atlanta, GA 30322 USA	Emory University	Walker, DL (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,Suite 4000, Atlanta, GA 30322 USA.							Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Gewirtz JC, 1997, NATURE, V388, P471, DOI 10.1038/41325; GOULD E, 1990, J NEUROSCI, V10, P1286; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776	12	6	6	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 4	2004	41	5					680	682		10.1016/S0896-6273(04)00114-X	http://dx.doi.org/10.1016/S0896-6273(04)00114-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003167	Bronze			2022-12-28	WOS:000221458200003
J	Gaudilliere, B; Konishi, Y; de la Iglesia, N; Yao, GI; Bonni, A				Gaudilliere, B; Konishi, Y; de la Iglesia, N; Yao, GI; Bonni, A			A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis	NEURON			English	Article							MOLECULAR MECHANISMS; EXPRESSION PATTERNS; GRANULE CELLS; KINASE-II; PROTEIN; ACTIVATION; CREB; PHOSPHORYLATION; OUTGROWTH; GROWTH	The elaboration of dendrites is fundamental to the establishment of neuronal polarity and connectivity, but the mechanisms that underlie dendritic morphogenesis are poorly understood. We found that the genetic knockdown of the transcription factor NeuroD in primary granule neurons including in organotypic cerebellar slices profoundly impaired the generation and maintenance of dendrites while sparing the development of axons. We also found that NeuroD mediated neuronal activity-dependent dendritogenesis. The activity-induced protein kinase CaMKII catalyzed the phosphorylation of NeuroD at distinct sites, including endogenous NeuroD at Ser336 in primary neurons, and thereby stimulated dendritic growth. These findings uncover an essential function for NeuroD in granule neuron dendritic morphogenesis. Our study also defines the CaMKII-NeuroD signaling pathway as a novel mechanism underlying activity-regulated dendritic growth that may play important roles in the developing and mature brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	de la Iglesia, Nuria/E-1420-2015	de la Iglesia, Nuria/0000-0002-1083-7715; Gaudilliere, Brice/0000-0002-3475-5706	NINDS NIH HHS [R01-NS41021-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altman J, 1997, DEV CEREBELLAR SYSTE; Borodinsky LN, 2002, J NEUROCHEM, V80, P1062, DOI 10.1046/j.1471-4159.2002.00795.x; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lee JE, 1997, DEV NEUROSCI-BASEL, V19, P27, DOI 10.1159/000111182; Lee JK, 2000, DEV DYNAM, V217, P361, DOI 10.1002/(SICI)1097-0177(200004)217:4<361::AID-DVDY3>3.0.CO;2-8; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Ma QF, 1997, J NEUROSCI, V17, P3644; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Wellmann H, 1999, J NEUROSCI METH, V92, P55, DOI 10.1016/S0165-0270(99)00094-1; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	44	203	211	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					229	241		10.1016/S0896-6273(03)00841-9	http://dx.doi.org/10.1016/S0896-6273(03)00841-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741104	Bronze			2022-12-28	WOS:000221457800009
J	Turkeltaub, PE; Flowers, DL; Verbalis, A; Miranda, M; Gareau, L; Eden, GF				Turkeltaub, PE; Flowers, DL; Verbalis, A; Miranda, M; Gareau, L; Eden, GF			The neural basis of hyperlexic reading: An fMRI case study	NEURON			English	Article							PHONOLOGICAL PROCESSING ABILITIES; AUTOMATED IMAGE REGISTRATION; WORD RECOGNITION; DYSLEXIC-CHILDREN; YOUNG-CHILDREN; DEVELOPMENTAL DYSLEXIA; BRAIN ACTIVATION; LANGUAGE; SKILLS; COMPREHENSION	Children with autism spectrum disorders in very rare cases display surprisingly advanced "hyperlexic" reading skills. Using functional magnetic resonance imaging (fMRI), we studied the neural basis of this precocious reading ability in a 9-year-old hyperlexic boy who reads 6 years in advance of his age. During covert reading, he demonstrated greater activity in the left inferior frontal and superior temporal cortices than both chronological age- and reading age-matched controls. Activity in the right inferior temporal sulcus was greater when compared to reading age-matched controls. These findings suggest that precocious reading is brought about by simultaneously drawing on both left hemisphere phonological and right hemisphere visual systems, reconciling the two prevailing, but seemingly contradictory, single hemisphere theories of hyperlexia. Hyperlexic reading is therefore associated with hyperactivation of the left superior temporal cortex, much in the same way as developmental dyslexia is associated with hypoactivation of this area.	Georgetown Univ, Ctr Med, Washington, DC 20057 USA; Wake Forest Univ, Med Ctr, Winston Salem, NC 27157 USA	Georgetown University; Wake Forest University	Eden, GF (corresponding author), Georgetown Univ, Ctr Med, 4000 Reservoir Rd,Bldg D Suite 150, Washington, DC 20057 USA.	edeng@georgetown.edu		Turkeltaub, Peter/0000-0003-2080-6055	NCRR NIH HHS [M01-RR13297] Funding Source: Medline; NICHD NIH HHS [HD37890, HD40095] Funding Source: Medline; NIMH NIH HHS [MH65000] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD040095, R01HD037890] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR013297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH065000] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AARON PG, 1990, READ WRIT, V2, P243, DOI 10.1007/BF00257974; Aram DM, 1997, TOP LANG DISORD, V17, P1, DOI 10.1097/00011363-199705000-00003; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; BURD L, 1989, LANCET, V2, P983; BURD L, 1985, PSYCHOL REP, V57, P236, DOI 10.2466/pr0.1985.57.1.236; BURD L, 1985, PERCEPT MOTOR SKILL, V60, P940, DOI 10.2466/pms.1985.60.3.940; BURD L, 1986, J AM ACAD CHILD ADOL, V26, P407; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catts HW, 2002, J SPEECH LANG HEAR R, V45, P1142, DOI 10.1044/1092-4388(2002/093); COBRINIK L, 1982, NEUROPSYCHOLOGIA, V20, P569, DOI 10.1016/0028-3932(82)90030-6; Cohen MJ, 1997, ARCH CLIN NEUROPSYCH, V12, P223, DOI 10.1016/S0887-6177(96)00038-8; Conel J.L., 1939, POSTNATAL DEV HUMAN; Eden GF, 1998, NEURON, V21, P279, DOI 10.1016/S0896-6273(00)80537-1; Eden GF, 2002, NAT NEUROSCI, V5, P1080, DOI 10.1038/nn946; Ehri L.C., 1999, READING DEV TEACHING, P79; ELLIOTT DE, 1976, BRAIN LANG, V3, P339, DOI 10.1016/0093-934X(76)90030-4; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; FISHER W, 1988, J MENT DEFIC RES, V32, P357; Flowers L, 2001, ANN DYSLEXIA, V51, P49, DOI 10.1007/s11881-001-0005-2; Frith U., 1983, BRIT J DEV PSYCHOL, V1, P329, DOI 10.1111/j.2044-835X.1983.tb00906.x; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Gaillard WD, 2003, NEUROLOGY, V60, P94, DOI 10.1212/WNL.60.1.94; Gaillard WD, 2001, NEUROLOGY, V57, P47, DOI 10.1212/WNL.57.1.47; Georgiewa P, 2002, NEUROSCI LETT, V318, P5, DOI 10.1016/S0304-3940(01)02236-4; Georgiewa P, 1999, NEUROREPORT, V10, P3459, DOI 10.1097/00001756-199911080-00036; GOLDBERG TE, 1984, BRAIN, V107, P759, DOI 10.1093/brain/107.3.759; GOLDBERG TE, 1987, J AUTISM DEV DISORD, V17, P29, DOI 10.1007/BF01487258; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; HEALY JM, 1982, BRAIN LANG, V17, P1, DOI 10.1016/0093-934X(82)90001-3; HEALY JM, 1982, READ RES QUART, V17, P319, DOI 10.2307/747522; Hoien Torleiv, 1988, SCAND J EDUC RES, V32, P163; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1973, NEUROLOGY, V23, P1107, DOI 10.1212/WNL.23.10.1107; Kanner L, 1943, NERV CHILD, V2, P217; KISTNER J, 1988, J AUTISM DEV DISORD, V18, P191, DOI 10.1007/BF02211946; KLEIN GS, 1964, AM J PSYCHOL, V77, P576, DOI 10.2307/1420768; Lindamood C., 1979, LINDAMOOD AUDITORY C; LOVAAS OI, 1989, J BEHAV THER EXP PSY, V20, P17; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; MEHEGAN CC, 1972, NEUROLOGY, V22, P1105, DOI 10.1212/WNL.22.11.1105; Nation K, 1999, PSYCHOL BULL, V125, P338, DOI 10.1037/0033-2909.125.3.338; PATTI PJ, 1993, J AUTISM DEV DISORD, V23, P397, DOI 10.1007/BF01046228; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; PRICE CJ, 1997, HUMAN BRAIN FUNCTION, P301; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Richman LC, 2002, BRAIN LANG, V82, P10, DOI 10.1016/S0093-934X(02)00007-X; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; RUMSEY JM, 1992, ARCH NEUROL-CHICAGO, V49, P527, DOI 10.1001/archneur.1992.00530290115020; SCHADLER M, 1981, MEM COGNITION, V9, P132, DOI 10.3758/BF03202327; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; SEYMOUR PHK, 1992, COGNITIVE NEUROPSYCH, V9, P89, DOI 10.1080/02643299208252054; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SIEGEL LS, 1984, NEUROPSYCHOLOGIA, V22, P577, DOI 10.1016/0028-3932(84)90022-8; SILBERBERG NE, 1967, EXCEPT CHILDREN, V34, P41, DOI 10.1177/001440296703400106; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; Simos PG, 2000, NEUROSCI LETT, V290, P61, DOI 10.1016/S0304-3940(00)01322-7; Simos PG, 2000, NEUROREPORT, V11, P2443, DOI 10.1097/00001756-200008030-00021; SNOWLING M, 1987, HYPERLEXIA DYSLEXIA; SPARKS RL, 1995, READ WRIT, V7, P217, DOI 10.1007/BF01027186; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; TEMPLE CM, 1990, READ WRIT, V2, P297, DOI 10.1007/BF00419385; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; TIROSH E, 1993, AM J MENT RETARD, V98, P84; Treiman R, 2000, CURR DIR PSYCHOL SCI, V9, P89, DOI 10.1111/1467-8721.00067; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; WAGNER RK, 1993, J EDUC PSYCHOL, V85, P83, DOI 10.1037/0022-0663.85.1.83; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468; Wechsler D., 1991, WISC 3 WECHSLER INTE; WELSH MC, 1987, BRAIN LANG, V32, P76, DOI 10.1016/0093-934X(87)90118-0; WHITEHOUSE D, 1984, J AUTISM DEV DISORD, V14, P281, DOI 10.1007/BF02409579; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49	86	56	58	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 8	2004	41	1					11	25		10.1016/S0896-6273(03)00803-1	http://dx.doi.org/10.1016/S0896-6273(03)00803-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	761YJ	14715131	Bronze			2022-12-28	WOS:000187942800005
J	Jensen, J; McIntosh, AR; Crawley, AP; Mikulis, DJ; Remington, G; Kapur, S				Jensen, J; McIntosh, AR; Crawley, AP; Mikulis, DJ; Remington, G; Kapur, S			Direct activation of the ventral striatum in anticipation of aversive stimuli	NEURON			English	Article							EXTRACELLULAR DOPAMINE LEVELS; NUCLEUS-ACCUMBENS DOPAMINE; NEURAL RESPONSES; BRAIN ACTIVITY; REWARD; COCAINE; ROBUST; OPTIMIZATION; REGISTRATION; INVOLVEMENT	The brain "reward" system, centered on the limbic ventral striatum, plays a critical role in the response to pleasure and pain. The ventral striatum is activated in animal and human studies during anticipation of appetitive/pleasurable events, but its role in aversive/ painful events is less clear. Here we present data from three human fMRI studies based on aversive conditioning using unpleasant cutaneous electrical stimulation and show that the ventral striatum is reliably activated. This activation is observed during anticipation and is not a consequence of relief after the aversive event. Further, the ventral striatum is activated in anticipation regardless of whether there is an opportunity to avoid the aversive stimulus or not. Our data suggest that the ventral striatum, a crucial element of the brain "reward" system, is directly activated in anticipation of aversive stimuli.	Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada; Rotman Res Inst, Baycrest Geriatr Ctr, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Imaging, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Toronto	Kapur, S (corresponding author), Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada.	shitij_kapur@camh.net	McIntosh, Anthony R/G-4955-2011; Jensen, Jimmy/H-7517-2014; Mikulis, David J/H-5167-2019	Jensen, Jimmy/0000-0001-6841-1808; Mikulis, David/0000-0003-3956-0892; McIntosh, Anthony/0000-0002-1784-5662; Kapur, Shitij/0000-0002-2231-2924				Adam JJ, 2003, COGNITIVE BRAIN RES, V16, P1, DOI 10.1016/S0926-6410(02)00204-5; [Anonymous], [No title captured]; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalivas PW, 1993, LIMBIC MOTOR CIRCUIT, P237; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Marota JJA, 2000, NEUROIMAGE, V11, P13, DOI 10.1006/nimg.1999.0520; MCCULLOUGH LD, 1992, PSYCHOPHARMACOLOGY, V109, P379, DOI 10.1007/BF02245888; Mesulam M. M., 2000, PRINCIPLES BEHAV COG; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SORG BA, 1991, BRAIN RES, V559, P29, DOI 10.1016/0006-8993(91)90283-2; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Talairach J, 1988, CO PLANAR STEREOTAXI; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	49	348	350	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1251	1257		10.1016/S0896-6273(03)00724-4	http://dx.doi.org/10.1016/S0896-6273(03)00724-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687557	Bronze			2022-12-28	WOS:000187503400021
J	Barlow, A; de Graaff, E; Pachnis, V				Barlow, A; de Graaff, E; Pachnis, V			Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET	NEURON			English	Article							ENDOTHELIN-B RECEPTOR; CREST-DERIVED MELANOCYTE; MICE LACKING; MOUSE MODEL; STEM-CELLS; C-RET; GDNF; EXPRESSION; PROLIFERATION; PRECURSORS	The enteric nervous system (ENS) in vertebrates is derived mainly from vagal neural crest cells that enter the foregut and colonize the entire wall of the gastrointestinal tract. Failure to completely colonize the gut results in the absence of enteric ganglia (Hirschsprung's disease). Two signaling systems mediated by RET and EDNRB have been identified as critical players in enteric neurogenesis. We demonstrate that interaction between these signaling pathways controls ENS development throughout the intestine. Activation of EDNRB specifically enhances the effect of RET signaling on the proliferation of uncommitted ENS progenitors. In addition, we reveal novel antagonistic roles of these pathways on the migration of ENS progenitors. Protein kinase A is a key component of the molecular mechanisms that integrate signaling by the two receptors. Our data provide strong evidence that the coordinate and balanced interaction between receptor tyrosine kinases and G protein-coupled receptors controls the development of the nervous system in mammals.	Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research	Pachnis, V (corresponding author), Natl Inst Med Res, MRC, Div Mol Neurobiol, The Ridgeway, London NW7 1AA, England.	vpachni@nimr.mrc.ac.uk	de Graaff, Esther/D-3287-2011	Pachnis, Vassilis/0000-0001-9733-7686				Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; COVENTRY S, 1994, LAB INVEST, V71, P82; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Dupin E, 2001, AN ACAD BRAS CIENC, V73, P533, DOI 10.1590/S0001-37652001000400007; Durbec PL, 1996, DEVELOPMENT, V122, P349; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Focke PJ, 2003, J NEUROBIOL, V55, P151, DOI 10.1002/neu.10204; Fuchs S, 2001, MOL MED, V7, P115, DOI 10.1007/BF03401945; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Gershon MD, 1999, CLIN EXP PHARMACOL P, V26, P985, DOI 10.1046/j.1440-1681.1999.03176.x; Gershon Michael D., 1994, P381; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hou L, 2000, DEVELOPMENT, V127, P5379; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; JAMES AF, 1994, NATURE, V370, P297, DOI 10.1038/370297a0; Jiao XX, 2002, J PHARMACOL EXP THER, V303, P247, DOI 10.1124/jpet.102.037747; KAPUR RP, 1992, DEVELOPMENT, V116, P167; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kimmel CB, 2003, DEVELOPMENT, V130, P1339, DOI 10.1242/dev.00338; Lahav R, 1998, P NATL ACAD SCI USA, V95, P14214, DOI 10.1073/pnas.95.24.14214; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leibl MA, 1999, GUT, V44, P246, DOI 10.1136/gut.44.2.246; LYON MF, 1996, GENETIC VARIANTS STR; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Natarajan D, 2002, DEVELOPMENT, V129, P5151; ONO K, 1994, NATURE, V370, P301, DOI 10.1038/370301a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pattyn A, 1997, DEVELOPMENT, V124, P4065; PAYETTE RF, 1987, J COMP NEUROL, V257, P237, DOI 10.1002/cne.902570209; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Reid K, 1996, DEVELOPMENT, V122, P3911; Rice J, 2000, DEV DYNAM, V217, P120, DOI 10.1002/(SICI)1097-0177(200001)217:1<120::AID-DVDY11>3.0.CO;2-U; ROTHMAN TP, 1984, NEUROSCIENCE, V12, P1293, DOI 10.1016/0306-4522(84)90022-8; Saarma M, 2000, EUR J BIOCHEM, V267, P6968, DOI 10.1046/j.1432-1327.2000.01826.x; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Sidebotham EL, 2002, J PEDIATR SURG, V37, P145, DOI 10.1053/jpsu.2002.30239; Taraviras S, 1999, CURR OPIN GENET DEV, V9, P321, DOI 10.1016/S0959-437X(99)80048-3; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Tokuda H, 2003, J BIOL CHEM, V278, P18930, DOI 10.1074/jbc.M209159200; Woodward MN, 2000, J PEDIATR SURG, V35, P25, DOI 10.1016/S0022-3468(00)80007-X; Worley DS, 2000, DEVELOPMENT, V127, P4383; Wu JJ, 1999, DEVELOPMENT, V126, P1161; Young HM, 1999, DEV DYNAM, V216, P137, DOI 10.1002/(SICI)1097-0177(199910)216:2<137::AID-DVDY5>3.0.CO;2-6; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100	63	194	200	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					905	916		10.1016/S0896-6273(03)00730-X	http://dx.doi.org/10.1016/S0896-6273(03)00730-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659090	Bronze			2022-12-28	WOS:000187042200008
J	Tamura, T; Chiang, AS; Ito, N; Liu, HP; Horiuchi, J; Tully, T; Saitoe, M				Tamura, T; Chiang, AS; Ito, N; Liu, HP; Horiuchi, J; Tully, T; Saitoe, M			Aging specifically impairs amnesiac-dependent memory in Drosophila	NEURON			English	Article							LONG-TERM POTENTIATION; MUTANT DROSOPHILA; OLFACTORY MEMORY; GENE; AGE; DEFICITS; ENCODES; LINOTTE; BRAIN; MELANOGASTER	Age-related memory impairment (AMI) is observed in many species. However, it is uncertain whether AMI results from a specific or a nonspecific decay in memory processing. In Drosophila, memory acquired after a single olfactory conditioning paradigm has three distinct phases: short-term memory (STM), middle-term memory (MTM), and longer-lasting anesthesia-resistant memory (ARM). Here, we demonstrate that age-related defects in olfactory memory are identical to those of the MTM mutant amnesiac (amn). Furthermore, amn flies do not exhibit an age-dependent decrease in memory, in contrast to other memory mutants. The absence of AMI in amn flies is restored by expression of an amn transgene predominantly in DPM cells. Thus, we propose that AMI in flies results from a specific decrease in amn-dependent MTM.	Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30043, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Gunma University; National Tsing Hua University; Cold Spring Harbor Laboratory	Saitoe, M (corresponding author), Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan.	saitoe@tmin.ac.jp		Chiang, Ann-Shyn/0000-0001-9668-7115; Saitoe, Minoru/0000-0001-9731-4214				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Beck CDO, 2000, J NEUROSCI, V20, P2944; BOYNTON S, 1992, GENETICS, V131, P655; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Chiang AS, 2001, J COMP NEUROL, V440, P1, DOI 10.1002/cne.1365; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Cook-Wiens E, 2002, EXP GERONTOL, V37, P1347, DOI 10.1016/S0531-5565(02)00096-7; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; FRESQUET N, 1993, Q J EXP PSYCHOL-B, V46, P399; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Ito K, 1998, LEARN MEMORY, V5, P52; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Moreau-Fauvarque C, 2002, NEUROREPORT, V13, P2309, DOI 10.1097/00001756-200212030-00028; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Sacchetti B, 2001, NEUROBIOL LEARN MEM, V76, P1, DOI 10.1006/nlme.2001.4014; SAITOE M, 2001, THEORY NEUROPLASTICI, P193; Savvateeva E, 2000, J NEURAL TRANSM, V107, P581, DOI 10.1007/s007020070080; Savvateeva E V, 1999, Ross Fiziol Zh Im I M Sechenova, V85, P167; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Shimada A, 1999, NEUROBIOL AGING, V20, P125, DOI 10.1016/S0197-4580(99)00044-5; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1990, COLD SPRING HARB SYM, V55, P203; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	47	112	115	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1003	1011		10.1016/S0896-6273(03)00732-3	http://dx.doi.org/10.1016/S0896-6273(03)00732-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659098	Bronze			2022-12-28	WOS:000187042200016
J	Makris, N; Gasic, GP; Seidman, LJ; Goldstein, JM; Gastfriend, DR; Elman, I; Albaugh, MD; Hodge, SM; Ziegler, DA; Sheahan, FS; Caviness, VS; Tsuang, MT; Kennedy, DN; Hyman, SE; Rosen, BR; Breiter, HC				Makris, N; Gasic, GP; Seidman, LJ; Goldstein, JM; Gastfriend, DR; Elman, I; Albaugh, MD; Hodge, SM; Ziegler, DA; Sheahan, FS; Caviness, VS; Tsuang, MT; Kennedy, DN; Hyman, SE; Rosen, BR; Breiter, HC			Decreased absolute amygdala volume in cocaine addicts	NEURON			English	Review							LEFT-RIGHT ASYMMETRY; ADULT HUMAN BRAIN; HIPPOCAMPAL VOLUME; WHITE-MATTER; VULNERABILITY INDICATOR; NUCLEUS-ACCUMBENS; TEMPORAL-LOBE; RISK-FACTORS; MRI; SCHIZOPHRENIA	The amygdala is instrumental to a set of brain processes that lead to cocaine consumption, including those that mediate reward and drug craving. This study examined the volumes of the amygdala and hippocampus in cocaine-addicted subjects and matched healthy controls and determined that the amygdala but not the hippocampus was significantly reduced in volume. The right-left amygdala asymmetry in control subjects was absent in the cocaine addicts. Topological analysis of amygdala isosurfaces (population averages) revealed that the isosurface of the cocaine-dependent group undercut the anterior and superior surfaces of the control group, implicating a difference in the corticomedial and basolateral nuclei. In cocaine addicts, amygdala volume did not correlate with any measure of cocaine use. The amygdala symmetry coefficient did correlate with baseline but not cocaine-primed craving. These findings argue for a condition that predisposes the individual to cocaine dependence by affecting the amygdala, or a primary event early in the course of cocaine use.	Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Collaborat, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Dept Psychiat, Ctr Morphometr Anal Dept Neurol, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Mental Hlth Ctr, Dept Psychiat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02120 USA; Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA 02120 USA; McLean Hosp, Belmont, MA 02478 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Calif San Diego, Inst Behav Genom, Dept Psychiat, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Div Addict, Cambridge, MA 02138 USA; Harvard Univ, Off Provost, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard University	Breiter, HC (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Collaborat, Boston, MA 02129 USA.	hbreiter@partners.org	Albaugh, Matthew/ABB-5839-2020; Ziegler, David/L-5717-2019; Albaugh, Matthew D/R-4349-2016; Kennedy, David N/H-3627-2012; Elman, Igor/O-2884-2017	Albaugh, Matthew/0000-0002-5971-6658; Elman, Igor/0000-0002-1345-2677	NIDA NIH HHS [DA14118, DA00265, DA09467] Funding Source: Medline; NIMH NIH HHS [MH435518, MH00976, MH63951, MH46318, MH56956] Funding Source: Medline; NINDS NIH HHS [NS34189] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000976, R01MH063951, R01MH056956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014118] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; AITKEN J, 1991, NATURE, V353, P306, DOI 10.1038/353306a0; Almasy L, 2001, AM J MED GENET, V105, P42, DOI 10.1002/1096-8628(20010108)105:1<42::AID-AJMG1055>3.3.CO;2-0; AMARAL D G, 1992, P1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Breiter HC, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1043; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BREITER HC, 1998, P INT SOC MAGN RESON, V1, P499; BREITER HC, 2004, IN PRESS COMPLEX SYS; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Dworkin S I, 1988, NIDA Res Monogr, V88, P185; Elman I, 2001, AM J DRUG ALCOHOL AB, V27, P193, DOI 10.1081/ADA-100103705; FILIPEK PA, 1994, CEREB CORTEX, V4, P344, DOI 10.1093/cercor/4.4.344; FLEISS JL, 1977, AM J PUBLIC HEALTH, V67, P1188, DOI 10.2105/AJPH.67.12.1188; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; FRAZIER JA, 2004, IN PRESS AM J PSYCHI; GALABURDA AM, 1990, NEUROPSYCHOLOGIA, V28, P529, DOI 10.1016/0028-3932(90)90032-J; GALLOWAY J, 1990, NATURE, V346, P223, DOI 10.1038/346223a0; GAWIN FH, 1988, NEW ENGL J MED, V318, P1173, DOI 10.1056/NEJM198805053181806; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hyatt BA, 1998, CELL, V93, P37, DOI 10.1016/S0092-8674(00)81144-7; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jenike MA, 1996, ARCH GEN PSYCHIAT, V53, P625; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kennedy DN, 1999, NEUROLOGY, V53, P1260, DOI 10.1212/WNL.53.6.1260; KENNEDY DN, 1989, IEEE T MED IMAGING, V8, P1, DOI 10.1109/42.20356; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KOOB GF, 1992, RES P ARNMD, V70, P79; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; KORNETSKY C, 1981, BRAIN RES, V209, P496, DOI 10.1016/0006-8993(81)90177-3; KRISHNAN KRR, 1991, J NEUROPSYCH CLIN N, V3, P387; Laakso A, 2002, NEURON, V36, P213, DOI 10.1016/S0896-6273(02)00972-8; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Lyoo IK, 2004, BIOL PSYCHIAT, V55, P648, DOI 10.1016/j.biopsych.2003.10.017; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; Mai J.K., 1997, ATLAS HUMAN BRAIN; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Meredith GE, 2000, J NEUROSCI, V20, P7798; Mesulam M, 2000, BRAIN COGNITION, V42, P4, DOI 10.1006/brcg.1999.1145; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Mountcastle VB, 1962, INTERHEMISPHER RELAT, P87; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; PETTIT HO, 1991, BRAIN RES, V539, P94, DOI 10.1016/0006-8993(91)90690-W; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Reich T, 1999, AM J HUM GENET, V65, P599, DOI 10.1086/302561; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 2001, SYNAPSE, V17, P8491; Roubertoux PL, 2003, GENETICS, V163, P1023; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; See RE, 2003, NEUROSCIENCE, V117, P477, DOI 10.1016/S0306-4522(02)00665-6; Seidman LJ, 1999, BIOL PSYCHIAT, V46, P941, DOI 10.1016/S0006-3223(99)00075-X; Seidman LJ, 2003, SCHIZOPHRENIA BULL, V29, P803, DOI 10.1093/oxfordjournals.schbul.a007048; Seidman LJ, 2002, ARCH GEN PSYCHIAT, V59, P839, DOI 10.1001/archpsyc.59.9.839; Self DW, 1998, J NEUROSCI, V18, P1848; STEIN EA, 1992, J PHARMACOL EXP THER, V262, P327; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Tsuang MT, 2001, HARVARD REV PSYCHIAT, V9, P267, DOI 10.1093/hrp/9.6.267; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; VINCENT KR, 1984, J CLIN PSYCHOL, V40, P400, DOI 10.1002/1097-4679(198403)40:2<400::AID-JCLP2270400202>3.0.CO;2-I; Volkow ND, 1999, AM J PSYCHIAT, V156, P19, DOI 10.1176/ajp.156.1.19; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; WISE RA, 1982, BEHAV BRAIN SCI, V5, P39, DOI 10.1017/S0140525X00010372; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	101	125	131	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					729	740		10.1016/j.neuron.2004.10.027	http://dx.doi.org/10.1016/j.neuron.2004.10.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541319	Bronze			2022-12-28	WOS:000225338100017
J	Cai, X; Liang, CW; Muralidharan, S; Kao, JPY; Tang, CM; Thompson, SM				Cai, X; Liang, CW; Muralidharan, S; Kao, JPY; Tang, CM; Thompson, SM			Unique roles of SK and Kv4.2 potassium channels in dendritic integration	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; RAT-BRAIN; SYNAPTIC EXCITATION; BASAL DENDRITES; CA2+ CHANNELS; CELLS; TRANSIENT; HIPPOCAMPUS	Focal activation of glutamate receptors in distal dendrites of hippocampal pyramidal cells triggers voltage-dependent Ca2+ channel-mediated plateau potentials that are confined to the stimulated dendrite. We examined the role of dendritic K+ conductances in determining the amplitude, duration, and spatial compartmentalization of plateau potentials. Manipulations that blocked SK-type Ca2+-activated K+ channels, including apamin and BAPTA dialysis, increased the duration of plateau potentials without affecting their amplitude or compartmentalization. Manipulations that blocked Kv4.2 A-type K+ channels, including a dominant-negative Kv4.2 construct and 4-aminopyridine, increased the amplitude of plateau potentials by allowing them to recruit neighboring dendrites. Prolongation of plateau potentials or block of Kv4.2 channels at branch points facilitated the ability of dendritic excitation to trigger fast action potentials. SK channels thus underlie repolarization of dendritic plateau potentials, whereas Kv4.2 channels confine these potentials to single dendritic branches, and both act in concert to regulate synaptic integration.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA; Univ Maryland, Neurol Serv, Baltimore VA Med Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Cai, Xiang/AAD-8012-2021; Thompson, Scott M/K-8921-2015	Kao, Joseph/0000-0002-8875-2180				Ariav G, 2003, J NEUROSCI, V23, P7750; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; BENARDO LS, 1982, J NEUROSCI, V2, P1614; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Finlayson K, 2001, NEUROPHARMACOLOGY, V41, P341, DOI 10.1016/S0028-3908(01)00067-3; Frick A, 2003, J NEUROSCI, V23, P3243; GAHWILER BH, 1998, CULTURING NERVE CELL, P379; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hosseini R, 2001, J PHYSIOL-LONDON, V535, P323, DOI 10.1111/j.1469-7793.2001.00323.x; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lancaster B, 2001, J PHYSIOL-LONDON, V536, P809, DOI 10.1111/j.1469-7793.2001.00809.x; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; MADISON DV, 1987, J NEUROSCI, V7, P733; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; MCALLISTER AK, 2000, BIOLISTIC TRANSFECTI; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Milojkovic BA, 2004, J PHYSIOL-LONDON, V558, P193, DOI 10.1113/jphysiol.2004.061416; Poolos NP, 1999, J NEUROSCI, V19, P5205; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Ro S, 2001, AM J PHYSIOL-GASTR L, V281, pG964, DOI 10.1152/ajpgi.2001.281.4.G964; RUTECKI PA, 1987, J NEUROPHYSIOL, V57, P1911, DOI 10.1152/jn.1987.57.6.1911; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sailer CA, 2002, J NEUROSCI, V22, P9698; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shah M, 2000, BRIT J PHARMACOL, V129, P627, DOI 10.1038/sj.bjp.0703111; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	50	217	223	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					351	364		10.1016/j.neuron.2004.09.026	http://dx.doi.org/10.1016/j.neuron.2004.09.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473972	Bronze			2022-12-28	WOS:000224635800016
J	Kay, JN; Baier, H				Kay, JN; Baier, H			Out-foxing fate: Molecular switches create neuronal diversity in the retina	NEURON			English	Editorial Material							BIPOLAR CELL-DIFFERENTIATION; HOMEOBOX GENE VSX1; SPECIFICATION	Progenitor cells in the mammalian retina generate at least 55 distinct kinds of neurons. Two reports in this issue of Neuron reveal two transcription factors (Foxn4 and Bhlhb4) that contribute to the development of this remarkable cellular diversity.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kay, JN (corresponding author), Univ Calif San Francisco, Dept Physiol, 1550 4th St, San Francisco, CA 94158 USA.		Kay, Jeremy/G-9309-2011					Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Inoue T, 2002, DEVELOPMENT, V129, P831; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Ohtoshi A, 2004, CURR BIOL, V14, P530, DOI 10.1016/j.cub.2004.02.027; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; WAGNER HJ, 1988, PHILOS T R SOC B, V321, P263, DOI 10.1098/rstb.1988.0094; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732	14	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 16	2004	43	6					759	760		10.1016/j.neuron.2004.09.001	http://dx.doi.org/10.1016/j.neuron.2004.09.001			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363386	Bronze			2022-12-28	WOS:000223992000001
J	Liu, SH; Lau, L; Wei, JS; Zhu, DY; Zou, SW; Sun, HS; Fu, YP; Liu, F; Lu, YM				Liu, SH; Lau, L; Wei, JS; Zhu, DY; Zou, SW; Sun, HS; Fu, YP; Liu, F; Lu, YM			Expression of Ca2+-Permeable AMPA receptor channels primes cell death in transient forebrain ischemia	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; GLOBAL CEREBRAL-ISCHEMIA; ELEMENT-BINDING PROTEIN; ADULT-RAT HIPPOCAMPUS; GLUR2 MESSENGER-RNA; CA2+ PERMEABILITY; GENE-EXPRESSION; SELECTIVE VULNERABILITY; GLUTAMATE RECEPTORS; RELATIVE ABUNDANCE	CA1 pyramidal neurons degenerate after transient global ischemia, whereas neurons in other regions of the hippocampus remain intact. A step in this selective injury is Ca2+ and/or Zn2+ entry through Ca2+-permeable AMPA receptor channels; reducing Ca2+ permeability of AMPA receptors via expression of Ca2+-impermeable GluR2(R) channels or activation of CRE transcription in the hippocampus of adult rats in vivo using shutoff-deficient pSFV-based vectors rescues vulnerable CA1 pyramidal neurons from forebrain ischemic injury. Conversely, the induction of Ca2+ and/or Zn2+ influx through AMPA receptors by expressing functional Ca2+-permeable GluR2(Q) channels causes the postischemic degeneration of hippocampal granule neurons that otherwise are insensitive to ischemic insult. Thus, the AMPA receptor subunit GluR2 gates entry of Ca2+ and/or Zn2+ that leads to cell death following transient forebrain ischemia.	Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Ctr Addict & Mental Hlth, Dept Neurosci, Clarke Div, Toronto, ON M5T 1R8, Canada	University of Calgary; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Lu, YM (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	luy@ucalgary.ca						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Anzai T, 2003, NEUROSCI RES, V46, P41, DOI 10.1016/S0168-0102(03)00023-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Calderone A, 2003, J NEUROSCI, V23, P2112; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; FRANK L, 1995, ACTA NEUROL SCAND, V92, P337; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; Gorter JA, 1997, J NEUROSCI, V17, P6179; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu RQ, 2001, BRAIN RES, V897, P27, DOI 10.1016/S0006-8993(01)02076-5; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kjoller C, 2000, NEUROCHEM INT, V37, P7, DOI 10.1016/S0197-0186(00)00008-5; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SH, 2003, J NEUROSCI, V23, P732; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Oguro K, 1999, J NEUROSCI, V19, P9218; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P2362, DOI 10.1073/pnas.261713299; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tanaka K, 1999, NEUROREPORT, V10, P2245, DOI 10.1097/00001756-199908020-00004; Van Damme P, 2002, J NEUROPHYSIOL, V88, P1279, DOI 10.1152/jn.2002.88.3.1279; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Walton M, 1996, MOL BRAIN RES, V43, P21, DOI 10.1016/S0169-328X(96)00144-1; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Zhu DY, 2003, J NEUROSCI, V23, P223	64	159	167	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					43	55		10.1016/j.neuron.2004.06.017	http://dx.doi.org/10.1016/j.neuron.2004.06.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233916	Bronze			2022-12-28	WOS:000222549800006
J	Yue, DT				Yue, DT			The dawn of high-resolution structure for the queen of ion channels	NEURON			English	Editorial Material							INTRAMOLECULAR INTERACTION; CA2+ CHANNEL; CALCIUM; SUBUNITS; PROTEINS; DOMAINS; PSD-95	Ca2+ channels are comprised of a main pore-forming alpha(1) subunit, complexed with beta, alpha(2)delta, and gamma subunits. Unlike a growing number of smaller ion channels, no atomic-level structures of Ca2+ channels have been resolved thus far. In this issue of Neuron, Opatowsky and colleagues report the crystal structure of a Ca2+ channel beta subunit, which draws together a recent wave of seminal reports on the structural organization of these essential molecules.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross 713,720 Rutland Ave, Baltimore, MD 21205 USA.							Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Miller C, 2003, NEURON, V40, P1049, DOI 10.1016/S0896-6273(03)00804-3; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; TAKAHASHI SX, 2004, P NATL ACAD SCI US; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6	13	13	13	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 13	2004	42	3					357	359		10.1016/S0896-6273(04)00259-4	http://dx.doi.org/10.1016/S0896-6273(04)00259-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134631	Bronze			2022-12-28	WOS:000221458700001
J	Kleinschmidt, A				Kleinschmidt, A			Thinking big: Many modules or much cortex?	NEURON			English	Editorial Material							MAGNITUDE; REPRESENTATIONS; NUMBERS	Is there a neural system dedicated to generic magnitude judgments? In this issue of Neuron, Pinel et al. report qualitative spatial overlap of fMRI responses during judgments of luminance, size, and numerical magnitude but also quantitative response differences in intraparietal cortex that mirror behavioral interference between perceptual and symbolic magnitude.	Univ Frankfurt Klinikum, Dept Neurol, Cognit Neurol Unit, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kleinschmidt, A (corresponding author), Univ Frankfurt Klinikum, Dept Neurol, Cognit Neurol Unit, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.							Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; NIEDER A, 2004, IN PRESS P NATL ACAD; Pansky A, 2002, J EXP PSYCHOL LEARN, V28, P259, DOI 10.1037//0278-7393.28.2.259; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	12	5	5	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					842	844		10.1016/S0896-6273(04)00154-0	http://dx.doi.org/10.1016/S0896-6273(04)00154-0			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046716	Bronze			2022-12-28	WOS:000221458300003
J	Kim, J; Ghosh, S; Nunziato, DA; Pitt, GS				Kim, J; Ghosh, S; Nunziato, DA; Pitt, GS			Identification of the components controlling inactivation of voltage-gated Ca2+ channels	NEURON			English	Article							EF-HAND MOTIF; CALCIUM-CHANNELS; CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; DEPENDENT INACTIVATION; CALMODULIN-BINDING; ALPHA(1C) SUBUNIT; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; DETERMINANTS	Ca2+-dependent inactivation (CDI) of L-type voltage-gated Ca2+ channels limits Ca2+ entry into neurons, thereby regulating numerous cellular events. Here we present the isolation and purification of the Ca2+-sensor complex, consisting of calmodulin (CaM) and part of the channel's pore-forming otic subunit, and demonstrate the Ca2+-dependent conformational shift that underlies inactivation. Dominant-negative CaM mutants that prevent CDI block the sensor's Ca2+-dependent conformational change. We show how IIe1654 in the CaM binding IQ motif of alpha(1c) forms the link between the Ca2+ sensor and the downstream inactivation machinery, using the alpha(1c) EF hand motif as a signal transducer to activate the putative pore-occluder, the alpha(1c) I-II intracellular linker.	Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, Div Cardiol, New York, NY 10032 USA	Columbia University; Columbia University	Pitt, GS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St,PH 7W 318, New York, NY 10032 USA.	gp2004@columbia.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	NHLBI NIH HHS [R01 HL071165-03, R01 HL071165, R01 HL071165-02, R01 HL071165-01, R01 HL71165] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071165] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams B, 1997, J GEN PHYSIOL, V110, P379, DOI 10.1085/jgp.110.4.379; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Ghosh S, 1996, GENE, V176, P249, DOI 10.1016/0378-1119(96)00260-0; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liddington RC, 2002, NATURE, V415, P373, DOI 10.1038/415373a; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	33	134	137	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					745	754		10.1016/S0896-6273(04)00081-9	http://dx.doi.org/10.1016/S0896-6273(04)00081-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003174	Bronze			2022-12-28	WOS:000221458200010
J	Heidelberger, R; Matthews, G				Heidelberger, R; Matthews, G			Vesicle priming and depriming: A SNAP decision	NEURON			English	Editorial Material							SYNAPTIC VESICLES	Synapses have a limited pool of vesicles that are docked and primed for rapid release. In neuroendocrine cells, splice variants of the SNARE protein SNAP-25 and phosphorylation of SNAP-25 independently influence the size of the releasable vesicle pool, possibly by altering the rate of vesicle depriming. Pre- and posttranslational modifications of SNAP-25 may therefore affect synaptic strength.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	University of Texas System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Heidelberger, R (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA.			Heidelberger, Ruth/0000-0002-8033-2050				Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0	6	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 5	2004	41	3					311	313		10.1016/S0896-6273(04)00039-X	http://dx.doi.org/10.1016/S0896-6273(04)00039-X			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766170	Bronze			2022-12-28	WOS:000221457900002
J	Cheung, ELM; Corey, DP				Cheung, ELM; Corey, DP			A gradient of single-channel conductance in the cochlea: tuning the cochlea's strings?	NEURON			English	Editorial Material							AUDITORY HAIR-CELLS; MECHANOELECTRICAL TRANSDUCTION; ADAPTATION	Frequency tuning in the vertebrate cochlea requires a continuously varying amplifier in auditory hair cells. In this issue of Neuron, Ricci et al. show that the mechanosensitive transduction channel, a possible amplifier component, has a single-channel conductance that increases systematically along the frequency axis of the turtle cochlea.	Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Harvard University; Howard Hughes Medical Institute	Cheung, ELM (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA.			Corey, David/0000-0003-4497-6016				Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370	9	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					875	876		10.1016/S0896-6273(03)00762-1	http://dx.doi.org/10.1016/S0896-6273(03)00762-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659085	Bronze			2022-12-28	WOS:000187042200003
J	Nakagawa, T; Futai, K; Lashuel, HA; Lo, I; Okamoto, K; Walz, T; Hayashi, Y; Sheng, M				Nakagawa, T; Futai, K; Lashuel, HA; Lo, I; Okamoto, K; Walz, T; Hayashi, Y; Sheng, M			Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions	NEURON			English	Article							LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY FRACTION; AMPA RECEPTOR ENDOCYTOSIS; GUANYLATE KINASE DOMAINS; TUMOR-SUPPRESSOR PROTEIN; INTRAMOLECULAR INTERACTION; DISTINCT MECHANISMS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; MAMMALIAN-CELLS	Single-particle electron microscopy (EM) combined with biochemical measurements revealed the molecular shape of SAP97 and a monomer-dimer transition that depended on the N-terminal L27 domain. Overexpression of SAP97 drove GluR1 to synapses, potentiated AMPA receptor (AMPAR) excitatory postsynaptic currents (EPSCs), and occluded LTP. Synaptic potentiation and GluR1 delivery were dissociable by L27 domain mutants that inhibit multimerization of SAP97. Loss of potentiation was correlated with faster turnover of monomeric SAP97 mutants in dendritic spines. We propose that L27-mediated interactions of SAP97 with itself or other proteins regulate the synaptic delivery of AMPARs. RNAi knockdown of endogenous PSD95 depleted surface GluR1 and impaired AMPA EPSCs. In contrast, RNAi knockdown of endogenous SAP97 reduced surface expression of both GluR1 and GluR2 and inhibited both AMPA and NMDA EPSCs. Thus SAP97 has a broader role than its close relative, PSD95, in the maintenance of synaptic function.	MIT, Picower Ctr Learning & Mem, Cambridge, MA 02139 USA; MIT, RIKEN, MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Lab Neural Architecture, Wako, Saitama 3510198, Japan; Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School	Hayashi, Y (corresponding author), MIT, Picower Ctr Learning & Mem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yhayashi@mit.edu; msheng@mit.edu	Lashuel, Hilal/M-3500-2017; Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019; Okamoto, Kenichi/E-4582-2013	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Sheng, Morgan/0000-0002-8703-5366; Walz, Thomas/0000-0003-2606-2835; Okamoto, Kenichi/0000-0001-9527-2444	NIGMS NIH HHS [GM62580, P01 GM062580] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Karnak D, 2002, J BIOL CHEM, V277, P46730, DOI 10.1074/jbc.M208781200; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marfatia SM, 2000, J BIOL CHEM, V275, P13759, DOI 10.1074/jbc.275.18.13759; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niethammer M, 1996, J NEUROSCI, V16, P2157; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Sala C, 2003, J NEUROSCI, V23, P6327; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Stein V, 2003, J NEUROSCI, V23, P5503; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200	62	196	201	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					453	467		10.1016/j.neuron.2004.10.012	http://dx.doi.org/10.1016/j.neuron.2004.10.012			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504326	Green Published, Bronze			2022-12-28	WOS:000224771700008
J	Dorris, MC; Glimcher, PW				Dorris, MC; Glimcher, PW			Activity in posterior parietal cortex is correlated with the relative subjective desirability of action	NEURON			English	Article							PERCEPTUAL DECISION; AREA LIP; REPRESENTATION; RESPONSES; SELECTION; NEURONS; SPACE; CELLS	Behavioral studies suggest that making a decision involves representing the overall desirability of all available actions and then selecting that action that is most desirable. Physiological studies have proposed that neurons in the parietal cortex play a role in selecting movements for execution. To test the hypothesis that these parietal neurons encode the subjective desirability of making particular movements, we exploited Nash's game theoretic equilibrium, during which the subjective desirability of multiple actions should be equal for human players. Behavior measured during a strategic game suggests that monkeys' choices, like those of humans, are guided by subjective desirability. Under these conditions, activity in the parietal cortex was correlated with the relative subjective desirability of actions irrespective of the specific combination of reward magnitude, reward probability, and response probability associated with each action. These observations may help place many recent findings regarding the posterior parietal cortex into a common conceptual framework.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Glimcher, PW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	glimcher@cns.nyu.edu		Glimcher, Paul/0000-0001-7872-3856				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Barlow H. B., 1961, P331; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Basso MA, 1998, J NEUROSCI, V18, P7519; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer C, 2003, BEHAV GAME THEORY; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Fudenberg D., 1994, GAME THEORY; Glimcher PW, 2003, BRADFORD BOOKS, P1; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; GLIMCHER PW, 2004, IN PRESS COGNITIVE N; GLIMCHER PW, 2005, IN PRESS ANN REV PSY, V56; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HERRNSTEIN RJ, 1964, J EXP ANAL BEHAV, V7, P179, DOI 10.1901/jeab.1964.7-179; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Kagel JH, 1995, HDB EXPT EC; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KREBS JR, 1996, BEHAV ECOLOGY; Kreps D. M, 1990, COURSE MICROECONOMIC; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Platt M.L., 2003, OCULOMOTOR SYSTEM NE, P1; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephens D.W., 1986, pi; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559	44	311	314	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					365	378		10.1016/j.neuron.2004.09.009	http://dx.doi.org/10.1016/j.neuron.2004.09.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473973	Bronze			2022-12-28	WOS:000224635800017
J	Kosolapov, A; Tu, LW; Wang, J; Deutsch, C				Kosolapov, A; Tu, LW; Wang, J; Deutsch, C			Structure acquisition of the T1 domain of Kv1.3 during biogenesis	NEURON			English	Article							GATED K+ CHANNELS; SHAKER POTASSIUM CHANNEL; LARGE RIBOSOMAL-SUBUNIT; BETA-SUBUNIT; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; SECRETORY PROTEINS; MEMBRANE; PEPTIDE; PORE	The T1 recognition domains of voltage-gated K+ (Kv) channel subunits form tetramers and acquire tertiary structure while still attached to their individual ribosomes. Here we ask when and in which compartment secondary and tertiary structures are acquired. We answer this question using biogenic intermediates and recently developed folding and accessibility assays to evaluate the status of the nascent Kv peptide both inside and outside of the ribosome. A compact structure (likely helical) that corresponds to a region of helicity in the mature structure is already manifest in the nascent protein within the ribosomal tunnel. The T1 domain acquires tertiary structure only after emerging from the ribosomal exit tunnel and complete synthesis of the T1-S1 linker. These measurements of ion channel folding within the ribosomal tunnel and its exit port bear on basic principles of protein folding and pave the way for understanding the molecular basis of protein misfolding, a fundamental cause of channelopathies.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Deutsch, C (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	cjd@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052302] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-07027] Funding Source: Medline; NIGMS NIH HHS [GM 52302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agmon I, 2003, EUR J BIOCHEM, V270, P2543, DOI 10.1046/j.1432-1033.2003.03634.x; Ashcroft FM, 2000, ION CHANNELS DIS; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; BEZRUKOV SM, 1994, NATURE, V370, P279, DOI 10.1038/370279a0; Bezrukov SM, 1996, MACROMOLECULES, V29, P8517, DOI 10.1021/ma960841j; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P171; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gilbert RJC, 2004, MOL CELL, V14, P57, DOI 10.1016/S1097-2765(04)00163-7; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SHEN NV, 1993, NEURON, V11, P67; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Tsalkova T, 1998, J MOL BIOL, V278, P713, DOI 10.1006/jmbi.1998.1721; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	41	49	49	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					295	307		10.1016/j.neuron.2004.09.011	http://dx.doi.org/10.1016/j.neuron.2004.09.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473968	Bronze			2022-12-28	WOS:000224635800012
J	Chuang, HH; Neuhausser, WM; Julius, D				Chuang, HH; Neuhausser, WM; Julius, D			The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel	NEURON			English	Article							NONSELECTIVE CATION CHANNEL; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; DROSOPHILA PHOTORECEPTORS; ION-CHANNEL; ACTIVATED CURRENT; PAIN PATHWAY; COLD; HEAT; MENTHOL	TRPM8, a member of the transient receptor potential family of ion channels, depolarizes somatosensory neurons in response to cold. TRPM8 is also activated by the cooling agents menthol and icilin. When exposed to menthol or cold, TRPM8 behaves like many ligand-gated channels, exhibiting rapid activation followed by moderate Ca2+-dependent adaptation. In contrast, icilin activates TRPM8 with extremely variable latency followed by extensive desensitization, provided that calcium is present. Here, we show that, to achieve full efficacy, icilin requires simultaneous elevation of cytosolic Ca2+, either via permeation through TRPM8 channels or by release from intracellular stores. Thus, two stimuli must be paired to elicit full channel activation, illustrating the potential for coincidence detection by TRP channels. Determinants of icilin sensitivity map to a region of TRPM8 that corresponds to the capsaicin binding site on the noxious heat receptor TRPV1, suggesting a conserved molecular logic for gating of these thermosensitive channels by chemical agonists.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu						Albert AP, 2003, J PHYSIOL-LONDON, V552, P789, DOI 10.1113/jphysiol.2003.052977; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Guler AD, 2002, J NEUROSCI, V22, P6408; Hardie RC, 2003, CELL CALCIUM, V33, P385, DOI 10.1016/S0143-4160(03)00051-4; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2001, J EXP BIOL, V204, P3403; HARDIE RC, 2004, NOVART FDN SYMP, V167, P263; Hardie Roger C, 2004, Novartis Found Symp, V258, P160; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lisman JE, 2002, ADV EXP MED BIOL, V514, P507; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; PAPAPOUTIAN A, 2002, NAT REV NEUROSCI, V190, P261; Papazian DM, 2002, NOVART FDN SYMP, V245, P178; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; SCHAFER K, 1989, BRAIN RES, V501, P66, DOI 10.1016/0006-8993(89)91027-5; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; WATANABE H, 2003, J PHARM PHARMACOL, V424, P434; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	50	235	253	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					859	869		10.1016/j.neuron.2004.08.038	http://dx.doi.org/10.1016/j.neuron.2004.08.038			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363396	Bronze			2022-12-28	WOS:000223992000011
J	Wang, F				Wang, F			Steering growth cones with a CCaMKII/calcineurin switch	NEURON			English	Editorial Material							CALCIUM	Calcium can regulate and induce both attractive and repulsive turnings by growth cones. In this issue of Neuron, Wen et al. report that differential activations of CaMKII and calcineurin (CaN) act as the read out for distinct patterns of intracellular calcium signals and a switch between attraction and repulsion.	Duke Univ, Med Ctr, Dept Cell Biol, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Wang, F (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Dept Neurobiol, Box 3709, Durham, NC 27710 USA.							Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Zheng JQ, 1996, PERSPECT DEV NEUROBI, V4, P205; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	11	1	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 16	2004	43	6					760	762		10.1016/j.neuron.2004.09.002	http://dx.doi.org/10.1016/j.neuron.2004.09.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363387	Bronze			2022-12-28	WOS:000223992000002
J	Hu, JY; Glickman, L; Wu, F; Schacher, S				Hu, JY; Glickman, L; Wu, F; Schacher, S			Serotonin regulates the secretion and autocrine action of a neuropeptide to activate MAPK required for long-term facilitation in Aplysia	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; SENSORY NEURONS; NEUROTROPHIC FACTOR; SYNAPTIC FACILITATION; MESSENGER-RNA; RESPONSE ELEMENT; PRESYNAPTIC FACILITATION; MACROMOLECULAR-SYNTHESIS; MECHANOSENSORY NEURONS	In Aplysia, long-term facilitation (LTF) of sensory neuron synapses requires activation of both protein kinase A (PKA) and mitogen-activated protein kinase (MAPK). We find that 5-HT through activation of PKA regulates secretion of the sensory neuron-specific neuropeptide sensorin, which binds autoreceptors to activate MAPK. Anti-sensorin antibody blocked LTF and MAPK activation produced by 5-HT and LTF produced by medium containing sensorin that was secreted from sensory neurons after 5-HT treatment. A single application of 5-HT followed by a 2 hr incubation with sensorin produced protein synthesis-dependent LTF, growth of new presynaptic varicosities, and activation of MAPK and its translocation into sensory neuron nuclei. Inhibiting PKA during 5-HT applications and inhibiting receptor tyrosine kinase or MAPK during sensorin application blocked both LTF and MAPK activation and translocation. Thus, long-term synaptic plasticity is produced when stimuli activate kinases in a specific sequence by regulating the secretion and autocrine action of a neuropeptide.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York State Psychiat Inst, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Schacher, S (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York State Psychiat Inst, 1051 Riverside Dr, New York, NY 10032 USA.	sms2@columbia.edu	Glickman, Leslie B./ADN-1090-2022		NCRR NIH HHS [RR-10294] Funding Source: Medline; NIMH NIH HHS [MH 60387] Funding Source: Medline; NINDS NIH HHS [NS 42159] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR010294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042159] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angers A, 2002, J NEUROSCI, V22, P5412; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Barbas D, 2003, LEARN MEMORY, V10, P373, DOI 10.1101/lm.66103; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bedi SS, 1998, J NEUROPHYSIOL, V79, P1371, DOI 10.1152/jn.1998.79.3.1371; BERGOLD PJ, 1992, NEURON, V8, P387, DOI 10.1016/0896-6273(92)90304-V; BERNIER L, 1982, J NEUROSCI, V2, P1682; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CEDAR H, 1972, J GEN PHYSIOL, V60, P570, DOI 10.1085/jgp.60.5.570; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Chang DJ, 2000, P NATL ACAD SCI USA, V97, P1829, DOI 10.1073/pnas.97.4.1829; Chin J, 1999, LEARN MEMORY, V6, P317; Chin J, 2002, J NEUROSCI, V22; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Dyer JR, 2003, NEUROSCIENCE, V116, P13, DOI 10.1016/S0306-4522(02)00566-3; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Evans GJO, 2003, BIOCHEM SOC T, V31, P824, DOI 10.1042/bst0310824; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hu JY, 2002, J NEUROSCI, V22, P2669, DOI 10.1523/JNEUROSCI.22-07-02669.2002; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Lee SH, 2003, MOL CELLS, V15, P233; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lin H, 2003, J NEUROBIOL, V57, P204, DOI 10.1002/neu.10275; Liu JM, 2004, J NEUROSCI, V24, P2465, DOI 10.1523/JNEUROSCI.4331-03.2004; Liu JM, 2003, BRAIN RES, V959, P68, DOI 10.1016/S0006-8993(02)03729-0; Liu K, 2003, J NEUROBIOL, V56, P275, DOI 10.1002/neu.10242; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Purcell AL, 2003, NEURON, V37, P473, DOI 10.1016/S0896-6273(03)00030-8; Roberson ED, 1999, J NEUROSCI, V19, P4337; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Santarelli L, 1996, J NEUROBIOL, V31, P297, DOI 10.1002/(SICI)1097-4695(199611)31:3<297::AID-NEU3>3.3.CO;2-P; Schacher S, 1999, J NEUROSCI, V19, P6338; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; SHUSTER MJ, 1985, NATURE, V313, P392, DOI 10.1038/313392a0; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; Steffensen I, 1995, INVERTEBR NEUROSCI, V1, P207, DOI 10.1007/BF02211022; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; Sun ZY, 2001, J NEUROBIOL, V46, P41, DOI 10.1002/1097-4695(200101)46:1<41::AID-NEU4>3.0.CO;2-R; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TAPLEY P, 1992, ONCOGENE, V7, P371; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Walters ET, 2004, J COMP NEUROL, V471, P219, DOI 10.1002/cne.20042; Yamamoto N, 1999, J NEUROCHEM, V73, P2415, DOI 10.1046/j.1471-4159.1999.0732415.x; Yanow SK, 1998, J NEUROCHEM, V70, P572; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; ZHU H, 1995, J NEUROSCI, V15, P4173	84	61	61	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					373	385		10.1016/j.neuron.2004.07.011	http://dx.doi.org/10.1016/j.neuron.2004.07.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294145	Bronze			2022-12-28	WOS:000223156900011
J	Hutton, M; McGowan, E				Hutton, M; McGowan, E			Clearing tau pathology with A beta immunotherapy - Reversible and irreversible stages revealed	NEURON			English	Editorial Material							ALZHEIMER-DISEASE; PHOSPHORYLATION; IMMUNIZATION; AGGREGATION	The report by Oddo and colleagues in this issue of Neuron demonstrates for the first time that clearance of amyloid also results in the removal of early-stage tau pathology in mice that develop both amyloid plaques and neurofibrillary tangles (NFT), the two hallmark lesions of Alzheimer's disease (AD). This result supports a primary role for Abeta in AD etiology.	Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Hutton, M (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.							Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p	11	9	10	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					293	294		10.1016/j.neuron.2004.07.023	http://dx.doi.org/10.1016/j.neuron.2004.07.023			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294135	Bronze			2022-12-28	WOS:000223156900001
J	Nyberg, L				Nyberg, L			Intact frontal memory effect in older age and dementia	NEURON			English	Editorial Material							ALZHEIMERS-DISEASE; MODEL	Older adults and demented patients show preserved functioning on certain tests of implicit memory. In this issue of Neuron, Lustig and Buckner demonstrate that both groups show comparable repetition-based effects on response time and prefrontal activity relative to younger adults.	Umea Univ, Dept Psychol, S-90187 Umea, Sweden	Umea University	Nyberg, L (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.		Nyberg, Lars/M-5986-2019	Nyberg, Lars/0000-0002-3367-1746				Backman L, 2000, J COGNITIVE NEUROSCI, V12, P134, DOI 10.1162/089892900561922; BRUN A, 1981, HISTOPATHOLOGY, V5, P549, DOI 10.1111/j.1365-2559.1981.tb01818.x; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gabrieli JDE, 1999, J EXP PSYCHOL GEN, V128, P479, DOI 10.1037/0096-3445.128.4.479; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Lustig C, 2004, NEURON, V42, P865, DOI 10.1016/j.neuron.2004.04.002; MACCOTTA L, 2004, IN PRESS J COGN NEUR; Nyberg L, 2003, P NATL ACAD SCI USA, V100, P13728, DOI 10.1073/pnas.1735487100; Nyberg L, 2003, PSYCHOL AGING, V18, P149, DOI 10.1037/0882-7974.18.1.149; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268	12	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 10	2004	42	5					701	702		10.1016/j.neuron.2004.05.016	http://dx.doi.org/10.1016/j.neuron.2004.05.016			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182711	Bronze			2022-12-28	WOS:000221975000003
J	Papazian, DM				Papazian, DM			BK channels: The spring between sensor and gate	NEURON			English	Editorial Material							K+ CHANNEL; POTASSIUM CHANNEL; STRUCTURAL BASIS; DOMAIN; PORE	K+ channels contain two main functional domains, an ion-selective pore and a sensor that determines whether the cytoplasmic pore gate is open or closed. In this issue of Neuron, Niu et al. provide compelling evidence that the link between sensor and gate is a remarkably simple mechanical spring.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Papazian, DM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.							Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	12	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					699	701		10.1016/j.neuron.2004.05.017	http://dx.doi.org/10.1016/j.neuron.2004.05.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182710	Bronze			2022-12-28	WOS:000221975000002
J	Goldberg, JA; Rokni, U; Sompolinsky, H				Goldberg, JA; Rokni, U; Sompolinsky, H			Patterns of ongoing activity and the functional architecture of the primary visual cortex	NEURON			English	Article							SPATIAL WORKING-MEMORY; HORIZONTAL CONNECTIONS; SPATIOTEMPORAL PATTERNS; ORIENTATION SELECTIVITY; CORTICAL-NEURONS; STRIATE CORTEX; DYNAMICS; REPRESENTATION; MECHANISMS; DIVERSITY	Ongoing spontaneous activity in the cerebral cortex exhibits complex spatiotemporal patterns in the absence of sensory stimuli. To elucidate the nature of this ongoing activity, we present a theoretical treatment of two contrasting scenarios of cortical dynamics: (1) fluctuations about a single background state and (2) wandering among multiple "attractor" states, which encode a single or several stimulus features' Studying simplified network rate models of the primary visual cortex (V1), we show that the single state scenario is characterized by fast and high-dimensional Gaussian-like fluctuations, whereas in the multiple state scenario the fluctuations are slow, low dimensional, and highly non-Gaussian. Studying a more realistic model that incorporates correlations in the feed-forward input, spatially restricted cortical interactions, and an experimentally derived layout of pinwheels, we show that recent optical-imaging data of ongoing activity in V1 are consistent with the presence of either a single background state or multiple attractor states encoding many features.	Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Harvard University; Hebrew University of Jerusalem	Goldberg, JA (corresponding author), Univ Texas, Dept Biol, 6900 N Loop,1604 West, San Antonio, TX 78249 USA.	jgoldberg@utsa.edu	Sompolinsky, Haim/ABB-8398-2021; Goldberg, Joshua/B-3398-2009	Goldberg, Joshua/0000-0002-5740-4087				ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Bosking WH, 1997, J NEUROSCI, V17, P2112; Braitenberg V, 1991, ANATOMY CORTEX STAT; Bressloff PC, 2003, PHILOS T R SOC B, V358, P1643, DOI 10.1098/rstb.2002.1109; Bressloff PC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.078102; Bressloff PC, 2002, NEURAL COMPUT, V14, P473, DOI 10.1162/089976602317250861; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; CONTRERAS D, 1995, J NEUROSCI, V15, P604; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; ERMENTROUT GB, 1979, BIOL CYBERN, V34, P137, DOI 10.1007/BF00336965; Fitzpatrick D, 2000, CURR BIOL, V10, pR187, DOI 10.1016/S0960-9822(00)00348-1; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GRINVALD A, 1999, MODERN TECHNIQUES NE, P894; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; JOLIFFE LIT, 1996, PRINCIPAL COMPONENT; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Muller T, 2000, NEURAL COMPUT, V12, P2573, DOI 10.1162/089976600300014854; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Ringach DL, 2003, NATURE, V425, P912, DOI 10.1038/425912a; Ringach DL, 2002, J NEUROSCI, V22, P5639; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; TSO DY, 1986, J NEUROSCI, V6, P1160; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tyler CJ, 1998, J COMP NEUROL, V400, P449, DOI 10.1002/(SICI)1096-9861(19981102)400:4<449::AID-CNE2>3.0.CO;2-A; Wang G, 2003, NEUROSCI LETT, V338, P77, DOI 10.1016/S0304-3940(02)01355-1; WELIKY M, 1994, J NEUROSCI, V14, P7291; Zhang K, 1996, J NEUROSCI, V16, P2112	40	61	64	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					489	500		10.1016/S0896-6273(04)00197-7	http://dx.doi.org/10.1016/S0896-6273(04)00197-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134644	Bronze			2022-12-28	WOS:000221458700014
J	Hallem, EA; Carlson, JR				Hallem, EA; Carlson, JR			The spatial code for Odors is changed by conditioning	NEURON			English	Editorial Material							DROSOPHILA-MELANOGASTER; OLFACTORY INFORMATION; BRAIN; NEURONS; MEMORY; ABLATION; FLY	Drosophila displays robust olfactory learning. In this issue of Neuron, Davis and colleagues use optical imaging to demonstrate that olfactory conditioning alters odor representations among the glomeruli of the fly antennal lobe. New synaptic activity is recruited into the representation of an odor and is localized to projection neurons (PNs).	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Hallem, EA (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.			Hallem, Elissa/0000-0003-0260-3174				DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Hammer M, 1998, LEARN MEMORY, V5, P146; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pavlov I. P., 1928, LECT CONDITIONED REF; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	13	10	10	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 13	2004	42	3					359	361		10.1016/S0896-6273(04)00256-9	http://dx.doi.org/10.1016/S0896-6273(04)00256-9			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134632	Bronze			2022-12-28	WOS:000221458700002
J	Baccus, SA; Meister, M				Baccus, SA; Meister, M			Retina versus cortex: Contrast adaptation in parallel visual pathways	NEURON			English	Editorial Material							TEMPORAL CONTRAST; GAIN-CONTROL; GANGLION-CELLS; INPUT; SYSTEM	Human vision adapts to the contrast of patterns by changing its sensitivity, but the origins of this perceptual adaptation have been disputed. In this issue of Neuron, Solomon et al. show that contrast adaptation in the primate arises mostly in the retina for the magnocellular pathway and mostly in the cortex for the parvocellular pathway. It appears that adaptation arises most strongly at sites that pool over many inputs.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Baccus, SA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.			Meister, Markus/0000-0003-2136-6506				BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Truchard AM, 2000, J NEUROSCI, V20, P3017; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531	14	30	30	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 8	2004	42	1					5	7		10.1016/S0896-6273(04)00187-4	http://dx.doi.org/10.1016/S0896-6273(04)00187-4			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066260	Bronze			2022-12-28	WOS:000221458400003
J	Coyle, IP; Koh, YH; Lee, WCM; Slind, J; Fergestad, T; Littleton, JT; Ganetzky, B				Coyle, IP; Koh, YH; Lee, WCM; Slind, J; Fergestad, T; Littleton, JT; Ganetzky, B			Nervous wreck, an SH3 adaptor protein that interacts with Wsp, regulates synaptic growth in Drosophila	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; ABL TYROSINE KINASE; PHOTORECEPTOR AXON GUIDANCE; WASP-FAMILY PROTEINS; ARP2/3 COMPLEX; ACTIN CYTOSKELETON; NEUROMUSCULAR-JUNCTION; FUNCTIONAL COMPONENTS; STRUCTURAL PLASTICITY; GENETIC DISSECTION	We describe the isolation and characterization of nwk (nervous wreck), a temperature-sensitive paralytic mutant that causes excessive growth of larval neuromuscular junctions (NMJs), resulting in increased synaptic bouton number and branch formation. Ultrastructurally, mutant boutons have reduced size and fewer active zones, associated with a reduction in synaptic transmission. nwk encodes an FCH and SH3 domain-containing adaptor protein that localizes to the perk active zone of presynaptic terminals and binds to the Drosophila ortholog of Wasp (Wsp), a key regulator of actin polymerization. wsp null mutants display synaptic overgrowth similar to nwk and enhance the nwk morphological phenotype in a dose-dependent manner. Evolutionarily, Nwk belongs to a previously undescribed family of adaptor proteins that includes the human srGAPs, which regulate Rho activity downstream of Robo receptors. We propose that Nwk controls synapse morphology by regulating actin dynamics downstream of growth signals in presynaptic terminals.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; MIT, Picower Ctr Learning & Memory, Dept Biol & Brain Cognit Sci, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT)	Ganetzky, B (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	ganetzky@wise.edu		Littleton, J. Troy/0000-0001-5576-2887	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015390, F32NS044722, R01NS043244] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32GM08349] Funding Source: Medline; NINDS NIH HHS [NS15390, NS43244, NS44722-01, R01 NS043244, R01 NS043244-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Caron E, 2002, CURR OPIN CELL BIOL, V14, P82, DOI 10.1016/S0955-0674(01)00298-8; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harden N, 1996, MOL CELL BIOL, V16, P1896; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mayer BJ, 2001, J CELL SCI, V114, P1253; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Qualmann B, 2002, INT REV CYTOL, V220, P93; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Soulard A, 2002, MOL CELL BIOL, V22, P7889, DOI 10.1128/MCB.22.22.7889-7906.2002; Takenawa T, 2001, J CELL SCI, V114, P1801; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Titus SA, 1997, J NEUROSCI, V17, P875; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; WU CF, 1978, P NATL ACAD SCI USA, V75, P4047, DOI 10.1073/pnas.75.8.4047; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	83	124	127	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					521	534		10.1016/S0896-6273(04)00016-9	http://dx.doi.org/10.1016/S0896-6273(04)00016-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980202	Bronze			2022-12-28	WOS:000221458100006
J	Kim, LA; Furst, J; Gutierrez, D; Butler, MH; Xu, SH; Goldstein, SAN; Grigorieff, N				Kim, LA; Furst, J; Gutierrez, D; Butler, MH; Xu, SH; Goldstein, SAN; Grigorieff, N			Three-dimensional structure of I-to: Kv4.2-KChIP2 ion channels by electron microscopy at 21 angstrom resolution	NEURON			English	Article							GATED K+ CHANNEL; NEURONAL CALCIUM SENSOR-1; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; BETA-SUBUNIT; T1 DOMAIN; PROTEIN; EXPRESSION; COMPLEX; MODULATION	Regulatory KChlP2 subunits assemble with pore-forming Kv4.2 subunits in 4:4 complexes to produce native voltage-gated potassium (Kv) channels like cardiac It, and neuronal I-A subtypes. Here, negative stain electron microscopy (EM) and single particle averaging reveal KChlP2 to create a novel similar to35 x 115 x 115 Angstrom, intracellular fenestrated rotunda: four peripheral columns that extend down from the membrane-embedded portion of the channel to enclose the Kv4.2 "hanging gondola" (a platform held beneath the transmembrane conduction pore by four internal columns). To reach the pore from the cytosol, ions traverse one of four external fenestrae to enter the rotundal vestibule and then cross one of four internal windows in the gondola.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat,Dept Cellular & Mol Physiol, New Haven, CT 06535 USA; Brandeis Univ, Howard Hughes Med Inst, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02454 USA	Yale University; Brandeis University; Howard Hughes Medical Institute	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat,Dept Cellular & Mol Physiol, 295 Congress Ave, New Haven, CT 06535 USA.	steve.goldstein@yale.edu	Kim, Leo/Y-3323-2018; Goldstein, Steven A./E-9817-2015	Kim, Leo/0000-0001-9106-6416; Grigorieff, Nikolaus/0000-0002-1506-909X; Goldstein, Steven A./0000-0001-5207-5061	NIGMS NIH HHS [GM07205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; KIM LA, 2003, IN PRESS J BIOLC HEM, V17; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Orlova EV, 2003, J MOL BIOL, V326, P1005, DOI 10.1016/S0022-2836(02)00708-8; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Sokolova O, 2003, P NATL ACAD SCI USA, V100, P12607, DOI 10.1073/pnas.2235650100; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	33	72	78	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					513	519		10.1016/S0896-6273(04)00050-9	http://dx.doi.org/10.1016/S0896-6273(04)00050-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980201	Bronze			2022-12-28	WOS:000221458100005
J	Smith, SM; Bergsman, JB; Harata, NC; Scheller, RH; Tsien, RW				Smith, SM; Bergsman, JB; Harata, NC; Scheller, RH; Tsien, RW			Recordings from single neocortical nerve terminals reveal a nonselective cation channel activated by decreases in extracellular calcium	NEURON			English	Article							POTASSIUM CHANNELS; SYNAPTIC CLEFT; NEUROMUSCULAR-JUNCTION; CA2+-SENSING RECEPTOR; CORTICAL SYNAPTOSOMES; CALCIMIMETIC COMPOUND; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; ION CHANNELS; RAT-BRAIN	Synaptic activity causes reductions in cleft [Ca2+] that may impact subsequent synaptic efficacy. Using modified patch-clamp techniques to record from single neocortical nerve terminals, we report that physiologically relevant reductions of extracellular [Ca2+] ([Ca2+](o)) activate voltage-dependent outward currents. These outward currents are carried by a novel nonselective cation (NSC) channel that is indirectly inhibited by various extracellular agents (rank order potency, Gd3+>spermidine>Ca2+>Mg2+, typical for [Ca2+], receptors). The identification of a Ca2+ sensor-NSC channel pathway establishes the existence of a mechanism by which presynaptic terminals can detect and respond to reductions in cleft [Ca2+]. Activation of NSC channels by falls in [Ca2+](o) would be expected during periods of high activity in the neocortex and may modulate the excitability of the presynaptic terminal.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Div Pulm & Crit Care Med, Div Mol Med, Portland, OR 97201 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Neurosci Program, Beckman Ctr, Stanford, CA 94305 USA	Stanford University; Oregon Health & Science University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Smith, Stephen/0000-0002-0331-7615; Harata, N. Charles/0000-0003-3287-4549				Armstrong CM, 1999, P NATL ACAD SCI USA, V96, P4154, DOI 10.1073/pnas.96.7.4154; BARTSCHAT DK, 1985, J PHYSIOL-LONDON, V361, P441, DOI 10.1113/jphysiol.1985.sp015654; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; BERS D, 1994, METHODS CELL BIOL PR, P3; BLAUSTEI.MP, 1972, P NATL ACAD SCI USA, V69, P2237, DOI 10.1073/pnas.69.8.2237; BORST JG, 1998, J PHYSL, V521, P123; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Burgo A, 2003, J PHYSIOL-LONDON, V549, P537, DOI 10.1113/jphysiol.2003.041871; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Formenti A, 2001, J PHYSIOL-LONDON, V535, P33, DOI 10.1111/j.1469-7793.2001.00033.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Fox J, 1999, J PHARMACOL EXP THER, V290, P480; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Johnson JP, 2001, J NEUROSCI, V21, P4143, DOI 10.1523/JNEUROSCI.21-12-04143.2001; KAUPPINEN RA, 1986, BIOCHIM BIOPHYS ACTA, V860, P178, DOI 10.1016/0005-2736(86)90513-4; Kennedy HJ, 1998, EXP PHYSIOL, V83, P449, DOI 10.1113/expphysiol.1998.sp004128; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NACHSHEN DA, 1985, J PHYSIOL-LONDON, V363, P87, DOI 10.1113/jphysiol.1985.sp015697; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; Rogers KV, 1997, BRAIN RES, V744, P47, DOI 10.1016/S0006-8993(96)01070-0; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sakmann Bert, 1995, P637; SCHMALZING G, 1985, BIOCHEM J, V225, P671, DOI 10.1042/bj2250671; SHIBUKI K, 1990, J PHYSIOL-LONDON, V422, P321, DOI 10.1113/jphysiol.1990.sp017986; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; Southan AP, 1998, J NEUROSCI, V18, P948; Stanley EF, 2000, J NEUROPHYSIOL, V83, P477, DOI 10.1152/jn.2000.83.1.477; Sun XP, 1999, J PHYSIOL-LONDON, V518, P639, DOI 10.1111/j.1469-7793.1999.0639p.x; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Ye CP, 1997, BRAIN RES BULL, V44, P75, DOI 10.1016/S0361-9230(97)00088-9; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18	57	50	52	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					243	256		10.1016/S0896-6273(03)00837-7	http://dx.doi.org/10.1016/S0896-6273(03)00837-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741105	Bronze			2022-12-28	WOS:000221457800010
J	Luo, Z; Je, HS; Wang, QA; Yang, F; Dobbins, GC; Yang, ZH; Xiong, WC; Lu, B; Mei, L				Luo, Z; Je, HS; Wang, QA; Yang, F; Dobbins, GC; Yang, ZH; Xiong, WC; Lu, B; Mei, L			Implication of geranylgeranyltransferase I in synapse formation	NEURON			English	Article							RECEPTOR GENE-EXPRESSION; ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; MUSCLE-CELLS; CARBOXYL METHYLATION; CDNA CLONING; PROTEIN; MUSK; DOMAIN; FARNESYLTRANSFERASE	Agrin activates the transmembrane tyrosine kinase MuSK to mediate acetylcholine receptor (AChR) clustering at the neuromuscular junction (NMJ). However, the intracellular signaling mechanism downstream of MuSK is poorly characterized. This study provides evidence that geranylgeranyltransferase I (GGT) is an important signaling component in the Agrin/MuSK pathway. Agrin causes a rapid increase in tyrosine phosphorylation of the alpha(G/F) subunit of GGT and in GGT activity. Inhibition of GGT activity or expression prevents muscle cells from forming AChR clusters in response to Agrin and attenuates the formation of neuromuscular synapses in spinal neuron-muscle co-cultures. Importantly, transgenic mice expressing an alpha(G/F) mutant demonstrate NMJ defects with wider end-plate bands and smaller AChR plaques. These results support the notion that prenylation is necessary for AChR clustering and the NMJ formation and/or maintenance, revealing an active role of GGT in Agrin/MuSK signaling.	Univ Alabama, Civitan Int Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Dept Phys Med, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Dept Rehab, Birmingham, AL 35294 USA; NICHHD, Lab Cellular & Synapt Neurophysiol, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham	Mei, L (corresponding author), Univ Alabama, Civitan Int Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA.		Yang, Feng/C-9530-2011; Mei, Lin/G-8755-2012; Lu, Bai/A-4018-2012; Je, Shawn/AHC-0995-2022; Luo, Zhen-Ge/GNM-7635-2022	Luo, Zhen-Ge/0000-0001-5037-0542; Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641; Je, hyunsoo/0000-0002-2924-5621	NINDS NIH HHS [T32NS07441] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007441] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES DA, 1993, GENOMICS, V18, P105, DOI 10.1006/geno.1993.1432; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Chappell J, 2000, J BIOL CHEM, V275, P31792, DOI 10.1074/jbc.M004798200; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Fazeli S, 1996, J CELL BIOL, V135, P241, DOI 10.1083/jcb.135.1.241; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hightower KE, 2001, BIOCHEM J, V360, P625, DOI 10.1042/0264-6021:3600625; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Ma L, 2003, J NEUROSCI, V23, P3164; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Mittaud P, 2001, J BIOL CHEM, V276, P14505, DOI 10.1074/jbc.M007024200; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; Strochlic L, 2001, J CELL BIOL, V153, P1127, DOI 10.1083/jcb.153.5.1127; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Weston C, 2003, J BIOL CHEM, V278, P6450, DOI 10.1074/jbc.M210249200; Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4; Wu Z, 1999, BIOCHEMISTRY-US, V38, P11239, DOI 10.1021/bi990583t; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; ZHANG FL, 1994, J BIOL CHEM, V269, P3175; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	55	65	69	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					703	717		10.1016/S0896-6273(03)00695-0	http://dx.doi.org/10.1016/S0896-6273(03)00695-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622576	Bronze			2022-12-28	WOS:000186651200007
J	Gabay, L; Lowell, S; Rubin, LL; Anderson, DJ				Gabay, L; Lowell, S; Rubin, LL; Anderson, DJ			Deregulation of dorsoventral patterning by FGF confers trilineage differentiation capacity on CNS stem cells in vitro	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIAL-RESTRICTED PRECURSORS; EMBRYONIC SPINAL-CORD; RAT CEREBRAL-CORTEX; OLIGODENDROCYTE LINEAGE; PROGENITOR CELLS; SONIC HEDGEHOG; NEURAL-TUBE; TRANSCRIPTION FACTORS; MAMMALIAN FOREBRAIN	The CNS is thought to develop from self-renewing stem cells that generate neurons, astrocytes, and oligodendrocytes. Other data, however, have suggested that astrocytes and oligodendrocytes are generated from separate progenitor populations. To reconcile these observations, we have prospectively isolated progenitors that do or do not express Olig2, an oligodendrocyte bHLH determination factor. Both Olig2 and Olig2(+) progenitors can behave as tripotential CNS stem cells (CNS-SCs) in vitro. Growth in FGF-2 causes induction of Olig2 in the former population, permitting oligodendrocyte differentiation; extinction of Olig2 in the latter cells permits astrocyte differentiation. The induction of Olig2 by FGF-2 is mediated, in part, via endogenous Sonic Hedgehog. These data indicate that clonogenic competence to generate neurons, astrocytes, and oligodendrocytes reflects a deregulation of dorsoventral patterning during expansion in vitro, raising the question of whether such trifatent cells actually exist in vivo.	CALTECH, Div Biol 21676, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Curis Pharmaceut Inc, Cambridge, MA 02138 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 21676, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Lowell, Sally/AAW-2992-2020	Lowell, Sally/0000-0002-4018-9480; Rubin, Lee/0000-0002-8658-841X				Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chandran S, 1998, GLIA, V24, P382, DOI 10.1002/(SICI)1098-1136(199812)24:4<382::AID-GLIA3>3.0.CO;2-5; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Culvenor JG, 2002, NEUROREPORT, V13, P1305, DOI 10.1097/00001756-200207190-00018; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GENSBURGER C, 1986, SCI VIE, V303, P465; Gritti A, 1996, J NEUROSCI, V16, P1091; Hall A, 1996, DEVELOPMENT, V122, P4085; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kuschel S, 2003, DEV BIOL, V260, P484, DOI 10.1016/S0012-1606(03)00252-5; LEBER SM, 1990, J NEUROSCI, V10, P2451; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rallu M, 2002, DEVELOPMENT, V129, P4963; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weiss S, 1996, J NEUROSCI, V16, P7599; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	62	258	268	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					485	499		10.1016/S0896-6273(03)00637-8	http://dx.doi.org/10.1016/S0896-6273(03)00637-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642274	Bronze			2022-12-28	WOS:000186379000009
J	Pleger, B; Foerster, AF; Ragert, P; Dinse, HR; Schwenkreis, P; Malin, JP; Nicolas, V; Tegenthoff, M				Pleger, B; Foerster, AF; Ragert, P; Dinse, HR; Schwenkreis, P; Malin, JP; Nicolas, V; Tegenthoff, M			Functional imaging of perceptual learning in human primary and secondary somatosensory cortex	NEURON			English	Article							CORTICAL REORGANIZATION; SOMATOTOPIC ORGANIZATION; RECEPTIVE-FIELDS; BRAILLE READERS; OWL MONKEYS; PLASTICITY; REPRESENTATION; PHANTOM; FMRI; LIMB	Cellular mechanisms underlying synaptic plasticity are in line with the Hebbian concept. In contrast, data linking Hebbian learning to altered perception are rare. Combining functional magnetic resonance imaging with psychophysical tests, we studied cortical reorganization in primary and secondary somatosensory cortex (SI and SII) and the resulting changes of tactile perception before and after tactile coactivation, a simple type of Hebbian learning. Coactivation on the right index finger (IF) for 3 hr lowered its spatial discrimination threshold. In parallel, blood-oxygen level-dependent (BOLD) signals from the right IF representation in SI and SII enlarged. The individual threshold reduction was linearly correlated with the enlargement in SI, implying a close relation between altered discrimination and cortical reorganization. Controls consisting of a single-site stimulation did not affect thresholds and cortical maps. Accordingly, changes within distributed cortical networks based on Hebbian mechanisms alter the individual percept.	Ruhr Univ Bochum, Inst Neuroinformat, Dept Theoret Biol, D-44780 Bochum, Germany; Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Neurol, D-44789 Bochum, Germany; Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Radiol, D-44789 Bochum, Germany; Ruhr Univ Bochum, Int Grad Sch Neurosci, IGSN, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Dinse, HR (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, Dept Theoret Biol, Univ Str 150, D-44780 Bochum, Germany.			dinse, hubert/0000-0001-9024-0451				Braun C, 2001, BRAIN, V124, P2259, DOI 10.1093/brain/124.11.2259; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Condes-Lara M, 2000, EUR J PAIN-LONDON, V4, P239, DOI 10.1053/eujp.2000.0176; Del Gratta C, 2000, NEUROREPORT, V11, P2035, DOI 10.1097/00001756-200006260-00046; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dinse HR, 2002, PERCEPTUAL LEARNING, P19; Disbrow E, 2000, J COMP NEUROL, V418, P1, DOI 10.1002/(SICI)1096-9861(20000228)418:1<1::AID-CNE1>3.0.CO;2-P; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Flor H, 2000, NEUROREPORT, V11, P1407, DOI 10.1097/00001756-200005150-00011; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Geyer S, 2000, NEUROIMAGE, V11, P684, DOI 10.1006/nimg.2000.0548; Godde B, 2000, J NEUROSCI, V20, P1597; Godde B, 1996, NEUROREPORT, V8, P281, DOI 10.1097/00001756-199612200-00056; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hebb Donald O., 1949, ORG BEHAV; James W., 1890, PSYCHOL BRIEF COURSE; Kilgard MP, 2002, BIOL CYBERN, V87, P333, DOI 10.1007/s00422-002-0352-z; Liepert J, 1999, EXP BRAIN RES, V125, P435, DOI 10.1007/s002210050700; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RECANZONE GH, 2000, NEW COGNITIVE NEUROS, P237; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Ruben J, 2001, CEREB CORTEX, V11, P463, DOI 10.1093/cercor/11.5.463; Simoes C, 2001, J NEUROPHYSIOL, V86, P1661, DOI 10.1152/jn.2001.86.4.1661; Sterr A, 1998, J NEUROSCI, V18, P4417; Talairach J., 1988, COPLANAR STEREOTAXIC; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Vega-Bermudez F, 1999, J NEUROPHYSIOL, V81, P2701, DOI 10.1152/jn.1999.81.6.2701; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WICKENS TD, 2002, ELEMENTARY SIGNAL DE	41	185	188	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					643	653		10.1016/S0896-6273(03)00677-9	http://dx.doi.org/10.1016/S0896-6273(03)00677-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642286	Bronze			2022-12-28	WOS:000186379000021
J	Kelleher, RJ; Govindarajan, A; Tonegawa, S				Kelleher, RJ; Govindarajan, A; Tonegawa, S			Translational regulatory mechanisms in persistent forms of synaptic plasticity	NEURON			English	Review							LONG-TERM POTENTIATION; LOCAL PROTEIN-SYNTHESIS; FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; IN-SITU HYBRIDIZATION; CAMKII MESSENGER-RNA; DEPENDENT LATE-PHASE; CA1 REGION; HIPPOCAMPAL-NEURONS; DENTATE GYRUS	Memory and synaptic plasticity exhibit distinct temporal phases, with long-lasting forms distinguished by their dependence on macromolecular synthesis. Prevailing models for the molecular mechanisms underlying long-lasting synaptic plasticity have largely focused on transcriptional regulation. However, a growing body of evidence now supports a crucial role for neuronal activity-dependent mRNA translation, which may occur in dendrites for a subset of neuronal mRNAs. Recent work has begun to define the signaling mechanisms coupling synaptic activation to the protein synthesis machinery. The ERK and mTOR signaling pathways have been shown to regulate the activity of the general translational machinery, while the translation of particular classes of mRNAs is additionally controlled by gene-specific mechanisms. Rapid enhancement of the synthesis of a diverse array of neuronal proteins through such mechanisms provides the components necessary for persistent forms of UP and LTD. These findings have important implications for the synapse specificity and associativity of protein synthesis-dependent changes in synaptic strength.	MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr,Ctr Canc Res,Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory,Dept Brain & Cognit, Howard Hughes Med Inst,Ctr Canc Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr,Ctr Canc Res,Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu			NIMH NIH HHS [P50-MH58880] Funding Source: Medline; NINDS NIH HHS [R01-NS32925, K08-NS02071] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032925, K08NS002071] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; AUTILIO LA, 1968, BIOCHEMISTRY-US, V7, P2615, DOI 10.1021/bi00847a025; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BANCO JL, 2004, IN PRESS J NEUROCHEM; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; BODIAN D, 1965, P NATL ACAD SCI USA, V53, P418, DOI 10.1073/pnas.53.2.418; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Carthew RW, 2002, CURR BIOL, V12, pR852, DOI 10.1016/S0960-9822(02)01352-0; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; FEIG S, 1993, J NEUROSCI, V13, P1010; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frey J U, 2001, Results Probl Cell Differ, V34, P27; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MORGAN IG, 1968, J NEUROCHEM, V15, P41, DOI 10.1111/j.1471-4159.1968.tb06172.x; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Carroll CM, 2004, NEUROPHARMACOLOGY, V47, P324, DOI 10.1016/j.neuropharm.2004.04.005; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Proud C, 2000, COLD SPRING HARBOR M, V39, P719; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sharma SK, 2003, J NEUROSCI, V23, P3899; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; STEWARD O, 1983, PROG BRAIN RES, V58, P131, DOI 10.1016/S0079-6123(08)60013-8; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stewart JJ, 2000, J CLIN PHARMACOL, V40, P347, DOI 10.1177/00912700022009044; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tiedge H, 1996, J NEUROSCI, V16, P7171; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WENZEL J, 1993, BRAIN RES, V619, P331, DOI 10.1016/0006-8993(93)91629-7; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	113	443	455	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					59	73		10.1016/j.neuron.2004.09.013	http://dx.doi.org/10.1016/j.neuron.2004.09.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450160	Bronze			2022-12-28	WOS:000224232600007
J	Kelley, AE				Kelley, AE			Memory and addiction: Shared neural circuitry and molecular mechanisms	NEURON			English	Review							LONG-TERM POTENTIATION; MESSENGER-RNA EXPRESSION; NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING BEHAVIOR; RECEPTOR STIMULATION INCREASES; PAVLOVIAN APPROACH BEHAVIOR; AFFERENT FIBER SYSTEM; DOPAMINE D1 RECEPTORS; MEDIUM SPINY NEURONS; NMDA RECEPTOR	An important conceptual advance in the past decade has been the understanding that the process of drug addiction shares striking commonalities with neural plasticity associated with natural reward learning and memory. Basic mechanisms involving dopamine, glutamate, and their intracellular and genomic targets have been the focus of attention in this research area. These two neurotransmitter systems, widely distributed in many regions of cortex, limbic system, and basal ganglia, appear to play a key integrative role in motivation, learning, and memory, thus modulating adaptive behavior. However, many drugs of abuse exert their primary effects precisely on these pathways and are able to induce enduring cellular alterations in motivational networks, thus leading to maladaptive behaviors. Current theories and research on this topic are reviewed from an integrative systems perspective, with special emphasis on cellular, molecular, and behavioral aspects of dopamine D-1 and glutamate NMDA signaling, instrumental learning, and drug cue conditioning.	Univ Wisconsin, Madison Med Sch, Neurosci Training Program, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Kelley, AE (corresponding author), Univ Wisconsin, Madison Med Sch, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	aekelley@wisc.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004788, R01DA009311, R01DA004788, R29DA004788] Funding Source: NIH RePORTER; NIDA NIH HHS [DA09311, DA04788] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; AIGNER TG, 1978, SCIENCE, V201, P534, DOI 10.1126/science.96531; Alleweireldt AT, 2002, PSYCHOPHARMACOLOGY, V159, P284, DOI 10.1007/s002130100904; Anagnostaras SG, 1996, BEHAV NEUROSCI, V110, P1397, DOI 10.1037/0735-7044.110.6.1397; Anderson SM, 2003, PSYCHOPHARMACOLOGY, V168, P132, DOI 10.1007/s00213-002-1298-5; Andrzejewski ME, 2004, BEHAV NEUROSCI, V118, P715, DOI 10.1037/0735-7044.118.4.715; Badiani A, 1997, J PHARMACOL EXP THER, V282, P787; Badiani A, 1998, J NEUROSCI, V18, P10579; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Baldwin AE, 2002, J NEUROSCI, V22, P1063, DOI 10.1523/JNEUROSCI.22-03-01063.2002; Baldwin AE, 2002, NEUROBIOL LEARN MEM, V77, P44, DOI 10.1006/nlme.2000.4002; BARTO AG, 1995, INFORMATION PROCESSI, P215; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bishop GB, 2002, NEUROBIOL DIS, V10, P334, DOI 10.1006/nbdi.2002.0518; Blair HT, 1998, NEURON, V21, P1387, DOI 10.1016/S0896-6273(00)80657-1; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; BOZARTH MA, 1985, JAMA-J AM MED ASSOC, V254, P81, DOI 10.1001/jama.254.1.81; Brancucci A, 2004, BRAIN RES, V997, P62, DOI 10.1016/j.brainres.2003.10.046; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Buck R, 1999, PSYCHOL REV, V106, P301, DOI 10.1037/0033-295X.106.2.301; Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cepeda C, 1998, J NEUROPHYSIOL, V79, P82, DOI 10.1152/jn.1998.79.1.82; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; CHILDRESS AR, 1986, BRIT J ADDICT, V81, P655; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Ciccocioppo R, 2001, P NATL ACAD SCI USA, V98, P1976, DOI 10.1073/pnas.98.4.1976; COLWILL RM, 1990, J EXP PSYCHOL ANIM B, V16, P40, DOI 10.1037/0097-7403.16.1.40; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Das S, 1997, SYNAPSE, V25, P227; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; De Leonibus E, 2003, EUR J NEUROSCI, V18, P2365, DOI 10.1046/j.1460-9568.2003.02939.x; Di Chiara G, 1998, J PSYCHOPHARMACOL, V12, P54, DOI 10.1177/026988119801200108; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DROUNGAS A, 1995, ADDICT BEHAV, V20, P657, DOI 10.1016/0306-4603(95)00029-C; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Espana RA, 2001, NEUROSCIENCE, V106, P699, DOI 10.1016/S0306-4522(01)00319-0; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fiorino DF, 1999, J NEUROSCI, V19, P456, DOI 10.1523/JNEUROSCI.19-01-00456.1999; Floresco SB, 2001, J NEUROSCI, V21, P2851, DOI 10.1523/JNEUROSCI.21-08-02851.2001; Floresco SB, 2001, J NEUROSCI, V21, P6370, DOI 10.1523/JNEUROSCI.21-16-06370.2001; Floyd NS, 2001, J COMP NEUROL, V432, P307, DOI 10.1002/cne.1105; Franklin TR, 2000, EUR J NEUROSCI, V12, P2097, DOI 10.1046/j.1460-9568.2000.00071.x; Franklin TR, 2000, NEUROPSYCHOPHARMACOL, V23, P633, DOI 10.1016/S0893-133X(00)00162-7; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; Ghasemzadeh MB, 2003, EUR J NEUROSCI, V18, P1645, DOI 10.1046/j.1460-9568.2003.02880.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; Goto Y, 2001, J NEUROSCI, V21; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Harvey J, 1997, J NEUROSCI, V17, P5271; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Hotsenpiller G, 2002, BEHAV NEUROSCI, V116, P634, DOI 10.1037//0735-7044.116.4.634; Hotsenpiller G, 2001, EUR J NEUROSCI, V14, P1843, DOI 10.1046/j.0953-816x.2001.01804.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Jay TM, 1998, EUR J NEUROSCI, V10, P3302, DOI 10.1046/j.1460-9568.1998.00389.x; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KAPLAN RF, 1985, J STUD ALCOHOL, V46, P267, DOI 10.15288/jsa.1985.46.267; Keefe KA, 1996, J COMP NEUROL, V367, P165, DOI 10.1002/(SICI)1096-9861(19960401)367:2<165::AID-CNE1>3.0.CO;2-3; KEHOE P, 1986, BEHAV NEUROSCI, V100, P359; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kelley AE, 2003, ANN NY ACAD SCI, V1003, P159, DOI 10.1196/annals.1300.061; Kelley AE, 2002, J NEUROSCI, V22, P3306; KELLEY AE, 2004, NEEDS EMOTIONS BRAIN; Kelly MP, 2003, J NEUROSCI, V23, P6443; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kenny PJ, 2003, ANN NY ACAD SCI, V1003, P415, DOI 10.1196/annals.1300.040; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Khroyan TV, 2003, PSYCHOPHARMACOLOGY, V168, P124, DOI 10.1007/s00213-002-1365-y; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Klebaur JE, 2002, BRAIN RES, V930, P30, DOI 10.1016/S0006-8993(01)03400-X; Konradi C, 1996, J NEUROSCI, V16, P4231; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Li YL, 2003, NEUROPSYCHOPHARMACOL, V28, P1082, DOI 10.1038/sj.npp.1300115; Liste I, 1997, EXP BRAIN RES, V115, P458, DOI 10.1007/PL00005715; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Lovinger DM, 2003, ANN NY ACAD SCI, V1003, P226, DOI 10.1196/annals.1300.014; LUDWIG AM, 1974, ARCH GEN PSYCHIAT, V30, P539; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; McFarland K, 2003, J NEUROSCI, V23, P3531; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Mulder AB, 1997, EUR J NEUROSCI, V9, P1603, DOI 10.1111/j.1460-9568.1997.tb01518.x; Mulder AB, 1998, J NEUROSCI, V18, P5095; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; Nesse RM, 1997, SCIENCE, V278, P63, DOI 10.1126/science.278.5335.63; Nestler EJ, 1999, BRAIN RES, V835, P10, DOI 10.1016/S0006-8993(98)01191-3; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; OBRIEN CP, 1992, RES P ARNMD, V70, P157; ODONNELL P, 1995, J NEUROSCI, V15, P3622; PachecoCano MT, 1996, EXP BRAIN RES, V110, P205; Panksepp JB, 2004, BEHAV BRAIN RES, V153, P171, DOI 10.1016/j.bbr.2003.11.014; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Pennartz CMA, 1997, NEUROSCIENCE, V81, P303, DOI 10.1016/S0306-4522(97)00118-8; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Peyron C, 1998, J NEUROSCI, V18, P9996; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Pierce RC, 1996, J NEUROSCI, V16, P1550; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; QI YL, 1989, P NATL ACAD SCI USA, V86, P8358, DOI 10.1073/pnas.86.21.8358; Ragozzino KE, 2001, EXP BRAIN RES, V139, P372, DOI 10.1007/s002210100795; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; RESCORLA RA, 1991, Q J EXP PSYCHOL-B, V43, P1; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Roullet P, 2001, J NEUROSCI, V21, P2143, DOI 10.1523/JNEUROSCI.21-06-02143.2001; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schoenbaum G, 2000, J NEUROSCI, V20, P5179; Schroeder BE, 2002, BEHAV NEUROSCI, V116, P727, DOI 10.1037//0735-7044.116.4.727; Schroeder BE, 2001, NEUROSCIENCE, V105, P535, DOI 10.1016/S0306-4522(01)00221-4; Schroeder BE, 2000, SYNAPSE, V37, P146; Schultes R. E., 1987, COCAINE CLIN BIOBEHA, P212; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; See RE, 2001, PSYCHOPHARMACOLOGY, V154, P301, DOI 10.1007/s002130000636; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Sheng M, 2000, NAT NEUROSCI, V3, P633, DOI 10.1038/76576; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; SIDEROFF SI, 1980, INT J ADDICT, V15, P529, DOI 10.3109/10826088009040035; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Smith-Roe SL, 1999, BEHAV NEUROSCI, V113, P703, DOI 10.1037/0735-7044.113.4.703; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Steiner H, 2000, J NEUROSCI, V20, P5449, DOI 10.1523/JNEUROSCI.20-14-05449.2000; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Sullivan RJ, 2002, ADDICTION, V97, P389, DOI 10.1046/j.1360-0443.2002.00024.x; Sutton MA, 1999, PSYCHOPHARMACOLOGY, V144, P95, DOI 10.1007/s002130050982; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Thomas KL, 2003, EUR J NEUROSCI, V17, P1964, DOI 10.1046/j.1460-9568.2003.02617.x; Thomas KL, 2002, EUR J NEUROSCI, V16, P1789, DOI 10.1046/j.1460-9568.2002.02247.x; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; Topple AN, 1998, NEUROSCI LETT, V252, P99, DOI 10.1016/S0304-3940(98)00574-6; TOTTERDELL S, 1989, J CHEM NEUROANAT, V2, P285; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Vezina P, 2002, J NEUROSCI, V22, P4654, DOI 10.1523/JNEUROSCI.22-11-04654.2002; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; WANG JQ, 1994, SYNAPSE, V18, P343, DOI 10.1002/syn.890180410; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; WICKENS J, 1995, INFORMATION PROCESSI, P187; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611; Will MJ, 2004, NEUROREPORT, V15, P1857, DOI 10.1097/00001756-200408260-00004; WILSON C, 1995, IMMIGRATION AMER IDE, P29; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	197	603	636	1	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					161	179		10.1016/j.neuron.2004.09.016	http://dx.doi.org/10.1016/j.neuron.2004.09.016			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450168	Bronze			2022-12-28	WOS:000224232600015
J	Walker, MP; Stickgold, R				Walker, MP; Stickgold, R			Sleep-dependent learning and memory consolidation	NEURON			English	Review							LONG-TERM POTENTIATION; EYE-MOVEMENT SLEEP; ELICITED PONTOGENICULOOCCIPITAL WAVES; REM-SLEEP; PARADOXICAL SLEEP; GENE-EXPRESSION; ACETYLCHOLINE-RELEASE; PROLONGED INCREASES; RAT HIPPOCAMPUS; NOCTURNAL SLEEP	While the functions of sleep remain largely unknown, one of the most exciting and contentious hypotheses is that sleep contributes importantly to memory. A large number of studies offer a substantive body of evidence supporting this role of sleep in what is becoming known as sleep-dependent memory processing. This review will provide evidence of sleep-dependent memory consolidation and sleep-dependent brain plasticity and is divided into five sections: (1) an overview of sleep stages, memory categories, and the distinct stages of memory development; (2) a review of the specific relationships between sleep and memory, both in humans and animals; (3) a survey of evidence describing sleep-dependent brain plasticity, including human brain imaging studies as well as animal studies of cellular neurophysiology and molecular biology. We close (4) with a consideration of unanswered questions as well as existing arguments against the role of sleep in learning and memory and (5) a concluding summary.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Psychiat,Ctr Sleep & Cognit, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Walker, MP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Psychiat,Ctr Sleep & Cognit, E FD 861,330 Brookline Ave, Boston, MA 02215 USA.	mwalker@hms.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067754, R01MH065292, R01MH092638] Funding Source: NIH RePORTER; NIMH NIH HHS [MH69,985, MH67,754, MH48,832, MH65,292] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMBROSINI MV, 1993, EUR J NEUROSCI, V5, P269, DOI 10.1111/j.1460-9568.1993.tb00493.x; AMBROSINI MV, 1992, PHYSIOL BEHAV, V51, P217, DOI 10.1016/0031-9384(92)90134-N; AMBROSINI MV, 1988, BRAZ J MED BIOL RES, V21, P141; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Atienza M, 2004, J COGNITIVE NEUROSCI, V16, P53, DOI 10.1162/089892904322755557; Beaulieu I, 2000, BRAIN COGNITION, V43, P27; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; CALLAWAY CW, 1987, CELL MOL NEUROBIOL, V7, P105, DOI 10.1007/BF00711551; Cantero JL, 2003, J NEUROSCI, V23, P10897; CHASE MH, 1990, ANNU REV PSYCHOL, V41, P557, DOI 10.1146/annurev.ps.41.020190.003013; CHEMIK DA, 1972, PERCEPT MOTOR SKILL, V34, P283; CIPOLLI C, 1979, SLEEP, V2, P193, DOI 10.1093/sleep/2.2.193; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cirelli C, 2000, SLEEP, V23, P453; Cirelli C, 1998, MOL BRAIN RES, V56, P293, DOI 10.1016/S0169-328X(98)00057-6; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Datta S, 2004, J NEUROSCI, V24, P1416, DOI 10.1523/JNEUROSCI.4111-03.2004; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DEKONINCK J, 1989, INT J PSYCHOPHYSIOL, V8, P43, DOI 10.1016/0167-8760(89)90018-4; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EMPSON JAC, 1970, NATURE, V227, P287, DOI 10.1038/227287a0; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FISHBEIN W, 1974, BRAIN RES, V79, P61, DOI 10.1016/0006-8993(74)90566-6; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gaab N, 2004, NEUROREPORT, V15, P731, DOI 10.1097/00001756-200403220-00032; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; GAIS S, 2004, IN PRESS P NATL ACAD; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; HENNEVIN E, 1987, BEHAV BRAIN RES, V24, P243, DOI 10.1016/0166-4328(87)90062-3; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Holscher C, 1997, J NEUROSCI, V17, P6470; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; KAMETANI H, 1990, LIFE SCI, V47, P421, DOI 10.1016/0024-3205(90)90300-G; Karashima A, 2002, BRAIN RES, V958, P347, DOI 10.1016/S0006-8993(02)03673-9; Karashima A, 2002, PSYCHIAT CLIN NEUROS, V56, P343, DOI 10.1046/j.1440-1819.2002.01019.x; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Landolt HP, 2001, ARCH GEN PSYCHIAT, V58, P268, DOI 10.1001/archpsyc.58.3.268; Landolt HP, 2001, NEUROPSYCHOPHARMACOL, V25, pS63, DOI 10.1016/S0893-133X(01)00321-9; LEWIN I, 1975, PSYCHOPHYSIOLOGY, V12, P349, DOI 10.1111/j.1469-8986.1975.tb01303.x; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; LYDIC R, 1988, HDB BEHAV STATE CONT; MANDAI O, 1989, PHYSIOL BEHAV, V46, P639, DOI 10.1016/0031-9384(89)90344-2; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; MARTINICOLOVIUS M, 1988, PHYSIOL BEHAV, V43, P93, DOI 10.1016/0031-9384(88)90103-5; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; MEIENBERG P, 1977, PHYSIOL PSYCHOL, V5, P250, DOI 10.3758/BF03335326; MENDELSON WB, 1982, PHARMACOL BIOCHEM BE, V16, P429, DOI 10.1016/0091-3057(82)90447-6; MINOT R, 1993, INT CLIN PSYCHOPHARM, V7, P181, DOI 10.1097/00004850-199300730-00009; MONTI JM, 1990, J AFFECT DISORDERS, V20, P201, DOI 10.1016/0165-0327(90)90145-X; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Oniani T N, 1987, Neurosci Behav Physiol, V17, P304, DOI 10.1007/BF01183059; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pearlman CA, 1969, 563 US NAV SUBM MED, P1; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Sanford LD, 2003, BEHAV GENET, V33, P43, DOI 10.1023/A:1021051516829; Sanford LD, 2001, ARCH ITAL BIOL, V139, P169; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shaffery JP, 1998, SLEEP, V21, P837, DOI 10.1093/sleep/21.8.837; Shaffery JP, 2002, NEUROSCIENCE, V110, P431, DOI 10.1016/S0306-4522(01)00589-9; Shaffery JP, 1999, DEV BRAIN RES, V114, P109, DOI 10.1016/S0165-3806(99)00027-9; SHIMA K, 1986, BRAIN RES, V399, P317, DOI 10.1016/0006-8993(86)91522-2; SHIROMANI P, 1979, PHYSIOL BEHAV, V22, P971, DOI 10.1016/0031-9384(79)90343-3; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; Smith C, 2003, SLEEP, V26, P185; SMITH C, 1986, PHYSIOL BEHAV, V36, P1053, DOI 10.1016/0031-9384(86)90479-8; SMITH C, 1991, CAN J PSYCHOL, V45, P115, DOI 10.1037/h0084279; SMITH C, 1982, PHYSIOL BEHAV, V29, P469, DOI 10.1016/0031-9384(82)90268-2; SMITH C, 1980, SLEEP, V3, P67; SMITH C, 1988, PHYSIOL BEHAV, V43, P213, DOI 10.1016/0031-9384(88)90240-5; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; STEIGER A, 1994, NEUROPSYCHOBIOLOGY, V30, P101, DOI 10.1159/000119145; Stensvag K, 1999, J FISH DIS, V22, P337, DOI 10.1046/j.1365-2761.1999.00174.x; Steriade M, 1998, Sleep Res Online, V1, P1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Steriade M, 1996, J NEUROSCI, V16, P2788; Steriade M., 2001, INTACT SLICED BRAIN; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stickgold R, 2002, J CLIN PSYCHOL, V58, P61, DOI 10.1002/jclp.1129; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; TILLEY AJ, 1978, BIOL PSYCHOL, V6, P293, DOI 10.1016/0301-0511(78)90031-5; Tononi G, 2001, ARCH ITAL BIOL, V139, P221; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Walker MP, 2002, COGNITIVE BRAIN RES, V14, P317, DOI 10.1016/S0926-6410(02)00134-9; WALKER MP, 2004, IN PRESS BEHAV BRAIN; Wetzel W, 2003, EUR J NEUROSCI, V18, P2611, DOI 10.1046/j.1460-9568.2003.02890.x; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; ZIMMERMAN J, 1970, PSYCHOPHYSIOLOGY, V7, P298; ZIMMERMAN JT, 1978, BIOL PSYCHIAT, V13, P301	125	584	600	0	153	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					121	133		10.1016/j.neuron.2004.08.031	http://dx.doi.org/10.1016/j.neuron.2004.08.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	858ZY	15450165	Bronze			2022-12-28	WOS:000224232600012
J	Li, SG; Mo, ZQ; Yang, XJ; Price, SM; Shen, MM; Xiang, MQ				Li, SG; Mo, ZQ; Yang, XJ; Price, SM; Shen, MM; Xiang, MQ			Foxn4 controls the genesis of amacrine and horizontal cells by retinal progenitors	NEURON			English	Article							GANGLION-CELL; HOMEOBOX GENE; VERTEBRATE RETINA; MOUSE RETINA; IN-VITRO; DIFFERENTIATION; EXPRESSION; MICE; NEURONS; FATE	During vertebrate retinogenesis, seven classes of cells are specified from multipotent progenitors. To date, the mechanisms underlying multipotent cell fate determination by retinal progenitors remain poorly understood. Here, we show that the Foxn4 winged helix/ forkhead transcription factor is expressed in a subset of mitotic progenitors during mouse retinogenesis. Targeted disruption of Foxn4 largely eliminates amacrine neurons and completely abolishes horizontal cells, while overexpression of Foxn4 strongly promotes an amacrine cell fate. These results indicate that Foxn4 is both necessary and sufficient for commitment to the amacrine cell fate and is nonredundantly required for the genesis of horizontal cells. Furthermore, we provide evidence that Foxn4 controls the formation of amacrine and horizontal cells by activating the expression of the retinogenic factors Math3, NeurOD1, and Prox1. Our data suggest a model in which Foxn4 cooperates with other key retinogenic factors to mediate the multipotent differentiation of retinal progenitors.	Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Dept Pediat, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Xiang, MQ (corresponding author), Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	xiang@cabm.rutgers.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657	NEI NIH HHS [EY12020] Funding Source: Medline; NICHD NIH HHS [HD42837] Funding Source: Medline; NIDCD NIH HHS [DC04594] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004594] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alexiades MR, 1997, DEVELOPMENT, V124, P1119; ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gouge A, 2001, MECH DEVELOP, V107, P203, DOI 10.1016/S0925-4773(01)00465-8; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Inoue T, 2002, DEVELOPMENT, V129, P831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Kim MJ, 2002, CANCER RES, V62, P2999; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Liu W, 2000, DEVELOPMENT, V127, P3237; Liu W, 2000, DEV DYNAM, V217, P320, DOI 10.1002/(SICI)1097-0177(200003)217:3<320::AID-DVDY10>3.0.CO;2-F; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Morrow EM, 1999, DEVELOPMENT, V126, P23; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; Pennesi ME, 2003, J NEUROSCI, V23, P453; Satow T, 2001, J NEUROSCI, V21, P1265; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; TOMITA K, 1995, EMBO J, V10, P54; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Young TL, 2004, NEURON, V41, P867, DOI 10.1016/S0896-6273(04)00141-2; Zhang XM, 2001, DEVELOPMENT, V128, P943	57	185	189	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					795	807		10.1016/j.neuron.2004.08.041	http://dx.doi.org/10.1016/j.neuron.2004.08.041			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363391	Bronze			2022-12-28	WOS:000223992000006
J	Wang, J; Ma, XJ; Yang, JS; Zheng, XY; Zugates, CT; Lee, CHJ; Lee, T				Wang, J; Ma, XJ; Yang, JS; Zheng, XY; Zugates, CT; Lee, CHJ; Lee, T			Transmembrane/juxtamembrane domain-dependent Dscam distribution and function during mushroom body neuronal morphogenesis	NEURON			English	Article							REPRESSIBLE CELL MARKER; DROSOPHILA DSCAM; MOSAIC ANALYSIS; AXON GUIDANCE; BODIES; RECEPTOR; NEUROBLAST; EXPRESSION; CHANNELS; ROLES	Besides 19,008 possible ectodomains, Drosophila Dscam contains two alternative transmembrane/juxtamembrane segments, respectively, derived from exon 17.1 and exon 17.2. We wondered whether specific Dscam isoforms mediate formation and segregation of axonal branches in the Drosophila mushroom bodies (MBs). Removal of various subsets of the 12 exon 4s does not affect MB neuronal morphogenesis, while expression of a Dscam transgene only partially rescues Dscam mutant phenotypes. Interestingly, differential rescuing effects are observed between two Dscam transgenes that each possesses one of the two possible exon 17s. Axon bifurcation/segregation abnormalities are better rescued by the exon 17.2-containing transgene, but coexpression of both transgenes is required for rescuing mutant viability. Meanwhile, exon 17.1 targets ectopically expressed Dscam-GFP to dendrites while Dscam[exon 17.2]-GFP is enriched in axons; only Dscam[exon 17.2] affects MB axons. These results suggest that exon 17.1 is minimally involved in axonal morphogenesis and that morphogenesis of MB axons probably involves multiple distinct exon 17.2-containing Dscam isoforms.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Hematol Oncol Sect, Dept Internal Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.	tzumin@life.uiuc.edu	Yang, Shun-Jen/G-2968-2015; Zheng, Xiaoyan/AAG-1251-2020	Zheng, Xiaoyan/0000-0003-4983-5503; Zugates, Christopher/0000-0003-1882-3665				Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Celotto AM, 2001, GENETICS, V159, P599; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Noveen A, 2000, DEVELOPMENT, V127, P3475; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; YANG MY, 1995, NEURON, V15, P45; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	24	140	141	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					663	672		10.1016/j.neuron.2004.06.033	http://dx.doi.org/10.1016/j.neuron.2004.06.033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339648	Bronze			2022-12-28	WOS:000223691900012
J	Ibanez-Tallon, I; Wen, H; Miwa, JM; Xing, J; Tekinay, AB; Ono, F; Brehm, P; Heintz, N				Ibanez-Tallon, I; Wen, H; Miwa, JM; Xing, J; Tekinay, AB; Ono, F; Brehm, P; Heintz, N			Tethering naturally occurring peptide toxins for cell-autonomous modulation of ion channels and receptors in vivo	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CENTRAL-NERVOUS-SYSTEM; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; ALPHA-CONOTOXIN; GENE-EXPRESSION; NMDA RECEPTORS; MEMORY; SNAKE; BUNGAROTOXIN	The physiologies of cells depend on electrochemical signals carried by ion channels and receptors. Venomous animals produce an enormous variety of peptide toxins with high affinity for specific ion channels and receptors. The mammalian prototoxin lynx1 shares with alpha-bungarotoxin the ability to bind and modulate nicotinic receptors (nAChRs); however, lynx1 is tethered to the membrane via a GPI anchor. We show here that several classes of neurotoxins, including bungarotoxins and cobratoxins, retain their selective antagonistic properties when tethered to the membrane. Targeted elimination of nAChR function in zebrafish can be achieved with tethered alpha-bungarotoxin, silencing synaptic transmission without perturbing synapse formation. These studies harness the pharmacological properties of peptide toxins for use in genetic experiments. When combined with specific methods of cell and temporal expression, the extension of this approach to hundreds of naturally occurring peptide toxins opens a new landscape for cell-autonomous regulation of cellular physiology in vivo.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu	ono, fumihito/A-6570-2008; Tekinay, Ayse Begum/A-7212-2015	Tekinay, Ayse Begum/0000-0002-4453-814X; ono, fumihito/0000-0001-7532-5262; Miwa, Julie/0000-0002-4418-3756				ADAMS ME, 1994, TRENDS NEUROSCI, V17, P151, DOI 10.1016/0166-2236(94)90092-2; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Catterall W A, 1999, Adv Neurol, V79, P441; Champtiaux N, 2004, PROG BRAIN RES, V145, P235, DOI 10.1016/S0079-6123(03)45016-4; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Gong M, 2003, CURR OPIN GENET DEV, V13, P215, DOI 10.1016/S0959-437X(03)00018-2; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Johns DC, 1999, J NEUROSCI, V19, P1691; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; LORING RH, 1986, BRAIN RES, V385, P30, DOI 10.1016/0006-8993(86)91543-X; LUKAS RJ, 1981, BIOCHEMISTRY-US, V20, P7373, DOI 10.1021/bi00529a008; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Nadal MS, 2001, J PHYSIOL-LONDON, V537, P801; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Ono F, 2002, J NEUROSCI, V22, P6491; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; Sato K, 2000, BIOCHEM BIOPH RES CO, V269, P254, DOI 10.1006/bbrc.2000.2284; Servent D, 1997, J BIOL CHEM, V272, P24279, DOI 10.1074/jbc.272.39.24279; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Terlau H, 1996, J NEUROPHYSIOL, V76, P1423, DOI 10.1152/jn.1996.76.3.1423; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006	41	67	72	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					305	311		10.1016/j.neuron.2004.07.015	http://dx.doi.org/10.1016/j.neuron.2004.07.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294139	Bronze			2022-12-28	WOS:000223156900005
J	Pena, F; Parkis, MA; Tryba, AK; Ramirez, JM				Pena, F; Parkis, MA; Tryba, AK; Ramirez, JM			Differential contribution of pacemaker properties to the generation of respiratory rhythms during normoxia and hypoxia	NEURON			English	Article							PERSISTENT SODIUM CURRENT; CENTRAL PATTERN GENERATORS; PRE-BOTZINGER COMPLEX; IN-VITRO; PLATEAU POTENTIALS; CORTICAL-NEURONS; NETWORK; RILUZOLE; GANGLION; HIPPOCAMPAL	Pacemaker neurons have been described in most neural networks. However, whether such neurons are essential for generating an activity pattern in a given preparation remains mostly unknown. Here, we show that in the mammalian respiratory network two types of pacemaker neurons exist. Differential blockade of these neurons indicates that their relative contribution to respiratory rhythm generation changes during the transition from normoxia to hypoxia. During hypoxia, blockade of neurons with sodium-dependent bursting properties abolishes respiratory rhythm generation, while in normoxia respiratory rhythm generation only ceases upon pharmacological blockade of neurons with heterogeneous bursting properties. We propose that respiratory rhythm generation in normoxia depends on a heterogeneous population of pacemaker neurons, while during hypoxia the respiratory rhythm is driven by only one type of pacemaker.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; IPN, Dept Farmacobiol, Ctr Invest & Estudios Avanzados, Mexico City 14330, DF, Mexico	University of Chicago; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Pena, F (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	jfpena@mail.cinvestav.mx		Tryba, Andrew/0000-0002-9610-9259; Pena-Ortega, Fernando/0000-0002-0348-4392; Ramirez, Jan-Marino/0000-0002-5626-3999	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068860, R01HL060120] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68860, HL60120] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arshavsky YI, 2003, BRAIN RES REV, V41, P229, DOI 10.1016/S0165-0173(02)00249-7; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Bremer F, 1938, ACTUAL SCI IND, V658, P3; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; CARPENTE.DO, 1967, J GEN PHYSIOL, V50, P1469, DOI 10.1085/jgp.50.6.1469; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONNOR JA, 1969, J EXP BIOL, V50, P275; Del Negro CA, 2002, J NEUROPHYSIOL, V88, P2242, DOI 10.1152/jn.00081.2002; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Di Prisco GV, 2000, J NEUROSCI, V20, P8169; Ghamari-Langroudi M, 2002, J PHYSIOL-LONDON, V545, P537, DOI 10.1113/jphysiol.2002.033589; HARRISWARRICK RM, 1987, J NEUROSCI, V7, P2113; HASUO H, 1990, J NEUROPHYSIOL, V64, P1838, DOI 10.1152/jn.1990.64.6.1838; HOUNSGAARD J, 1979, ACTA PHYSIOL SCAND, V106, P91, DOI 10.1111/j.1748-1716.1979.tb06375.x; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; JENNINGS DP, 1978, BRAIN RES, V149, P347, DOI 10.1016/0006-8993(78)90480-8; Johnston D., 1995, FDN CELLULAR NEUROPH; Kiehn O, 1997, NEUROSCIENCE, V77, P613; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; KRAMER RH, 1985, J PHYSIOL-LONDON, V362, P107, DOI 10.1113/jphysiol.1985.sp015666; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Lytton WW, 1996, NEUROSCIENCE, V70, P673, DOI 10.1016/S0306-4522(96)83006-5; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 2002, NATURE, V417, P318, DOI 10.1038/417318a; MARDER E, 1984, J EXP BIOL, V112, P147; McCrimmon DR, 2000, BIOESSAYS, V22, P6, DOI 10.1002/(SICI)1521-1878(200001)22:1<6::AID-BIES3>3.0.CO;2-Q; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1378, DOI 10.1152/jn.1982.48.6.1378; Morisset V, 1999, J NEUROSCI, V19, P7309, DOI 10.1523/JNEUROSCI.19-17-07309.1999; NEHER E, 1992, METHOD ENZYMOL, V207, P123; ONeill MJ, 1997, EUR J PHARMACOL, V332, P121, DOI 10.1016/S0014-2999(97)01074-1; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; PARTRIDGE LD, 1994, BRAIN RES REV, V19, P319, DOI 10.1016/0165-0173(94)90017-5; Pena F, 2002, J NEUROSCI, V22, P11055; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; Poets CF, 1999, PEDIATR RES, V45, P350, DOI 10.1203/00006450-199903000-00010; Ramirez JM, 1998, J NEUROPHYSIOL, V80, P3137, DOI 10.1152/jn.1998.80.6.3137; Ramirez JM, 1996, J PHYSIOL-LONDON, V491, P799, DOI 10.1113/jphysiol.1996.sp021258; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1997, J NEUROPHYSIOL, V78, P2483, DOI 10.1152/jn.1997.78.5.2483; RICHTER DW, 1991, J PHYSIOL-LONDON, V443, P231, DOI 10.1113/jphysiol.1991.sp018832; SCHWINDT PC, 1982, J NEUROPHYSIOL, V48, P875, DOI 10.1152/jn.1982.48.4.875; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shuai J, 2003, BIOPHYS J, V84, P2099, DOI 10.1016/S0006-3495(03)75017-6; Siniscalchi A, 1997, BRIT J PHARMACOL, V120, P225, DOI 10.1038/sj.bjp.0700905; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; Spadoni F, 2002, NEUROREPORT, V13, P1167, DOI 10.1097/00001756-200207020-00019; Staley KJ, 2001, J NEUROPHYSIOL, V86, P2736, DOI 10.1152/jn.2001.86.6.2736; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; SWANDULLA D, 1985, J NEUROPHYSIOL, V54, P1430, DOI 10.1152/jn.1985.54.6.1430; Telgkamp P, 1999, J NEUROPHYSIOL, V82, P2163, DOI 10.1152/jn.1999.82.5.2163; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; TRAUB RD, 1979, J NEUROPHYSIOL, V42, P476, DOI 10.1152/jn.1979.42.2.476; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Tryba AK, 2003, J NEUROSCI, V23, P3538; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; WATANABE A, 1967, J GEN PHYSIOL, V50, P839, DOI 10.1085/jgp.50.4.839; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; Zona C, 1998, NEUROSCIENCE, V85, P931, DOI 10.1016/S0306-4522(97)00604-0	62	259	263	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					105	117		10.1016/j.neuron.2004.06.023	http://dx.doi.org/10.1016/j.neuron.2004.06.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233921	Bronze			2022-12-28	WOS:000222549800011
J	Hayashi, ML; Choi, SY; Rao, BSS; Jung, HY; Lee, HK; Zhang, DW; Chattarji, S; Kirkwood, A; Tonegawa, S				Hayashi, ML; Choi, SY; Rao, BSS; Jung, HY; Lee, HK; Zhang, DW; Chattarji, S; Kirkwood, A; Tonegawa, S			Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant- negative PAK transgenic mice	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; NMDA RECEPTORS; NEUROTROPHIC FACTOR; PYRAMIDAL CELLS; HIPPOCAMPAL LTP; PLASTICITY; AMPA; SYNAPSES; ACTIN	Molecular and cellular mechanisms for memory consolidation in the cortex are poorly known. To study the relationships between synaptic structure and function in the cortex and consolidation of long-term memory, we have generated transgenic mice in which catalytic activity of PAK, a critical regulator of actin remodeling, is inhibited in the postnatal forebrain. Cortical neurons in these mice displayed fewer dendritic spines and an increased proportion of larger synapses compared to wild-type controls. These alterations in basal synaptic morphology correlated with enhanced mean synaptic strength and impaired bidirectional synaptic modifiability (enhanced LTP and reduced LTD) in the cortex. By contrast, spine morphology and synaptic plasticity were normal in the hippocampus of these mice. Importantly, these mice exhibited specific deficits in the consolidation phase of hippocampus-dependent memory. Thus, our results provide evidence for critical relationships between synaptic morphology and bidirectional modifiability of synaptic strength in the cortex and consolidation of long-term memory.	MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr,Ctr Canc Res,Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; Johns Hopkins Univ, Dept Neurosci, Mind Brain Inst, Baltimore, MD 21208 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Johns Hopkins University	Tonegawa, S (corresponding author), MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr,Ctr Canc Res,Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Lee, Hey-Kyoung/0000-0002-5554-983X; Choi, Se-Young/0000-0001-7534-5167				Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BEKKERS JM, 1994, MOL CELLULAR MECH NE; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; CROWLEY JN, 2000, WHATS WRONG MY HOUSE; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GOSLIN K, 1990, J NEUROSCI, V10, P588; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Huber KM, 1998, NEUROPHARMACOLOGY, V37, P571, DOI 10.1016/S0028-3908(98)00050-1; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mackenzie P J, 1999, J Neurosci, V19, pRC13; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MORALES M, 1989, J COMP NEUROL, V279, P666, DOI 10.1002/cne.902790412; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ramon-Moliner E., 1970, CONT RES METHODS NEU; Regehr WG, 2001, SYNAPSES, P135; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schikorski T, 1997, J NEUROSCI, V17, P5858; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Vyas A, 2002, J NEUROSCI, V22, P6810; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	84	220	230	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					773	787		10.1016/j.neuron.2004.05.003	http://dx.doi.org/10.1016/j.neuron.2004.05.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182717	Bronze			2022-12-28	WOS:000221975000009
J	Buckner, RL				Buckner, RL			The potion's magic	NEURON			English	Editorial Material							HUMAN OLFACTORY CORTEX; IMAGERY	During remembering, a perception of the past is constructed that includes sensory details of the original episode. In this issue of Neuron, Gottfried and colleagues provide evidence for selective piriform activation during recognition of visual cues previously paired with scents. These data provide evidence of sensory-specific reactivation of olfactory cortex during remembering.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Dept Radiol, St Louis, MO 63130 USA; Washington Univ, Dept Anat & Neurobiol, Howard Hughes Med Inst, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.							Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; James W., 1890, PRINCIPLES PSYCHOL; KOSSLYN SM, 1994, IMAGE BRAIN RESOLUIT; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	10	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 27	2004	42	4					526	527		10.1016/j.neuron.2004.05.007	http://dx.doi.org/10.1016/j.neuron.2004.05.007			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157415	Bronze			2022-12-28	WOS:000221708300004
J	Deadwyler, SA; Hampson, RE				Deadwyler, SA; Hampson, RE			Differential but complementary mnemonic functions of the hippocampus and subiculum	NEURON			English	Article							DELAYED-NONMATCH; SAMPLE PERFORMANCE; NEURONAL-ACTIVITY; ENSEMBLE ACTIVITY; MEMORY FORMATION; SPATIAL MEMORY; RAT; ORGANIZATION; NAVIGATION; SYSTEM	In this study we describe how the hippocampus and subiculum act in concert to encode information in a spatial delayed-nonmatch-to-sample (DNMS) task. This encoding was functionally partitioned between neurons within subiculum and hippocampus to uniquely identify trial-specific information accounting for both spatial and temporal constraints on performance within and between trials. Encoding by subicular neurons in the task was normally accurate and specific, but only if delays were shorter than 15 s, whereas trial-specific information encoded by hippocampal neurons was subject to strong biases from prior trial sequences and was accessible only when delays exceeded 15 s. The two structures operated in a complementary manner to encode information correctly on 75% of all trials using the above strategies. The remaining 25% of trials were at risk due to inherent idiosyncrasies by which hippocampal and subicular neurons encoded information and became errors when the random sequence of trials conflicted with these constraints.	Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Deadwyler, SA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	sdeadwyl@wfubmc.edu		Hampson, Robert/0000-0002-8648-9462	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003502, R37DA003502] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 00119, DA 03502, DA 08509] Funding Source: Medline; NIMH NIH HHS [MH 61397] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agster KL, 2002, J NEUROSCI, V22, P5760; Anderson MI, 2003, J NEUROPHYSIOL, V90, P655, DOI 10.1152/jn.00723.2002; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 2002, Q J EXP PSYCHOL-A, V55, P1057, DOI 10.1080/02724980244000224; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; BURWELL RD, 2000, SCIENCE, P25; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1993, SCIENCE, V261, P993, DOI 10.1126/science.8351525; Fernandez G, 2002, HIPPOCAMPUS, V12, P514, DOI 10.1002/hipo.10050; Frank LM, 2003, TRENDS NEUROSCI, V26, P400, DOI 10.1016/S0166-2236(03)00176-0; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Golob EJ, 2001, BEHAV NEUROSCI, V115, P285, DOI 10.1037/0735-7044.115.2.285; Hampson RE, 1996, P NATL ACAD SCI USA, V93, P13487, DOI 10.1073/pnas.93.24.13487; Hampson RE, 2003, HIPPOCAMPUS, V13, P529, DOI 10.1002/hipo.10119; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hampson RE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0002.2002; Hampson RE, 1998, NEURONAL ENSEMBLES: STRATEGIES FOR RECORDING AND DECODING, P207; Hampson RE, 1999, J NEUROSCI, V19, P1492; HAMPSON RE, 2000, PARAHIPOCAPAL REGION; Holdstock JS, 2002, HIPPOCAMPUS, V12, P341, DOI 10.1002/hipo.10011; Kloosterman F, 2003, J COMP NEUROL, V455, P156, DOI 10.1002/cne.10472; Kobayashi T, 2003, NEUROSCIENCE, V117, P1025, DOI 10.1016/S0306-4522(02)00700-5; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Moses SN, 2002, BRAIN RES BULL, V58, P517, DOI 10.1016/S0361-9230(02)00820-1; Muir GM, 2003, HIPPOCAMPUS, V13, P93, DOI 10.1002/hipo.10052; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pihlajamaki M, 2003, HIPPOCAMPUS, V13, P67, DOI 10.1002/hipo.10049; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Suzuki WA, 2000, ANN NY ACAD SCI, V911, P175; Van Elzakker M, 2003, HIPPOCAMPUS, V13, P334, DOI 10.1002/hipo.10083; WIENER SI, 1989, J NEUROSCI, V9, P2737; Wilson MA, 2002, NEUROBIOL LEARN MEM, V78, P565, DOI 10.1006/nlme.2002.4098; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	44	98	100	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					465	476		10.1016/S0896-6273(04)00195-3	http://dx.doi.org/10.1016/S0896-6273(04)00195-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134642	Bronze			2022-12-28	WOS:000221458700012
J	Zink, CF; Pagnoni, G; Martin-Skurski, ME; Chappelow, JC; Berns, GS				Zink, CF; Pagnoni, G; Martin-Skurski, ME; Chappelow, JC; Berns, GS			Human striatal responses to monetary reward depend on saliency	NEURON			English	Article							TONICALLY ACTIVE NEURONS; VENTRAL STRIATUM; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; NEURAL RESPONSES; ORBITOFRONTAL CORTEX; MONKEY STRIATUM; HUMAN BRAIN; ANTICIPATION; FMRI	While the striatum has been implicated in reward processing, an alternative view contends that the striatum processes salient events in general. Using fMRI, we investigated human striatal responses to monetary reward while modulating the saliency surrounding its receipt. Money was maximally salient when its receipt depended on a correct response (active) and minimally salient when its receipt was completely independent of the task (passive). The saliency manipulation was confirmed by skin conductance responses and subjective ratings of the stimuli. Significant caudate and nucleus accumbens activations occurred following the active compared to passive money. Such activations were attributed to saliency rather than the motor requirement associated with the active money because striatal activations were not observed when the money was replaced by inconsequential, nonrewarding stimuli. The present study provides evidence that the striatum's role in reward processing is dependent on the saliency associated with reward, rather than value or hedonic feelings.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Berns, GS (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gberns@emory.edu	Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA000367] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB 002635] Funding Source: Medline; NIDA NIH HHS [K08 DA 00367] Funding Source: Medline; NIMH NIH HHS [F31 MH 67348] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cannon CM, 2003, J NEUROSCI, V23, P10827; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; WILLIAMS GV, 1993, BEHAV BRAIN RES, V55, P243, DOI 10.1016/0166-4328(93)90120-F; Zink CF, 2003, J NEUROSCI, V23, P8092	41	323	327	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					509	517		10.1016/S0896-6273(04)00183-7	http://dx.doi.org/10.1016/S0896-6273(04)00183-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134646	Bronze			2022-12-28	WOS:000221458700016
J	Bowers, MS; McFarland, K; Lake, RW; Peterson, YK; Lapish, CC; Gregory, ML; Lanier, SM; Kalivas, PW				Bowers, MS; McFarland, K; Lake, RW; Peterson, YK; Lapish, CC; Gregory, ML; Lanier, SM; Kalivas, PW			Activator of G protein signaling 3: A gatekeeper of cocaine sensitization and drug seeking	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; CONDITIONED PLACE PREFERENCE; IBOTENIC ACID LESIONS; NUCLEUS-ACCUMBENS; INDUCED REINSTATEMENT; PERTUSSIS TOXIN; BEHAVIORAL SENSITIZATION; GLUTAMATE TRANSMISSION; PYRAMIDAL NEURONS; REGULATORY MOTIF	Chronic cocaine administration reduces G protein signaling efficacy. Here, we report that the expression of AGS3, which binds to GialphaGDP and inhibits GDP dissociation, was upregulated in the prefrontal cortex (PFC) during late withdrawal from repeated cocaine administration. Increased AGS3 was mimicked in the PFC of drug-naive rats by microinjecting a peptide containing the Gialpha binding domain (GPR) of AGS3 fused to the cell permeability domain of HIV-Tat. Infusion of Tat-GPR mimicked the phenotype of chronic cocaine-treated rats by manifesting sensitized locomotor behavior and drug seeking and by increasing glutamate transmission in nucleus accumbens. By preventing cocaine withdrawal-induced AGS3 expression with antisense oligonucleotides, signaling through Gia was normalized, and both cocaine-induced relapse to drug seeking and locomotor sensitization were prevented. When antisense oligonucleotide infusion was discontinued, drug seeking and sensitization were restored. It is proposed that AGS3 gates the expression of cocaine-induced plasticity by regulating G protein signaling in the PFC.	Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu		Bowers, M Scott/0000-0003-0047-6765; Lanier, Stephen/0000-0002-2740-7607	NIAAA NIH HHS [F32 AA015464] Funding Source: Medline; NIDA NIH HHS [DA-12513, DA-03960, R01 DA003906, DA-015369, R01 DA003906-09, P50 DA015369, R01 DA012513, R01 DA012513-01A1] Funding Source: Medline; NIMH NIH HHS [MH-40817, MH-90531] Funding Source: Medline; NINDS NIH HHS [NS-24821] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024821, R01NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA015464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003906, R01DA012513, P50DA015369] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bishop GB, 2002, NEUROBIOL DIS, V10, P334, DOI 10.1006/nbdi.2002.0518; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blumer JB, 2003, RECEPTOR CHANNEL, V9, P195, DOI 10.1080/10606820390203839; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Bowers MS, 2003, EUR J NEUROSCI, V17, P1273, DOI 10.1046/j.1460-9568.2003.02537.x; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Burchett SA, 1999, J NEUROCHEM, V72, P1529, DOI 10.1046/j.1471-4159.1999.721529.x; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; CARROLL KM, 1998, THERAPY MANUALS DRUG, P1; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; HENRY DJ, 1995, J NEUROSCI, V15, P6287; Hotsenpiller G, 2001, EUR J NEUROSCI, V14, P1843, DOI 10.1046/j.0953-816x.2001.01804.x; Hummel M, 2003, BRAIN RES, V965, P100, DOI 10.1016/S0006-8993(02)04142-2; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Li Y, 1999, BEHAV BRAIN RES, V104, P119, DOI 10.1016/S0166-4328(99)00060-1; Li Y, 1999, SYNAPSE, V34, P169, DOI 10.1002/(SICI)1098-2396(19991201)34:3<169::AID-SYN1>3.0.CO;2-C; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; Milliken G. A., 1984, ANAL MESSY DATA; Morgan AD, 2003, NEUROPSYCHOPHARMACOL, V28, P932, DOI 10.1038/sj.npp.1300100; *NAT I DRUG AB, 2000, RES REP SER COC AB A; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; NESTLER EJ, 1990, J NEUROCHEM, V55, P1079, DOI 10.1111/j.1471-4159.1990.tb04602.x; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Pierce RC, 1996, J NEUROSCI, V16, P1550; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Ribas C, 2002, J BIOL CHEM, V277, P50223, DOI 10.1074/jbc.C200567200; ROSS EM, 1994, METHOD ENZYMOL, V237, P26; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Schaffhauser H, 2000, J NEUROSCI, V20, P5663, DOI 10.1523/JNEUROSCI.20-15-05663.2000; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SELF DW, 1994, J NEUROSCI, V14, P6239; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shoji S, 1997, J PHARMACOL EXP THER, V280, P129; SMITH JA, 1995, BRAIN RES, V683, P264, DOI 10.1016/0006-8993(95)00383-2; STEKETEE JD, 1991, J PHARMACOL EXP THER, V259, P916; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STRIPLIN CD, 1993, SYNAPSE, V14, P10, DOI 10.1002/syn.890140103; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Trantham H, 2002, NEUROSCIENCE, V113, P749, DOI 10.1016/S0306-4522(02)00246-4; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Xi ZX, 2003, J NEUROSCI, V23, P3498; Xi ZX, 2002, J PHARMACOL EXP THER, V303, P608, DOI 10.1124/jpet.102.039735; Zhang K, 2000, NEUROSCIENCE, V101, P5, DOI 10.1016/S0306-4522(00)00344-4	62	188	194	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					269	281		10.1016/S0896-6273(04)00159-X	http://dx.doi.org/10.1016/S0896-6273(04)00159-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091342	Bronze, Green Accepted			2022-12-28	WOS:000221458500011
J	Kentros, CG; Agnihotri, NT; Streater, S; Hawkins, RD; Kandel, ER				Kentros, CG; Agnihotri, NT; Streater, S; Hawkins, RD; Kandel, ER			Increased attention to spatial context increases both place field stability and spatial memory	NEURON			English	Article							LONG-TERM STABILITY; HIPPOCAMPAL CA1; LANDMARK STABILITY; REFERENCE FRAMES; CELL DISCHARGE; TASK; RATS; NAVIGATION; LOCATION; NEURONS	The hippocampal formation is critical for the acquisition and consolidation of memories. When recorded in freely moving animals, hippocampal pyramidal neurons fire in a location-specific manner: they are "place" cells, comprising a hippocampal representation of the animal's environment. To explore the relationship between place cells and spatial memory, we recorded from mice in several behavioral contexts. We found that long-term stability of place cell firing fields correlates with the degree of attentional demands and that successful spatial task performance was associated with stable place fields. Furthermore, conditions that maximize place field stability greatly increase orientation to novel cues. This suggests that storage and retrieval of place cells is modulated by a top-down cognitive process resembling attention and that place cells are neural correlates of spatial memory. We propose a model whereby attention provides the requisite neuromodulatation to switch short-term homosynaptic plasticity to long-term heterosynaptic plasticity, and we implicate dopamine in this process.	Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, New York State Psychiat Inst, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Howard Hughes Medical Institute	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu		Kentros, Clifford/0000-0003-3850-3829	NIH HHS [NH50733] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Besheer J, 1999, BEHAV BRAIN RES, V103, P35, DOI 10.1016/S0166-4328(99)00021-2; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; FOX SE, 1975, EXP NEUROL, V49, P299, DOI 10.1016/0014-4886(75)90213-7; Gothard KM, 1996, J NEUROSCI, V16, P823; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Jeffery KJ, 1998, NEUROPHARMACOLOGY, V37, P677, DOI 10.1016/S0028-3908(98)00053-7; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Lenck-Santini PP, 2002, J NEUROSCI, V22, P9035; Lever C, 2002, BIOL CYBERN, V87, P356, DOI 10.1007/s00422-002-0360-z; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Ludvig N, 1999, PHYSIOL BEHAV, V67, P57, DOI 10.1016/S0031-9384(99)00048-7; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Redish AD, 2001, BEHAV BRAIN RES, V127, P81, DOI 10.1016/S0166-4328(01)00356-4; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Rotenberg A, 1997, PHILOS T R SOC B, V352, P1505, DOI 10.1098/rstb.1997.0137; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; SMITH RS, 1995, JAX NOTES FALL, V463; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; Zinyuk L, 2000, P NATL ACAD SCI USA, V97, P3771, DOI 10.1073/pnas.050576397	42	295	300	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					283	295		10.1016/S0896-6273(04)00192-8	http://dx.doi.org/10.1016/S0896-6273(04)00192-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091343	Bronze			2022-12-28	WOS:000221458500012
J	Keysers, C; Wicker, B; Gazzola, V; Anton, JL; Fogassi, L; Gallese, V				Keysers, C; Wicker, B; Gazzola, V; Anton, JL; Fogassi, L; Gallese, V			A touching sight: SII/PV activation during the observation and experience of touch	NEURON			English	Article							SOMATOSENSORY CORTEX; LATERAL SULCUS; MIRROR NEURONS; AREAS; RECOGNITION; PREMOTOR; PARIETAL; REPRESENTATION; ORGANIZATION; DISGUST	Watching the movie scene in which a tarantula crawls on James Bond's chest can make us literally shiver-as if the spider crawled on our own chest. What neural mechanisms are responsible for this "tactile empathy"? The observation of the actions of others activates the premotor cortex normally involved in the execution of the same actions. If a similar mechanism applies to the sight of touch, movies depicting touch should automatically activate the somatosensory cortex of the observer. Here we found using fMRI that the secondary but not the primary somatosensory cortex is activated both when the participants were touched and when they observed someone or something else getting touched by objects. The neural mechanisms enabling our own sensation of touch may therefore be a window also to our understanding of touch.	Univ Groningen, BCN, Neuroimaging Ctr, NL-9713 AW Groningen, Netherlands; CNRS, Inst Neurosci Physiol & Cognit, F-13402 Marseille 20, France; CHU Timone, Ctr Imagerie RMN Fonct, F-13385 Marseille 05, France; Univ Parma, Dept Neurosci Physiol, I-43100 Parma, Italy; Univ Parma, Dept Psychol, I-43100 Parma, Italy	University of Groningen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Parma; University of Parma	Keysers, C (corresponding author), Univ Groningen, BCN, Neuroimaging Ctr, NL-9713 AW Groningen, Netherlands.	c.keysers@med.rug.nl; vittorio.gallese@unipr.it	Keysers, Christian/H-6251-2013; FOGASSI, Leonardo/K-3541-2018	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619; FOGASSI, Leonardo/0000-0003-3348-039X				Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Bradshaw JL, 2001, J NEUROL NEUROSUR PS, V70, P135; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brett M, 2002, NEUROIMAGE, V16; Brodmann K., 1909, LOCALIZATION CEREBRA; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; CASELLI RJ, 1993, NEUROLOGY, V43, P762, DOI 10.1212/WNL.43.4.762; Cipolloni PB, 1999, J COMP NEUROL, V403, P431; Del Gratta C, 2000, NEUROREPORT, V11, P2035, DOI 10.1097/00001756-200006260-00046; Disbrow E, 2000, J COMP NEUROL, V418, P1, DOI 10.1002/(SICI)1096-9861(20000228)418:1<1::AID-CNE1>3.0.CO;2-P; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; EICKHOFF S, 2002, NEUROIMAGE, V16; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GARCHA HS, 1980, CORTEX, V16, P397, DOI 10.1016/S0010-9452(80)80041-4; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Penfield W, 1954, EPILEPSY FUNCTIONAL; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROBINSON CJ, 1980, J COMP NEUROL, V192, P93, DOI 10.1002/cne.901920106; Servos P, 2001, COGNITIVE BRAIN RES, V12, P307, DOI 10.1016/S0926-6410(01)00041-6; VOGT O, 1911, J PSYCHOL NEUROL, V18, P107; von Economo C, 1925, CYTOARCHITEKTONIK HI; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	38	564	579	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					335	346		10.1016/S0896-6273(04)00156-4	http://dx.doi.org/10.1016/S0896-6273(04)00156-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091347	Bronze			2022-12-28	WOS:000221458500016
J	Young, TL; Cepko, CL				Young, TL; Cepko, CL			A role for ligand-gated ion channels in rod photoreceptor development	NEURON			English	Article							INHIBITORY GLYCINE RECEPTOR; MATERNAL TAURINE DEFICIENCY; RAT SPINAL-CORD; POSTNATAL-DEVELOPMENT; PROGENITOR CELLS; BIPOLAR CELLS; IN-VITRO; SYNAPTIC INHIBITION; CHLORIDE CURRENT; GENE-EXPRESSION	Neurotransmitter receptors are central to communication at synapses. Many components of the machinery for neurotransmission are present prior to synapse formation, suggesting a developmental role. Here, evidence is presented that signaling through glycine receptor alpha2 (GlyRalpha2) and GABA(A) receptors plays a role in photoreceptor development in the vertebrate retina. The signaling is likely mediated by taurine, which is present at high levels throughout the developing central nervous system (CNS). Taurine potentiates the production of rod photoreceptors, and this induction is inhibited by strychnine, an antagonist of glycine receptors, and bicuculline, an antagonist of GABA receptors. Gain-of-function experiments showed that signaling through GlyRalpha2 induced exit from mitosis and an increase in rod photoreceptors. Furthermore, targeted knockdown of GlyRalpha2 decreased the number of photoreceptors while increasing the number of other retinal cell types. These data support a previously undescribed role for these ligand-gated ion channels during the early stages of CNS development.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu		Young-Pearse, Tracy/0000-0001-7846-1542	NEI NIH HHS [R01EY09676] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009676] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ALTSHULER DM, 1991, P RET RES F, V3, P37; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Bockelmann R, 1998, NEUROCHEM RES, V23, P469, DOI 10.1023/A:1022418231496; BOOS R, 1993, J NEUROSCI, V13, P2874; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Bres V, 2000, BRIT J PHARMACOL, V130, P1976, DOI 10.1038/sj.bjp.0703492; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen CB, 2002, DEVELOPMENT, V129, P2401; CURTIS DR, 1974, J NEUROCHEM, V23, P605, DOI 10.1111/j.1471-4159.1974.tb06066.x; CURTIS DR, 1971, BRAIN RES, V32, P69, DOI 10.1016/0006-8993(71)90156-9; Deleuze C, 1998, J PHYSIOL-LONDON, V507, P463, DOI 10.1111/j.1469-7793.1998.463bt.x; Etter A, 1999, J NEUROCHEM, V72, P318, DOI 10.1111/jnc.1999.72.1.318; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; FUJII A, 1975, J MED CHEM, V18, P502, DOI 10.1021/jm00239a013; GOLDINGER A, 1980, NEUROSCI LETT, V16, P91, DOI 10.1016/0304-3940(80)90107-X; GREFERATH U, 1994, VISUAL NEUROSCI, V11, P721, DOI 10.1017/S0952523800003023; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HILTON FK, 1981, J EXP ZOOL, V216, P493, DOI 10.1002/jez.1402160318; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HORIKOSHI T, 1988, MOL BRAIN RES, V4, P97, DOI 10.1016/0169-328X(88)90002-2; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; HUXTABLE RJ, 1980, FED PROC, V39, P2685; IMAKI H, 1986, DEV NEUROSCI-BASEL, V8, P160, DOI 10.1159/000112251; INOUE M, 1988, NEUROSCI RES, V5, P380, DOI 10.1016/0168-0102(88)90024-7; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; KISHI M, 1988, BIOCHIM BIOPHYS ACTA, V939, P615, DOI 10.1016/0005-2736(88)90109-5; Koulen P, 1996, J NEUROSCI, V16, P2127; LAKE N, 1994, VISUAL NEUROSCI, V11, P253, DOI 10.1017/S0952523800001619; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEHMANN A, 1984, J NEUROCHEM, V42, P1286, DOI 10.1111/j.1471-4159.1984.tb02785.x; LEWIS CA, 1991, J NEUROPHYSIOL, V66, P1291, DOI 10.1152/jn.1991.66.4.1291; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; LOMBARDINI JB, 1991, BRAIN RES REV, V16, P151, DOI 10.1016/0165-0173(91)90003-Q; LOMBARDINI JB, 1978, J NUTR, V108, P428, DOI 10.1093/jn/108.3.428; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; MACAIONE S, 1974, J NEUROCHEM, V22, P887, DOI 10.1111/j.1471-4159.1974.tb04313.x; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Byrne MB, 2000, J NEUROCHEM, V74, P2087, DOI 10.1046/j.1471-4159.2000.0742087.x; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Pasantes-Morales H, 1998, ADV EXP MED BIOL, V442, P209; PASANTESMORALES H, 1976, J NEUROCHEM, V27, P1103, DOI 10.1111/j.1471-4159.1976.tb00315.x; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Saransaari P, 1999, NEUROSCIENCE, V94, P949, DOI 10.1016/S0306-4522(99)00384-X; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; SCHAEFFER JM, 1981, J NEUROCHEM, V36, P1597, DOI 10.1111/j.1471-4159.1981.tb00606.x; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; STRANGE K, 1995, KIDNEY INT, V48, P994, DOI 10.1038/ki.1995.381; Sturman J A, 1987, Adv Exp Med Biol, V217, P113; STURMAN JA, 1986, J NUTR, V116, P655, DOI 10.1093/jn/116.4.655; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; STURMAN JA, 1988, J NUTR, V118, P1169, DOI 10.1093/jn/118.10.1169; STURMAN JA, 1985, ADV EXP MED BIOL, V179, P43; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tapia JC, 1998, SYNAPSE, V28, P185; TAUCK DL, 1988, NEUROSCIENCE, V27, P193, DOI 10.1016/0306-4522(88)90230-8; Thio LL, 2003, J NEUROPHYSIOL, V90, P89, DOI 10.1152/jn.00612.2002; Vu TQ, 2000, J NEUROSCI, V20, P1414; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Wu ZY, 2003, AMINO ACIDS, V24, P155, DOI 10.1007/s00726-002-0314-8	82	116	125	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					867	879		10.1016/S0896-6273(04)00141-2	http://dx.doi.org/10.1016/S0896-6273(04)00141-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046720	Bronze			2022-12-28	WOS:000221458300007
J	Rea, R; Li, J; Dharia, A; Levitan, ES; Sterling, P; Kramer, RH				Rea, R; Li, J; Dharia, A; Levitan, ES; Sterling, P; Kramer, RH			Streamlined synaptic vesicle cycle in cone photoreceptor terminals	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; RETINAL BIPOLAR CELLS; MOTOR-NERVE TERMINALS; RIBBON SYNAPSE; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; PEROXIDASE UPTAKE; MEMBRANE; ENDOCYTOSIS; FM1-43	Cone photoreceptors tonically release neurotransmitter in the dark through a continuous cycle of exocytosis and endocytosis. Here, using the synaptic vesicle marker FM1-43, we elucidate specialized features of the vesicle cycle. Unlike retinal bipolar cell terminals, where stimulation triggers bulk membrane retrieval, cone terminals appear to exclusively endocytose small vesicles. These retain their integrity until exocytosis, without pooling their membranes in endosomes. Endocytosed vesicles rapidly disperse through the terminal and are reused with no apparent delay. Unlike other synapses where most vesicles are immobilized and held in reserve, only a small fraction (<15%) becomes immobilized in cones. Photobleaching experiments suggest that vesicles move by diffusion and not by molecular motors on the cytoskeleton and that vesicle movement is not rate limiting for release. The huge reservoir of vesicles that move rapidly throughout cone terminals and the lack of a reserve pool are unique features, providing cones with a steady supply for continuous release.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA	University of California System; University of California Berkeley; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kramer, RH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	rhkramer@berkeley.edu			NATIONAL EYE INSTITUTE [R01EY008124, R01EY012608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385] Funding Source: NIH RePORTER; NEI NIH HHS [EY12608, EY08124] Funding Source: Medline; NINDS NIH HHS [NS32385] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; BERK DA, 1993, BIOPHYS J, V65, P2428, DOI 10.1016/S0006-3495(93)81326-2; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; COOPER NGF, 1983, J ULTRA MOL STRUCT R, V84, P252, DOI 10.1016/S0022-5320(83)80005-7; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Guatimosim C, 2002, J NEUROCHEM, V82, P1047, DOI 10.1046/j.1471-4159.2002.01029.x; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Mack AF, 2000, VISUAL NEUROSCI, V17, P823, DOI 10.1017/S0952523800176011; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Meyers JR, 2003, J NEUROSCI, V23, P4054; Morgans CW, 2000, MICROSC RES TECHNIQ, V50, P141, DOI 10.1002/1097-0029(20000715)50:2<141::AID-JEMT6>3.0.CO;2-B; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Paillart C, 2003, J NEUROSCI, V23, P4092; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; RIPPS H, 1976, J CELL BIOL, V70, P86, DOI 10.1083/jcb.70.1.86; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; SCHACHER S, 1976, J CELL BIOL, V70, P178, DOI 10.1083/jcb.70.1.178; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2000, J NEUROSCI, V20, P7986; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	100	100	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					755	766		10.1016/S0896-6273(04)00088-1	http://dx.doi.org/10.1016/S0896-6273(04)00088-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003175	Bronze			2022-12-28	WOS:000221458200011
J	Horning, MS; Mayer, ML				Horning, MS; Mayer, ML			Regulation of AMPA receptor gating by ligand binding core dimers	NEURON			English	Article							GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ION-CHANNEL; GLUR2; ACTIVATION; MECHANISM; SELECTIVITY; ANTAGONISM; MODULATION	Ionotropic glutamate receptors are tetramers, the isolated ligand binding cores of which assemble as dimers. Previous work on nondesensitizing AMPA receptor mutants, which combined crystallography, ultracentrifugation, and patch-clamp recording, showed that dimer formation by the ligand binding cores is required for activation of ion channel gating by agonists. To define the mechanisms responsible for stabilization of dimer assembly in native AMPA receptors, contacts between the adjacent ligand binding cores were individually targeted by amino acid substitutions, using the GluR2 crystal structure as a guide to design mutants. We show that disruption of a salt bridge, hydrogen bond network, and intermolecular van der Waals contacts between helices D and J in adjacent ligand binding cores greatly accelerates desensitization. Conservation of these contacts in AMPA and kainate receptors indicates that they are important determinants of dimer stability and that the dimer interface is a key structural element in the gating mechanism of these glutamate receptor families.	NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Horning, MS (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	mlm@helix.nih.gov	Mayer, Mark/AAE-7356-2019; Mayer, Mark L/H-5500-2013	Mayer, Mark/0000-0003-4378-8451; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Hogner A, 2003, J MED CHEM, V46, P214, DOI 10.1021/jm020989v; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2003, BIOCHEMISTRY-US, V42, P5201, DOI 10.1021/bi020632t; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	24	117	122	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					379	388		10.1016/S0896-6273(04)00018-2	http://dx.doi.org/10.1016/S0896-6273(04)00018-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766177	Bronze			2022-12-28	WOS:000221457900009
J	Pineda, VV; Athos, JI; Wang, HB; Celver, J; Ippolito, D; Boulay, G; Birnbaumer, L; Storm, DR				Pineda, VV; Athos, JI; Wang, HB; Celver, J; Ippolito, D; Boulay, G; Birnbaumer, L; Storm, DR			Removal of G(i alpha 1) constraints on adenylyl cyclase in the hippocampus enhances LTP and impairs memory formation	NEURON			English	Article							LONG-TERM POTENTIATION; MEDIATED GENE-EXPRESSION; LATE-PHASE; PROTEIN-KINASE; RECEPTOR; CAMP; CA1; CREB; TRANSCRIPTION; INDUCTION	Stimulation of adenylyl cyclase in the hippocampus is critical for memory formation. However, generation of cAMP signals within an optimal range for memory may require a balance between stimulatory and inhibitory mechanisms. The role of adenylyl cyclase inhibitory mechanisms for memory has not been addressed. One of the mechanisms for inhibition of adenylyl cyclase is through activation of G(i)-coupled receptors, a mechanism that could serve as a constraint on memory formation. Here we report that ablation of G(ialpha1) by gene disruption increases hippocampal adenylyl cyclase activity and enhances LTP in area CA1. Furthermore, gene ablation of G(ialpha1) or antisense oligonucleotide-mediated depletion of G(ialpha1) disrupted hippocampus-dependent memory. We conclude that G(ialpha1) provides a critical mechanism for tonic inhibition of adenylyl cyclase activity in the hippocampus. We hypothesize that loss of G(ialpha1) amplifies the responsiveness of CA1 postsynaptic neurons to stimuli that strengthen synaptic efficacy, thereby diminishing synapse-specific plasticity required for new memory formation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Boulay, Guylain/D-9773-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019318, R01DK019318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIGES101643, Z01ES101643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH064311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS042475, R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC04156] Funding Source: Medline; NIDDK NIH HHS [DK-19318] Funding Source: Medline; NIGMS NIH HHS [32 GM07270] Funding Source: Medline; NIMH NIH HHS [1F31MH064311] Funding Source: Medline; NINDS NIH HHS [NS 20498, 1F31NS042475] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ALBERT PR, 1990, J BIOL CHEM, V265, P5825; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; ATHOS J, 2001, CURRENT PROTOCOLS NE, V14; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BREDER CD, 1992, J NEUROSCI, V12, P3920; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Dutar P, 2002, NEUROSCIENCE, V112, P455, DOI 10.1016/S0306-4522(02)00074-X; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Galeotti N, 2001, BRIT J PHARMACOL, V133, P267, DOI 10.1038/sj.bjp.0704081; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Moneta D, 2002, EUR J NEUROSCI, V16, P843, DOI 10.1046/j.1460-9568.2002.02146.x; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Musshoff U, 2002, HIPPOCAMPUS, V12, P165, DOI 10.1002/hipo.1105; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Poser S, 2003, J NEUROSCI, V23, P4420; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Reed TM, 2002, J NEUROSCI, V22, P5188, DOI 10.1523/JNEUROSCI.22-12-05188.2002; Sanna PP, 2002, J NEUROSCI, V22, P3359; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Sweatt JD, 2001, CURR BIOL, V11, pR391, DOI 10.1016/S0960-9822(01)00216-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZASTAWNY RL, 1994, J NEUROCHEM, V62, P2099	47	83	83	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					153	163		10.1016/S0896-6273(03)00813-4	http://dx.doi.org/10.1016/S0896-6273(03)00813-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715142	Bronze			2022-12-28	WOS:000187942800016
J	Matsui, K; Jahr, CE				Matsui, K; Jahr, CE			Ectopic release of synaptic vesicles	NEURON			English	Article							CA2+-PERMEABLE AMPA RECEPTORS; FROG NEUROMUSCULAR-JUNCTION; CEREBELLAR PURKINJE-CELLS; RAT HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; GLIAL-CELLS; TIME-COURSE; GLUTAMATERGIC SYNAPSES; GRANULE CELL; FIBER	Exocytosis of synaptic vesicles is generally assumed to occur only at ultrastructurally defined presynaptic active zones. If release is restricted to these sites, receptors not located within the synaptic cleft must be activated by transmitter that diffuses out of the cleft or not be activated at all. Here we report that AMPA receptor-mediated quantal events resulting from climbing fiber release are observed in Bergmann glial cells in the cerebellar cortex. These quantal events are not coincident with quanta recorded in neighboring Purkinje cells which receive input from the same climbing fiber. As Bergmann glial membranes are excluded from the synaptic cleft, we propose that exocytosis can occur from climbing fiber release sites located directly across from Bergmann glial membranes. Such ectopic release may account for the majority of the Bergmann glial AMPA response evoked by climbing fiber stimulation.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.		Matsui, Ko/AAE-3687-2019	Matsui, Ko/0000-0003-1068-9705	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040056, R56NS040056] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40056] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Franks KM, 2003, J NEUROSCI, V23, P3186; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; LAZAROVICI P, 1992, J PHARMACOL EXP THER, V263, P1317; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Palay S.L., 1974, CEREBELLAR CORTEX; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Solessio E, 2000, J NEUROPHYSIOL, V83, P418, DOI 10.1152/jn.2000.83.1.418; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yamada K, 2000, J COMP NEUROL, V418, P106; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	51	110	114	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1173	1183		10.1016/S0896-6273(03)00788-8	http://dx.doi.org/10.1016/S0896-6273(03)00788-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687551	Bronze			2022-12-28	WOS:000187503400015
J	Mazer, JA; Gallant, JL				Mazer, JA; Gallant, JL			Goal-related activity in V4 during free viewing visual search: Evidence for a ventral stream visual salience map	NEURON			English	Article							FRONTAL EYE FIELDS; EXTRASTRIATE AREA V4; SPATIAL ATTENTION; CORTICAL-NEURONS; SINGLE NEURONS; MACAQUE; CORTEX; SELECTION; RESPONSES; MOVEMENTS	Natural exploration of complex visual scenes depends on saccadic eye movements toward important locations. Saccade targeting is thought to be mediated by a retinotopic map that represents the locations of salient features. In this report, we demonstrate that extrastriate ventral area V4 contains a retinotopic salience map that guides exploratory eye movements during a naturalistic free viewing visual search task. In more than half of recorded cells, visually driven activity is enhanced prior to saccades that move the fovea toward the location previously occupied by a neuron's spatial receptive field. This correlation suggests that bottom-up processing in V4 influences the oculomotor planning process. Half of the neurons also exhibit top-down modulation of visual responses that depends on search target identity but not visual stimulation. Convergence of bottom-up and top-down processing streams in area V4 results in an adaptive, dynamic map of salience that guides oculomotor planning during natural vision.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mazer, JA (corresponding author), Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA.		Gallant, Jack L/C-4426-2011; Mazer, James/R-9886-2019		NATIONAL EYE INSTITUTE [R01EY012241] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012241] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bichot NP, 2001, NEUROPSYCHOLOGIA, V39, P972, DOI 10.1016/S0028-3932(01)00022-7; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; FISCHER B, 1981, EXP BRAIN RES, V44, P129; FISCHER B, 1981, EXP BRAIN RES, V41, P431; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gawne TJ, 2000, J NEUROPHYSIOL, V84, P2691, DOI 10.1152/jn.2000.84.5.2691; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Niebur E, 1996, ADV NEUR IN, V8, P802; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; STANTON GB, 1993, J COMP NEUROL, V330, P286, DOI 10.1002/cne.903300209; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	40	188	191	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1241	1250		10.1016/S0896-6273(03)00764-5	http://dx.doi.org/10.1016/S0896-6273(03)00764-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687556	Bronze			2022-12-28	WOS:000187503400020
J	Krapivinsky, G; Krapivinsky, L; Manasian, Y; Ivanov, A; Tyzio, R; Pellegrino, C; Ben-Ari, Y; Clapham, DE; Medina, I				Krapivinsky, G; Krapivinsky, L; Manasian, Y; Ivanov, A; Tyzio, R; Pellegrino, C; Ben-Ari, Y; Clapham, DE; Medina, I			The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; MAP KINASE; MOLECULAR-MECHANISMS; MICE LACKING; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; SIGNALING PATHWAY	The NMDA subtype of glutamate receptors (NMDAR) at excitatory neuronal synapses plays a key role in synaptic plasticity. The extracellular signal-regulated kinase (ERK1,2 or ERK) pathway is an essential component of NMDAR signal transduction controlling the neuroplasticity underlying memory processes, neuronal development, and refinement of synaptic connections. Here we show that NR2B, but not NR2A or NR1 subunits of the NMDAR, interacts in vivo and in vitro with RasGRF1, a Ca2+/calmodulin-dependent Ras-guanine-nucleotide-releasing factor. Specific disruption of this interaction in living neurons abrogates NMDAR-dependent ERK activation. Thus, RasGRF1 serves as NMDAR-dependent regulator of the ERK kinase pathway. The specific association of RasGRF1 with the NR2B subunit and study of ERK activation in neurons with varied content of NR2B suggests that NR2B-containing channels are the dominant activators of the NMDA-dependent ERK pathway.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; INSERM, INMED, U29, F-13009 Marseille, France	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Medina, Igor/O-5532-2016; Pellegrino, Christophe/P-5266-2016	Clapham, David/0000-0002-4459-9428; Medina, Igor/0000-0001-6839-5414; Pellegrino, Christophe/0000-0002-0669-4918; Ivanov, Anton/0000-0002-8650-6322; Ben-Ari, Yehezkel/0000-0001-6208-8480				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Becq H, 1999, J NEUROSCI RES, V58, P553, DOI 10.1002/(SICI)1097-4547(19991115)58:4<553::AID-JNR8>3.0.CO;2-8; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Giese KP, 2001, NEUROPHARMACOLOGY, V41, P791, DOI 10.1016/S0028-3908(01)00096-X; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Iida N, 2001, J NEUROSCI, V21, P6459, DOI 10.1523/JNEUROSCI.21-17-06459.2001; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kiyama Y, 1998, J NEUROSCI, V18, P6704; KURINO M, 1995, J NEUROCHEM, V65, P1282; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Oh JS, 2002, NEURON, V33, P151; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Platenik J, 2000, LIFE SCI, V67, P335, DOI 10.1016/S0024-3205(00)00632-9; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sturani E, 1997, EXP CELL RES, V235, P117, DOI 10.1006/excr.1997.3660; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tonini R, 2001, MOL CELL NEUROSCI, V18, P691, DOI 10.1006/mcne.2001.1050; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vanoni M, 1999, J BIOL CHEM, V274, P36656, DOI 10.1074/jbc.274.51.36656; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia ZG, 1996, J NEUROSCI, V16, P5425; ZHONG J, 1994, MOL PHARMACOL, V45, P846; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; ZIPPEL R, 1997, MOL BRAIN RES, V48, P140	50	342	352	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					775	784		10.1016/S0896-6273(03)00645-7	http://dx.doi.org/10.1016/S0896-6273(03)00645-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622581	Bronze			2022-12-28	WOS:000186651200012
J	Mu, YY; Otsuka, T; Horton, AC; Scott, DB; Ehlers, MD				Mu, YY; Otsuka, T; Horton, AC; Scott, DB; Ehlers, MD			Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors	NEURON			English	Article							EARLY SECRETORY PATHWAY; PROTEIN-KINASE-C; ENDOPLASMIC-RETICULUM; VISUAL-CORTEX; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; RETENTION SIGNAL; NR1 SUBUNIT; MEMBRANE-PROTEINS	Activity-dependent targeting of NMDA receptors (NMDARs) is a key feature of synapse formation and plasticity. Although mechanisms for rapid trafficking of glutamate receptors have been identified, the molecular events underlying chronic accumulation or loss of synaptic NMDARs have remained unclear. Here we demonstrate that activity controls NMDAR synaptic accumulation by regulating forward trafficking at the endoplasmic reticulum (ER). ER export is accelerated by the alternatively spliced C2' domain of the NR1 subunit and slowed by the C2 splice cassette. This mRNA splicing event at the C2/C2' site is activity dependent, with C2' variants predominating upon activity blockade and C2 variants abundant with increased activity. The switch to C2' accelerates NMDAR forward trafficking by enhancing recruitment of nascent NMDARs to ER exit sites via binding of a divaline motif within C2' to COPII coats. These results define a novel pathway underlying activity-dependent targeting of glutamate receptors, providing an unexpected mechanistic link between activity, mRNA splicing, and membrane trafficking during excitatory synapse modification.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Cell & Mol Biol Program, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehiers@neuro.duke.edu			NIAAA NIH HHS [F31 AA 13220] Funding Source: Medline; NINDS NIH HHS [NS 39402] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA013220] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Ehlers MD, 1998, J NEUROSCI, V18, P720; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lissin DV, 1999, J NEUROSCI, V19, P1263; LODISH HF, 1988, J BIOL CHEM, V263, P2107; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nufer O, 2002, J CELL SCI, V115, P619; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, J NEUROSCI, V19, P7781; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	51	195	201	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					581	594		10.1016/S0896-6273(03)00676-7	http://dx.doi.org/10.1016/S0896-6273(03)00676-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642281	Bronze			2022-12-28	WOS:000186379000016
J	Reddy, LV; Koirala, S; Sugiura, Y; Herrera, AA; Ko, CP				Reddy, LV; Koirala, S; Sugiura, Y; Herrera, AA; Ko, CP			Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo	NEURON			English	Article							PERISYNAPTIC SCHWANN-CELLS; PERIPHERAL-NERVE REGENERATION; RAT SOLEUS MUSCLE; EXTRACELLULAR-MATRIX; END-PLATE; ACETYLCHOLINE-RECEPTORS; NEUROTROPHIC FACTORS; TRANSMITTER RELEASE; FROG; TERMINALS	To investigate the in vivo role of glial cells in synaptic function, maintenance, and development, we have developed an approach to selectively ablate perisynaptic Schwann cells (PSCs), the glial cells at the neuromuscular junction (NMJ), en masse from live frog muscles. In adults, following acute PSC ablation, synaptic structure and function were not altered. However, 1 week after PSC ablation, presynaptic function decreased by approximately half, while postsynaptic function was unchanged. Retraction of nerve terminals increased over 10-fold at PSC-ablated NMJs. Furthermore, nerve-evoked muscle twitch tension was reduced. In tadpoles, repeated in vivo observations revealed that PSC processes lead nerve terminal growth. In the absence of PSCs, growth and addition of synapses was dramatically reduced, and existing synapses underwent widespread retraction. Our findings provide in vivo evidence that glial cells maintain presynaptic structure and function at adult synapses and are vital for the growth and stability of developing synapses.	Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Ko, CP (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	cko@usc.edu	Ko, Chien-Ping/AAN-2314-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017954] Funding Source: NIH RePORTER; NINDS NIH HHS [NS017954] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Astrow SH, 1998, J NEUROCYTOL, V27, P667, DOI 10.1023/A:1006916232627; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BIRKS R, 1960, J PHYSIOL-LONDON, V150, P145, DOI 10.1113/jphysiol.1960.sp006379; CARATSCH CG, 1994, NEUROSCI LETT, V166, P97, DOI 10.1016/0304-3940(94)90849-4; Castonguay A, 2001, Prog Brain Res, V132, P227; Castonguay A, 2001, J NEUROSCI, V21, P1911, DOI 10.1523/JNEUROSCI.21-06-01911.2001; CHEN LL, 1991, J NEUROSCI, V11, P2920; CHEN LL, 1994, J NEUROSCI, V14, P796; FALLON JR, 1985, J NEUROSCI, V5, P3169; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Fu Q, 1998, J NEUROCHEM, V71, P549; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; GRIM M, 1992, ANAT EMBRYOL, V186, P311; GRINNELL AD, 1980, J PHYSIOL-LONDON, V307, P301, DOI 10.1113/jphysiol.1980.sp013436; GRINNELL AD, 1991, RES NEUROL, V5, P151; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Herrera AA, 2000, J NEUROBIOL, V45, P237, DOI 10.1002/1097-4695(200012)45:4<237::AID-NEU5>3.0.CO;2-J; Hirata K, 1997, J NEUROCYTOL, V26, P799, DOI 10.1023/A:1018570500052; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; KELLY AM, 1969, J CELL BIOL, V42, P154, DOI 10.1083/jcb.42.1.154; KO CP, 1987, J NEUROCYTOL, V16, P567, DOI 10.1007/BF01668509; Ko CP, 1996, J NEUROSCI, V16, P1780; Koirala S, 2000, J NEUROBIOL, V44, P343, DOI 10.1002/1097-4695(20000905)44:3<343::AID-NEU5>3.0.CO;2-O; KOIRALA S, 2003, IN PRESS J NEUROCYTO; KRAUSE M, 1985, J NEUROCYTOL, V14, P765, DOI 10.1007/BF01170827; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Love FM, 1998, J NEUROSCI, V18, P9376; Lubischer JL, 1999, J NEUROSCI, V19, P8931, DOI 10.1523/JNEUROSCI.19-20-08931.1999; Macleod GT, 2001, J NEUROSCI, V21, P2380, DOI 10.1523/JNEUROSCI.21-07-02380.2001; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYER MM, 1961, EXPERIMENTAL IMMUNOC, P148; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Neethling FA, 1999, J IMMUNOL METHODS, V222, P31, DOI 10.1016/S0022-1759(98)00175-6; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Peng HB, 2003, J NEUROSCI, V23, P5050; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; RANDALL D, 2001, ANIMAL PHYSL, P379; REIST NE, 1992, P NATL ACAD SCI USA, V89, P7625, DOI 10.1073/pnas.89.16.7625; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; RILEY DA, 1981, J NEUROCYTOL, V10, P425, DOI 10.1007/BF01262414; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; ROBITAILLE R, 2002, TRIPARTITE SYNAPSE, P224; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sendtner M, 1998, CYTOKINE GROWTH F R, V9, P1, DOI 10.1016/S1359-6101(97)00033-6; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SLATER CR, 1982, DEV BIOL, V94, P23, DOI 10.1016/0012-1606(82)90064-1; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Volterra A., 2002, TRIPARTITE SYNAPSE; WALPORT M, 1998, IMMUNOLOGY, P43; Werle MJ, 1996, J NEUROBIOL, V30, P293, DOI 10.1002/(SICI)1097-4695(199606)30:2<293::AID-NEU10>3.0.CO;2-L; Yang JF, 2001, J NEUROSCI, V21, P9572, DOI 10.1523/JNEUROSCI.21-24-09572.2001; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	65	134	138	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					563	580		10.1016/S0896-6273(03)00682-2	http://dx.doi.org/10.1016/S0896-6273(03)00682-2			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642280	Bronze			2022-12-28	WOS:000186379000015
J	Zheng, JJ; Lee, S; Zhou, ZJ				Zheng, JJ; Lee, S; Zhou, ZJ			A developmental switch in the excitability and function of the starburst network in the mammalian retina	NEURON			English	Article							CHOLINERGIC AMACRINE CELLS; SELECTIVE GANGLION-CELLS; DEVELOPING RABBIT RETINA; DIRECTIONAL SELECTIVITY; SYNAPTIC ORGANIZATION; DENDRITIC MORPHOLOGY; SYMPATHETIC NEURONS; TRANSMITTER RELEASE; COTRANSPORTER KCC2; NERVOUS-SYSTEM	Dual patch-clamp recording and Ca2+ uncaging revealed Ca2+-dependent corelease of ACh and GABA from, and the presence of reciprocal nicotinic and GABAergic synapses between, starburst cells in the perinatal rabbit retina. With maturation, the nicotinic synapses between starburst cells dramatically diminished, whereas the GABAergic synapses remained and changed from excitatory to inhibitory, indicating a coordinated conversion of the starburst network excitability from an early hyperexcitatory to a mature nonepileptic state. We show that this transition allows the starburst cells to use their neurotransmitters; for two completely different functions. During early development, the starburst network mediates recurrent excitation and spontaneous retinal waves, which are important for visual system development. After vision begins, starburst cells release GABA in a prolonged and Ca2+-dependent manner and inhibit each other laterally via direct GABAergic synapses, which may be important for visual integration, such as the detection of motion direction.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NEI NIH HHS [EY10894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010894] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Amthor FR, 1996, VISUAL NEUROSCI, V13, P303, DOI 10.1017/S0952523800007549; Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; Asmus SE, 2000, J NEUROSCI, V20, P1495; Baldridge WH, 1996, J NEUROSCI, V16, P5060; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRANDON C, 1987, BRAIN RES, V426, P119, DOI 10.1016/0006-8993(87)90431-8; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Chiao CC, 2002, J NEUROSCI, V22, P10509; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Firth SI, 2003, J COMP NEUROL, V466, P80, DOI 10.1002/cne.10880; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Guidry G L, 1998, Adv Pharmacol, V42, P895; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; HUTCHINS JB, 1995, EXP EYE RES, V60, P113, DOI 10.1016/S0014-4835(95)80001-8; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keyser KT, 2000, VISUAL NEUROSCI, V17, P743, DOI 10.1017/S095252380017508X; Kim IB, 2000, J COMP NEUROL, V427, P604, DOI 10.1002/1096-9861(20001127)427:4<604::AID-CNE8>3.0.CO;2-C; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; Macneil MA, 1999, J COMP NEUROL, V413, P305; MARIANI AP, 1988, J COMP NEUROL, V267, P269, DOI 10.1002/cne.902670209; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1210, DOI 10.1152/jn.1976.39.6.1210; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MILLAR TJ, 1987, NEUROSCI LETT, V74, P281, DOI 10.1016/0304-3940(87)90310-7; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sernagor E, 2003, J NEUROSCI, V23, P7621; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Vu TQ, 2000, J NEUROSCI, V20, P1414; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WONG ROL, 1989, J COMP NEUROL, V287, P164, DOI 10.1002/cne.902870203; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhou ZJ, 2001, J NEUROSCI, V21, P5158, DOI 10.1523/JNEUROSCI.21-14-05158.2001; Zhou ZJ, 2000, J NEUROSCI, V20, P6570, DOI 10.1523/JNEUROSCI.20-17-06570.2000; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	61	111	115	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 2	2004	44	5					851	864		10.1016/j.neuron.2004.11.015	http://dx.doi.org/10.1016/j.neuron.2004.11.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877DQ	15572115	Bronze			2022-12-28	WOS:000225548400012
J	Cottrell, JR; Borok, E; Horvath, TL; Nedivi, E				Cottrell, JR; Borok, E; Horvath, TL; Nedivi, E			CPG2: A brain- and synapse-specific protein that regulates the endocytosis of glutamate receptors	NEURON			English	Article							DENDRITIC SPINES; AMPA; INTERNALIZATION; PLASTICITY; TRANSMISSION; EXPRESSION; SYNAPTOJANIN; CYTOSKELETON; ENDOPHILIN; MECHANISMS	Long-term maintenance and modification of synaptic strength involve the turnover of neurotransmitter receptors. Glutamate receptors are constitutively and acutely internalized, presumptively through clathrin-mediated receptor endocytosis. Here, we show that cpg2 is a brain-specific splice variant of the syne-1 gene that encodes a protein specifically localized to a postsynaptic endocytotic zone of excitatory synapses. RNAi-mediated CPG2 knockdown increases the number of postsynaptic clathrin-coated vesicles, some of which traffic NMDA receptors, disrupts the constitutive internalization of glutamate receptors, and inhibits the activity-induced internalization of synaptic AMPA receptors. Manipulating CPG2 levels also affects dendritic spine size, further supporting a function in regulating membrane transport. Our results suggest that CPG2 is a key component of a specialized postsynaptic endocytic mechanism devoted to the internalization of synaptic proteins, including glutamate receptors. The activity dependence and distribution of cpg2 expression further suggest that it contributes to the capacity for postsynaptic plasticity inherent to excitatory synapses.	MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Yale University; Yale University	Nedivi, E (corresponding author), MIT, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nedivi@mit.edu	Nedivi, Elly/ABC-9923-2021		NEI NIH HHS [R01 EY011894-08, R01 EY011894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011894] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lee WCA, 2002, J NEUROSCI, V22, P1807, DOI 10.1523/JNEUROSCI.22-05-01807.2002; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	85	90	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					677	690		10.1016/j.neuron.2004.10.025	http://dx.doi.org/10.1016/j.neuron.2004.10.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541315	Green Accepted, Bronze			2022-12-28	WOS:000225338100013
J	Demyanenko, GP; Schachner, M; Anton, E; Schmid, R; Feng, GP; Sanes, J; Maness, PF				Demyanenko, GP; Schachner, M; Anton, E; Schmid, R; Feng, GP; Sanes, J; Maness, PF			Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex	NEURON			English	Article							CELL-ADHESION MOLECULE; REELER MUTANT MOUSE; RAT VISUAL-CORTEX; EXTRACELLULAR-MATRIX; CORTICAL DEVELOPMENT; LAMINAR ORGANIZATION; CYTOPLASMIC DOMAIN; PYRAMIDAL NEURONS; MIGRATING NEURONS; RADIAL MIGRATION	We show that the neural cell recognition molecule Close Homolog of L1 (CHL1) is required for neuronal positioning and dendritic growth of pyramidal neurons in the posterior region of the developing mouse neocortex. CHL1 was expressed in pyramidal neurons in a high-caudal to low-rostral gradient within the developing cortex. Deep layer pyramidal neurons of CHL1-minus mice were shifted to lower laminar positions in the visual and somatosensory cortex and developed misoriented, often inverted apical dendrites. Impaired migration of CHL1-minus cortical neurons was suggested by strikingly slower rates of radial migration in cortical slices, failure to potentiate integrin-dependent haptotactic cell migration in vitro, and accumulation of migratory cells in the intermediate and ventricular/subventricular zones in vivo. The restriction of CHL1 expression and effects of its deletion in posterior neocortical areas suggests that CHL1 may regulate area-specific neuronal connectivity and, by extension, function in the visual and somatosensory cortex.	Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ Hamburg, D-20246 Hamburg, Germany; Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; Harvard Univ, Sch Med, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Ctr Brain Sci, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Hamburg; Duke University; Harvard University; Harvard University	Maness, PF (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	srclab@med.unc.edu	Feng, Guoping/Y-2827-2019; Schmid, Ralf/AAN-1011-2021	Schmid, Ralf/0000-0002-1721-5775	NIMH NIH HHS [MH064056] Funding Source: Medline; NINDS NIH HHS [NS26620, P30NS045892] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026620, P30NS045892] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Demyanenko GP, 2001, DEV BRAIN RES, V126, P21, DOI 10.1016/S0165-3806(00)00129-2; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; GALILEO DS, 1992, GLIA, V5, P210, DOI 10.1002/glia.440050307; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; HATTEN ME, 1986, J NEUROSCI, V6, P2676; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kizhatil K, 2002, J NEUROSCI, V22, P7948; KOESTER SE, 1992, J NEUROSCI, V12, P1382; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Kurumaji A, 2001, AM J MED GENET, V105, P99; Liu Q, 2000, J NEUROSCI, V20, P7682; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MILLER MW, 1988, J COMP NEUROL, V274, P387, DOI 10.1002/cne.902740308; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nauta W., 1986, FUNDAMENTAL NEUROANA; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Rice DS, 1998, DEVELOPMENT, V125, P3719; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; Stettler EM, 2004, J COMP NEUROL, V468, P441, DOI 10.1002/cne.10987; Takahashi T, 1996, J NEUROSCI, V16, P5762; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Zhang ZQ, 1998, J NEUROSCI, V18, P6928	63	91	94	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					423	437		10.1016/j.neuron.2004.10.016	http://dx.doi.org/10.1016/j.neuron.2004.10.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504324	Green Published, Bronze			2022-12-28	WOS:000224771700006
J	Buckner, RL				Buckner, RL			Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate	NEURON			English	Review							WHITE-MATTER LESIONS; FAMILIAL ALZHEIMERS-DISEASE; AGE-RELATED-CHANGES; ENTORHINAL CORTEX; COGNITIVE FUNCTION; EPISODIC MEMORY; CEREBRAL-CORTEX; FDG-PET; DIFFERENTIAL VULNERABILITY; CORTICAL DISCONNECTION	Memory decline in aging results from multiple factors that influence both executive function and the medial temporal lobe memory system. In advanced aging, frontal-striatal systems are preferentially vulnerable to white matter change, atrophy, and certain forms of neurotransmitter depletion. Frontal-striatal change may underlie mild memory difficulties in aging that are most apparent on tasks demanding high levels of attention and controlled processing. Through separate mechanisms, Alzheimer's disease preferentially affects the medial temporal lobe and cortical networks, including posterior cingulate and retrosplenial cortex early in its progression, often before clinical symptoms are recognized. Disruption of the medial temporal lobe memory system leads directly to memory impairment. Recent findings further suggest that age-associated change is not received passively. Reliance on reserve is emerging as an important factor that determines who ages gracefully and who declines rapidly. Functional imaging studies, in particular, suggest increased recruitment of brain areas in older adults that may reflect a form of compensation.	Washington Univ, Howard Hughes Med Inst, Dept Psychol, St Louis, MO 63130 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Buckner, RL (corresponding author), Washington Univ, Howard Hughes Med Inst, Dept Psychol, 1 Brookings Dr,Campus Box 1125, St Louis, MO 63130 USA.	rbuckner@artsci.wustl.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026	NIA NIH HHS [P01 AG03991, P01 AG05681] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; ANTONINI A, 1993, ARCH NEUROL-CHICAGO, V50, P474, DOI 10.1001/archneur.1993.00540050026010; ARNSTEN AFT, 1995, J NEUROSCI, V15, P3429; Backman L, 2000, AM J PSYCHIAT, V157, P635; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; Backman L., 2000, HDB AGING COGNITION, VVolume 2, P499; Balota D. A., 2001, HDB NEUROPSYCHOLOGY, V6, P51, DOI DOI 10.1037/A0014888; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Becker JT, 1996, NEUROLOGY, V46, P692, DOI 10.1212/WNL.46.3.692; BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V81, P261, DOI 10.1007/BF00305867; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; BRAYNE C, 1988, LANCET, V1, P1265; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2003, J NEUROSCI, V23, P3999; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; CRAIK FIM, 1990, PSYCHOL AGING, V5, P148, DOI 10.1037/0882-7974.5.1.148; Csernansky JG, 2000, NEUROLOGY, V55, P1636, DOI 10.1212/WNL.55.11.1636; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; de Groot JC, 2000, ANN NEUROL, V47, P145; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; DECARLI C, 2004, IN PRESS NEUROBIOL A; DECARLI C, 2002, VASCULAR COGNITIVE I, P433; Della-Maggiore V, 2002, REV NEUROSCIENCE, V13, P167; Desgranges B, 2002, BRAIN, V125, P1116, DOI 10.1093/brain/awf097; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Gabrieli JDE, 1996, P NATL ACAD SCI USA, V93, P13534, DOI 10.1073/pnas.93.24.13534; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; GOLDMANRAKIC PS, 1981, NEUROSCIENCE, V6, P177, DOI 10.1016/0306-4522(81)90053-1; Golomb J, 1996, NEUROLOGY, V47, P810, DOI 10.1212/WNL.47.3.810; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; HEAD D, 2004, IN PRESS CEREB CORTE; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; HENSON RN, 1999, J NEUROSCI, V19, P3692; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; HERHOLZ K, 1995, ALZ DIS ASSOC DIS, V9, P6, DOI 10.1097/00002093-199505000-00004; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Huppert FA, 1994, DEMENTIA NORMAL AGEI, P291; HUPPERT FA, 1994, DEMENTIA NORMAL AGIN, P3; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jack CR, 2000, CUR CLIN NEUROL, P127; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; JENNINGS JM, 1993, PSYCHOL AGING, V8, P283, DOI 10.1037/0882-7974.8.2.283; Johnson MK, 2004, PSYCHOL SCI, V15, P127, DOI 10.1111/j.0963-7214.2004.01502009.x; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; Killiany RJ, 2002, NEUROLOGY, V58, P1188, DOI 10.1212/WNL.58.8.1188; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; KUMAR A, 1991, NEUROPSYCHOPHARMACOL, V4, P35; Langley LK, 2000, MICROSC RES TECHNIQ, V51, P75, DOI 10.1002/1097-0029(20001001)51:1<75::AID-JEMT8>3.0.CO;2-6; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; LOESSNER A, 1995, J NUCL MED, V36, P1141; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Longstreth WT, 2002, STROKE, V33, P2376, DOI 10.1161/01.STR.0000032241.58727.49; Lustig C, 2004, NEURON, V42, P865, DOI 10.1016/j.neuron.2004.04.002; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; MADDEN DJ, 2001, NEUROIMAGE, V14, P143; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meguro K, 2003, INT PSYCHOGERIATR, V15, P9, DOI 10.1017/S104161020300872X; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nyberg L, 2003, P NATL ACAD SCI USA, V100, P13728, DOI 10.1073/pnas.1735487100; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Pantoni L, 1997, ANN NY ACAD SCI, V826, P92, DOI 10.1111/j.1749-6632.1997.tb48463.x; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Park D.C., 2004, COGNITIVE NEUROSCIEN; Park DC, 2003, J COGNITIVE NEUROSCI, V15, P1122, DOI 10.1162/089892903322598094; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; Petkov CI, 2004, J INT NEUROPSYCH SOC, V10, P371, DOI 10.1017/S1355617704103056; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; RAICHLE ME, 1987, NERVOUS SYSTEM, V5, P643; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Raz N., 2004, COGNITIVE NEUROSCIEN; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; RINNE JO, 1993, J CEREBR BLOOD F MET, V13, P310, DOI 10.1038/jcbfm.1993.39; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Rosen AC, 2002, NEUROREPORT, V13, P2425, DOI 10.1097/00001756-200212200-00010; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Rubin DC, 1999, AGING NEUROPSYCHOL C, V6, P241, DOI 10.1076/1382-5585(199912)06:04;1-B;FT241; Rubin EH, 1998, ARCH NEUROL-CHICAGO, V55, P395, DOI 10.1001/archneur.55.3.395; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Salat DH, 1999, ARCH NEUROL-CHICAGO, V56, P338, DOI 10.1001/archneur.56.3.338; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; SCHACTER DL, 1991, PSYCHOL AGING, V6, P559, DOI 10.1037/0882-7974.6.4.559; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schaie K. W., 1996, INTELLECTUAL DEV ADU; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Small SA, 2000, MICROSC RES TECHNIQ, V51, P101, DOI 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Small SA, 2002, ANN NEUROL, V51, P290, DOI 10.1002/ana.10105; Soderlund H, 2003, CORTEX, V39, P1093, DOI 10.1016/S0010-9452(08)70879-7; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stebbins GT, 2002, PSYCHOL AGING, V17, P44, DOI 10.1037//0882-7974.17.1.44; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P589, DOI 10.1076/jcen.25.5.589.14571; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Thompson PM, 2003, J NEUROSCI, V23, P994; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 2000, TRENDS NEUROSCI, V23, P195, DOI 10.1016/S0166-2236(00)01579-4; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wu CC, 2002, ANN NY ACAD SCI, V977, P403, DOI 10.1111/j.1749-6632.2002.tb04844.x; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Zacks R.T., 2000, HDB AGING COGNITION, P293, DOI DOI 10.3758/S13423-011-0086-9	173	1016	1048	3	172	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					195	208		10.1016/j.neuron.2004.09.006	http://dx.doi.org/10.1016/j.neuron.2004.09.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450170	Bronze			2022-12-28	WOS:000224232600017
J	Davis, RL				Davis, RL			Olfactory learning	NEURON			English	Review							ANTERIOR PIRIFORM CORTEX; LONG-TERM-MEMORY; DROSOPHILA MUSHROOM BODIES; INDUCED OSCILLATORY RESPONSES; ENCODING NEURAL ASSEMBLIES; ANTENNAL LOBE; BASOLATERAL AMYGDALA; ORBITOFRONTAL CORTEX; ODOR REPRESENTATIONS; PERIRHINAL CORTEX	The olfactory nervous systems of insects and mammals exhibit many similarities, suggesting that the mechanisms for olfactory learning may be shared. Neural correlates of olfactory memory are distributed among many neurons within the olfactory nervous system. Perceptual olfactory learning may be mediated by alterations in the odorant receptive fields of second and/or third order olfactory neurons, and by increases in the coherency of activity among ensembles of second order neurons. Operant olfactory conditioning is associated with an increase in the coherent population activity of these neurons. Olfactory classical conditioning increases the odor responsiveness and synaptic activity of second and perhaps third order neurons. Operant and classical conditioning both produce an increased responsiveness to conditioned odors in neurons of the basolateral amygdala. Molecular genetic studies of olfactory learning in Drosophila have revealed numerous molecules that function within the third order olfactory neurons for normal olfactory learning.	Baylor Coll Med, Dept Mol & Cellular Biol, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	rdavis@bcm.tmc-edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 19904] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Chiang AS, 2004, CURR BIOL, V14, P263, DOI 10.1016/j.cub.2004.02.003; Christensen TA, 2003, P NATL ACAD SCI USA, V100, P11076, DOI 10.1073/pnas.1934001100; Chu S, 2000, CHEM SENSES, V25, P111, DOI 10.1093/chemse/25.1.111; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, J NEUROBIOL, V54, P238, DOI 10.1002/neu.10170; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Faber T, 2001, NATURWISSENSCHAFTEN, V88, P472, DOI 10.1007/s001140100263; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fletcher ML, 2003, J NEUROSCI, V23, P6946; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holscher Christian, 2002, Neural Plast, V9, P41, DOI 10.1155/NP.2002.41; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Insausti R, 2002, BRAIN RES BULL, V57, P557, DOI 10.1016/S0361-9230(01)00684-0; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1998, LEARN MEMORY, V5, P124; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; Lessing D, 1999, CURR OPIN NEUROBIOL, V9, P766, DOI 10.1016/S0959-4388(99)00035-5; Litaudon P, 1997, EUR J NEUROSCI, V9, P1593, DOI 10.1111/j.1460-9568.1997.tb01517.x; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mcguire S.E., 2001, SCIENCE, V10, P1126; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mouly AM, 2002, LEARN MEMORY, V9, P66, DOI 10.1101/lm.45602; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Otto T, 2000, BEHAV BRAIN RES, V110, P119, DOI 10.1016/S0166-4328(99)00190-4; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; PERAZZONA B, 2004, IN PRESS J NEUROSCI; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Ravel N, 2003, EUR J NEUROSCI, V17, P350, DOI 10.1046/j.1460-9568.2003.02445.x; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Schettino LF, 2001, BEHAV NEUROSCI, V115, P1257, DOI 10.1037//0735-7044.115.6.1257; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Sun XJ, 1997, J COMP NEUROL, V379, P2, DOI 10.1002/(SICI)1096-9861(19970303)379:1<2::AID-CNE2>3.0.CO;2-8; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Vermetten E, 2003, J CLIN PSYCHIAT, V64, P202, DOI 10.4088/JCP.v64n0214; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson DA, 2000, J NEUROPHYSIOL, V83, P139, DOI 10.1152/jn.2000.83.1.139; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Wilson DA, 2001, LEARN MEMORY, V8, P279, DOI 10.1101/lm.42601; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	113	142	146	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					31	48		10.1016/j.neuron.2004.09.008	http://dx.doi.org/10.1016/j.neuron.2004.09.008			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450158	Bronze			2022-12-28	WOS:000224232600005
J	Vertes, RP				Vertes, RP			Memory consolidation in sleep: Dream or reality	NEURON			English	Review							ALTERED NREM SLEEP; EYE-MOVEMENT SLEEP; REM-SLEEP; COGNITIVE FUNCTION; PARADOXICAL SLEEP; GENE-EXPRESSION; PSYCHOMOTOR PERFORMANCE; RETROGRADE-AMNESIA; OXIDASE-INHIBITORS; TIME-COURSE	We discuss several lines of evidence refuting the hypothesis that procedural or declarative memories are processed/consolidated in sleep. One of the strongest arguments against a role for sleep in declarative memory involves the demonstration that the marked suppression or elimination of REM sleep in subjects on antidepressant drugs or with brainstem lesions produces no detrimental effects on cognition. Procedural memory, like declarative memory, undergoes a slow, time-dependent period of consolidation. A process has recently been described wherein performance on some procedural tasks improves with the mere passage of time and has been termed "enhancement." Some studies, but not others, have reported that the consolidation/enhancement of perceptual and motor skills is dependent on sleep. We suggest that consolidation or enhancement, initiated in waking with task acquisition, could in some instances extend to sleep, but sleep would serve no unique role in these processes. In sum, there is no compelling evidence to support a relationship between sleep and memory consolidation.	Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Vertes, RP (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	vertes@ccs.fau.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001476, R01MH063519] Funding Source: NIH RePORTER; NIMH NIH HHS [MH01476, MH63519] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKINDELE MO, 1970, ELECTROEN CLIN NEURO, V29, P47, DOI 10.1016/0013-4694(70)90078-7; ALLAIN H, 1992, PSYCHOPHARMACOLOGY, V106, pS56, DOI 10.1007/BF02246237; AMADOBOCCARA I, 1995, NEUROSCI BIOBEHAV R, V19, P479, DOI 10.1016/0149-7634(94)00068-C; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; BENINGTON JH, 1994, PROG NEUROBIOL, V44, P433, DOI 10.1016/0301-0082(94)90005-1; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BLAKESLEE S, 2000, NY TIMES        0307; Born J, 2000, BEHAV BRAIN SCI, V23, P912, DOI 10.1017/S0140525X00264029; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Braun AR, 1998, SCIENCE, V279, P91, DOI 10.1126/science.279.5347.91; CAIRNS H, 1952, BRAIN, V75, P109, DOI 10.1093/brain/75.2.109; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cirelli C, 1998, MOL BRAIN RES, V56, P293, DOI 10.1016/S0169-328X(98)00057-6; COENEN AML, 1985, PHYSIOL BEHAV, V35, P501, DOI 10.1016/0031-9384(85)90130-1; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; CURRAN HV, 1986, EUR J CLIN PHARMACOL, V29, P601, DOI 10.1007/BF00635900; CURRAN HV, 1988, PSYCHOPHARMACOLOGY, V95, P520; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEMENT WC, 1965, J NERV MENT DIS, V140, P119, DOI 10.1097/00005053-196502000-00002; DEPTULA D, 1990, J CLIN PSYCHOPHARM, V10, P105, DOI 10.1097/00004714-199004000-00005; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Dubnau J, 2003, J NEUROBIOL, V54, P238, DOI 10.1002/neu.10170; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 1989, NEUROBIOLOGY MEMORY; DUNLEAVY DL, 1973, ARCH GEN PSYCHIAT, V28, P353; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Fairbairn RA, 2001, P YORKS GEOL SOC, V53, P265, DOI 10.1144/pygs.53.4.265; FAIRWEATHER DB, 1993, HUM PSYCHOPHARM CLIN, V8, P41, DOI 10.1002/hup.470080108; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FISHBEIN W, 1977, BEHAV BIOL, V19, P425, DOI 10.1016/S0091-6773(77)91903-4; FISHBEIN W, 1971, PHYSIOL BEHAV, V6, P279, DOI 10.1016/0031-9384(71)90155-7; FISHBEIN W, 1970, BEHAV BIOL, V5, P171; Flanagan O, 2000, BEHAV BRAIN SCI, V23, P936, DOI 10.1017/S0140525X00404024; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; FREUND S, 1900, INTERPRETATION DREAM; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Georgotas A, 1989, Int Psychogeriatr, V1, P135, DOI 10.1017/S1041610289000141; Georgotas A, 1983, Arch Gerontol Geriatr, V2, P249, DOI 10.1016/0167-4943(83)90028-6; GERETSEGGER C, 1994, INT CLIN PSYCHOPHARM, V9, P25, DOI 10.1097/00004850-199400910-00004; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Gottselig JM, 2004, NEUROSCIENCE, V127, P557, DOI 10.1016/j.neuroscience.2004.05.053; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; HINDMARCH I, 1990, J CLIN PSYCHIAT, V51, P34; HINDMARCH I, 1988, EUR J CLIN PHARMACOL, V35, P221, DOI 10.1007/BF00609258; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; Hobson JA, 1998, NEUROREPORT, V9, pR1, DOI 10.1097/00001756-199802160-00033; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; HORNE JA, 1984, BIOL PSYCHOL, V18, P165, DOI 10.1016/0301-0511(84)90001-2; Horne JA, 2000, NEUROSCI BIOBEHAV R, V24, P777, DOI 10.1016/S0149-7634(00)00037-3; HORNE JA, 1988, WE SLEEP FUNCTIONS S; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Jones B E, 1998, Adv Neurol, V77, P75; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KERR JS, 1993, INT CLIN PSYCHOPHARM, V8, P341, DOI 10.1097/00004850-199300840-00025; KERR JS, 1992, INT CLIN PSYCHOPHARM, V7, P101, DOI 10.1097/00004850-199207020-00007; KNEGTERING H, 1994, DRUG AGING, V5, P192, DOI 10.2165/00002512-199405030-00005; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; KUPFER DJ, 1972, PSYCHOPHARMACOLOGIA, V27, P183, DOI 10.1007/BF00422798; LAMPING DL, 1984, PSYCHOPHARMACOLOGY, V84, P254, DOI 10.1007/BF00427455; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LAVIE P, 1984, NEUROLOGY, V34, P118, DOI 10.1212/WNL.34.1.118; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LILJEQUIST R, 1974, PSYCHOPHARMACOLOGIA, V39, P181, DOI 10.1007/BF00440847; LINNOILA M, 1983, ACTA PSYCHIAT SCAND, V68, P175, DOI 10.1111/j.1600-0447.1983.tb11121.x; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCGRATH MJ, 1978, PSYCHOL BULL, V85, P24, DOI 10.1037/0033-2909.85.1.24; MCNAIR DM, 1984, PSYCHOPHARMACOLOGY, V83, P134, DOI 10.1007/BF00429721; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; Nofzinger EA, 1997, BRAIN RES, V770, P192, DOI 10.1016/S0006-8993(97)00807-X; OSORIO I, 1980, ANN NEUROL, V7, P277, DOI 10.1002/ana.410070312; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; PISHKIN V, 1978, COMPR PSYCHIAT, V19, P171, DOI 10.1016/0010-440X(78)90063-9; RASKIN A, 1983, PSYCHOPHARMACOL BULL, V19, P649; RECHTSCHAFFEN A, 1995, BEHAV BRAIN RES, V69, P55, DOI 10.1016/0166-4328(95)00020-T; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RempelClower NL, 1996, J NEUROSCI, V16, P5233; SALETU B, 1980, J NEURAL TRANSM, V49, P63, DOI 10.1007/BF01249190; SALETU B, 1988, J CLIN PSYCHIAT, V49, P59; Schwartz S, 2003, TRENDS COGN SCI, V7, P325, DOI 10.1016/S1364-6613(03)00162-1; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Siegel JM, 1999, NEUROSCIENCE, V91, P391, DOI 10.1016/S0306-4522(98)00588-0; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; Smith C, 2000, BEHAV BRAIN SCI, V23, P1007, DOI 10.1017/S0140525X00224035; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; SPRING B, 1992, PSYCHOPHARMACOLOGY, V108, P327, DOI 10.1007/BF02245119; Squire L. R., 1987, MEMORY BRAIN; Squire L. R., 1984, NEUROBIOLOGY LEARNIN, P3; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 2000, BEHAV BRAIN SCI, V23, P1011, DOI 10.1017/S0140525X00904023; THOMPSON PJ, 1982, PSYCHOL MED, V12, P539, DOI 10.1017/S003329170005563X; THOMPSON PJ, 1991, HUM PSYCHOPHARM CLIN, V6, P79, DOI 10.1002/hup.470060202; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Tulving E., 1984, ADV PSYCHOL, V18, P163, DOI [10.1016/S0166-4115(08)62626-6, DOI 10.1016/S0166-4115(08)62626-6]; TULVING E, 1947, ORG MEMORY, P382; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; VALLDEORIOLA F, 1993, SLEEP, V16, P184, DOI 10.1093/sleep/16.2.184; VANHULZEN ZJM, 1982, PHYSIOL BEHAV, V29, P581, DOI 10.1016/0031-9384(82)90223-2; VANHULZEN ZJM, 1980, PHYSIOL BEHAV, V25, P807, DOI 10.1016/0031-9384(80)90298-X; VANLUIJTELAAR ELJM, 1986, PHYSIOL BEHAV, V36, P603, DOI 10.1016/0031-9384(86)90341-0; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P1057, DOI 10.1017/S0140525X00984024; VERTES RP, 1984, PROG NEUROBIOL, V22, P241, DOI 10.1016/0301-0082(84)90020-0; VERTES RP, 1986, NEUROSCI BIOBEHAV R, V10, P371, DOI 10.1016/0149-7634(86)90002-3; VOGEL GW, 1975, ARCH GEN PSYCHIAT, V32, P749; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WALKER MP, 2004, IN PRESS BEHAV BRAIN; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WYATT RJ, 1971, ARCH GEN PSYCHIAT, V24, P145; WYATT RJ, 1969, PSYCHOPHARMACOLOGIA, V15, P236; WYATT RJ, 1971, NEW ENGL J MED, V285, P987, DOI 10.1056/NEJM197110282851802; Zepelin H, 2000, PRINCIPLES PRACTICE, P82; Zepelin Harold, 1989, PRINCIPLES PRACTICE, P30	144	121	126	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					135	148		10.1016/j.neuron.2004.08.034	http://dx.doi.org/10.1016/j.neuron.2004.08.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	858ZY	15450166	Bronze			2022-12-28	WOS:000224232600013
J	Fellin, T; Pascual, O; Gobbo, S; Pozzan, T; Haydon, PG; Carmignoto, G				Fellin, T; Pascual, O; Gobbo, S; Pozzan, T; Haydon, PG; Carmignoto, G			Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors	NEURON			English	Article							METHYL-D-ASPARTATE; CALCIUM OSCILLATIONS; HIPPOCAMPAL SYNAPSES; CATIONIC CURRENT; RELEASE; NEUROTOXICITY; COMMUNICATION; POTENTIATION; MECHANISMS; INCREASE	Fast excitatory neurotransmission is mediated by activation of synaptic ionotropic glutamate receptors. In hippocampal slices, we report that stimulation of Schaffer collaterals evokes in CAi neurons delayed inward currents with slow kinetics, in addition to fast excitatory postsynaptic currents. Similar slow events also occur spontaneously, can still be observed when neuronal activity and synaptic glutamate release are blocked, and are found to be mediated by glutamate released from astrocytes acting preferentially on extrasynaptic NMDA receptors. The slow currents can be triggered by stimuli that evoke Ca2+ oscillations in astrocytes, including photolysis of caged Ca2+ in single astrocytes. As revealed by paired recording and Ca2+ imaging, a striking feature of this NMDA receptor response is that it occurs synchronously in multiple CA1 neurons. Our results reveal a distinct mechanism for neuronal excitation and synchrony and highlight a functional link between astrocytic glutamate and extrasynaptic NMDA receptors.	Univ Padua, CNR, Ist Neurosci, I-35121 Padua, Italy; Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Pennsylvania	Carmignoto, G (corresponding author), Univ Padua, CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.	gcarmi@bio.unipd.it	Carmignoto, Giorgio/A-8375-2018; Pascual, Olivier/E-9533-2017; Pascual, Olivier/AAE-1449-2020	Carmignoto, Giorgio/0000-0003-3063-6774; Pascual, Olivier/0000-0002-5730-9880; Pascual, Olivier/0000-0002-5730-9880	NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037585, R01NS043142] Funding Source: NIH RePORTER; NIMH NIH HHS [P20-MH-071705] Funding Source: Medline; NINDS NIH HHS [R01 NS43142, R37 NS37585] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Congar P, 1997, J NEUROSCI, V17, P5366; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; CREPEL V, 1994, J NEUROPHYSIOL, V72, P1561, DOI 10.1152/jn.1994.72.4.1561; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kullmann DM, 1999, ACTA PHYSIOL SCAND, V166, P79; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Matthias K, 2003, J NEUROSCI, V23, P1750; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Porter JT, 1996, J NEUROSCI, V16, P5073; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Sul JY, 2004, NEURON GLIA BIOL, V1, P3, DOI 10.1017/S1740925X04000031; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zanotti S, 1997, J NEUROCHEM, V69, P594; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	53	703	721	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					729	743		10.1016/j.neuron.2004.08.011	http://dx.doi.org/10.1016/j.neuron.2004.08.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339653	Bronze			2022-12-28	WOS:000223691900017
J	Goulding, M				Goulding, M			How early is firing required for wiring?	NEURON			English	Editorial Material							PERIOD	Activity is known to be important for the refinement of neural connections in the developing brain. In this issue of Neuron, Hanson and Landmesser provide evidence that GABA-dependent spontaneous bursting of motor neurons in the embryonic spinal cord is required for the correct execution of an early axon pathfinding decision.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; DAHM LM, 1991, J NEUROSCI, V11, P238; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Milner LD, 1999, J NEUROSCI, V19, P3007; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5	11	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 2	2004	43	5					601	603		10.1016/j.neuron.2004.08.027	http://dx.doi.org/10.1016/j.neuron.2004.08.027			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339640	Bronze			2022-12-28	WOS:000223691900004
J	Van Gelder, RN				Van Gelder, RN			Resetting the clock: Dexras1 defines a path	NEURON			English	Editorial Material							CIRCADIAN CLOCK; MELANOPSIN; PEPTIDE; MICE	The signaling pathways by which light and activity shift the circadian clock are not well understood. In this issue of Neuron, Cheng et al. analyze mice lacking Dexras1 (a Ras family GTPase protein) and demonstrate an important role for G(i/o) signaling mediating both photic and nonphotic phase shifts of the circadian clock.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave, St Louis, MO 63110 USA.		Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659				Chang DC, 2001, NEURON, V29, P555, DOI 10.1016/S0896-6273(01)00230-6; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Cheng HYM, 2004, NEURON, V43, P715, DOI 10.1016/j.neuron.2004.08.021; ESKIN A, 1979, FED PROC, V38, P2570; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200	9	5	5	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 2	2004	43	5					603	604		10.1016/j.neuron.2004.08.029	http://dx.doi.org/10.1016/j.neuron.2004.08.029			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339641	Bronze			2022-12-28	WOS:000223691900005
J	Koh, TW; Verstreken, P; Bellen, HJ				Koh, TW; Verstreken, P; Bellen, HJ			Dap160/intersectin acts as a stabilizing scaffold required for synaptic development and vesicle endocytosis	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; CYSTEINE STRING PROTEIN; ADAPTER PROTEIN; EPS15 HOMOLOGY; REVERSIBLE BLOCKAGE; QUANTAL SIZE; DROSOPHILA; INTERSECTIN; ENDOPHILIN; SINGLE	We describe the isolation of mutations in dynamin-associated protein 160 kDa (dap160), the Drosophila homolog of intersectin, a putative adaptor for proteins involved in endocytosis, cytoskeletal regulation, and signaling. We show that partial loss-of-function mutants display temperature-sensitive (ts) paralysis, whereas null mutants show ts defects in endocytosis. Loss-of-function mutants exhibit bouton overgrowth at larval neuromuscular junctions (NMJs), but evoked neurotransmission is normal. Mutant NMJs show a mild endocytic defect at 22degreesC, which is strongly enhanced at 34degreesC. The levels of dynamin, synaptojanin and endophilin are severely reduced in dap160 mutant NMJs, suggesting that Dap160 serves to stabilize an endocytic macromolecular complex. Electron microscopy reveals fewer vesicles, aberrant large vesicles, and an accumulation of endocytic intermediates at active and periactive zones in mutant terminals. Our data suggest that Dap160, like dynamin, is involved in synaptic vesicle retrieval at active and periactive zones.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Koh, Tong-Wey/M-3774-2013; Verstreken, Patrik/AAC-7591-2022	Koh, Tong-Wey/0000-0001-9136-3189; Verstreken, Patrik/0000-0002-5073-5393; Bellen, Hugo/0000-0001-5992-5989				BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Butler H, 2001, GENETICS, V158, P1597; Casso D, 2000, MECH DEVELOP, V91, P449; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Estes PS, 1996, J NEUROSCI, V16, P5443; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grant D, 1998, GENETICS, V149, P1019; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Karunanithi S, 2002, J NEUROSCI, V22, P10267; KIM YT, 1987, J NEUROSCI, V7, P3245; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kjaerulff O, 2002, NAT CELL BIOL, V4, pE245, DOI 10.1038/ncb1102-e245; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mayer BJ, 2001, J CELL SCI, V114, P1253; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ranjan R, 1998, J NEUROSCI, V18, P956; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Stimson DT, 1998, J NEUROSCI, V18, P9638; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Tang HY, 1996, MOL CELL BIOL, V16, P4897; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	76	174	184	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					193	205		10.1016/j.neuron.2004.06.029	http://dx.doi.org/10.1016/j.neuron.2004.06.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260956	Bronze			2022-12-28	WOS:000222905400009
J	Lee, H; Engel, U; Rusch, J; Scherrer, S; Sheard, K; Van Vactor, D				Lee, H; Engel, U; Rusch, J; Scherrer, S; Sheard, K; Van Vactor, D			The microtubule plus end tracking protein orbit/MAST/CLASP acts downstream of the tyrosine kinase Abl in mediating axon guidance	NEURON			English	Article							GROWTH CONE MOTILITY; F-ACTIN; CYTOSKELETAL DYNAMICS; SHORT-STOP; DROSOPHILA; ABELSON; RECEPTOR; SUBSTRATE; BEHAVIOR; NEURONS	Axon guidance requires coordinated remodeling of actin and microtubule polymers. Using a genetic screen, we identified the microtubule-associated protein Orbit/MAST as a partner of the Abelson (Abl) tyrosine kinase. We find identical axon guidance phenotypes in orbit/MAST and Ab/ mutants at the midline, where the repellent Slit restricts axon crossing. Genetic interaction and epistasis assays indicate that Orbit/MAST mediates the action of Slit and its receptors, acting downstream of Abl. We find that Orbit/MAST protein localizes to Drosophila growth cones. Higher-resolution imaging of the Orbit/MAST ortholog CLASP in Xenopus growth cones suggests that this family of microtubule plus end tracking proteins identifies a subset of microtubules that probe the actin-rich peripheral growth cone domain, where guidance signals exert their initial influence on cytoskeletal organization. These and other data suggest a model where Abl acts as a central signaling node to coordinate actin and microtubule dynamics downstream of guidance receptors.	Harvard Univ, Sch Med, Dept Cell Biol,Harvard Canc Ctr, Program Neurosci,Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med,Harvard Ctr Neurodegenerat & Repair, Dept Cell Biol, Program Neurosci, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol,Harvard Canc Ctr, Program Neurosci,Dana Farber Canc Inst, 240 Longwood Ave, Boston, MA 02115 USA.	davie@hms.harvard.edu	Engel, Ulrike/AAO-7719-2020; Scherrer, Simone/F-3663-2019; Engel, Ulrike/E-5456-2014	Engel, Ulrike/0000-0002-6953-6845; Scherrer, Simone/0000-0001-9548-8798; Van Vactor, Jr., David L./0000-0001-8156-9482	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909, P01NS040043] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35909, NS40043] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Buck KB, 2002, J NEUROSCI, V22, P9358; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; FEDOROVA SA, 1997, RUSS J GENET, V33, P1286; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Goold RG, 2001, J CELL SCI, V114, P4273; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Hely TA, 1998, P ROY SOC B-BIOL SCI, V265, P1801, DOI 10.1098/rspb.1998.0505; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; LEBRAND C, 2004, IN PRESS NEURON; Lee H, 2003, CURR BIOL, V13, pR152, DOI 10.1016/S0960-9822(03)00080-0; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee S, 2002, DEVELOPMENT, V129, P1195; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liebl EC, 2003, DEVELOPMENT, V130, P3217, DOI 10.1242/dev.00545; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Maiato H, 2003, CELL CYCLE, V2, P511, DOI 10.4161/cc.2.6.576; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Moresco EMY, 2003, CURR OPIN NEUROBIOL, V13, P535, DOI 10.1016/j.conb.2003.08.002; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; MYERS PZ, 1993, J NEUROSCI, V13, P127; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Rusch J, 2000, NEURON, V28, P637, DOI 10.1016/S0896-6273(00)00143-4; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schwab ME, 2000, NATURE, V403, P257, DOI 10.1038/35002226; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stepanova T, 2003, J NEUROSCI, V23, P2655; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Van Vactor D, 1999, ADV MOLEC BIOL, P490; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	81	129	131	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					913	926		10.1016/j.neuron.2004.05.020	http://dx.doi.org/10.1016/j.neuron.2004.05.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207236	Bronze			2022-12-28	WOS:000222329300007
J	Lee, I; Rao, G; Knierim, JJ				Lee, I; Rao, G; Knierim, JJ			A double dissociation between hippocampal subfields: Differential time course of CA3 and CA1 place cells for processing changed environments	NEURON			English	Article							MEMORY CONSOLIDATION; DECLARATIVE MEMORY; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NMDA RECEPTORS; UNIT-ACTIVITY; SPATIAL MAP; AREA CA3; EXPERIENCE; PLASTICITY	Computational theories have suggested different functions for the hippocampal subfields (e.g., CA1 and CA3) in memory. However, it has been difficult to find dissociations relevant to these hypothesized functions in investigations of the hippocampal correlates of space ("place fields") in freely behaving animals. The current study demonstrates a double dissociation between the shifts in the center of mass (COM) of the place fields that were simultaneously recorded in CA1 and CA3 when familiar cue configurations were dynamically changed over days. The COM of CA3 place fields shifted backward in the first experience of the cue-changed environment, whereas the COM of CA1 place fields did not display the backward shift until the next day. These results support the hypothesis that CA3 plays a key role in the rapid formation of representations of new spatiotemporal sequences, whereas CA1 may be more important for comparing currently experienced sequence information with stored sequences in the CA3 network.	Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77225 USA	University of Texas System	Knierim, JJ (corresponding author), Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77225 USA.	james.j.knierim@uth.tmc.edu		Knierim, James/0000-0002-1796-2930	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH063297] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH63297] Funding Source: Medline; NINDS NIH HHS [R01 NS29456] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		August DA, 1999, J COMPUT NEUROSCI, V6, P71, DOI 10.1023/A:1008861001091; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Frank LM, 2002, J NEUROSCI, V22, P3817; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kali S, 2000, J NEUROSCI, V20, P7463; KIRK RE, 1989, STAT INTRO; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; LYNCH G, 1992, J COGNITIVE NEUROSCI, V4, P189, DOI 10.1162/jocn.1992.4.3.189; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P741; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mizumori SJY, 1995, BEHAV NEUROSCI, V109, P1081; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shen JM, 1997, J NEUROSCI, V17, P6769; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	52	178	179	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					803	815		10.1016/j.neuron.2004.05.010	http://dx.doi.org/10.1016/j.neuron.2004.05.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182719	Bronze			2022-12-28	WOS:000221975000011
J	Vanzetta, I; Slovin, H; Omer, DB; Grinvald, A				Vanzetta, I; Slovin, H; Omer, DB; Grinvald, A			Columnar resolution of blood volume and oximetry functional maps in the behaving monkey: Implications for fMRI	NEURON			English	Article							INDEPENDENT COMPONENT ANALYSIS; RAT FOREPAW STIMULATION; CAT VISUAL-CORTEX; INTRINSIC SIGNALS; SENSORY STIMULATION; NEURONAL-ACTIVITY; OCULAR DOMINANCE; AUDITORY-CORTEX; TEMPORAL CHARACTERISTICS; IMAGING SPECTROSCOPY	The ultimate goal of high-resolution functional brain mapping is single-condition (stimulus versus no-stimulus maps) rather than differential imaging (comparing two "stimulus maps"), because the appropriate ("orthogonal") stimuli are rarely available. This requires some component(s) of activity-dependent hemodynamic signals to closely colocalize with electrical activity, like the early increase in deoxyhemoglobin, shown previously to yield high-quality functional single-condition maps. Conversely, nonlocal vascular responses dominate in cerebral blood volume (CBV)based single-condition maps. Differential CBV maps are largely restricted to the parenchyma, implying that part of the CBV response does colocalize with electrical activity at fine spatial scale. By removing surface vascular activation from optical imaging data, we document the existence of a capillary CBV response component, regulated at fine spatial scale and yielding single-condition maps exhibiting similar to100 mum resolution. Blood volume and -flow based single-condition functional mapping at columnar level should thus be feasible, provided that the capillary response component is selectively imaged.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Vanzetta, I (corresponding author), CNRS, UMR 6193, INCM, Equipe Dynam Vis & Act, Bat N,31 Chemin Josephy Aiguier, F-13402 Marseille 20, France.	vanzetta@incm.cnrs-mrs.fr	Omer, David/AAF-1960-2019; GRINVALD, AMIRAM/AAH-9919-2019	Omer, David/0000-0001-7402-9453; Slovin, Hamutal/0000-0001-6350-8141				Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bakin JS, 1996, CEREB CORTEX, V6, P120, DOI 10.1093/cercor/6.2.120; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bosking WH, 1997, J NEUROSCI, V17, P2112; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cannestra AF, 2001, CEREB CORTEX, V11, P773, DOI 10.1093/cercor/11.8.773; Cannestra AF, 1996, NEUROIMAGE, V3, P202, DOI 10.1006/nimg.1996.0022; CARMONA RA, 1995, IEEE T MED IMAGING, V14, P556, DOI 10.1109/42.414621; ChenBee CH, 1996, J NEUROSCI METH, V68, P27, DOI 10.1016/0165-0270(96)00056-8; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; Esposito F, 2002, HUM BRAIN MAPP, V16, P146, DOI 10.1002/hbm.10034; Everson R, 1997, BIOL CYBERN, V77, P407, DOI 10.1007/s004220050400; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gabbay M, 2000, NEUROIMAGE, V11, P313, DOI 10.1006/nimg.2000.0547; Goodyear BG, 2001, HUM BRAIN MAPP, V14, P210, DOI 10.1002/hbm.1053; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Harel N, 2000, NEUROIMAGE, V11, P302, DOI 10.1006/nimg.1999.0537; Hess A, 1996, NEUROREPORT, V7, P2643, DOI 10.1097/00001756-199611040-00047; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Kim DS, 2000, NAT NEUROSCI, V3, P414, DOI 10.1038/74771; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Logothetis N, 2000, NAT NEUROSCI, V3, P413, DOI 10.1038/74768; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Martin C, 2002, J NEUROSCI METH, V120, P25, DOI 10.1016/S0165-0270(02)00185-1; Masino SA, 2003, J NEUROPHYSIOL, V89, P1702, DOI 10.1152/jn.00860.2002; Mayhew J, 1999, NEUROIMAGE, V10, P304, DOI 10.1006/nimg.1999.0460; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; MOLGEDEY L, 1994, PHYS REV LETT, V72, P3634, DOI 10.1103/PhysRevLett.72.3634; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Roy C S, 1890, J Physiol, V11, P85; SCHIESSL I, 1999, P 1 ICA99 WORKSH AUS, V1, P179; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 2001, J NEUROSCI, V21, P6820, DOI 10.1523/JNEUROSCI.21-17-06820.2001; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; SIROVICH L, 1992, INT J SUPERCOMPUT AP, V6, P50, DOI 10.1177/109434209200600104; Sirovich L, 1996, PHYSICA D, V96, P355, DOI 10.1016/0167-2789(96)00033-4; Sornborger A, 2003, NEUROIMAGE, V18, P610, DOI 10.1016/S1053-8119(02)00045-9; Spitzer MW, 2001, J NEUROPHYSIOL, V85, P1283, DOI 10.1152/jn.2001.85.3.1283; Stetter M, 2000, NEUROIMAGE, V11, P482, DOI 10.1006/nimg.2000.0551; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vanzetta I, 2001, NEUROIMAGE, V13, P959, DOI 10.1006/nimg.2001.0843; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q; Zheng Y, 2001, NEUROIMAGE, V13, P447, DOI 10.1006/nimg.2000.0705	70	73	74	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 10	2004	42	5					843	854		10.1016/j.neuron.2004.04.004	http://dx.doi.org/10.1016/j.neuron.2004.04.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182722	Bronze			2022-12-28	WOS:000221975000014
J	Bennett, MK; Reed, RR				Bennett, MK; Reed, RR			Silence sets on a sensory map	NEURON			English	Editorial Material								Recent efforts to understand the contribution of neuronal activity in the creation of the olfactory sensory map have focused on odor-evoked events. In this issue of Neuron, Yu et al. discover a new role for neuronal activity in the organization and maintenance of the olfactory system. Their results highlight the role of spontaneous activity and synaptic transmission in axon outgrowth and olfactory neuron survival.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet,Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Bennett, MK (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet,Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.							Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	9	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					521	522		10.1016/j.neuron.2004.05.006	http://dx.doi.org/10.1016/j.neuron.2004.05.006			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157412	Bronze			2022-12-28	WOS:000221708300001
J	Deisseroth, K; Singla, S; Toda, H; Monje, M; Palmer, TD; Malenka, RC				Deisseroth, K; Singla, S; Toda, H; Monje, M; Palmer, TD; Malenka, RC			Excitation-neurogenesis coupling in adult neural stem/progenitor cells	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; STEM-CELLS; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; EXTRACELLULAR POTASSIUM; SYNAPTIC-TRANSMISSION; CREB PHOSPHORYLATION; SUBVENTRICULAR ZONE	A wide variety of in vivo manipulations influence neurogenesis in the adult hippocampus. It is not known, however, if adult neural stem/progenitor cells (NPCs) can intrinsically sense excitatory neural activity and thereby implement a direct coupling between excitation and neurogenesis. Moreover, the theoretical significance of activity-dependent neurogenesis in hippocampal-type memory processing networks has not been explored. Here we demonstrate that excitatory stimuli act directly on adult hippocampal NPCs to favor neuron production. The excitation is sensed via Ca(v)1.2/ 1.3 (L-type) Call channels and NMDA receptors on the proliferating precursors. Excitation through this pathway acts to inhibit expression of the glial fate genes Hes1 and Id2 and increase expression of NeuroD, a positive regulator of neuronal differentiation. These activity-sensing properties of the adult NPCs, when applied as an "excitation-neurogenesis coupling rule" within a Hebbian neural network, predict significant advantages for both the temporary storage and the clearance of memories.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.		Palmer, Theo/GSI-6635-2022; Toda, Hiroki/C-6932-2016	Toda, Hiroki/0000-0002-1596-4131; Palmer, Theo/0000-0002-6266-1862				Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cai L, 2000, DEVELOPMENT, V127, P3021; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 2002, DEVELOPMENT, V129, P1871; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; CLAIBORNE BJ, 1990, J COMP NEUROL, V302, P206, DOI 10.1002/cne.903020203; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Graham B, 1999, NEURAL COMPUT, V11, P117, DOI 10.1162/089976699300016845; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jinnah HA, 2000, MOVEMENT DISORD, V15, P542, DOI 10.1002/1531-8257(200005)15:3<542::AID-MDS1019>3.0.CO;2-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Liu JL, 1998, J NEUROSCI, V18, P7768; LONGO VG, 1988, PHARMACOL BIOCHEM BE, V29, P785, DOI 10.1016/0091-3057(88)90207-9; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 1997, J NEUROSCI, V17, P3727; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Petreanu L, 2002, J NEUROSCI, V22, P6106; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toma JG, 2000, J NEUROSCI, V20, P7648; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0	80	508	567	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					535	552		10.1016/S0896-6273(04)00266-1	http://dx.doi.org/10.1016/S0896-6273(04)00266-1			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157417	Bronze			2022-12-28	WOS:000221708300006
J	Ruiz-Canada, C; Ashley, J; Moeckel-Cole, S; Drier, E; Yin, J; Budnik, V				Ruiz-Canada, C; Ashley, J; Moeckel-Cole, S; Drier, E; Yin, J; Budnik, V			New synaptic bouton formation is disrupted by misregulation of microtubule stability in aPKC mutants	NEURON			English	Article							PROTEIN-KINASE-C; CELL-POLARITY; ALPHA-ACTININ; GROWTH CONES; DISCS-LARGE; DROSOPHILA; NEUROBLASTS; COMPLEX; BAZOOKA; BINDING	The Baz/Par-3-Par-6-aPKC complex is an evolutionarily conserved cassette critical for the development of polarity in epithelial cells, neuroblasts, and oocytes. aPKC is also implicated in long-term synaptic plasticity in mammals and the persistence of memory in flies, suggesting a synaptic function for this cassette. Here we show that at Drosophila glutamatergic synapses, aPKC controls the formation and structure of synapses by regulating microtubule (MT) dynamics. At the presynapse, aPKC regulates the stability of MTs by promoting the association of the MAP1B-related protein Futsch to MTs. At the postsynapse, aPKC regulates the synaptic cytoskeleton by controlling the extent of Actin-rich and MT-rich areas. In addition, we show that Baz and Par-6 are also expressed at synapses and that their synaptic localization depends on aPKC activity. Our findings establish a novel role for this complex during synapse development and provide a cellular context for understanding the role of aPKC in synaptic plasticity and memory.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Massachusetts System; University of Massachusetts Worcester; Cold Spring Harbor Laboratory	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu		Ashley, James/0000-0002-6693-1014	NIMH NIH HHS [R01 MH067774] Funding Source: Medline; NINDS NIH HHS [R01 NS030072, R01 NS3700] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Banan A, 2002, AM J PHYSIOL-GASTR L, V283, pG909, DOI 10.1152/ajpgi.00143.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dubreuil RR, 1997, MOL BIOL CELL, V8, P1933, DOI 10.1091/mbc.8.10.1933; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Goold RG, 1999, J CELL SCI, V112, P3373; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Packard M, 2003, CURR OPIN NEUROBIOL, V13, P527, DOI 10.1016/j.conb.2003.09.008; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	44	121	123	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					567	580		10.1016/S0896-6273(04)00255-7	http://dx.doi.org/10.1016/S0896-6273(04)00255-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157419	Green Accepted, Bronze			2022-12-28	WOS:000221708300008
J	Tong, F				Tong, F			Splitting the spotlight of visual attention	NEURON			English	Editorial Material							CORTEX; SIGNALS; SEARCH; FIELD	Can the brain attend to more than a single location at one time? In this issue of Neuron, McMains and Somers report psychophysical and fMRI evidence showing that subjects can attend to two separate locations concurrently and that divided spatial attention leads to separate zones of attentional enhancement in early visual cortex.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Tong, F (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.							Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Kramer AF, 1995, PSYCHOL SCI, V6, P381, DOI 10.1111/j.1467-9280.1995.tb00530.x; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McMains SA, 2004, NEURON, V42, P677, DOI 10.1016/S0896-6273(04)00263-6; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Zipser K, 1996, J NEUROSCI, V16, P7376	11	9	9	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 27	2004	42	4					524	526		10.1016/j.neuron.2004.05.005	http://dx.doi.org/10.1016/j.neuron.2004.05.005			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157414	Bronze			2022-12-28	WOS:000221708300003
J	Yu, CR; Power, J; Barnea, G; O'Donnell, S; Brown, HE; Osborne, J; Axel, R; Gogos, JA				Yu, CR; Power, J; Barnea, G; O'Donnell, S; Brown, HE; Osborne, J; Axel, R; Gogos, JA			Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; SPONTANEOUS RETINAL WAVES; ODORANT RECEPTORS; GENE-EXPRESSION; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; POSTNATAL-DEVELOPMENT; TYROSINE-HYDROXYLASE	We have developed a genetic approach to examine the role of spontaneous activity and synaptic release in the establishment and maintenance of an olfactory sensory map. Conditional expression of tetanus toxin light chain, a molecule that inhibits synaptic release, does not perturb targeting during development, but neurons that express this molecule in a competitive environment fail to maintain appropriate synaptic connections and disappear. Overexpression of the inward rectifying potassium channel, Kir2.1, diminishes the excitability of sensory neurons and more severely disrupts the formation of an olfactory map. These studies suggest that spontaneous neural activity is required for the establishment and maintenance of the precise connectivity inherent in an olfactory sensory map.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Yu, CR (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NIDCD NIH HHS [R01-DC006292-01] Funding Source: Medline; NIMH NIH HHS [K01 MH001888, 5K01 MH01888, 5P50 MH 50733] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733, K01MH001888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006292] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Horton JC, 1996, J NEUROSCI, V16, P1791; Johns DC, 1999, J NEUROSCI, V19, P1691; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kim H, 2000, J COMP NEUROL, V422, P297; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROSPARS JP, 1994, BRAIN RES, V662, P31, DOI 10.1016/0006-8993(94)90793-5; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STONE DM, 1990, MOL BRAIN RES, V8, P291, DOI 10.1016/0169-328X(90)90042-C; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	62	276	279	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 27	2004	42	4					553	566		10.1016/S0896-6273(04)00224-7	http://dx.doi.org/10.1016/S0896-6273(04)00224-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157418	Bronze			2022-12-28	WOS:000221708300007
J	Bashaw, GJ				Bashaw, GJ			Semaphorin signaling unplugged: A nervey AKAP cAMP(s) out on plexin	NEURON			English	Review							GROWTH CONE GUIDANCE; KINASE; PROTEIN; DROSOPHILA	Semaphorins signal through Plexin receptors to mediate a range of predominantly repulsive effects on axons in the developing nervous system. Semaphorin-directed repulsive turning responses of cultured Xenopus neurons can be converted to attraction by manipulating cyclic nucleotide signaling pathways. cAMP- and cGMP-dependent response conversions are observed for many families of guidance cues, but a direct molecular link between guidance receptors and cyclic nucleotides has remained elusive. Recent findings indicate that the Drosophila (A) under bar-(k) under bar inase (a) under bar nchoring protein (AKAP) Nervy couples Plexin to PKA to modulate Semaphorin repulsion, suggesting a mechanism for the integration of diverse signaling inputs to the growth cone.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.							Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Castellani V, 2002, CURR OPIN NEUROBIOL, V12, P532, DOI 10.1016/S0959-4388(02)00357-4; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Diviani D, 2001, J CELL SCI, V114, P1431; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dontchev VD, 2002, J NEUROSCI, V22, P6659; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fukuyama T, 2001, ONCOGENE, V20, P6225, DOI 10.1038/sj.onc.1204794; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Schillace RV, 2002, J IMMUNOL, V168, P1590, DOI 10.4049/jimmunol.168.4.1590; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	21	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					363	366		10.1016/S0896-6273(04)00258-2	http://dx.doi.org/10.1016/S0896-6273(04)00258-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134633	Bronze			2022-12-28	WOS:000221458700003
J	Yanike, M; Wirth, S; Suzuki, WA				Yanike, M; Wirth, S; Suzuki, WA			Representation of well-learned information in the monkey hippocampus	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; RECEPTIVE-FIELD PLASTICITY; PRIMATE PREFRONTAL CORTEX; VISUAL RECOGNITION MEMORY; TIME-LIMITED ROLE; NEURONAL-ACTIVITY; INFEROTEMPORAL CORTEX; RETROGRADE-AMNESIA; AUDITORY-CORTEX	In the neocortex, extensive training results in enhanced neuronal selectivity for learned stimuli relative to novel stimuli. This enhanced selectivity has been taken as evidence for learning-related plasticity. Much less is known, in contrast, about the representation of well-learned information in the hippocampus. In this study, we examined the responses of individual hippocampal neurons to well-learned and novel stimuli presented in the context of an associative learning task. There was no difference in the response magnitude or visual response latency of hippocampal neurons to the well-learned and novel stimuli. In contrast, hippocampal neurons responded significantly more selectively to the well-learned stimuli relative to the novel stimuli. These findings show that hippocampal cells, like neocortical cells, show greater selectivity to well-learned stimuli compared to novel stimuli.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Suzuki, WA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	wendy@cns.nyu.edu	Wirth, Sylvia/M-4752-2017	Wirth, Sylvia/0000-0001-7002-329X				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Bayley PJ, 2003, NEURON, V38, P135, DOI 10.1016/S0896-6273(03)00156-9; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; EIFUKU S, 1995, J NEUROSCI, V15, P4952; Erickson CA, 1999, J NEUROSCI, V19, P10404; FAHY FL, 1993, EXP BRAIN RES, V96, P457; Frank LM, 2002, J NEUROSCI, V22, P3817; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1989, J NEUROPHYSIOL, V61, P669, DOI 10.1152/jn.1989.61.3.669; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; Moody SL, 1998, J NEUROSCI, V18, P399; Murray EA, 1996, BEHAV NEUROSCI, V110, P1261; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; Reed JM, 1998, J NEUROSCI, V18, P3943; RempelClower NL, 1996, J NEUROSCI, V16, P5233; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Seigel S., 1988, NONPARAMETRIC STAT B; Sigala N, 2002, J COGNITIVE NEUROSCI, V14, P187, DOI 10.1162/089892902317236830; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WILSON FAW, 1990, BEHAV BRAIN RES, V40, P7, DOI 10.1016/0166-4328(90)90038-G; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; ZHU XO, 1995, EUR J NEUROSCI, V7, P753, DOI 10.1111/j.1460-9568.1995.tb00679.x; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	52	39	39	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					477	487		10.1016/S0896-6273(04)00193-X	http://dx.doi.org/10.1016/S0896-6273(04)00193-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134643	Bronze			2022-12-28	WOS:000221458700013
J	Buccino, G; Vogt, S; Ritzl, A; Fink, GR; Zilles, K; Freund, HJ; Rizzolatti, G				Buccino, G; Vogt, S; Ritzl, A; Fink, GR; Zilles, K; Freund, HJ; Rizzolatti, G			Neural circuits underlying imitation learning of hand actions: An event-related fMRI study	NEURON			English	Article							PREFRONTAL CORTEX; CORTICAL ACTIVITY; GRASP REPRESENTATIONS; FINGER CONFIGURATIONS; FUNCTIONAL PROPERTIES; MOTOR FACILITATION; PREMOTOR; NEURONS; MODULATION; MOVEMENT	The neural bases of imitation learning are virtually unknown. In the present study, we addressed this issue using an event-related fMRI paradigm. Musically naive participants were scanned during four events: (1) observation of guitar chords played by a guitarist, (2) a pause following model observation, (3) execution of the observed chords, and (4) rest. The results showed that the basic circuit underlying imitation learning consists of the inferior parietal lobule and the posterior part of the inferior frontal gyrus plus the adjacent premotor cortex (mirror neuron circuit). This circuit, known to be involved in action understanding, starts to be active during the observation of the guitar chords. During pause, the middle frontal gyrus (area 46) plus structures involved in motor preparation (dorsal premotor cortex, superior parietal lobule, rostral mesial areas) also become active. Given the functional properties of area 46, a model of imitation learning is proposed based on interactions between this area and the mirror neuron system.	Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; Forschungszentrum Julich, Inst Med, D-52428 Julich, Germany; Univ Klinikum, Rhein Westfal TH Aachen, Neurol Klin, D-52062 Aachen, Germany; Univ Dusseldorf, C&O Vogt Hirnoforschungsinst, D-40210 Dusseldorf, Germany	University of Parma; Lancaster University; Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University Hospital; Heinrich Heine University Dusseldorf	Rizzolatti, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giacomo.rizzolatti@unipr.it	Zilles, Karl/J-9704-2013; Buccino, Giovanni/AAC-4503-2022; Zilles, Karl/Y-3784-2019; Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012	Zilles, Karl/0000-0001-9296-9959; Buccino, Giovanni/0000-0001-5432-1756; Zilles, Karl/0000-0002-4705-4175; Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Vogt, Stefan Reinhold/0000-0003-4627-3410				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Andersen RA, 1987, HDB PHYSL 1, VV, P483; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Byrne R., 1995, THINKING APE EVOLUTI; BYRNE RW, 2002, IMITATIVE MIND DEV E, P122; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 1998, COGN NEUROPSYCHOL, V15, P553, DOI 10.1080/026432998381023; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; HIKOSAKA O, 2000, COGNITIVE NEUROSCIEN, P553; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jellema T., 2002, IMITATIVE MIND DEV E, P267; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Johnson Frey SH, 2003, NEURON, V39, P1053, DOI DOI 10.1016/S0896-6273(03)00524-5; Kimmig H, 2001, EXP BRAIN RES, V141, P184, DOI 10.1007/s002210100844; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; LEINONEN L, 1979, EXP BRAIN RES, V34, P321; LEINONEN L, 1979, EXP BRAIN RES, V34, P299; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; MELTZOFF AN, 2002, IMITIATIVE MIND DEV; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Passingham RE, 2000, EXP BRAIN RES, V133, P103, DOI 10.1007/s002210000405; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1990, EXP BRAIN RES, V82, P337; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; RIZZOLATTI G, 2003, PERSPECTIVES IMITATI; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sakai K, 1999, J NEUROSCI, V19, P10074; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Talairach I., 1988, COPLANAR STEREOTACTI; Tanaka S, 2002, NEUROREPORT, V13, P1599, DOI 10.1097/00001756-200209160-00005; Tanaka S, 2001, NEUROREPORT, V12, P1171, DOI 10.1097/00001756-200105080-00024; Thorndike E. L., 1898, PSYCHOL REV MONOGRAP, V2, P1, DOI DOI 10.1037/H0092987; Tomasello M, 1997, PRIMATE COGNITION; Visalberghi E, 2002, FROM ANIM ANIMAT, P471; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Vogt S, 2002, IMITATIVE MIND DEV E, P206, DOI DOI 10.1017/CB09780511489969.012	76	649	682	0	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					323	334		10.1016/S0896-6273(04)00181-3	http://dx.doi.org/10.1016/S0896-6273(04)00181-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091346	Bronze			2022-12-28	WOS:000221458500015
J	Bulow, HE; Hobert, O				Bulow, HE; Hobert, O			Differential sulfations and epimerization define heparan sulfate specificity in nervous system development	NEURON			English	Article							ELEGANS VULVAL MORPHOGENESIS; CAENORHABDITIS-ELEGANS; C-ELEGANS; EXTRACELLULAR-MATRIX; KALLMANN-SYNDROME; AXON GUIDANCE; SLIT PROTEIN; CELL; GENE; PROTEOGLYCANS	Heparan sulfate proteoglycans (HSPG) are components of the extracellular matrix through which axons navigate to reach their targets. The heparan sulfate (HS) side chains of HSPGs show complex and differentially regulated patterns of secondary modifications, including sulfations of distinct hydroxyl groups and epimerization of an asymmetric carbon atom. These modifications endow the HSPG-containing extracellular matrix with the potential to code for an enormous molecular diversity. Attempting to decode this diversity, we analyzed C. elegans animals lacking three HS-modifying enzymes, glucuronyl C5-epimerase, heparan 60-sulfotransferase, and 20-sulfotransferase. Each of the mutant animals exhibit distinct as well as overlapping axonal and cellular guidance defects in specific neuron classes. We have linked individual HS modifications to two specific guidance systems, the sax-3/Robo and kal-1/Anosmin-1 systems, whose activity is dependent on different HS modifications in different cellular contexts. Our results demonstrate that the molecular diversity in HS encodes information that is crucial for different aspects of neuronal development.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854				Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Bennett KL, 1997, J BIOL CHEM, V272, P26940, DOI 10.1074/jbc.272.43.26940; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Chang Z, 2000, FASEB J, V14, P137, DOI 10.1096/fasebj.14.1.137; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huang CC, 2003, DEVELOPMENT, V130, P3343, DOI 10.1242/dev.00481; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Irie A, 2002, DEVELOPMENT, V129, P61; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Letourneau PC, 1992, CURR OPIN GENET DEV, V2, P625, DOI 10.1016/S0959-437X(05)80183-2; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Morio H, 2003, BIOCHEM BIOPH RES CO, V301, P317, DOI 10.1016/S0006-291X(02)03031-0; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; Rugarli EI, 2002, DEVELOPMENT, V129, P1283; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shworak NW, 2002, GLYCOCONJUGATE J, V19, P355, DOI 10.1023/A:1025377206600; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; SoussiYanicostas N, 1996, J CELL SCI, V109, P1749; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; WILLIAMS BD, 1992, GENETICS, V131, P609; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; [No title captured]	63	201	213	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					723	736		10.1016/S0896-6273(04)00084-4	http://dx.doi.org/10.1016/S0896-6273(04)00084-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003172	Bronze			2022-12-28	WOS:000221458200008
J	Heuckeroth, RO				Heuckeroth, RO			Finding your way to the end: A tale of GDNF and endothelin-3	NEURON			English	Editorial Material							HIRSCHSPRUNG-DISEASE; ENTERIC NEURONS; B RECEPTOR; EDNRB; RET	Both RET and EDNRB are essential for neural crest development in many parts of the embryo. In this issue of Neuron, two articles by Barlow et al. and Kruger et al. demonstrate that within the developing enteric nervous system these receptors have synergistic, stage-dependent effects on neural crest precursor proliferation and antagonistic effects on cell migration.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Heuckeroth, RO (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Dept Pediat, 660 S Euclid Ave,Box 8208, St Louis, MO 63110 USA.			Heuckeroth, Robert/0000-0002-3282-1765				Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; GERSHON MD, 1995, CURR BIOL, V5, P601, DOI 10.1016/S0960-9822(95)00120-5; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7	10	7	7	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					871	873		10.1016/S0896-6273(03)00763-3	http://dx.doi.org/10.1016/S0896-6273(03)00763-3			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659083	Bronze			2022-12-28	WOS:000187042200001
J	Culham, J				Culham, J			Attention-grabbing motion in the human brain	NEURON			English	Editorial Material							FMRI ACTIVATION; APPARENT MOTION; PERCEPTION	Visual motion signals can be derived either through a lower-order mechanism in which motion detectors register changes in luminance over space and time or through a higher-order mechanism that tracks salient features as they change position. A recent fMRI study by Claeys and colleagues (this issue of Neuron) reports a new area of the human brain that responds to the motion of salient features and to apparent motion.	Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Culham, J (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.		Culham, Jody C./A-9863-2013	Culham, Jody C./0000-0003-0754-2999				ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Claeys KG, 2003, NEURON, V40, P631, DOI 10.1016/S0896-6273(03)00590-7; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Lu ZL, 1999, P NATL ACAD SCI USA, V96, P8289, DOI 10.1073/pnas.96.14.8289; SEIFFERT A, 2003, J VIS, V3, P236; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	10	3	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					451	452		10.1016/S0896-6273(03)00689-5	http://dx.doi.org/10.1016/S0896-6273(03)00689-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642268	Bronze			2022-12-28	WOS:000186379000003
J	McClure, SM; Li, J; Tomlin, D; Cypert, KS; Montague, LM; Montague, PR				McClure, SM; Li, J; Tomlin, D; Cypert, KS; Montague, LM; Montague, PR			Neural correlates of behavioral preference for culturally familiar drinks	NEURON			English	Article							MULTISENSORY INTEGRATION; REWARD VALUE; FMRI; INTENSITY; RESPONSES; ENGAGEMENT; EMOTION; VALENCE; ANXIETY; CORTEX	Coca-Cola(R) (Coke(R)) and Pepsi(R) are nearly identical in chemical composition, yet humans routinely display strong subjective preferences for one or the other. This simple observation raises the important question of how cultural messages combine with content to shape our perceptions; even to the point of modifying behavioral preferences for a primary reward like a sugared drink. We delivered Coke and Pepsi to human subjects in behavioral taste tests and also in passive experiments carried out during functional magnetic resonance imaging (fMRI. Two conditions were examined: (1) anonymous delivery of Coke and Pepsi and (2) brand-cued delivery of Coke and Pepsi. For the anonymous task, we report a consistent neural response in the ventromedial prefrontal cortex that correlated with subjects' behavioral preferences for these beverages. In the brand-cued experiment, brand knowledge for one of the drinks had a dramatic influence on expressed behavioral preferences and on the measured brain responses.	Baylor Coll Med, Dept Neurosci, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Montague, PR (corresponding author), Baylor Coll Med, Dept Neurosci, Menninger Dept Psychiat & Behav Sci, 1 Balyor Plaza, Houston, TX 77030 USA.	read@bcm.tmc.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-11723] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Anderson AK, 2003, NEURON, V39, P581, DOI 10.1016/S0896-6273(03)00504-X; Armony JL, 2001, NEUROREPORT, V12, P3407, DOI 10.1097/00001756-200110290-00051; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Chacko Emme, 2003, N Z Med J, V116, pU649; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Ford ES, 2003, OBES RES, V11, P1223, DOI 10.1038/oby.2003.168; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Iidaka T, 2003, HIPPOCAMPUS, V13, P429, DOI 10.1002/hipo.10059; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Laurienti PJ, 2003, HUM BRAIN MAPP, V19, P213, DOI 10.1002/hbm.10112; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Markowitsch HJ, 2003, CORTEX, V39, P643, DOI 10.1016/S0010-9452(08)70858-X; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McEchron MD, 1999, HIPPOCAMPUS, V9, P385, DOI 10.1002/(SICI)1098-1063(1999)9:4<385::AID-HIPO5>3.0.CO;2-K; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Popkin BM, 2003, OBES RES, V11, P1325, DOI 10.1038/oby.2003.179; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE, 1999, MENT RETARD DEV D R, V5, P72, DOI 10.1002/(SICI)1098-2779(1999)5:1<72::AID-MRDD8>3.3.CO;2-L; Wallace MT, 1997, J NEUROSCI, V17, P2429; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wyatt HR, 2003, PRIMARY CARE, V30, P267, DOI 10.1016/S0095-4543(03)00006-X; Zimmet P, 2003, DIABETES METAB, V29, pS9; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	41	683	716	5	197	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					379	387		10.1016/j.neuron.2004.09.019	http://dx.doi.org/10.1016/j.neuron.2004.09.019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473974	Bronze			2022-12-28	WOS:000224635800018
J	Wiltgen, BJ; Brown, RAM; Talton, LE; Silva, AJ				Wiltgen, BJ; Brown, RAM; Talton, LE; Silva, AJ			New circuits for old memories: The role of the neocortex in consolidation	NEURON			English	Review							MEDIAL TEMPORAL-LOBE; CALMODULIN KINASE-II; TIME-DEPENDENT REORGANIZATION; GRADED RETROGRADE-AMNESIA; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; NMDA RECEPTOR; HIPPOCAMPAL DAMAGE; CONTEXTUAL FEAR	Studies of learning and memory have provided a great deal of evidence implicating hippocampal mechanisms in the initial storage of facts and events. However, until recently, there were few hints as to how and where this information was permanently stored. A recent series of rodent molecular and cellular cognition studies provide compelling evidence for the involvment of specific neocortical regions in the storage of information initially processed in the hippocampus. Areas of the prefrontal cortex, including the anterior cingulate and prelimbic cortices, and the temporal cortex show robust increases in activity specifically following remote memory retrieval. Importantly, damage to or inactivation of these areas produces selective remote memory deficits. Additionally, transgenic studies provide glimpses into the molecular and cellular mechanisms underlying cortical memory consolidation. The studies reviewed here represent the first exciting steps toward the understanding of the molecular, cellular, and systems mechanisms of how the brain stores our oldest and perhaps most defining memories.	Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622, R01AG017499, F32AG023403, R37AG013622, U01AG013622] Funding Source: NIH RePORTER; NIA NIH HHS [AG023403, AG17499, AG13622] Funding Source: Medline; NINDS NIH HHS [NS038480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; AOU SJ, 1992, J NEUROSCI, V12, P560; Barbizet J, 1970, Acta Psychiatr Belg, V70, P157; Bayley PJ, 2003, NEURON, V38, P135, DOI 10.1016/S0896-6273(03)00156-9; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Burnham WH, 1903, AM J PSYCHOL, V14, P382; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Dash PK, 2004, BRAIN RES REV, V45, P30, DOI 10.1016/j.brainresrev.2004.02.001; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Korsakoff SS, 1887, VESTN PSYCHIAT, V4, P2; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayford M, 1997, CURR BIOL, V7, pR580, DOI 10.1016/S0960-9822(06)00287-9; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moyer JR, 1996, J NEUROSCI, V16, P5536; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Ribot T. A., 1882, DIS MEMORY; ROSE FC, 1960, BRAIN, V83, P195, DOI 10.1093/brain/83.2.195; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; Schacter DL, 1998, NEUROBIOL LEARN MEM, V70, P284, DOI 10.1006/nlme.1998.3854; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 2003, J NEUROBIOL, V54, P224, DOI 10.1002/neu.10169; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Sweatt JD, 2001, CURR BIOL, V11, pR391, DOI 10.1016/S0960-9822(01)00216-0; Takehara K, 2003, J NEUROSCI, V23, P9897; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vann SD, 2000, J NEUROSCI, V20, P2711; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wittenberg GM, 2002, HIPPOCAMPUS, V12, P637, DOI 10.1002/hipo.10102; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2; Xiang JZ, 2004, NEURON, V42, P817, DOI 10.1016/j.neuron.2004.05.013; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	86	235	239	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					101	108		10.1016/j.neuron.2004.09.015	http://dx.doi.org/10.1016/j.neuron.2004.09.015			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450163	Bronze			2022-12-28	WOS:000224232600010
J	Lee, SH; Simonetta, A; Sheng, M				Lee, SH; Simonetta, A; Sheng, M			Subunit rules governing the sorting of internalized AMPA receptors in hippocampal neurons	NEURON			English	Article							SYNAPTIC-TRANSMISSION; GLUR1 SUBUNIT; TRAFFICKING; DOMAIN; PHOSPHORYLATION; PLASTICITY; BINDING; LTP; DEGRADATION; REQUIREMENT	Removal of synaptic AMPA receptors is important for synaptic depression. Here, we characterize the roles of individual subunits in the inducible redistribution of AMPA receptors from the cell surface to intracellular compartments in cultured hippocampal neurons. The intracellular accumulation of GluR2 and GluR3 but not GluR1 is enhanced by AMPA, NMDA, or synaptic activity. After AMPA-induced internalization, homomeric GluR2 enters the recycling pathway, but following NMDA, GluR2 is diverted to late endosomes/lysosomes. In contrast, GluR1 remains in the recycling pathway, and GluR3 is targeted to lysosomes regardless of NMDA receptor activation. Interaction with NSF plays a role in regulated lysosomal targeting of GluR2. GluR1/GluR2 heteromeric receptors behave like GluR2 homomers, and endogenous AMPA receptors show differential activity-dependent sorting similar to homomeric GluR2. Thus, GluR2 is a key subunit that controls recycling and degradation of AMPA receptors after internalization.	MIT, RIKEN, Neurosci Res Ctr, Howard Hughes Med Inst,Picower Ctr Learning & Mem, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Sheng, M (corresponding author), MIT, RIKEN, Neurosci Res Ctr, Howard Hughes Med Inst,Picower Ctr Learning & Mem, Cambridge, MA 02139 USA.	msheng@mit.edu	Lee, Sang/R-7518-2019	Sheng, Morgan/0000-0002-8703-5366; Lee, Sang H./0000-0001-5467-0331	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35050] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fu J, 2003, J NEUROSCI, V23, P7592; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HUME IR, 1991, SCIENCE, V52, P81; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Prekeris R, 1999, J NEUROSCI, V19, P10324; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	45	203	220	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					221	236		10.1016/j.neuron.2004.06.015	http://dx.doi.org/10.1016/j.neuron.2004.06.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260958	Bronze			2022-12-28	WOS:000222905400011
J	Freedman, DJ				Freedman, DJ			Posterior parietal cortex: space... and beyond	NEURON			English	Editorial Material							PREFRONTAL CORTEX; SINGLE NEURONS	How do we decide how to react to a stimulus or event? To do so requires recognition of the stimulus itself as well as an appreciation of the context within which that stimulus is encountered. In this issue of Neuron, Stoet and Snyder report that neurons in the parietal cortex of monkeys can carry contextual information related to the rules that are relevant for solving a visual discrimination task.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Freedman, DJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave WAB 222, Boston, MA 02115 USA.							Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Stoet G, 2003, ANIM COGN, V6, P121, DOI 10.1007/s10071-003-0170-2; Stoet G, 2003, NEUROPSYCHOLOGIA, V41, P1357, DOI 10.1016/S0028-3932(03)00048-4; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	11	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					881	883		10.1016/j.neuron.2004.06.010	http://dx.doi.org/10.1016/j.neuron.2004.06.010			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207232	Bronze			2022-12-28	WOS:000222329300003
J	Corneil, BD; Olivier, E; Munoz, DP				Corneil, BD; Olivier, E; Munoz, DP			Visual responses on neck muscles reveal selective gating that prevents express Saccades	NEURON			English	Article							MONKEY SUPERIOR COLLICULUS; EYE-HEAD COORDINATION; UNRESTRAINED GAZE SHIFTS; RHESUS-MONKEY; DISCHARGE CHARACTERISTICS; ELECTRICAL-STIMULATION; QUANTITATIVE-ANALYSIS; NEURONAL-ACTIVITY; FIRING PATTERNS; BURST NEURONS	Express saccades promote the acquisition of visual targets at extremely short reaction times. Because of the head's considerable inertia, it is unknown whether express saccades are accompanied by a parallel command to the head. Here, by recording electromyographic (EMG) activity from monkey neck muscles, we demonstrate that visual target presentation elicits time-locked, lateralized recruitment of neck muscles at extremely short latencies (55-95 ms). Remarkably, such recruitment not only accompanies express saccades, but also precedes nonexpress saccades, occasionally by up to 150 ms. These results demonstrate selective gating of components of descending commands from the superior colliculus to prevent express saccades yet permit recruitment of a head orienting synergy. We conclude that such selective gating aids eye-head coordination by permitting force development at neck muscles while a decision to commit to a gaze shift is being made, optimizing the contribution of the more inertial head to the ensuing gaze shift.	Queens Univ, Dept Physiol, Ctr Neurosci Studies, CIHR Grp Sensory Motor Syst, Kingston, ON K7L 3N6, Canada; Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Catholic Univ Louvain, Sch Med, Neurophysiol Lab, B-1200 Brussels, Belgium	Queens University - Canada; Western University (University of Western Ontario); Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Corneil, BD (corresponding author), Queens Univ, Dept Physiol, Ctr Neurosci Studies, CIHR Grp Sensory Motor Syst, Kingston, ON K7L 3N6, Canada.	bcorneil@uwo.ca	Corneil, Brian D/K-6401-2013	Corneil, Brian D/0000-0002-4702-7089				ANDREDESHAYS C, 1988, EXP BRAIN RES, V69, P399; ANDREDESHAYS C, 1991, EXP BRAIN RES, V84, P359; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BIZZI E, 1972, BRAIN RES, V40, P45, DOI 10.1016/0006-8993(72)90104-7; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; Carpenter RHS, 1988, MOVEMENTS EYES; Corneil BD, 1999, J NEUROPHYSIOL, V82, P1406, DOI 10.1152/jn.1999.82.3.1406; Corneil BD, 2001, J NEUROPHYSIOL, V86, P1729, DOI 10.1152/jn.2001.86.4.1729; Corneil BD, 2002, J NEUROPHYSIOL, V88, P2000, DOI 10.1152/jn.2002.88.4.2000; Corneil BD, 2002, J NEUROPHYSIOL, V88, P1980, DOI 10.1152/jn.2002.88.4.1980; Cullen KE, 2000, J NEUROPHYSIOL, V83, P630, DOI 10.1152/jn.2000.83.1.630; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dorris MC, 1997, J NEUROSCI, V17, P8566; Edelman JA, 1996, J NEUROPHYSIOL, V76, P908, DOI 10.1152/jn.1996.76.2.908; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; FISCHER B, 1983, BRAIN RES, V260, P21, DOI 10.1016/0006-8993(83)90760-6; Freedman EG, 2001, BIOL CYBERN, V84, P453, DOI 10.1007/PL00007989; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; FUCHS AF, 1970, J NEUROPHYSIOL, V33, P382, DOI 10.1152/jn.1970.33.3.382; FUCHS AF, 1988, J NEUROPHYSIOL, V60, P1874, DOI 10.1152/jn.1988.60.6.1874; GALIANA HL, 1992, ANN NY ACAD SCI, V656, P452; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Goldberg SJ, 1998, J NEUROSCI, V18, P10629; Goossens HHLM, 1997, EXP BRAIN RES, V114, P542, DOI 10.1007/PL00005663; GRANTYN A, 1989, PROG BRAIN RES, V80, P159; Gribble PL, 2002, EXP BRAIN RES, V145, P372, DOI 10.1007/s00221-002-1122-9; GUITTON D, 1991, J NEUROPHYSIOL, V66, P1605, DOI 10.1152/jn.1991.66.5.1605; GUITTON D, 1990, J NEUROPHYSIOL, V64, P509, DOI 10.1152/jn.1990.64.2.509; Herst AN, 2001, VISION RES, V41, P3307, DOI 10.1016/S0042-6989(01)00158-4; INGLE D, 1973, BRAIN BEHAV EVOLUT, V8, P211, DOI 10.1159/000124355; ISA T, 1995, J NEUROPHYSIOL, V74, P73, DOI 10.1152/jn.1995.74.1.73; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Ling L, 1999, J NEUROPHYSIOL, V82, P2808, DOI 10.1152/jn.1999.82.5.2808; Luce R.D., 1991, RESPONSE TIMES THEIR; MCPEEK RM, 1994, VISION RES, V34, P2293, DOI 10.1016/0042-6989(94)90108-2; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Pelisson D, 2001, VISION RES, V41, P3283, DOI 10.1016/S0042-6989(01)00224-3; Peterson B.W., 1988, CONTROL HEAD MOVEMEN; PHILLIPS JO, 1995, J NEUROPHYSIOL, V73, P1632, DOI 10.1152/jn.1995.73.4.1632; Richmond FJR, 2001, J NEUROPHYSIOL, V86, P1717, DOI 10.1152/jn.2001.86.4.1717; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; Roy JE, 1998, NAT NEUROSCI, V1, P404, DOI 10.1038/1619; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; SCHILLER PH, 1970, EXP BRAIN RES, V10, P347, DOI 10.1007/BF02324764; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; SEGRAVES MA, 1992, HEAD NECK SENSORY MO, P292; Siegmund GP, 2001, J PHYSIOL-LONDON, V535, P289, DOI 10.1111/j.1469-7793.2001.00289.x; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; SPARKS DL, 1989, REV OCULOMOTOR RES N, P213; Sylvestre PA, 1999, J NEUROPHYSIOL, V82, P2612, DOI 10.1152/jn.1999.82.5.2612; USUI S, 1982, IEEE T BIO-MED ENG, V29, P686, DOI 10.1109/TBME.1982.324861; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; Vidal, 1992, HEAD NECK SENSORY MO, P101; ZANGEMEISTER WH, 1982, EXP NEUROL, V77, P563, DOI 10.1016/0014-4886(82)90228-X	62	79	79	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 10	2004	42	5					831	841		10.1016/S0896-6273(04)00267-3	http://dx.doi.org/10.1016/S0896-6273(04)00267-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	828LO	15182721	Bronze			2022-12-28	WOS:000221975000013
J	Krolak-Salmon, P; Henaff, MA; Vighetto, A; Bertrand, O; Mauguiere, F				Krolak-Salmon, P; Henaff, MA; Vighetto, A; Bertrand, O; Mauguiere, F			Early amygdala reaction to fear spreading in occipital, temporal, and frontal cortex: A depth electrode ERP study in human	NEURON			English	Article							EMOTIONAL FACIAL EXPRESSIONS; HUMAN EXTRASTRIATE CORTEX; EVENT-RELATED FMRI; FACE PERCEPTION; VISUAL-CORTEX; CONDITIONED FEAR; FRONTOTEMPORAL DEMENTIA; AFFECT RECOGNITION; PREFRONTAL CORTEX; NEURAL RESPONSE	The amygdala involvement in fear processing has been reported in behavioral, electrophysiological, and functional imaging studies. However, the literature does not provide precise data on the temporal course of facial emotional processing. Intracranial event-related potentials to facial expressions were recorded in epileptic patients implanted with depth electrodes during a presurgical evaluation. Specific potentials to fear beginning 200 ms poststimulus were observed in amygdala, both individually in two patients and in a ten patient population study. These potentials occurred 100 ms earlier than potentials to disgust recorded in insula in a previous study. Potentials to fear were confined in amygdala during a first transient period and then, during a second period of sustained activity, spread to occipito-temporal, anterior temporal, and orbitofrontal cortex in two patients. This study clarifies the temporal course of the involvement of these structures known to be part of a neural network recruited to process emotional information.	Hop Neurol, F-69003 Lyon, France; INSERM, Unite 280, F-69424 Lyon 04, France; Univ Lyon 1, Federat Neurosci Inst, F-69003 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Krolak-Salmon, P (corresponding author), Hop Neurol, F-69003 Lyon, France.	pierre.krolak-salmon@chu-lyon.fr	krolak-salmon, pierre/AAV-2152-2020; Bertrand, Olivier/B-6165-2008; anand, amit/A-7222-2009	Bertrand, Olivier/0000-0003-0733-7979; MAUGUIERE, Francois/0000-0003-4291-4727				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anderson AK, 2003, J NEUROSCI, V23, P5627; ARMONY JL, 1995, BEHAV NEUROSCI, V109, P246, DOI 10.1037/0735-7044.109.2.246; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BUCHANAN L, 1998, INC, V20, P9; Cain ME, 2002, J NEUROSCI, V22, P11026; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Canli T, 2000, J NEUROSCI, V20; CARRETIE L, 1995, INT J PSYCHOPHYSIOL, V19, P183, DOI 10.1016/0167-8760(95)00004-C; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Damasio A.R., 2003, LOOKING SPINOZA JOY; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman P., 1976, PICTURES FACIAL AFFE; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Grossman M, 2001, NEUROLOGY, V57, P1947, DOI 10.1212/WNL.57.11.1947; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HITCHCOCK JM, 1991, BEHAV NEUROSCI, V105, P826, DOI 10.1037/0735-7044.105.6.826; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; Ioannides AA, 2000, HUM BRAIN MAPP, V11, P77, DOI 10.1002/1097-0193(200010)11:2<77::AID-HBM20>3.0.CO;2-0; Kajiwara R, 2003, J NEUROPHYSIOL, V89, P2176, DOI 10.1152/jn.01033.2002; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Krolak-Salmon P, 2003, ANN NEUROL, V53, P73, DOI 10.1002/ana.10403; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lange K, 2003, BIOL PSYCHIAT, V53, P226, DOI 10.1016/S0006-3223(02)01455-5; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Meletti S, 2003, NEUROLOGY, V60, P426, DOI 10.1212/WNL.60.3.426; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Silver H, 2002, SCHIZOPHR RES, V55, P171, DOI 10.1016/S0920-9964(01)00208-0; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Streit M, 2001, AM J PSYCHIAT, V158, P1429, DOI 10.1176/appi.ajp.158.9.1429; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Talairach J., 1973, PROGR NEUROL SURG, V5, P297, DOI [DOI 10.1159/000394343, 10.1159/000394343]; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	71	224	228	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					665	676		10.1016/S0896-6273(04)00264-8	http://dx.doi.org/10.1016/S0896-6273(04)00264-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157426	Bronze			2022-12-28	WOS:000221708300015
J	Ibanez, CF				Ibanez, CF			Lipid rafts as organizing platforms for cell chemotaxis and axon guidance	NEURON			English	Editorial Material							GANGLIOSIDE	Lipid rafts are thought to serve as plasma membrane platforms for localized trafficking and signaling. Recent findings reported by Guirland et al. in this issue of Neuron and by Gomez-Mouton in a recent issue of JCB support a direct role of lipid microdomains in organizing spatial signaling during axon guidance and cell chemotaxis by concentrating the gradient-sensing machinery at the leading edge.	Karolinska Inst, Div Mol Neurobiol, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Neurosci, S-17177 Stockholm, Sweden.							FERRARI G, 1995, J BIOL CHEM, V270, P3074, DOI 10.1074/jbc.270.7.3074; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Pitto M, 1998, FEBS LETT, V439, P93, DOI 10.1016/S0014-5793(98)01344-1; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680	12	11	11	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					3	5		10.1016/S0896-6273(04)00194-1	http://dx.doi.org/10.1016/S0896-6273(04)00194-1			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066259	Bronze			2022-12-28	WOS:000221458400002
J	van den Maagdenberg, AMJM; Pietrobon, D; Pizzorusso, T; Kaja, S; Broos, LAM; Cesetti, T; van de Ven, RCG; Tottene, A; van der Kaa, J; Plomp, JJ; Frants, RR; Ferrari, MD				van den Maagdenberg, AMJM; Pietrobon, D; Pizzorusso, T; Kaja, S; Broos, LAM; Cesetti, T; van de Ven, RCG; Tottene, A; van der Kaa, J; Plomp, JJ; Frants, RR; Ferrari, MD			A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; CALCIUM-CHANNEL; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; ABSENCE EPILEPSY; CENTRAL SYNAPSE; MUTANT MICE; MUTATIONS; SUBUNIT; AURA	Migraine is a common, disabling, multifactorial, episodic neurovascular disorder of unknown etiology. Familial hemiplegic migraine type 1 (FHM-1) is a Mendelian subtype of migraine with aura that is caused by missense mutations in the CACNA1A gene that encodes the alpha(1) subunit of neuronal Ca(v)2.1 Ca2+ channels. We generated a knockin mouse model carrying the human pure FHM-1 R192Q mutation and found multiple gain-of-function effects. These include increased Ca(v)2.1 current density in cerebellar neurons, enhanced neurotransmission at the neuromuscular junction, and, in the intact animal, a reduced threshold and increased velocity of cortical spreading depression (CSD; the likely mechanism for the migraine aura). Our data show that the increased susceptibility for CSD and aura in migraine may be due to cortical hyperexcitability. The R192Q FHM-1 mouse is a promising animal model to study migraine mechanisms and treatments.	Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2333 AL Leiden, Netherlands; Univ Padua, Dept Biomed Sci, CNR, Inst Neurosci, I-35121 Padua, Italy; CNR, Inst Neurosci, Scuola Normale Super, I-56100 Pisa, Italy; Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Maagdenberg, AMJM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Wssenaarseweg 72, NL-2333 AL Leiden, Netherlands.	maagdenberg@lumc.nl; dani@civ.bio.unipd.it	Kaja, Simon/C-2267-2015; Ferrari, Michel D./ABE-3758-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Pizzorusso, Tommaso/D-1399-2013	Kaja, Simon/0000-0001-6878-521X; Ferrari, Michel D./0000-0001-9691-9449; Pizzorusso, Tommaso/0000-0001-5614-0668	Telethon [E.1297, E.0847] Funding Source: Medline	Telethon(Fondazione Telethon)		Ayata C, 2000, NEUROSCIENCE, V95, P639; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Cutrer FM, 1998, ANN NEUROL, V43, P25, DOI 10.1002/ana.410430108; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dove LS, 1998, J NEUROSCI, V18, P7687; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1999, HUM MOL GENET, V8, P1907, DOI 10.1093/hmg/8.10.1907; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Goadsby PJ, 2001, ANN NEUROL, V49, P4, DOI 10.1002/1531-8249(200101)49:1<4::AID-ANA3>3.0.CO;2-W; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hans M, 1999, J NEUROSCI, V19, P1610; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hong KW, 1999, J CEREBR BLOOD F MET, V19, P53, DOI 10.1097/00004647-199901000-00006; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Knight YE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0002.2002; Kors EE, 2002, CURR OPIN NEUROL, V15, P311, DOI 10.1097/00019052-200206000-00014; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Pineda JC, 1998, J NEUROPHYSIOL, V79, P2522, DOI 10.1152/jn.1998.79.5.2522; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Timmermann DB, 2002, J NEUROSCI RES, V67, P48, DOI 10.1002/jnr.10074; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	45	468	473	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					701	710		10.1016/S0896-6273(04)00085-6	http://dx.doi.org/10.1016/S0896-6273(04)00085-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003170	Bronze			2022-12-28	WOS:000221458200006
J	Tsvetkov, E; Shin, RM; Bolshakov, VY				Tsvetkov, E; Shin, RM; Bolshakov, VY			Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning	NEURON			English	Article							LATERAL AMYGDALA; SYNAPTIC TRANSMISSION; PYRAMIDAL NEURONS; FIBER SYNAPSES; NMDA RECEPTORS; PARALLEL FIBER; LTP; MEMORY; SPILLOVER; RELEASE	Long-term synaptic modifications in afferent inputs to the amygdala underlie fear conditioning in animals. Fear conditioning to a single sensory modality does not generalize to other cues, implying that synaptic modifications in fear conditioning pathways are input specific. The mechanisms of pathway specificity of long-term potentiation (LTP) are poorly understood. Here we show that inhibition of glutamate transporters leads to the loss of input specificity of LTP in the amygdala slices, as assessed by monitoring synaptic responses at two independent inputs converging on a single postsynaptic neuron. Diffusion of glutamate ("spillover") from stimulated synapses, paired with postsynaptic depolarization, is sufficient to induce LTP in the heterosynaptic pathway, whereas an enzymatic glutamate scavenger abolishes this effect. These results establish active glutamate uptake as a crucial mechanism maintaining the pathway specificity of LTP in the neural circuitry of fear conditioning.	Harvard Univ, Sch Med, Dept Psychiat, McLean Hosp, Belmont, MA 02478 USA	Harvard University; McLean Hospital	Bolshakov, VY (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu	Tsvetkov, Evgeny/C-1085-2016; Tsvetkov, Evgeny A/B-6573-2016	Tsvetkov, Evgeny/0000-0001-9339-1677; Tsvetkov, Evgeny A/0000-0002-6784-0907	NIDA NIH HHS [DA15098] Funding Source: Medline; NINDS NIH HHS [NS44185] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; KAPP B S, 1992, P229; Kapp BS, 1984, NEUROPSYCHOLOGY MEMO, P473; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levenson J, 2000, P NATL ACAD SCI USA, V97, P12858, DOI 10.1073/pnas.220256497; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Levenson Jonathan M., 2002, Current Molecular Medicine (Hilversum), V2, P593, DOI 10.2174/1566524023362069; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ng KT, 1997, NEUROSCI BIOBEHAV R, V21, P45, DOI 10.1016/0149-7634(95)00079-8; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rusakov DA, 2002, TRENDS NEUROSCI, V25, P492, DOI 10.1016/S0166-2236(02)02230-0; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930	54	95	95	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					139	151		10.1016/S0896-6273(03)00800-6	http://dx.doi.org/10.1016/S0896-6273(03)00800-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715141	Bronze			2022-12-28	WOS:000187942800015
J	Brionne, TC; Tesseur, I; Masliah, E; Wyss-Coray, T				Brionne, TC; Tesseur, I; Masliah, E; Wyss-Coray, T			Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain	NEURON			English	Article							GROWTH-FACTOR-BETA; MIDBRAIN DOPAMINERGIC-NEURONS; BONE MORPHOGENETIC PROTEINS; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; APOPTOTIC CELLS; TRANSGENIC MICE; EXTRACELLULAR-MATRIX; TARGETED DISRUPTION	TGF-beta1 is a key regulator of diverse biological processes in many tissues and cell types, but its exact function in the developing and adult mammalian CNS is still unknown. We report that lack of TGF-beta1 expression in neonatal Tgfb1(-/-) mice results in a widespread increase in degenerating neurons accompanied by reduced expression of synaptophysin and laminin and a prominent microgliosis. Lack of TGF-beta1 also strongly reduces survival of primary neurons cultured from Tgfb1(-/-) mice. TGF-beta1 deficiency in adult Tgfb1(-/+) mice results in increased neuronal susceptibility to excitotoxic injury, whereas astroglial overexpression of TGF-beta1 protects adult mice against neurodegeneration in acute, excitotoxic and chronic injury paradigms. This study reveals a nonredundant function for TGF-beta1 in maintaining neuronal integrity and survival of CNS neurons and in regulating microglial activation. Because individual TGF-beta1 expression levels in the brain vary considerably between humans, this finding could have important implications for susceptibility to neurodegeneration.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; GRECC, VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831	NIA NIH HHS [AG15871, AG5131, AG18440] Funding Source: Medline; NINDS NIH HHS [NS40994] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R37AG018440, R01AG015871, R01AG018440] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcantara S, 1997, J NEUROSCI, V17, P3623; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Buttini M, 1999, J NEUROSCI, V19, P4867; Chagraoui H, 2001, EUR CYTOKINE NETW, V12, P561; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chin J, 2002, J NEUROSCI, V22; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; Dunker N, 2001, DEVELOPMENT, V128, P1933; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Farkas LM, 2003, J NEUROSCI, V23, P5178; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; GEISER AG, 1993, P NATL ACAD SCI USA, V90, P9944, DOI 10.1073/pnas.90.21.9944; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hecker KH, 1996, BIOTECHNIQUES, V20, P478; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Indyk JA, 2003, NEUROSCIENCE, V116, P359, DOI 10.1016/S0306-4522(02)00704-2; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Krieglstein K, 1998, EUR J NEUROSCI, V10, P2746, DOI 10.1046/j.1460-9568.1998.00324.x; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Letterio JJ, 2000, CYTOKINE GROWTH F R, V11, P81, DOI 10.1016/S1359-6101(99)00031-3; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409; Longenecker G, 2002, CYTOKINE, V18, P43, DOI 10.1006/cyto.2002.1025; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; MASLIAH E, 1992, LAB INVEST, V66, P285; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MCCARTNEYFRANCIS NL, 1994, J LEUKOCYTE BIOL, V55, P401, DOI 10.1002/jlb.55.3.401; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schober A, 1999, J NEUROSCI, V19, P2008; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tesseur I, 2000, AM J PATHOL, V157, P1495, DOI 10.1016/S0002-9440(10)64788-8; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Unsicker K, 2002, ADV EXP MED BIOL, V513, P353; Unsicker K, 2000, CYTOKINE GROWTH F R, V11, P97, DOI 10.1016/S1359-6101(99)00033-7; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; WYSSCORAY T, 1995, AM J PATHOL, V147, P53; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	67	269	283	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1133	1145		10.1016/S0896-6273(03)00766-9	http://dx.doi.org/10.1016/S0896-6273(03)00766-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687548	Bronze			2022-12-28	WOS:000187503400012
J	Molko, N; Cachia, A; Riviere, D; Mangin, JF; Bruandet, M; Le Bihan, D; Cohen, L; Dehaene, S				Molko, N; Cachia, A; Riviere, D; Mangin, JF; Bruandet, M; Le Bihan, D; Cohen, L; Dehaene, S			Functional and structural alterations of the intraparietal sulcus in a developmental dyscalculia of genetic origin	NEURON			English	Article							VOXEL-BASED MORPHOMETRY; FRAGILE-X-SYNDROME; TURNERS-SYNDROME; HUMAN-BRAIN; WHITE-MATTER; LANGUAGE; REPRESENTATION; NUMBERS; CORTEX; ABNORMALITIES	Cognitive theories of numerical representation suggest that understanding of numerical quantities is driven by a magnitude representation associated with the intraparietal sulcus and possibly under genetic control. The aim of this study was to investigate, using fMRI and structural imaging, the interaction between the abnormal development of numerical representation in an X-linked condition, Turner syndrome (TS), and the development of the intraparietal sulcus. fMRI during exact and approximate calculation in TS showed an abnormal modulation of intraparietal activations as a function of number size. Morphological analysis revealed an abnormal length, depth, and sulcal geometry of the right intraparietal sulcus, suggesting an important disorganization of this region in TS. Thus, a genetic form of developmental dyscalculia can be related to both functional and structural anomalies of the right intraparietal sulcus, suggesting a crucial role of this region in the development of arithmetic abilities.	Hop La Pitie Salpetriere, INSERM, U562, Paris, France; Hop La Pitie Salpetriere, Unite Neuroactivat Fonctionnelle, Paris, France; INSERM, ERM 0205, Serv Hosp Freder Joliot, CEA DSV,IFR 49, Orsay, France; Hop La Pitie Salpetriere, Serv Neurol 1, IFR 49, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Molko, N (corresponding author), Hop La Pitie Salpetriere, INSERM, U562, Paris, France.	molko@wanadoo.fr	Mangin, Jean-Francois/AAI-8983-2020	cohen, laurent/0000-0002-5010-9085; Cachia, Arnaud/0000-0003-2125-4985				ALEXANDER D, 1966, NEUROPSYCHOLOGIA, V4, P265, DOI 10.1016/0028-3932(66)90032-7; ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barnea-Goraly N, 2003, AM J MED GENET B, V118B, P81, DOI 10.1002/ajmg.b.10035; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brown WE, 2002, PSYCHIAT RES-NEUROIM, V116, P187, DOI 10.1016/S0925-4927(02)00086-0; BRUANDET M, 2003, IN PRESS NEUROPSYCHO; Cappelletti M, 2001, NEUROPSYCHOLOGIA, V39, P1224, DOI 10.1016/S0028-3932(01)00035-5; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; CLARK C, 1990, CAN J NEUROL SCI, V17, P140, DOI 10.1017/S0317167100030341; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; DEHAENE S, 2003, IN PRESS COGN NEUROP; Dehaene S., 1995, MATH COGNITION, P83, DOI DOI 10.1155/2014/461647; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Eliez S, 2001, ARCH GEN PSYCHIAT, V58, P64, DOI 10.1001/archpsyc.58.1.64; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fryer SL, 2003, DEV MED CHILD NEUROL, V45, P320, DOI 10.1017/S0012162203000604; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; JACKSON M, 1986, CORTEX, V22, P611, DOI 10.1016/S0010-9452(86)80020-X; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; KOSC L, 1974, J LEARN DISABIL, V7, P164, DOI 10.1177/002221947400700309; Langdon D W, 1997, J Int Neuropsychol Soc, V3, P260; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Levy LM, 1999, NEUROLOGY, V53, P639, DOI 10.1212/WNL.53.3.639; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; MURPHY DGM, 1993, LANCET, V342, P1197, DOI 10.1016/0140-6736(93)92184-U; Murphy DGM, 1997, BIOL PSYCHIAT, V41, P285, DOI 10.1016/S0006-3223(95)00660-5; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; PIAZZA M, 2002, QUANTIFYING BRAIN FU; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Reiss AL, 2000, MENT RETARD DEV D R, V6, P186, DOI 10.1002/1098-2779(2000)6:3<186::AID-MRDD6>3.0.CO;2-9; REISS AL, 1995, ANN NEUROL, V38, P731, DOI 10.1002/ana.410380507; Rivera SM, 2002, HUM BRAIN MAPP, V16, P206, DOI 10.1002/hbm.10048; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Ross J, 2000, MENT RETARD DEV D R, V6, P135, DOI 10.1002/1098-2779(2000)6:2<135::AID-MRDD8>3.0.CO;2-K; ROVET J, 1994, J CLIN EXP NEUROPSYC, V16, P820, DOI 10.1080/01688639408402696; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Temple CM, 1998, DEV NEUROPSYCHOL, V14, P47, DOI 10.1080/87565649809540700; Temple CM, 2002, Q J EXP PSYCHOL-A, V55, P733, DOI 10.1080/02724980143000550; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	60	262	269	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					847	858		10.1016/S0896-6273(03)00670-6	http://dx.doi.org/10.1016/S0896-6273(03)00670-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	744UL	14622587	Bronze, Green Published			2022-12-28	WOS:000186651200018
J	Coesmans, M; Weber, JT; De Zeeuw, CI; Hansel, C				Coesmans, M; Weber, JT; De Zeeuw, CI; Hansel, C			Bidirectional parallel fiber plasticity in the cerebellum under climbing fiber control	NEURON			English	Article							LONG-TERM DEPRESSION; PURKINJE-CELL; CALCIUM TRANSIENTS; SYNAPTIC PLASTICITY; POSTSYNAPTIC CA2+; ACTION-POTENTIALS; NITRIC-OXIDE; LTD; INDUCTION; COINCIDENCE	Cerebellar parallel fiber (PF)-Purkinje cell (PC) synapses can undergo postsynaptically expressed long-term depression (LTD) or long-term potentiation (LTP) depending on whether or not the climbing fiber (CF) input is coactivated during tetanization. Here, we show that modifications of the postsynaptic calcium load using the calcium chelator BAPTA or photolytic calcium uncaging result in a reversal of the expected polarity of synaptic gain change. At higher concentrations, BAPTA blocks PF-LTP. These data indicate that PF-LTD requires a higher calcium threshold amplitude than PF-LTP induction and suggest that CF activity acts as a polarity switch by providing dendritic calcium transients. Moreover, previous CF-LTD induction changes the relative PF-LTD versus -LTP induction probability. These findings suggest that bidirectional cerebellar learning is governed by a calcium threshold rule operating "inverse" to the mechanism previously described at other glutamatergic synapses (BCM rule) and that the LTD/LTP induction probability is under heterosynaptic climbing fiber control.	Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hansel, C (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.	c.hansel@erasmusmc.nl						Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bear MF, 2001, SYNAPSES, P455; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Chen CF, 1997, J NEUROSCI, V17, P8687; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Connor JA, 1999, CAN J PHYSIOL PHARM, V77, P722, DOI 10.1139/cjpp-77-9-722; Cormier RJ, 2001, J NEUROPHYSIOL, V85, P399, DOI 10.1152/jn.2001.85.1.399; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hartell Nicholas A, 2002, Cerebellum, V1, P3, DOI 10.1080/147342202753203041; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Launey T, 2004, P NATL ACAD SCI USA, V101, P676, DOI 10.1073/pnas.0302914101; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ohyama T, 2002, ANN NY ACAD SCI, V978, P425, DOI 10.1111/j.1749-6632.2002.tb07585.x; Reynolds T, 2000, J PHYSIOL-LONDON, V527, P563, DOI 10.1111/j.1469-7793.2000.00563.x; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Shen Y, 2002, NAT NEUROSCI, V5, P725, DOI 10.1038/nn895; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Weber JT, 2003, P NATL ACAD SCI USA, V100, P2878, DOI 10.1073/pnas.0536420100; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	70	286	289	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 18	2004	44	4					691	700		10.1016/j.neuron.2004.10.031	http://dx.doi.org/10.1016/j.neuron.2004.10.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874GE	15541316	Bronze			2022-12-28	WOS:000225338100014
J	Shah, MM; Anderson, AE; Leung, V; Lin, XD; Johnston, D				Shah, MM; Anderson, AE; Leung, V; Lin, XD; Johnston, D			Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons	NEURON			English	Article							TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL GENE-EXPRESSION; CURRENT-SOURCE-DENSITY; SYNAPTIC-TRANSMISSION; DENTATE GYRUS; IN-VITRO; DENDRITIC I(H); CA1; CORTEX; RAT	The entorhinal cortex (EC) provides the predominant excitatory drive to the hippocampal CA1 and subicular neurons in chronic epilepsy. Discerning the mechanisms underlying signal integration within EC neurons is essential for understanding network excitability alterations involving the hippocampus during epilepsy. Twenty-four hours following a single seizure episode when there were no behavioral or electrographic seizures, we found enhanced spontaneous activity still present in the rat EC in vivo and in vitro. The increased excitability was accompanied by a profound reduction in I-h in EC layer III neurons and a significant decline in HCN1 and HCN2 subunits that encode for h channels. Consequently, dendritic excitability was enhanced, resulting in increased neuronal firing despite hyperpolarized membrane potentials. The loss Of Ih and the increased neuronal excitability persisted for 1 week following seizures. Our results suggest that dendritic I-h plays an important role in determining the excitability of EC layer III neurons and their associated neural networks.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	djohnston@mail.ns.utexas.edu		Shah, Mala/0000-0002-8323-4739	Wellcome Trust [063247] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson AE, 1997, EPILEPSY RES, V26, P433, DOI 10.1016/S0920-1211(96)01010-8; Anderson AE, 1999, NEUROSCIENCE, V92, P73, DOI 10.1016/S0306-4522(98)00746-5; Arzimanoglou A, 2002, EPILEPTIC DISORD, V4, P173; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Barbarosie M, 2000, J NEUROPHYSIOL, V83, P1115, DOI 10.1152/jn.2000.83.3.1115; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Becker AJ, 2003, EUR J NEUROSCI, V18, P2792, DOI 10.1111/j.1460-9568.2003.02993.x; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Ben-Ari Y, 2001, EPILEPSIA, V42, P5, DOI 10.1046/j.1528-1157.2001.042suppl.3005.x; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Dickson CT, 1997, NEUROSCIENCE, V81, P937, DOI 10.1016/S0306-4522(97)00263-7; DOLLER HJ, 1982, BRAIN RES, V237, P1, DOI 10.1016/0006-8993(82)90553-4; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; DU F, 1995, J NEUROSCI, V15, P6301; Dudek FE, 2002, PROG BRAIN RES, V135, P53; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Fountain NB, 1998, J NEUROPHYSIOL, V80, P230, DOI 10.1152/jn.1998.80.1.230; Gloveli T, 1997, NEUROSCIENCE, V77, P629, DOI 10.1016/S0306-4522(96)00494-0; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Jung HY, 2001, J NEUROSCI, V21, P3312, DOI 10.1523/JNEUROSCI.21-10-03312.2001; Klar M, 2003, N-S ARCH PHARMACOL, V367, P422, DOI 10.1007/s00210-003-0707-6; Kobayashi M, 2003, J NEUROSCI, V23, P8471; LEUNG LS, 1995, J NEUROPHYSIOL, V73, P2392, DOI 10.1152/jn.1995.73.6.2392; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGEE JC, 2000, DENDRITES; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; van der Linden S, 1998, EUR J NEUROSCI, V10, P1479, DOI 10.1046/j.1460-9568.1998.00162.x; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Varga AW, 2000, LEARN MEMORY, V7, P321, DOI 10.1101/lm.35300; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; White HS, 2002, NEUROLOGY, V59, pS7, DOI 10.1212/WNL.59.9_suppl_5.S7; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wu K, 2003, NEUROSCIENCE, V116, P599, DOI 10.1016/S0306-4522(02)00567-5; YECKEL MF, 1995, HIPPOCAMPUS, V5, P108, DOI 10.1002/hipo.450050204	54	231	239	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					495	508		10.1016/j.neuron.2004.10.011	http://dx.doi.org/10.1016/j.neuron.2004.10.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504329	Bronze, Green Accepted			2022-12-28	WOS:000224771700011
J	Dan, Y; Poo, MM				Dan, Y; Poo, MM			Spike timing-dependent plasticity of neural circuits	NEURON			English	Review							LONG-TERM POTENTIATION; PRESYNAPTIC NEURONAL EXCITABILITY; RAT HIPPOCAMPAL SLICE; E-S COMPONENT; SYNAPTIC PLASTICITY; INTRINSIC EXCITABILITY; NMDA RECEPTORS; CA1 REGION; POSTSYNAPTIC ACTIVITY; SENSORY DEPRIVATION	Recent findings of spike timing-dependent plasticity (STDP) have stimulated much interest among experimentalists and theorists. Beyond the traditional correlation-based Hebbian plasticity, STDP opens up new avenues for understanding information coding and circuit plasticity that depend on the precise timing of neuronal spikes. Here we summarize experimental characterization of STDP at various synapses, the underlying cellular mechanisms, and the associated changes in neuronal excitability and dendritic integration. We also describe STDP in the context of complex spike patterns and its dependence on the dendritic location of the synapse. Finally, we discuss timing-dependent modification of neuronal receptive fields and human visual perception and the computational significance of STDP as a synaptic learning rule.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu; mpoo@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY014887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER; NEI NIH HHS [EY014887] Funding Source: Medline; NINDS NIH HHS [NS 36999] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; ANDERSEN P, 1980, J PHYSL, V2, P463; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; ASZTELY F, 1994, HIPPOCAMPUS, V4, P148, DOI 10.1002/hipo.450040205; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bernard C, 2003, J NEUROPHYSIOL, V90, P1807, DOI 10.1152/jn.00286.2003; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Boettiger CA, 2001, NEURON, V31, P809, DOI 10.1016/S0896-6273(01)00403-2; Buchs NJ, 2002, J COMPUT NEUROSCI, V13, P167, DOI 10.1023/A:1020210230751; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; FROEMKE RC, 2003, SOC NEUR 33 ANN M NE; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kempter R, 2001, P NATL ACAD SCI USA, V98, P4166, DOI 10.1073/pnas.061369698; Kepecs A, 2002, BIOL CYBERN, V87, P446, DOI 10.1007/s00422-002-0358-6; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li CY, 2004, NEURON, V41, P257, DOI 10.1016/S0896-6273(03)00847-X; Lin YW, 2003, J NEUROSCI, V23, P4173; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2001, SYNAPSES, P393; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mel BW, 1998, J NEUROSCI, V18, P4325; MELIZA CD, 2004, SOC NEUR 34 ANN M SA; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; MILLER KD, 1994, PROG BRAIN RES, V102, P303; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Moyer JR, 1996, J NEUROSCI, V16, P5536; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nowotny T, 2003, J NEUROSCI, V23, P9776; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; PUGLIESE AM, 1994, NEUROSCIENCE, V62, P1021, DOI 10.1016/0306-4522(94)90340-9; RAO RPM, 2000, PEDICTIVE SEQUENCE L; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Suri RE, 2002, BIOL CYBERN, V87, P440, DOI 10.1007/s00422-002-0355-9; TOMASULO RA, 1993, J NEUROPHYSIOL, V69, P165, DOI 10.1152/jn.1993.69.1.165; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	96	655	683	6	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					23	30		10.1016/j.neuron.2004.09.007	http://dx.doi.org/10.1016/j.neuron.2004.09.007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450157	Bronze			2022-12-28	WOS:000224232600004
J	Malenka, RC; Bear, MF				Malenka, RC; Bear, MF			LTP and LTD: An embarrassment of riches	NEURON			English	Review							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; MOSSY FIBER SYNAPSES; PROTEIN-KINASE-C; VENTRAL TEGMENTAL AREA; POTENTIATED SYNAPTIC RESPONSES; ACTIVITY-DEPENDENT REGULATION; COCAINE-INDUCED POTENTIATION; HIPPOCAMPAL CA1 REGION; GLUTAMATE RECEPTORS	LTP and LTD, the long-term potentiation and depression of excitatory synaptic transmission, are widespread phenomena expressed at possibly every excitatory synapse in the mammalian brain. It is now clear that "LTP" and "LTD" are not unitary phenomena. Their mechanisms vary depending on the synapses and circuits in which they operate. Here we review those forms of LTP and LTD for which mechanisms have been most firmly established. Examples are provided that show how these mechanisms can contribute to experience-dependent modifications of brain function.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Stanford University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Bear, Mark/0000-0002-9903-2541				Abraham WC, 2003, NEUROSCIENTIST, V9, P463, DOI 10.1177/1073858403259119; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; AEL DE, 2002, CELL, V108, P849; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1990, J NEUROSCI, V10, P909; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown GP, 2000, J NEUROSCI, V20, P7880; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Calixto E, 2003, J NEUROSCI, V23, P4842; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; Choi KH, 2003, ANN NY ACAD SCI, V1003, P372, DOI 10.1196/annals.1300.029; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; Doherty AJ, 2000, BRIT J PHARMACOL, V131, P239, DOI 10.1038/sj.bjp.0703574; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Endo S, 2003, NEUROPHARMACOLOGY, V45, P863, DOI 10.1016/S0028-3908(03)00210-7; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Faas GC, 2002, J NEUROSCI, V22, P6885; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Feinmark SJ, 2003, J NEUROSCI, V23, P11427; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; GEAN PW, 1993, NEUROSCI LETT, V158, P170, DOI 10.1016/0304-3940(93)90256-K; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hendricson AW, 2002, J PHARMACOL EXP THER, V301, P938, DOI 10.1124/jpet.301.3.938; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hrabetova S, 2001, MOL BRAIN RES, V95, P146, DOI 10.1016/S0169-328X(01)00185-1; Hrabetova S, 1996, J NEUROSCI, V16, P5324; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kamal A, 1999, EUR J NEUROSCI, V11, P3512, DOI 10.1046/j.1460-9568.1999.00769.x; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kamiya H, 2002, J NEUROSCI, V22, P10524; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; Kawamura Y, 2004, EUR J NEUROSCI, V19, P1591, DOI 10.1111/j.1460-9568.2004.03258.x; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kemp N, 1997, NEUROPHARMACOLOGY, V36, P397, DOI 10.1016/S0028-3908(96)90015-5; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim CH, 1999, J NEUROSCI, V19, P4314; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lauri SE, 2003, NEURON, V39, P327, DOI 10.1016/S0896-6273(03)00369-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Li R, 2004, NEUROSCI LETT, V357, P87, DOI 10.1016/j.neulet.2003.11.004; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; Mockett B, 2002, EUR J NEUROSCI, V15, P1819, DOI 10.1046/j.1460-9568.2002.02008.x; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakano M, 2004, EUR J NEUROSCI, V19, P2881, DOI 10.1111/j.0953-816X.2004.03390.x; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neves SR, 2002, BIOESSAYS, V24, P1110, DOI 10.1002/bies.1154; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Otto C, 2001, J NEUROSCI, V21, P5520, DOI 10.1523/JNEUROSCI.21-15-05520.2001; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Philpot BD, 2002, NEURON, V33, P665, DOI 10.1016/S0896-6273(02)00618-9; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rammes G, 2003, J PHYSIOL-LONDON, V546, P455, DOI 10.1113/jphysiol.2002.033514; REGEHR WG, 1991, NEURON, V7, P451, DOI 10.1016/0896-6273(91)90297-D; Reid CA, 2004, J NEUROSCI, V24, P3618, DOI 10.1523/JNEUROSCI.3567-03.2004; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sajikumar S, 2003, NEUROSCI LETT, V338, P147, DOI 10.1016/S0304-3940(02)01400-3; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sawtell NB, 1999, J NEUROPHYSIOL, V82, P3594, DOI 10.1152/jn.1999.82.6.3594; Scheiderer CL, 2004, J NEUROPHYSIOL, V91, P1071, DOI 10.1152/jn.00420.2003; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; SJOSTROM PJ, 2004, IN PRESS J NEUROPHYS; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sudhof TC, 2001, SYNAPSES, P275; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tan YS, 2003, CELL MOL NEUROBIOL, V23, P187, DOI 10.1023/A:1022949922364; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thiels E, 1996, HIPPOCAMPUS, V6, P43, DOI 10.1002/(SICI)1098-1063(1996)6:1<43::AID-HIPO8>3.0.CO;2-8; Thiels E, 2002, J NEUROSCI, V22, P2054, DOI 10.1523/JNEUROSCI.22-06-02054.2002; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; van Dam EJM, 2002, NEUROSCI LETT, V320, P129, DOI 10.1016/S0304-3940(02)00037-X; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vekovischeva OY, 2001, J NEUROSCI, V21, P4451, DOI 10.1523/JNEUROSCI.21-12-04451.2001; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang HB, 2003, J NEUROSCI, V23, P9710; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WILLIAMS JH, 1993, SEMIN NEUROSCI, V5, P149, DOI 10.1016/S1044-5765(05)80048-X; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wu J, 2004, NEUROSCIENCE, V123, P507, DOI 10.1016/j.neuroscience.2003.09.013; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; XIAO MY, 1995, J NEUROSCI, V15, P4496; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhao WF, 2004, J NEUROSCI, V24, P76, DOI 10.1523/JNEUROSCI.4515-03.2004; Zho WM, 2002, J NEUROSCI, V22, P8838; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	275	2708	2803	7	428	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 30	2004	44	1					5	21		10.1016/j.neuron.2004.09.012	http://dx.doi.org/10.1016/j.neuron.2004.09.012			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	858ZY	15450156	Bronze			2022-12-28	WOS:000224232600003
J	Fitzjohn, SM; Collingridge, GL				Fitzjohn, SM; Collingridge, GL			Endocannabinoids: Losing inhibition to increase learning capacity?	NEURON			English	Editorial Material							DEPOLARIZATION-INDUCED SUPPRESSION; INDUCTION; SYNAPSES	Recent work has implicated endocannabinoids in various forms of synaptic plasticity. In this issue of Neuron, Chevaleyre and Castillo describe a new mechanism whereby a CB1 receptor-mediated LTD of inhibitory synaptic transmission facilitates the subsequent induction of LTP in a narrow band of synapses surrounding a region of potentiated synapses.	Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Fitzjohn, SM (corresponding author), Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England.		collingridge, graham/AAI-8362-2020; Bisogno, Tiziana/B-7891-2015; Fišar, Zdeněk/A-3295-2008; Collingridge, Graham L/C-4605-2015	Fišar, Zdeněk/0000-0002-3389-0287; Collingridge, Graham L/0000-0002-9572-5359; Fitzjohn, Stephen/0000-0002-3859-7530				Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Freund TF, 2003, NEURON, V38, P362, DOI 10.1016/S0896-6273(03)00262-9; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; HERRON CE, 1985, NEUROSCI LETT, V61, P255, DOI 10.1016/0304-3940(85)90473-2; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; WIGSTROM H, 1983, NATURE, V31, P453; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5	14	1	2	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 16	2004	43	6					762	764		10.1016/j.neuron.2004.09.004	http://dx.doi.org/10.1016/j.neuron.2004.09.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855RS	15363388	Bronze			2022-12-28	WOS:000223992000003
J	Chklovskii, DB				Chklovskii, DB			Synaptic connectivity and neuronal morphology: Viewpoint two sides of the same coin	NEURON			English	Editorial Material							LENGTH MINIMIZATION APPROACH; MAMMALIAN VISUAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; CORTICAL AREAS; COMPONENT PLACEMENT; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; GANGLION-CELLS; RAT NEOCORTEX	Neurons often possess elaborate axonal and dendritic arbors. Why do these arbors exist and what determines their form and dimensions? To answer these questions, I consider the wiring up of a large highly interconnected neuronal network, such as the cortical column. Implementation of such a network in the allotted volume requires all the salient features of neuronal morphology: the existence of branching dendrites and axons and the presence of dendritic spines. Therefore, the requirement of high interconnectivity is, in itself, sufficient to account for the existence of these features. Moreover, the actual lengths of axons and dendrites are close to the smallest possible length for a given interconnectivity, arguing that high interconnectivity is essential for cortical function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.edu			NIMH NIH HHS [MH69838] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069838] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLMAN JM, 1974, BRAIN RES, V76, P247, DOI 10.1016/0006-8993(74)90458-2; Anderson JC, 2002, J COMP NEUROL, V443, P56, DOI 10.1002/cne.10100; Anderson JC, 1998, J NEUROSCI, V18, P10525; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BARLOW HB, 1986, VISION RES, V26, P81, DOI 10.1016/0042-6989(86)90072-6; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Braitenberg V, 1998, CORTEX STAT GEOMETRY; CAJAL SRY, 1899, TEXTURE NERVOUS SYST, V1; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; Changizi MA, 2001, BIOL CYBERN, V84, P207, DOI 10.1007/s004220000205; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; Chklovskii DB, 2000, PHYSICA A, V284, P318, DOI 10.1016/S0378-4371(00)00219-3; CHKLOVSKII DB, 2004, IN PRESS NEUROL COMP, V16; COWEY A, 1979, Q J EXP PSYCHOL, V31, P1, DOI 10.1080/14640747908400703; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Hsu A, 1998, VISION RES, V38, P2539, DOI 10.1016/S0042-6989(97)00370-2; Karbowski J, 2003, J COMPUT NEUROSCI, V15, P347, DOI 10.1023/A:1027467911225; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, 1993, J NEUROSCI, V13, P413; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; MURRE JMJ, 1995, BIOL CYBERN, V73, P529, DOI 10.1007/BF00199545; NAFSTAD HJ, 1966, Z ZELLFORSCH MIK ANA, V73, P234, DOI 10.1007/BF00334866; NELSON ME, 1990, TRENDS NEUROSCI, V13, P403, DOI 10.1016/0166-2236(90)90119-U; Okada T, 2001, BIOL BULL, V200, P252, DOI 10.2307/1543506; PANICO J, 1995, J COMP NEUROL, V361, P479, DOI 10.1002/cne.903610311; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; PROTHERO JW, 1984, BRAIN BEHAV EVOLUT, V24, P152, DOI 10.1159/000121313; PURVES D, 1981, J NEUROSCI, V1, P441; PURVES D, 1985, SCIENCE, V228, P298, DOI 10.1126/science.3983631; PURVES D, 1986, J NEUROSCI, V6, P158; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; ROSE GJ, 1992, P NATL ACAD SCI USA, V89, P9662, DOI 10.1073/pnas.89.20.9662; RUPPIN E, 1993, BIOL CYBERN, V70, P89, DOI 10.1007/BF00202570; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; SCHUZ A, 1995, J BRAIN RES, V36, P113; Shefi O, 2004, NEUROCOMPUTING, V58, P487, DOI [10.1016/j.neucom.2004.01.85, 10.1016/j.neucom.2004.01.085]; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; STERLING P, 1988, J NEUROSCI, V8, P623; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; TOWER DB, 1954, J COMP NEUROL, V101, P19, DOI 10.1002/cne.901010103; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	72	177	181	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					609	617		10.1016/j.neuron.2004.08.012	http://dx.doi.org/10.1016/j.neuron.2004.08.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339643	Bronze			2022-12-28	WOS:000223691900007
J	Carello, CD; Krauzlis, RJ				Carello, CD; Krauzlis, RJ			Manipulating intent: Evidence for a causal role of the superior colliculus in target selection	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; CHOICE REACTION-TIME; VISUAL-SEARCH TASK; NEURONAL-ACTIVITY; ELECTRICAL-STIMULATION; SPATIAL ATTENTION; PURSUIT; MONKEY; MICROSTIMULATION; DISCRIMINATION	The superior colliculus (SC) is well known for its role in the motor control of saccades. Recent work has shown that it also plays a role in the selection of saccades, but a causal role in the process of target selection has not been demonstrated. We applied subthreshold microstimulation to the SC while monkeys performed a task requiring them to select a stimulus as the target for a pursuit or saccade movement. Stimulation increased the proportion of selections toward the stimulus that appeared contralateral to the site of stimulation and also decreased their latencies. For pursuit, this stimulation-induced contralateral response bias was with respect to the initial target location and not the direction of eye movement, demonstrating a causal effect on target choice distinct from any effect on motor preparation. These results show that the SC helps decide the object of the next movement, beyond its traditional responsibility of saccade production.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego	Carello, CD (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA USA.	ccarello@ucsd.edu		Richard, Krauzlis/0000-0002-1826-0447	NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER; NEI NIH HHS [EY12212] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler SA, 2002, J VISION, V2, P627, DOI 10.1167/2.9.5; Asrress KN, 2001, VISION RES, V41, P2645, DOI 10.1016/S0042-6989(01)00107-9; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; Basso MA, 1998, J NEUROSCI, V18, P7519; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carpenter RHS, 1981, EYE MOVEMENTS COGNIT, P237; Dorris MC, 1997, J NEUROSCI, V17, P8566; GIRVIN JP, 1979, SENS PROCESS, V3, P66; GLIMCHER PW, 1993, J NEUROPHYSIOL, V69, P953, DOI 10.1152/jn.1993.69.3.953; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P266, DOI 10.1152/jn.1985.53.1.266; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Keller EL, 2003, ANN NY ACAD SCI, V1004, P29, DOI 10.1196/annals.1303.004; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2002, ANN NY ACAD SCI, V956, P409, DOI 10.1111/j.1749-6632.2002.tb02842.x; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan Gordon D., 1994, P189; Macmillan N. A., 1991, DETECTION THEORY USE; McGarry T, 2003, Q J EXP PSYCHOL-A, V56, P601, DOI 10.1080/02724980244000549; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; McPeek RM, 2003, J NEUROPHYSIOL, V89, P2577, DOI 10.1152/jn.00657.2002; McPeek RM, 2002, J NEUROPHYSIOL, V87, P1805, DOI 10.1152/jn.00501.2001; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SCHWARZ W, 1993, PSYCHOL RES-PSYCH FO, V55, P200, DOI 10.1007/BF00419607; SHELIGA BM, 1995, NEUROREPORT, V6, P585, DOI 10.1097/00001756-199502000-00044; SPARKS DL, 1990, ANNU REV NEUROSCI, V13, P309, DOI 10.1146/annurev.ne.13.030190.001521; SPARKS DL, 1989, NEUROBIOLOGY SACCADI, V3, P213; STRYKER MP, 1975, EXP BRAIN RES, V23, P103; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	52	143	145	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 19	2004	43	4					575	583		10.1016/j.neuron.2004.07.026	http://dx.doi.org/10.1016/j.neuron.2004.07.026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312655	Bronze			2022-12-28	WOS:000223436400015
J	Koob, GF; Greenwell, TN				Koob, GF; Greenwell, TN			Neuropeptide S: A novel activating anxiolytic?	NEURON			English	Editorial Material							CORTICOTROPIN-RELEASING-FACTOR; AROUSAL; RATS	Many different neuropharmacological agents modulate arousal and anxiety, yet to date, few endogenous substances have produced arousal with an anxiolytic effect. In this issue of Neuron, Xu et al. describe the localization and characterization of a novel neuropeptide, neuropeptide S (and its cognate receptor), that is unique in its arousing and anxiolytic-like properties.	Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute	Koob, GF (corresponding author), Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA.			Greenwell, Thomas/0000-0001-6069-0064				FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 1999, BRAIN RES, V848, P141, DOI 10.1016/S0006-8993(99)01991-5; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; NESBITT PD, 1973, J PERS SOC PSYCHOL, V25, P137, DOI 10.1037/h0034256; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; SUTTON RE, 1982, NATURE, V297, P331, DOI 10.1038/297331a0; Van Bockstaele EJ, 1998, J NEUROENDOCRINOL, V10, P743, DOI 10.1046/j.1365-2826.1998.00254.x; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	9	18	21	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 19	2004	43	4					441	442		10.1016/j.neuron.2004.08.007	http://dx.doi.org/10.1016/j.neuron.2004.08.007			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312642	Bronze			2022-12-28	WOS:000223436400002
J	Melman, YF; Um, SY; Krumerman, A; Kagan, A; McDonald, TV				Melman, YF; Um, SY; Krumerman, A; Kagan, A; McDonald, TV			KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity	NEURON			English	Article							LONG-QT SYNDROME; DEPENDENT K+ CHANNEL; I-KS CHANNELS; CARDIAC-ARRHYTHMIA; MOLECULAR-BASIS; KVLQT1; MINK; MUTATION; PROTEINS; FORM	Potassium channels control the resting membrane potential and excitability of biological tissues. Many voltage-gated potassium channels are controlled through interactions with accessory subunits of the KCNE family through mechanisms still not known. Gating of mammalian channel KCNQ1 is dramatically regulated by KCNE subunits. We have found that multiple segments of the channel pore structure bind to the accessory protein KCNE1. The sites that confer KCNE1 binding are necessary for the functional interaction, and all sites must be present in the channel together for proper regulation by the accessory subunit. Specific gating control is localized to a single site of interaction between the ion channel and accessory subunit. Thus, direct physical interaction with the ion channel pore is the basis of KCNE1 regulation of K+ channels.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	mcdonald@aecom.yu.edu			NHLBI NIH HHS [R01 HL075615] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075615] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bianchi L, 1999, HUM MOL GENET, V8, P1499, DOI 10.1093/hmg/8.8.1499; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Chen QY, 1999, CIRCULATION, V99, P1344, DOI 10.1161/01.CIR.99.10.1344; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMMILL OP, 1981, PFLUGERS ARCH, V391, P85; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Krahn AD, 2000, AM HEART J, V140, P146, DOI 10.1067/mhj.2000.106599; Kurokawa J, 2001, J GEN PHYSIOL, V117, P43, DOI 10.1085/jgp.117.1.43; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Peri R, 2001, J BIOL CHEM, V276, P738, DOI 10.1074/jbc.M008445200; Romey G, 1997, J BIOL CHEM, V272, P16713, DOI 10.1074/jbc.272.27.16713; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroer TA, 2000, TRAFFIC, V1, P3, DOI 10.1034/j.1600-0854.2000.010102.x; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Tai KK, 1998, NATURE, V391, P605, DOI 10.1038/35416; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Tapper AR, 2001, J BIOL CHEM, V276, P38249; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665	43	120	122	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					927	937		10.1016/j.neuron.2004.06.001	http://dx.doi.org/10.1016/j.neuron.2004.06.001			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207237	Bronze			2022-12-28	WOS:000222329300008
J	Fukuto, HS; Ferkey, DM; Apicella, AJ; Lans, H; Sharmeen, T; Chen, W; Lefkowitz, RJ; Jansen, G; Schafer, WR; Hart, AC				Fukuto, HS; Ferkey, DM; Apicella, AJ; Lans, H; Sharmeen, T; Chen, W; Lefkowitz, RJ; Jansen, G; Schafer, WR; Hart, AC			G protein-coupled receptor kinase function is essential for chemosensation in C-elegans	NEURON			English	Article							HETEROTRIMERIC G-PROTEINS; NUCLEOTIDE-GATED CHANNEL; GLR-1 GLUTAMATE-RECEPTOR; CAENORHABDITIS-ELEGANS; RHODOPSIN KINASE; BETA-ARRESTINS; DESENSITIZATION; NEURONS; MICE; EXPRESSION	G protein-coupled receptors (GPCRs) mediate diverse signaling processes, including olfaction. G protein-coupled receptor kinases (GRKs) are important regulators of G protein signal transduction that specifically phosphorylate activated GPCRs to terminate signaling. Despite previously described roles for GRKs in GPCR signal downregulation, animals lacking C. elegans G protein-coupled receptor kinase-2 (Ce-grk-2) function are not hypersensitive to odorants. Instead, decreased Ce-grk-2 function in adult sensory neurons profoundly disrupts chemosensation, based on both behavioral analysis and Ca2+ imaging. Although mammalian arrestin proteins cooperate with GRKs in receptor desensitization, loss of C. elegans arrestin-1 (arr-1) does not disrupt chemosensation. Either overexpression of the C. elegans Galpha. subunit odr-3 or loss of eat-16, which encodes a regulator of G protein signaling (FIGS) protein, restores chemosensation in Ce-grk-2 mutants. These results demonstrate that loss of GRK function can lead to reduced GPCR signal transduction and suggest an important role for RGS proteins in the regulation of chemosensation.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Erasmus University Rotterdam; Erasmus MC; Duke University; Howard Hughes Medical Institute	Hart, AC (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149-7202 13th St, Charlestown, MA 02129 USA.	hart@helix.mgh.harvard.edu	Jansen, Gert/HCI-8852-2022; Lefkowitz, Robert/AAW-2649-2021; Lans, Hannes/C-9902-2016; Lans, Hannes/S-4181-2019	Lans, Hannes/0000-0003-4417-5358; Lans, Hannes/0000-0003-4417-5358; Jansen, Gert/0000-0002-7524-171X; Schafer, William/0000-0002-6676-8034; Chen, Wei/0000-0002-9934-4000	NIGMS NIH HHS [R01 GM057918, R01 GM057918-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057918] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BRENNER S, 1974, GENETICS, V77, P71; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; METAYE T, 1997, J CLIN ENDOCR METAB, V388, P882; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; PAO CS, 2002, SCI STKE, pPE42; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; TERWILLIGER RZ, 1994, J NEUROCHEM, V63, P1983; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214; WILIAMS BD, 1992, GENETICS, V131, P609; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175	65	70	85	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					581	593		10.1016/S0896-6273(04)00252-1	http://dx.doi.org/10.1016/S0896-6273(04)00252-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157420	Bronze			2022-12-28	WOS:000221708300009
J	Opatowsky, Y; Chen, CC; Campbell, KP; Hirsch, JA				Opatowsky, Y; Chen, CC; Campbell, KP; Hirsch, JA			Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha 1 interaction domain	NEURON			English	Article							CA2+ CHANNEL; CRYSTAL-STRUCTURE; GUANYLATE KINASE; ALPHA(1)-BETA INTERACTION; AMINO-TERMINUS; PROTEIN; INACTIVATION; DETERMINANTS; MECHANISM; MEMBRANE	Voltage-dependent calcium channels (VDCC) are multiprotein assemblies that regulate the entry of extracellular calcium into electrically excitable cells and serve as signal transduction centers. The alpha1 subunit forms the membrane pore while the intracellular beta subunit is responsible for trafficking of the channel to the plasma membrane and modulation of its electrophysiological properties. Crystallographic analyses of a beta subunit functional core alone and in complex with a alpha1 interaction domain (AID) peptide, the primary binding site of beta to the alpha1 subunit, reveal that beta represents a novel member of the MAGUK protein family. The findings illustrate how the guanylate kinase fold has been fashioned into a protein-protein interaction module by alteration of one of its substrate sites. Combined results indicate that the AID peptide undergoes a helical transition in binding to beta. We outline the mechanistic implications for understanding the beta subunit's broad regulatory role of the VDCC, particularly via the AID.	Tel Aviv Univ, Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Tel Aviv University; Howard Hughes Medical Institute; University of Iowa; University of Iowa	Hirsch, JA (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel.	jhirsch@post.tau.ac.il	Chen, Chien-Chang/D-2023-2015; Tuluc, Petronel/C-2527-2011; Hirsch, Joel/AAC-8000-2021	Chen, Chien-Chang/0000-0001-8850-4278; Hirsch, Joel/0000-0001-7544-8668; Campbell, Kevin/0000-0003-2066-5889				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Anderson CAF, 2002, STRUCTURE, V10, P175, DOI 10.1016/S0969-2126(02)00700-1; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Bichet D, 2000, BIOCHEM BIOPH RES CO, V277, P729, DOI 10.1006/bbrc.2000.3750; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Catterall WA, 1996, J BIOENERG BIOMEMBR, V28, P219, DOI 10.1007/BF02110697; Cens T, 1998, PFLUG ARCH EUR J PHY, V435, P865, DOI 10.1007/s004240050595; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FILI NBS, 2003, P NATL ACAD SCI USA, V100, P14469; Geib S, 2002, BIOCHEM J, V364, P285, DOI 10.1042/bj3640285; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Herlitze S, 2003, J BIOENERG BIOMEMBR, V35, P621, DOI 10.1023/B:JOBB.0000008027.19384.c0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones SW, 1998, J BIOENERG BIOMEMBR, V30, P299, DOI 10.1023/A:1021977304001; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Marquart A, 1997, FEBS LETT, V407, P137, DOI 10.1016/S0014-5793(97)00316-5; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; OPATOWSKY Y, 2004, IN PRESS ACTA CRYS D; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1997, IN PRESS ACTA CRYS D, P307; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Restituito S, 2001, BIOPHYS J, V81, P89, DOI 10.1016/S0006-3495(01)75682-2; Restituito S, 2000, J NEUROSCI, V20, P9046; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Shatsky M, 2002, PROTEINS, V48, P242, DOI 10.1002/prot.10100; STEHLE T, 1992, J MOL BIOL, V224, P1127, DOI 10.1016/0022-2836(92)90474-X; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wang MC, 2004, J BIOL CHEM, V279, P7159, DOI 10.1074/jbc.M308057200; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; YANG AS, 1995, J MOL BIOL, V252, P351, DOI 10.1006/jmbi.1995.0502	84	206	213	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					387	399		10.1016/S0896-6273(04)00250-8	http://dx.doi.org/10.1016/S0896-6273(04)00250-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134636	Bronze			2022-12-28	WOS:000221458700006
J	Hama, H; Hara, C; Yamaguchi, K; Miyawaki, A				Hama, H; Hara, C; Yamaguchi, K; Miyawaki, A			PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes	NEURON			English	Article							PROTEIN-KINASE-C; ISOLATED HIPPOCAMPAL-NEURONS; SYNAPTIC ACTIVITY; DENDRITIC SPINES; NMDA RECEPTORS; CELL-ADHESION; AMPA; SUBSTRATE; SYNAPSES; GLIA	Here we provide evidence that astrocytes affect neuronal synaptogenesis by the process of adhesion. Local contact with astrocytes via integrin receptors elicited protein kinase C (PKC) activation in individual dissociated neurons cultured in astrocyte-conditioned medium. This activation, initially focal, soon spread throughout the entire neuron. We then demonstrated pharmacologically that the arachidonic acid cascade, triggered by the integrin reception, is responsible for the global activation of PKC. Local astrocytic contact also facilitated excitatory synaptogenesis throughout the neuron, a process which could be blocked by inhibitors of both integrins and PKC. Thus, propagation of PKC signaling represents an underlying mechanism for global neuronal maturation following local astrocyte adhesion.	RIKEN, Lab Cell Funct Dynam, Adv Technol Dev Grp, Wako, Saitama 3510198, Japan; RIKEN, Lab Learning & Memory, Brain Sci Inst, Wako, Saitama 3510198, Japan; CREST, Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Miyawaki, A (corresponding author), RIKEN, Lab Cell Funct Dynam, Adv Technol Dev Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.go.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235				ALBERT KA, 1986, P NATL ACAD SCI USA, V83, P2822, DOI 10.1073/pnas.83.9.2822; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; AUER KL, 1995, MOL BIOL CELL, V6, P1305, DOI 10.1091/mbc.6.10.1305; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BENNETT V, 1988, J BIOL CHEM, V263, P5860; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dijkstra S, 1999, NEUROSCIENCE, V92, P1331, DOI 10.1016/S0306-4522(99)00060-3; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Goslin K., 1998, CULTURING NERVE CELL, P339; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hering H, 2003, J NEUROSCI, V23, P3262; Hohnke CD, 2000, J NEUROSCI, V20, P8051; Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sawano A, 2002, BIOPHYS J, V82, P1076, DOI 10.1016/S0006-3495(02)75467-2; Sheng MHT, 2001, SYNAPSES, P315; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sudhof TC, 2001, SYNAPSES, P177; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Whitfield RA, 1999, BIOCHEM BIOPH RES CO, V258, P306, DOI 10.1006/bbrc.1999.0642; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yamamoto H, 1998, ARCH BIOCHEM BIOPHYS, V359, P151, DOI 10.1006/abbi.1998.0920	41	221	232	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					405	415		10.1016/S0896-6273(04)00007-8	http://dx.doi.org/10.1016/S0896-6273(04)00007-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766179	Bronze			2022-12-28	WOS:000221457900011
J	Kobayashi, K; Poo, MM				Kobayashi, K; Poo, MM			Spike train timing-dependent associative modification of hippocampal CA3 recurrent synapses by mossy fibers	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; KAINATE RECEPTORS; PYRAMIDAL CELLS; NMDA RECEPTORS; IN-VIVO; NEURONS	In the CA3 region of the hippocampus, extensive recurrent associational/commissural (A/C) connections made by pyramidal cells may function as a network for associative memory storage and recall. We here report that long-term potentiation (LTP) at the A/C synapses can be induced by association of brief spike trains in mossy fibers (MFs) from the dentate gyrus and A/C fibers. This LTP not only required substantial overlap between spike trains in MFs and A/C fibers, but also depended on the temporal order of these spike trains in a manner not predicted by the well-known rule of spike timing-dependent plasticity and requiring activation of type 1 metabotropic glutamate receptors. Importantly, spike trains in a putative single MF input provided effective postsynaptic activity for the induction of LTP at A/C synapses. Thus, the timing of spike trains in individual MFs may code information that is crucial for the associative modification of CA3 recurrent synapses.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu	Kobayashi, Katsunori/V-5326-2018	Kobayashi, Katsunori/0000-0001-8537-8448	NINDS NIH HHS [NS 36999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BARNES CA, 1990, PROG BRAIN RES, V83, P287; BENNETT MR, 1994, PHILOS T R SOC B, V343, P167, DOI 10.1098/rstb.1994.0019; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRADLER JE, 1989, SYNAPSE, V4, P132, DOI 10.1002/syn.890040207; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; Clark BP, 1997, BIOORG MED CHEM LETT, V7, P2777, DOI 10.1016/S0960-894X(97)10071-3; Conner JM, 1997, J NEUROSCI, V17, P2295; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; Kobayashi K, 1999, EUR J NEUROSCI, V11, P1633, DOI 10.1046/j.1460-9568.1999.00578.x; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Litschig S, 1999, MOL PHARMACOL, V55, P453; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Martinez CO, 2002, BRAIN RES, V940, P86, DOI 10.1016/S0006-8993(02)02598-2; McMahon DBT, 2002, J NEUROPHYSIOL, V88, P528, DOI 10.1152/jn.2002.88.1.528; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Miura M, 2002, J NEUROSCI, V22, P8379; Mori M, 2002, J PHYSIOL-LONDON, V544, P793, DOI 10.1113/jphysiol.2002.030163; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; ROLLS ET, 1998, NEURAL NETWORKS BRAI, P95; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smith MA, 1997, NEUROREPORT, V8, P1829, DOI 10.1097/00001756-199705260-00008; THOMAS MJ, 1995, BRAIN RES, V695, P45, DOI 10.1016/0006-8993(95)00757-H; Tsukamoto M, 2003, J PHYSIOL-LONDON, V546, P665, DOI 10.1113/jphysiol.2002.033803; Urban NN, 1996, J NEUROSCI, V16, P4293; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wilsch VW, 1998, J NEUROSCI, V18, P6071; YAMAMOTO C, 1978, EXP NEUROL, V58, P242, DOI 10.1016/0014-4886(78)90137-1; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	61	80	81	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					445	454		10.1016/S0896-6273(03)00873-0	http://dx.doi.org/10.1016/S0896-6273(03)00873-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766182	Bronze			2022-12-28	WOS:000221457900014
J	Marois, R; Yi, DJ; Chun, MM				Marois, R; Yi, DJ; Chun, MM			The neural fate of consciously perceived and missed events in the aftentional blink	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; SERIAL VISUAL PRESENTATION; ANTERIOR CINGULATE CORTEX; HUMAN OBJECT AREAS; ATTENTIONAL BLINK; PARIETAL CORTEX; VISUOSPATIAL ATTENTION; DIRECTED ATTENTION; TEMPORAL CORTEX; ERROR-DETECTION	Cognitive models of attention propose that visual perception is a product of two stages of visual processing: early operations permit rapid initial categorization of the visual world, while later attention-demanding capacity-limited stages are necessary for the conscious report of the stimuli. Here we used the attentional blink paradigm and fMRI to neurally distinguish these two stages of vision. Subjects detected a face target and a scene target presented rapidly among distractors at fixation. Although the second, scene target frequently went undetected by the subjects, it nonetheless activated regions of the medial temporal cortex involved in high-level scene representations, the parahippocampal place area (PPA). This PPA activation was amplified when the stimulus was consciously perceived. By contrast, the frontal cortex was activated only when scenes were successfully reported. These results suggest that medial temporal cortex permits rapid categorization of the visual input, while the frontal cortex is part of a capacity-limited attentional bottleneck to conscious report.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Marois, R (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Dept Psychol, 530 Wilson Hall, Nashville, TN 37203 USA.	rene.marois@vanderbilt.edu		Chun, Marvin/0000-0003-1070-7993	NATIONAL EYE INSTITUTE [R01EY014193] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014193] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah MJ, 1997, SEMIN NEUROL, V17, P145, DOI 10.1055/s-2008-1040924; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Jolic&OELIG;ur P., 2001, LIMITS ATTENTION, P82; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Neisser U., 1967, COGNITIVE PSYCHOL; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pins D, 2003, CEREB CORTEX, V13, P461, DOI 10.1093/cercor/13.5.461; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Ross NE, 1999, J EXP PSYCHOL HUMAN, V25, P1483, DOI 10.1037/0096-1523.25.6.1483; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Sheppard DM, 2002, PSYCHOL SCI, V13, P410, DOI 10.1111/1467-9280.00473; SHIFFRIN RM, 1972, J EXP PSYCHOL, V93, P72, DOI 10.1037/h0032453; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Weiskrantz L, 2003, P NATL ACAD SCI USA, V100, P10500, DOI 10.1073/pnas.1734039100; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	67	218	224	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					465	472		10.1016/S0896-6273(04)00012-1	http://dx.doi.org/10.1016/S0896-6273(04)00012-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766184	Bronze			2022-12-28	WOS:000221457900016
J	Li, CY; Lu, JT; Wu, CP; Duan, SM; Poo, MM				Li, CY; Lu, JT; Wu, CP; Duan, SM; Poo, MM			Bidirectional modification of presynaptic neuronal excitability accompanying spike timing-dependent synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; SPINY STELLATE NEURONS; PROTEIN-KINASE-A; INTRINSIC EXCITABILITY; PYRAMIDAL CELLS; POTASSIUM CURRENTS; K+ CHANNELS; BARREL; ACTIVATION; INCREASES	Correlated pre- and postsynaptic activity that induces long-term potentiation is known to induce a persistent enhancement of the intrinsic excitability of the presynaptic neuron. Here we report that, associated with the induction of long-term depression in hippocampal cultures and in somatosensory cortical slices, there is also a persistent reduction in the excitability of the presynaptic neuron. This reduction requires postsynaptic Ca2+ elevation and presynaptic PKA- and PKC-dependent modification of slow-inactivating K+ channels. The bidirectional changes in neuronal excitability and synaptic efficacy exhibit identical requirements for the temporal order of pre- and postsynaptic activation but reflect two distinct aspects of activity-induced modification of neural circuits.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn; rnpoo@uclink.berkeley.edu		Li, Chengyu/0000-0001-6829-0209	NINDS NIH HHS [NS 36999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Bear MF, 2001, SYNAPSES, P455; Beaumont V, 2002, NEURON, V33, P601, DOI 10.1016/S0896-6273(02)00581-0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Churchland PS, 2017, COMPUT NEUROSCI-MIT; CONN PJ, 1989, J NEUROSCI, V9, P473; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FICKER E, 1992, J PHYSIOL-LONDON, V445, P431, DOI 10.1113/jphysiol.1992.sp018932; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Grosse G, 2000, J NEUROSCI, V20, P1869; Heath BM, 2000, J PHYSIOL-LONDON, V522, P391, DOI 10.1111/j.1469-7793.2000.t01-2-00391.x; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCNAUGHTON BL, 1994, P NATL ACAD SCI USA, V91, P4830, DOI 10.1073/pnas.91.11.4830; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Moyer JR, 1996, J NEUROSCI, V16, P5536; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; PAYET MD, 1992, J BIOL CHEM, V267, P18270; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RUMELHART DE, 1986, PARALLEL DISTRIBUTED, V1, P316; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Vaquero CF, 2001, J NEUROSCI, V21, P8624, DOI 10.1523/JNEUROSCI.21-21-08624.2001; WATHEY JC, 1992, J NEUROSCI, V12, P607; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	57	66	69	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					257	268		10.1016/S0896-6273(03)00847-X	http://dx.doi.org/10.1016/S0896-6273(03)00847-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741106	Bronze			2022-12-28	WOS:000221457800011
J	Bell, TJ; Thaler, C; Castiglioni, AJ; Helton, TD; Lipscombe, D				Bell, TJ; Thaler, C; Castiglioni, AJ; Helton, TD; Lipscombe, D			Cell-specific alternative splicing increases calcium channel current density in the pain pathway	NEURON			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; N-TYPE; OMEGA-CONOTOXIN; CA2+ CHANNEL; FUNCTIONAL EXPRESSION; ALPHA(1B) SUBUNIT; MICE LACKING; MEMBRANE-PROPERTIES; CAPSAICIN RECEPTOR	N-type calcium channels are critical for pain transduction. Inhibitors of these channels are powerful analgesics, but clinical use of current N-type blockers; remains limited by undesirable actions in other regions of the nervous system. We now demonstrate that a unique splice isoform of the N-type channel is restricted exclusively to dorsal root ganglia. By a combination of functional and molecular analyses at the single-cell level, we show that the DRG-specific exon, e37a, is preferentially present in Ca(V)2.2 mRNAs expressed in neurons that contain nociceptive markers, VR1 and Na(V)1.8. Cell-specific inclusion of exon 37a correlates closely with significantly larger N-type currents in nociceptive neurons. This unique splice isoform of the N-type channel could represent a novel target for pain management.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	diane_lipscombe@brown.edu			NIGMS NIH HHS [GM07601] Funding Source: Medline; NIMH NIH HHS [MH19118] Funding Source: Medline; NINDS NIH HHS [NS43082, NS29967] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029967, F32NS043082, R29NS029967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Baccei ML, 2000, J NEUROPHYSIOL, V83, P2227, DOI 10.1152/jn.2000.83.4.2227; Black DL, 1998, NEURON, V20, P165, DOI 10.1016/S0896-6273(00)80444-4; Blair NT, 2002, J NEUROSCI, V22, P10277; BOWERSOX SS, 1995, J PHARMACOL EXP THER, V273, P248; Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brose WG, 1997, CLIN J PAIN, V13, P256, DOI 10.1097/00002508-199709000-00012; Cahill AL, 2000, J NEUROSCI, V20, P1685; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J PHARMACOL EXP THER, V269, P1117; COOPOLA T, 1994, FEBS LETT, V338, P1; Cox B, 2000, Curr Rev Pain, V4, P488; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; Felix R, 1999, RECEPTOR CHANNEL, V6, P351; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; HEYMAN I, 1985, NEUROSCI LETT, V56, P69, DOI 10.1016/0304-3940(85)90442-2; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; HOLZ GG, 1988, J NEUROSCI, V8, P463; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; KERR LM, 1988, EUR J PHARMACOL, V146, P181, DOI 10.1016/0014-2999(88)90501-8; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Lin ZX, 1999, J NEUROSCI, V19, P5322; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2002, CIRC RES, V90, P933, DOI 10.1161/01.RES.0000019740.52306.92; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; LIPSCOMBE D, 2003, CALCIUM CHANNEL PHAR; Lu Q, 1999, J BIOL CHEM, V274, P34566, DOI 10.1074/jbc.274.49.34566; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; MAGGI CA, 1990, NEUROSCI LETT, V114, P203, DOI 10.1016/0304-3940(90)90072-H; Matthews EA, 2001, PAIN, V92, P235, DOI 10.1016/S0304-3959(01)00255-X; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Pan JQ, 2000, J NEUROSCI, V20, P4769; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; RITTER AM, 1992, J NEUROPHYSIOL, V68, P2033, DOI 10.1152/jn.1992.68.6.2033; ROSE ML, 1997, CARDIOVASC ENG, V2, P19; Saegusa H, 2002, NEUROSCI RES, V43, P1, DOI 10.1016/S0168-0102(02)00017-2; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; Simen AA, 2001, J NEUROSCI, V21, P7587, DOI 10.1523/JNEUROSCI.21-19-07587.2001; Soong TW, 2002, J NEUROSCI, V22, P10142; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	70	159	173	2	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 8	2004	41	1					127	138		10.1016/S0896-6273(03)00801-8	http://dx.doi.org/10.1016/S0896-6273(03)00801-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715140	Bronze			2022-12-28	WOS:000187942800014
J	Ramos, BP; Birnbaum, SG; Lindenmayer, I; Newton, SS; Duman, RS; Arnsten, AFT				Ramos, BP; Birnbaum, SG; Lindenmayer, I; Newton, SS; Duman, RS; Arnsten, AFT			Dysregulation of protein kinase a signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline	NEURON			English	Article							LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; MEMORY CONSOLIDATION; ADENYLYL CYCLASES; SPATIAL MEMORY; CYCLIC-AMP; IMMUNOHISTOCHEMICAL LOCALIZATION; ALPHA-2 ANTAGONIST; IMPROVES MEMORY; LOCUS-COERULEUS	Activation of the cAMP/protein kinase A (PKA) pathway has been proposed as a mechanism for improving age-related cognitive deficits based on studies of hippocampal function. However, normal aging also afflicts prefrontal cortical cognitive functioning. Here, we report that agents that increase PKA activity impair rather than improve prefrontal cortical function in aged rats and monkeys with prefrontal cortical deficits. Conversely, PKA inhibition ameliorates prefrontal cortical cognitive deficits. Western blot and immunohistochemical analyses of rat brain further indicate that the cAMP/PKA pathway becomes disinhibited in the prefrontal cortex with advancing age. These data demonstrate that PKA inhibition, rather than activation, is the appropriate strategy for restoring prefrontal cortical cognitive abilities in the elderly.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University; Yale University	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	amy.arnsten@yale.edu			NIA NIH HHS [AG06036] Funding Source: Medline; NIMH NIH HHS [MH45481] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045481, R29MH045481, R37MH045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006036, R37AG006036] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; ANDO S, 1991, NEUROSCI LETT, V128, P17, DOI 10.1016/0304-3940(91)90750-N; Araki T, 1997, METAB BRAIN DIS, V12, P83, DOI 10.1007/BF02676356; Araki T, 1995, BRAIN RES, V704, P227, DOI 10.1016/0006-8993(95)01117-X; ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Baker LP, 1999, J NEUROSCI, V19, P180, DOI 10.1523/JNEUROSCI.19-01-00180.1999; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Barros DM, 2000, BEHAV BRAIN RES, V114, P183, DOI 10.1016/S0166-4328(00)00226-6; BARTUS RT, 1978, J GERONTOL, V33, P858, DOI 10.1093/geronj/33.6.858; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; CARLSON S, 1992, BEHAV NEURAL BIOL, V58, P113, DOI 10.1016/0163-1047(92)90327-Z; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Colombo PJ, 1997, P NATL ACAD SCI USA, V94, P14195, DOI 10.1073/pnas.94.25.14195; Coven E, 1998, J NEUROCHEM, V71, P1865; DETOLEDOMORRELL L, 1984, BEHAV NEURAL BIOL, V42, P1, DOI 10.1016/S0163-1047(84)90364-9; DIVAC I, 1971, NEUROPSYCHOLOGIA, V9, P175, DOI 10.1016/0028-3932(71)90041-8; FELDMAN ML, 1975, ANAT EMBRYOL, V148, P279, DOI 10.1007/BF00319848; Franowicz JS, 1998, PSYCHOPHARMACOLOGY, V136, P8, DOI 10.1007/s002130050533; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Herndon JG, 1997, BEHAV BRAIN RES, V87, P25, DOI 10.1016/S0166-4328(96)02256-5; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LANGRETH R, 2002, FORBES          0204; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; MONS N, 1995, P NATL ACAD SCI USA, V92, P8473, DOI 10.1073/pnas.92.18.8473; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIELSENBOHLMAN L, 1995, CEREB CORTEX, V5, P541, DOI 10.1093/cercor/5.6.541; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; Punch LJ, 1997, J NEUROSCI, V17, P8520; Rama P, 1996, PHARM BIOCH BEHAV, V54, P1; RANDT CT, 1982, PHARMACOL BIOCHEM BE, V17, P677, DOI 10.1016/0091-3057(82)90344-6; RAPP PR, 1989, J NEUROSCI, V9, P3568; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Stuss D. T., 2002, PR FRONTAL LOBE FUNC, P392; Tanila H, 1996, BRAIN RES BULL, V40, P117, DOI 10.1016/0361-9230(96)00026-3; Tanila H, 2001, HIPPOCAMPUS, V11, P793, DOI 10.1002/hipo.1095; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Taylor JR, 1999, J NEUROSCI, V19; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Zhang HT, 2000, PSYCHOPHARMACOLOGY, V150, P311, DOI 10.1007/s002130000414; Zhang HT, 2000, NEUROPSYCHOPHARMACOL, V23, P198, DOI 10.1016/S0893-133X(00)00108-1; Zhu J, 2001, CNS DRUG REV, V7, P387	62	181	190	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					835	845		10.1016/S0896-6273(03)00694-9	http://dx.doi.org/10.1016/S0896-6273(03)00694-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	744UL	14622586	Bronze			2022-12-28	WOS:000186651200017
J	Szwed, M; Bagdasarian, K; Ahissar, E				Szwed, M; Bagdasarian, K; Ahissar, E			Encoding of vibrissal active touch	NEURON			English	Article							FOLLICLE-SINUS COMPLEXES; SOMATOSENSORY SYSTEM; TRIGEMINAL GANGLION; MYSTACIAL PAD; TEMPORAL FREQUENCY; WHISKER MOVEMENTS; RAT THALAMUS; MOTOR-NERVE; INNERVATION; RESPONSES	Mammals acquire much of their sensory information by actively moving their sensory organs. Yet, the principles of encoding by active sensing are not known. Here we investigated the encoding principles of active touch by rat whiskers (vibrissae). We induced artificial whisking in anesthetized rats and recorded from first-order neurons in the trigeminal ganglion. During active touch, first-order trigeminal neurons presented a rich repertoire of responses, which could not be inferred from their responses to passive deflection stimuli. Individual neurons encoded four specific events: whisking, contact with object, pressure against object, and detachment from object. Whisking-responsive neurons fired at specific deflection angles, reporting the actual whiskers' position with high precision. Touch-responsive neurons encoded the horizontal coordinate of objects' position by spike timing. These findings suggest two specific encoding-decoding schemes.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Ahissar E, 2001, Prog Brain Res, V130, P75; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354, DOI 10.1152/jn.2001.86.1.354; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Ahissar E, 1998, NEURAL COMPUT, V10, P597, DOI 10.1162/089976698300017683; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; BROWN AWS, 1974, J PHYSIOL-LONDON, V238, P387, DOI 10.1113/jphysiol.1974.sp010531; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Fundin BT, 1997, J COMP NEUROL, V389, P545; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GIBSON JM, 1983, SOMATOSENS RES, V1, P51, DOI 10.3109/07367228309144540; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; GOTTSCHALDT KM, 1973, J PHYSIOL-LONDON, V235, P287, DOI 10.1113/jphysiol.1973.sp010388; Haidarliu S, 1997, J COMP NEUROL, V385, P515, DOI 10.1002/(SICI)1096-9861(19970908)385:4<515::AID-CNE3>3.0.CO;2-6; Haidarliu S, 1999, J NEUROSCI METH, V94, P27, DOI 10.1016/S0165-0270(99)00123-5; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kelly MK, 1999, J NEUROSCI, V19, P9117, DOI 10.1523/JNEUROSCI.19-20-09117.1999; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; MOSCONI TM, 1993, J COMP NEUROL, V328, P222; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; Pali J, 2000, NEUROREPORT, V11, P849, DOI 10.1097/00001756-200003200-00038; Prigg T, 2002, PHYSIOL BEHAV, V77, P671, DOI 10.1016/S0031-9384(02)00917-4; RICE FL, 1986, J COMP NEUROL, V252, P154, DOI 10.1002/cne.902520203; RICE FL, 1993, J COMP NEUROL, V337, P366, DOI 10.1002/cne.903370303; SEMBA K, 1986, J COMP NEUROL, V247, P144, DOI 10.1002/cne.902470203; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Tracey David J., 1995, P689; WAITE PME, 1992, J COMP NEUROL, V322, P233, DOI 10.1002/cne.903220209; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	44	213	215	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					621	630		10.1016/S0896-6273(03)00671-8	http://dx.doi.org/10.1016/S0896-6273(03)00671-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642284	Bronze			2022-12-28	WOS:000186379000019
J	Lee, JS; von der Hardt, S; Rusch, MA; Stringer, SE; Stickney, HL; Talbot, WS; Geisler, R; Nusslein-Volhard, C; Selleck, SB; Chien, CB; Roehl, H				Lee, JS; von der Hardt, S; Rusch, MA; Stringer, SE; Stickney, HL; Talbot, WS; Geisler, R; Nusslein-Volhard, C; Selleck, SB; Chien, CB; Roehl, H			Axon sorting in the optic tract requires HSPG synthesis by ext2 (dackel) and extl3 (boxer)	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; TUMOR SUPPRESSORS EXT1; ZEBRAFISH DANIO-RERIO; RETINOTECTAL PROJECTION; CAENORHABDITIS-ELEGANS; TOUT-VELU; TARGET RECOGNITION; VISUAL-SYSTEM; MOUSE EMBRYOS; SLIT PROTEIN	Retinal ganglion cell (RGC) axons are topographically ordered in the optic tract according to their retinal origin. In zebrafish dackel (dak) and boxer (box) mutants, some dorsal RGC axons missort in the optic tract but innervate the tectum topographically. Molecular cloning reveals that dak and box encode ext2 and ext13, glycosyltransferases implicated in heparan sulfate (HS) biosynthesis. Both genes are required for HS synthesis, as shown by biochemical and immunohistochemical analysis, and are expressed maternally and then ubiquitously, likely playing permissive roles. Missorting in box can be rescued by overexpression of ext13. dak;box double mutants show synthetic pathfinding phenotypes that phenocopy robot mutants, suggesting that Robot function requires HS in vivo; however, tract sorting does not require Robo function, since it is normal in robot null mutants. This genetic evidence that heparan sulfate proteoglycan function is required for optic tract sorting provides clues to begin understanding the underlying molecular mechanisms.	Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84103 USA; Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; Univ Minnesota, Dept Pediat & Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Cell Biol & Dev, Minneapolis, MN 55455 USA; Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; Univ Sheffield, Ctr Dev & Biomed Genet, Dept Biomed Sci, Sheffield S20 3TN, S Yorkshire, England	Utah System of Higher Education; University of Utah; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; University of Sheffield	Chien, CB (corresponding author), Univ Utah, Dept Neurobiol & Anat, 20 North 1900 East, Salt Lake City, UT 84103 USA.	chi-bin.chien@neuro.utah.edu	Geisler, Robert/K-6201-2013	Geisler, Robert/0000-0002-3909-8311	NCI NIH HHS [5U01-CA91290] Funding Source: Medline; NCRR NIH HHS [RR12349] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA091290] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012349] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Baier H, 1996, DEVELOPMENT, V123, P415; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; CHAN SO, 1994, J COMP NEUROL, V344, P20, DOI 10.1002/cne.903440103; CHIEN CB, 1995, DEVELOPMENT, V121, P2621; Chung KY, 2001, J COMP NEUROL, V436, P236, DOI 10.1002/cne.1245; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; FUJISAWA H, 1981, BRAIN RES, V206, P27, DOI 10.1016/0006-8993(81)90098-6; GEISLER R, 2002, TUBINGEN MAP ZEBRAFI; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; HALFTER W, 1993, J NEUROSCI, V13, P2863; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hoffman-Kim D, 1998, J NEUROSCI, V18, P5881; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Irie A, 2002, DEVELOPMENT, V129, P61; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2002, J BIOL CHEM, V277, P13659, DOI 10.1074/jbc.M111630200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; LEE JS, 2004, IN PRESS NAT REV GEN; Leung KM, 2003, EUR J NEUROSCI, V17, P1755, DOI 10.1046/j.1460-9568.2003.02605.x; Lewis KE, 1999, DEV BIOL, V208, P14, DOI 10.1006/dbio.1998.9169; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MCFARLANE S, 1995, NEURON, V15, P1017, DOI 10.1016/0896-6273(95)90091-8; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Morio H, 2003, BIOCHEM BIOPH RES CO, V301, P317, DOI 10.1016/S0006-291X(02)03031-0; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Picker A, 1999, DEVELOPMENT, V126, P2967; Princivalle M, 2002, INT J DEV BIOL, V46, P267; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; Schilling TF, 1996, DEVELOPMENT, V123, P329; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Stickney HL, 2002, GENOME RES, V12, P1929, DOI 10.1101/gr.777302; STRAZNICKY C, 1979, J EMBRYOL EXP MORPH, V50, P253; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Talbot WS, 1999, METHOD CELL BIOL, V60, P259; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Trowe T, 1996, DEVELOPMENT, V123, P439; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Walz A, 1997, DEVELOPMENT, V124, P2421; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6	70	131	132	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 16	2004	44	6					947	960		10.1016/j.neuron.2004.11.029	http://dx.doi.org/10.1016/j.neuron.2004.11.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	881CZ	15603738	Bronze			2022-12-28	WOS:000225842300009
J	Dyhrfjeld-Johnsen, J; Soltesz, I				Dyhrfjeld-Johnsen, J; Soltesz, I			Dendritic h channelopathy in epileptogenesis	NEURON			English	Editorial Material							EPILEPSY		Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Dyhrfjeld-Johnsen, J (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.			Dyhrfjeld-Johnsen, Jonas/0000-0003-0875-909X				Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen K, 2002, TRENDS PHARMACOL SCI, V23, P552, DOI 10.1016/S0165-6147(02)02110-7; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011	8	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 28	2004	44	3					402	403		10.1016/j.neuron.2004.10.018	http://dx.doi.org/10.1016/j.neuron.2004.10.018			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866KF	15504320	Bronze			2022-12-28	WOS:000224771700002
J	Dunaevsky, A				Dunaevsky, A			Connecting the dots: From actin polymerization to synapse formation	NEURON			English	Editorial Material							DENDRITIC SPINES; CORTEX; PLASTICITY; MORPHOLOGY; MOTILITY	Protrusive behavior of dendritic spines on developing neurons has been previously suggested to mediate the formation of new axodendritic synaptic contacts. A study by Zito et al. in this issue of Neuron links actin polymerization in dendritic spines with the motility that the spines exhibit and the synapses that they form.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Dunaevsky, A (corresponding author), Brown Univ, Dept Neurosci, 190 Thayer St, Providence, RI 02912 USA.							Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	15	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					216	218		10.1016/j.neuron.2004.10.003	http://dx.doi.org/10.1016/j.neuron.2004.10.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473960	Bronze			2022-12-28	WOS:000224635800004
J	Flames, N; Long, JE; Garratt, AN; Fischer, TM; Gassmann, M; Birchmeier, C; Lai, C; Rubenstein, JLR; Marin, O				Flames, N; Long, JE; Garratt, AN; Fischer, TM; Gassmann, M; Birchmeier, C; Lai, C; Rubenstein, JLR; Marin, O			Short- and long-range attraction of cortical GABAergic interneurons by Neuregulin-1	NEURON			English	Article							MEDIAL GANGLIONIC EMINENCE; DEVELOPING CEREBRAL-CORTEX; SCHWANN-CELL MOTILITY; AT-RISK HAPLOTYPE; NEOCORTICAL DEVELOPMENT; TANGENTIAL MIGRATION; NEURONAL MIGRATION; MAMMARY-GLAND; RADIAL GLIA; SCHIZOPHRENIA	Most cortical interneurons arise from the subcortical telencephalon, but the molecules that control their migration remain largely unidentified. Here, we show that different isoforms of Neuregulin-1 are expressed in the developing cortex and in the route that migrating interneurons follow toward the cortex, whereas a population of the migrating interneurons express ErbB4 a receptor for Neuregulin-1. The different isoforms of Neuregulin-1 act as short- and long-range attractants for migrating interneurons, and perturbing ErbB4 function in vitro decreases the number of interneurons that tangentially migrate to the cortex. In vivo, loss of Neuregulin-1/ErbB4 signaling causes an alteration in the tangential migration of cortical interneurons and a reduction in the number of GABAergic interneurons in the postnatal cortex. These observations provide evidence that Neuregulin-1 and its ErbB4 receptor directly control neuronal migration in the nervous system.	CSIC, Inst Neurociencias Alicante, San Juan de Alicante 03550, Spain; Univ Miguel Hernandez, San Juan de Alicante 03550, Spain; Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Max Delbrueck Ctr, D-13125 Berlin, Germany; Scripps Res Inst, La Jolla, CA 92037 USA; Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Scripps Research Institute; University of Basel	Marin, O (corresponding author), CSIC, Inst Neurociencias Alicante, San Juan de Alicante 03550, Spain.	o.marin@umh.es	Marin, Oscar/F-3856-2012; Garratt, Alistair/HGC-0774-2022; Garratt, Alistair/AAG-2715-2021; Garratt, Alistair N/D-9893-2013; Flames, Nuria/L-2290-2017	Marin, Oscar/0000-0001-6264-7027; Garratt, Alistair N/0000-0001-9631-3041; Flames, Nuria/0000-0003-0961-0609; Gassmann, Martin/0000-0001-6201-3032	NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [R01MH51561, K02MH01046, R01MH49428] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051561, R01MH049428, K02MH001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Anton ES, 1997, DEVELOPMENT, V124, P3501; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Caric D, 2001, DEVELOPMENT, V128, P4203; Casarosa S, 1999, DEVELOPMENT, V126, P525; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Corvin AP, 2004, MOL PSYCHIATR, V9, P208, DOI 10.1038/sj.mp.4001412; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jimenez D, 2002, DEV BIOL, V244, P155, DOI 10.1006/dbio.2002.0586; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Keverne EB, 1999, BRAIN RES BULL, V48, P467, DOI 10.1016/S0361-9230(99)00025-8; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Li T, 2004, MOL PSYCHIATR, V9, P698, DOI 10.1038/sj.mp.4001485; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Martinez S, 1999, DEVELOPMENT, V126, P1189; Mazumdar A, 2001, CANCER RES, V61, P400; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Polleux F, 2002, DEVELOPMENT, V129, P3147; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sussel L, 1999, DEVELOPMENT, V126, P3359; TAN SS, 1995, DEVELOPMENT, V121, P1029; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tang JX, 2004, MOL PSYCHIATR, V9, P11, DOI 10.1038/sj.mp.4001436; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Wichterle H, 2003, P NATL ACAD SCI USA, V100, P727, DOI 10.1073/pnas.242721899; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	58	329	339	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					251	261		10.1016/j.neuron.2004.09.028	http://dx.doi.org/10.1016/j.neuron.2004.09.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473965	Bronze			2022-12-28	WOS:000224635800009
J	He, XP; Kotloski, R; Nef, S; Luikart, BW; Parada, LF; McNamara, JO				He, XP; Kotloski, R; Nef, S; Luikart, BW; Parada, LF; McNamara, JO			Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model	NEURON			English	Article							LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; SEIZURE-INDUCED ACTIVATION; MESSENGER-RNA EXPRESSION; DENTATE GRANULE CELLS; MOSSY FIBER PATHWAY; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; KAINIC ACID; RAT-BRAIN	Epileptogenesis is the process whereby a normal brain becomes epileptic. We hypothesized that the neurotrophin brain-derived neurotrophic factor (BDNF) activates its receptor, TrkB, in the hippocampus during epileptogenesis and that BDNF-mediated activation of TrkB is required for epileptogenesis. We tested these hypotheses in Synapsin-Cre conditional BDNF-/- and TrkB(-/-) mice using the kindling model. Despite marked reductions of BDNF expression, only a modest impairment of epileptogenesis and increased hippocampal TrkB activation were detected in BDNF-/- mice. In contrast, reductions of electrophysiological measures and no behavioral evidence of epileptogenesis were detected in TrkB(-/-) mice. Importantly, TrkB(-/-) mice exhibited behavioral endpoints of epileptogenesis, tonic-clonic seizures. Whereas TrkB can be activated, and epileptogenesis develops in BDNF-/- mice, the plasticity of epileptogenesis is eliminated in TrkB(-/-) mice. Its requirement for epileptogenesis in kindling implicates TrkB and downstream signaling pathways as attractive molecular targets for drugs for preventing epilepsy.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA	Duke University; Duke University; Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McNamara, JO (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	jmc@neuro.duke.edu	Nef, Serge/AAV-6445-2020; Parada, luis F/B-9400-2014; Luikart, Bryan/D-2683-2012	Nef, Serge/0000-0001-5462-0676; 	NINDS NIH HHS [R01 NS056217, NS17771] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217, P01NS017771] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Binder DK, 1999, J NEUROSCI, V19, P4616; Binder DK, 1999, J NEUROSCI, V19, P1424; Danzer SC, 2004, HIPPOCAMPUS, V14, P345, DOI 10.1002/hipo.10190; Danzer SC, 2002, J NEUROSCI, V22, P9754; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; Elmer E, 1997, EXP NEUROL, V145, P93, DOI 10.1006/exnr.1997.6478; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Golarai G, 1996, J NEUROPHYSIOL, V75, P343, DOI 10.1152/jn.1996.75.1.343; Gowers WR, 1881, EPILEPSY OTHER CHRON; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; He XP, 2002, J NEUROSCI, V22, P7502; HOLMES KH, 1990, BRAIN RES, V506, P227, DOI 10.1016/0006-8993(90)91255-F; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Katoh-Semba R, 1999, NEUROSCI RES, V35, P19, DOI 10.1016/S0168-0102(99)00059-0; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; KRAUS JE, 1994, J NEUROSCI, V14, P4196; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1; MCNAMARA JO, 1987, NEUROTRANSMITTERS EP, P115; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; NADLER JV, 1980, BRAIN RES, V182, P1; Okragly AJ, 1997, EXP NEUROL, V145, P592, DOI 10.1006/exnr.1997.6500; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Saarelainen T, 2001, CELL MOL NEUROBIOL, V21, P429, DOI 10.1023/A:1012775808253; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; SCHWARK WS, 1987, EPILEPSY RES, V1, P63, DOI 10.1016/0920-1211(87)90052-0; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; SUTULA T, 1987, BRAIN RES, V420, P109, DOI 10.1016/0006-8993(87)90245-9; TANAKA T, 1982, ELECTROEN CLIN NEURO, V54, P288, DOI 10.1016/0013-4694(82)90178-X; Tremblay E, 1984, Rev Electroencephalogr Neurophysiol Clin, V14, P241, DOI 10.1016/S0370-4475(84)80011-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	52	226	240	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					31	42		10.1016/j.neuron.2004.06.019	http://dx.doi.org/10.1016/j.neuron.2004.06.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233915	Bronze			2022-12-28	WOS:000222549800005
J	Korzus, E; Rosenfeld, MG; Mayford, M				Korzus, E; Rosenfeld, MG; Mayford, M			CBP histone acetyltransferase activity is a critical component of memory consolidation	NEURON			English	Article							LONG-TERM-MEMORY; RUBINSTEIN-TAYBI-SYNDROME; ELEMENT-BINDING PROTEIN; MEDIATES TRANSCRIPTIONAL ACTIVATION; IMPAIRED RECOGNITION MEMORY; CAMP-RESPONSIVE ELEMENT; GENE-EXPRESSION; SYNAPTIC PLASTICITY; COACTIVATORS P300; NUCLEAR RECEPTORS	The stabilization of learned information into long-term memories requires new gene expression. CREB binding protein (CBP) is a coactivator of transcription that can be independently regulated in neurons. CBP functions both as a platform for recruiting other required components of the transcriptional machinery and as a histone acetyltransferase (HAT) that alters chromatin structure. To dissect the chromatin remodeling versus platform function of CBP or the developmental versus adult role of this gene, we generated transgenic mice that express CBP in which HAT activity is eliminated. Acquisition of new information and short-term memory is spared in these mice, while the stabilization of short-term memory into long-term memory is impaired. The behavioral phenotype is due to an acute requirement for CBP HAT activity in the adult as it is rescued by both suppression of transgene expression or by administration of the histone deacetylase inhibitor Trichostatin A (TSA) in adult animals.	Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Korzus, E (corresponding author), Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA 92037 USA.	ekorzus@ucsd.edu		Mayford, Mark/0000-0002-9001-5024	NIMH NIH HHS [K01 MH01785, K01 MH001785] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001785] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREW RJ, 1980, ADV STUD BEHAV, P337; BACHEVALIER J, 1990, ANN NY ACAD SCI, V608, P457, DOI 10.1111/j.1749-6632.1990.tb48906.x; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Butler LM, 2000, CANCER RES, V60, P5165; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Clark RE, 2000, J NEUROSCI, V20, P8853; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS S, 1992, J NEUROSCI, V12, P21; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HENNEKAM RCM, 1990, AM J MED GENET, P56; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCGAUGH JL, 1972, MEMORY CONSOLIDATION; MCKEE RD, 1993, J EXP PSYCHOL LEARN, V19, P397, DOI 10.1037/0278-7393.19.2.397; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Neely KE, 2002, MOL GENET METAB, V76, P1, DOI 10.1016/S1096-7192(02)00014-8; Nervi C, 2001, CANCER RES, V61, P1247; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, BLOOD, V93, P2771; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Peters M, 2003, J NEUROSCI, V23, P9752; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Squire L. R., 1987, MEMORY BRAIN; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; WORLEY PF, 1990, COLD SH Q B, V55, P213, DOI 10.1101/SQB.1990.055.01.023; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	65	623	663	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2004	42	6					961	972		10.1016/j.neuron.2004.06.002	http://dx.doi.org/10.1016/j.neuron.2004.06.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833HZ	15207240	Bronze, Green Accepted			2022-12-28	WOS:000222329300011
J	Zhou, W; Chung, IB; Liu, ZQ; Goldin, AL; Dong, K				Zhou, W; Chung, IB; Liu, ZQ; Goldin, AL; Dong, K			A voltage-gated calcium-selective channel encoded by a sodium channel-like gene	NEURON			English	Article							NA+-CHANNEL; FUNCTIONAL EXPRESSION; KNOCKDOWN-RESISTANCE; GENOMIC ORGANIZATION; MOLECULAR-CLONING; MEMBRANE-PROTEIN; ALPHA(1) SUBUNIT; ION CHANNELS; FROG-MUSCLE; EVOLUTION	BSC1, which was originally identified by its sequence similarity to voltage-gated Na+ channels, encodes a functional voltage-gated cation channel whose properties differ significantly from Na+ channels. BSC1 has slower kinetics of activation and inactivation than Na+ channels, it is more selective for Ba2+ than for Na+, it is blocked by Cd2+, and Na+ currents through BSC1 are blocked by low concentrations of Ca2+. All of these properties are more similar to voltage-gated Ca2+ channels than to voltage-gated Na+ channels. The selectivity for Ba2+ is partially due to the presence of a glutamate in the pore-forming region of domain III, since replacing that residue with lysine (normally present in voltage-gated Na+ channels) makes the channel more selective for Na+. BSC1 appears to be the prototype of a novel family of invertebrate voltage-dependent cation channels with a close structural and evolutionary relationship to voltage-gated Na+ and Ca2+ channels.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	University of California System; University of California Irvine; Michigan State University; Michigan State University	Goldin, AL (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.	agoldin@uci.edu; dongk@msu.edu	Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026729] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080255, R01 GM080255-01A1] Funding Source: Medline; NINDS NIH HHS [NS26729] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Amat C, 1998, J NEUROPHYSIOL, V80, P2718, DOI 10.1152/jn.1998.80.5.2718; Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Castella Claude, 2001, Invertebrate Neuroscience, V4, P85; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chiamvimonvat N, 1996, J PHYSIOL-LONDON, V491, P51, DOI 10.1113/jphysiol.1996.sp021195; Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3; Eberl DF, 1998, GENETICS, V148, P1159; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; Goldin AL, 2002, J EXP BIOL, V205, P575; GRABNER M, 1994, FEBS LETT, V339, P189, DOI 10.1016/0014-5793(94)80413-3; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1989, Q J EXP PHYSIOL CMS, V74, P785, DOI 10.1113/expphysiol.1989.sp003349; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HILLE B, 1988, CELLULAR MECHANISMS, P511; HILLE B, 1987, SYNAPTIC FUNCTION, P163; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; HONG CS, 1994, J NEUROSCI, V14, P5160; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Jeziorski MC, 1998, J BIOL CHEM, V273, P22792, DOI 10.1074/jbc.273.35.22792; Kimura T, 1997, BIOCHEM BIOPH RES CO, V230, P147, DOI 10.1006/bbrc.1996.5732; Kulkarni NH, 2002, GENETICS, V161, P1507; KURUMA A, 2002, AM J PHYSIOL, V276, pC161; Liu ZQ, 2001, INSECT BIOCHEM MOLEC, V31, P703, DOI 10.1016/S0965-1748(00)00178-8; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Nagahora H, 2000, BIOCHEM BIOPH RES CO, V275, P558, DOI 10.1006/bbrc.2000.3290; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; SALKOFF L, 1987, SCIENCE, V237, P744, DOI 10.1126/science.2441469; Smith LA, 1996, J NEUROSCI, V16, P7868; Smith TJ, 1997, INSECT BIOCHEM MOLEC, V27, P807, DOI 10.1016/S0965-1748(97)00065-9; Spafford JD, 1999, RECEPTOR CHANNEL, V6, P493; STRONG M, 1993, MOL BIOL EVOL, V10, P221; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; Tan JG, 2002, J NEUROSCI, V22, P5300; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSIEN RY, 1983, ANNU REV BIOPHYS BIO, V12, P91, DOI 10.1146/annurev.bb.12.060183.000515; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Watanabe U, 2003, BRAIN RES, V967, P247, DOI 10.1016/S0006-8993(03)02247-9; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; White Gena B., 1998, Invertebrate Neuroscience, V3, P317, DOI 10.1007/BF02577691; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699	48	52	57	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					101	112		10.1016/S0896-6273(04)00148-5	http://dx.doi.org/10.1016/S0896-6273(04)00148-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066268	Green Accepted, Bronze			2022-12-28	WOS:000221458400011
J	Zhu, HT; Luo, LQ				Zhu, HT; Luo, LQ			Diverse functions of N-cadherin in dendritic and axonal terminal arborization of olfactory projection neurons	NEURON			English	Article							REPRESSIBLE CELL MARKER; DROSOPHILA E-CADHERIN; PRECISE CONNECTIONS; WIRING SPECIFICITY; MOSAIC ANALYSIS; ADHESION; RECEPTOR; MAP; BRAIN; REPRESENTATION	The cadherin superfamily of cell adhesion molecules have been proposed to play important roles in determining synaptic specificity in developing nervous systems. We examine the function of N-cadherin in Drosophila second order olfactory projection neurons (PNs), each of which must selectively target their dendrites to one of similar to50 glomeruli. Our results do not support an instructive role for N-cadherin in selecting dendritic targets; rather, N-cadherin is essential for PNs to restrict their dendrites to single glomeruli. Mosaic analyses suggest that N-cadherin mediates dendro-dendritic interactions between PNs and thus contributes to refinement of PN dendrites to single glomeruli. N-cadherin is also essential for the development of PN axon terminal arbors in two distinct central targets: regulating branch stability in the lateral horn and restricting high-order branching in the mushroom body. Although the N-cadherin locus potentially encodes eight alternatively spliced isoforms, transgenic expression of one isoform is sufficient to rescue all phenotypes.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484; DUNINBORKOWSKI OM, 1995, DEV BIOL, V168, P689, DOI 10.1006/dbio.1995.1115; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Keller A, 2003, CURR OPIN NEUROBIOL, V13, P103, DOI 10.1016/S0959-4388(03)00011-4; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Malun D, 1996, J COMP NEUROL, V368, P1, DOI 10.1002/(SICI)1096-9861(19960422)368:1<1::AID-CNE1>3.0.CO;2-7; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Newsome TP, 2000, DEVELOPMENT, V127, P851; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	39	110	113	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 8	2004	42	1					63	75		10.1016/S0896-6273(04)00142-4	http://dx.doi.org/10.1016/S0896-6273(04)00142-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KF	15066265	Bronze			2022-12-28	WOS:000221458400008
J	Karlin, A				Karlin, A			A touching picture of nicotinic binding	NEURON			English	Editorial Material							RECEPTORS; PROTEIN; REVEALS; DOMAIN	The snail acetylcholine binding protein (AChBP) is homologous to the extracellular domains of the nicotinic ACh receptors. In this issue of Neuron, Celie et al. show how the crystal structures of AChBP in complexes with carbamylcholine and nicotine reveal the basis for agonist recognition by ACh receptors.	Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA	Columbia University	Karlin, A (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.			KARLIN, ARTHUR/0000-0002-4813-752X				Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A., 1969, J GEN PHYSIOL, V54, P245; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	9	13	13	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 25	2004	41	6					841	842		10.1016/S0896-6273(04)00151-5	http://dx.doi.org/10.1016/S0896-6273(04)00151-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046715	Bronze			2022-12-28	WOS:000221458300002
J	Singer, T; Kiebel, SJ; Winston, JS; Dolan, RJ; Frith, CD				Singer, T; Kiebel, SJ; Winston, JS; Dolan, RJ; Frith, CD			Brain responses to the acquired moral status of faces	NEURON			English	Article							EVENT-RELATED FMRI; HUMAN AMYGDALA; NEURAL RESPONSES; ORBITOFRONTAL CORTEX; FACIAL EXPRESSIONS; DIFFERENTIAL RESPONSE; INDIRECT RECIPROCITY; SOCIAL COGNITION; ULTIMATUM GAME; REWARD	We examined whether neural responses associated with judgments of socially relevant aspects of the human face extend to stimuli that acquire their significance through learning in a meaningful interactive context, specifically reciprocal cooperation. During fMRI, subjects made gender judgments on faces of people who had been introduced as fair (cooperators) or unfair (defector) players through repeated play of a sequential Prisoner's Dilemma game. To manipulate moral responsibility, players were introduced as either intentional or nonintentional agents. Our behavioral (likebility ratings and memory performance) as well as our imaging data confirm the saliency of social fairness for human interactions. Relative to neutral faces, faces of intentional cooperators engendered increased activity in left amygdala, bilateral insula, fusiform gyrus, STS, and reward-related areas. Our data indicate that rapid learning regarding the moral status of others is expressed in altered neural activity within a system associated with social cognition.	UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London	Singer, T (corresponding author), UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, Mortimer St, London WC1N 3BG, England.	t.singer@fil.ion.ucl.ac.uk	Frith, Chris D/A-2171-2009; Kiebel, Stefan J/B-1551-2009; Winston, Joel/F-6180-2010	Frith, Chris D/0000-0002-8665-0690; Kiebel, Stefan J/0000-0002-5052-1117; Winston, Joel/0000-0002-3957-0612; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alexander R., 1987, BIOL MORAL SYSTEMS; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bachevailer J, 2000, AMYGDALA FUNCTIONAL, P509; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Buchel C, 1999, J NEUROSCI, V19, P10869; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Churchland PS, 2002, SCIENCE, V296, P308, DOI 10.1126/science.1070564; Cosmides L, 2000, NEW COGNITIVE NEUROS, P1259; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; CRITCHLEY HD, 2004, IN PRESS NAT NEUROSC; DAMASIO AR, 1994, DESCARTES ERROR; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LeDoux J., 1998, EMOTIONAL BRAIN; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mealey L, 1996, ETHOL SOCIOBIOL, V17, P119, DOI 10.1016/0162-3095(95)00131-X; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Opfer JE, 2002, COGNITION, V86, P97, DOI 10.1016/S0010-0277(02)00171-3; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2001, NAT NEUROSCI, V4, P775, DOI 10.1038/90467; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; ROLLS ET, 1997, NEUROIMAGE, V5, P199; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; TRIVERS R, 1971, Q REV BIOL, V46, P39; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Whalen PJ, 1998, J NEUROSCI, V18, P411; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	67	283	289	3	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 19	2004	41	4					653	662		10.1016/S0896-6273(04)00014-5	http://dx.doi.org/10.1016/S0896-6273(04)00014-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980212	Green Published, Bronze			2022-12-28	WOS:000221458100016
J	Zhou, W; Qian, Y; Kunjilwar, K; Pfaffinger, PJ; Choe, S				Zhou, W; Qian, Y; Kunjilwar, K; Pfaffinger, PJ; Choe, S			Structural insights into the functional interaction of KChIP1 with Shal-type K+ channels	NEURON			English	Article							NEURONAL CALCIUM SENSOR-1; GATED POTASSIUM CHANNEL; PHOSPHATIDYLINOSITOL 4-KINASE ISOFORM; DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BINDING PROTEINS; CALMODULIN; DOMAIN; KV4	Four Kv channel-interacting proteins (KChlP1 through KChlP4) interact directly with the N-terminal domain of three Shal-type voltage-gated potassium channels (Kv4.1, Kv4.2, and Kv4.3) to modulate cell surface expression and function of Kv4 channels. Here we report a 2.0 A crystal structure of the core domain of KChIP1 (KChlP1*) in complex with the N-terminal fragment of Kv4.2 (Kv4.2N30). The complex reveals a clam-shaped dimeric assembly. Four EF-hands from each KChlP1 form each shell of the clam. The N-terminal end of Kv4.2 forming an alpha helix (alpha1) and the C-terminal alpha helix (H10) of KChlP1 are enclosed nearly coaxially by these shells. As a result, the H10 of KChlP1 and all of Kv4.2 mediate interactions between these two molecules, structurally reminiscent of the interactions between calmodulin and its target peptides. Site-specific mutagenesis combined with functional characterization shows that those interactions mediated by alpha1 and H10 are essential to the modulation of Kv4.2 by KChlPs.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Baylor College of Medicine; Salk Institute; University of California System; University of California San Diego	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.	ppfaff@cns.neusc.bcm.tmc.edu; choe@salk.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444, R01NS031583] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NIGMS NIH HHS [GM56653] Funding Source: Medline; NINDS NIH HHS [R01 NS31583, P01 NS37444] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Huttner IG, 2003, J BIOL CHEM, V278, P4862, DOI 10.1074/jbc.M207920200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; KIM LA, 2003, IN PRESS J BIOL CHEM, DOI DOI 10.1074/jbc.m311332200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Li M, 2000, NAT NEUROSCI, V3, P202, DOI 10.1038/72898; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Malin SA, 2001, J NEUROSCI, V21, P8004, DOI 10.1523/JNEUROSCI.21-20-08004.2001; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; O'Callaghan DW, 2003, BIOCHEM SOC T, V31, P963; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Ren XM, 2003, J BIOL CHEM, V278, P43564, DOI 10.1074/jbc.M302337200; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schrader LA, 2002, J NEUROSCI, V22, P10123; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Yap Kyoko L, 2002, Methods Mol Biol, V173, P317; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	57	105	112	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					573	586		10.1016/S0896-6273(04)00045-5	http://dx.doi.org/10.1016/S0896-6273(04)00045-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980206	Bronze			2022-12-28	WOS:000221458100010
J	Appel, B; Eisen, JS				Appel, B; Eisen, JS			Retinoids run rampant: Multiple roles during spinal cord and motor neuron development	NEURON			English	Review							TRANSCRIPTIONAL CODES; PRIMARY NEUROGENESIS; CHICK-EMBRYO; ACID; IDENTITY; DIFFERENTIATION; FGF; SPECIFICATION; SIGNALS	Learning how the incredible diversity of neurons in the vertebrate central nervous system (CNS) is generated is a central focus of developmental neuroscience. Three studies in the September 25, 2003, issue of Neuron bring us closer to this goal by revealing how the interplay between Fibroblast Growth Factor (FGF), retinoic acid (RA), and Sonic hedgehog (Shh) signaling regulate progression of spinal cord progenitor cells through various phases of development and specify particular types of spinal motor neurons (MNs).	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Vanderbilt University; University of Oregon	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	b.appel@vanderbilt.edu; eisen@uoneuro.uoregon.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672				Begemann G, 2001, BIOESSAYS, V23, P981, DOI 10.1002/bies.1142; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; DUIDATO S, 2003, DEVELOPMENT, V130, P2981; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; Franco PG, 1999, DEVELOPMENT, V126, P4257; Guidato S, 2003, MOL CELL NEUROSCI, V23, P81, DOI 10.1016/S1044-7431(03)00020-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mathis L, 2000, DEVELOPMENT, V127, P1277; Mercader N, 2000, DEVELOPMENT, V127, P3961; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ohuchi H, 1999, CELL TISSUE RES, V296, P45, DOI 10.1007/s004410051265; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Sharpe C, 2000, MECH DEVELOP, V91, P69, DOI 10.1016/S0925-4773(99)00273-7; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487	17	53	57	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					461	464		10.1016/S0896-6273(03)00688-3	http://dx.doi.org/10.1016/S0896-6273(03)00688-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642271	Bronze			2022-12-28	WOS:000186379000006
J	Lucas, P; Ukhanov, K; Leinders-Zufall, T; Zufall, F				Lucas, P; Ukhanov, K; Leinders-Zufall, T; Zufall, F			A diacylglycerol-gated cation channel in vomeronasal neuron dendrites is impaired in TRPC2 mutant mice: Mechanism of pheromone transduction	NEURON			English	Article							RECEPTOR POTENTIAL CHANNEL; MOUSE TRANSIENT RECEPTOR; SENSITIVE CHANNELS; SENSORY NEURONS; CALCIUM TRANSIENTS; STORE DEPLETION; ION CHANNELS; FATTY-ACIDS; CA2+ ENTRY; CYCLIC-GMP	Vomeronasal sensory neurons play a crucial role in detecting pheromones, but the chernoelectrical transduction mechanism remains unclear and controversial. A major barrier to the resolution of this question has been the lack of an activation mechanism of a key transduction component, the TRPC2 channel. We have identified a Ca2+-permbable cation channel in vomeronasal neuron dendrite's that is gated by the lipid messenger diacylglycerol DAG), independently of Ca2+ or protein kinase C. We demonstrate that ablation of the TRPC2 gene causes a severe deficit in the DAG-gated channel, indicating that TRPC2 encodes a principal subunit of this channel and that the primary electrical response to pheromones depends on DAG but not Ins(1,4,5)P-3, Ca2+ stores, or arachidonic acid. Thus, a previously unanticipated mechanism involving direct channel opening by DAG underlies the transduction of sensory cues in the accessory olfactory system.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Leinders-Zufall, T (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	tlein001@umaryland.edu; fzufa001@umaryland.edu	Leinders-Zufall, Trese/S-3664-2019; Leinders-Zufall, Trese/B-4103-2009; Lucas, Philippe/I-6020-2016; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Lucas, Philippe/0000-0003-2166-8248				Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brann JH, 2002, J NEUROCHEM, V83, P1452, DOI 10.1046/j.1471-4159.2002.01266.x; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Cinelli AR, 2002, J NEUROPHYSIOL, V87, P1449, DOI 10.1152/jn.00651.2001; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; Gjerstad J, 2003, NEUROSCIENCE, V119, P193, DOI 10.1016/S0306-4522(03)00115-5; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hofmann T, 2000, BIOCHEM J, V351, P115, DOI 10.1042/0264-6021:3510115; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Inamura I, 1999, J PHYSIOL-LONDON, V517, P731, DOI 10.1111/j.1469-7793.1999.0731s.x; Inamura K, 2000, EUR J NEUROSCI, V12, P3529, DOI 10.1046/j.1460-9568.2000.00233.x; Inamura K, 1997, NEUROSCI LETT, V233, P129, DOI 10.1016/S0304-3940(97)00655-1; Inamura K, 1997, CHEM SENSES, V22, P93, DOI 10.1093/chemse/22.1.93; Johnston RE, 1998, ANN NY ACAD SCI, V855, P333, DOI 10.1111/j.1749-6632.1998.tb10592.x; Keverne EB, 2002, CURR BIOL, V12, pR807, DOI 10.1016/S0960-9822(02)01314-3; Kiselyov K, 1999, TRENDS NEUROSCI, V22, P334, DOI 10.1016/S0166-2236(99)01426-5; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Kroner C, 1996, NEUROREPORT, V7, P2989, DOI 10.1097/00001756-199611250-00038; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Liman ER, 2003, J PHYSIOL-LONDON, V548, P777, DOI 10.1113/jphysiol.2002.037119; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; LUO YQ, 1994, J BIOL CHEM, V269, P16867; Menco BPM, 2001, J COMP NEUROL, V438, P468, DOI 10.1002/cne.1329; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Norlin EM, 2003, CURR BIOL, V13, P1214, DOI 10.1016/S0960-9822(03)00452-4; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Sasaki K, 1999, BRAIN RES, V823, P161, DOI 10.1016/S0006-8993(99)01164-6; Spehr M, 2002, J NEUROSCI, V22, P8429; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TANIGUCHI M, 1995, NEUROSCI LETT, V188, P5, DOI 10.1016/0304-3940(95)11379-B; Taniguchi M, 2000, CHEM SENSES, V25, P67, DOI 10.1093/chemse/25.1.67; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Trotier D, 1998, CHEM SENSES, V23, P49, DOI 10.1093/chemse/23.1.49; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Wekesa KS, 1997, ENDOCRINOLOGY, V138, P3497, DOI 10.1210/en.138.8.3497; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yildirim E, 2003, P NATL ACAD SCI USA, V100, P2220, DOI 10.1073/pnas.0438036100; YOUNES A, 1992, J BIOL CHEM, V267, P842; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; ZUFALL F, 1991, J NEUROSCI, V11, P3573; ZUFALL F, 1991, P NATL ACAD SCI USA, V88, P8520, DOI 10.1073/pnas.88.19.8520; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	66	238	246	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 30	2003	40	3					551	561		10.1016/S0896-6273(03)00675-5	http://dx.doi.org/10.1016/S0896-6273(03)00675-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642279	Bronze			2022-12-28	WOS:000186379000014
J	Quick, MW				Quick, MW			Regulating the conducting states of a mammalian serotonin transporter	NEURON			English	Article							BIOGENIC-AMINE TRANSPORTERS; SYNTAXIN 1A; DOPAMINE TRANSPORTER; EXPRESSION; CHANNEL; VESICLE; PROTEIN; NEURONS; EXCITABILITY; CONDUCTANCES	Serotonin transporters (SERTs), sites of psychostimulant action, display multiple conducting states in expression systems. These include a substrate-independent transient conductance, two separate substrate-independent leak conductances associated with Na+ and H+, and a substrate-dependent conductance of variable stoichiometry, which exceeds that predicted from electroneutral substrate transport. The present data show that the SNARE protein syntaxin 1A binds the N-terminal tail of SERT, and this interaction regulates two SERT-conducting states. First, substrate-induced currents are absent because Na+ flux becomes strictly coupled to 5HT transport. Second, Na+-mediated leak currents are eliminated. These two SERT-conducting states are present endogenously in thalamocortical neurons, act to depolarize the membrane potential, and are modulated by molecules that disrupt SERT and syntaxin 1A interactions. These data show that protein interactions govern SERT activity and suggest that both cell excitability and psychostimulant-mediated effects will be dependent upon the state of association among SERT and its interacting partners.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Quick, MW (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way,HNB 228, Los Angeles, CA 90089 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010509, R01DA010509] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10509] Funding Source: Medline; NIMH NIH HHS [MH61468] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Cao YW, 1997, J NEUROSCI, V17, P2257; Cao YW, 1998, J NEUROSCI, V18, P7739; Chang YC, 1999, NAT NEUROSCI, V2, P219, DOI 10.1038/6313; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fleckenstein AE, 2000, EUR J PHARMACOL, V406, P1, DOI 10.1016/S0014-2999(00)00639-7; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; GU H, 1994, J BIOL CHEM, V269, P7124; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MANN CD, 1992, J NEUROCHEM, V59, P1856, DOI 10.1111/j.1471-4159.1992.tb11020.x; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Quick MW, 2002, P NATL ACAD SCI USA, V99, P5686, DOI 10.1073/pnas.082712899; Quick MW, 2002, INT J DEV NEUROSCI, V20, P219, DOI 10.1016/S0736-5748(02)00021-7; QUICK MW, 1994, METH NEUROSCI, V19, P261; REITH MEA, 1989, BIOCHEM PHARMACOL, V38, P2091, DOI 10.1016/0006-2952(89)90062-2; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Sonders MS, 1997, J NEUROSCI, V17, P960; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sung U, 2003, J NEUROSCI, V23, P1697; WHITWORTH TL, 2002, J NEUROSCI RC, V192, P1	37	120	122	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					537	549		10.1016/S0896-6273(03)00605-6	http://dx.doi.org/10.1016/S0896-6273(03)00605-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642278	Bronze			2022-12-28	WOS:000186379000013
